Citrus Sinensis ID: 014909
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 416 | 2.2.26 [Sep-21-2011] | |||||||
| Q2V452 | 441 | CBL-interacting serine/th | yes | no | 0.987 | 0.931 | 0.858 | 0.0 | |
| Q2QY53 | 438 | CBL-interacting protein k | yes | no | 0.995 | 0.945 | 0.850 | 0.0 | |
| Q2RAX3 | 454 | CBL-interacting protein k | yes | no | 0.995 | 0.911 | 0.819 | 0.0 | |
| Q84VQ3 | 439 | CBL-interacting serine/th | no | no | 0.997 | 0.945 | 0.797 | 0.0 | |
| Q6X4A2 | 449 | CBL-interacting protein k | no | no | 0.990 | 0.917 | 0.769 | 0.0 | |
| Q8LIG4 | 445 | CBL-interacting protein k | no | no | 0.987 | 0.923 | 0.710 | 0.0 | |
| Q93VD3 | 482 | CBL-interacting serine/th | no | no | 0.973 | 0.840 | 0.735 | 0.0 | |
| Q6ZLP5 | 450 | CBL-interacting protein k | no | no | 0.995 | 0.92 | 0.704 | 0.0 | |
| Q9MAM1 | 447 | CBL-interacting serine/th | no | no | 0.992 | 0.923 | 0.692 | 1e-175 | |
| Q10SC8 | 456 | CBL-interacting protein k | no | no | 0.973 | 0.888 | 0.703 | 1e-173 |
| >sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 758 bits (1958), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/411 (85%), Positives = 388/411 (94%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
++KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI+RE+AT
Sbjct: 6 QVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIAT 65
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
MKL+KHPNVV+LYEVM SKTKIFI+LE+VTGGELFDKIVN GRMKEDEARRYFQQLI+AV
Sbjct: 66 MKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAV 125
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
DYCHSRGVYHRDLKPENLLLD+YGNLK+SDFGLSALSQQVRDDGLLHT+CGTPNYVAPEV
Sbjct: 126 DYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEV 185
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244
LNDRGYDG+TAD+WSCGV+L+VLLAGYLPFDDSNLMNLYKKIS+ EF CPPWLS A KL
Sbjct: 186 LNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKL 245
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQK 304
I RILDPNPMTR+T E+ EDEWFKKDYKPPVFEE+ D+N+DD++AVFKDSEEH VTE++
Sbjct: 246 ITRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTEKR 305
Query: 305 EEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGFD 364
EEQP A+NAFE+IS+S+GLNL NLFD EQ+FKRETR T R ANEII KIEEAAKPLGFD
Sbjct: 306 EEQPAAINAFEIISMSRGLNLENLFDPEQEFKRETRITLRGGANEIIEKIEEAAKPLGFD 365
Query: 365 VHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
V KKNYKMRLEN+KAGRKGNLNVATE+FQVAPSLHMV+V K+KGDTLEFHK
Sbjct: 366 VQKKNYKMRLENVKAGRKGNLNVATEIFQVAPSLHMVQVSKSKGDTLEFHK 416
|
Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q2QY53|CIPKW_ORYSJ CBL-interacting protein kinase 32 OS=Oryza sativa subsp. japonica GN=CIPK32 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 749 bits (1935), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/415 (85%), Positives = 387/415 (93%), Gaps = 1/415 (0%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MS K+KRRVGKYE+GRTIGEGTFAKVKFAR++ETG+PVA+KILDKEKVLKHKM EQIKR
Sbjct: 1 MSTTKVKRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E++TMKL+KHPNVVR+YEVMGSKTKI+IVLE+VTGGELFD IVNHGRM+EDEARRYFQQL
Sbjct: 61 EISTMKLIKHPNVVRIYEVMGSKTKIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLD+YGNLKVSDFGLSALSQQ++DDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVL D+GYDG+ ADLWSCGVILFVLLAGYLPF+DSNLM LYKKIS AEFT PPW SF
Sbjct: 181 APEVLEDQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFP 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
A++L+ RILDPNPMTR+TIPEILEDEWFKK YK P F+EK DT LDDV AVF DSEEHHV
Sbjct: 241 AKRLLTRILDPNPMTRVTIPEILEDEWFKKGYKRPEFDEKYDTTLDDVYAVFNDSEEHHV 300
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKP 360
TE+KEE P A+NAFELIS+S GLNLGNLFD+EQ+FKRETRFTS+CP EI+ KIEEAAKP
Sbjct: 301 TEKKEE-PEALNAFELISMSAGLNLGNLFDSEQEFKRETRFTSKCPPKEIVRKIEEAAKP 359
Query: 361 LGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
LGFDV KKNYK+RLE +KAGRKGNLNVATE+ QVAPSLHMVEVRKAKGDTLEFHK
Sbjct: 360 LGFDVQKKNYKLRLEKVKAGRKGNLNVATEILQVAPSLHMVEVRKAKGDTLEFHK 414
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RAX3|CIPKX_ORYSJ CBL-interacting protein kinase 33 OS=Oryza sativa subsp. japonica GN=CIPK33 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 738 bits (1906), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/431 (81%), Positives = 387/431 (89%), Gaps = 17/431 (3%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MS K+KRRVGKYE+GRTIGEGTFAKVKFAR++ETG+PVA+KILDKEKVLKHKM EQIKR
Sbjct: 1 MSTTKVKRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E++TMKL+KHPNVVR+YEVMGSKT I+IVLE+VTGGELFD IVNHGRM+EDEARRYFQQL
Sbjct: 61 EISTMKLIKHPNVVRIYEVMGSKTNIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLD+YGNLKVSDFGLSALSQQ++DDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVL D+GYDG+ ADLWSCGVILFVLLAGYLPF+DSNLM LYKKIS AEFT PPW SF
Sbjct: 181 APEVLEDQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFP 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
A++L+ RILDPNPMTRITIPEILEDEWFKK YK P F+EK DT LDDV+AVF DSEEHHV
Sbjct: 241 AKRLLTRILDPNPMTRITIPEILEDEWFKKGYKRPEFDEKYDTTLDDVDAVFNDSEEHHV 300
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKP 360
TE+KEE P A+NAFELIS+S GLNLGNLFD+EQ+FKRETRFTS+CP EI+ KIEEAAKP
Sbjct: 301 TEKKEE-PEALNAFELISMSAGLNLGNLFDSEQEFKRETRFTSKCPPKEIVRKIEEAAKP 359
Query: 361 LGFDVHKKNY----------------KMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVR 404
LGFDV KKNY K+RLE +KAGRKGNLNVATE+ QVAPSLHMVEVR
Sbjct: 360 LGFDVQKKNYKICSPCLTTICMNIPFKLRLEKVKAGRKGNLNVATEILQVAPSLHMVEVR 419
Query: 405 KAKGDTLEFHK 415
KAKGDTLEFHK
Sbjct: 420 KAKGDTLEFHK 430
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q84VQ3|CIPKQ_ARATH CBL-interacting serine/threonine-protein kinase 26 OS=Arabidopsis thaliana GN=CIPK26 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 712 bits (1838), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 331/415 (79%), Positives = 378/415 (91%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M++PK++RRVGKYEVG+T+G+GTFAKV+ A N+ETGE VALKILDKEKVLKHKMAEQI+R
Sbjct: 1 MNRPKVQRRVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ TMKL+ HPNVVRLYEV+ SKTKI+IVLEF TGGELFDKIV+ GR+KE+ AR+YFQQL
Sbjct: 61 EICTMKLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDA GNLKVSDFGLSALS+QVR DGLLHT CGTPNY
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYA 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLND+GYDG+TADLWSCGVILFVLLAGYLPF+DSNLM LYKKI A E+ CPPWLS
Sbjct: 181 APEVLNDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
A+ LI RILDPNPMTRITIPE+L D WFKK+YKP VFEEK++ NLDDV+AVFKDSEEHHV
Sbjct: 241 AKNLIVRILDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHV 300
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKP 360
TE+KEEQP +MNAFELIS+S+ L+LGNLF+ E+ FKRETRF ++ AN+++ KIEEA+KP
Sbjct: 301 TEKKEEQPTSMNAFELISMSRALDLGNLFEEEEGFKRETRFAAKGAANDLVQKIEEASKP 360
Query: 361 LGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
LGFD+ KKNYKMRLEN+ AGRKGNL VATE+FQV+PSLHM+EVRK KGDTLEFHK
Sbjct: 361 LGFDIQKKNYKMRLENVTAGRKGNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHK 415
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6X4A2|CIPKV_ORYSJ CBL-interacting protein kinase 31 OS=Oryza sativa subsp. japonica GN=CIPK31 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 687 bits (1774), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 317/412 (76%), Positives = 371/412 (90%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA 63
PK+KRRVGKYE+GRTIGEGTFAKV+FA+N+E EPVA+KILDKEKV KH++ EQI+RE+
Sbjct: 11 PKVKRRVGKYELGRTIGEGTFAKVRFAKNTENDEPVAIKILDKEKVQKHRLVEQIRREIC 70
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINA 123
TMKLVKHPNVVRL+EVMGSK +IFIVLE+VTGGELF+ I +GR+KE+EAR+YFQQLINA
Sbjct: 71 TMKLVKHPNVVRLFEVMGSKARIFIVLEYVTGGELFEIIATNGRLKEEEARKYFQQLINA 130
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
VDYCHSRGVYHRDLK ENLLLDA GNLKVSDFGLSAL++QV+ DGLLHTTCGTPNYVAPE
Sbjct: 131 VDYCHSRGVYHRDLKLENLLLDASGNLKVSDFGLSALTEQVKADGLLHTTCGTPNYVAPE 190
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243
V+ DRGYDG+ AD+WSCGVIL+VLLAG+LPF+D N++ LYKKIS A+FTCP W S A+K
Sbjct: 191 VIEDRGYDGAAADIWSCGVILYVLLAGFLPFEDDNIIALYKKISEAQFTCPSWFSTGAKK 250
Query: 244 LIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQ 303
LI RILDPNP TRITI +ILED WFKK YKPPVF+EK +T+ DDV+A F DSE+ HV E+
Sbjct: 251 LITRILDPNPTTRITISQILEDPWFKKGYKPPVFDEKYETSFDDVDAAFGDSEDRHVKEE 310
Query: 304 KEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGF 363
E+QP +MNAFELISL++ LNL NLF+A++++KRETRFTS+CP EII KIEEAAKPLGF
Sbjct: 311 TEDQPTSMNAFELISLNQALNLDNLFEAKKEYKRETRFTSQCPPKEIITKIEEAAKPLGF 370
Query: 364 DVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
D+ KKNYKMR+EN+KAGRKGNLNVATEVFQVAPSLH+VE++KAKGDTLEF K
Sbjct: 371 DIQKKNYKMRMENLKAGRKGNLNVATEVFQVAPSLHVVELKKAKGDTLEFQK 422
|
Involved in cold stress tolerance. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LIG4|CIPK3_ORYSJ CBL-interacting protein kinase 3 OS=Oryza sativa subsp. japonica GN=CIPK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 635 bits (1638), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 292/411 (71%), Positives = 352/411 (85%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
K++R +GKYE+GR IG+GTFAKV+FA+N ETG+ VA+KILDK KV KH++ EQI+RE+ T
Sbjct: 11 KVRRCLGKYELGRAIGQGTFAKVRFAKNMETGDHVAIKILDKAKVQKHRLVEQIRREICT 70
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
MKL++HPNVV L+EVMGSKT+IFIVLE+V GGEL D I GR+KEDEAR+YFQQLINAV
Sbjct: 71 MKLIQHPNVVHLHEVMGSKTRIFIVLEYVMGGELHDIIATSGRLKEDEARKYFQQLINAV 130
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
DYCHSRGVYHRDLK ENLLLD GN+KVSDFGLSA+S+QV+ DGLLHTTCGTPNYVAPEV
Sbjct: 131 DYCHSRGVYHRDLKLENLLLDTAGNIKVSDFGLSAISEQVKADGLLHTTCGTPNYVAPEV 190
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244
+ D+GYDG+ ADLWSCGVILFVLLAGYLPF+D N+++LY KIS A+FTCP W S A++L
Sbjct: 191 IEDKGYDGALADLWSCGVILFVLLAGYLPFEDENIVSLYNKISGAQFTCPSWFSAEAKRL 250
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQK 304
IARILDPNP TRIT ++L+D+WFKK Y+ PVF++K DV F DSEE HV E
Sbjct: 251 IARILDPNPATRITTSQVLQDQWFKKGYESPVFDDKYYPYFHDVYDAFGDSEEKHVKEAM 310
Query: 305 EEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGFD 364
EEQP MNAFELISL+KGLNL N F++++ +KRETRFTS+CP EIIN+IEEAA LGF+
Sbjct: 311 EEQPTLMNAFELISLNKGLNLDNFFESDKKYKRETRFTSQCPPKEIINRIEEAANLLGFN 370
Query: 365 VHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
+ K+NY+MR+EN+K GRKG+LN+ATEVFQVAPSLH+VE++KAKGDTLEF K
Sbjct: 371 IQKRNYRMRMENIKEGRKGHLNIATEVFQVAPSLHVVELKKAKGDTLEFQK 421
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93VD3|CIPKN_ARATH CBL-interacting serine/threonine-protein kinase 23 OS=Arabidopsis thaliana GN=CIPK23 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 635 bits (1637), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 303/412 (73%), Positives = 352/412 (85%), Gaps = 7/412 (1%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
VGKYE+GRT+GEGTFAKVKFARN E G+ VA+K++DKEKVLK+KM QIKRE++TMKL+K
Sbjct: 28 VGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLIK 87
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
HPNV+R++EVM SKTKI+ VLEFVTGGELFDKI ++GR+KEDEAR+YFQQLINAVDYCHS
Sbjct: 88 HPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHS 147
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
RGVYHRDLKPENLLLDA G LKVSDFGLSAL QQVR+DGLLHTTCGTPNYVAPEV+N++G
Sbjct: 148 RGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKG 207
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249
YDG+ ADLWSCGVILFVL+AGYLPF+DSNL +LYKKI AEFTCPPW S +A+KLI RIL
Sbjct: 208 YDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRIL 267
Query: 250 DPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHH--VTEQKEE- 306
DPNP TRIT E++E+EWFKK YK P FE D +LDDV+A+F DS E V E++EE
Sbjct: 268 DPNPATRITFAEVIENEWFKKGYKAPKFEN-ADVSLDDVDAIFDDSGESKNLVVERREEG 326
Query: 307 --QPVAMNAFELISLSKGLNLGNLFDAEQDF-KRETRFTSRCPANEIINKIEEAAKPLGF 363
PV MNAFELIS S+GLNLG+LF+ + KR+TRFTS+ ANEI+ KIE AA P+GF
Sbjct: 327 LKTPVTMNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAPMGF 386
Query: 364 DVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
DV NYKM+L K+GRKG L VATEVFQVAPSL+MVE+RK+ GDTLEFHK
Sbjct: 387 DVKTNNYKMKLTGEKSGRKGQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHK 438
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein leads to activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1 in low K(+) condition, in response to calcium signaling and during the stomatal opening regulation by monitoring the turgor pressure in guard cells. In response to low nitrate concentration, phosphorylates NRT1.1, switching it from a low-affinity nitrate transporter to a high-affinity transporter. Confers tolerance to low potassium conditions. Involved in drought sensitivity and leaf transpiration. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 634 bits (1635), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 295/419 (70%), Positives = 359/419 (85%), Gaps = 5/419 (1%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MS + RVG+YE+GRT+GEGTFAKVKFARN+++GE VA+KILDK+KVLKHKM QIKR
Sbjct: 1 MSVSGGRTRVGRYELGRTLGEGTFAKVKFARNADSGENVAIKILDKDKVLKHKMIAQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E++TMKL++HPNV+R++EVM SKTKI+IV+E VTGGELFDKI + GR+KED+AR+YFQQL
Sbjct: 61 EISTMKLIRHPNVIRMHEVMASKTKIYIVMELVTGGELFDKIASRGRLKEDDARKYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDA G LKVSDFGLSALSQQVR+DGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDASGTLKVSDFGLSALSQQVREDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEV+N++GYDG+ ADLWSCGVILFVL+AGYLPF+DSNLM+LYKKI A+F+CP W S +
Sbjct: 181 APEVINNKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLMSLYKKIFKADFSCPSWFSTS 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDS--EEH 298
A+KLI +ILDPNP TRITI E++ +EWFKK Y+PP F E D NLDD+ ++F +S +
Sbjct: 241 AKKLIKKILDPNPSTRITIAELINNEWFKKGYQPPRF-ETADVNLDDINSIFNESGDQTQ 299
Query: 299 HVTEQKEEQPVAMNAFELISLSKGLNLGNLFD--AEQDFKRETRFTSRCPANEIINKIEE 356
V E++EE+P MNAFELIS S+GLNLG LF+ ++ KRETRF SR PANEI++KIE
Sbjct: 300 LVVERREERPSVMNAFELISTSQGLNLGTLFEKQSQGSVKRETRFASRLPANEILSKIEA 359
Query: 357 AAKPLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
AA P+GF+V K+NYK++L+ GRKG L +ATEVF+V PSL+MVE+RK+ GDTLEFHK
Sbjct: 360 AAGPMGFNVQKRNYKLKLQGENPGRKGQLAIATEVFEVTPSLYMVELRKSNGDTLEFHK 418
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9MAM1|CIPK9_ARATH CBL-interacting serine/threonine-protein kinase 9 OS=Arabidopsis thaliana GN=CIPK9 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 614 bits (1583), Expect = e-175, Method: Compositional matrix adjust.
Identities = 288/416 (69%), Positives = 354/416 (85%), Gaps = 3/416 (0%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ P + RVG YE+GRT+GEG+FAKVK+A+N+ TG+ A+KILD+EKV +HKM EQ+KRE
Sbjct: 8 ATPASRTRVGNYEMGRTLGEGSFAKVKYAKNTVTGDQAAIKILDREKVFRHKMVEQLKRE 67
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
++TMKL+KHPNVV + EVM SKTKI+IVLE V GGELFDKI GR+KEDEARRYFQQLI
Sbjct: 68 ISTMKLIKHPNVVEIIEVMASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRYFQQLI 127
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
NAVDYCHSRGVYHRDLKPENL+LDA G LKVSDFGLSA S+QVR+DGLLHT CGTPNYVA
Sbjct: 128 NAVDYCHSRGVYHRDLKPENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGTPNYVA 187
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PEVL+D+GYDG+ AD+WSCGVILFVL+AGYLPFD+ NLM LYK+I AEF+CPPW S A
Sbjct: 188 PEVLSDKGYDGAAADVWSCGVILFVLMAGYLPFDEPNLMTLYKRICKAEFSCPPWFSQGA 247
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVF-EEKKDTNLDDVEAVFKDSEEHHV 300
+++I RIL+PNP+TRI+I E+LEDEWFKK YKPP F ++ +D +DDV+A F +S+E V
Sbjct: 248 KRVIKRILEPNPITRISIAELLEDEWFKKGYKPPSFDQDDEDITIDDVDAAFSNSKECLV 307
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAE-QDFKRETRFTSRCPANEIINKIEEAAK 359
TE+K E+PV+MNAFELIS S +L NLF+ + Q K+ETRFTS+ A+EI++K+EE AK
Sbjct: 308 TEKK-EKPVSMNAFELISSSSEFSLENLFEKQAQLVKKETRFTSQRSASEIMSKMEETAK 366
Query: 360 PLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
PLGF+V K NYK++++ K+GRKG L+VATEVF+VAPSLH+VE+RK GDTLEFHK
Sbjct: 367 PLGFNVRKDNYKIKMKGDKSGRKGQLSVATEVFEVAPSLHVVELRKTGGDTLEFHK 422
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10SC8|CIPK9_ORYSJ CBL-interacting protein kinase 9 OS=Oryza sativa subsp. japonica GN=CIPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 608 bits (1569), Expect = e-173, Method: Compositional matrix adjust.
Identities = 287/408 (70%), Positives = 343/408 (84%), Gaps = 3/408 (0%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
RVG+YE+G+TIGEG+FAKVK AR++ TG+ +A+K+LD+ VL+HKM EQIKRE++TMKL+
Sbjct: 23 RVGRYELGKTIGEGSFAKVKVARDTRTGDTLAIKVLDRNHVLRHKMVEQIKREISTMKLI 82
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
KHPNVV+L+EVM SK+KI++VLE+V GGELFDKIVN GR+ EDEARRYF QLINAVDYCH
Sbjct: 83 KHPNVVQLHEVMASKSKIYMVLEYVDGGELFDKIVNSGRLGEDEARRYFHQLINAVDYCH 142
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
SRGVYHRDLKPENLLLD++G LKVSDFGLSA + Q ++DGLLHT CGTPNYVAPEVL D+
Sbjct: 143 SRGVYHRDLKPENLLLDSHGALKVSDFGLSAFAPQTKEDGLLHTACGTPNYVAPEVLADK 202
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248
GYDG AD+WSCG+ILFVL+AGYLPFDD NLM LYK I A+ +CP W S A+K I RI
Sbjct: 203 GYDGMAADVWSCGIILFVLMAGYLPFDDPNLMTLYKLICKAKVSCPHWFSSGAKKFIKRI 262
Query: 249 LDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQP 308
LDPNP TRITI +ILED+WFKKDYKPP+FE+ +D +LDDV+A F SEE+ V E K E+P
Sbjct: 263 LDPNPCTRITIAQILEDDWFKKDYKPPLFEQGEDVSLDDVDAAFDCSEENLVAE-KREKP 321
Query: 309 VAMNAFELISLSKGLNLGNLFDAEQ--DFKRETRFTSRCPANEIINKIEEAAKPLGFDVH 366
+MNAF LIS S+G NLGNLF+ E KRET FTS+C EI++KIEEA PLGF+V
Sbjct: 322 ESMNAFALISRSQGFNLGNLFEKEMMGMVKRETSFTSQCTPQEIMSKIEEACGPLGFNVR 381
Query: 367 KKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFH 414
K+NYKM+L+ K GRKG L+VATEVF+VAPSLHMVE+RK GDTLEFH
Sbjct: 382 KQNYKMKLKGDKTGRKGYLSVATEVFEVAPSLHMVELRKTGGDTLEFH 429
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 416 | ||||||
| 255583653 | 466 | CBL-interacting serine/threonine-protein | 0.997 | 0.890 | 0.956 | 0.0 | |
| 224120590 | 440 | predicted protein [Populus trichocarpa] | 0.997 | 0.943 | 0.944 | 0.0 | |
| 225435981 | 439 | PREDICTED: CBL-interacting serine/threon | 0.997 | 0.945 | 0.942 | 0.0 | |
| 147815805 | 439 | hypothetical protein VITISV_010092 [Viti | 0.997 | 0.945 | 0.942 | 0.0 | |
| 154425355 | 441 | CBL-interacting protein kinase [Vigna un | 0.997 | 0.941 | 0.918 | 0.0 | |
| 224106656 | 440 | predicted protein [Populus trichocarpa] | 0.997 | 0.943 | 0.925 | 0.0 | |
| 62857008 | 441 | Ser/Thr protein kinase [Lotus japonicus] | 0.997 | 0.941 | 0.910 | 0.0 | |
| 357493713 | 441 | CBL-interacting protein kinase [Medicago | 0.997 | 0.941 | 0.908 | 0.0 | |
| 449463875 | 444 | PREDICTED: CBL-interacting serine/threon | 0.997 | 0.934 | 0.898 | 0.0 | |
| 357493719 | 476 | CBL-interacting protein kinase [Medicago | 0.997 | 0.871 | 0.837 | 0.0 |
| >gi|255583653|ref|XP_002532581.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223527690|gb|EEF29798.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 832 bits (2148), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/415 (95%), Positives = 407/415 (98%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR
Sbjct: 28 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 87
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEARRYFQQL
Sbjct: 88 EVATMKLIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARRYFQQL 147
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLD YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 148 INAVDYCHSRGVYHRDLKPENLLLDTYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 207
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF
Sbjct: 208 APEVLNDRGYDGATADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFG 267
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
A KLI RILDPNPMTRITIPEIL DEWFKKDYK PVFEEK+DTNLDDVEAVFKDSEEHHV
Sbjct: 268 AMKLITRILDPNPMTRITIPEILVDEWFKKDYKVPVFEEKEDTNLDDVEAVFKDSEEHHV 327
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKP 360
TE+KEEQP AMNAFELIS+SKGLNLGNLFD+EQ FKRETRFTS+CPANEII+KIEEAAKP
Sbjct: 328 TEKKEEQPTAMNAFELISMSKGLNLGNLFDSEQGFKRETRFTSKCPANEIIHKIEEAAKP 387
Query: 361 LGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
LGFDVHKKNYKMRLENMKAGRKGNLNVATE+FQVAPSLHMVEVRKAKGDTLEFHK
Sbjct: 388 LGFDVHKKNYKMRLENMKAGRKGNLNVATEIFQVAPSLHMVEVRKAKGDTLEFHK 442
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224120590|ref|XP_002330980.1| predicted protein [Populus trichocarpa] gi|116265926|gb|ABJ91211.1| CBL-interacting protein kinase 3 [Populus trichocarpa] gi|118485622|gb|ABK94661.1| unknown [Populus trichocarpa] gi|222872772|gb|EEF09903.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 821 bits (2120), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/416 (94%), Positives = 406/416 (97%), Gaps = 1/416 (0%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR
Sbjct: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ TMKL+KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEARRYFQQL
Sbjct: 61 EIETMKLIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
IN VDYCHSRGV+HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INVVDYCHSRGVFHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSN+MNLYKKISAAEFTCPPWLSF
Sbjct: 181 APEVLNDRGYDGTTADLWSCGVILFVLLAGYLPFDDSNVMNLYKKISAAEFTCPPWLSFG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
A KLI RILDPNPMTRITIPEIL DEWFKK YKPPVFEEK+DTNLDDVEAVFKDSEEHHV
Sbjct: 241 AMKLITRILDPNPMTRITIPEILVDEWFKKGYKPPVFEEKEDTNLDDVEAVFKDSEEHHV 300
Query: 301 TEQK-EEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAK 359
TE+K EEQP AMNAFELIS+SKGLNLGNLFD EQ+FKRETRFTSRCPANEII+KIEEAAK
Sbjct: 301 TEKKEEEQPTAMNAFELISMSKGLNLGNLFDGEQEFKRETRFTSRCPANEIIHKIEEAAK 360
Query: 360 PLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
PLGFDVHKKNYKMRLEN+KAGRKGNLNVATE+FQVAPSLHMVEVRKAKGDTLEFHK
Sbjct: 361 PLGFDVHKKNYKMRLENVKAGRKGNLNVATEIFQVAPSLHMVEVRKAKGDTLEFHK 416
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225435981|ref|XP_002271894.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 3 [Vitis vinifera] gi|229609837|gb|ACQ83534.1| CBL-interacting protein kinase 18 [Vitis vinifera] gi|296083952|emb|CBI24340.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 817 bits (2110), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/415 (94%), Positives = 402/415 (96%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M+ PK+KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVA+KILDKEKVLKHKMAEQIKR
Sbjct: 1 MNPPKVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVAIKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEARRYFQQL
Sbjct: 61 EVATMKLIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSNLM LYKKISAAEFTCPPWLSF
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLLAGYLPFDDSNLMILYKKISAAEFTCPPWLSFG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
A KLI RILDPNPMTRITIPEILEDEWFKK YKPPVFEEK D NLDDVEAVFKDSEEHHV
Sbjct: 241 AMKLITRILDPNPMTRITIPEILEDEWFKKGYKPPVFEEKGDANLDDVEAVFKDSEEHHV 300
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKP 360
TE+ EEQP AMNAFELIS+S+GLNLGNLFD EQ FKRETRFTS+CPANEII+KIEEA KP
Sbjct: 301 TEKTEEQPAAMNAFELISMSRGLNLGNLFDIEQGFKRETRFTSKCPANEIIHKIEEAVKP 360
Query: 361 LGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
LGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK
Sbjct: 361 LGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147815805|emb|CAN70422.1| hypothetical protein VITISV_010092 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 815 bits (2105), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/415 (94%), Positives = 401/415 (96%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M+ PK+KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVA+KILDKEKVLKHKMAEQIKR
Sbjct: 1 MNPPKVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVAIKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEARRYFQQL
Sbjct: 61 EVATMKLIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSNLM LYKKISAAEFTCPPWLSF
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLLAGYLPFDDSNLMILYKKISAAEFTCPPWLSFG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
A KLI RILDPNPMTRITIPEILEDEWFKK YKPPVFEEK D NLDDVEAVFKDSEEHHV
Sbjct: 241 AMKLITRILDPNPMTRITIPEILEDEWFKKGYKPPVFEEKGDANLDDVEAVFKDSEEHHV 300
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKP 360
TE+ EEQP AMNAFELIS+S GLNLGNLFD EQ FKRETRFTS+CPANEII+KIEEA KP
Sbjct: 301 TEKTEEQPAAMNAFELISMSXGLNLGNLFDIEQGFKRETRFTSKCPANEIIHKIEEAVKP 360
Query: 361 LGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
LGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK
Sbjct: 361 LGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|154425355|dbj|BAF74756.1| CBL-interacting protein kinase [Vigna unguiculata] | Back alignment and taxonomy information |
|---|
Score = 802 bits (2072), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/415 (91%), Positives = 399/415 (96%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVG YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI+R
Sbjct: 1 MSQPKIKRRVGIYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVVRLYEVMGSKTKI++VLEFVTGGELFDKIVNHGRM E+EARRYFQQL
Sbjct: 61 EVATMKLIKHPNVVRLYEVMGSKTKIYVVLEFVTGGELFDKIVNHGRMSENEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLD YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDTYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVL+AGYLPFDD NLMNLYKKISAAEFTCPPWLSF+
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLVAGYLPFDDPNLMNLYKKISAAEFTCPPWLSFS 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
ARKLI RILDP+P TRITIPEIL+DEWFKKDYKPPVFEE + NLDDVEAVFKDSEEHHV
Sbjct: 241 ARKLITRILDPDPTTRITIPEILDDEWFKKDYKPPVFEENGEINLDDVEAVFKDSEEHHV 300
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKP 360
TE+KEEQP +MNAFELIS+SKGLNL NLFD EQ FKRETRFTS+ PA+EIINKIEEAAKP
Sbjct: 301 TEKKEEQPTSMNAFELISMSKGLNLENLFDTEQGFKRETRFTSKSPADEIINKIEEAAKP 360
Query: 361 LGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
LGFDV KKNYKMRL N+KAGRKGNLNVATE+FQVAPSLHMVEVRKAKGDTLEFHK
Sbjct: 361 LGFDVQKKNYKMRLANVKAGRKGNLNVATEIFQVAPSLHMVEVRKAKGDTLEFHK 415
|
Source: Vigna unguiculata Species: Vigna unguiculata Genus: Vigna Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106656|ref|XP_002314239.1| predicted protein [Populus trichocarpa] gi|116265928|gb|ABJ91212.1| CBL-interacting protein kinase 4 [Populus trichocarpa] gi|222850647|gb|EEE88194.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 801 bits (2069), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/416 (92%), Positives = 402/416 (96%), Gaps = 1/416 (0%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVGKYE+GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR
Sbjct: 1 MSQPKIKRRVGKYEMGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMK +KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEAR YF QL
Sbjct: 61 EVATMKRIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARGYFHQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGV+HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVFHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+ ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF
Sbjct: 181 APEVLNDRGYDGAPADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
A KLI RILDPNPMTRIT+ EIL DEWFKK YK PVFEEK+DTNLDDVEAVFKDSEE+HV
Sbjct: 241 AMKLITRILDPNPMTRITVSEILVDEWFKKGYKTPVFEEKEDTNLDDVEAVFKDSEENHV 300
Query: 301 TEQK-EEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAK 359
TE+K EEQP AMNAFELIS+S+GLNLGNLFD EQ+FKRETRFTS+CPANEII+KIEEAAK
Sbjct: 301 TEKKEEEQPTAMNAFELISMSRGLNLGNLFDGEQEFKRETRFTSKCPANEIIHKIEEAAK 360
Query: 360 PLGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
PLGFDVHKKNYKMRLEN+KAGRKGNLNVATE+FQ+APSLHMVEVRKAKGDTLEFHK
Sbjct: 361 PLGFDVHKKNYKMRLENVKAGRKGNLNVATEIFQMAPSLHMVEVRKAKGDTLEFHK 416
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|62857008|dbj|BAD95889.1| Ser/Thr protein kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 794 bits (2051), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/415 (91%), Positives = 398/415 (95%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M+QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGE VALKILDKEKVLKHKMAEQIKR
Sbjct: 1 MNQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEAVALKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVV+LYEV+GSKTKI++VLEFVTGGELFDKIVNHGRM EDEARRYFQQL
Sbjct: 61 EVATMKLIKHPNVVQLYEVLGSKTKIYMVLEFVTGGELFDKIVNHGRMCEDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
IN VDYCHSRGVYHRDLKPENLLLDA GNLKVSDFGLSALSQQ++DDGLLHTTCGTPNYV
Sbjct: 121 INTVDYCHSRGVYHRDLKPENLLLDACGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLND+GYDG+TADLWSCGVILFVL+AGYLPFDD NLM LYKKISAAEFTCPPWLSF+
Sbjct: 181 APEVLNDKGYDGATADLWSCGVILFVLVAGYLPFDDPNLMELYKKISAAEFTCPPWLSFS 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
ARKLI RILDPNPMTRITI EILEDEWFKKDYKPP+F+E +TNLDDVEAVFKDSEEHHV
Sbjct: 241 ARKLITRILDPNPMTRITIAEILEDEWFKKDYKPPIFQENGETNLDDVEAVFKDSEEHHV 300
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKP 360
TE+KEEQP AMNAFELIS+SKGLNL NLFD EQ FKRETRFTS+ PANEII+KIEEAAKP
Sbjct: 301 TEKKEEQPTAMNAFELISMSKGLNLENLFDVEQGFKRETRFTSKSPANEIISKIEEAAKP 360
Query: 361 LGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
LGFDV KKNYKMRL N+KAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK
Sbjct: 361 LGFDVQKKNYKMRLANVKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357493713|ref|XP_003617145.1| CBL-interacting protein kinase [Medicago truncatula] gi|355518480|gb|AET00104.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 794 bits (2050), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/415 (90%), Positives = 396/415 (95%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVG YEVGRTIGEGTFAKVKFARNSETGE VALKILDKEKVLKHKMAEQIKR
Sbjct: 1 MSQPKIKRRVGIYEVGRTIGEGTFAKVKFARNSETGEAVALKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ATMKL+KHPNVVRLYEVMGS+TKI+IVLEFVTGGELFDKIVNHGRM E EARRYFQQL
Sbjct: 61 EIATMKLIKHPNVVRLYEVMGSRTKIYIVLEFVTGGELFDKIVNHGRMGEPEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
IN VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INVVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVL+AGYLPFDD NLM LYKKIS+A+FTCPPWLSF+
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLVAGYLPFDDPNLMELYKKISSADFTCPPWLSFS 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
ARKLI RILDPNPMTRIT+ EIL+DEWFKKDYKPPVFEE +TNLDDVEAVFKDSEEHHV
Sbjct: 241 ARKLITRILDPNPMTRITMAEILDDEWFKKDYKPPVFEESGETNLDDVEAVFKDSEEHHV 300
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKP 360
TE+KEEQP +MNAFELIS+S+GLNL NLFD EQ FKRETRFTS+ PA+EIINKIEEAAKP
Sbjct: 301 TEKKEEQPTSMNAFELISMSRGLNLENLFDVEQGFKRETRFTSQSPADEIINKIEEAAKP 360
Query: 361 LGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
LGFDV KKN+KMRL N KAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK
Sbjct: 361 LGFDVQKKNFKMRLANSKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463875|ref|XP_004149656.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 3-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 791 bits (2044), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/415 (89%), Positives = 399/415 (96%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
++QPK+KR VGKYE+GRTIGEGTFAKVKFA+NSETGE VA+KILDKEKVLKHKMAEQIKR
Sbjct: 6 VNQPKVKRLVGKYEMGRTIGEGTFAKVKFAKNSETGEHVAIKILDKEKVLKHKMAEQIKR 65
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ATMKL++HP+VV+L+EVMGSKTKIFIVLEFVTGGELFDKIVNHGRM E+EARRYFQQL
Sbjct: 66 EIATMKLIQHPHVVQLFEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMSENEARRYFQQL 125
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV+DDGLLHTTCGTPNYV
Sbjct: 126 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVKDDGLLHTTCGTPNYV 185
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS
Sbjct: 186 APEVLNDRGYDGATADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSLD 245
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
A KLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE+K NLDDVEAVFKDSEEHHV
Sbjct: 246 AMKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEQKIANLDDVEAVFKDSEEHHV 305
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKP 360
TE+KEE P AMNAFELIS+SKGLNL NLF EQ+FKRETRFTS+C ANEI+NKIEEAAKP
Sbjct: 306 TEKKEEHPAAMNAFELISMSKGLNLANLFGTEQEFKRETRFTSKCSANEIVNKIEEAAKP 365
Query: 361 LGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
LGFDV KKNYKMRLEN+KAGRKGNLNVATE+ QVAPS+H+VE+RKAKGDTLEFHK
Sbjct: 366 LGFDVQKKNYKMRLENVKAGRKGNLNVATEILQVAPSVHVVEMRKAKGDTLEFHK 420
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357493719|ref|XP_003617148.1| CBL-interacting protein kinase [Medicago truncatula] gi|355518483|gb|AET00107.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 776 bits (2004), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/450 (83%), Positives = 396/450 (88%), Gaps = 35/450 (7%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVG YEVGRTIGEGTFAKVKFARNSETGE VALKILDKEKVLKHKMAEQIKR
Sbjct: 1 MSQPKIKRRVGIYEVGRTIGEGTFAKVKFARNSETGEAVALKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEV-----------------------------------MGSKTK 85
E+ATMKL+KHPNVVRLYEV MGS+TK
Sbjct: 61 EIATMKLIKHPNVVRLYEVADMMTFLFINLTNHADTKFDDSVVLFAYPLAFSLVMGSRTK 120
Query: 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD 145
I+IVLEFVTGGELFDKIVNHGRM E EARRYFQQLIN VDYCHSRGVYHRDLKPENLLLD
Sbjct: 121 IYIVLEFVTGGELFDKIVNHGRMGEPEARRYFQQLINVVDYCHSRGVYHRDLKPENLLLD 180
Query: 146 AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG+TADLWSCGVILF
Sbjct: 181 AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGATADLWSCGVILF 240
Query: 206 VLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265
VL+AGYLPFDD NLM LYKKIS+A+FTCPPWLSF+ARKLI RILDPNPMTRIT+ EIL+D
Sbjct: 241 VLVAGYLPFDDPNLMELYKKISSADFTCPPWLSFSARKLITRILDPNPMTRITMAEILDD 300
Query: 266 EWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQPVAMNAFELISLSKGLNL 325
EWFKKDYKPPVFEE +TNLDDVEAVFKDSEEHHVTE+KEEQP +MNAFELIS+S+GLNL
Sbjct: 301 EWFKKDYKPPVFEESGETNLDDVEAVFKDSEEHHVTEKKEEQPTSMNAFELISMSRGLNL 360
Query: 326 GNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGFDVHKKNYKMRLENMKAGRKGNL 385
NLFD EQ FKRETRFTS+ PA+EIINKIEEAAKPLGFDV KKN+KMRL N KAGRKGNL
Sbjct: 361 ENLFDVEQGFKRETRFTSQSPADEIINKIEEAAKPLGFDVQKKNFKMRLANSKAGRKGNL 420
Query: 386 NVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
NVATEVFQVAPSLHMVEVRKAKGDTLEFHK
Sbjct: 421 NVATEVFQVAPSLHMVEVRKAKGDTLEFHK 450
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 416 | ||||||
| TAIR|locus:2059279 | 451 | CIPK3 "CBL-interacting protein | 0.987 | 0.911 | 0.858 | 7e-196 | |
| TAIR|locus:1005716172 | 439 | CIPK26 "calcineurin B-like pro | 0.997 | 0.945 | 0.797 | 4.1e-184 | |
| TAIR|locus:2009812 | 482 | CIPK23 "CBL-interacting protei | 0.980 | 0.846 | 0.732 | 6.3e-163 | |
| TAIR|locus:2155233 | 446 | SOS2 "SALT OVERLY SENSITIVE 2" | 0.983 | 0.917 | 0.626 | 1.7e-137 | |
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 0.980 | 0.916 | 0.593 | 1.6e-132 | |
| TAIR|locus:1005716169 | 831 | AT5G21222 [Arabidopsis thalian | 0.721 | 0.361 | 0.766 | 1.1e-124 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.947 | 0.893 | 0.552 | 4.2e-118 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.942 | 0.892 | 0.534 | 2.8e-114 | |
| TAIR|locus:2181047 | 421 | CIPK15 "CBL-interacting protei | 0.947 | 0.935 | 0.548 | 1.5e-113 | |
| TAIR|locus:2169444 | 456 | CIPK2 "CBL-interacting protein | 0.968 | 0.883 | 0.523 | 5.2e-113 |
| TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1897 (672.8 bits), Expect = 7.0e-196, P = 7.0e-196
Identities = 353/411 (85%), Positives = 388/411 (94%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
++KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI+RE+AT
Sbjct: 16 QVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIAT 75
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
MKL+KHPNVV+LYEVM SKTKIFI+LE+VTGGELFDKIVN GRMKEDEARRYFQQLI+AV
Sbjct: 76 MKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAV 135
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
DYCHSRGVYHRDLKPENLLLD+YGNLK+SDFGLSALSQQVRDDGLLHT+CGTPNYVAPEV
Sbjct: 136 DYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEV 195
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244
LNDRGYDG+TAD+WSCGV+L+VLLAGYLPFDDSNLMNLYKKIS+ EF CPPWLS A KL
Sbjct: 196 LNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKL 255
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQK 304
I RILDPNPMTR+T E+ EDEWFKKDYKPPVFEE+ D+N+DD++AVFKDSEEH VTE++
Sbjct: 256 ITRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTEKR 315
Query: 305 EEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGFD 364
EEQP A+NAFE+IS+S+GLNL NLFD EQ+FKRETR T R ANEII KIEEAAKPLGFD
Sbjct: 316 EEQPAAINAFEIISMSRGLNLENLFDPEQEFKRETRITLRGGANEIIEKIEEAAKPLGFD 375
Query: 365 VHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
V KKNYKMRLEN+KAGRKGNLNVATE+FQVAPSLHMV+V K+KGDTLEFHK
Sbjct: 376 VQKKNYKMRLENVKAGRKGNLNVATEIFQVAPSLHMVQVSKSKGDTLEFHK 426
|
|
| TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1786 (633.8 bits), Expect = 4.1e-184, P = 4.1e-184
Identities = 331/415 (79%), Positives = 378/415 (91%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M++PK++RRVGKYEVG+T+G+GTFAKV+ A N+ETGE VALKILDKEKVLKHKMAEQI+R
Sbjct: 1 MNRPKVQRRVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ TMKL+ HPNVVRLYEV+ SKTKI+IVLEF TGGELFDKIV+ GR+KE+ AR+YFQQL
Sbjct: 61 EICTMKLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDA GNLKVSDFGLSALS+QVR DGLLHT CGTPNY
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYA 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLND+GYDG+TADLWSCGVILFVLLAGYLPF+DSNLM LYKKI A E+ CPPWLS
Sbjct: 181 APEVLNDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
A+ LI RILDPNPMTRITIPE+L D WFKK+YKP VFEEK++ NLDDV+AVFKDSEEHHV
Sbjct: 241 AKNLIVRILDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHV 300
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKP 360
TE+KEEQP +MNAFELIS+S+ L+LGNLF+ E+ FKRETRF ++ AN+++ KIEEA+KP
Sbjct: 301 TEKKEEQPTSMNAFELISMSRALDLGNLFEEEEGFKRETRFAAKGAANDLVQKIEEASKP 360
Query: 361 LGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
LGFD+ KKNYKMRLEN+ AGRKGNL VATE+FQV+PSLHM+EVRK KGDTLEFHK
Sbjct: 361 LGFDIQKKNYKMRLENVTAGRKGNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHK 415
|
|
| TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1586 (563.4 bits), Expect = 6.3e-163, P = 6.3e-163
Identities = 304/415 (73%), Positives = 354/415 (85%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
+ RVGKYE+GRT+GEGTFAKVKFARN E G+ VA+K++DKEKVLK+KM QIKRE++TMK
Sbjct: 25 RTRVGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMK 84
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
L+KHPNV+R++EVM SKTKI+ VLEFVTGGELFDKI ++GR+KEDEAR+YFQQLINAVDY
Sbjct: 85 LIKHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDY 144
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
CHSRGVYHRDLKPENLLLDA G LKVSDFGLSAL QQVR+DGLLHTTCGTPNYVAPEV+N
Sbjct: 145 CHSRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVIN 204
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246
++GYDG+ ADLWSCGVILFVL+AGYLPF+DSNL +LYKKI AEFTCPPW S +A+KLI
Sbjct: 205 NKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIK 264
Query: 247 RILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHH--VTEQK 304
RILDPNP TRIT E++E+EWFKK YK P FE D +LDDV+A+F DS E V E++
Sbjct: 265 RILDPNPATRITFAEVIENEWFKKGYKAPKFENA-DVSLDDVDAIFDDSGESKNLVVERR 323
Query: 305 EE---QPVAMNAFELISLSKGLNLGNLFDAEQDF-KRETRFTSRCPANEIINKIEEAAKP 360
EE PV MNAFELIS S+GLNLG+LF+ + KR+TRFTS+ ANEI+ KIE AA P
Sbjct: 324 EEGLKTPVTMNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAP 383
Query: 361 LGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
+GFDV NYKM+L K+GRKG L VATEVFQVAPSL+MVE+RK+ GDTLEFHK
Sbjct: 384 MGFDVKTNNYKMKLTGEKSGRKGQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHK 438
|
|
| TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1346 (478.9 bits), Expect = 1.7e-137, P = 1.7e-137
Identities = 260/415 (62%), Positives = 326/415 (78%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
K RRVGKYEVGRTIGEGTFAKVKFARN++TG+ VA+KI+ K +LK++M +QIKRE++
Sbjct: 3 KKMRRVGKYEVGRTIGEGTFAKVKFARNTDTGDNVAIKIMAKSTILKNRMVDQIKREISI 62
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
MK+V+HPN+VRLYEV+ S +KI+IVLEFVTGGELFD+IV+ GR++E E+R+YFQQL++AV
Sbjct: 63 MKIVRHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVDAV 122
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
+CH +GVYHRDLKPENLLLD GNLKVSDFGLSAL Q+ + LL TTCGTPNYVAPEV
Sbjct: 123 AHCHCKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVE--LLRTTCGTPNYVAPEV 180
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244
L+ +GYDGS AD+WSCGVILFV+LAGYLPF +++L LY+KI+AAEF+CPPW S + L
Sbjct: 181 LSGQGYDGSAADIWSCGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFL 240
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQK 304
I RILDPNP TRI I I +D WF+ +Y P E+++ NLDD+ AVF E +V E
Sbjct: 241 IHRILDPNPKTRIQIQGIKKDPWFRLNYVPIRAREEEEVNLDDIRAVFDGIEGSYVAENV 300
Query: 305 E---EQPVAMNAFELISLSKGLNLGNLFDAEQDF-KRETRFTSRCPANEIINKIEEAAKP 360
E E P+ MNAFE+I+LS+GLNL LFD QDF KR+TRF SR +EII IE A
Sbjct: 301 ERNDEGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANS 360
Query: 361 LGFDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
+GF H +N+K RLE + + + G L V E+++VAPSL MV+VRKA G+TLE+HK
Sbjct: 361 MGFKSHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHK 415
|
|
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1299 (462.3 bits), Expect = 1.6e-132, P = 1.6e-132
Identities = 245/413 (59%), Positives = 318/413 (76%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM 65
+ R+VGKYE+GRTIGEGTFAKVKFA+N+ETGE VA+KI+D+ ++K KM +QIKRE++ M
Sbjct: 2 VVRKVGKYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIM 61
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
KLV+HP VVRLYEV+ S+TKI+I+LE++TGGELFDKIV +GR+ E EAR+YF QLI+ VD
Sbjct: 62 KLVRHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVD 121
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
YCHS+GVYHRDLKPENLLLD+ GNLK+SDFGLSAL +Q +L TTCGTPNYVAPEVL
Sbjct: 122 YCHSKGVYHRDLKPENLLLDSQGNLKISDFGLSALPEQ--GVTILKTTCGTPNYVAPEVL 179
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245
+ +GY+G+ AD+WSCGVIL+VL+AGYLPFD+ +L LY KI AEF+CP + + A+ LI
Sbjct: 180 SHKGYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSKIDKAEFSCPSYFALGAKSLI 239
Query: 246 ARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQ-- 303
RILDPNP TRITI EI +DEWF KDY P + + NLDDV A F D EE +
Sbjct: 240 NRILDPNPETRITIAEIRKDEWFLKDYTPVQLIDYEHVNLDDVYAAFDDPEEQTYAQDGT 299
Query: 304 KEEQPVAMNAFELISLSKGLNLGNLFDAEQD-FKRETRFTSRCPANEIINKIEEAAKPLG 362
++ P+ +NAF+LI LS+GLNL LFD +D K +TRF S PAN +++ +E ++ +G
Sbjct: 300 RDTGPLTLNAFDLIILSQGLNLATLFDRGKDSMKHQTRFISHKPANVVLSSMEVVSQSMG 359
Query: 363 FDVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHK 415
F H +NYKMR+E + A + + +V EVF+VAPS+ MV+++ A GD E+ K
Sbjct: 360 FKTHIRNYKMRVEGLSANKTSHFSVILEVFKVAPSILMVDIQNAAGDAEEYLK 412
|
|
| TAIR|locus:1005716169 AT5G21222 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1225 (436.3 bits), Expect = 1.1e-124, P = 1.1e-124
Identities = 230/300 (76%), Positives = 261/300 (87%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MS+PK++R VGKYEVGR IGE F K++ A ++ETG+PVAL ILDK+KVLKHKMAEQIKR
Sbjct: 1 MSEPKVRRWVGKYEVGRLIGECNFGKLRSAVDTETGDPVALMILDKDKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E++ MKL+ HPNVV+LYEV+ SK KI+IVLEF++GG+LFDKI N GRM EDEA+RYFQQL
Sbjct: 61 EISIMKLINHPNVVQLYEVLASKAKIYIVLEFISGGKLFDKIKNDGRMNEDEAQRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDA NLKV++FGL ALSQQ DGL HT CG P+Y
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAQENLKVAEFGLIALSQQAGGDGLRHTACGNPDYA 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLND+GYDG+ ADLWSCGVILFVLLAGYLPF+DS+L LYKKIS+A+F+CPPWLS
Sbjct: 181 APEVLNDQGYDGAKADLWSCGVILFVLLAGYLPFEDSSLTTLYKKISSADFSCPPWLSSG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
+ LI RILDPNPMTRITIPEILED WFKKDYKP VFEEKK+ NL DVEAVFKDSEE V
Sbjct: 241 VKNLIVRILDPNPMTRITIPEILEDVWFKKDYKPAVFEEKKEANLADVEAVFKDSEEGRV 300
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1163 (414.5 bits), Expect = 4.2e-118, P = 4.2e-118
Identities = 226/409 (55%), Positives = 303/409 (74%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
G+YE+GR +G GTFAKV ARN +TG+ VA+K++ KEKV+K M +QIKRE++ M++VKH
Sbjct: 22 GRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMRMVKH 81
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
PN+V L+EVM SK+KI+ +E V GGELF K+ GR++ED AR YFQQLI+AVD+CHSR
Sbjct: 82 PNIVELHEVMASKSKIYFAMELVRGGELFAKVAK-GRLREDVARVYFQQLISAVDFCHSR 140
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
GVYHRDLKPENLLLD GNLKV+DFGLSA ++ ++ DGLLHTTCGTP YVAPEV+ +GY
Sbjct: 141 GVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILKKGY 200
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250
DG+ ADLWSCGVILFVLLAGYLPF D NL+N+Y+KI +F CP WLS AR+L+ ++LD
Sbjct: 201 DGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTKLLD 260
Query: 251 PNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEH--HVTEQKEEQP 308
PNP TRITI ++++ WFKK + + N + V A +EE + + +E+
Sbjct: 261 PNPNTRITIEKVMDSPWFKK-------QATRSRN-EPVAATITTTEEDVDFLVHKSKEET 312
Query: 309 VAMNAFELISLSKGLNLGNLFDAEQ-DFKRETRFTSRCPANEIINKIEEAAKPLG--FDV 365
+NAF +I+LS+G +L LF+ ++ + KRE RF + PA+ +I+ +EEAA+ +G FDV
Sbjct: 313 ETLNAFHIIALSEGFDLSPLFEEKKKEEKREMRFATSRPASSVISSLEEAAR-VGNKFDV 371
Query: 366 HKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFH 414
K ++R+E + GRKG L V E+F VAPS +VEV+K GDTLE++
Sbjct: 372 RKSESRVRIEGKQNGRKGKLAVEAEIFAVAPSFVVVEVKKDHGDTLEYN 420
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1127 (401.8 bits), Expect = 2.8e-114, P = 2.8e-114
Identities = 216/404 (53%), Positives = 300/404 (74%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KYE+GR +G+GTFAKV ARN +TGE VA+K++DK+KV K + +QIKRE++ M+LV+HP
Sbjct: 11 KYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREISVMRLVRHP 70
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+VV L+EVM SKTKI+ +E+V GGELFDK V+ G++KE+ AR+YFQQLI A+DYCHSRG
Sbjct: 71 HVVFLHEVMASKTKIYFAMEYVKGGELFDK-VSKGKLKENIARKYFQQLIGAIDYCHSRG 129
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
VYHRDLKPENLLLD G+LK+SDFGLSAL + + DGLLHTTCGTP YVAPEV+ +GYD
Sbjct: 130 VYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKKGYD 189
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
G+ AD+WSCGV+L+VLLAG+LPF + NL+ +Y+KI+ EF CP W +KL++RILDP
Sbjct: 190 GAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRILDP 249
Query: 252 NPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQPVAM 311
NP +RI I +I+E+ WF+K +K E K ++++ D H K P++
Sbjct: 250 NPNSRIKIEKIMENSWFQKGFKK--IETPKSPESHQIDSLISDV--HAAFSVK---PMSY 302
Query: 312 NAFELIS-LSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEE-AAKPLGFDVHKKN 369
NAF+LIS LS+G +L LF+ E+ + E++FT++ A EI++K EE A F++ K +
Sbjct: 303 NAFDLISSLSQGFDLSGLFEKEE--RSESKFTTKKDAKEIVSKFEEIATSSERFNLTKSD 360
Query: 370 YKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEF 413
+++E+ + GRKG+L + E+F+V S HMVE +K+ GDT+E+
Sbjct: 361 VGVKMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKSGGDTMEY 404
|
|
| TAIR|locus:2181047 CIPK15 "CBL-interacting protein kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1120 (399.3 bits), Expect = 1.5e-113, P = 1.5e-113
Identities = 222/405 (54%), Positives = 303/405 (74%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+YEVG+ +G+GTFAKV AR+ +TG+ VA+K++DKE++LK M EQIKRE++ M+L++HP
Sbjct: 11 RYEVGKFLGQGTFAKVYHARHLKTGDSVAIKVIDKERILKVGMTEQIKREISAMRLLRHP 70
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V L+EVM +K+KI+ V+E V GGELF+K V+ G+++ED AR+YFQQL+ AVD+CHSRG
Sbjct: 71 NIVELHEVMATKSKIYFVMEHVKGGELFNK-VSTGKLREDVARKYFQQLVRAVDFCHSRG 129
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRDLKPENLLLD +GNLK+SDFGLSALS R DGLLHTTCGTP YVAPEV++ GYD
Sbjct: 130 VCHRDLKPENLLLDEHGNLKISDFGLSALSDSRRQDGLLHTTCGTPAYVAPEVISRNGYD 189
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
G AD+WSCGVILFVLLAGYLPF DSNLM LYKKI AE P WL+ A++L+ RILDP
Sbjct: 190 GFKADVWSCGVILFVLLAGYLPFRDSNLMELYKKIGKAEVKFPNWLAPGAKRLLKRILDP 249
Query: 252 NPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQPVAM 311
NP TR++ +I++ WF+K + EE K++ ++ E V ++E + E+++++ + +
Sbjct: 250 NPNTRVSTEKIMKSSWFRKGLQ----EEVKESVEEETE-VDAEAEGNASAEKEKKRCINL 304
Query: 312 NAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGFDVHKKNYK 371
NAFE+ISLS G +L LF+ ++ K E RFTS A+EI K+ E K L V KK ++
Sbjct: 305 NAFEIISLSTGFDLSGLFEKGEE-KEEMRFTSNREASEITEKLVEIGKDLKMKVRKKEHE 363
Query: 372 MRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKV 416
R++ M A + + V EVF++APS HMV ++K+ GDT E+ +V
Sbjct: 364 WRVK-MSA--EATV-VEAEVFEIAPSYHMVVLKKSGGDTAEYKRV 404
|
|
| TAIR|locus:2169444 CIPK2 "CBL-interacting protein kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1115 (397.6 bits), Expect = 5.2e-113, P = 5.2e-113
Identities = 215/411 (52%), Positives = 297/411 (72%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+YEVGR +G+GTFAKV F R++ T E VA+K++DK+KV++ +++QIKRE++ M++ KHP
Sbjct: 11 RYEVGRLLGQGTFAKVYFGRSNHTNESVAIKMIDKDKVMRVGLSQQIKREISVMRIAKHP 70
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
NVV LYEVM +K++I+ V+E+ GGELF+K+ G++KED A +YF QLI+AVD+CHSRG
Sbjct: 71 NVVELYEVMATKSRIYFVIEYCKGGELFNKVAK-GKLKEDVAWKYFYQLISAVDFCHSRG 129
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
VYHRD+KPENLLLD NLKVSDFGLSAL+ R DGLLHTTCGTP YVAPEV+N +GY+
Sbjct: 130 VYHRDIKPENLLLDDNDNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEVINRKGYE 189
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
G+ AD+WSCGV+LFVLLAGYLPF D+NLM +Y+KI A+F CP W + ++L+ ++LDP
Sbjct: 190 GTKADIWSCGVVLFVLLAGYLPFHDTNLMEMYRKIGKADFKCPSWFAPEVKRLLCKMLDP 249
Query: 252 NPMTRITIPEILEDEWFKKDY--KPPVFEEKKDTNLDDVEAVFK--DSEEHHVTEQKEEQ 307
N TRITI +I E WF+K K E+ + + + + S ++ E E
Sbjct: 250 NHETRITIAKIKESSWFRKGLHLKQKKMEKMEKQQVREATNPMEAGGSGQNENGENHEPP 309
Query: 308 PVA-MNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGFDVH 366
+A +NAF++I+LS G L LF D KRE+RF S+ PA+EII+K+ E AK L +
Sbjct: 310 RLATLNAFDIIALSTGFGLAGLFGDVYD-KRESRFASQKPASEIISKLVEVAKCLKLKIR 368
Query: 367 KKNYKM-RLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKV 416
K+ + +LE +K G+ G L + E+FQV P+ H+VEV+K GDT+E+ K+
Sbjct: 369 KQGAGLFKLERVKEGKNGILTMDAEIFQVTPTFHLVEVKKCNGDTMEYQKL 419
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6X4A2 | CIPKV_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7694 | 0.9903 | 0.9175 | no | no |
| Q2V452 | CIPK3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8588 | 0.9879 | 0.9319 | yes | no |
| Q2QY53 | CIPKW_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.8506 | 0.9951 | 0.9452 | yes | no |
| Q8LIG4 | CIPK3_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7104 | 0.9879 | 0.9235 | no | no |
| Q84VQ3 | CIPKQ_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7975 | 0.9975 | 0.9453 | no | no |
| Q10SC8 | CIPK9_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7034 | 0.9735 | 0.8881 | no | no |
| Q93VD3 | CIPKN_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7354 | 0.9735 | 0.8402 | no | no |
| Q2RAX3 | CIPKX_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.8190 | 0.9951 | 0.9118 | yes | no |
| Q6ZLP5 | CIPKN_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7040 | 0.9951 | 0.92 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.994 |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | CIPK3 | SubName- Full=CBL-interacting protein kinase 3 (Putative uncharacterized protein); (440 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | CBL1 | SubName- Full=Calcineurin B-like protein 1; (213 aa) | • | 0.702 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 416 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-108 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-94 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-79 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-76 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-71 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-66 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-64 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-63 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-61 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-61 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-60 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-53 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-53 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-52 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-50 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-50 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-49 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 2e-48 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-47 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-47 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-47 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-47 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-47 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-46 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-46 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-46 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-46 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-46 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-45 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-45 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-44 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-44 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-44 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-43 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-43 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-43 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-43 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-42 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-41 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-41 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-41 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-41 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-41 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-41 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-40 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-40 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-40 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-40 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-40 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-39 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-39 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-39 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-39 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-39 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-38 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-38 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-38 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-38 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-38 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-38 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-38 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-37 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-37 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-37 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-37 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-37 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-37 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-37 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-36 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-36 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-36 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-36 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-36 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-35 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-35 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-35 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-34 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-34 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-34 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-34 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-34 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-34 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-34 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-34 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-34 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-33 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-33 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-33 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-33 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-33 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-33 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-32 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-32 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-32 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-32 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-32 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-32 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-32 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-31 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-31 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-31 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-31 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-31 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-31 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-31 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-30 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-30 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-30 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-30 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-30 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-30 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-30 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-30 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-29 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-29 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-29 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-28 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-28 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-28 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-28 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-28 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-28 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-28 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-28 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-28 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-27 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-27 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-27 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-27 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-27 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-27 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-27 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-26 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-26 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 1e-26 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-25 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-25 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-25 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-25 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-25 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-24 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-24 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-24 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-24 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-24 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-24 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-23 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-23 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-23 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-23 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-23 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-22 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-22 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-22 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-22 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-22 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-22 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-22 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-22 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-21 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-21 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-21 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-21 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-21 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-21 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-20 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-20 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-20 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-20 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-20 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-20 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-19 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-18 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-17 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-17 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-14 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-10 | |
| cd12120 | 95 | cd12120, AMPKA_C_like, C-terminal regulatory domai | 1e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-09 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 7e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.002 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 317 bits (816), Expect = e-108
Identities = 116/260 (44%), Positives = 174/260 (66%), Gaps = 10/260 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YE+ +GEG+F KV AR+ +TG+ VA+K++ K+K+ K + E+I RE+ +K +KHPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR--ERILREIKILKKLKHPN 58
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+VRLY+V + K+++V+E+ GG+LFD + GR+ EDEAR Y +Q+++A++Y HS+G+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
HRDLKPEN+LLD G++K++DFGL+ Q+ L T GTP Y+APEVL +GY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 193 STADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAAEFTCPPW---LSFTARKLIARI 248
+ D+WS GVIL+ LL G PF D L+ L+KKI + PP +S A+ LI ++
Sbjct: 176 A-VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 249 LDPNPMTRITIPEILEDEWF 268
L +P R+T E L+ +F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 283 bits (726), Expect = 4e-94
Identities = 104/263 (39%), Positives = 154/263 (58%), Gaps = 10/263 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YE+ R +G G+F V A++ TG+ VA+KIL K K K + +RE+ ++ + HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+VRL + K +++V+E+ GG+LFD + G + EDEA++ Q++ ++Y HS G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
HRDLKPEN+LLD G +K++DFGL+ + ++ L T GTP Y+APEVL G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAK--KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-----EFTCPPWLSF--TARKLI 245
D+WS GVIL+ LL G PF N+++ + I EF P W S A+ LI
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 246 ARILDPNPMTRITIPEILEDEWF 268
+ L+ +P R T EIL+ WF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 245 bits (628), Expect = 4e-79
Identities = 97/262 (37%), Positives = 153/262 (58%), Gaps = 11/262 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E +T+G G+F +V R+ +G+ ALKIL K K++K K E + E ++ ++HP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V LY + +++V+E+V GGELF + GR E AR Y Q++ A++Y HS +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPENLLLD+ G +K++DFG + R G +T CGTP Y+APE++ +GY G
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFA-----KRVKGRTYTLCGTPEYLAPEIILSKGY-G 176
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
D W+ G++++ +LAGY PF D N + +Y+KI + P + S A+ LI +L +
Sbjct: 177 KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD 236
Query: 253 PMTRI-----TIPEILEDEWFK 269
R+ + +I WF
Sbjct: 237 LTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 237 bits (606), Expect = 3e-76
Identities = 98/253 (38%), Positives = 150/253 (59%), Gaps = 6/253 (2%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G+F KV R +TG+ A+K+L K+K++K K E E + + HP +V+L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
++ K+++VLE+ GGELF + GR E+ AR Y +++ A++Y HS G+ +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 198
PEN+LLDA G++K++DFGL+ + +T CGTP Y+APEVL +GY G D W
Sbjct: 121 PENILLDADGHIKLTDFGLAKEL--SSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWW 177
Query: 199 SCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT 258
S GV+L+ +L G PF + +Y+KI P +LS AR LI+ +L +P R+
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237
Query: 259 ---IPEILEDEWF 268
EI +F
Sbjct: 238 SGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 222 bits (569), Expect = 3e-71
Identities = 96/249 (38%), Positives = 139/249 (55%), Gaps = 37/249 (14%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+GEG F V AR+ +TG+ VA+KI+ KE + E++ RE+ +K + HPN+V+LY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 79 VMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
V + +++V+E+ GG L D + N G++ EDE R Q++ ++Y HS G+ HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 138 KPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
KPEN+LLD+ G +K++DFGLS L D LL T GTP Y+APEVL +GY +D
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTS--DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256
+WS GVIL+ L P L + LI ++L +P R
Sbjct: 177 IWSLGVILYEL---------------------------PEL----KDLIRKMLQKDPEKR 205
Query: 257 ITIPEILED 265
+ EILE
Sbjct: 206 PSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 212 bits (543), Expect = 2e-66
Identities = 90/279 (32%), Positives = 152/279 (54%), Gaps = 24/279 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHP 71
++ G+ IGEG+F+ V A+ ET + A+KILDK +++K K + +K E + +L HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+++LY + ++ VLE+ GEL I +G + E R Y +++ A++Y HS+G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLS------ALSQQVRDDGLLHTT------------ 173
+ HRDLKPEN+LLD ++K++DFG + + + + D +
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 233
GT YV+PE+LN+ G ++DLW+ G I++ +L G PF SN ++KI E++
Sbjct: 183 VGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 234 PPWLSFTARKLIARILDPNPMTRITI----PEILEDEWF 268
PP A+ LI ++L +P R+ + E+ +F
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 6e-64
Identities = 90/259 (34%), Positives = 140/259 (54%), Gaps = 11/259 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KYE+ + IG+G+F KV R G+ LK +D + K E EV +K + HP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN-MSEKEREDALNEVKILKKLNHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----MKEDEARRYFQQLINAVDYC 127
N+++ YE K K+ IV+E+ GG+L KI + E++ +F QL A+ Y
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
HSR + HRD+KP+N+ L + G +K+ DFG+S LS L T GTP Y++PE+
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS---TVDLAKTVVGTPYYLSPELCQ 176
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLI 245
++ Y+ +D+WS G +L+ L PF+ NL+ L KI ++ P S R L+
Sbjct: 177 NKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLV 235
Query: 246 ARILDPNPMTRITIPEILE 264
+ +L +P R +I +IL+
Sbjct: 236 SSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 4e-63
Identities = 88/262 (33%), Positives = 145/262 (55%), Gaps = 12/262 (4%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
I +G + +V A+ TG+ A+K++ K +++ +Q+ E + + P VV+LY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
K +++V+E++ GG+L + N G + ED AR Y +++ A++Y HS G+ HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLL------HTTCGTPNYVAPEVLNDRGYDG 192
P+N+L+D+ G+LK++DFGLS + R L GTP+Y+APEV+ +G+
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-S 179
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--PWLSFTARKLIARILD 250
T D WS G IL+ L G PF +++ I + P +S A LI+++L
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239
Query: 251 PNPMTRI---TIPEILEDEWFK 269
P+P R+ +I EI +FK
Sbjct: 240 PDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 1e-61
Identities = 94/249 (37%), Positives = 148/249 (59%), Gaps = 6/249 (2%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
++ +E+G T+G G+F +V+ A++ TGE A+K L K ++LK K + + +E + + +
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
HP +V + + +++ +LEFV GGELF + GR D A+ Y +L+ A +Y H
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH 135
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
S+ + +RDLKPENLLLD G++KV+DFG +++V D T CGTP Y+APEV+ +
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFG---FAKKVPDR--TFTLCGTPEYLAPEVIQSK 190
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248
G+ G D W+ GV+L+ +AGY PF D +Y+KI A P W AR L+ +
Sbjct: 191 GH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGL 249
Query: 249 LDPNPMTRI 257
L + R+
Sbjct: 250 LQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 4e-61
Identities = 91/261 (34%), Positives = 144/261 (55%), Gaps = 17/261 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G G F +V+ + ALK + K +++ E I E ++ HP +V+LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
K I++++E+ GGEL+ + + G E AR Y ++ A +Y H+RG+ +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 198
PENLLLD+ G +K+ DFG +++++ T CGTP YVAPE++ ++GYD + D W
Sbjct: 121 PENLLLDSNGYVKLVDFG---FAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYW 176
Query: 199 SCGVILFVLLAGYLPF--DDSNLMNLYKKI----SAAEFTCPPWLSFTARKLIARILDPN 252
S G++L+ LL G PF DD + M +Y I EF P ++ A+ LI ++L N
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF--PNYIDKAAKDLIKQLLRRN 234
Query: 253 PMTRI-----TIPEILEDEWF 268
P R+ I +I + +WF
Sbjct: 235 PEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 195 bits (499), Expect = 3e-60
Identities = 79/263 (30%), Positives = 136/263 (51%), Gaps = 9/263 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++ G +G G+F V A + +TGE +A+K ++ + E ++RE+ + ++HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHP 59
Query: 72 NVVRLYEVMGSKTKIF--IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
N+VR Y + K I LE+V+GG L + G++ E R+Y +Q++ + Y HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
G+ HRD+K N+L+D+ G +K++DFG + + + GTP ++APEV+
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPP---WLSFTARKLI 245
Y G AD+WS G + + G P+ + N M KI ++ P LS A+ +
Sbjct: 180 Y-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSG-EPPEIPEHLSEEAKDFL 237
Query: 246 ARILDPNPMTRITIPEILEDEWF 268
+ L +P R T E+L+ +
Sbjct: 238 RKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 2e-53
Identities = 90/278 (32%), Positives = 153/278 (55%), Gaps = 20/278 (7%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
E +T+G GTF +V R+ + ALK++ +V++ K + + E +K V HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
++RL+ + +++++E+V GGELF + N GR Y +++ A++Y HS+ +
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPEN+LLD G++K++DFG ++++RD T CGTP Y+APEV+ +G+
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFG---FAKKLRDR--TWTLCGTPEYLAPEVIQSKGH-N 176
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
D W+ G++++ +L GY PF D N +Y+KI A + P L A+ LI ++L +
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVD 236
Query: 253 PMTRI-----TIPEILEDEWFK---------KDYKPPV 276
R+ ++ WFK + KPP+
Sbjct: 237 RTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPI 274
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 181 bits (458), Expect = 6e-53
Identities = 97/313 (30%), Positives = 151/313 (48%), Gaps = 28/313 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + R +GEG+F +V AR+ + VALK+L K+ K K E+ RE+ + + HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 72 -NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYC 127
N+V+LY+ + +++V+E+V GG L D + GR + E EA Q+++A++Y
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 128 HSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSAL----SQQVRDDGLLHTTCGTPNYVAP 182
HS+G+ HRD+KPEN+LLD G +K+ DFGL+ L L T+ GTP Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 183 EVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKISAAEFTC--- 233
EVL Y S++D+WS G+ L+ LL G PF+ + K I
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 234 ------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDD 287
P +S A L+ ++L +P R++ L + K + DD
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL-AHLKLKESDLSDLLKPDD 296
Query: 288 VEAVFKDSEEHHV 300
+
Sbjct: 297 SAPLRLSLPPSLE 309
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 3e-52
Identities = 87/260 (33%), Positives = 141/260 (54%), Gaps = 11/260 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+E+ IG+G F +V AR+ TG+ VA+K++ K + + K E+I E+ +K KHP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKK--EKIINEIQILKKCKHP 57
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSR 130
N+V+ Y K +++IV+EF +GG L D + + + E + ++L+ ++Y HS
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
G+ HRD+K N+LL + G +K+ DFGLSA Q+ D +T GTP ++APEV+N + Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPY 174
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---AAEFTCPPWLSFTARKLIAR 247
D AD+WS G+ L G P+ + M KI+ P S + + +
Sbjct: 175 DY-KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233
Query: 248 ILDPNPMTRITIPEILEDEW 267
L NP R T ++L+ +
Sbjct: 234 CLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 1e-50
Identities = 90/266 (33%), Positives = 137/266 (51%), Gaps = 16/266 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
YEV TIG+G+F V+ R G+ + K +D + K +Q+ EV ++ +KHP
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN-MTEKEKQQLVSEVNILRELKHP 59
Query: 72 NVVRLY--EVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVD 125
N+VR Y + S ++IV+E+ GG+L I ++E+ R QL+ A+
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 126 YCHSRG-----VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
CH+R V HRDLKP N+ LDA N+K+ DFGL+ + D T GTP Y+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTPYYM 177
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PPWLSF 239
+PE LN YD + D+WS G +++ L A PF N + L KI +F P S
Sbjct: 178 SPEQLNHMSYDEKS-DIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236
Query: 240 TARKLIARILDPNPMTRITIPEILED 265
++I +L+ +P R + E+L+
Sbjct: 237 ELNEVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 3e-50
Identities = 106/340 (31%), Positives = 161/340 (47%), Gaps = 60/340 (17%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-----HKMAEQIKREVATMKL 67
+EV + IG G F +V R+ +TG+ A+K+L K ++K H AE R++ +
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAE---RDI--LAD 57
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
P +V+LY + +++V+E++ GG+L + ++ E+ AR Y +L+ A+D
Sbjct: 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA---------------LSQQVRDDGLLH- 171
H G HRD+KP+N+L+DA G++K++DFGL + RD+ L+
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 172 -----------TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220
+T GTP+Y+APEVL Y D WS GVIL+ +L G+ PF L
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQ 236
Query: 221 NLYKKISAAE--FTCPP--WLSFTARKLIARIL-DP-NPMTRITIPEILEDEWFKK---- 270
Y KI + PP +S A LI R+L DP + + EI +FK
Sbjct: 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFE--EIKSHPFFKGIDWE 294
Query: 271 ---DYKPPV---FEEKKDT-NLDDVEAVFKDSEEHHVTEQ 303
+ KPP DT N DD E D + Q
Sbjct: 295 NLRETKPPFVPELSSPLDTSNFDDFE---DDKDLSDYLSQ 331
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 5e-49
Identities = 88/306 (28%), Positives = 135/306 (44%), Gaps = 74/306 (24%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----REVATMK 66
YE +GEGT+ V AR+ +TGE VALK LD E+ E I RE++ +K
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-------EGIPSTALREISLLK 53
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGE-----LFDKIVNHGRMKEDEARRYFQQLI 121
+KHPN+V+L +V+ ++ K+++V E+ + DK G + + + QL+
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDK--RPGPLSPNLIKSIMYQLL 108
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPN-- 178
+ YCHS + HRDLKP+N+L++ G LK++DFGL+ A +R T
Sbjct: 109 RGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--------TYTHEVV 160
Query: 179 ---YVAPEVL-NDRGYDGSTADLWSCGVIL------FVLLAG------------------ 210
Y APE+L + Y + D+WS G I L G
Sbjct: 161 TLWYRAPEILLGSKHYSTA-VDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPT 219
Query: 211 --------YLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEI 262
LP D + + P L L++++L NP RI+ E
Sbjct: 220 EESWPGVTKLP-DYKPTFPKFPPKDLEKVL--PRLDPEGIDLLSKMLQYNPAKRISAKEA 276
Query: 263 LEDEWF 268
L+ +F
Sbjct: 277 LKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 2e-48
Identities = 67/106 (63%), Positives = 80/106 (75%), Gaps = 1/106 (0%)
Query: 312 NAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGFDVHKKN-Y 370
NAF+LISLS GL+L LF+ E + KRETRFTSR PA EII K+EEAAK LGF V KK
Sbjct: 1 NAFDLISLSSGLDLSGLFEEEDEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKEG 60
Query: 371 KMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKV 416
++LE K GRKG L V+ EVF+V PSL +VEV+K+ GDTLE+HK
Sbjct: 61 GVKLEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKF 106
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 2e-47
Identities = 86/259 (33%), Positives = 132/259 (50%), Gaps = 15/259 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNVVRLY 77
I +G F V A+ TG+ A+K+L K ++ +K E A M + P V +LY
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
SK +++V+E++ GG+ I G + ED A++Y +++ V+ H RG+ HRD+
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
KPENLL+D G+LK++DFGLS + + GTP+Y+APE + G D +D
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVG-DDKMSDW 176
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNP 253
WS G ++F L GY PF ++ I + P + S A LI R+L +P
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236
Query: 254 MTRI---TIPEILEDEWFK 269
R+ EI +FK
Sbjct: 237 AKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 3e-47
Identities = 90/276 (32%), Positives = 143/276 (51%), Gaps = 29/276 (10%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G + +V A+ +TGE VALK + K + K + E + K +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
+++ +E+V GG+ + N G + ED AR Y ++ AVD H G HRDLK
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLL---HTTCGTPNYVAPEVLNDRGYDGSTA 195
PEN L+DA G++K++DFGLS G++ ++ G+P+Y+APEVL +GYD T
Sbjct: 129 PENFLIDASGHIKLTDFGLSK--------GIVTYANSVVGSPDYMAPEVLRGKGYD-FTV 179
Query: 196 DLWSCGVILFVLLAGYLPFDDS-------NLMNLYKKISAAEFTCPPW-LSFTARKLIAR 247
D WS G +L+ L G+ PF S NL + + + P + LS A LI +
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITK 239
Query: 248 ILDPNPMTRI-TIPEILEDEWFKK-------DYKPP 275
+++ +P R ++ +I +FK+ + KPP
Sbjct: 240 LIN-DPSRRFGSLEDIKNHPFFKEVDWNELRELKPP 274
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 3e-47
Identities = 72/248 (29%), Positives = 135/248 (54%), Gaps = 7/248 (2%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ R IG+G F KV + +T + A+K ++K+K ++ + E ++ + HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V L+ + +++V++ + GG+L + + E++ + + +++ A++Y HS+G+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
HRD+KP+N+LLD G++ ++DF ++ +V D L +T GTP Y+APEVL +GY
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTPGYMAPEVLCRQGY-S 177
Query: 193 STADLWSCGVILFVLLAGYLPFD--DSNLMNLYK-KISAAEFTCPPWLSFTARKLIARIL 249
D WS GV + L G P+ + + + K A+ P S A I ++L
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237
Query: 250 DPNPMTRI 257
+ +P R+
Sbjct: 238 ERDPQKRL 245
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 5e-47
Identities = 85/242 (35%), Positives = 138/242 (57%), Gaps = 4/242 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVR 75
R +G+G+F KV AR E+G A+K+L K+ +L+ E E + L + HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
LY + ++F V+EFV GG+L I R E AR Y ++ +A+ + H +G+ +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD G+ K++DFG+ + + + T CGTP+Y+APE+L + Y G +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMC--KEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W+ GV+L+ +L G+ PF+ N +L++ I E P WLS A ++ + NP
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237
Query: 256 RI 257
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 8e-47
Identities = 80/261 (30%), Positives = 130/261 (49%), Gaps = 11/261 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y++G IG G F V N ETG+ VA+K + EK+ + + I +E+ +K +KHP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V+ + + ++I+LE+ G L I G E Y Q++ + Y H +G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+K N+L G +K++DFG++ ++ + GTP ++APEV+ G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMSGA- 176
Query: 192 GSTA-DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW---LSFTARKLIAR 247
STA D+WS G + LL G P+ D N M +I + PP +S + + +
Sbjct: 177 -STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI--VQDDHPPLPEGISPELKDFLMQ 233
Query: 248 ILDPNPMTRITIPEILEDEWF 268
+P R T ++L+ W
Sbjct: 234 CFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 1e-46
Identities = 88/267 (32%), Positives = 140/267 (52%), Gaps = 23/267 (8%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
G IG GTF KV A N +TGE +A+K + + K ++I E+ ++L+KHPN+V+
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA--RRYFQQLINAVDYCHSRGVY 133
Y V + K++I +E+ +GG L + ++ HGR+ DE R Y QL+ + Y HS G+
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRI-LDEHVIRVYTLQLLEGLAYLHSHGIV 121
Query: 134 HRDLKPENLLLDAYGNLKVSDFG----LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
HRD+KP N+ LD G +K+ DFG L + + + + GTP Y+APEV+
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG--EEVQSLAGTPAYMAPEVITGGK 179
Query: 190 YDG--STADLWSCGVILFVLLAGYLPFD--DSNLMNLYKKISAAEFTCPPW-----LSFT 240
G AD+WS G ++ + G P+ D+ ++ + A PP LS
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF-HVGAGH--KPPIPDSLQLSPE 236
Query: 241 ARKLIARILDPNPMTRITIPEILEDEW 267
+ + R L+ +P R T E+L+ +
Sbjct: 237 GKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 1e-46
Identities = 86/245 (35%), Positives = 143/245 (58%), Gaps = 7/245 (2%)
Query: 17 RTIGEGTFAKVKFARN---SETGEPVALKILDKEKVLKH-KMAEQIKREVATMKLVKHPN 72
+ +G+G + KV R ++TG+ A+K+L K ++++ K K E ++ VKHP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V L + K++++LE+++GGELF + G ED A Y ++ A+++ H +G+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPEN+LLDA G++K++DFGL + + + + HT CGT Y+APE+L G+ G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLC--KESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
D WS G +++ +L G PF N KI + PP+L+ AR L+ ++L N
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238
Query: 253 PMTRI 257
P +R+
Sbjct: 239 PSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 90/257 (35%), Positives = 138/257 (53%), Gaps = 8/257 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+GTF KV R TG+ A+KIL KE ++ E ++ +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ ++ V+E+ GGELF + ED AR Y ++++A+ Y HS V +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
LK ENL+LD G++K++DFGL + + D + T CGTP Y+APEVL D Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256
W GV+++ ++ G LPF + + L++ I E P LS A+ L+A +L +P R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 257 I-----TIPEILEDEWF 268
+ EI+E +F
Sbjct: 238 LGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 9e-46
Identities = 84/242 (34%), Positives = 138/242 (57%), Gaps = 4/242 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+ +G+G+F KV A T E A+K+L K+ +L+ E E + L KHP + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ +K ++F V+E+V GG+L I GR E AR Y +++ + + H RG+ +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD+ G++K++DFG+ + + T CGTP+Y+APE+L+ + Y +
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMC--KEGILGGVTTSTFCGTPDYIAPEILSYQPYGPA-V 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W+ GV+L+ +LAG PF+ + L++ I E P WLS A+ ++ L NP
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237
Query: 256 RI 257
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 9e-46
Identities = 85/241 (35%), Positives = 133/241 (55%), Gaps = 3/241 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+GTF KV R TG A+KIL KE ++ E ++ +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ ++ V+E+ GGELF + E+ AR Y ++++A++Y HSR V +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
+K ENL+LD G++K++DFGL + + D + T CGTP Y+APEVL D Y G D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256
W GV+++ ++ G LPF + + L++ I E P LS A+ L+A +L +P R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 257 I 257
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-45
Identities = 87/242 (35%), Positives = 134/242 (55%), Gaps = 4/242 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVR 75
+ IG+G+F KV A++ G+ A+K+L K+ +LK K + I E + K VKHP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + K++ VL++V GGELF + E AR Y ++ +A+ Y HS + +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKPEN+LLD+ G++ ++DFGL + + T CGTP Y+APEVL + YD T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W G +L+ +L G PF + +Y I P +S +AR L+ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237
Query: 256 RI 257
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 2e-45
Identities = 94/279 (33%), Positives = 159/279 (56%), Gaps = 27/279 (9%)
Query: 17 RTIGEGTFAKVKFARN---SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G+G+F KV R + G+ A+K+L K+ LK + + K E + V HP +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVL-KKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 133
V+L+ ++ K++++L+F+ GG+LF ++ E++ + Y +L A+D+ HS G+
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGS 193
+RDLKPEN+LLD G++K++DFGLS + + + ++ CGT Y+APEV+N RG+ S
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178
Query: 194 TADLWSCGVILFVLLAGYLPF---DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250
AD WS GV++F +L G LPF D M + I A+ P +LS A+ L+ +
Sbjct: 179 -ADWWSFGVLMFEMLTGSLPFQGKDRKETMTM---ILKAKLGMPQFLSPEAQSLLRALFK 234
Query: 251 PNPMTRI-TIPEILED----------EW---FKKDYKPP 275
NP R+ P+ +E+ +W ++++ KPP
Sbjct: 235 RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPP 273
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 5e-44
Identities = 91/270 (33%), Positives = 146/270 (54%), Gaps = 9/270 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+GTF KV + TG A+KIL KE ++ E ++ +HP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHR 135
+ ++ V+E+ GGELF + ED AR Y ++++A+DY HS + V +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK ENL+LD G++K++DFGL + ++D + T CGTP Y+APEVL D Y G
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W GV+++ ++ G LPF + + L++ I E P LS A+ L++ +L +P
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237
Query: 256 RI-----TIPEILEDEWFKKDYKPPVFEEK 280
R+ EI++ ++F V+E+K
Sbjct: 238 RLGGGPDDAKEIMQHKFFAGIVWQDVYEKK 267
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 6e-44
Identities = 85/241 (35%), Positives = 134/241 (55%), Gaps = 3/241 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+GTF KV R +G+ A+KIL KE ++ E +K +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+K ++ V+E+V GGELF + ED R Y ++++A+DY HS + +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
LK ENL+LD G++K++DFGL + + D + T CGTP Y+APEVL D Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC--KEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256
W GV+++ ++ G LPF + + L++ I + P LS A+ L++ +L +P R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237
Query: 257 I 257
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 6e-44
Identities = 100/312 (32%), Positives = 152/312 (48%), Gaps = 29/312 (9%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG+G+F KV R +T ALK + K ++ E + V P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
S K+++VL F+ GGELF + GR AR Y +L+ A++ H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 198
PEN+LLD G++ + DFGL L+ ++DD +T CGTP Y+APE+L GY D W
Sbjct: 121 PENILLDYQGHIALCDFGLCKLN--MKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWW 177
Query: 199 SCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT 258
+ GV+L+ +L G PF D N+ +Y+KI P A+ L+ +L +P R+
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237
Query: 259 I---PEILEDEWFKK-------------DYKPPVFEEKKDTNLDD-------VEAVFKDS 295
EI +F + +KP V +N D+ +++V DS
Sbjct: 238 YNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKPIDSVVDDS 297
Query: 296 EEHHVTEQKEEQ 307
H++E ++Q
Sbjct: 298 ---HLSETVQQQ 306
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 2e-43
Identities = 87/272 (31%), Positives = 141/272 (51%), Gaps = 16/272 (5%)
Query: 13 YEVGRTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLV 68
+E+ R +G G + KV R + G+ A+K+L K ++ K K AE + E ++ V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 69 KH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
+ P +V L+ + TK+ ++L++V GGELF + E E R Y +++ A+D+
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN- 186
H G+ +RD+K EN+LLD+ G++ ++DFGLS ++ ++ CGT Y+APEV+
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRG 180
Query: 187 -DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----PPWLSFTA 241
G+D D WS GV+ F LL G PF N +IS P +S A
Sbjct: 181 GSGGHD-KAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239
Query: 242 RKLIARILDPNPMTRI---TIPEILEDEWFKK 270
R I ++L+ +P R+ EI +F+
Sbjct: 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 6e-43
Identities = 87/242 (35%), Positives = 136/242 (56%), Gaps = 4/242 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV-ATMKLVKHPNVVR 75
+ IG+G+F KV AR+ + A+K+L K+ +LK K + I E +K VKHP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + K++ VL+++ GGELF + E AR Y ++ +A+ Y HS + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKPEN+LLD+ G++ ++DFGL + + +G T CGTP Y+APEVL+ + YD T
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLC--KENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W G +L+ +L G PF N +Y I P ++ +AR L+ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237
Query: 256 RI 257
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 8e-43
Identities = 91/273 (33%), Positives = 138/273 (50%), Gaps = 17/273 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVR 75
+ IG+G+F KV A+ G A+K+L K+ +LK K I E + K +KHP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + K++ VL++V GGELF + E AR Y ++ +A+ Y HS + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKPEN+LLD+ G++ ++DFGL + V + T CGTP Y+APEVL YD T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W G +L+ +L G PF ++ +Y I P + A L+ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237
Query: 256 RI-TIPEILE------------DEWFKKDYKPP 275
R+ + LE D+ + K PP
Sbjct: 238 RLGAKADFLEIKNHVFFSPINWDDLYHKRITPP 270
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 9e-43
Identities = 95/262 (36%), Positives = 141/262 (53%), Gaps = 16/262 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMKLVKHP 71
+ IG+G+F KV A+ G+ A+K+L K+ VL KH MAE R V +K VKHP
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAE---RNV-LLKNVKHP 56
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+V L+ + K++ VL+FV GGELF + E AR Y ++ +A+ Y HS
Sbjct: 57 FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN 116
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ +RDLKPEN+LLD+ G++ ++DFGL D T CGTP Y+APEV+ + YD
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT--TFCGTPEYLAPEVIRKQPYD 174
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
+T D W G +L+ +L G PF ++ +Y I P S TA ++ +L+
Sbjct: 175 -NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEK 233
Query: 252 NPMTRI----TIPEILEDEWFK 269
+ R+ EI E +F+
Sbjct: 234 DRQRRLGAKEDFLEIQEHPFFE 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-42
Identities = 90/300 (30%), Positives = 139/300 (46%), Gaps = 57/300 (19%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE----QIKREVATMKLV 68
YE IGEGT+ +V ARN +TGE VALK K+ E RE+ ++ +
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK-----KIRMENEKEGFPITAIREIKLLQKL 55
Query: 69 KHPNVVRLYEVMGSKTK--IFIVLEFV----TGGELFDKIVNHGRMK--EDEARRYFQQL 120
+HPN+VRL E++ SK K I++V E++ TG +++ +K E + + Y +QL
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG------LLDSPEVKFTESQIKCYMKQL 109
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + Y HS G+ HRD+K N+L++ G LK++DFGL A R+ T Y
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWYR 168
Query: 181 APEVL-NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----------SAA 229
PE+L Y D+WS G IL L G F S + +KI +
Sbjct: 169 PPELLLGATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227
Query: 230 EFTCPPW---------------------LSFTARKLIARILDPNPMTRITIPEILEDEWF 268
+ PW + +A L+ ++L +P RI+ + L+ E+F
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 1e-41
Identities = 97/309 (31%), Positives = 143/309 (46%), Gaps = 64/309 (20%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK-I-LDKEKVLKHKMAEQIKREVATMKLVK 69
+YE G+ +GEGT+A V AR+ ETG VA+K I L + K K + RE+ ++ +K
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
HPN++ L +V G K+ I +V EF+ + DK + + + + Y + ++Y
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIKSYMLMTLRGLEY 117
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN-------- 178
HS + HRDLKP NLL+ + G LK++DFGL+ + G+PN
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLA-------------RSFGSPNRKMTHQVV 164
Query: 179 ---YVAPEVLNDRGYDGSTADLWSCGVILFVLLAG--YLPFDDSNLMNLYKKISAA---- 229
Y APE+L + G D+WS G I LL +LP DS++ L KI A
Sbjct: 165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP-GDSDIDQL-GKIFEALGTP 222
Query: 230 ------EFTCPP-WLSFTARK-----------------LIARILDPNPMTRITIPEILED 265
T P ++ F L+ R+L NP RIT + LE
Sbjct: 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282
Query: 266 EWFKKDYKP 274
+F D P
Sbjct: 283 PYFSNDPAP 291
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 1e-41
Identities = 99/331 (29%), Positives = 152/331 (45%), Gaps = 56/331 (16%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E + IG G F +V+ + +TG A+K L K ++L+ + ++ E + +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV+LY + +++++E++ GG++ ++ E+E R Y + I A+D H G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGL-------------------------SALSQQVRDD 167
HRD+KP+NLLLDA G++K+SDFGL +S+ +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 168 GLLHT-----------TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216
T T GTP+Y+APEV GY D WS GVI++ +L GY PF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 217 SNLMNLYKKISAAEFTC--PP--WLSFTARKLIARILDPNPMTRITIP---EILEDEWFK 269
N Y+KI + T P LS A+ LI R+ R+ EI +FK
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFK 300
Query: 270 -------KDYKPPVFEEKK---DT-NLDDVE 289
++ P+ E K DT N DD E
Sbjct: 301 GVDWEHIRERPAPIIPELKSITDTSNFDDFE 331
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-41
Identities = 72/201 (35%), Positives = 109/201 (54%), Gaps = 6/201 (2%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y++ IGEG V A++ ETGE VALK + + L+ + Q RE+ ++ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRR-LEGGIPNQALREIKALQACQHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSR 130
VV+L +V + +V+E++ L + + + R + E + + Y + L+ V Y H+
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL-NDRG 189
G+ HRDLKP NLL+ A G LK++DFGL+ L + L T Y APE+L R
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARL-FSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 190 YDGSTADLWSCGVILFVLLAG 210
YD DLW+ G I LL G
Sbjct: 178 YDPG-VDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 4e-41
Identities = 80/266 (30%), Positives = 133/266 (50%), Gaps = 17/266 (6%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALK---ILDKEKVLKHKMAEQIKREVATMKLVKH 70
E + +G+G+ V R+ TG+ ALK + E+ K Q+ RE+ T++ +
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK-----QLLRELKTLRSCES 58
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS- 129
P VV+ Y + +I IVLE++ GG L D + G++ E +Q++ +DY H+
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
R + HRD+KP NLL+++ G +K++DFG+S + + D +T GT Y++PE +
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--QCNTFVGTVTYMSPERIQGE- 175
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-----SFTARKL 244
AD+WS G+ L G PF + ++ + A PP L S R
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235
Query: 245 IARILDPNPMTRITIPEILEDEWFKK 270
I+ L +P R + E+L+ + KK
Sbjct: 236 ISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 6e-41
Identities = 81/264 (30%), Positives = 141/264 (53%), Gaps = 13/264 (4%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+G +++ + IG+G F+ V A G VALK + +++ K + +E+ +K +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVD 125
HPNV++ ++ IVLE G+L I + + K E +YF QL +A++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEV 184
+ HS+ + HRD+KP N+ + A G +K+ D GL S + H+ GTP Y++PE
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA---AHSLVGTPYYMSPER 177
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAAEFTCPPWLSFTA- 241
+++ GY+ + D+WS G +L+ + A PF D NL +L KKI ++ P ++
Sbjct: 178 IHENGYNFKS-DIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE 236
Query: 242 -RKLIARILDPNPMTRITIPEILE 264
R L++R ++P+P R I +L+
Sbjct: 237 LRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 9e-41
Identities = 80/242 (33%), Positives = 136/242 (56%), Gaps = 4/242 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+ +G+G+F KV A T E A+K+L K+ +L+ + E + L KHP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ +K ++F V+E+V GG+L +I + E +R Y ++ A+ + H GV +R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLDA G+ K++DFG+ + + + T CGTP+Y+APE+L + Y G +
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMC--KEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W+ GV+++ ++AG PF+ N +L++ I + P WLS A ++ + NP
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237
Query: 256 RI 257
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-40
Identities = 73/253 (28%), Positives = 130/253 (51%), Gaps = 6/253 (2%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH--KMAEQIKREVATMKLVKHPNV 73
G+ +G+G F +V + +TG +A+K + + K ++ E+ +K ++H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 133
V+ Y + + I +E++ GG + D++ +G + E R+Y +Q++ V+Y HS +
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTPNYVAPEVLNDRGYDG 192
HRD+K N+L D+ GN+K+ DFG S Q + G + + GTP +++PEV++ GY G
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-G 185
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--AEFTCPPWLSFTARKLIARILD 250
AD+WS G + +L P+ + M KI+ P +S AR + R
Sbjct: 186 RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFV 245
Query: 251 PNPMTRITIPEIL 263
N R + E+L
Sbjct: 246 ENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 3e-40
Identities = 87/251 (34%), Positives = 138/251 (54%), Gaps = 11/251 (4%)
Query: 3 QPKIKRRVGKYE---VGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQI 58
+PK K ++ KYE RT+G G+F +V A +E PVA+K +K K++K K + +
Sbjct: 20 EPKRKNKM-KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHV 78
Query: 59 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 118
E + + HP V LY ++ +++VLEFV GGE F + + R D Y
Sbjct: 79 FSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAA 138
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
Q++ +Y S + +RDLKPENLLLD G +K++DFG + + D +T CGTP
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPE 193
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS 238
Y+APE+L + G+ G AD W+ G+ ++ +L G PF + + +Y+KI P +L
Sbjct: 194 YIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLD 252
Query: 239 FTARKLIARIL 249
+ L+ ++L
Sbjct: 253 NNCKHLMKKLL 263
|
Length = 340 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-40
Identities = 92/286 (32%), Positives = 152/286 (53%), Gaps = 22/286 (7%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE---VATMKLVKHPNVVR 75
IG+GTF +V R +T A+K+L K++++ K E + L + P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L + + +++V ++++GGELF + GR ED A+ Y +L+ A+++ H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV-LNDRGYDGST 194
DLKPEN+LLDA G++ + DFGLS + D+ +T CGT Y+APEV L+++GY
Sbjct: 121 DLKPENILLDATGHIALCDFGLS--KANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177
Query: 195 ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-WLSFTARKLIARILDPNP 253
D WS GV++F + G+ PF + +Y+ I+ + P LS R+ + +L+ NP
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237
Query: 254 MTRI----TIPEILEDEWF---------KKDYKPPVFEEKKDTNLD 286
R+ E+ E +F KK PP F+ D++ D
Sbjct: 238 QHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPP-FKPIVDSDED 282
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 4e-40
Identities = 88/281 (31%), Positives = 151/281 (53%), Gaps = 15/281 (5%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE--QIKREVATMKLVKHPNVV 74
+ +G+G+F KV A T E A+K L K+ VL+ E ++R V + +HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLT 59
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
L+ +K +F V+E++ GG+L I + GR E AR Y ++I + + H +G+ +
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLK +N+LLD G++K++DFG+ + + +G T CGTP+Y+APE+L + Y+ S
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMC--KENMNGEGKASTFCGTPDYIAPEILKGQKYNESV 177
Query: 195 ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPM 254
D WS GV+L+ +L G PF + L+ I P W+S A+ ++++ + +P
Sbjct: 178 -DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPT 236
Query: 255 TRITIPEILEDEWFKK--DYK-------PPVFEEKKDTNLD 286
R+ + + F + D++ PP F+ K + D
Sbjct: 237 KRLGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSD 277
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 5e-40
Identities = 82/251 (32%), Positives = 140/251 (55%), Gaps = 13/251 (5%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
R IG G++AKV +T A+K++ KE V + + ++ E + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ +++++F V+EFV+GG+L + ++ E+ AR Y ++ A+++ H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLDA G++K++D+G+ + +R T CGTPNY+APE+L Y S
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMC--KEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV- 177
Query: 196 DLWSCGVILFVLLAGYLPFD-----DSNLMN----LYKKISAAEFTCPPWLSFTARKLIA 246
D W+ GV++F ++AG PFD D+ N L++ I + P LS A ++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237
Query: 247 RILDPNPMTRI 257
L+ +P R+
Sbjct: 238 GFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 76/257 (29%), Positives = 130/257 (50%), Gaps = 7/257 (2%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVATMKLVK 69
++ G +G G+F V N + G+ A+K L + + +Q+++E+A + ++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
HPN+V+ + ++I LE V GG L + +G E R Y +Q++ ++Y H
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
R HRD+K N+L+D G +K++DFG +++QV + + G+P ++APEV+ +G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFG---MAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTCPPWLSFTARKLIAR 247
G AD+WS G + + G P+ + KI S P LS A+ I +
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237
Query: 248 ILDPNPMTRITIPEILE 264
L +P R T E+LE
Sbjct: 238 CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 87/258 (33%), Positives = 139/258 (53%), Gaps = 10/258 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+YE+ + IGEG+F K+ A+ E +K +D K + K E K+EV + +KHP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK-MPVKEKEASKKEVILLAKMKHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRM-KEDEARRYFQQLINAVDYCHS 129
N+V + ++FIV+E+ GG+L +I G + ED+ +F Q+ + + H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 130 RGVYHRDLKPENLLLDAYGNL-KVSDFGLSALSQQVRDDGLLHTTC-GTPNYVAPEVLND 187
R + HRD+K +N+ L G + K+ DFG +++Q+ D L TC GTP Y++PE+ +
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFG---IARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIA 246
R Y+ T D+WS G +L+ L PF+ +NL L KI F P S R LI+
Sbjct: 177 RPYNNKT-DIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLIS 235
Query: 247 RILDPNPMTRITIPEILE 264
++ +P R +I IL+
Sbjct: 236 QLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 99/316 (31%), Positives = 163/316 (51%), Gaps = 28/316 (8%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
K++ + Y+V + IG G F +V+ R+ + + A+K+L K +++K + E
Sbjct: 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
M P VV+L+ +++V+E++ GG+L + + N+ + E A+ Y +++ A+
Sbjct: 97 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLAL 155
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH--TTCGTPNYVAP 182
D HS G+ HRD+KP+N+LLD +G+LK++DFG ++ + G++ T GTP+Y++P
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG---TCMKMDETGMVRCDTAVGTPDYISP 212
Query: 183 EVLNDR---GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----SAAEFTCPP 235
EVL + GY G D WS GV LF +L G PF +L+ Y KI ++ F
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV 272
Query: 236 WLSFTARKLIARILDPNP--MTRITIPEILEDEWFKKDY----------KPPVFEEKKD- 282
+S A+ LI L + R + EI + +FK D P V E D
Sbjct: 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDI 332
Query: 283 --TNLDDVEAVFKDSE 296
+N DD+E D E
Sbjct: 333 DSSNFDDIEDDKGDVE 348
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 5e-39
Identities = 81/267 (30%), Positives = 135/267 (50%), Gaps = 16/267 (5%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALK-------ILDKEKVLKHKMAEQIKREVATMKLV 68
G IG+GT+ +V A N TGE +A+K I + + M + ++ E+ T+K +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
H N+V+ ++ + I LE+V GG + + +GR +E R + +Q++ + Y H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND- 187
S+G+ HRDLK +NLL+DA G K+SDFG+S S + D+ + G+ ++APEV++
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 188 -RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP------PWLSFT 240
+GY D+WS G ++ + AG P+ D + K+ P LS
Sbjct: 186 SQGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPV 244
Query: 241 ARKLIARILDPNPMTRITIPEILEDEW 267
A + NP R T E+L+ +
Sbjct: 245 ALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 9e-39
Identities = 70/256 (27%), Positives = 124/256 (48%), Gaps = 11/256 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
++V + +G+G++ V + + ALK +D + + + + + E+ + V HPN
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHPN 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVDYCH 128
++ E K+ IV+E+ G+L I + + E E R F QL+ + H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ + HRDLK N+LL A +K+ D G+S + ++ + T GTP+Y+APEV R
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAPEVWKGR 176
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIAR 247
Y +D+WS G +L+ + PF+ ++ +L K+ ++ PP S + I
Sbjct: 177 PYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRS 235
Query: 248 ILDPNPMTRITIPEIL 263
+L P R +IL
Sbjct: 236 MLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 84/257 (32%), Positives = 141/257 (54%), Gaps = 14/257 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IGEG+ V A + TG VA+K +D + K + E + EV M+ +HPN+V +Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
++++V+EF+ GG L D IV H RM E++ ++ A+ + H++GV HRD+K
Sbjct: 84 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142
Query: 139 PENLLLDAYGNLKVSDFGLSA-LSQQV-RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
+++LL + G +K+SDFG A +S++V R L+ GTP ++APEV++ Y G+ D
Sbjct: 143 SDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPEVISRLPY-GTEVD 197
Query: 197 LWSCGVILFVLLAGYLP-FDDSNL--MNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
+WS G+++ ++ G P F++ L M + + +S R + R+L +P
Sbjct: 198 IWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDP 257
Query: 254 MTRITIPEILEDEWFKK 270
R T E+L + K
Sbjct: 258 AQRATAAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 81/256 (31%), Positives = 141/256 (55%), Gaps = 14/256 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEK-VLKHKMAEQIKREVATMKLV 68
+E+ + +G G + KV R +TG+ A+K+L K V K K E + E ++ V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 69 KH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
+ P +V L+ ++ K+ ++L++V+GGE+F + EDE R Y ++I A+++
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTCGTPNYVAPEVL 185
H G+ +RD+K EN+LLD+ G++ ++DFGLS LS++ ++ CGT Y+APE++
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT---YSFCGTIEYMAPEII 178
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----PPWLSFTA 241
+G G D WS G+++F LL G PF N ++S C P ++ A
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238
Query: 242 RKLIARILDPNPMTRI 257
+ L+ ++L +P R+
Sbjct: 239 QDLLHKLLRKDPKKRL 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 83/268 (30%), Positives = 141/268 (52%), Gaps = 31/268 (11%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E + I G + V R+ ET + A+K ++K+ ++ +Q+ E + ++P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV ++ +K + +V+E+V GG+ + N G + D AR YF + + A++Y H+ G+
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT------------------- 173
HRDLKP+NLL+ + G++K++DFGLS + GL+ T
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKI-------GLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 174 -CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT 232
CGTP Y+APEV+ +GY G D W+ G+IL+ L G +PF L+ ++ + +
Sbjct: 176 VCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 234
Query: 233 CPPW---LSFTARKLIARILDPNPMTRI 257
P L A+ LI+R+L NP+ R+
Sbjct: 235 WPEGDEALPADAQDLISRLLRQNPLERL 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 96/308 (31%), Positives = 156/308 (50%), Gaps = 28/308 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
++V + IG G F +V+ R+ + + A+K+L K +++K + E M
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V+L+ +++V+E++ GG+L + + N+ + E AR Y +++ A+D HS G
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGF 163
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH--TTCGTPNYVAPEVLNDRGY 190
HRD+KP+N+LLD G+LK++DFG ++ +G++ T GTP+Y++PEVL +G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCM---KMDANGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 191 D---GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----SAAEFTCPPWLSFTARK 243
D G D WS GV L+ +L G PF +L+ Y KI ++ F +S A+
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKD 280
Query: 244 LIARILDPNP--MTRITIPEILEDEWFKKDY---------KPPVFEEKK---DT-NLDDV 288
LI L + R + EI +FK D PV E DT N DD+
Sbjct: 281 LICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNFDDI 340
Query: 289 EAVFKDSE 296
E K+ E
Sbjct: 341 EDDDKNEE 348
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 4e-38
Identities = 81/258 (31%), Positives = 140/258 (54%), Gaps = 11/258 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY + IGEG+F K ++ E G+ +K ++ K + K E+ ++EVA + +KHP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK-MSPKEREESRKEVAVLSNMKHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYCH 128
N+V+ E ++IV+++ GG+L+ KI N R ED+ +F Q+ A+ + H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVLND 187
R + HRD+K +N+ L G +K+ DFG++ L+ V L T GTP Y++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE---LARTCIGTPYYLSPEICEN 175
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIA 246
R Y+ + +D+W+ G +L+ + F+ N+ NL KI + S+ R L++
Sbjct: 176 RPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVS 234
Query: 247 RILDPNPMTRITIPEILE 264
++ NP R ++ ILE
Sbjct: 235 QLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 5e-38
Identities = 81/222 (36%), Positives = 117/222 (52%), Gaps = 17/222 (7%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALK---ILDKEKVLKHKMAEQIKREVATMKL 67
KYEV +GEG + V RN TGE VA+K + ++ +K + REV ++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK----KTALREVKVLRQ 56
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFV--TGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
++H N+V L E K ++++V E+V T EL + + G + D R Y QL+ A+
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIA 114
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEV 184
YCHS + HRD+KPEN+L+ G LK+ DFG + AL + L T Y APE+
Sbjct: 115 YCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP--LTDYVATRWYRAPEL 172
Query: 185 L-NDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYK 224
L D Y G D+W+ G I+ LL G F DS++ LY
Sbjct: 173 LVGDTNY-GKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 5e-38
Identities = 80/268 (29%), Positives = 137/268 (51%), Gaps = 21/268 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y+ IGEG +V A + TG+ VA+K K ++ K E I E+ MK KHP
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIK---KMRLRKQNK-ELIINEILIMKDCKHP 75
Query: 72 NVVRLYE---VMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYC 127
N+V Y+ V +++V+E++ GG L D I + RM E + ++++ ++Y
Sbjct: 76 NIVDYYDSYLVGDE---LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLN 186
HS+ V HRD+K +N+LL G++K++DFG +A L+++ ++ GTP ++APEV+
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK---SKRNSVVGTPYWMAPEVIK 189
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKISAA---EFTCPPWLSFTAR 242
+ Y D+WS G++ + G P + L L+ I+ P S +
Sbjct: 190 RKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-LITTKGIPPLKNPEKWSPEFK 247
Query: 243 KLIARILDPNPMTRITIPEILEDEWFKK 270
+ + L +P R + E+L+ + KK
Sbjct: 248 DFLNKCLVKDPEKRPSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 139 bits (350), Expect = 1e-37
Identities = 82/251 (32%), Positives = 141/251 (56%), Gaps = 13/251 (5%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
R IG G++AKV R +T A+K++ KE V + + ++ E + HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ +++++F V+E+V GG+L + ++ E+ AR Y ++ A++Y H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD+ G++K++D+G+ + +R T CGTPNY+APE+L Y G +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 196 DLWSCGVILFVLLAGYLPFD--------DSNLMN-LYKKISAAEFTCPPWLSFTARKLIA 246
D W+ GV++F ++AG PFD D N + L++ I + P LS A ++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237
Query: 247 RILDPNPMTRI 257
L+ +P R+
Sbjct: 238 SFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 86/272 (31%), Positives = 133/272 (48%), Gaps = 23/272 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YE+ IG G A V A E VA+K +D EK +++++EV M HPN
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNHPN 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFD---KIVNHGRMKEDEARRYFQQLINAVDYCHS 129
VV+ Y ++++V+ +++GG L D G + E ++++ ++Y HS
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQV-RDDGLLHTTCGTPNYVAPEVLN- 186
G HRD+K N+LL G++K++DFG+SA L+ R + T GTP ++APEV+
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYKKISAAEFTCPPWLSFTA---- 241
GYD AD+WS G+ L G P+ M L + PP L A
Sbjct: 181 VHGYD-FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND----PPSLETGADYKK 235
Query: 242 -----RKLIARILDPNPMTRITIPEILEDEWF 268
RK+I+ L +P R T E+L+ ++F
Sbjct: 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 97/308 (31%), Positives = 157/308 (50%), Gaps = 28/308 (9%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM 65
++ + YEV + IG G F +V+ R+ T + A+K+L K +++K + E M
Sbjct: 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
P VV+L+ +++V+E++ GG+L + + N+ + E AR Y +++ A+D
Sbjct: 98 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALD 156
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH--TTCGTPNYVAPE 183
HS G HRD+KP+N+LLD G+LK++DFG ++ +G++ T GTP+Y++PE
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFG---TCMKMNKEGMVRCDTAVGTPDYISPE 213
Query: 184 VLNDR---GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----SAAEFTCPPW 236
VL + GY G D WS GV L+ +L G PF +L+ Y KI ++ F
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 273
Query: 237 LSFTARKLIARILDPNP--MTRITIPEILEDEWFKKDY----------KPPVFEEKKD-- 282
+S A+ LI L + R + EI +FK D P V + D
Sbjct: 274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDID 333
Query: 283 -TNLDDVE 289
+N DD+E
Sbjct: 334 TSNFDDIE 341
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 4e-37
Identities = 85/287 (29%), Positives = 146/287 (50%), Gaps = 22/287 (7%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLY 77
+G+G+F KV A T E A+KIL K+ +++ E E + L P + +L+
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
+ +++ V+E+V GG+L I G+ KE A Y ++ + + HS+G+ +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
K +N++LDA G++K++DFG+ + + T CGTP+Y+APE++ + Y G + D
Sbjct: 128 KLDNVMLDAEGHIKIADFGMC--KENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI 257
W+ GV+L+ +LAG PFD + L++ I + P LS A + +L +P R+
Sbjct: 185 WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRL 244
Query: 258 TI-----PEILEDEWFKK-------------DYKPPVFEEKKDTNLD 286
+I E +F++ +KP V + N D
Sbjct: 245 GCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFD 291
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 4e-37
Identities = 80/249 (32%), Positives = 141/249 (56%), Gaps = 11/249 (4%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVR 75
R IG G++AKV R + + A+K++ KE V + + ++ E + +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + +++F+V+E+V GG+L + ++ E+ AR Y ++ A+++ H RG+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLDA G++K++D+G+ + + T CGTPNY+APE+L Y G +
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMC--KEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 196 DLWSCGVILFVLLAGYLPFD---DSNLMN----LYKKISAAEFTCPPWLSFTARKLIARI 248
D W+ GV++F ++AG PFD D+ MN L++ I P +LS A ++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237
Query: 249 LDPNPMTRI 257
L+ +P R+
Sbjct: 238 LNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 8e-37
Identities = 88/264 (33%), Positives = 135/264 (51%), Gaps = 25/264 (9%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILD--KEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G+G F KV A++ ETG A KI+ E+ L+ M E + + KHPN+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVE-----IDILSECKHPNIVGL 67
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHR 135
YE + K++I++EF GG L ++ R + E + R +Q++ A+++ HS V HR
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN-----DRGY 190
DLK N+LL G++K++DFG+SA ++ T GTP ++APEV+ D Y
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNK--STLQKRDTFIGTPYWMAPEVVACETFKDNPY 185
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL------SFTARKL 244
D AD+WS G+ L L P + N M + KI +E PP L S +
Sbjct: 186 D-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE---PPTLDQPSKWSSSFNDF 241
Query: 245 IARILDPNPMTRITIPEILEDEWF 268
+ L +P R T E+L+ +
Sbjct: 242 LKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 9e-37
Identities = 76/243 (31%), Positives = 111/243 (45%), Gaps = 42/243 (17%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +TIG G F +V R +T A+K L K VL A +K E + +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV+LY K ++ V++++ GG++ ++ G +ED AR Y +L A++ H G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSA------------LSQQVRDDG------------ 168
HRD+KP+N+L+D G++K++DFGL R D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 169 -----------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211
L H+ GTPNY+APEVL GY D WS GVIL+ +L G
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQ 241
Query: 212 LPF 214
PF
Sbjct: 242 PPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 1e-36
Identities = 90/308 (29%), Positives = 148/308 (48%), Gaps = 43/308 (13%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+G +V R TG+ ALK+LDK++++K +++ E + + HP + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 77 YEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
Y ++T + +V+++ GGELF + + E+ AR Y +++ A++Y H G+ +
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALS----QQVRDDGL-----------LHTT------ 173
RDLKPEN+LL G++ +SDF LS S V T
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 174 ------CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS 227
GT Y+APEV++ G+ GS D W+ G++L+ +L G PF SN + I
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245
Query: 228 AAEFTCP--PWLSFTARKLIARILDPNPMTRI----TIPEILEDEWFK-------KDYKP 274
E T P P +S +AR LI ++L +P R+ EI + +F+ + P
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTP 305
Query: 275 PVFEEKKD 282
P+ D
Sbjct: 306 PIIPRPDD 313
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 2e-36
Identities = 77/244 (31%), Positives = 131/244 (53%), Gaps = 4/244 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+ +G+G+F KV A T + A+K L K+ VL E E + L +HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
LY +K +F V+E++ GG+L I + + A Y ++I + + HS+G+ +R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD G++K++DFG+ + + D T CGTP+Y+APE+L + Y ++
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMC--KENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D WS GV+L+ +L G PF + L++ I P WL+ A+ ++ ++ P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237
Query: 256 RITI 259
R+ +
Sbjct: 238 RLGV 241
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 83/268 (30%), Positives = 131/268 (48%), Gaps = 34/268 (12%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKIL---DKEKVLKHKMAEQIKREVATMKLVKH 70
E IG G V + TG ALK++ ++ V + QI RE+ ++ V H
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR-----QICREIEILRDVNH 131
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
PNVV+ +++ +I ++LEF+ GG L + + D AR Q+++ + Y H R
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRR 187
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV----LN 186
+ HRD+KP NLL+++ N+K++DFG+S + Q D +++ GT Y++PE LN
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLN 245
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPF------DDSNLMNLYKKISAAEFTCPPWLSFT 240
YDG D+WS GV + G PF D ++LM A + PP T
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM------CAICMSQPPEAPAT 299
Query: 241 A----RKLIARILDPNPMTRITIPEILE 264
A R I+ L P R + ++L+
Sbjct: 300 ASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 6e-36
Identities = 81/266 (30%), Positives = 139/266 (52%), Gaps = 4/266 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+ +G+G+F KV A GE A+K L K+ VL E E + L ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
LY +K +F V+EF+ GG+L I + GR A Y +++ + + HS+G+ +R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N++LD G++K++DFG+ + V D T CGTP+Y+APE+L Y S
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV- 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D WS GV+L+ +L G PF + L++ I P W++ ++ ++ ++ + +P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237
Query: 256 RITIPEILEDEWFKKDYKPPVFEEKK 281
R+ + + F K E+++
Sbjct: 238 RLGVVGNIRGHPFFKTINWTALEKRE 263
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 8e-36
Identities = 78/259 (30%), Positives = 132/259 (50%), Gaps = 11/259 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KYE R +G G F V R + V +K + E++ K + E +KL+ HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHS 129
N++ YE + IV+E+ GG L + I + ED +F Q++ A+ + H+
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 130 RGVYHRDLKPENLLLDAYGN-LKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLND 187
+ + HRDLK +N+LLD + +K+ DFG+S LS + + +T GTP Y++PE+
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK----AYTVVGTPCYISPELCEG 175
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIA 246
+ Y+ +D+W+ G +L+ L + F+ +NL L KI + F S R+LI
Sbjct: 176 KPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLIL 234
Query: 247 RILDPNPMTRITIPEILED 265
+L+ +P R + +I+
Sbjct: 235 SMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 1e-35
Identities = 91/309 (29%), Positives = 158/309 (51%), Gaps = 21/309 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLY 77
+G+G+F KV A T E A+KIL K+ V++ E E + L K P + +L+
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
+ +++ V+E+V GG+L +I GR KE A Y ++ + + HS+G+ +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
K +N++LD+ G++K++DFG+ + + D T CGTP+Y+APE++ + Y G + D
Sbjct: 128 KLDNVMLDSEGHIKIADFGMC--KENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI 257
W+ GV+L+ +LAG PF+ + L++ I P +S A + ++ +P R+
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRL 244
Query: 258 TI-PE----ILEDEWFK---------KDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQ 303
PE I E +F+ K+ +PP + + ++ + F H
Sbjct: 245 GCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACGRDAENFDKFFT---RHPPVLT 301
Query: 304 KEEQPVAMN 312
+Q V MN
Sbjct: 302 PPDQEVIMN 310
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 71/202 (35%), Positives = 111/202 (54%), Gaps = 11/202 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
Y+ IGEGT+ V AR+ TGE VA+K + K + + + RE+ +K + HPN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPN 59
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSR 130
+++L +V K +++V EF+ K++ + + E + Y QL+ + +CHS
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMD--TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVL-NDR 188
G+ HRDLKPENLL++ G LK++DFG L++ +T T Y APE+L D+
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFG---LARSFGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 189 GYDGSTADLWSCGVILFVLLAG 210
GY + D+WS G I LL+
Sbjct: 175 GY-STPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 9e-35
Identities = 78/240 (32%), Positives = 134/240 (55%), Gaps = 4/240 (1%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLY 77
+G+G+F KV A T E A+KIL K+ V++ E E + L K P + +L+
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
+ +++ V+E+V GG+L I G+ KE +A Y ++ + + H RG+ +RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
K +N++LD+ G++K++DFG+ + + D T CGTP+Y+APE++ + Y G + D
Sbjct: 128 KLDNVMLDSEGHIKIADFGMC--KEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI 257
W+ GV+L+ +LAG PFD + L++ I + P LS A + ++ +P R+
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 68/197 (34%), Positives = 106/197 (53%), Gaps = 11/197 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-REV-ATMKLVKH 70
Y+V + +G+GTF V ARN ETGE VA+K + K+K + E + REV + KL +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKF--YSWEECMNLREVKSLRKLNEH 57
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEARRYFQQLINAVDYCH 128
PN+V+L EV +++ V E++ G L+ + + E R Q++ + + H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
G +HRDLKPENLL+ +K++DFG L++++R T Y APE+L
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFG---LAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 189 GYDGSTADLWSCGVILF 205
S D+W+ G I+
Sbjct: 174 TSYSSPVDIWALGCIMA 190
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 84/321 (26%), Positives = 146/321 (45%), Gaps = 25/321 (7%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
++V +G G F +V+ R TG+ A+K++ K +L + + E + + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
+ +L K +++V+E+ GG+L + + + ED A+ Y +L+ A+ H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAPEVLND-R 188
HRD+KPEN+L+D G++K++DFG +A ++ + ++++ GTP+Y+APEVL
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAA---RLTANKMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 189 GYDGST----ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----SAAEFTCPPWLSFT 240
G T D WS GVI + ++ G PF + Y I +F P +S
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239
Query: 241 ARKLIARILDPNPMTRITI------PEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKD 294
LI +L R+ P + +W P F + DD + F +
Sbjct: 240 FLDLIQSLL-CGQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTLKS--DDDTSNFDE 296
Query: 295 SEEHH-VTEQKEEQPVAMNAF 314
E++ Q + N F
Sbjct: 297 PEKNSTRRSQSSTTQLKPNGF 317
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 3e-34
Identities = 81/272 (29%), Positives = 132/272 (48%), Gaps = 38/272 (13%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E + IG G F +V+ + +TG A+KIL K +L+ + I+ E +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV+++ K +++++EF+ GG++ ++ + E+ + Y + + A+D H G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGL-SALSQQVRDD------------------------ 167
HRD+KP+NLLLDA G++K+SDFGL + L + R +
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 168 --------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL 219
L ++T GTP+Y+APEV GY+ D WS GVI++ +L GY PF
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 220 MNLYKKIS--AAEFTCPPW--LSFTARKLIAR 247
Y+K+ PP +S A+ LI R
Sbjct: 242 QETYRKVMNWKETLVFPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 4e-34
Identities = 77/256 (30%), Positives = 145/256 (56%), Gaps = 13/256 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARN---SETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLV 68
+E+ + +G G + KV R ++G+ A+K+L K ++ K K E + E ++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 69 KH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
+ P +V L+ + TK+ ++L+++ GGELF + R KE E + Y +++ A+++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL-- 185
H G+ +RD+K EN+LLD+ G++ ++DFGLS + + ++ CGT Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRG 180
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPF----DDSNLMNLYKKISAAEFTCPPWLSFTA 241
D G+D D WS GV+++ LL G PF + ++ + ++I +E P +S A
Sbjct: 181 GDGGHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239
Query: 242 RKLIARILDPNPMTRI 257
+ +I R+L +P R+
Sbjct: 240 KDIIQRLLMKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 4e-34
Identities = 89/288 (30%), Positives = 136/288 (47%), Gaps = 49/288 (17%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKI--LDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+GEGT+A V RN TGE VALK LD E+ RE++ MK +KH N+VRL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEE----GTPSTAIREISLMKELKHENIVRL 63
Query: 77 YEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
++V+ ++ K+ +V E++ + D G + + + + QL+ + +CH V H
Sbjct: 64 HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG----TPNYVAPEVL-NDRG 189
RDLKP+NLL++ G LK++DFGL+ R G+ T T Y AP+VL R
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLA------RAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 190 YDGSTADLWSCGVILFVLLAGYLPF---DDSNLMNLYKKI--SAAEFTCP---------- 234
Y S D+WS G I+ ++ G F ++ + + +I + E T P
Sbjct: 178 YSTSI-DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236
Query: 235 --------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268
P L+ R+L NP RI+ + L+ WF
Sbjct: 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 5e-34
Identities = 78/194 (40%), Positives = 107/194 (55%), Gaps = 20/194 (10%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKIL----DKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
IGEGT+ V AR+ TGE VALK + + E V + RE++ +K + HPN+V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI-----REISLLKELNHPNIV 61
Query: 75 RLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
RL +V+ S+ K+++V EF+ + D G + + Y QL+ + YCHS V
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHSHRV 120
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEV-LNDRGY 190
HRDLKP+NLL+D G LK++DFGL+ A VR H T Y APE+ L R Y
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEVV-TLWYRAPEILLGSRQY 177
Query: 191 DGSTA-DLWSCGVI 203
ST D+WS G I
Sbjct: 178 --STPVDIWSIGCI 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 80/282 (28%), Positives = 126/282 (44%), Gaps = 50/282 (17%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ IG+G F +V+ + +TG+ A+K L K ++ K +K E + P VV L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
Y +++++EF+ GG+L ++ + ED R Y + + A++ H G HRD
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDG---------------------------- 168
+KP+N+L+D G++K+SDFGLS + D
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 169 -----------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211
+ ++T GTP+Y+APE+ +GY G D WS G I+F L G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245
Query: 212 LPFDDSNLMNLYKKISAAE----FTCPPWLSFTARKLIARIL 249
PF N Y+KI F LS A LI R++
Sbjct: 246 PPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI 287
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 9e-34
Identities = 76/256 (29%), Positives = 125/256 (48%), Gaps = 9/256 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
Y R +G+G F + R +E V K ++ + L K E+ + L++HPN
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHPN 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSR 130
++ Y + I +E+ GG L+DKIV +E+ Y Q+++AV Y H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTPNYVAPEVLNDRG 189
G+ HRD+K N+ L G +K+ DFG +S+ + + + T GTP Y++PE+
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFG---ISKILGSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARI 248
Y+ +D+W+ G +L+ LL FD +N +NL KI +T S L+ +
Sbjct: 178 YN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236
Query: 249 LDPNPMTRITIPEILE 264
L +P R T E+L+
Sbjct: 237 LQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 9e-34
Identities = 78/242 (32%), Positives = 119/242 (49%), Gaps = 7/242 (2%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI---KREVATMKLVKHPNVVR 75
+G G F KV A +TGE A+K L K ++ E + KR T +HP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ ++ + V+E+ GG+L I + E A Y ++ + Y H + +R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +NLLLD G +K++DFGL D T CGTP ++APEVL + Y +
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVLTETSYTRAV- 182
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W GV+++ +L G PF + ++ I E P +LS A ++ R+L NP
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPER 242
Query: 256 RI 257
R+
Sbjct: 243 RL 244
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 79/262 (30%), Positives = 131/262 (50%), Gaps = 18/262 (6%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALK--ILD----KEKVLKHKMAEQIKREVATMKLVK 69
G IG G+F V N+ +GE +A+K L K K M + + RE+A +K ++
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
H N+V+ + I LE+V GG + + N+G +E R + +Q++ ++Y H+
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-------GTPNYVAP 182
RG+ HRD+K N+L+D G +K+SDFG +S+++ + L T G+ ++AP
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFG---ISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI-SAAEFTCPPWLSFTA 241
EV+ Y AD+WS G ++ +L G PF D + KI A P +S A
Sbjct: 182 EVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEA 240
Query: 242 RKLIARILDPNPMTRITIPEIL 263
+ + + + R T E+L
Sbjct: 241 IDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 3e-33
Identities = 72/265 (27%), Positives = 129/265 (48%), Gaps = 12/265 (4%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKILD---KEKVLKHKMAEQIKREVATMKLVKHPN 72
G+ +G G F+ AR+ +TG +A+K + + ++ E +++E+ M + HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
++R+ + + +E++ GG + + +G KE Y +QL+ + Y H +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 133 YHRDLKPENLLLDAYGN-LKVSDFGLSA-LSQQVRDDGLLH-TTCGTPNYVAPEVLNDRG 189
HRD+K NLL+D+ G L+++DFG +A L+ + G GT ++APEVL
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK---KISAAEFT--CPPWLSFTARKL 244
Y G + D+WS G ++ + P++ N KI++A P LS R +
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243
Query: 245 IARILDPNPMTRITIPEILEDEWFK 269
R L+ P R E+L+ F+
Sbjct: 244 TLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 82/272 (30%), Positives = 132/272 (48%), Gaps = 38/272 (13%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E + IG G F +V+ + +TG A+KIL K +L+ + I+ E +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV+++ K +++++EF+ GG++ ++ + E+E + Y + + A+D H G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGL-SALSQQVRDD------------------------ 167
HRD+KP+NLLLD+ G++K+SDFGL + L + R +
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 168 --------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL 219
L +T GTP+Y+APEV GY+ D WS GVI++ +L GY PF
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 220 MNLYKKIS--AAEFTCPPW--LSFTARKLIAR 247
YKK+ PP +S A+ LI R
Sbjct: 242 QETYKKVMNWKETLIFPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 6e-33
Identities = 80/255 (31%), Positives = 132/255 (51%), Gaps = 11/255 (4%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+ + + + IG G F++V A G PVALK + ++ K +E+ +K +
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVD 125
HPNV++ Y ++ IVLE G+L I + + K E +YF QL +A++
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
+ HSR V HRD+KP N+ + A G +K+ D GL H+ GTP Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERI 178
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAAEFTCPPWLSFTA-- 241
++ GY+ +D+WS G +L+ + A PF D NL +L KKI ++ P ++
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237
Query: 242 RKLIARILDPNPMTR 256
R+L+ ++P+P R
Sbjct: 238 RQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 9e-33
Identities = 83/278 (29%), Positives = 140/278 (50%), Gaps = 29/278 (10%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKIL----DKEKVLKHKMAEQIKREVATMKL 67
+ E+ IG G + V ++ TG VALKI+ + V I+REVA +
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV------SDIQREVALLSQ 55
Query: 68 VKH---PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
++ PN+ + Y +++I++E+ GG + ++ G + E ++++ A+
Sbjct: 56 LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVAL 114
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
Y H GV HRD+K N+L+ GN+K+ DFG++AL Q T GTP ++APEV
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEV 172
Query: 185 LND-RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-----S 238
+ + + YD + AD+WS G+ ++ + G P+ D + I ++ PP L S
Sbjct: 173 ITEGKYYD-TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK---PPRLEDNGYS 228
Query: 239 FTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
R+ +A LD P R++ E+L+ +W K K PV
Sbjct: 229 KLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPV 266
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 9e-33
Identities = 79/263 (30%), Positives = 137/263 (52%), Gaps = 11/263 (4%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+ +++ + IG G F++V A +PVALK + +++ K + +E+ +K +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVD 125
HPNV++ + ++ IVLE G+L I + K E +YF QL +AV+
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
+ HSR V HRD+KP N+ + A G +K+ D GL H+ GTP Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 178
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAAEFTCPPWLSFTA-- 241
++ GY+ +D+WS G +L+ + A PF D NL +L +KI ++ P ++
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237
Query: 242 RKLIARILDPNPMTRITIPEILE 264
R+L++ + P+P R I + +
Sbjct: 238 RELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 75/265 (28%), Positives = 135/265 (50%), Gaps = 16/265 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ + IG+G+F +V A + T + VA+K++D E+ E I++E+ + + P
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE--IEDIQQEIQFLSQCRSP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+ + Y +K++I++E+ GG D ++ G++ E ++++ ++Y H G
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHTTCGTPNYVAPEVLNDRGY 190
HRD+K N+LL G++K++DFG+S Q+ +T GTP ++APEV+ GY
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSG---QLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-----SFTARKLI 245
D AD+WS G+ L G P D + M + I PP L S + +
Sbjct: 176 D-EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN---PPSLEGNKFSKPFKDFV 231
Query: 246 ARILDPNPMTRITIPEILEDEWFKK 270
+ L+ +P R + E+L+ ++ KK
Sbjct: 232 SLCLNKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 68/216 (31%), Positives = 116/216 (53%), Gaps = 11/216 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+++ +GEG++ V A + ETG+ VA+K++ E+ L ++I +E++ +K P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-----QEIIKEISILKQCDSPY 59
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
+V+ Y T ++IV+E+ G + D KI N + E+E Q + ++Y HS
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSN 118
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
HRD+K N+LL+ G K++DFG+S Q +T GTP ++APEV+ + GY
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
+ + AD+WS G+ + G P+ D + M I
Sbjct: 177 N-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI 211
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 2e-32
Identities = 73/249 (29%), Positives = 123/249 (49%), Gaps = 11/249 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ IG+G+F V A+K +D K + + E+ E + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK-MNRREREEAIDEARVLAKLDSSY 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSR 130
++R YE K K+ IV+E+ G+L + + ED+ R+F Q++ + + HS+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ HRD+K NL LDAY N+K+ D G++ LS +T GTP Y++PE+ D+
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN---TNFANTIVGTPYYLSPELCEDKP 177
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR--KLIAR 247
Y+ +D+W+ GV+L+ G PFD +N L KI F P ++ + +LI +
Sbjct: 178 YN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP-PVSQMYSQQLAQLIDQ 235
Query: 248 ILDPNPMTR 256
L + R
Sbjct: 236 CLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 71/189 (37%), Positives = 103/189 (54%), Gaps = 10/189 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKI--LDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
IGEGT+ V ARN TGE VALK LD E + RE++ +K + HPN+V+L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 64
Query: 77 YEVMGSKTKIFIVLEFVTGG-ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
+V+ ++ K+++V EF+ + F + + Y QL+ + +CHS V HR
Sbjct: 65 LDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 124
Query: 136 DLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
DLKP+NLL++ G +K++DFGL+ A VR H T Y APE+L Y +
Sbjct: 125 DLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYSTA 181
Query: 195 ADLWSCGVI 203
D+WS G I
Sbjct: 182 VDIWSLGCI 190
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 96/295 (32%), Positives = 141/295 (47%), Gaps = 49/295 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKIL----DKEKVLKHKMAEQIKREVATMKL 67
KYE IGEGT+ V A+N ET E VALK + D E V + RE+ +K
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-----REICLLKE 55
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVD 125
+KH N+VRLY+V+ S K+ +V E+ + FD +G + + + + QL+ +
Sbjct: 56 LKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLA 113
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEV 184
+CHS V HRDLKP+NLL++ G LK++DFGL+ A VR T Y P+V
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC---YSAEVVTLWYRPPDV 170
Query: 185 L-NDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKI-----SAAEFTCP--- 234
L + Y S D+WS G I L P F +++ + K+I + E + P
Sbjct: 171 LFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229
Query: 235 ---------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268
P L+ T R L+ +L NP+ RI+ E L+ +F
Sbjct: 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 3e-32
Identities = 80/243 (32%), Positives = 113/243 (46%), Gaps = 46/243 (18%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+T+G G F +V AR +T A+K L K+ VL +K E + + VVRL
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
Y K ++ V++++ GG++ ++ G ED AR Y +L AV+ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 137 LKPENLLLDAYGNLKVSDFGL---------SALSQ---QVRDDG---------------- 168
+KP+N+L+D G++K++DFGL S Q VR D
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 169 -----------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211
L H+ GTPNY+APEVL GY D WS GVIL+ +L G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245
Query: 212 LPF 214
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 67/200 (33%), Positives = 108/200 (54%), Gaps = 6/200 (3%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G F +V + TG+ A K LDK+++ K K + E ++ V +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLINAVDYCHSRGVYHRD 136
+K + +V+ + GG+L I N G EAR F Q+I +++ H R + +RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
LKPEN+LLD +GN+++SD GL+ +++ + GTP Y+APEVL YD + D
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAV---ELKGGKKIKGRAGTPGYMAPEVLQGEVYD-FSVD 176
Query: 197 LWSCGVILFVLLAGYLPFDD 216
++ G L+ ++AG PF
Sbjct: 177 WFALGCTLYEMIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 5e-32
Identities = 84/332 (25%), Positives = 139/332 (41%), Gaps = 69/332 (20%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK-ILDKEKVLKHKMAEQIKREVATMKLVKH 70
+YE+ + IG G + V A + TG VA+K I + L A++I RE+ ++ ++H
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLID--AKRILREIKLLRHLRH 58
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFD----KIVNHGRMKEDEARRYFQ-QL 120
N++ L +++ + ++IV E L + K++ + D+ +YF Q+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTE------LMETDLHKVIKSPQPLTDDHIQYFLYQI 112
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + Y HS V HRDLKP N+L+++ +LK+ DFGL A +D T YV
Sbjct: 113 LRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGL-ARGVDPDEDEKGFLT----EYV 167
Query: 181 ------APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI------- 226
APE+ L+ Y + D+WS G I LL F + ++ I
Sbjct: 168 VTRWYRAPELLLSSSRYTKA-IDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226
Query: 227 -----------SAAEF-----TCPPWLSFT---------ARKLIARILDPNPMTRITIPE 261
A + P + A L+ ++L +P RIT E
Sbjct: 227 SEEDLKFITSEKARNYLKSLPKKPK-KPLSKLFPGASPEAIDLLEKMLVFDPKKRITADE 285
Query: 262 ILEDEWFKKDYKP---PVFEEK-KDTNLDDVE 289
L + + + P PV + DD E
Sbjct: 286 ALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDE 317
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 9e-32
Identities = 71/210 (33%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVATMKLV 68
YE IGEG + V AR+ TG VALK KV E I RE+A +K +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALK-----KVRVPLSEEGIPLSTLREIALLKQL 55
Query: 69 K---HPNVVRLYEV-----MGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQ 118
+ HPN+VRL +V + K+ +V E V K G + + + +
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMR 114
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTP 177
QL+ VD+ HS + HRDLKP+N+L+ + G +K++DFGL+ ++ + T+ T
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA----RIYSFEMALTSVVVTL 170
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVL 207
Y APEVL Y + D+WS G I L
Sbjct: 171 WYRAPEVLLQSSY-ATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 71/214 (33%), Positives = 106/214 (49%), Gaps = 23/214 (10%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVAT 64
V KYE IG+GTF +V AR+ +T + VALK +++ EK A RE+
Sbjct: 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA---LREIKI 64
Query: 65 MKLVKHPNVVRLYEVMGSKTK--------IFIVLEFVT---GGELFDKIVNHGRMKEDEA 113
++L+KH NVV L E+ +K ++V EF G L +K V + E
Sbjct: 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFTLSEI 121
Query: 114 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHT 172
++ + L+N + Y H + HRD+K N+L+ G LK++DFGL+ A S +T
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 173 T-CGTPNYVAPEV-LNDRGYDGSTADLWSCGVIL 204
T Y PE+ L +R Y G D+W G I+
Sbjct: 182 NRVVTLWYRPPELLLGERDY-GPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 81/252 (32%), Positives = 138/252 (54%), Gaps = 16/252 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IGEG+ V AR +G VA+K++D + K + E + EV M+ +H NVV +Y+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
++++++EF+ GG L D IV+ R+ E++ + ++ A+ Y HS+GV HRD+K
Sbjct: 86 SYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 198
+++LL G +K+SDFG A Q +D + GTP ++APEV++ Y G+ D+W
Sbjct: 145 SDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIW 201
Query: 199 SCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL------SFTARKLIARILDPN 252
S G+++ ++ G P+ + + K++ + PP L S R + R+L
Sbjct: 202 SLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---PPKLKNAHKISPVLRDFLERMLTRE 258
Query: 253 PMTRITIPEILE 264
P R T E+L+
Sbjct: 259 PQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 87/308 (28%), Positives = 130/308 (42%), Gaps = 63/308 (20%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-------R 60
R V +YE I EGT+ V AR+ +TGE VALK K KM ++ + R
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--------KLKMEKEKEGFPITSLR 53
Query: 61 EVATMKLVKHPNVVRLYE-VMGSK-TKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYF 117
E+ + ++HPN+V + E V+GS KI++V+E+V +L + + E +
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM 112
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
QL++ V + H + HRDLK NLLL+ G LK+ DFGL+ T
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP-------YTQ 165
Query: 178 N-----YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI------ 226
Y APE+L + D+WS G I LL F + ++ KI
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGT 225
Query: 227 ---------------SAAEFTCPPW-----------LSFTARKLIARILDPNPMTRITIP 260
FT P+ LS L+ R+L +P RI+
Sbjct: 226 PTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAE 285
Query: 261 EILEDEWF 268
+ L+ +F
Sbjct: 286 DALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 87/281 (30%), Positives = 133/281 (47%), Gaps = 34/281 (12%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLV 68
G +E+ IGEGT+ KV AR+ +TG+ VA+KI+D + E+IK E + K
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYS 60
Query: 69 KHPNVVRLYEV------MGSKTKIFIVLEFVTGG---ELFDKIVNHG-RMKEDEARRYFQ 118
HPN+ Y G+ ++++V+E GG +L + G R+KE+ +
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
+ + + Y H V HRD+K +N+LL +K+ DFG+SA Q G +T GTP
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPY 178
Query: 179 YVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYKKISAAEFT 232
++APEV+ D YD + +D+WS G+ L G P D + M L+K
Sbjct: 179 WMAPEVIACDEQPDASYD-ARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP--- 234
Query: 233 CPPWLSFTAR------KLIARILDPNPMTRITIPEILEDEW 267
PP L I+ L N R + E+LE +
Sbjct: 235 -PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-31
Identities = 83/258 (32%), Positives = 137/258 (53%), Gaps = 18/258 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IGEG+ V A TG+ VA+K +D + K + E + EV M+ H NVV +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
++++V+EF+ GG L D IV H RM E++ ++ A+ Y H++GV HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 139 PENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
+++LL + G +K+SDFG A +S++V L GTP ++APEV++ Y G+ D+
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL---VGTPYWMAPEVISRLPY-GTEVDI 201
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL------SFTARKLIARILDP 251
WS G+++ ++ G P+ + + ++I PP + S R + +L
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD---NLPPRVKDSHKVSSVLRGFLDLMLVR 258
Query: 252 NPMTRITIPEILEDEWFK 269
P R T E+L+ + K
Sbjct: 259 EPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 74/266 (27%), Positives = 124/266 (46%), Gaps = 24/266 (9%)
Query: 14 EVGRTIGEGTFAKVK----FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
E+G+ +GEG F +V T VA+K L + + + E+ E + MK +
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEER--EEFLEEASIMKKLS 59
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCH 128
HPN+VRL V ++IV E++ GG+L D + HG + + + Q+ ++Y
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVL 185
S+ HRDL N L+ +K+SDFG LS+ + +D G ++APE L
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFG---LSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 186 NDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS-----AAEFTCPPWLSF 239
D + S +D+WS GV+L+ + G P+ + + + + CP L
Sbjct: 177 KDGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDEL-- 233
Query: 240 TARKLIARILDPNPMTRITIPEILED 265
+L+ + +P R T E++ED
Sbjct: 234 --YELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 5e-31
Identities = 75/243 (30%), Positives = 112/243 (46%), Gaps = 46/243 (18%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+T+G G F +V A +T A+K L K+ VL +K E + + VV+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
Y K ++ V++++ GG++ ++ E AR Y +L A++ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 137 LKPENLLLDAYGNLKVSDFGL---------SALSQQ---VRDDG---------------- 168
+KP+N+L+D G++K++DFGL S Q+ +R D
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 169 -----------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211
L H+ GTPNY+APEVL +GY D WS GVILF +L G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 212 LPF 214
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-31
Identities = 84/272 (30%), Positives = 138/272 (50%), Gaps = 25/272 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILD--KEKVLKHKMAEQIKREVATMKLVKH 70
+E+ +G+G F KV A+N ETG A K+++ E+ L+ M E + + H
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVE-----IEILATCNH 68
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHS 129
P +V+L K++I++EF GG + ++ R + E + + +Q++ A+ Y HS
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA---LSQQVRDDGLLHTTCGTPNYVAPEV-- 184
+ HRDLK N+LL G++K++DFG+SA + Q RD + GTP ++APEV
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVM 183
Query: 185 ---LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLS 238
+ D YD AD+WS G+ L + P + N M + KI+ +E + P S
Sbjct: 184 CETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWS 242
Query: 239 FTARKLIARILDPNPMTRITIPEILEDEWFKK 270
R + LD +P TR + ++LE +
Sbjct: 243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 74/243 (30%), Positives = 126/243 (51%), Gaps = 12/243 (4%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKIL--DKEKVLKHKMAEQIKREVATMKLVKHPNV 73
G+ +G+G F +V + +TG +A K + D E K ++ E+ +K ++H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 74 VRLYEVM---GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
V+ Y + KT + I +E++ GG + D++ +G + E R+Y +Q++ + Y HS
Sbjct: 67 VQYYGCLRDRAEKT-LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHTTCGTPNYVAPEVLNDRG 189
+ HRD+K N+L D+ GN+K+ DFG S Q + G + + GTP +++PEV++ G
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT---ARKLIA 246
Y G AD+WS G + +L P+ + M KI A + T P S AR +
Sbjct: 186 Y-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI-ATQPTNPQLPSHISEHARDFLG 243
Query: 247 RIL 249
I
Sbjct: 244 CIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 22/201 (10%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKIL---DKEKVLKHKMAEQIKREVATMKLV 68
YE+ + IG GT+ V AR+ TGE VA+K++ + E I++E++ +K
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDF------EIIQQEISMLKEC 57
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYC 127
+HPN+V + + K++IV+E+ GG L D V G + E + ++ + + Y
Sbjct: 58 RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL---SQQVRDDGLLHTTCGTPNYVAPEV 184
H G HRD+K N+LL G++K++DFG+SA + R + GTP ++APEV
Sbjct: 118 HETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK-----SFIGTPYWMAPEV 172
Query: 185 LNDR---GYDGSTADLWSCGV 202
GYDG D+W+ G+
Sbjct: 173 AAVERKGGYDGK-CDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 94/308 (30%), Positives = 139/308 (45%), Gaps = 53/308 (17%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
R V ++E IGEGT+ V AR++ +GE VALK + + + + RE+ +
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLN 62
Query: 68 VKHPNVVRLYEVMGSK--TKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINA 123
++HPN+V L EV+ K IF+V+E+ L D + E + + QL+
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT--PFSESQVKCLMLQLLRG 120
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN----- 178
+ Y H + HRDLK NLLL G LK++DFGL+ L TP
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG-------LPAKPMTPKVVTLW 173
Query: 179 YVAPEVL-NDRGYDGSTADLWSCGVILFVLLAG--YLP----FDDSNLM---------NL 222
Y APE+L Y + D+W+ G IL LLA LP + +L+ ++
Sbjct: 174 YRAPELLLGCTTYTTAI-DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232
Query: 223 YKKIS----AAEFTCP-----------PWLSFTARKLIARILDPNPMTRITIPEILEDEW 267
+ S +FT P PWLS +L+ +L +P R T E LE +
Sbjct: 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292
Query: 268 FKKDYKPP 275
FK+ KP
Sbjct: 293 FKE--KPL 298
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 77/255 (30%), Positives = 128/255 (50%), Gaps = 8/255 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y V R +GEG+F + ++ + + A+K + K E ++E + +KHP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHP 58
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRM-KEDEARRYFQQLINAVDYCHS 129
N+V E + ++IV+E+ GG+L KI + G++ ED ++F Q+ V + H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ V HRD+K +N+ L G +K+ DFG + L T GTP YV PE+ +
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGAYACTYVGTPYYVPPEIWENMP 176
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARI 248
Y+ + +D+WS G IL+ L PF ++ NL K+ + P S+ R LI ++
Sbjct: 177 YN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235
Query: 249 LDPNPMTRITIPEIL 263
NP +R + IL
Sbjct: 236 FKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 72/244 (29%), Positives = 129/244 (52%), Gaps = 8/244 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKIL--DKEKVLKHKMAEQIKREVATMKLVKH 70
+ +G+ +G+G F +V +++TG +A+K + D E K ++ E+ +K + H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 71 PNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
+V+ Y + + + I +E + GG + D++ ++G + E+ R+Y +Q++ V Y H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHTTCGTPNYVAPEVLND 187
S + HRD+K N+L D+ GN+K+ DFG S Q + G + + GTP +++PEV++
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT--CPPWLSFTARKLI 245
GY G AD+WS G + +L P+ + M KI+ PP +S R +
Sbjct: 184 EGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242
Query: 246 ARIL 249
RI
Sbjct: 243 KRIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 66/220 (30%), Positives = 120/220 (54%), Gaps = 6/220 (2%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKIL--DKEKVLKHKMAEQIKREVATMKLVKH 70
+ +G+ +G G F +V +++TG +A+K + D + K ++ E+ +K ++H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 71 PNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
+V+ Y + K+ I +E++ GG + D++ +G + E+ RRY +Q++ V Y H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHTTCGTPNYVAPEVLND 187
S + HRD+K N+L D+ GN+K+ DFG S Q + G + + GTP +++PEV++
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS 227
GY G AD+WS + +L P+ + M KI+
Sbjct: 184 EGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-30
Identities = 73/201 (36%), Positives = 114/201 (56%), Gaps = 11/201 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-REVATMKLVKH---PNVV 74
IG G F +V R ++TG+ A+K LDK+++ K K E + E + LV P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
+ + K+ +L+ + GG+L + HG E E R Y ++I +++ H+R V +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND-RGYDGS 193
RDLKP N+LLD +G++++SD GL+ + + H + GT Y+APEVL YD S
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYD-S 175
Query: 194 TADLWSCGVILFVLLAGYLPF 214
+AD +S G +LF LL G+ PF
Sbjct: 176 SADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 9e-30
Identities = 81/256 (31%), Positives = 137/256 (53%), Gaps = 29/256 (11%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-----L 67
+E+ + IG G F +V + TG+ A+KIL+K ++LK + E A + L
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLK-------RAETACFREERDVL 55
Query: 68 VKHPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAV 124
V + L+ + +++V+++ GG+L + R+ ED AR Y +++ A+
Sbjct: 56 VNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI 115
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAP 182
D H G HRD+KP+N+LLD G+++++DFG S L ++ DG + + GTP+Y++P
Sbjct: 116 DSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG-SCL--RLLADGTVQSNVAVGTPDYISP 172
Query: 183 EVL----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW 236
E+L + +G G D WS GV ++ +L G PF +L+ Y KI + F PP
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD 232
Query: 237 ---LSFTARKLIARIL 249
+S A+ LI R++
Sbjct: 233 VTDVSEEAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 76/221 (34%), Positives = 119/221 (53%), Gaps = 18/221 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKI-LDKEKVLKHKMAEQIK-REVATMKLVK 69
KYE +GEG++ V ++ ETG+ VA+K L+ E KM ++I RE+ +K ++
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED---DKMVKKIAMREIRMLKQLR 58
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
H N+V L EV K ++++V EFV L D + E R+Y Q++ +++CHS
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGTPNYVAPEVL- 185
+ HRD+KPEN+L+ G +K+ DFG + A +V D + T Y APE+L
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-----ATRWYRAPELLV 173
Query: 186 NDRGYDGSTADLWSCGVILFVLLAG--YLPFDDSNLMNLYK 224
D Y G D+W+ G ++ +L G P DS++ LY
Sbjct: 174 GDTKY-GRAVDIWAVGCLVTEMLTGEPLFP-GDSDIDQLYH 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 71/200 (35%), Positives = 112/200 (56%), Gaps = 9/200 (4%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-REVATMKLVKH---PNVV 74
IG G F +V R ++TG+ A+K LDK+++ K K E + E + LV P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
+ + K+ +L+ + GG+L + HG E E R Y ++I +++ H+R V +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLKP N+LLD +G++++SD GL+ + + H + GT Y+APEVL S+
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSS 176
Query: 195 ADLWSCGVILFVLLAGYLPF 214
AD +S G +LF LL G+ PF
Sbjct: 177 ADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-29
Identities = 69/263 (26%), Positives = 124/263 (47%), Gaps = 25/263 (9%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
G+ +GEG F +V + + VA+K L ++ + E+ RE M+ + HP
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI--EEFLREARIMRKLDHP 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
NVV+L V + ++IV+E++ GG+L + + ++ + + Q+ ++Y S+
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P-NYVAPEVLNDR 188
HRDL N L+ +K+SDFG LS+ + DD G P ++APE L +
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFG---LSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 189 GYDGSTA-DLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-----TCPPWLSFTA 241
+ ++ D+WS GV+L+ + G P+ + + + + CPP L
Sbjct: 179 KF--TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPEL---- 232
Query: 242 RKLIARILDPNPMTRITIPEILE 264
L+ + +P R T E++E
Sbjct: 233 YDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-29
Identities = 73/212 (34%), Positives = 119/212 (56%), Gaps = 12/212 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IGEGT+ V RN +TG+ VA+K + E + + I RE++ +K ++HPN+V L +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI-REISLLKELQHPNIVCLQD 66
Query: 79 VMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
V+ +++++++ EF++ + D + M + + Y Q++ + +CHSR V HRD
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126
Query: 137 LKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHT-TCGTPNYVAPEVLNDRGYDGST 194
LKP+NLL+D G +K++DFGL+ A VR ++T T Y APEVL +
Sbjct: 127 LKPQNLLIDNKGVIKLADFGLARAFGIPVR----VYTHEVVTLWYRAPEVLLGSPRYSTP 182
Query: 195 ADLWSCGVILFVLLAGYLPF--DDSNLMNLYK 224
D+WS G I F +A P DS + L++
Sbjct: 183 VDIWSIGTI-FAEMATKKPLFHGDSEIDQLFR 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 5e-29
Identities = 67/266 (25%), Positives = 117/266 (43%), Gaps = 25/266 (9%)
Query: 17 RTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +GEG F +V + VA+K L ++ + + + +E MK + HPNV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER--KDFLKEARVMKKLGHPNV 58
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLI-------NAV 124
VRL V + +++VLE++ GG+L D + + + + L+ +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---A 181
+Y S+ HRDL N L+ +K+SDFG LS+ V DD G + A
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFG---LSRDVYDDDYYRKKTGGKLPIRWMA 175
Query: 182 PEVLNDRGYDGSTA-DLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-TCPPWLS 238
PE L D + ++ D+WS GV+L+ + G P+ + + + + P +
Sbjct: 176 PESLKDGIF--TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCP 233
Query: 239 FTARKLIARILDPNPMTRITIPEILE 264
+L+ +P R T E++E
Sbjct: 234 DELYELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 7e-29
Identities = 78/266 (29%), Positives = 137/266 (51%), Gaps = 13/266 (4%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
K++ ++E IG+G V A + TG+ VA+K ++ ++ K E I E+ M+
Sbjct: 18 KKKYTRFE---KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMR 71
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
KHPN+V + ++++V+E++ GG L D +V M E + ++ + A+++
Sbjct: 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 130
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
HS V HRD+K +N+LL G++K++DFG A Q + T GTP ++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---AEFTCPPWLSFTARK 243
+ Y G D+WS G++ ++ G P+ + N + I+ E P LS R
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 247
Query: 244 LIARILDPNPMTRITIPEILEDEWFK 269
+ R L+ + R + E+L+ + K
Sbjct: 248 FLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 70/264 (26%), Positives = 122/264 (46%), Gaps = 26/264 (9%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
G+ +GEG F +V VA+K L ++ + E+ RE M+ + HP
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI--EEFLREARIMRKLDHP 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHS 129
N+V+L V + + IV+E++ GG+L D + + + + + Q+ ++Y S
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P-NYVAPEVLND 187
+ HRDL N L+ +K+SDFG LS+ + DD G P ++APE L +
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFG---LSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 188 RGYDGSTA-DLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-----TCPPWLSFT 240
+ ++ D+WS GV+L+ + G P+ + + + + CPP L
Sbjct: 179 GKF--TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPEL--- 233
Query: 241 ARKLIARILDPNPMTRITIPEILE 264
KL+ + +P R T E++E
Sbjct: 234 -YKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 73/249 (29%), Positives = 132/249 (53%), Gaps = 15/249 (6%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ + IG G F +V + + A+KIL+K ++LK + E + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRG 131
+ L+ + +++V+++ GG+L + R+ ED AR Y +++ A+D H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAPEVL---- 185
HRD+KP+N+L+D G+++++DFG S L ++ +DG + ++ GTP+Y++PE+L
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFG-SCL--KLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTCPPW---LSFT 240
+ +G G D WS GV ++ +L G PF +L+ Y KI F P +S
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239
Query: 241 ARKLIARIL 249
A+ LI R++
Sbjct: 240 AKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 83/263 (31%), Positives = 138/263 (52%), Gaps = 18/263 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IGEG+ V A +G+ VA+K +D + K + E + EV M+ +H NVV +Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
++++V+EF+ GG L D IV H RM E++ ++ A+ H++GV HRD+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 139 PENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
+++LL G +K+SDFG A +S++V L GTP ++APE+++ Y G D+
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL---VGTPYWMAPELISRLPY-GPEVDI 199
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL------SFTARKLIARILDP 251
WS G+++ ++ G P+ + + K I PP L S + + + R+L
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPKLKNLHKVSPSLKGFLDRLLVR 256
Query: 252 NPMTRITIPEILEDEWFKKDYKP 274
+P R T E+L+ + K P
Sbjct: 257 DPAQRATAAELLKHPFLAKAGPP 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 81/263 (30%), Positives = 132/263 (50%), Gaps = 18/263 (6%)
Query: 31 RNSETGEPVALKILD-KEKVL-------KHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82
RN T VA + D KEKV+ + A + E+ + H +V+ ++ S
Sbjct: 77 RNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS 136
Query: 83 KTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
K+ +++E+ +GG+L +I H +E E F Q++ A+D HSR + HRDLK
Sbjct: 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLK 196
Query: 139 PENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
N+ L G +K+ DFG S S V D + + CGTP Y+APE+ + Y AD+
Sbjct: 197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLD-VASSFCGTPYYLAPELWERKRYS-KKADM 254
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARILDPNPMTR 256
WS GVIL+ LL + PF + + +++ ++ P +S + L+ +L NP R
Sbjct: 255 WSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALR 314
Query: 257 ITIPEILEDEWFKKDYKPPVFEE 279
T ++L E+ K Y +F++
Sbjct: 315 PTTQQLLHTEFLK--YVANLFQD 335
|
Length = 478 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 75/249 (30%), Positives = 129/249 (51%), Gaps = 15/249 (6%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ + IG G F +V + T A+KIL+K ++LK + E +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRG 131
+ L+ + +++V+++ GG+L + R+ ED AR Y +++ A+ H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAPEVL---- 185
HRD+KP+N+LLD G+++++DFG S L ++ DG + ++ GTP+Y++PE+L
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG-SCL--KMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPWL---SFT 240
+ G G D WS GV ++ +L G PF +L+ Y KI E F P + S
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239
Query: 241 ARKLIARIL 249
A+ LI R++
Sbjct: 240 AKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 82/262 (31%), Positives = 130/262 (49%), Gaps = 23/262 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR----EVATMKL 67
KY + R +G G V A+ GEP A+K++D E M+E K EV +
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG-----MSEADKNRAQAEVCCLLN 87
Query: 68 VKHPNVVRLYEVMGSKTK--------IFIVLEFVTGGELFDKIVNHGR----MKEDEARR 115
++V+ +E K I +VL++ G+L +I + + +E EA
Sbjct: 88 CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL 147
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
F Q++ AV + HS+ + HRD+K N+LL + G +K+ DFG S + D + T CG
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CP 234
TP YVAPE+ + Y AD++S GV+L+ LL PFD N+ + K A + P
Sbjct: 208 TPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266
Query: 235 PWLSFTARKLIARILDPNPMTR 256
P +S ++++ +L +P R
Sbjct: 267 PSISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-28
Identities = 79/266 (29%), Positives = 139/266 (52%), Gaps = 13/266 (4%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
K++ +YE IG+G V A + TG+ VA+K ++ +K K ++ I E+ MK
Sbjct: 18 KKKYTRYE---KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL---IINEILVMK 71
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+K+PN+V + ++F+V+E++ GG L D +V M E + ++ + A+++
Sbjct: 72 ELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEF 130
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
H+ V HRD+K +N+LL G++K++DFG A Q + T GTP ++APEV+
Sbjct: 131 LHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---AAEFTCPPWLSFTARK 243
+ Y G D+WS G++ ++ G P+ + N + I+ E P LS R
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247
Query: 244 LIARILDPNPMTRITIPEILEDEWFK 269
+ R L+ + R + E+L+ + K
Sbjct: 248 FLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 4e-28
Identities = 77/261 (29%), Positives = 134/261 (51%), Gaps = 10/261 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY IG+G V A + TG+ VA+K ++ ++ K ++ I E+ M+ K+P
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL---IINEILVMRENKNP 76
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V + ++++V+E++ GG L D +V M E + ++ + A+D+ HS
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLHSNQ 135
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+K +N+LL G++K++DFG A Q + T GTP ++APEV+ + Y
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---AAEFTCPPWLSFTARKLIARI 248
G D+WS G++ ++ G P+ + N + I+ E P LS R + R
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252
Query: 249 LDPNPMTRITIPEILEDEWFK 269
L+ + R + E+L+ + K
Sbjct: 253 LEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 85/282 (30%), Positives = 144/282 (51%), Gaps = 29/282 (10%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILD--KEKVLKHKMAEQIKREVATMKLVKH 70
+E+ +G+G F KV A+N ETG A K++D E+ L+ M E + + H
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVE-----IDILASCDH 61
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHS 129
PN+V+L + + ++I++EF GG + ++ R + E + R +Q + A++Y H
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV--RDDGLLHTTCGTPNYVAPEVL-- 185
+ HRDLK N+L G++K++DFG+SA + + R D + GTP ++APEV+
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMC 177
Query: 186 ---NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242
DR YD AD+WS G+ L + P + N M + KI+ +E PP L+ +R
Sbjct: 178 ETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PPTLAQPSR 233
Query: 243 ------KLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFE 278
+ + L+ N R T ++L+ + + P+ E
Sbjct: 234 WSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIRE 275
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 9e-28
Identities = 73/263 (27%), Positives = 126/263 (47%), Gaps = 11/263 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVK 69
+Y + + +G+G+F V ++ + LK+L + V L Q +E + +
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVD 125
HP +V+ + + I+ E+ G +L K+ + E++ +F QL+ V
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
Y H R + HRDLK +N+ L LK+ DFG+S L D L T GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEAL 177
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKL 244
+GYD S +D+WS G IL+ + F+ N +++ +I + P S +
Sbjct: 178 KHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236
Query: 245 IARILDPNPMTRITIPEILEDEW 267
+ +L+ +P R + EIL + +
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 81/303 (26%), Positives = 135/303 (44%), Gaps = 68/303 (22%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMK-LVK 69
Y++ IGEGTF++V A++ +TG+ A+K + K K EQ+ RE+ ++ L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 70 HPNVVRLYEVM-----GSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINA 123
HPN++RL EV+ G +F +++ L++ I R + E + Y QL+ +
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMD----MNLYELIKGRKRPLPEKRVKSYMYQLLKS 112
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV--- 180
+D+ H G++HRD+KPEN+L+ LK++DFG S P Y
Sbjct: 113 LDHMHRNGIFHRDIKPENILIKDD-ILKLADFG-SC-----------RGIYSKPPYTEYI 159
Query: 181 ------APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---------------- 218
APE L GY G D+W+ G + F +L+ + F +N
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPD 219
Query: 219 --LMNLYKKISAAEFTCP-----------PWLSFTARKLIARILDPNPMTRITIPEILED 265
++ ++K + P P S L+ ++L +P RIT + L
Sbjct: 220 AEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279
Query: 266 EWF 268
+F
Sbjct: 280 PYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 77/261 (29%), Positives = 134/261 (51%), Gaps = 10/261 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY IG+G V A + TG+ VA++ ++ ++ K E I E+ M+ K+P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNP 77
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V + ++++V+E++ GG L D +V M E + ++ + A+++ HS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+K +N+LL G++K++DFG A Q + T GTP ++APEV+ + Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 193
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---AAEFTCPPWLSFTARKLIARI 248
G D+WS G++ ++ G P+ + N + I+ E P LS R + R
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 249 LDPNPMTRITIPEILEDEWFK 269
LD + R + E+L+ ++ K
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 79/264 (29%), Positives = 134/264 (50%), Gaps = 15/264 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG+G+F +V ++ T E VA+KI+D E+ E I++E+ + P + R Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
TK++I++E++ GG D ++ G ++E ++++ +DY HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYDGSTADL 197
N+LL G++K++DFG++ Q+ D + T GTP ++APEV+ YD AD+
Sbjct: 129 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-FKADI 184
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL----SFTARKLIARILDPNP 253
WS G+ L G P D + M + I PP L S ++ + L+ +P
Sbjct: 185 WSLGITAIELAKGEPPNSDLHPMRVLFLIPK---NSPPTLEGQYSKPFKEFVEACLNKDP 241
Query: 254 MTRITIPEILEDEWFKKDYKPPVF 277
R T E+L+ ++ + K F
Sbjct: 242 RFRPTAKELLKHKFITRYTKKTSF 265
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 69/227 (30%), Positives = 113/227 (49%), Gaps = 9/227 (3%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLK-HKMAEQIKREVATMKLVKHPN 72
G +G+G + V + + G+ +A+K LD VL K E+++ EV +K +KH N
Sbjct: 5 GEVLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V+ I I +EFV GG + + G + E +Y +Q+++ V Y H+ V
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 133 YHRDLKPENLLLDAYGNLKVSDFG----LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
HRD+K N++L G +K+ DFG L+ + +L + GTP ++APEV+N+
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 235
GY G +D+WS G +F + G P + + I A P
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR 229
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 76/267 (28%), Positives = 122/267 (45%), Gaps = 24/267 (8%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G V + TG+ +A+K + E + + +QI RE+ + P +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGF 64
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKI--VNHGRMKEDEARRYFQQLINAVDYCHS-RGVY 133
Y + I I +E++ GG L DKI GR+ E + ++ + Y H +
Sbjct: 65 YGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGS 193
HRD+KP N+L+++ G +K+ DFG+S Q V + L T GT +Y+APE + Y
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVS--GQLV--NSLAKTFVGTSSYMAPERIQGNDYSVK 179
Query: 194 TADLWSCGVILFVLLAGYLPFDDSN-----LMNLYKKISAAEFTCPPWL-----SFTARK 243
+D+WS G+ L L G P+ N + L + I PP L S +
Sbjct: 180 -SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---PPRLPSGKFSPDFQD 235
Query: 244 LIARILDPNPMTRITIPEILEDEWFKK 270
+ L +P R + E+LE + KK
Sbjct: 236 FVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 80/260 (30%), Positives = 134/260 (51%), Gaps = 15/260 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG+G+F +V ++ T + VA+KI+D E+ E I++E+ + P V + Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
TK++I++E++ GG D ++ G E + ++++ +DY HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYDGSTADL 197
N+LL G++K++DFG++ Q+ D + T GTP ++APEV+ YD S AD+
Sbjct: 129 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADI 184
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL----SFTARKLIARILDPNP 253
WS G+ L G P D + M + I PP L S ++ I L+ +P
Sbjct: 185 WSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLTGEFSKPFKEFIDACLNKDP 241
Query: 254 MTRITIPEILEDEWFKKDYK 273
R T E+L+ ++ K+ K
Sbjct: 242 SFRPTAKELLKHKFIVKNAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-27
Identities = 93/296 (31%), Positives = 140/296 (47%), Gaps = 48/296 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+YE IGEGT+ V AR+ T E +ALK + E+ + + I RE++ +K ++H
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQHG 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR------YFQQLINAVD 125
N+VRL +V+ S+ ++++V E+ L + H D A+ Y Q++ +
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 126 YCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPE 183
YCHS V HRDLKP+NLL+D N LK++DFGL+ A VR H T Y APE
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVV-TLWYRAPE 173
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKI--------------- 226
+L + + D+WS G I F + P DS + L+K
Sbjct: 174 ILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232
Query: 227 SAAEF--TCPPW-----------LSFTARKLIARILDPNPMTRITIPEILEDEWFK 269
S ++ P W L L++++L +P RIT LE E+FK
Sbjct: 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-27
Identities = 72/203 (35%), Positives = 107/203 (52%), Gaps = 11/203 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVATMKLVK 69
KYE IGEG++ V RN ETG+ VA+K + ++ + K+A RE+ +K +K
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA---LREIRMLKQLK 58
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
HPN+V L EV K K+ +V E+ L + N + E ++ Q + AV++CH
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTPNYVAPEVL-ND 187
HRD+KPEN+L+ G +K+ DFG + + DD +T T Y APE+L D
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD---YTDYVATRWYRAPELLVGD 175
Query: 188 RGYDGSTADLWSCGVILFVLLAG 210
Y G D+W+ G + LL G
Sbjct: 176 TQY-GPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 8e-27
Identities = 75/261 (28%), Positives = 133/261 (50%), Gaps = 17/261 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG+G+F +V ++ T + VA+KI+D E+ E I++E+ + P V + Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
TK++I++E++ GG D ++ G + E + ++++ +DY HS HRD+K
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 139 PENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
N+LL +G +K++DFG++ Q++ + + GTP ++APEV+ YD S AD
Sbjct: 129 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV----GTPFWMAPEVIKQSAYD-SKAD 183
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL----SFTARKLIARILDPN 252
+WS G+ L G P + + M + I PP L S ++ + L+
Sbjct: 184 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVEACLNKE 240
Query: 253 PMTRITIPEILEDEWFKKDYK 273
P R T E+L+ ++ + K
Sbjct: 241 PSFRPTAKELLKHKFIVRFAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 15/216 (6%)
Query: 34 ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLY-EVMGSKTKIFIVLEF 92
TG VA+K+L + + + +RE A + HPN+V L +F V E+
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---N 149
V G L + + G + E R Q+++A+ H++G+ HRDLKP+N+++ G +
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 150 LKVSDFGLSALSQQVRDDGLLHTT-----CGTPNYVAPEVLNDRGYDGSTA--DLWSCGV 202
KV DFG+ L VRD + T GTP Y APE L RG + T DL++ G+
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL--RG-EPVTPNSDLYAWGL 177
Query: 203 ILFVLLAGYLPFDDSNLMN-LYKKISAAEFTCPPWL 237
I L G +++ LY+++S + + PPW+
Sbjct: 178 IFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWI 213
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 71/214 (33%), Positives = 110/214 (51%), Gaps = 24/214 (11%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKI--LDKEKVLKHKMAEQIKREVAT 64
KR V K+++ IGEGT+ +V AR+ +TGE VALK LD EK RE+
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKI 59
Query: 65 MKLVKHPNVVRLYEVMGSKTK----------IFIVLEFVTG---GELFDKIVNHGRMKED 111
++ + H N+V L E++ K ++V E++ G L +V+ ED
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSED 116
Query: 112 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171
+ + +QL+ ++YCH + HRD+K N+LL+ G +K++DFGL+ L ++ +
Sbjct: 117 HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN--SEESRPY 174
Query: 172 TT-CGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 204
T T Y PE+L G D+WSCG IL
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-26
Identities = 37/58 (63%), Positives = 46/58 (79%), Gaps = 1/58 (1%)
Query: 311 MNAFELISLSKGLNLGNLFDAEQDFKR-ETRFTSRCPANEIINKIEEAAKPLGFDVHK 367
+NAF+LISLS GL+L LF+ E+ K+ ETRFTSR PA+EII+K+EE AK LGF V K
Sbjct: 1 LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVKK 58
|
Length = 58 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 76/268 (28%), Positives = 130/268 (48%), Gaps = 23/268 (8%)
Query: 13 YEVGRTIGEGTFAKV-KFARNSETGEPVALK-------ILDKEKVLKHKMAEQIKREVAT 64
Y V +G G F V K + + +ALK K+K + K I EV
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 65 MK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIV-NHGRMKEDEARRYFQQ 119
+K ++HPN+VR Y+ +++IV++ + G GE F+ + R E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 120 LINAVDYCH-SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
++ A+ Y H + + HRDL P N++L + ++DFG L++Q + + L + GT
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG---LAKQKQPESKLTSVVGTIL 178
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS 238
Y PE++ + Y G AD+W+ G IL+ + PF +N+++L KI A + P
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
Query: 239 FT--ARKLIARILDPNPMTRITIPEILE 264
++ +I L P+ R P+I++
Sbjct: 238 YSEDVTDVITSCLTPDAEAR---PDIIQ 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 6/200 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R +G+G F +V + TG+ A K L+K+++ K K E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLINAVDYCHSRGVYH 134
+K + +VL + GG+L I N G DE R F ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLKPEN+LLD YG++++SD GL+ ++ + + GT Y+APEV+ + Y +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERY-TFS 181
Query: 195 ADLWSCGVILFVLLAGYLPF 214
D W G +++ ++ G PF
Sbjct: 182 PDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 78/260 (30%), Positives = 125/260 (48%), Gaps = 14/260 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ + IG GT+ V ARN TGE A+K++ E + +Q E+ MK KH N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHSN 67
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V + + K++I +EF GG L D G + E + ++ + + Y HS+G
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV--LNDRGY 190
HRD+K N+LL G++K++DFG+SA Q + GTP ++APEV + +G
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL------SFTARKL 244
D+W+ G+ L P D + M ++ + F PP L S +
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ-PPKLKDKMKWSNSFHHF 244
Query: 245 IARILDPNPMTRITIPEILE 264
+ L NP R T ++L+
Sbjct: 245 VKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 87/302 (28%), Positives = 134/302 (44%), Gaps = 54/302 (17%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVATMKL 67
YE IGEGT+ KV AR+ TG+ VALK K E I RE++ +++
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALK-----KTRLEMDEEGIPPTALREISLLQM 56
Query: 68 VKH-PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGR-----MKEDEARRY 116
+ +VRL +V + K +++V E++ +L + ++GR + + +
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLS-ALSQQVRDDGLLHTTC 174
QL+ V +CH GV HRDLKP+NLL+D LK++D GL A S V+ H
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIV 173
Query: 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF-DDS---NLMNLYKKI-SAA 229
T Y APEVL + + D+WS G I + F DS L++++K + +
Sbjct: 174 -TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232
Query: 230 EFTCP-----------------------PWLSFTARKLIARILDPNPMTRITIPEILEDE 266
E P P LS L+ ++L +P RI+ L
Sbjct: 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP 292
Query: 267 WF 268
+F
Sbjct: 293 YF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 78/238 (32%), Positives = 120/238 (50%), Gaps = 27/238 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK-ILDKEKVLKHKMAEQIKREVATMK-LVK 69
KYE+ + +G+G + V A + T E VALK I D + A++ RE+ ++ L
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD--AQRTFREIMFLQELGD 65
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFD----KIVNHGRMKEDEARRYFQQLINAVD 125
HPN+V+L V+ ++ I L F E + ++ +++ R QL+ A+
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVF----EYMETDLHAVIRANILEDVHKRYIMYQLLKALK 121
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTT--CGTPNYVAP 182
Y HS V HRDLKP N+LL++ +K++DFGL+ +LS+ + T T Y AP
Sbjct: 122 YIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181
Query: 183 EVLNDRGYDGSTA-----DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 235
E+L GST D+WS G IL +L G F ++ +N +KI E PP
Sbjct: 182 EILL-----GSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI--IEVIGPP 232
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 51/170 (30%), Positives = 92/170 (54%), Gaps = 2/170 (1%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
I G F KV R + A+K++ K ++ M Q++ E + L K P +V LY
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
+ S +++V+E++ GG++ + +G E+ A +Y ++ A+DY H G+ HRDLK
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
P+N+L+ G++K++DFGLS ++ + + + TP+ P+ R
Sbjct: 132 PDNMLISNEGHIKLTDFGLSKVT--LNRELNMMDILTTPSMAKPKNDYSR 179
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 63/200 (31%), Positives = 106/200 (53%), Gaps = 6/200 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R +G+G F +V + TG+ A K L+K+++ K K E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYH 134
+K + +VL + GG+L I N G +E+ A Y +++ ++ H +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLKPEN+LLD YG++++SD GL+ ++ + + GT Y+APEVLN++ Y +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---KIPEGESIRGRVGTVGYMAPEVLNNQRY-TLS 181
Query: 195 ADLWSCGVILFVLLAGYLPF 214
D W G +++ ++ G PF
Sbjct: 182 PDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 8/201 (3%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR-EVATMKLVKHPNVVRLY 77
+G+G F +V + TG+ A K LDK++ LK K E++ E ++ V P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKR-LKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSRGVYHR 135
SKT + +V+ + GG+L I N G + R Y Q+ + + HS + +R
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR 119
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
D+KPEN+LLD GN ++SD GL+ +++D + GT Y+APE+L + Y
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYSYPV- 175
Query: 196 DLWSCGVILFVLLAGYLPFDD 216
D ++ G ++ ++AG PF D
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 91/325 (28%), Positives = 151/325 (46%), Gaps = 50/325 (15%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKHP 71
Y+ IGEG + V A + TG VA+K K +H+ ++ RE+ ++ KH
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIK---KISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 72 NVVRLYEVMGSKT-----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
N++ + +++ + ++IV E + +L+ K++ + D + + Q++ + Y
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQYFLYQILRGLKY 121
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEV- 184
HS V HRDLKP NLLL+ +LK+ DFGL+ ++ D G L T Y APE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 185 LNDRGYDGSTA-DLWSCGVILFVLLAGYLPF---DDSNLMNLYKKI----SAAEFTC--- 233
LN +GY + A D+WS G IL +L+ F D + +NL + S + C
Sbjct: 182 LNSKGY--TKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239
Query: 234 ----------P-----PWLSF------TARKLIARILDPNPMTRITIPEILEDEWFKKDY 272
P PW A L+ ++L NP RIT+ E L + ++ +
Sbjct: 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299
Query: 273 KP---PVFEEKKDTNLDDVEAVFKD 294
P PV EE + + + + K+
Sbjct: 300 DPSDEPVAEEPFPFDFELFDDLPKE 324
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 67/196 (34%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
K+EV +GEG + V R+ ET E VA+K K+ ++ E RE+ ++ +K
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
N+V L E + K+++V E+V EL +++ N + ++ R Y QLI A+ +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVRSYIYQLIKAIHWCHK 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRD+KPENLL+ LK+ DFG + LS+ + T Y +PE+L
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG--SNANYTEYVATRWYRSPELLLGA 176
Query: 189 GYDGSTADLWSCGVIL 204
Y G D+WS G IL
Sbjct: 177 PY-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 8e-24
Identities = 76/229 (33%), Positives = 114/229 (49%), Gaps = 22/229 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKHP 71
+E+ TIG+GT+ KV N + G A+KILD H + E+I+ E +K L HP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP----IHDIDEEIEAEYNILKALSDHP 75
Query: 72 NVVRLYEVMGSKT-----KIFIVLEFVTGGELFDKI---VNHG-RMKEDEARRYFQQLIN 122
NVV+ Y + K ++++VLE GG + D + + G RM+E + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ + H HRD+K N+LL G +K+ DFG+SA R +T+ GTP ++AP
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAP 193
Query: 183 EVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
EV+ D YD + D+WS G+ L G P D + M KI
Sbjct: 194 EVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 1e-23
Identities = 67/200 (33%), Positives = 105/200 (52%), Gaps = 20/200 (10%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVVRL 76
+GEG++A V R+ TG+ VALK E L+H+ RE + +K +KH N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALK----EIRLEHEEGAPFTAIREASLLKDLKHANIVTL 68
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHR 135
++++ +K + +V E++ +L + + G + R + QL+ + YCH R V HR
Sbjct: 69 HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHR 127
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKP+NLL+ G LK++DFGL A ++ V + T Y P+VL GST
Sbjct: 128 DLKPQNLLISERGELKLADFGL-ARAKSVPSKTYSNEVV-TLWYRPPDVLL-----GSTE 180
Query: 196 -----DLWSCGVILFVLLAG 210
D+W G I + + G
Sbjct: 181 YSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 86/293 (29%), Positives = 127/293 (43%), Gaps = 35/293 (11%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALK-ILDKEKVLKHKMAEQIKREVATMKLVK 69
K +GEG V R TG ALK I K QI RE+ K K
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK---QILRELEINKSCK 57
Query: 70 HPNVVRLYE--VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR-------RYFQQL 120
P +V+ Y + S + I I +E+ GG L D I + ++K+ R + + +
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSI--YKKVKKRGGRIGEKVLGKIAESV 114
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + Y HSR + HRD+KP N+LL G +K+ DFG+S + V + L T GT Y+
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELV--NSLAGTFTGTSFYM 170
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS--------NLMNLYKKISAAEFT 232
APE + + Y T+D+WS G+ L + PF L++ + E
Sbjct: 171 APERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229
Query: 233 CPP-----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEK 280
P W S + I + L+ +P R T ++LE W K K V K
Sbjct: 230 DEPGNGIKW-SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAK 281
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-23
Identities = 79/260 (30%), Positives = 126/260 (48%), Gaps = 16/260 (6%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YE+ + +G GT+ V ARN TGE A+KI+ E + I++E+ +K KH N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL---IQQEIFMVKECKHCN 67
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V + S+ K++I +E+ GG L D G + E + ++ + + Y HS+G
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL---NDRG 189
HRD+K N+LL G++K++DFG++A + + GTP ++APEV + G
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL------SFTARK 243
Y+ D+W+ G+ L P D + M +S + F PP L S T
Sbjct: 186 YN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ-PPKLKDKTKWSSTFHN 243
Query: 244 LIARILDPNPMTRITIPEIL 263
+ L NP R T +L
Sbjct: 244 FVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 3e-23
Identities = 78/267 (29%), Positives = 127/267 (47%), Gaps = 33/267 (12%)
Query: 19 IGEGTFAKVKFARNSETGEPVALK---ILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
+G+GT+ V AR+ T +A+K D V + + E+A +KH N+V+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV------QPLHEEIALHSYLKHRNIVQ 69
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEA--RRYFQQLINAVDYCHSRGV 132
I +E V GG L + + G +K++E Y +Q++ + Y H +
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129
Query: 133 YHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND--RG 189
HRD+K +N+L++ Y G +K+SDFG S + + T GT Y+APEV++ RG
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTS--KRLAGINPCTETFTGTLQYMAPEVIDKGPRG 187
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC---------PPWLSFT 240
Y G+ AD+WS G + + G PF + + AA F P LS
Sbjct: 188 Y-GAPADIWSLGCTIVEMATGKPPFIE------LGEPQAAMFKVGMFKIHPEIPESLSAE 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEW 267
A+ I R +P+P R + ++L+D +
Sbjct: 241 AKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 75/242 (30%), Positives = 121/242 (50%), Gaps = 37/242 (15%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
R+ +YEV + IG G F +V ++ T E K + + LK + Q+ EV M+ +
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREKSQLVIEVNVMREL 69
Query: 69 KHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLIN 122
KH N+VR + +K K++I++EF G+L I G+++E +QL++
Sbjct: 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 123 AVDYCHS-------RGVYHRDLKPENLLLDA-----------YGNL------KVSDFGLS 158
A+ YCH+ V HRDLKP+N+ L NL K+ DFGLS
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 159 ALSQQVRDDGLLHTTCGTPNYVAPEVL--NDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216
+ + + + H+ GTP Y +PE+L + YD +D+W+ G I++ L +G PF
Sbjct: 190 ---KNIGIESMAHSCVGTPYYWSPELLLHETKSYD-DKSDMWALGCIIYELCSGKTPFHK 245
Query: 217 SN 218
+N
Sbjct: 246 AN 247
|
Length = 1021 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 8e-23
Identities = 75/249 (30%), Positives = 122/249 (48%), Gaps = 15/249 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G F +V + TG+ A K L+K+++ K K E E + V +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
+KT + +V+ + GG+L I N + E A Y Q+I+ +++ H R + +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
RDLKPEN+LLD GN+++SD GL+ Q + G GTP ++APE+L YD
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY----AGTPGFMAPELLQGEEYDF 176
Query: 193 STADLWSCGVILFVLLAGYLPF----DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248
S D ++ GV L+ ++A PF + L ++I T P S ++ +
Sbjct: 177 SV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235
Query: 249 LDPNPMTRI 257
L +P R+
Sbjct: 236 LAKDPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 9e-23
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 16/203 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK----HKMAEQIKREVATMKL 67
+Y+ IG G + V A ++ +G+ VA+K K+ +A++ RE+ ++
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKILRH 60
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFV---TGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
KH N++ + +++ F + V +L I + + E+ R + QL+ +
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGL 120
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL--SALSQQVRDDGLLHTTCGTPNYVAP 182
Y HS V HRDLKP NLL++ L++ DFG+ S + T Y AP
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 183 EVLNDRGYDGSTA-DLWSCGVIL 204
E+L + +TA D+WS G I
Sbjct: 181 ELLLSLP-EYTTAIDMWSVGCIF 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 9e-23
Identities = 80/319 (25%), Positives = 143/319 (44%), Gaps = 51/319 (15%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKE-KVLKHKMAEQIKREVATMKLVKH 70
+Y+ +G G + +V A +++TG VA+K L + + H A++ RE+ +K + H
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIH--AKRTYRELRLLKHMDH 73
Query: 71 PNVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
NV+ L +V + +++V + G +L + IV ++ +D + Q++ +
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQILRGL 131
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
Y HS G+ HRDLKP N+ ++ LK+ DFGL+ + D + T Y APE+
Sbjct: 132 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPEI 186
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI------------------ 226
+ + + T D+WS G I+ LL G F S+ ++ K+I
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246
Query: 227 SAAEF--TCP-----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273
SA + + P + A L+ ++L +P RIT E L + + +
Sbjct: 247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306
Query: 274 P---PVFEEKKDTNLDDVE 289
P PV D + + +
Sbjct: 307 PEDEPV-APPYDQSFESRD 324
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-22
Identities = 74/273 (27%), Positives = 126/273 (46%), Gaps = 22/273 (8%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R IG G+F V FAR+ T E VA+K + ++ + I +EV ++ ++HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 77 YEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
+ ++V+E+ G ++ + V+ ++E E + + Y HS H
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSHERIH 138
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL--NDRG-YD 191
RD+K N+LL G +K++DFG ++L ++ GTP ++APEV+ D G YD
Sbjct: 139 RDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYD 192
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA-----RKLIA 246
G D+WS G+ L P + N M+ I+ + P LS R +
Sbjct: 193 GK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---SPTLSSNDWSDYFRNFVD 248
Query: 247 RILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
L P R + E+L+ + ++ P V +
Sbjct: 249 SCLQKIPQDRPSSEELLKHRFVLRERPPTVIID 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-22
Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 6/200 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R +G+G F +V + TG+ A K L+K+++ K K E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLINAVDYCHSRGVYH 134
+K + +VL + GG+L I + G +E R F ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLKPEN+LLD +G++++SD GL+ V + + GT Y+APEV+ + Y S
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYTFS- 181
Query: 195 ADLWSCGVILFVLLAGYLPF 214
D W+ G +L+ ++AG PF
Sbjct: 182 PDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-22
Identities = 75/232 (32%), Positives = 116/232 (50%), Gaps = 27/232 (11%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
+E+ TIG+GT+ KV N + G A+KILD + E+I+ E ++ L
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPN 77
Query: 70 HPNVVRLYEVMGSKTK-----IFIVLEFVTGG---ELFDKIVNHG-RMKEDEARRYFQQL 120
HPNVV+ Y + K +++VLE GG EL ++ G R+ E
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTCGTPN 178
+ + + H+ + HRD+K N+LL G +K+ DFG+SA S ++R + T+ GTP
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN----TSVGTPF 193
Query: 179 YVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYK 224
++APEV+ D YD + D+WS G+ L G P FD + L+K
Sbjct: 194 WMAPEVIACEQQYDYSYD-ARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-22
Identities = 67/224 (29%), Positives = 113/224 (50%), Gaps = 21/224 (9%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
G +E+ +G GT+ +V R+ +TG+ A+K++D + E+IK E+ +K
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSH 71
Query: 70 HPNVVRLYEVM------GSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLI 121
H N+ Y G ++++V+EF G + D + N +KED ++++
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+ + H+ V HRD+K +N+LL +K+ DFG+SA Q R G +T GTP ++A
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 189
Query: 182 PEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220
PEV+ D YD +D+WS G+ + G P D + M
Sbjct: 190 PEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 77/312 (24%), Positives = 127/312 (40%), Gaps = 54/312 (17%)
Query: 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-----------REVA 63
G +GEGT+ KV+ A ++ TG+ VA+K + ++ ++ RE+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLIN 122
M +KH N++ L +V I +V++ + K+V+ R+ E + + Q++N
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCILLQILN 130
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGTPN- 178
++ H HRDL P N+ +++ G K++DFGL+ T
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 179 --------YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKI 226
Y APE+L D+WS G I LL G F N L +++ +
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL 250
Query: 227 SAAEFT-------CPPWLSFTARK-----------------LIARILDPNPMTRITIPEI 262
P + FT RK L+ +L NP+ RI+ E
Sbjct: 251 GTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA 310
Query: 263 LEDEWFKKDYKP 274
L+ E+FK D P
Sbjct: 311 LKHEYFKSDPLP 322
|
Length = 335 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 84/318 (26%), Positives = 144/318 (45%), Gaps = 53/318 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK----HKMAEQIKREVATMKL 67
+Y + +G G F V AR+ TG+ VA+K K++K +A++ RE+ +K
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-----KIMKPFSTPVLAKRTYRELKLLKH 65
Query: 68 VKHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
++H N++ L ++ S I+ V E + G +++ +++ + + Q++ + Y
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKY 123
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV-L 185
HS GV HRDLKP N+L++ +LK+ DFGL+ + Q + G + T Y APE+ L
Sbjct: 124 VHSAGVVHRDLKPSNILINENCDLKICDFGLARI-QDPQMTGYVSTR----YYRAPEIML 178
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----------- 234
+ YD D+WS G I +L G F + +N + I+ T P
Sbjct: 179 TWQKYD-VEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237
Query: 235 --------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274
+A L+ ++L +P RI+ E L + + P
Sbjct: 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297
Query: 275 ---PVFEEKKDTNLDDVE 289
PV EEK D + +D +
Sbjct: 298 TDEPVAEEKFDWSFNDAD 315
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 17 RTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQ----IKREVATMKLV 68
+ +GEG F KV+ R TGE VA+K L H EQ +RE+ ++ +
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVK------SLNHSGEEQHRSDFEREIEILRTL 63
Query: 69 KHPNVVRL----YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLIN 122
H N+V+ + G ++ ++E++ G L D + H R + + R + Q+
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRL--IMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICK 120
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVA 181
+DY S+ HRDL N+L+++ +K+SDFGL+ + + +D + +P + A
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLL 208
PE L + S +D+WS GV L+ L
Sbjct: 181 PECLRTSKFS-SASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 80/319 (25%), Positives = 132/319 (41%), Gaps = 58/319 (18%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVATMKLV 68
+Y R +G G+ V A +S+ + VA+K +L + +KH + RE+ ++ +
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL-----REIKIIRRL 59
Query: 69 KHPNVVRLYEVMGSKTK--------------IFIVLEFVTGGELFDKIVNHGRMKEDEAR 114
H N+V++YEV+G ++IV E++ ++ G + E+ AR
Sbjct: 60 DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHAR 117
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLS-ALSQQVRDDGLLHT 172
+ QL+ + Y HS V HRDLKP N+ ++ LK+ DFGL+ + G L
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 173 TCGTPNYVAPE-VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNL------ 222
T Y +P +L+ Y D+W+ G I +L G F ++ M L
Sbjct: 178 GLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236
Query: 223 ----------------YKKISAAEFTCP-----PWLSFTARKLIARILDPNPMTRITIPE 261
+ + E P P ++ A + +IL NPM R+T E
Sbjct: 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296
Query: 262 ILEDEWFKKDYKPPVFEEK 280
L + Y P E
Sbjct: 297 ALMHPYM-SCYSCPFDEPV 314
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 5e-22
Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 6/200 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R +G+G F +V + TG+ A K L+K+++ K K E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLINAVDYCHSRGVYH 134
+K + +VL + GG+L I N G DE R F +L ++ + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLKPEN+LLD G++++SD GL+ Q+ + + GT Y+APEV+N+ Y S
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAV---QIPEGETVRGRVGTVGYMAPEVINNEKYTFS- 181
Query: 195 ADLWSCGVILFVLLAGYLPF 214
D W G +++ ++ G PF
Sbjct: 182 PDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 5e-22
Identities = 71/253 (28%), Positives = 129/253 (50%), Gaps = 12/253 (4%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH--KMAEQIKREVATMKLVKHPNVV 74
R +G+G++ +V R+ G+ +K L+ + K AEQ E + +KHPN+V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ---EAQLLSQLKHPNIV 62
Query: 75 RLYEVM-GSKTKIFIVLEFVTGGELFDKIVNH-GRM-KEDEARRYFQQLINAVDYCHSRG 131
E G ++IV+ F GG+L+ K+ G++ E++ +F Q+ A+ Y H +
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ HRDLK +N+ L +KV D G++ + + D + T GTP Y++PE+ +++ Y+
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYN 180
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNL-YKKISAAEFTCPPWLSFTARKLIARILD 250
+D+W+ G ++ + F+ ++ +L Y+ I P S +LIA +L
Sbjct: 181 -YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLS 239
Query: 251 PNPMTRITIPEIL 263
P R ++ IL
Sbjct: 240 KRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 5e-22
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 19/276 (6%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
EV +G+G + V + TG +A+K + E L QI E+ + P +
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYI 61
Query: 74 VRLYEVMGSKTKIFIVLEFVTGG---ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
V Y + +++ +E++ G +L+ V + ED RR ++ + +
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 131 -GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL---- 185
+ HRD+KP N+L++ G +K+ DFG+S V L T G +Y+APE +
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVAS--LAKTNIGCQSYMAPERIKSGG 177
Query: 186 -NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL----SFT 240
N +D+WS G+ + + G P+ N++ ++SA PP L S
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
A+ +A+ L+ P R T ++LE W K V
Sbjct: 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADV 273
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 40/224 (17%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVAT 64
++ YE+ +GEGTF +V AR +TG VALK K+L H + RE+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKI 60
Query: 65 MKLVKHPNVVRLYEVMGSKTK--------IFIVLEFVT---GGELFDKIVNHGRMKEDEA 113
+K +KHPNVV L ++ + +++V ++ G L + V + E +
Sbjct: 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQI 117
Query: 114 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 173
+ Y QL+ ++Y H + HRD+K N+L+D G LK++DFG L++
Sbjct: 118 KCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG---LARPYDGPPPNPKG 174
Query: 174 CGTPN------------YVAPE-VLNDRGYDGSTADLWSCGVIL 204
G Y PE +L +R Y + D+W G +
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVF 217
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-21
Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG G F +V R PVA+K + L + + +E +K HPN+VRL
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
V K I+IV+E V GG+ + G R+K E + + ++Y S+ HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN----YVAPEVLNDRGYDGS 193
N L+ LK+SDFG+S + +DG+ +T G + APE LN Y S
Sbjct: 121 AARNCLVTEKNVLKISDFGMS----REEEDGVYASTGGMKQIPVKWTAPEALNYGRYS-S 175
Query: 194 TADLWSCGVILFVLLA-GYLPFDDSNLMN 221
+D+WS G++L+ + G +P+ +NL N
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPY--ANLSN 202
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 92/340 (27%), Positives = 162/340 (47%), Gaps = 55/340 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH-KMAEQIKREVATMKLVKH 70
+Y++ IG+G++ V A ++ TGE VA+K ++ V +H A +I RE+ ++L++H
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIND--VFEHVSDATRILREIKLLRLLRH 58
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
P++V + +M ++ I++V E + +L I + + + + + QL+ A+
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEV 184
Y H+ V+HRDLKP+N+L +A LK+ DFGL+ ++ + T T Y APE+
Sbjct: 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 185 LNDRGYDGSTA-DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-------- 235
+ A D+WS G I +L G F N+++ I+ T P
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237
Query: 236 -----WLS---------FT---------ARKLIARILDPNPMTRITIPEILEDEWFK--- 269
+LS F+ A +L+ R+L +P R T E L D +FK
Sbjct: 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297
Query: 270 -KDYKP---PV------FEEKKDTNLDDVEAVFKDSEEHH 299
+ +P P+ FE ++ T D E ++++ E+H
Sbjct: 298 KVEREPSAQPITKLEFEFERRRLTKEDVRELIYREILEYH 337
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 3e-21
Identities = 68/224 (30%), Positives = 113/224 (50%), Gaps = 21/224 (9%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
G +E+ +G GT+ +V R+ +TG+ A+K++D + E+IK+E+ +K
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 61
Query: 70 HPNVVRLYEVM------GSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLI 121
H N+ Y G ++++V+EF G + D I N +KE+ ++++
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+ + H V HRD+K +N+LL +K+ DFG+SA Q R G +T GTP ++A
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 179
Query: 182 PEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220
PEV+ D YD +DLWS G+ + G P D + M
Sbjct: 180 PEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-21
Identities = 71/265 (26%), Positives = 121/265 (45%), Gaps = 14/265 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG G+F V FA NS T E VA+K + ++ + I +EV ++ +KHPN +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
+ ++V+E+ G V+ ++E E + + Y HS + HRD+K
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV---LNDRGYDGSTA 195
N+LL G +K++DFG ++ S ++ GTP ++APEV +++ YDG
Sbjct: 149 AGNILLTEPGQVKLADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKV- 201
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIARILDPN 252
D+WS G+ L P + N M+ I+ + W + + R + L
Sbjct: 202 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW-TDSFRGFVDYCLQKI 260
Query: 253 PMTRITIPEILEDEWFKKDYKPPVF 277
P R E+L ++ ++D V
Sbjct: 261 PQERPASAELLRHDFVRRDRPARVL 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 5e-21
Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 27/223 (12%)
Query: 48 KVLKHKMAEQIKREVAT-MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG 106
K++K K I+ V MK +PN ++LY + + ++++++ G+LFD + G
Sbjct: 47 KIIKAKNFNAIEPMVHQLMK--DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG 104
Query: 107 RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSAL--SQQ 163
++ E E ++ +QL+ A++ H + H D+K EN+L D + + D+GL + +
Sbjct: 105 KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS 164
Query: 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----- 218
D GT +Y +PE + YD S D W+ GV+ + LL G PF +
Sbjct: 165 CYD--------GTLDYFSPEKIKGHNYDVSF-DWWAVGVLTYELLTGKHPFKEDEDEELD 215
Query: 219 ---LMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT 258
L+ +K + +S A + +L N R+T
Sbjct: 216 LESLLKRQQK----KLPFIKNVSKNANDFVQSMLKYNINYRLT 254
|
Length = 267 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 6e-21
Identities = 65/195 (33%), Positives = 104/195 (53%), Gaps = 10/195 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVVRL 76
+GEGT+A V R+ T VALK E L+H+ REV+ +K +KH N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALK----EIRLEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHR 135
++++ ++ + +V E++ +L + N G M + + QL+ + YCH R + HR
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKP+NLL++ G LK++DFGL A ++ V + T Y P+VL +
Sbjct: 128 DLKPQNLLINEKGELKLADFGL-ARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPI 185
Query: 196 DLWSCGVILFVLLAG 210
D+W G IL+ + G
Sbjct: 186 DMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 7e-21
Identities = 86/338 (25%), Positives = 140/338 (41%), Gaps = 77/338 (22%)
Query: 13 YEVGRTIGEGTFAKVKFARNSET--GEPVALK----ILDKEKVLKHKMAEQIKREVATMK 66
YE+ + +G+G + V ARN+ET E VA+K + K+ + K + RE+ ++
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-----RELKLLR 56
Query: 67 LVK-HPNVVRLYEVMGSKTKIFIVLEFVTGG---------ELFD----KIVNHGRMKEDE 112
+ H N+ LY+ ++ V G EL + +I+ G+ D
Sbjct: 57 HFRGHKNITCLYD-----------MDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDA 105
Query: 113 ARRYF-QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ--QVRDDGL 169
+ F Q++ + Y HS V HRDLKP NLL++A LK+ DFGL+ + G
Sbjct: 106 HFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165
Query: 170 LHTTCGTPNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLAG------------------ 210
+ T Y APE+ L+ + Y + D+WS G IL LL
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAI-DVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ 224
Query: 211 YLPFDDSNLMNLYKKISAAEFT----CPPWLSFT---------ARKLIARILDPNPMTRI 257
L D ++ A + P F A L+ ++L +P RI
Sbjct: 225 VLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI 284
Query: 258 TIPEILE----DEWFKKDYKPPVFEEKKDTNLDDVEAV 291
++ E LE W D PV ++ D + + +++
Sbjct: 285 SVEEALEHPYLAIWHDPD-DEPVCQKPFDFSFESEDSM 321
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 9e-21
Identities = 84/308 (27%), Positives = 134/308 (43%), Gaps = 58/308 (18%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
KY + IG G + V A+NSET E VA+K + +++ A++ RE+ ++ + H
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN--AFDNRIDAKRTLREIKLLRHLDH 63
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFD----KIVNHGRMKEDEARRYF-QQL 120
NV+ + ++M + ++IV E L D +I+ + D+ +YF QL
Sbjct: 64 ENVIAIKDIMPPPHREAFNDVYIVYE------LMDTDLHQIIRSSQTLSDDHCQYFLYQL 117
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + Y HS V HRDLKP NLLL+A +LK+ DFGL+ + + + T Y
Sbjct: 118 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--KGDFMTEYVVTRWYR 175
Query: 181 APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPF-------------------DDSNLM 220
APE+ LN Y + D+WS G I LL F + +L
Sbjct: 176 APELLLNCSEY-TTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234
Query: 221 NL--------------YKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDE 266
+ + S A P + A L+ ++L +P RIT+ E L
Sbjct: 235 FIRNEKARRYIRSLPYTPRQSFARLF--PHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292
Query: 267 WFKKDYKP 274
+ + P
Sbjct: 293 YLASLHDP 300
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 73/205 (35%), Positives = 109/205 (53%), Gaps = 19/205 (9%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETG-EPVALKILDKEKVLKHKMAEQIKREVATMKLVK- 69
+YE IGEG + KV AR+ + G VALK + + + + M REVA ++ ++
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 60
Query: 70 --HPNVVRLYEV-----MGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQL 120
HPNVVRL++V +TK+ +V E V DK+ G + + + QL
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMMFQL 119
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-SQQVRDDGLLHTTCGTPNY 179
+ +D+ HS V HRDLKP+N+L+ + G +K++DFGL+ + S Q+ L + T Y
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----ALTSVVVTLWY 175
Query: 180 VAPEVLNDRGYDGSTADLWSCGVIL 204
APEVL Y + DLWS G I
Sbjct: 176 RAPEVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-20
Identities = 67/244 (27%), Positives = 107/244 (43%), Gaps = 34/244 (13%)
Query: 22 GTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81
G KV ++ T + LK L K + I V PN+V L++ +
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCV--------PNMVCLHKYIV 55
Query: 82 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141
S+ +F+VL+ GG+L+ I + E+ +R+ +++ A+D H G+ RDL P N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 142 LLLDAYGNLKVSDFG-LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA--DLW 198
+LLD G+++++ F S + + + + C APEV G T D W
Sbjct: 116 ILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC------APEV---GGISEETEACDWW 166
Query: 199 SCGVILFVLLAGYLPFDDSNLMNLYKKISAA-----EFTCPPWLSFTARKLIARILDPNP 253
S G ILF LL G L + + P W+S AR L+ ++L NP
Sbjct: 167 SLGAILFELLTG---------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNP 217
Query: 254 MTRI 257
R+
Sbjct: 218 TERL 221
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 12/220 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKE-KVLKHKMAEQIKREVATMKLVKH 70
+Y+ +G G + V A ++ + VA+K L + + L H A + RE+ +K +KH
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIH--ARRTYRELRLLKHMKH 73
Query: 71 PNVVRLYEVMGSKTKI--FIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
NV+ L +V T I F + VT G + IV ++ ++ + QL+ + Y
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
HS G+ HRDLKP N+ ++ L++ DFG L++Q D+ + T Y APE++
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFG---LARQADDE--MTGYVATRWYRAPEIML 188
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
+ + T D+WS G I+ LL G F ++ ++ K+I
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 14/211 (6%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+ YE +GEG++A V ++ G+ VALK++ ++ + RE + +K +
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGL 60
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
KH N+V L++++ +K + +V E+V + DK + G + + + + QL+ + Y
Sbjct: 61 KHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSY 118
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG---TPNYVAPE 183
H R + HRDLKP+NLL+ G LK++DFGL A ++ V HT T Y P+
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGL-ARAKSVPS----HTYSNEVVTLWYRPPD 173
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214
VL + D+W G I ++ G F
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 77/285 (27%), Positives = 130/285 (45%), Gaps = 22/285 (7%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R IG G+F V FAR+ T E VA+K + ++ + I +EV ++ +KHPN +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ ++V+E+ G V+ ++E E + + Y HS + HRD
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV---LNDRGYDGS 193
+K N+LL G +K++DFG ++++ ++ GTP ++APEV +++ YDG
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGK 204
Query: 194 TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIARILD 250
D+WS G+ L P + N M+ I+ E W + R + L
Sbjct: 205 V-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYF-RNFVDSCLQ 262
Query: 251 PNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDS 295
P R T E+L+ + V E+ +T L D+ KD+
Sbjct: 263 KIPQDRPTSEELLKHMF--------VLRERPETVLIDLIQRTKDA 299
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 5e-20
Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 16/237 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y + +G G + V A + TG VA+K L + A++ RE+ +K +KH
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHE 74
Query: 72 NVVRLYEVMGSKTKI------FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
NV+ L +V + ++V+ F+ G K++ H ++ ED + Q++ +
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
Y H+ G+ HRDLKP NL ++ LK+ DFGL+ + D + T Y APEV+
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVI 187
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242
+ + T D+WS G I+ +L G F + ++ +I + T P F +
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI--MKVTGTPSKEFVQK 242
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 9e-20
Identities = 66/204 (32%), Positives = 107/204 (52%), Gaps = 18/204 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-- 69
+YE IG G + V AR+ +G VALK + + + + + REVA +K ++
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAF 59
Query: 70 -HPNVVRLYEVMGS-----KTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLI 121
HPN+VRL +V + +TK+ +V E V DK+ G + + + +Q +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFL 118
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-SQQVRDDGLLHTTCGTPNYV 180
+D+ H+ + HRDLKPEN+L+ + G +K++DFGL+ + S Q+ ++ T Y
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW----YR 174
Query: 181 APEVLNDRGYDGSTADLWSCGVIL 204
APEVL Y + D+WS G I
Sbjct: 175 APEVLLQSTY-ATPVDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 9e-20
Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 10/204 (4%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVVRL 76
+GEGT+A V R+ T VALK E L+H+ REV+ +K +KH N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALK----EIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHR 135
++++ + + +V E++ +L + + G M + + Q++ + YCH R V HR
Sbjct: 70 HDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKP+NLL++ G LK++DFGL A ++ V + T Y P+VL +
Sbjct: 129 DLKPQNLLINERGELKLADFGL-ARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQI 186
Query: 196 DLWSCGVILFVLLAGYLPFDDSNL 219
D+W G I F + +G F S +
Sbjct: 187 DMWGVGCIFFEMASGRPLFPGSTV 210
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 71/265 (26%), Positives = 123/265 (46%), Gaps = 36/265 (13%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++G TIG+G F V G+ VA+K L + A+ E + M ++HPN+
Sbjct: 9 KLGATIGKGEFGDVM--LGDYRGQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNL 62
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI-------NAVDY 126
V+L V+ ++IV E++ G L D + + GR A Q + ++Y
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR-----AVITLAQQLGFALDVCEGMEY 117
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVL 185
+ HRDL N+L+ KVSDFGL+ + Q +D G L P + APE L
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL------PVKWTAPEAL 171
Query: 186 NDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA-----AEFTCPPWLSF 239
++ + + +D+WS G++L+ + + G +P+ L ++ + A CPP +
Sbjct: 172 REKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEV-- 228
Query: 240 TARKLIARILDPNPMTRITIPEILE 264
K++ + +P R T ++ E
Sbjct: 229 --YKVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 57/232 (24%), Positives = 109/232 (46%), Gaps = 17/232 (7%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ + R +G G F +V VA+KIL + +LK + ++EV +K ++H +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQQD---FQKEVQALKRLRHKH 63
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQ-QLINAVDYCHSR 130
++ L+ V ++I+ E + G L + + G++ + Q+ + Y +
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRG 189
HRDL N+L+ KV+DFGL+ L +++D L + P + APE +
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA-----AEFTCPP 235
+ + +D+WS G++L+ + G +P+ N +Y +I+A CP
Sbjct: 181 FS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQ 231
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+GEG++A V + G+ VALK++ + + + RE + +K +KH N+V L++
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
++ +K + V E++ +L ++ H G + R + QL+ + Y H + + HRDL
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129
Query: 138 KPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
KP+NLL+ G LK++DFGL+ ++ Q ++ T Y P+VL S
Sbjct: 130 KPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-----TLWYRPPDVLLGATDYSSA 184
Query: 195 ADLWSCGVILFVLLAG 210
D+W G I +L G
Sbjct: 185 LDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVVRL 76
+GEGT+A V R+ T VALK E L+H+ REV+ +K +KH N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALK----EIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 77 YEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
++++ ++ + +V E++ + D N M + + QL+ ++YCH R V H
Sbjct: 70 HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN--VKLFLFQLLRGLNYCHRRKVLH 127
Query: 135 RDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
RDLKP+NLL++ G LK++DFGL+ ++ + + ++ T Y P++L
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-----TLWYRPPDILLGSTDY 182
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNL 219
+ D+W G I + + G F S +
Sbjct: 183 STQIDMWGVGCIFYEMSTGRPLFPGSTV 210
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 6e-19
Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 22/198 (11%)
Query: 19 IGEGTFAKVKFAR-NSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
+G+G+F V+ ++ G+ PVA+K L +K+ + + +E A M + H N++R
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD--IMDDFLKEAAIMHSLDHENLIR 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--------RYFQQLINAVDYC 127
LY V+ + + +V E G L D R+++D Y Q+ N + Y
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLD------RLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLN 186
S+ HRDL N+LL + +K+ DFGL Q D ++ P + APE L
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 187 DRGYDGSTADLWSCGVIL 204
R + +D+W GV L
Sbjct: 174 TRTFS-HASDVWMFGVTL 190
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 71/308 (23%), Positives = 135/308 (43%), Gaps = 53/308 (17%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+ +Y++ R IG+G +V A + VALK + ++ + ++ RE +
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR------------RYF 117
HP +V +Y + ++ + ++ G L ++ KE ++ F
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD---------G 168
++ ++Y HS+GV HRDLKP+N+LL +G + + D+G + + +D
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 169 LLHTT-------CGTPNYVAPEVLNDRGYDGS-TADLWSCGVILFVLLAGYLPF---DDS 217
+ +++ GTP+Y+APE L G S + D+++ GVIL+ +L P+
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237
Query: 218 NLMNLYKKISAAEFT----CPPWLSFTARKLIARILDPNPMTRI-TIPEILED------- 265
+ +S E PP+LS ++ + L +P R ++ E+ +D
Sbjct: 238 KISYRDVILSPIEVAPYREIPPFLS----QIAMKALAVDPAERYSSVQELKQDLEPHLQG 293
Query: 266 --EWFKKD 271
EW K
Sbjct: 294 SPEWTVKA 301
|
Length = 932 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-18
Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 16/233 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKE-KVLKHKMAEQIKREVATMKLVKH 70
+Y+ +G G + V A +++TG VA+K L + + + H A++ RE+ +K +KH
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYRELRLLKHMKH 75
Query: 71 PNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
NV+ L +V +++V + G + IV ++ +D + Q++ +
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 133
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
Y HS + HRDLKP NL ++ LK+ DFGL+ D + T Y APE+
Sbjct: 134 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEI 188
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL 237
+ + + T D+WS G I+ LL G F ++ ++ K I T L
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 241
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 7e-18
Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 15/221 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y + +G G + V A + TGE VA+K L + A++ RE+ +K ++H
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHE 74
Query: 72 NVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
NV+ L +V S ++V+ ++ KI+ H + ED+ + Q++ +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGH-PLSEDKVQYLVYQMLCGLK 131
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
Y HS G+ HRDLKP NL ++ LK+ DFGL+ + D + T Y APEV+
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA-----DAEMTGYVVTRWYRAPEVI 186
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
+ + T D+WS G I+ +L G F + ++ +I
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 227
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 8e-18
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 10/217 (4%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R IG G+F V FAR+ E VA+K + ++ + I +EV ++ ++HPN ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ ++V+E+ G V+ ++E E + + Y HS + HRD
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV---LNDRGYDGS 193
+K N+LL G +K+ DFG +++ + GTP ++APEV +++ YDG
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 194 TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230
D+WS G+ L P + N M+ I+ E
Sbjct: 195 V-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 230
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 9e-18
Identities = 73/273 (26%), Positives = 115/273 (42%), Gaps = 51/273 (18%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKIL-------DKEKVLKHKMAEQIKREVATMKLVK 69
IG+G F V E VA+K K K L+ E +K
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQ---------EAEILKQYD 50
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDE--ARRYFQQLINA---V 124
HPN+V+L V K I+IV+E V GG L + R K++ ++ Q ++A +
Sbjct: 51 HPNIVKLIGVCVQKQPIYIVMELVPGGSL----LTFLRKKKNRLTVKKLLQMSLDAAAGM 106
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN----YV 180
+Y S+ HRDL N L+ LK+SDFG+S + + G+ + G +
Sbjct: 107 EYLESKNCIHRDLAARNCLVGENNVLKISDFGMS----REEEGGIYTVSDGLKQIPIKWT 162
Query: 181 APEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYK--------KISAAEF 231
APE LN Y S +D+WS G++L+ G P+ + N ++ A +
Sbjct: 163 APEALNYGRYT-SESDVWSYGILLWETFSLGDTPY--PGMSNQQTRERIESGYRMPAPQL 219
Query: 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
CP + +L+ + +P R + EI
Sbjct: 220 -CPEEI----YRLMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 58/194 (29%), Positives = 88/194 (45%), Gaps = 12/194 (6%)
Query: 17 RTIGEGTFAKVK---FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G G F V + S VA+K L +E + K ++ RE + M + HP +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCI 58
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 133
VRL V + + +V+E G L + + + + Q+ + Y S+
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGT-P-NYVAPEVLNDRGY 190
HRDL N+LL K+SDFG+S AL D TT G P + APE +N +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALG--AGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 191 DGSTADLWSCGVIL 204
S +D+WS GV L
Sbjct: 176 S-SKSDVWSYGVTL 188
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 72/260 (27%), Positives = 122/260 (46%), Gaps = 28/260 (10%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G F +V F + PVA+K ++ L ++ + E +K HPN+V+L
Sbjct: 3 LGKGNFGEV-FKGTLKDKTPVAVKTCKED--LPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN-AVD------YCHSRG 131
V + I+IV+E V GG+ + R K+DE + +QL+ A+D Y S+
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAAGMAYLESKN 113
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN----YVAPEVLND 187
HRDL N L+ LK+SDFG+S ++D ++++ G + APE LN
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALNY 168
Query: 188 RGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245
Y S +D+WS G++L+ + G P+ +++ +CP K++
Sbjct: 169 GRYS-SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVM 227
Query: 246 ARILDPNPMTRITIPEILED 265
R D P R E+ ++
Sbjct: 228 QRCWDYKPENRPKFSELQKE 247
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 87/355 (24%), Positives = 147/355 (41%), Gaps = 83/355 (23%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDK--EKVLKHKMAEQIKREVATMKLVK 69
+Y+ + IG G V A ++ TG+ VA+K L + + V K A RE+ MKLV
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRA---YRELVLMKLVN 73
Query: 70 HPNVVRLYEVMGSKTK------IFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYF-QQL 120
H N++ L V + +++V+E + ++ ++H RM Y Q+
Sbjct: 74 HKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS------YLLYQM 127
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + + HS G+ HRDLKP N+++ + LK+ DFG L++ ++ T Y
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYR 184
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----- 235
APEV+ GY D+WS G I+ ++ G + F ++ ++ + KI T
Sbjct: 185 APEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243
Query: 236 ----------------WLSFT----------------------ARKLIARILDPNPMTRI 257
SF AR L++++L +P RI
Sbjct: 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI 303
Query: 258 TIPEILEDE----WFKKD--YKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEE 306
++ + L+ W+ PP D ++D+ EH V E KE
Sbjct: 304 SVDDALQHPYINVWYDPSEVEAPP--PAPYDHSIDER--------EHTVEEWKEL 348
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA-EQIKREVATMKLVKHPNVVR 75
R IG G F V + G+ VALK + V ++ ++ +++ RE+ + KH NV+
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKM--PNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63
Query: 76 LYEVM-----GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
+++ +I++V E + +L IV+ + D + + Q++ + Y HS
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA 122
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAPEVLNDR 188
G+ HRD+KP NLL+++ LK+ DFGL+ + + D H T T Y APE+L
Sbjct: 123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEP---DESKHMTQEVVTQYYRAPEILMGS 179
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSN 218
+ S D+WS G I LL + F +
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRRILFQAQS 209
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 83/344 (24%), Positives = 146/344 (42%), Gaps = 64/344 (18%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y+ + IG G V A ++ G VA+K L + A++ RE+ +K V H
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVNHK 80
Query: 72 NVVRLYEVMGSKTK------IFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINA 123
N++ L V + +++V+E + ++ ++H RM Q++
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMS-----YLLYQMLCG 135
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+ + HS G+ HRDLKP N+++ + LK+ DFG L++ + ++ T Y APE
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTACTNFMMTPYVVTRYYRAPE 192
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI------SAAEFTCP--- 234
V+ GY D+WS G I+ L+ G + F ++ ++ + K+ +AEF
Sbjct: 193 VILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251
Query: 235 ------------PWLSFT---------------------ARKLIARILDPNPMTRITIPE 261
P +SF AR L++++L +P RI++ E
Sbjct: 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311
Query: 262 ILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKE 305
L + Y P E + D + + EH + E KE
Sbjct: 312 ALRHPYITVWYDPAE-AEAPPPQIYDAQL---EEREHAIEEWKE 351
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 2e-17
Identities = 71/254 (27%), Positives = 119/254 (46%), Gaps = 16/254 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G G F V + + VA+K +++ + + E+ K MKL HP +V+L
Sbjct: 10 KELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAK---VMMKL-SHPKLVQL 64
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
Y V + ++IV EF+ G L + + G++ +D Q + ++Y HR
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRGYDG 192
DL N L+ + G +KVSDFG +++ V DD ++ G + PEV N Y
Sbjct: 125 DLAARNCLVSSTGVVKVSDFG---MTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYS- 179
Query: 193 STADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-SFTARKLIARILD 250
S +D+WS GV+++ V G +PF+ + + + IS P L S T +++
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWH 239
Query: 251 PNPMTRITIPEILE 264
P R T E+L
Sbjct: 240 EKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 16/196 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
K +G IGEG F V + TG+ VA+K + + A+ E A M + H
Sbjct: 7 KLTLGEIIGEGEFGAV--LQGEYTGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHK 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHS 129
N+VRL V+ ++IV+E ++ G L + + GR + ++ + ++Y S
Sbjct: 60 NLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ + HRDL N+L+ G KVSDFGL+ + D+ L + APE L +
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKK 173
Query: 190 YDGSTADLWSCGVILF 205
+ S +D+WS GV+L+
Sbjct: 174 FS-SKSDVWSYGVLLW 188
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 37/223 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFAR--NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
KYE+ IG GT+ +V A+ N + G+ A+K +K +++ RE+A ++ +K
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 70 HPNVVRLYEVMGSKT--KIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQ------- 118
H NVV L EV ++++ ++ D +I+ R R
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQA---KRVSIPPSMVKSL 113
Query: 119 --QLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGL-----SALSQQVRDD 167
Q++N V Y HS V HRDLKP N+L+ G +K+ D GL + L D
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 168 GLLHTTCGTPNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLA 209
++ T Y APE+ L R Y D+W+ G I LL
Sbjct: 174 PVVVTIW----YRAPELLLGARHYT-KAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 9e-17
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 16 GRTIGEGTFAKVKFA--RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G G F V R VA+K++ +E + + E M + HPN+
Sbjct: 9 LKELGSGQFGVVHLGKWRGKID---VAIKMI-REGAMSE---DDFIEEAKVMMKLSHPNL 61
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 132
V+LY V + IFIV E++ G L + + G++ + + A++Y S G
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRG 189
HRDL N L+ +KVSDFG L++ V DD + GT + PEV D
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFG---LARYVLDDQYTSSQ-GTKFPVKWAPPEVF-DYS 176
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPFD 215
S +D+WS GV+++ V G +P++
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 18/225 (8%)
Query: 13 YEVGRT-------IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM 65
+E+ RT +G G + +V + VA+K L KE ++ E+ +E A M
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAVM 56
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ--QLINA 123
K +KHPN+V+L V + +I+ EF+T G L D + R + + + Q+ +A
Sbjct: 57 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 116
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAP 182
++Y + HRDL N L+ +KV+DFGLS L D H P + AP
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAP 174
Query: 183 EVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
E L + +D+W+ GV+L+ + G P+ +L +Y+ +
Sbjct: 175 ESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 72/276 (26%), Positives = 118/276 (42%), Gaps = 35/276 (12%)
Query: 17 RTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
R +GEG F KV+ R TGE VA+K L E H +K+E+ ++ + H N
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHEN 67
Query: 73 VVRLYEVM--GSKTKIFIVLEFVTGG---ELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
+V+ + I +++EF+ G E + N +K+ +Y Q+ +DY
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQ--QLKYAVQICKGMDYL 125
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY-VAPEVL- 185
SR HRDL N+L+++ +K+ DFGL+ + ++ + +P + APE L
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--------------- 230
+ Y S D+WS GV L+ LL Y + S + K I
Sbjct: 186 QSKFYIAS--DVWSFGVTLYELLT-YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242
Query: 231 --FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
PP +L+ + + P R T ++E
Sbjct: 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
Y V +T+ G+ +V A +PV LKI K L M ++ V HP+
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAM---------LLQNVNHPS 118
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
V+R+ + + S +VL + +L+ + + D+A +Q++ + Y H++
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGY 190
+ HRD+K EN+ ++ + + D G + GL GT APEVL Y
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL----AGTVETNAPEVLARDKY 233
Query: 191 DGSTADLWSCGVILFVLLA 209
+ S AD+WS G++LF +LA
Sbjct: 234 N-SKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-16
Identities = 65/217 (29%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE-QIKREVATMKLVKHPNVVR 75
+ +G G F VK+ + VA+K++ KE M+E + E M + H +V+
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMI-KEG----SMSEDEFIEEAKVMMKLSHEKLVQ 63
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYH 134
LY V + I+IV E+++ G L + + HG R + + + + + Y S+ H
Sbjct: 64 LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIH 123
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRGYD 191
RDL N L+D G +KVSDFG LS+ V DD ++ G+ + PEVL +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFG---LSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFS 179
Query: 192 GSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
S +D+W+ GV+++ V G +P++ N +K+S
Sbjct: 180 -SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS 215
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 2e-16
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 17 RTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
R +GEG F KV N TGE VA+K L +E ++ K+E+ +K + H N
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHEN 67
Query: 73 VVRLY---EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+V+ G K + +++E+V G L D + H ++ + + QQ+ + Y HS
Sbjct: 68 IVKYKGCCSEQGGKG-LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHS 125
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA------LSQQVRDDGLLHTTCGTPNY-VAP 182
+ HRDL N+LLD +K+ DFGL+ +VR+DG +P + A
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAV 179
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLL 208
E L + + ++ D+WS GV L+ LL
Sbjct: 180 ECLKENKFSYAS-DVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 12/208 (5%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
E +G G V ++ TG +A K++ K + +QI RE+ M + P +
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYI 65
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSR-G 131
V Y ++ I + +EF+ G L D+I G + + + ++ + Y ++
Sbjct: 66 VSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR 124
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
+ HRD+KP N+L+++ G +K+ DFG+S L + D T GT Y++PE + Y
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD-----TFVGTSTYMSPERIQGGKY 179
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSN 218
+D+WS G+ + L G PF SN
Sbjct: 180 T-VKSDVWSLGISIIELALGKFPFAFSN 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 24/212 (11%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV--KH--PNVV 74
IG GT +V R +TG +A+K ++ + E+ KR + + +V H P +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVK-----QMRRTGNKEENKRILMDLDVVLKSHDCPYIV 77
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSR-G 131
+ Y + + +FI +E + DK++ G + ED + ++ A+ Y + G
Sbjct: 78 KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT-TCGTPNYVAPEVLN---- 186
V HRD+KP N+LLDA GN+K+ DFG+S + V D T + G Y+APE ++
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISG--RLV--DSKAKTRSAGCAAYMAPERIDPPDP 191
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSN 218
+ YD AD+WS G+ L L G P+ +
Sbjct: 192 NPKYD-IRADVWSLGISLVELATGQFPYKNCK 222
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 8e-16
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMK 66
+ E + +G G F V GE PVA+K+L +E K ++I E M
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMA 64
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVD 125
V HP+VVRL + S + ++ + + G L D + NH + + Q+ +
Sbjct: 65 SVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-TP-NYVAPE 183
Y + + HRDL N+L+ ++K++DFGL+ L D+ H G P ++A E
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPIKWMALE 181
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDD 216
+ R Y +D+WS GV ++ L+ G P++
Sbjct: 182 SILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 36/219 (16%)
Query: 17 RTIGEGTFAKVKFARNSETGEP---VALKIL-----DKEKVLKHKMAEQIKREVATMKLV 68
+ IG G F +V R G+ VA+K L DK+++ E + M
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-------DFLTEASIMGQF 62
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN------ 122
HPN++RL V+ + I+ E++ G L DK ++E++ + QL+
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKF-----LRENDGKFTVGQLVGMLRGIA 116
Query: 123 -AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG--TP-N 178
+ Y HRDL N+L+++ KVSDFG LS+++ D +TT G P
Sbjct: 117 SGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFG---LSRRLEDSEATYTTKGGKIPIR 173
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDD 216
+ APE + R + S +D+WS G++++ V+ G P+ D
Sbjct: 174 WTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 20/201 (9%)
Query: 19 IGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQI---KREVATMKLVKHP 71
+G+G F V+ R TGE VA+K L+H AE + +RE+ +K ++H
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVK------KLQHSTAEHLRDFEREIEILKSLQHD 65
Query: 72 NVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYC 127
N+V+ V S + + +V+E++ G L D + H R + D + Y Q+ ++Y
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYL 124
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY-VAPEVLN 186
S+ HRDL N+L+++ +K+ DFGL+ + Q ++ + +P + APE L
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 187 DRGYDGSTADLWSCGVILFVL 207
+ + +D+WS GV+L+ L
Sbjct: 185 ESKFS-VASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 24/204 (11%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G G V ++ +G +A K++ E +K + QI RE+ + P +V Y
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG------- 131
S +I I +E + GG L D+++ EA+R ++++ V RG
Sbjct: 71 AFYSDGEISICMEHMDGGSL-DQVLK-------EAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 132 --VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ HRD+KP N+L+++ G +K+ DFG+S Q + D + ++ GT +Y++PE L
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTH 178
Query: 190 YDGSTADLWSCGVILFVLLAGYLP 213
Y +D+WS G+ L L G P
Sbjct: 179 YS-VQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 14 EVGRTIGEGTFAKV-KFARNSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+GR IGEG F V + S E VA+K + E+ +E M+ H
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDH 66
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHS 129
P++V+L V+ ++ ++IV+E GEL + VN + Y QL A+ Y S
Sbjct: 67 PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P-NYVAPEVLND 187
+ HRD+ N+L+ + +K+ DFGLS + D+ + G P ++APE +N
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY---LEDESYYKASKGKLPIKWMAPESINF 182
Query: 188 RGYDGSTADLWSCGVILF-VLLAGYLPF 214
R + S +D+W GV ++ +L+ G PF
Sbjct: 183 RRFT-SASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 35/204 (17%)
Query: 16 GRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
R +G G F +V N T VA+K L K + E +E MK ++H +V
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTT--KVAVKTL-KPGTMS---PEAFLQEAQIMKKLRHDKLV 64
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR-YFQQLI-------NAVDY 126
+LY V + I+IV E+++ G L D +K E ++ QL+ + Y
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTP---NYVAP 182
SR HRDL N+L+ K++DFGL+ L + DD +T G + AP
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARL---IEDD--EYTAREGAKFPIKWTAP 173
Query: 183 EVLNDRGYDGST--ADLWSCGVIL 204
E N Y T +D+WS G++L
Sbjct: 174 EAAN---YGRFTIKSDVWSFGILL 194
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 53/216 (24%), Positives = 101/216 (46%), Gaps = 32/216 (14%)
Query: 12 KYEVGRTIGEGTFAKV--KFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMK 66
K + R +G+G+F V A+ GE VA+K +++ ++ ++ + E + MK
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMK 64
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--------RYFQ 118
+VVRL V+ + +V+E + G+L + + R + + ++ Q
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQKFIQ 123
Query: 119 ---QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL---SQQVRDDG--LL 170
++ + + Y ++ HRDL N ++ +K+ DFG++ + R G LL
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 171 HTTCGTP-NYVAPEVLNDRGYDGSTADLWSCGVILF 205
P ++APE L D G + +D+WS GV+L+
Sbjct: 184 ------PVRWMAPESLKD-GVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 4e-15
Identities = 62/228 (27%), Positives = 110/228 (48%), Gaps = 22/228 (9%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+TIG+G F V G VA+K + + A+ E + M ++H N+V+L
Sbjct: 12 QTIGKGEFGDVMLG--DYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQL 64
Query: 77 YEVM-GSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVY 133
V+ K ++IV E++ G L D + + GR + D ++ + A++Y +
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFV 124
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGS 193
HRDL N+L+ KVSDFGL+ + +D G L + APE L ++ + +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFS-T 178
Query: 194 TADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA-----AEFTCPP 235
+D+WS G++L+ + + G +P+ L ++ ++ A CPP
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 226
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 75/300 (25%), Positives = 129/300 (43%), Gaps = 47/300 (15%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI-----KREV----AT 64
EV +G G + V R+ TG +A+K ++ + KR + +
Sbjct: 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVK----------RIRATVNSQEQKRLLMDLDIS 53
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHG-RMKEDEARRYFQQLI 121
M+ V P V Y + + ++I +E + + + K+ + G + ED + ++
Sbjct: 54 MRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIV 113
Query: 122 NAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
A++Y HS+ V HRD+KP N+L++ G +K+ DFG+S + D G Y+
Sbjct: 114 KALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYM 170
Query: 181 APE----VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 236
APE LN +GYD +D+WS G+ + L G P+D + ++++ P
Sbjct: 171 APERINPELNQKGYD-VKSDVWSLGITMIELATGRFPYD--SWKTPFQQLKQVVEEPSPQ 227
Query: 237 L---SFTA--RKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAV 291
L F+ + + + L N R PE+L+ P FE N D V
Sbjct: 228 LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH---------PFFELHLSKNTDVASFV 278
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 65/269 (24%), Positives = 120/269 (44%), Gaps = 19/269 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y+ + IG G V A ++ VA+K L + A++ RE+ MK V H
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHK 76
Query: 72 NVVRLYEVMGSKTK------IFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINA 123
N++ L V + +++V+E + ++ ++H RM Q++
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLYQMLCG 131
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+ + HS G+ HRDLKP N+++ + LK+ DFG L++ ++ T Y APE
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPE 188
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTAR 242
V+ GY D+WS G I+ ++ + F + ++ + K+ T CP ++
Sbjct: 189 VILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 243 KLIARILDPNPMTRITIPEILEDEWFKKD 271
+ + + +T P++ D F D
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPAD 276
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 6e-15
Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLY 77
+G G V A + T +A+K++ + ++ + +QI E+ + P ++ Y
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSELEILYKCDSPYIIGFY 65
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
+ +I I EF+ GG L D + ++ E R ++ + Y S + HRD+
Sbjct: 66 GAFFVENRISICTEFMDGGSL-DV---YRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDV 121
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
KP N+L++ G +K+ DFG+S +Q V + + T GT Y+APE ++ Y G +D+
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVS--TQLV--NSIAKTYVGTNAYMAPERISGEQY-GIHSDV 176
Query: 198 WSCGVILFVLLAGYLPF 214
WS G+ L G P+
Sbjct: 177 WSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 18/223 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y+ + IG G V A ++ VA+K L + A++ RE+ MK V H
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHK 83
Query: 72 NVVRLYEVMGSKTK------IFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINA 123
N++ L V + ++IV+E + ++ ++H RM Q++
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLYQMLCG 138
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+ + HS G+ HRDLKP N+++ + LK+ DFG L++ ++ T Y APE
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPE 195
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
V+ GY D+WS G I+ ++ G + F ++ ++ + K+
Sbjct: 196 VILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 63/266 (23%), Positives = 124/266 (46%), Gaps = 33/266 (12%)
Query: 1 MSQPKIKRR---VGKYEVGRTIGEGTFAKV---------------KFARNSETGEPVALK 42
++Q K+K + + V + G F K+ + ++ G+P +
Sbjct: 135 LAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCER 194
Query: 43 ILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV---LEFVTGGELF 99
++ K + A Q++ E+ + + H N++++ E++ S+ +++ +F ++
Sbjct: 195 LIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMY 254
Query: 100 DKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
D+ + R + R +QL+ AV+Y H + + HRD+K EN+ L+ G + + DFG +
Sbjct: 255 DEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314
Query: 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDS 217
++ R + + GT +PE+L GY T D+WSCG+IL +L+ + P D
Sbjct: 315 MPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEIT-DIWSCGLILLDMLSHDFCPIGDG 372
Query: 218 ------NLMNLYKKISAA--EFTCPP 235
L+ + +S EF PP
Sbjct: 373 GGKPGKQLLKIIDSLSVCDEEFPDPP 398
|
Length = 501 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 8/202 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E +G G V + +G +A K++ E +K + QI RE+ + P
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 64
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-G 131
+V Y S +I I +E + GG L + GR+ E + +I + Y +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ HRD+KP N+L+++ G +K+ DFG+S Q + D + ++ GT +Y++PE L Y
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTHYS 180
Query: 192 GSTADLWSCGVILFVLLAGYLP 213
+D+WS G+ L + G P
Sbjct: 181 -VQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 50/223 (22%), Positives = 102/223 (45%), Gaps = 19/223 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+G+ + V A++ T VA+K ++ + + + +++E+ T + ++HPN
Sbjct: 4 TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPN 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHS 129
++ +++++V + G D + H G + E + ++NA+DY HS
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-------NYVAP 182
+G HR +K ++LL G + +S GL ++ P +++P
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 183 EVL--NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY 223
EVL N +GY+ +D++S G+ L G++PF D +
Sbjct: 178 EVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 18/231 (7%)
Query: 17 RTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ IG G F +V R G+ PVA+K L K + E + M HPN+
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHPNI 67
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 132
+ L V+ + IV E++ G L + H G+ + + + + + Y G
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY 127
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRG 189
HRDL N+L+++ KVSDFGLS + + D +TT G + APE + R
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS-----AAEFTCP 234
+ S +D+WS G++++ V+ G P+ + + ++ K I A CP
Sbjct: 186 FT-SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCP 235
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 17/211 (8%)
Query: 19 IGEG--TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
IG G V AR TGE V ++ ++ E ++M ++ E+ KL HPN+V
Sbjct: 6 IGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPY 64
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYH 134
+ ++++V F+ G D I H M E Q ++ A+DY H G H
Sbjct: 65 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVH 124
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY-------VAPEVL-- 185
R +K ++L+ G + +S GL + + L P Y ++PEVL
Sbjct: 125 RSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQ 182
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216
N +GYD + +D++S G+ L G++PF D
Sbjct: 183 NLQGYD-AKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 8e-14
Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 26/232 (11%)
Query: 19 IGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKR----EVATMKLVKHP 71
IG G F +V R G+ VA+K LK E+ +R E + M HP
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIK------TLKSGYTEKQRRDFLSEASIMGQFDHP 65
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV--NHGRMKEDEARRYFQQLINAVDYCHS 129
N++ L V+ + I+ EF+ G L D + N G+ + + + + Y
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLN 186
HRDL N+L+++ KVSDFGLS + D ++ G + APE +
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 187 DRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE--FTCPP 235
R + S +D+WS G++++ V+ G P+ D M+ I+A E + PP
Sbjct: 185 YRKFT-SASDVWSYGIVMWEVMSYGERPYWD---MSNQDVINAIEQDYRLPP 232
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 26/222 (11%)
Query: 13 YEVGRTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+ +GR +G+G F V+ A+ + + VA+K+L K + E+ RE A MK
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 70 HPNVVRLYEV-MGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI-- 121
HPNV++L V + S+ K ++L F+ G+L ++ R+ E+ Q L+
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRF 118
Query: 122 -----NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
+ ++Y S+ HRDL N +L+ + V+DFG LS+++ C +
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFG---LSKKIYSGDYYRQGCAS 175
Query: 177 P---NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 214
++A E L D Y + +D+W+ GV ++ ++ G P+
Sbjct: 176 KLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 19 IGEGTFAKVKFARNSETGEPVALK----ILDKEKVLKHKMAEQIKREV-ATMKLVKHPNV 73
IG G F V + +G +A+K +D+ K +++ ++ M+ P +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE------KEQKRLLMDLDVVMRSSDCPYI 65
Query: 74 VRLYEVMGSKTKIFIVLEFV-TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG- 131
V+ Y + + +I +E + + F K V + +K ++++ + +
Sbjct: 66 VKFYGALFREGDCWICMELMDISLDKFYKYV-YEVLK----SVIPEEILGKIAVATVKAL 120
Query: 132 --------VYHRDLKPENLLLDAYGNLKVSDFGLSALSQ----QVRDDGLLHTTCGTPNY 179
+ HRD+KP N+LLD GN+K+ DFG+S + RD G C P Y
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAG-----C-RP-Y 173
Query: 180 VAPEVLNDRGYDGS--TADLWSCGVILFVLLAGYLPFDDSN 218
+APE ++ DG +D+WS G+ L+ + G P+ N
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-13
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 15/228 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG G F V E + VA+K + +E + E E M + HP +V+LY
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTI-REGAMSE---EDFIEEAQVMMKLSHPKLVQLYG 66
Query: 79 VMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
V ++ I +V EF+ G L D + G+ ++ + + Y S V HRDL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRGYDGST 194
N L+ +KVSDFG++ V DD +T GT + +PEV + Y S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRF---VLDDQYTSST-GTKFPVKWSSPEVFSFSKYS-SK 181
Query: 195 ADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
+D+WS GV+++ V G P+++ + + + I+A P L+ +
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQS 229
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G G V + +G +A K++ E +K + QI RE+ + P +V Y
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYIVGFYG 66
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG------- 131
S +I I +E + GG L D+++ +A R + ++ + RG
Sbjct: 67 AFYSDGEISICMEHMDGGSL-DQVLK-------KAGRIPENILGKISIAVLRGLTYLREK 118
Query: 132 --VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ HRD+KP N+L+++ G +K+ DFG+S Q + D + ++ GT +Y++PE L
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTH 174
Query: 190 YDGSTADLWSCGVILFVLLAGYLP 213
Y + D+WS G+ L + G P
Sbjct: 175 YTVQS-DIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 39/223 (17%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEP-----VALKILDKEKVLKHKMAEQIKREVATMK 66
+ +G+ +GEG F +V A P VA+K+L K+ + +++ + E+ MK
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVS-EMEMMK 70
Query: 67 LV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ------- 118
++ KH N++ L V + +++V+E+ G L D + R + A
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETL 129
Query: 119 ----------QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-- 166
Q+ +++ S+ HRDL N+L+ +K++DFGL+ RD
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA------RDIH 183
Query: 167 --DGLLHTTCG-TP-NYVAPEVLNDRGYDGSTADLWSCGVILF 205
D TT G P ++APE L DR Y + D+WS GV+L+
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLLW 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 6e-13
Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 30/222 (13%)
Query: 15 VGRTIGEGTFAKVKFAR-NSETGEP--VALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+G+ +GEG F V + + + G VA+K + K + + E+ E A MK HP
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 72 NVVRLYEV---MGSKTKI---FIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLIN- 122
NV++L V S KI ++L F+ G+L ++ + Q L+
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL---YSRLGGLPEKLPLQTLLKF 118
Query: 123 AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
VD Y +R HRDL N +L + V+DFG LS+++
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFG---LSKKIYSGDYYRQGRIA 175
Query: 177 P---NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 214
++A E L DR Y S +D+W+ GV ++ + G P+
Sbjct: 176 KMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 17 RTIGEGTFAKV--KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
+ +G G F +V + NS VA+K L + E E MK ++H +V
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTK---VAVKTLKPGTMSVQAFLE----EANLMKTLQHDKLV 64
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
RLY V+ + I+I+ E++ G L D K G++ + + Q+ + Y +
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRG 189
HRDL+ N+L+ K++DFGL+ +V +D G + APE +N G
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLA----RVIEDNEYTAREGAKFPIKWTAPEAIN-FG 179
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPF 214
+D+WS G++L+ ++ G +P+
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 30/88 (34%), Positives = 52/88 (59%), Gaps = 1/88 (1%)
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
+QL++A+DY H G+ HRD+K EN+L++ ++ + DFG + ++ + GT
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILF 205
+ APEVL Y + D+WS G+++F
Sbjct: 327 DTNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 70/229 (30%), Positives = 107/229 (46%), Gaps = 27/229 (11%)
Query: 1 MSQPKIKRRVGK-YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK 59
M I R K Y++G IG G+F V A +T E VA+K KVL+ +
Sbjct: 55 MIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK-----KVLQDPQYKN-- 107
Query: 60 REVATMKLVKHPNVVRLYE------VMGSKTKIF--IVLEFVTGGELFDKIVNHGRMKED 111
RE+ MK + H N++ L + ++ IF +V+EF+ + K + H
Sbjct: 108 RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYMKHYARNNH 165
Query: 112 E-----ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVR 165
+ Y QL A+ Y HS+ + HRDLKP+NLL+D + LK+ DFG + +
Sbjct: 166 ALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG--SAKNLLA 223
Query: 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214
+ C + Y APE++ + DLWS G I+ ++ GY F
Sbjct: 224 GQRSVSYIC-SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 8e-12
Identities = 54/246 (21%), Positives = 102/246 (41%), Gaps = 30/246 (12%)
Query: 19 IGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+GEG F KV + VA+K L + + K+ ++ ++E M ++HPN+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNI 70
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ--------------- 118
V L V + ++ E++ G+L + +V + + A +
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 119 -QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
Q+ ++Y S HRDL N L+ +K+SDFGLS + +
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVL----LAGYLPFDDSNLMNLYKK--ISAAEF 231
++ PE + G + +D+WS GV+L+ + L Y F + ++ + + +
Sbjct: 191 RWMPPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPE 249
Query: 232 TCPPWL 237
CP +
Sbjct: 250 DCPARV 255
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 65/248 (26%), Positives = 101/248 (40%), Gaps = 40/248 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSE-TGEP----VALKILDKEKVLKHKMAEQIKREVATMK 66
+G+T+GEG F KV A G VA+K+L + + E +K
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD--LLSEFNLLK 58
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL----------------FDKIVNHGRMKE 110
V HP+V++LY + +++E+ G L D N +
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 111 DEAR--------RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162
+ R + Q+ + Y + HRDL N+L+ +K+SDFGLS
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS--RD 176
Query: 163 QVRDDGLLHTTCG-TP-NYVAPEVLNDRGYDGSTADLWSCGVILF--VLLAG--YLPFDD 216
+D + + G P ++A E L D Y + +D+WS GV+L+ V L G Y
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
Query: 217 SNLMNLYK 224
L NL K
Sbjct: 236 ERLFNLLK 243
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 17 RTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
R +G G F +V N+ T PVA+K L K + + E MK ++HP +++
Sbjct: 12 RKLGAGQFGEVWEGLWNNTT--PVAVKTL-KPGTMD---PKDFLAEAQIMKKLRHPKLIQ 65
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVY 133
LY V + I+IV E + G L + + +K + Q+ + + Y ++
Sbjct: 66 LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYI 125
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRGY 190
HRDL N+L+ KV+DFGL+ +V + + G + APE Y
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLA----RVIKEDIYEAREGAKFPIKWTAPEAAL---Y 178
Query: 191 DGST--ADLWSCGVILFVLLA-GYLPF 214
+ + +D+WS G++L ++ G +P+
Sbjct: 179 NRFSIKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVATMKL 67
+YE G +G GT+ V A+ + + +KE LK I RE+A ++
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKD-------EKEYALKQIEGTGISMSACREIALLRE 54
Query: 68 VKHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHGRMKEDE---------ARRY 116
+KHPNV+ L +V S + K++++ ++ +L+ I H K ++ +
Sbjct: 55 LKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSL 113
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSAL-SQQVRDDGLLH 171
Q+++ + Y H+ V HRDLKP N+L+ G +K++D G + L + ++ L
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 208
T Y APE+L + D+W+ G I LL
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 15 VGRTIGEGTFAKVKFAR-------NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
+G+ +GEG F +V A + VA+K+L K+ +A+ I E+ MKL
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLADLIS-EMELMKL 73
Query: 68 V-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI---------VNHGRMKEDEARRYF 117
+ KH N++ L V + +++++E+ G L + + K E + F
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 118 QQLINAV-------DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170
+ L++ +Y SR HRDL N+L+ +K++DFGL+ + D
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI--DYYK 191
Query: 171 HTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
T+ G ++APE L DR Y +D+WS G++++
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMW 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 5e-11
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 29/217 (13%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVATMKL 67
+YE G +G GT+ V A+ + + D++ LK I RE+A ++
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKD-------DRDYALKQIEGTGISMSACREIALLRE 54
Query: 68 VKHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHGRMKEDE---------ARRY 116
+KHPNV+ L +V S K++++ ++ +L+ I H K ++ +
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSL 113
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSAL-SQQVRDDGLLH 171
Q+++ + Y H+ V HRDLKP N+L+ G +K++D G + L + ++ L
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 208
T Y APE+L + D+W+ G I LL
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 63/252 (25%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFAR-----NSETGEP--VALKILDKEKVLKHKM 54
+ PK + + +G+ +GEG F +V A + +P VA+K+L + K
Sbjct: 3 ADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--DKD 60
Query: 55 AEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGEL-----------FDKI 102
+ E+ MK++ KH N++ L +++++E+ + G L D
Sbjct: 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYS 120
Query: 103 VNHGRMKEDEARRYFQQLIN-------AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155
+ ++ E++ F+ L++ ++Y S+ HRDL N+L+ +K++DF
Sbjct: 121 FDTCKLPEEQLT--FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADF 178
Query: 156 GLSALSQQVRDDGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYL 212
GL+ + D TT G ++APE L DR Y +D+WS GV+L+ + G
Sbjct: 179 GLARDVHNI--DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGS 235
Query: 213 PFDDSNLMNLYK 224
P+ + L+K
Sbjct: 236 PYPGIPVEELFK 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 17 RTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G G F V GE PVA+K L + K ++I E M V +P+
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPH 70
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ----QLINAVDYCH 128
V RL + + T + ++ + + G L D + H K++ +Y Q+ ++Y
Sbjct: 71 VCRLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-TP-NYVAPEVLN 186
R + HRDL N+L+ ++K++DFGL+ L D+ H G P ++A E +
Sbjct: 127 ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--DEKEYHAEGGKVPIKWMALESIL 184
Query: 187 DRGYDGSTADLWSCGVILFVLLA-GYLPFD 215
R Y +D+WS GV ++ L+ G P+D
Sbjct: 185 HRIYT-HQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 66/267 (24%), Positives = 107/267 (40%), Gaps = 29/267 (10%)
Query: 18 TIGEGTFAKVKFARNSETGE-----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
T+G G F +V A+ E V +K L K K + +RE+ + + H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE--FRRELDMFRKLSHKN 69
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGEL--FDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
VVRL + +++LE+ G+L F + K +Q + A+ +
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV-ALCTQIAL 128
Query: 131 GV--------YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVA 181
G+ HRDL N L+ + +KVS LS + P ++A
Sbjct: 129 GMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS--KDVYNSEYYKLRNALIPLRWLA 186
Query: 182 PEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF----DDSNLMNLYKKISAAEFTCPPW 236
PE + + + + D+WS GV+++ V G LPF D+ L L + E P
Sbjct: 187 PEAVQEDDFSTKS-DVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL--QAGKLELPVPEG 243
Query: 237 LSFTARKLIARILDPNPMTRITIPEIL 263
KL+ R NP R + E++
Sbjct: 244 CPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 68/281 (24%), Positives = 111/281 (39%), Gaps = 48/281 (17%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVATMKLVKHPN 72
R +GEG F KV F EP K L K LK + + RE + +H N
Sbjct: 11 RELGEGAFGKV-FLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-------MKEDEAR-------RYFQ 118
+V+ Y V +V E++ G+L + +HG +
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT----- 173
Q+ + + Y S+ HRDL N L+ +K+ DFG+S RD ++TT
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS------RD---VYTTDYYRV 180
Query: 174 CGTP----NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA 228
G ++ PE + R + + +D+WS GV+L+ + G P+ + + + I+
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239
Query: 229 AEF-----TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
TCP ++ +P RI I +I E
Sbjct: 240 GRLLQRPRTCPS----EVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 2/155 (1%)
Query: 60 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 119
RE+ +K + H ++ L K+ + +V+ +LF + G + ++A ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
L+ A+ Y H RG+ HRD+K EN+ LD N + DFG + D + GT
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214
+PE+L Y T D+WS G++LF + +
Sbjct: 254 NSPELLALDPYCAKT-DIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 34/232 (14%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-----TMKLVKHPNV 73
IGEG F +V AR + G L++ K +K ++ R+ A KL HPN+
Sbjct: 3 IGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA----------------RRYF 117
+ L + +++ +E+ G L D + ++ D A +
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-- 175
+ +DY + HRDL N+L+ K++DFGLS + + T G
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 173
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226
++A E LN Y + +D+WS GV+L+ +++ G P+ LY+K+
Sbjct: 174 PVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-10
Identities = 22/86 (25%), Positives = 35/86 (40%), Gaps = 4/86 (4%)
Query: 335 FKRETRFTSRCPANEIINKIEEAAKPLGFDVHKKNYKM----RLENMKAGRKGNLNVATE 390
K E SR +EI I + + G ++ + +L N + E
Sbjct: 2 KKWELEIHSRIDPSEIYEGIHKVLEGWGKNLVFRITNFIITGKLVNDHILFLRSTLFEIE 61
Query: 391 VFQVAPSLHMVEVRKAKGDTLEFHKV 416
V++V P L MV+ +K G T F K+
Sbjct: 62 VYEVGPGLFMVDFKKKTGSTKTFTKL 87
|
This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 24/234 (10%)
Query: 17 RTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ IG G F +V K E VA+K L K + + E + M H
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEV--AVAIKTLKPGYTEKQR--QDFLSEASIMGQFSHH 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV--NHGRMKEDEARRYFQQLINAVDYCHS 129
N++RL V+ I+ E++ G L DK + + G + + + + Y
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD 125
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLN 186
HRDL N+L+++ KVSDFGLS + + D +TT G + APE +
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED--DPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 187 DRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS-----AAEFTCP 234
R + S +D+WS G++++ V+ G P+ D + + K I+ A CP
Sbjct: 184 YRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCP 236
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 17 RTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
+ +G G F +V A N T VA+K + + E E MK ++H +V+
Sbjct: 12 KKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVK 65
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR--------YFQQLINAVDYC 127
L+ V+ +K I+I+ EF+ G L D +K DE + + Q+ + +
Sbjct: 66 LHAVV-TKEPIYIITEFMAKGSLLD------FLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLN 186
R HRDL+ N+L+ A K++DFGL+ + + ++ P + APE +N
Sbjct: 119 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAIN 176
Query: 187 DRGYDGSTADLWSCGVILFVLLA-GYLPF 214
G +D+WS G++L ++ G +P+
Sbjct: 177 -FGSFTIKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 19/215 (8%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
E+GR G V AR++ TG V ++I D E + + + ++ EV +HPN+
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHL-KALQNEVVLSHFFRHPNI 61
Query: 74 VRLYEVMGSKTKIFIVLEFVTGG---ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
+ + V + + ++++ F+ G L G M E + ++Y H
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQN 120
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY-------VAPE 183
G HR++K ++L+ G + +S GLS L VR+ P + ++PE
Sbjct: 121 GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 184 VLND--RGYDGSTADLWSCGVILFVLLAGYLPFDD 216
+L GY+ +D++S G+ L G +PF D
Sbjct: 179 LLRQDLYGYN-VKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 50/190 (26%), Positives = 87/190 (45%), Gaps = 6/190 (3%)
Query: 19 IGEGTFAKVK--FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G F VK + ++ + VA+KIL K + +++ RE M+ + +P +VR+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ +++ +V+E G L + + + E Q+ + Y HRD
Sbjct: 62 IGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRGYDGSTA 195
L N+LL K+SDFGLS + T P + APE +N + S +
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS-SKS 179
Query: 196 DLWSCGVILF 205
D+WS GV+++
Sbjct: 180 DVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 15 VGRTIGEGTFAKVKFAR--NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+G+T+GEG F V + ++ VA+K + + +M E E MK HPN
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEM-EDFLSEAVCMKEFDHPN 61
Query: 73 VVRLYEV--MGSKTKIF----IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI----- 121
V+RL V +++ + ++L F+ G+L ++ + R+ + Q L+
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTD 120
Query: 122 --NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA------LSQQVRDDGLLHTT 173
+ ++Y S+ HRDL N +L+ N+ V+DFGLS +Q R +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM---- 176
Query: 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
++A E L DR Y + +D+WS GV ++
Sbjct: 177 --PVKWIAIESLADRVYT-TKSDVWSFGVTMW 205
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 62/241 (25%), Positives = 112/241 (46%), Gaps = 40/241 (16%)
Query: 15 VGRTIGEGTFAKVKFAR--NSETGEP-----VALKILDKEKVLKHKMAEQIKREVATMKL 67
+G+ +GEG F +V A + +P VA+K+L K + +++ I E+ MK+
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEMMKM 79
Query: 68 V-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY---------- 116
+ KH N++ L +++++E+ + G L + + R + Y
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----RARRPPGMEYCYNPTQVPEE 135
Query: 117 ---FQQLIN-------AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166
F+ L++ ++Y S+ HRDL N+L+ +K++DFGL+ +
Sbjct: 136 QLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI-- 193
Query: 167 DGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLY 223
D TT G ++APE L DR Y +D+WS GV+L+ + G P+ + L+
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
Query: 224 K 224
K
Sbjct: 253 K 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 60/248 (24%), Positives = 113/248 (45%), Gaps = 32/248 (12%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFAR-------NSETGEPVALKILDKEKVLKHKMAE 56
P+ + K +G+ +GEG F +V A + VA+K+L K+ + +++
Sbjct: 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSD 66
Query: 57 QIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI------------- 102
+ E+ MK++ KH N++ L +++++E+ + G L + +
Sbjct: 67 LVS-EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 103 ---VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159
V +M + Q+ ++Y S+ HRDL N+L+ +K++DFGL+
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
Query: 160 LSQQVRDDGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDD 216
+ D TT G ++APE L DR Y +D+WS GV+++ + G P+
Sbjct: 186 DVNNI--DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPG 242
Query: 217 SNLMNLYK 224
+ L+K
Sbjct: 243 IPVEELFK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 34/232 (14%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-----TMKLVKHPNV 73
IGEG F +V A + G + I K+LK +E R+ A KL HPN+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAI----KMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA----------------RRYF 117
+ L ++ ++I +E+ G L D + ++ D A ++
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-- 175
+ + Y + HRDL N+L+ K++DFGLS ++ + T G
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGRL 180
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226
++A E LN Y + +D+WS GV+L+ +++ G P+ LY+K+
Sbjct: 181 PVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 56/221 (25%), Positives = 86/221 (38%), Gaps = 27/221 (12%)
Query: 14 EVGRTIGEGTFAKVKFA-----RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+ R +G G F +V VA+K L + + E M
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQDESDFLMEALIMSKF 66
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY-FQQLIN-AVD- 125
H N+VRL V + FI+LE + GG+L + R + + + L+ A D
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDL-KSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 126 -----YCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSA---LSQQVRDDGLLHTTC 174
Y HRD+ N LL G K++DFG++ + R G
Sbjct: 126 AKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG---RAM 182
Query: 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 214
++ PE D G S D+WS GV+L+ + GY+P+
Sbjct: 183 LPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 16/193 (8%)
Query: 17 RTIGEGTFAKV--KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
+ +G G F +V + VA+K L K+ + E E MK ++HP +V
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTK---VAIKSL-KQGSMS---PEAFLAEANLMKQLQHPRLV 64
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
RLY V+ ++ I+I+ E++ G L D K ++ ++ Q+ + + +
Sbjct: 65 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRGYD 191
HRDL+ N+L+ K++DFGL+ L + ++ P + APE +N G
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAIN-YGTF 180
Query: 192 GSTADLWSCGVIL 204
+D+WS G++L
Sbjct: 181 TIKSDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREV 62
IKRR + R +GEG F KV F P K+L K LK + +RE
Sbjct: 2 IKRR--DIVLKRELGEGAFGKV-FLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREA 58
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG---------------- 106
+ ++H ++V+ Y V G + +V E++ G+L + HG
Sbjct: 59 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118
Query: 107 RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA---LSQQ 163
+ + Q+ + + Y S+ HRDL N L+ A +K+ DFG+S +
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178
Query: 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
R G HT ++ PE + R + + +D+WS GVIL+
Sbjct: 179 YRVGG--HTMLPI-RWMPPESIMYRKFT-TESDVWSFGVILW 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 63/232 (27%), Positives = 105/232 (45%), Gaps = 34/232 (14%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-----TMKLVKHPNV 73
IGEG F +V AR + G L++ K +K ++ R+ A KL HPN+
Sbjct: 15 IGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA---------RRYFQQLIN-- 122
+ L + +++ +E+ G L D + ++ D A QQL++
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 123 -----AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-- 175
+DY + HRDL N+L+ K++DFGLS Q+V + T G
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV----YVKKTMGRL 185
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226
++A E LN Y + +D+WS GV+L+ +++ G P+ LY+K+
Sbjct: 186 PVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVVRL 76
IG G F KV + G A +++ KE EQ+ +EV + + HPNV++
Sbjct: 3 IGNGWFGKV-LLGEAHRGMSKA-RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQL----INAVDYCHSRG 131
+VLEF G+L + + N G + + + Q++ + + + H
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTP-NYVAPEVLNDRG 189
H DL N L A ++K+ D+GL AL Q +D + C P ++APE++ RG
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGL-ALE-QYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 190 YDGSTAD------LWSCGVILFVLL-AGYLPFDD 216
D D +WS GV ++ L A P+ D
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 64/241 (26%), Positives = 108/241 (44%), Gaps = 42/241 (17%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
++++ +GEGTF KV A + + E A+KI+ V K+ +I E+ M+ V+
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIV--RNVPKYTRDAKI--EIQFMEKVRQ 184
Query: 71 PNVVRLYEVMG------SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI--- 121
+ + +M ++T ++ G L D I+ HG R+ Q+I
Sbjct: 185 ADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSH----RHLAQIIFQT 240
Query: 122 -NAVDYCHSR-GVYHRDLKPENLLLDAYGN----------------LKVSDFGLSALSQQ 163
A+DY H+ + H DLKPEN+L++ +++ D G +
Sbjct: 241 GVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH 300
Query: 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNL 222
R T +Y +PEV+ G+ ST D+WS G I++ L G L +D NL +L
Sbjct: 301 SRT-----AIVSTRHYRSPEVVLGLGWMYST-DMWSMGCIIYELYTGKLLYDTHDNLEHL 354
Query: 223 Y 223
+
Sbjct: 355 H 355
|
Length = 467 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 8e-09
Identities = 49/175 (28%), Positives = 70/175 (40%), Gaps = 29/175 (16%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSE--TGEP---VALKILDKEKVLKHKMAEQIKREVATM 65
E R IG+G F +V AR EP VA+K+L +E M +RE A M
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALM 62
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-------KIVNHGRMKEDEARRYFQ 118
HPN+V+L V + ++ E++ G+L + + AR+
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 119 ---------QLINAVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
QL A Y R HRDL N L+ +K++DFGLS
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G G F V GE PVA+KIL++ K + + E M + HP+
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPH 70
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
+VRL V S T I +V + + G L D + H + + Q+ + Y R
Sbjct: 71 LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP--NYVAPEVLNDRG 189
+ HRDL N+L+ + ++K++DFGL+ L + D+ + G ++A E ++ R
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEG--DEKEYNADGGKMPIKWMALECIHYRK 187
Query: 190 YDGSTADLWSCGVILFVLLA-GYLPFD 215
+ +D+WS GV ++ L+ G P+D
Sbjct: 188 FT-HQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 54/235 (22%), Positives = 99/235 (42%), Gaps = 22/235 (9%)
Query: 17 RTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
R +G G F ++ K E PVA+ L K + E T+ H
Sbjct: 11 RILGTGRFGELCRGCLKLPSKREL--PVAIHTLRAGCSDKQRRG--FLAEALTLGQFDHS 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
N+VRL V+ + IV E+++ G L + H G++ + L + + Y
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM 126
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN--YVAPEVLNDR 188
G H+ L +L+++ K+S F Q+ + + + T G + APE +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQ-Y 182
Query: 189 GYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS-----AAEFTCPPWL 237
+ S +D+WS G++++ +++ G P+ D + ++ K + A CP L
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLL 237
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G G F V GE PVA+K+L + K ++I E M V P
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPY 70
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
V RL + + T + +V + + G L D + + R+ + + Q+ + Y
Sbjct: 71 VCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-TP-NYVAPEVLNDRG 189
+ HRDL N+L+ + ++K++DFGL+ L D+ H G P ++A E + R
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDI--DETEYHADGGKVPIKWMALESILHRR 187
Query: 190 YDGSTADLWSCGVILFVLLA-GYLPFD 215
+ +D+WS GV ++ L+ G P+D
Sbjct: 188 FT-HQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 24/208 (11%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNV 73
R +GEG F KV A P KIL K LK + RE + ++H ++
Sbjct: 11 RELGEGAFGKVFLAECYNLC-PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-------------RMKEDEARRYFQQL 120
V+ Y V + +V E++ G+L + HG + + + QQ+
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA---LSQQVRDDGLLHTTCGTP 177
+ Y S+ HRDL N L+ +K+ DFG+S + R G HT
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--HTMLPI- 186
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILF 205
++ PE + R + + +D+WS GV+L+
Sbjct: 187 RWMPPESIMYRKFT-TESDVWSLGVVLW 213
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 67/261 (25%), Positives = 117/261 (44%), Gaps = 17/261 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G G F +V + + VA+K L + E E MK ++H +V+L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQL 66
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVN-HGR-MKEDEARRYFQQLINAVDYCHSRGVYH 134
Y V+ S+ I+IV E+++ G L D + + GR +K Q+ + Y H
Sbjct: 67 YAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIH 125
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRGYDGS 193
RDL+ N+L+ K++DFGL+ L + ++ P + APE G
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRFTI 182
Query: 194 TADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDP 251
+D+WS G++L L+ G +P+ N + +++ CP + +L+ +
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKK 242
Query: 252 NPMTRITIPEILEDEWFKKDY 272
+P R T E L+ F +DY
Sbjct: 243 DPEERPTF-EYLQS--FLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 77/315 (24%), Positives = 125/315 (39%), Gaps = 83/315 (26%)
Query: 12 KYEVGRTIGEGTFAKV--KFARNSETGEP---VALKILDKEKVLKHKMAEQIKREVATMK 66
K + R +G+G+F V AR+ GE VA+K +++ L+ ++ + E + MK
Sbjct: 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMK 64
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELF--------DKIVNHGRMKE--DEARRY 116
+VVRL V+ +V+E + G+L + N GR E +
Sbjct: 65 GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 124
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---------- 166
++ + + Y +++ HRDL N ++ +K+ DFG++ RD
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT------RDIYETDYYRKG 178
Query: 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL--------------------- 204
GLL ++APE L D G +++D+WS GV+L
Sbjct: 179 GKGLLPV-----RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 232
Query: 205 FVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
FV+ GYL D+ CP ++ L+ NP R T EI+
Sbjct: 233 FVMDGGYLDQPDN---------------CPERVT----DLMRMCWQFNPKMRPTFLEIV- 272
Query: 265 DEWFKKDYKPPVFEE 279
K D P F E
Sbjct: 273 -NLLKDDLHPS-FPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G F +V + T + VA+K L + M E +E MK ++H +V LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 79 VMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
V+ S+ I+IV EF+ G L D K + +K + Q+ + + Y HRD
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRGYDGSTA 195
L+ N+L+ K++DFGL+ L + ++ P + APE G +
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRFTIKS 184
Query: 196 DLWSCGVILFVLLA-GYLPF 214
D+WS G++L L+ G +P+
Sbjct: 185 DVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 57/249 (22%), Positives = 107/249 (42%), Gaps = 40/249 (16%)
Query: 19 IGEGTFAKVK----FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
+GE F K+ + + + VA+K L + + ++E + M + HPN+V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ--WGEFQQEASLMAELHHPNIV 70
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIV-------------NHGRMKEDEARRYFQ--- 118
L V+ + + ++ E++ G+L + ++ G +K F
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 119 -QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL-----SALSQQVRDDGLLHT 172
Q+ ++Y S H+DL N+L+ ++K+SD GL SA +V+ LL
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL----LAGYLPFDDSNLMNLYKK--I 226
++ PE + G S +D+WS GV+L+ + L Y F + ++ + +K +
Sbjct: 191 -----RWMPPEAIM-YGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244
Query: 227 SAAEFTCPP 235
CPP
Sbjct: 245 LPCSEDCPP 253
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 15/214 (7%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
+I R + EV +G+G F +V + T VA+K L + E +E
Sbjct: 2 EIPRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQV 54
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLIN 122
MK ++H +V+LY V+ S+ I+IV E+++ G L D K ++ + Q+ +
Sbjct: 55 MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVA 181
+ Y HRDL+ N+L+ KV+DFGL+ L + ++ P + A
Sbjct: 114 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTA 171
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPF 214
PE G +D+WS G++L L G +P+
Sbjct: 172 PEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 7e-08
Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 17 RTIGEGTFAKV------KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+G G F +V VA+K L K + K E +K E M H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-KEFLK-EAHLMSNFNH 58
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN-AVDYCHS 129
PN+V+L V +I++E + GG+L + + + ++L++ +D
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 130 RGVY-------HRDLKPENLLLDAYGN-----LKVSDFGL-----SALSQQVRDDGLLHT 172
VY HRDL N L+ G +K+ DFGL + + +GLL
Sbjct: 119 -CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 214
++APE L D G + +D+WS GV+++ +L G P+
Sbjct: 178 -----RWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 36/155 (23%), Positives = 73/155 (47%), Gaps = 11/155 (7%)
Query: 61 EVATMKLVKHPNVVRLYEVMGS----KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 116
E ++ + HP++++L G+ K I+ + T +L+ + + +
Sbjct: 133 EAHILRAINHPSIIQL---KGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAI 187
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
+ ++ A+ Y H + HRD+K EN+ ++ G++ + DFG + + + + GT
Sbjct: 188 ERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-YYGWAGT 246
Query: 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211
APE+L Y G D+WS G++LF + +
Sbjct: 247 IATNAPELLARDPY-GPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 8e-08
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 22/198 (11%)
Query: 19 IGEGTFAKVK--FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G F VK + + VA+K+L E + + +++ RE M + +P +VR+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR-----RYFQQLINAVDYCHSRG 131
V ++ + +V+E +GG L + K+DE Q+ + Y +
Sbjct: 61 IGVCEAEA-LMLVMEMASGGPLNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTP---NYVAPEVLND 187
HRDL N+LL K+SDFGLS AL DD + APE +N
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGA---DDSYYKARSAGKWPLKWYAPECINF 172
Query: 188 RGYDGSTADLWSCGVILF 205
R + S +D+WS G+ ++
Sbjct: 173 RKFS-SRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 35/219 (15%)
Query: 21 EGTFAKVKFAR-NSETG---EPVALKILDKEKVLKHKMAEQIKR---EVATMKLVKHPNV 73
EGTF ++ + E E V +K V H Q+ E + + H N+
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVK-----TVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 74 VRLYEVMGSKT-KIFIVLEFVTGGEL--FDKIVNHGRMKEDEARRYFQ------QLINAV 124
+ + V F++ ++ G L F + G +A Q Q+ +
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN------ 178
Y H RGV H+D+ N ++D +K++D +ALS RD + C N
Sbjct: 131 SYLHKRGVIHKDIAARNCVIDEELQVKITD---NALS---RDLFPMDYHCLGDNENRPVK 184
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDD 216
++A E L ++ Y S +D+WS GV+L+ L+ G P+ +
Sbjct: 185 WMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 28/266 (10%)
Query: 17 RTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
R IG+G F V + A+K L++ L+ EQ +E MK HPNV
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE--VEQFLKEGIIMKDFSHPNV 58
Query: 74 VRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ-QLINAVDYCHSRG 131
+ L + S+ +VL ++ G+L + I + + F Q+ ++Y S+
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL----HTTCGTP-NYVAPEVLN 186
HRDL N +LD +KV+DFG L++ + D HT P ++A E L
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFG---LARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 187 DRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLY------KKISAAEFTCPPWLSF 239
+ + + +D+WS GV+L+ L+ G P+ D + ++ +++ E+ CP L
Sbjct: 176 TQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEY-CPDPLY- 232
Query: 240 TARKLIARILDPNPMTRITIPEILED 265
+++ P P R T E++
Sbjct: 233 ---EVMLSCWHPKPEMRPTFSELVSR 255
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 6 IKRR--VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK---HKMAEQIKR 60
IKRR V K+E +GEG F KV A P K+L K LK + +R
Sbjct: 2 IKRRDIVLKWE----LGEGAFGKVFLAECHNL-LPEQDKMLVAVKALKEASESARQDFQR 56
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----MKEDEARRY 116
E + +++H ++VR Y V + +V E++ G+L + +HG + E
Sbjct: 57 EAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAP 116
Query: 117 FQ-----------QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA---LSQ 162
Q Q+ + + Y S HRDL N L+ +K+ DFG+S +
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176
Query: 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
R G T ++ PE + R + + +D+WS GV+L+
Sbjct: 177 YYRVGG---RTMLPIRWMPPESILYRKFT-TESDIWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 32/168 (19%)
Query: 19 IGEGTFAKVKFAR------------NSETGEP--VALKIL--DKEKVLKHKMAEQIKREV 62
+GEG F +V G+P VA+K+L D K ++ ++IK
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK--- 69
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL------------FDKIVNHGRMKE 110
M +K+PN++RL V S + ++ E++ G+L F N +
Sbjct: 70 -IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 111 DEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
Q+ + + Y S HRDL N L+ + +K++DFG+S
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 56/246 (22%), Positives = 109/246 (44%), Gaps = 30/246 (12%)
Query: 19 IGEGTFAKVKFAR--NSETGEP---VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+GE F KV + GE VA+K L K+K + + E+ K E ++HPN+
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKA-EGPLREEFKHEAMMRSRLQHPNI 70
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIV------NHGRMKED-------EARRYFQ-- 118
V L V+ + + ++ + + +L + +V + G +D E +
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 119 -QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
Q+ +++ S V H+DL N+L+ N+K+SD GL L+ +
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVL----LAGYLPFDDSNLMNLY--KKISAAEF 231
+++PE + G +D+WS GV+L+ + L Y + + +++ + +++
Sbjct: 191 RWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPD 249
Query: 232 TCPPWL 237
CP W+
Sbjct: 250 DCPAWV 255
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 64/243 (26%), Positives = 105/243 (43%), Gaps = 54/243 (22%)
Query: 14 EVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KL 67
G+T+G G F KV A S+ VA+K+L + E + E+ M L
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER--EALMSELKIMSHL 95
Query: 68 VKHPNVVRLYEVMGSKTK---IFIVLEFVTGGELFDKIVNHGRMKE------DEARRYFQ 118
H N+V L +G+ T I ++ E+ G+L +N R K ++ +
Sbjct: 96 GNHENIVNL---LGACTIGGPILVITEYCCYGDL----LNFLRRKRESFLTLEDLLSFSY 148
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
Q+ + + S+ HRDL N+LL +K+ DFGL+ RD +++ + N
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA------RD--IMNDS----N 196
Query: 179 YV------------APEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFD----DSNLMN 221
YV APE + + Y +D+WS G++L+ + + G P+ DS
Sbjct: 197 YVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK 255
Query: 222 LYK 224
L K
Sbjct: 256 LIK 258
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 40/213 (18%)
Query: 17 RTIGEGTFAKVKFARNSETGE----------PVALKILDKEKVLKHKMAEQIKREVATMK 66
+G+GTF + + V LK+L H+ + + M
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS----DHRDSLAFFETASLMS 56
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF----QQLIN 122
+ H ++V+LY V I +V E+V G L D ++ R K + + + +QL +
Sbjct: 57 QLSHKHLVKLYGVCVRDENI-MVEEYVKFGPL-DVFLH--REKNNVSLHWKLDVAKQLAS 112
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGN-------LKVSDFG--LSALSQQVRDDGLLHTT 173
A+ Y + + H ++ +N+L+ YG +K+SD G ++ LS++ R + +
Sbjct: 113 ALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI---- 168
Query: 174 CGTPNYVAPEVL-NDRGYDGSTADLWSCGVILF 205
P ++APE + N + AD WS G L
Sbjct: 169 ---P-WIAPECIRNGQASLTIAADKWSFGTTLL 197
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 52/220 (23%), Positives = 99/220 (45%), Gaps = 40/220 (18%)
Query: 12 KYEVGRTIGEGTFAKV--KFARNSETGEP---VALKILDKEKVLKHKMAEQIKREVATMK 66
K + R +G+G+F V A+ EP VA+K +++ ++ ++ + E + MK
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 64
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-------KIVNHGRMKEDEARRYFQ- 118
+VVRL V+ +++E +T G+L ++ N+ ++ Q
Sbjct: 65 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM 124
Query: 119 --QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---------- 166
++ + + Y ++ HRDL N ++ +K+ DFG++ RD
Sbjct: 125 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYETDYYRKG 178
Query: 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
GLL +++PE L D G + +D+WS GV+L+
Sbjct: 179 GKGLLPV-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 35/124 (28%), Positives = 55/124 (44%), Gaps = 16/124 (12%)
Query: 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP 234
GTP+Y+APE+L + + G D W+ GV LF L G PF+D +++ I +
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI--- 597
Query: 235 PW------LSFTARKLIARILDPNPMTRITIPEILED------EWFKKDYKPPVFEEKKD 282
PW LS A+ I +L +P R + E+ + +W + F + D
Sbjct: 598 PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENLQNQTMPFIPQPD 657
Query: 283 TNLD 286
D
Sbjct: 658 DETD 661
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 39/175 (22%), Positives = 67/175 (38%), Gaps = 29/175 (16%)
Query: 11 GKYEVGRTIGEGTFAKV--------------KFARNSETGEP--VALKILDKEKVLKHKM 54
+GEG F +V FA N P VA+K+L + +
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNAR 63
Query: 55 AEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL---------FDKIVNH 105
+ +K EV + + PN+ RL V + +++E++ G+L +
Sbjct: 64 EDFLK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 106 G-RMKEDEARRYF-QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
+ Y Q+ + + Y S HRDL N L+ +K++DFG+S
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 44/201 (21%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA----TMKLVKHP 71
+ +G G F V G+ ++KI K ++ + Q +E+ M + H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGD--SIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69
Query: 72 NVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS 129
+VRL + G+ ++ V + G L D + H + + Q+ + Y
Sbjct: 70 YIVRLLGICPGASLQL--VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE 127
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDR 188
+ HR+L N+LL + ++++DFG++ L D ++ TP ++A E +
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP-DDKKYFYSEHKTPIKWMALESILFG 186
Query: 189 GYDGSTADLWSCGVILFVLLA 209
Y +D+WS GV ++ +++
Sbjct: 187 RYT-HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 25/102 (24%)
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
Y Q+ +++ SR HRDL N+LL +K+ DFGL+ RD
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RD------IYK 225
Query: 176 TPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
P+YV APE + D+ Y + +D+WS GV+L+
Sbjct: 226 DPDYVRKGDARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLW 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 26/88 (29%), Positives = 46/88 (52%), Gaps = 9/88 (10%)
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR---RYFQQLINAVDYCHSRGV 132
L ++M SK + V + L K+ + + E E + +Q++ A+D HS G+
Sbjct: 222 LADLMQSKEFPYNVEPY-----LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276
Query: 133 YHRDLKPENLLLD-AYGNLKVSDFGLSA 159
HRD+KP+N++ G+ K+ D G +A
Sbjct: 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAA 304
|
Length = 566 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 41/163 (25%), Positives = 72/163 (44%), Gaps = 26/163 (15%)
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-----DGLL 170
Y Q+ +++ SR HRDL N+LL +K+ DFGL+ RD D +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RDIYKDPDYVR 232
Query: 171 HTTCGTP-NYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFD----DSNLMNLYK 224
+ P ++APE + D+ Y + +D+WS GV+L+ + + G P+ + K
Sbjct: 233 KGSARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK 291
Query: 225 ---KISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
++ A E P +++ +P R T ++E
Sbjct: 292 DGTRMRAPENATP-----EIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 42/176 (23%), Positives = 75/176 (42%), Gaps = 39/176 (22%)
Query: 19 IGEGTFAKV--------------KFARNSETGEP--VALKILDKEKVLKHKMAEQIKREV 62
+GEG F +V +F N G P VA+KIL + K+ + +K EV
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKIL-RPDANKNARNDFLK-EV 70
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR-------- 114
+ +K PN++RL V + + ++ E++ G+L ++ ++ + + E
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPPA 129
Query: 115 ------------RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
Q+ + + Y S HRDL N L+ +K++DFG+S
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 29/167 (17%)
Query: 19 IGEGTFAKV---------KFARNSETGEP-------VALKILDKEKVLKHKMAEQIKREV 62
+GEG F +V KF + + VA+K+L +E K+ + +K E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDANKNARNDFLK-EI 70
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQ 118
M +K PN++RL V + + ++ E++ G+L + H K D +
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 119 QLIN-------AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
LI + Y S HRDL N L+ +K++DFG+S
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 34/112 (30%), Positives = 53/112 (47%), Gaps = 26/112 (23%)
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
Y Q+ +++ SR HRDL N+LL +K+ DFG L++ + D
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG---LARDIYKD-------- 232
Query: 176 TPNYV------------APEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPF 214
P+YV APE + DR Y +D+WS GV+L+ + + G P+
Sbjct: 233 -PDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 20/66 (30%), Positives = 35/66 (53%)
Query: 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150
EF+ G+ + + + + +Q++ + H G+ HRD+KPENLL+ G +
Sbjct: 289 EFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQV 348
Query: 151 KVSDFG 156
K+ DFG
Sbjct: 349 KIIDFG 354
|
Length = 507 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 27/136 (19%), Positives = 49/136 (36%), Gaps = 23/136 (16%)
Query: 33 SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-----PNVVRLYEVMGSKTKIF 87
E LKI + +REVA ++L+ P V+ E S +
Sbjct: 18 GTKDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGE---SDGWSY 69
Query: 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY---HRDLKPENLLL 144
+++E++ G L + ++ +L H + H DL P N+L+
Sbjct: 70 LLMEWIEGETLDEVSEEEKEDIAEQLAELLAKL-------HQLPLLVLCHGDLHPGNILV 122
Query: 145 DAYGNLKVSDFGLSAL 160
D L + D+ +
Sbjct: 123 DDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 33/243 (13%)
Query: 39 VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98
V LK+LD +A + M V H ++ ++ V ++ +V EFV G L
Sbjct: 47 VVLKVLDPSH---RDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103
Query: 99 FDKIV--NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-------N 149
D + GR+ QQL +A+ Y + + H ++ +N+LL G
Sbjct: 104 -DVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPF 162
Query: 150 LKVSDFGLS--ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF-V 206
+K+SD G+S ALS++ R + + ++APE + + AD WS G L +
Sbjct: 163 IKLSDPGVSFTALSREERVERI--------PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
Query: 207 LLAGYLPFDD---SNLMNLY-KKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEI 262
G +P + S Y KK E +C + LI++ L P R + I
Sbjct: 215 CFDGEVPLKERTPSEKERFYEKKHRLPEPSCKELAT-----LISQCLTYEPTQRPSFRTI 269
Query: 263 LED 265
L D
Sbjct: 270 LRD 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 7e-04
Identities = 63/288 (21%), Positives = 121/288 (42%), Gaps = 52/288 (18%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVV 74
+ IG G F KV +G A +++ KE + + EQ+K E + ++H N++
Sbjct: 1 KEIGNGWFGKV-ILGEVNSGYTPA-QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA------RRYFQQLINAVDYCH 128
+ T +V+EF G+L + R E +R ++ + + H
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDL-KGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN-------YVA 181
H DL N LL A +K+ D+GLS + ++D + TP+ ++A
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHN--KYKEDYYV-----TPDQLWVPLRWIA 170
Query: 182 PEVLNDRGYDGSTAD------LWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTCP 234
PE++++ + D +WS GV ++ L G P Y+ +S +
Sbjct: 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP---------YRHLSDEQV--- 218
Query: 235 PWLSFTARKLIARILDPNPMTRITIP----EILEDEWFKKDYKPPVFE 278
L++T R+ ++ P P ++ + E+++ W + + +P E
Sbjct: 219 --LTYTVREQQLKL--PKPRLKLPLSDRWYEVMQFCWLQPEQRPSAEE 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 8e-04
Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 28/195 (14%)
Query: 39 VALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGE 97
V LK+LD H+ E A+M + V H ++V LY V + +V EFV G
Sbjct: 35 VILKVLDP----SHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGP 90
Query: 98 LFDKIVNHGRMKEDEARRYFQ---QLINAVDYCHSRGVYHRDLKPENLLLDAYG------ 148
L + H + F+ QL +A+ Y + + H ++ +N+LL G
Sbjct: 91 L--DLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECG 148
Query: 149 -NLKVSDFG--LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
+K+SD G ++ LS+Q + + ++APE + D AD WS G L+
Sbjct: 149 PFIKLSDPGIPITVLSRQECVERI--------PWIAPECVEDSKNLSIAADKWSFGTTLW 200
Query: 206 -VLLAGYLPFDDSNL 219
+ G +P D L
Sbjct: 201 EICYNGEIPLKDKTL 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.002
Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 7/95 (7%)
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
NV +Y V I V+E++ G L D ++N M+E E R +L+ + HS G
Sbjct: 62 NVPAVYFVDPENFII--VMEYIEGEPLKD-LINSNGMEELELSREIGRLVGKL---HSAG 115
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166
+ H DL N++L G + + DFGL+ S+ + D
Sbjct: 116 IIHGDLTTSNMILSG-GKIYLIDFGLAEFSKDLED 149
|
Length = 211 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 36/123 (29%), Positives = 58/123 (47%), Gaps = 30/123 (24%)
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
Q+ +++ S+ HRDL N+LL +K+ DFGL+ RD ++H + N
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLA------RD--IMHDS----N 292
Query: 179 YV------------APEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFD----DSNLMN 221
YV APE + D Y + +D+WS G++L+ + + G P+ DS N
Sbjct: 293 YVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351
Query: 222 LYK 224
K
Sbjct: 352 KIK 354
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 28/101 (27%), Positives = 54/101 (53%), Gaps = 6/101 (5%)
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH--TTCGT 176
Q+ N +++ S+ HRDL N+L+ +K+ DFGL+ +RD + +T
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLA--RDIMRDSNYISKGSTFLP 304
Query: 177 PNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDD 216
++APE + + Y + +D+WS G++L+ + G P+ +
Sbjct: 305 LKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 416 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.89 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.66 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.55 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.52 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.42 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.42 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.33 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.32 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.27 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.24 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.12 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.11 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.04 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.0 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.91 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.87 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.84 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.75 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.69 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.67 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.67 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.64 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.62 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.57 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.33 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.31 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.24 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.12 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.08 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.08 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.07 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.06 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.97 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.97 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.96 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.89 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.86 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.76 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.71 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.59 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.52 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.48 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.47 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.47 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.42 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.34 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 97.12 | |
| PLN02236 | 344 | choline kinase | 97.08 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.01 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.93 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.8 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.71 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.49 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.46 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.3 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.25 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.09 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.14 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.13 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.06 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.97 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 94.89 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-66 Score=489.59 Aligned_cols=260 Identities=40% Similarity=0.732 Sum_probs=235.2
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHH----HHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK----MAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
.-+.|.+.++||+|+||.|.+|..+.+|+.||||++++.+..... ....+++|+++|++|+|||||+++++|+.++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456789999999999999999999999999999999987755421 3355789999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC---CCeEEeeccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGLSALS 161 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~---~~vkl~DFGla~~~ 161 (416)
..|+||||+.||+|++++..++.+.|+..+.|++||+.|+.|||++||+||||||+|||++.+ ..+||+|||+|+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999776 67999999999976
Q ss_pred ccccCCCCcccccCCcccccchhhccCC--CCCChhhHHHHHHHHHHHhhCCCCCCCCchHH-HHHHhhcCccCCCC--C
Q 014909 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYKKISAAEFTCPP--W 236 (416)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~--~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~-~~~~i~~~~~~~~~--~ 236 (416)
+ ......+.||||.|.|||++.+.+ +++.++||||+|||||.+|+|.+||.+..... +.++|..+.+.+-| |
T Consensus 330 g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 330 G---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred c---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 5 456778999999999999998765 44468999999999999999999999876654 88999999877643 4
Q ss_pred --CCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 237 --LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 237 --~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
+|.++++||++||..||++|||++|+|+||||+..
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 89999999999999999999999999999999854
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-64 Score=493.22 Aligned_cols=262 Identities=61% Similarity=1.066 Sum_probs=247.2
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcH--HHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH--KMAEQIKREVATMKLVK-HPNVVRLYEVMGSK 83 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~--~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 83 (416)
....++|.+++.||+|+||+|++|.+..++..||+|+++++..... ...+.+.+|+.++++++ ||||+++++++.+.
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 3678899999999999999999999999999999998887633311 35678889999999999 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC-CCeEEeecccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQ 162 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~-~~vkl~DFGla~~~~ 162 (416)
..+|+||||+.||+|+++|...++++|.+++.+|+||++||+|||++||+||||||||||++.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999 999999999998764
Q ss_pred cccCCCCcccccCCcccccchhhccCC-CCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCC-CHH
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-SFT 240 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~-~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-s~~ 240 (416)
.....+.+.||||.|+|||++.+.. |.+.++|||||||+||.|++|+.||.+.+...++.+|..+.+.+|.|+ |++
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence 3456789999999999999999988 999999999999999999999999999999999999999999999999 999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 241 ARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
+++|+++||.+||.+|+|+.+|+.||||+.
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999999998
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-65 Score=503.00 Aligned_cols=264 Identities=45% Similarity=0.851 Sum_probs=251.1
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
...+|-|+++++||.|+-|.|.+|+|..||+..|||++.+...........+.+||.||+.+.||||+++|+++++..++
T Consensus 8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l 87 (786)
T KOG0588|consen 8 KNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL 87 (786)
T ss_pred cccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence 45789999999999999999999999999999999999987544555567899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+|+||++||+||+++...|+++|.++..+|+||+.|+.|||..+|+||||||+|+|||..+++||+|||+|.+- ..
T Consensus 88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~~ 164 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE---VP 164 (786)
T ss_pred EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc---cC
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999863 34
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~ 246 (416)
+..+.+.||+|.|.|||++.+.+|+|.++||||||||||.||+|++||++.+...++.++..|.+.+|..+|+++++||+
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr 244 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLR 244 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHH
Confidence 67889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 247 RILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
+||..||.+|+|.+||++|||+.....
T Consensus 245 ~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred HHhccCccccccHHHHhhCchhhcCCC
Confidence 999999999999999999999987543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-63 Score=490.56 Aligned_cols=263 Identities=38% Similarity=0.700 Sum_probs=249.8
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
.+|..++.||+|+|+.||.+++..+|+.||+|++.+....+....+.+.+||+|++.|+|||||+++++|++.+++|+|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 34999999999999999999999999999999999988888888999999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
|+|+.++|..++++.+.++|.+|+.|++||+.||.|||+++|+|||||..|++++++.+|||+|||||+.... +....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--DGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC--ccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999997654 33456
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~ 250 (416)
.+.||||.|+||||+...++. ..+||||+|||||.||+|++||+..+..+.+.+|...++.+|..+|.++++||++||+
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHs-fEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHS-FEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ceecCCCcccChhHhccCCCC-CchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 789999999999999988875 8899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCHhHHhcCcccccCCCCCc
Q 014909 251 PNPMTRITIPEILEDEWFKKDYKPPV 276 (416)
Q Consensus 251 ~dP~~R~t~~eil~h~~~~~~~~~~~ 276 (416)
+||.+|||+++||.|+||++++.|..
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~g~~p~~ 280 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKSGFTPAR 280 (592)
T ss_pred CCcccCCCHHHHhcCHhhhCCCcCCC
Confidence 99999999999999999988776543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-61 Score=451.58 Aligned_cols=261 Identities=38% Similarity=0.708 Sum_probs=244.4
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
....+.|++.+.||+|+||+|++++.+++++.||+|++++..+......+.++.|..||..++||.||+++..|++...+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 35678999999999999999999999999999999999999988877789999999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+|+||+.||+|+.+|++.+.++|+.++.|+..|+.||.|||++||+||||||||||||.+|+++|+|||+|+..-. .
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--~ 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--D 178 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc--C
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999985332 3
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCC-CCCCCHHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PPWLSFTARKLI 245 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~-~~~~s~~~~~ll 245 (416)
+....+.|||+.|||||++.+.+|+ .++|.||||+++|+|++|.+||.+.+...++++|..+.... |..+|.++++||
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll 257 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLL 257 (357)
T ss_pred CCccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHH
Confidence 4456678999999999999999996 89999999999999999999999999999999999998444 455999999999
Q ss_pred HHhcCCCCCCCC----CHhHHhcCccccc
Q 014909 246 ARILDPNPMTRI----TIPEILEDEWFKK 270 (416)
Q Consensus 246 ~~~L~~dP~~R~----t~~eil~h~~~~~ 270 (416)
+++|..||++|. ++.+|.+||||..
T Consensus 258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred HHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 999999999996 6999999999985
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-61 Score=434.34 Aligned_cols=257 Identities=38% Similarity=0.747 Sum_probs=246.0
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
-.+.+|++.++||.|+||.|.+++++.+|..||+|++++..+.+....+...+|..+|+.+.||.++++++.+.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 56789999999999999999999999999999999999999988888999999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
+||||++||+|+.++++.+++++..|++|+.||+.||+|||+++|++|||||||||||.+|++||+|||+|+...
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS----- 195 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999997542
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~ 247 (416)
+...+.||||.|+|||++...+|. .++|.|||||++|||++|++||.+.+...+|++|..+...+|+.+|+++++||++
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 336789999999999999999996 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCC-----CHhHHhcCccccc
Q 014909 248 ILDPNPMTRI-----TIPEILEDEWFKK 270 (416)
Q Consensus 248 ~L~~dP~~R~-----t~~eil~h~~~~~ 270 (416)
+|+.|-.+|. ..++|..||||+.
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCccccc
Confidence 9999999994 5789999999984
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-60 Score=462.17 Aligned_cols=263 Identities=35% Similarity=0.671 Sum_probs=247.1
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 85 (416)
.+...+|.+++.||.|+|++|++|+++.+++.||||++++..+.++...+.+.+|-.+|.+| .||+|++||-.|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 56778999999999999999999999999999999999999999988889999999999999 79999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+|+|+||+++|+|.++|.+-+.+++..++.|+.||++||+|||++|||||||||||||+|++|++||+|||.|+++....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998765432
Q ss_pred CC---------CC--cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC
Q 014909 166 DD---------GL--LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP 234 (416)
Q Consensus 166 ~~---------~~--~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~ 234 (416)
.. .. ..+.+||..|++||++.+... ++.+|||+||||||.|++|.+||.+.+....+++|....+.+|
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 22 11 145789999999999987655 5899999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 235 ~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
+.+++.+++||+++|..||.+|+|+++|.+||||..
T Consensus 308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 999999999999999999999999999999999985
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-59 Score=438.56 Aligned_cols=264 Identities=41% Similarity=0.757 Sum_probs=250.0
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
-.+|++.++||+|.||+|.+|.....|..||||.|+++++.+++..-.+++||+||..|+||||+.+|++|++.+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35799999999999999999999999999999999999999998899999999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
|||+.+|+|+|+|.+.+.++|.+++.+|+||++|+.|||.++++|||||.+|||+|.|+++||+|||++..+. ....
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~---~~kf 208 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA---DKKF 208 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---cccH
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998765 3567
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhc
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L 249 (416)
+++.||+|.|.+||++++.+|.++.+|-|||||+||.|..|..||++.+...+..+|..+.+.-|+ -+.++.-||+.||
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIRwmL 287 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIRWML 287 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHHHHH
Confidence 899999999999999999999999999999999999999999999999999999999999887665 4567899999999
Q ss_pred CCCCCCCCCHhHHhcCcccccCCCCCcc
Q 014909 250 DPNPMTRITIPEILEDEWFKKDYKPPVF 277 (416)
Q Consensus 250 ~~dP~~R~t~~eil~h~~~~~~~~~~~~ 277 (416)
..||++|.|+++|-.|-|.+=++.-+..
T Consensus 288 mVNP~RRATieDiAsHWWvNwgy~~~V~ 315 (668)
T KOG0611|consen 288 MVNPERRATIEDIASHWWVNWGYNMPVI 315 (668)
T ss_pred hcCcccchhHHHHhhhheeecccccccc
Confidence 9999999999999999999877765443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-58 Score=431.60 Aligned_cols=261 Identities=38% Similarity=0.675 Sum_probs=239.8
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
...+++|.+.+.||+|+||.||+|+++.++..||||.+.+.+. .....+.+..||.+|+.++|||||++++++.+++.+
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI 84 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence 4578999999999999999999999999999999999998765 344678899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC------CCeEEeecccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY------GNLKVSDFGLSAL 160 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~------~~vkl~DFGla~~ 160 (416)
|+|||||+||+|.++|.+.+.++|..++.++.||+.||++||+++|+||||||.||||+.. -.+||+|||+|+.
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999999999999999999999999999999999999999999999999875 3589999999987
Q ss_pred cccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc---CCCCCC
Q 014909 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWL 237 (416)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~ 237 (416)
.. ......+.||||.|||||++....|+ .|+|+||+|+|||+|++|+.||+..+..+++..+..+.. .++.++
T Consensus 165 L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~ 240 (429)
T KOG0595|consen 165 LQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL 240 (429)
T ss_pred CC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhc
Confidence 65 45677899999999999999988897 889999999999999999999999999999888877654 344568
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 238 s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
+....+|+...|..+|..|.+..+-+.|+++....
T Consensus 241 s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 241 SNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred cCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 99999999999999999999999999999998654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-58 Score=445.10 Aligned_cols=265 Identities=36% Similarity=0.639 Sum_probs=240.6
Q ss_pred cccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
+.+..+++|++++.||+||||+||+|+.+.||+.||+|+++++.....+.++.++.|-.+|...++|+||++|..|++..
T Consensus 135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 135 RTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 44667899999999999999999999999999999999999999888888999999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
++||||||++||++..+|.+.+.|+|+.+++|+.+++.|++.||+.|++||||||+|+|||..|++||+|||||+.....
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998543210
Q ss_pred --------------------cCCCC-------------------------cccccCCcccccchhhccCCCCCChhhHHH
Q 014909 165 --------------------RDDGL-------------------------LHTTCGTPNYVAPEVLNDRGYDGSTADLWS 199 (416)
Q Consensus 165 --------------------~~~~~-------------------------~~~~~gt~~y~aPEvl~~~~~~~~~~DIwS 199 (416)
..+.. ..+.+|||.||||||+.+.+|. ..+|.||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWS 373 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWS 373 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHH
Confidence 00000 1135799999999999999985 8999999
Q ss_pred HHHHHHHHhhCCCCCCCCchHHHHHHhhcCc--cCCCCC--CCHHHHHHHHHhcCCCCCCCCC---HhHHhcCcccccC
Q 014909 200 CGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW--LSFTARKLIARILDPNPMTRIT---IPEILEDEWFKKD 271 (416)
Q Consensus 200 lGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~--~s~~~~~ll~~~L~~dP~~R~t---~~eil~h~~~~~~ 271 (416)
||||+||||.|++||.+.+..+.+.+|.... ..+|.. +++++.|||.++|. ||++|.. ++||.+||||+.-
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 9999999999999999999999999987665 555654 78999999999999 9999985 9999999999863
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-57 Score=423.07 Aligned_cols=257 Identities=28% Similarity=0.484 Sum_probs=232.3
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE-EE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK-IF 87 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~ 87 (416)
...+.+.++.||+|+.|+||+++|+.+++.+|+|++... .++...+++.+|+.+++..+|||||++|+.|.++.. ++
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence 344677889999999999999999999999999999543 345567899999999999999999999999999985 99
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~-~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
++||||+||+|.+.+...++++|.....++.++++||.|||+ ++|+||||||+|||++..|.|||||||.++....
T Consensus 155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn--- 231 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN--- 231 (364)
T ss_pred eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh---
Confidence 999999999999999998999999999999999999999995 9999999999999999999999999999886543
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCC-----chHHHHHHhhcC-ccCCCCC-CCH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-----NLMNLYKKISAA-EFTCPPW-LSF 239 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~-----~~~~~~~~i~~~-~~~~~~~-~s~ 239 (416)
....+..||..|||||.+.+..|. .++||||||+.+.||++|+.||... +..+++..|..+ .+..|.. +|+
T Consensus 232 -S~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ 309 (364)
T KOG0581|consen 232 -SIANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSP 309 (364)
T ss_pred -hhcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCH
Confidence 256788999999999999998885 8899999999999999999999875 566778888774 4556665 999
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
++++||..||++||.+|||+.|+++|||+++..
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 999999999999999999999999999998754
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-56 Score=426.66 Aligned_cols=268 Identities=37% Similarity=0.678 Sum_probs=236.7
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHH-----------HHHHHHHHHHHHhcCCCCCcce
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-----------MAEQIKREVATMKLVKHPNVVR 75 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~hpnIv~ 75 (416)
.+.+.+|++++.||+|.||+|.+|++..+++.||||++.+....+.. ..+.+++||.||+++.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 56789999999999999999999999999999999999876543321 2368999999999999999999
Q ss_pred EEEEEEeC--CEEEEEEeccCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEE
Q 014909 76 LYEVMGSK--TKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152 (416)
Q Consensus 76 l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl 152 (416)
|+++..+. +.+|||+|||..|.+.. ...++. +++.+|+.|+++++.||+|||.+||+||||||+|+||+++|++||
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 99999865 67999999999998754 444455 999999999999999999999999999999999999999999999
Q ss_pred eeccccccccccc---CCCCcccccCCcccccchhhcc---CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHh
Q 014909 153 SDFGLSALSQQVR---DDGLLHTTCGTPNYVAPEVLND---RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226 (416)
Q Consensus 153 ~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPEvl~~---~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i 226 (416)
+|||.+..+.... .+..+....|||.|+|||.+.+ ..+.+.+.||||+||+||.|+.|++||.+....+++.+|
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI 331 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI 331 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence 9999987653321 2223455899999999999987 557789999999999999999999999999999999999
Q ss_pred hcCccCCCCC--CCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCCCC
Q 014909 227 SAAEFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275 (416)
Q Consensus 227 ~~~~~~~~~~--~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~~ 275 (416)
......+|.. +.+.+++||.+||.+||.+|+++.+|..|||.......+
T Consensus 332 vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 332 VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 9988888766 799999999999999999999999999999999875544
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-58 Score=404.50 Aligned_cols=260 Identities=38% Similarity=0.724 Sum_probs=237.8
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
...-+.|++.+.||+|+|+.|+++.+..+|+.+|+|+++..+.... ..+.+.+|+.|-+.|+||||+++++.+.+....
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFH 85 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence 4566789999999999999999999999999999999998776655 468899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc---CCCeEEeeccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~---~~~vkl~DFGla~~~~~ 163 (416)
|+|+|++.|++|+.-|...--.+|..+-.+++||++||.|||.+||+|||+||+|+|+-. ..-+||+|||+|....
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 999999999999888877777899999999999999999999999999999999999954 3459999999997544
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCC--C--CCH
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP--W--LSF 239 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~--~s~ 239 (416)
.........|||.|||||++...+|. .++|||+||||||-+|.|++||.+.+...+|+.|..+.+.+|+ | +++
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~ 241 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTP 241 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCH
Confidence 45566778999999999999998885 8899999999999999999999999999999999999887765 3 899
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 240 TARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
++++|+++||..||.+|+|+.|+|+|||+...
T Consensus 242 ~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 242 EAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 99999999999999999999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-55 Score=413.57 Aligned_cols=260 Identities=31% Similarity=0.559 Sum_probs=223.2
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--EEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--KIF 87 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~ 87 (416)
..+|..++.||+|+||.||++.+..+|...|||.+...... ..+.+.+|+.+|++++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 45699999999999999999999999999999999876322 1677999999999999999999999755444 699
Q ss_pred EEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc-CCCeEEeecccccccccc-
Q 014909 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQV- 164 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~- 164 (416)
++|||++||+|.+++...+ +++|..++.|.+||++||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999987 7999999999999999999999999999999999999999 799999999998865531
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCC-CchHHHHHHhhcC--ccCCCCCCCHHH
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAA--EFTCPPWLSFTA 241 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~-~~~~~~~~~i~~~--~~~~~~~~s~~~ 241 (416)
..........|||.|||||++......+.++||||+||++.||+||+.||.. .........+... .+.+|.++|.++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1122334578999999999999633434589999999999999999999987 3444433344333 357889999999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 242 RKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
++||.+|+..||++|||++++|+|||.....
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 9999999999999999999999999998754
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-55 Score=387.92 Aligned_cols=258 Identities=37% Similarity=0.716 Sum_probs=244.8
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
-.+++|++++.||+|-||.||+|+.++++-.||+|++.++.+...+...++++|++|.+.|+||||+++|++|-+...+|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 36788999999999999999999999999999999999999888888899999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 88 IVLEFVTGGELFDKIV--NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~--~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+++||+.+|+|+..+. ...++++..+..|+.|++.|+.|||.++|+||||||+|+|++..|.+||+|||-+....
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 9999999999999999 66789999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll 245 (416)
.+.-.+.|||..|.|||...+.+++ ..+|+||+|++.||++.|.+||...+..+.|++|....+.+|+.+|.++.|||
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI 253 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLI 253 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHH
Confidence 3455789999999999999999997 88999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCccccc
Q 014909 246 ARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.+||.++|.+|.+..|++.|||+..
T Consensus 254 ~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 254 SRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHhccCccccccHHHHhhhHHHHh
Confidence 9999999999999999999999865
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-54 Score=431.77 Aligned_cols=260 Identities=32% Similarity=0.598 Sum_probs=242.7
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTK 85 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 85 (416)
...+.+|.+.+.||+|+||+|++|..+.+++.||||++++..+...+..+..+.|-.|+...+ ||.+++++..|+++++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 457889999999999999999999999999999999999999988888999999999998886 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+|+||||+.||++. .+...+.+++..|+.|+..++.||.|||++||||||||.+|||+|.+|++||+|||+++. ...
T Consensus 444 l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe--~m~ 520 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE--GMG 520 (694)
T ss_pred EEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc--cCC
Confidence 99999999999954 445557899999999999999999999999999999999999999999999999999974 223
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll 245 (416)
......|.||||.|||||++.+..|. .++|.|||||+|||||.|..||.+.+..+++..|...++..|.|+|.++.+++
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il 599 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIM 599 (694)
T ss_pred CCCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHH
Confidence 44567889999999999999999885 89999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCC-----HhHHhcCccccc
Q 014909 246 ARILDPNPMTRIT-----IPEILEDEWFKK 270 (416)
Q Consensus 246 ~~~L~~dP~~R~t-----~~eil~h~~~~~ 270 (416)
+++|.+||.+|.. +++|.+||||+.
T Consensus 600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred HHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 9999999999996 588999999985
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-55 Score=399.42 Aligned_cols=256 Identities=27% Similarity=0.474 Sum_probs=221.7
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+++|+....+|+|+||.|++++++.||+.||||.+-.+. .++...+-..|||++|++++|||+|.++++|.....+++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 468999999999999999999999999999999986543 3344556778999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 90 LEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
+|||+. ++.+-++. ..+++++.++.|+.|++.|+.|||+++++|||||||||||+.+|.+||||||+|+.... .+.
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd 156 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGD 156 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccc
Confidence 999987 44555554 45799999999999999999999999999999999999999999999999999997654 445
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc------------------
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------------ 230 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~------------------ 230 (416)
..+.++.|.+|+|||.+.+...+|.++||||+||++.||++|.+.|++.+..++...|...-
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 67788999999999999986666899999999999999999999999988776655543211
Q ss_pred -cCCC------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 014909 231 -FTCP------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (416)
Q Consensus 231 -~~~~------------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~ 269 (416)
..+| +.++.-+.+|+++||+.||++|++.+++|.||||.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 0111 23577889999999999999999999999999994
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-55 Score=419.00 Aligned_cols=265 Identities=41% Similarity=0.742 Sum_probs=245.8
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
++.-|=|.+.++||+|-|+.|.+|+|.-+|+.||||++++.+.... ....+..|+..|+.++|||||++|++..+...+
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence 3455679999999999999999999999999999999999876543 457788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEe-ccCCCeEEeecccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL-DAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl-~~~~~vkl~DFGla~~~~~~ 164 (416)
|+|+|+-+||+|+|+|.++ ..+.|+.+++||.||+.|+.|||+..++||||||+|+++ .+-|-|||.|||++..+.+
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P- 171 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP- 171 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC-
Confidence 9999999999999999886 479999999999999999999999999999999999876 4569999999999886654
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHH
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 244 (416)
...+.+.||+..|.|||++.+..|+.+++||||||||||-+.+|++||...+..+.+-.|....+..|..+|.++++|
T Consensus 172 --G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdL 249 (864)
T KOG4717|consen 172 --GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDL 249 (864)
T ss_pred --cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHH
Confidence 456789999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCcccccCCCCC
Q 014909 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~h~~~~~~~~~~ 275 (416)
|..||..||.+|.+.++|..|+|++...+++
T Consensus 250 I~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 250 IQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred HHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 9999999999999999999999999766543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-56 Score=399.64 Aligned_cols=248 Identities=32% Similarity=0.567 Sum_probs=222.5
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEE-EE-EeCCE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE-VM-GSKTK 85 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~-~~~~~ 85 (416)
.....|++.+.||+|+||+||++.+..+|..+|.|.++-... +....+.+..|+.+|++|+|||||++++ .+ ++...
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 455679999999999999999999999999999999985443 4445688999999999999999999998 33 44555
Q ss_pred EEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh--CC--cEeecCCCCcEEeccCCCeEEeeccc
Q 014909 86 IFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHS--RG--VYHRDLKPENLLLDAYGNLKVSDFGL 157 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~--~g--ivHrDlkp~NILl~~~~~vkl~DFGl 157 (416)
+++|||||.+|+|...|+. .+.++|..+++||.|++.||.+||+ .. |+||||||.||+|+.+|.+||+|||+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 9999999999999998865 3469999999999999999999999 45 99999999999999999999999999
Q ss_pred ccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccC-CC-C
Q 014909 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CP-P 235 (416)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~-~~-~ 235 (416)
++.+.. ......+.+|||.||+||++.+.+|+ .++||||+||++|||++-++||.+.+...+.++|.+++++ +| .
T Consensus 175 ~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~ 251 (375)
T KOG0591|consen 175 GRFLSS--KTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDE 251 (375)
T ss_pred HhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHH
Confidence 998765 33456788999999999999999997 9999999999999999999999999999999999999876 55 5
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCH
Q 014909 236 WLSFTARKLIARILDPNPMTRITI 259 (416)
Q Consensus 236 ~~s~~~~~ll~~~L~~dP~~R~t~ 259 (416)
.+|.++..||..|+.+||.+||+.
T Consensus 252 ~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 252 HYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HhhhHHHHHHHHHccCCcccCCCc
Confidence 689999999999999999999986
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-55 Score=424.92 Aligned_cols=258 Identities=33% Similarity=0.591 Sum_probs=241.6
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+++|.+.+.||+|+||.||+|+.+.+.+.||+|.+++.... +.....+++|++|++.++|||||.+++.|++..++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 46899999999999999999999999999999999987643 33568899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
.|||.| +|+.++..++.++|+.++.+..|+++||.|||+++|.|||+||.|||+++.|++|+||||+|+.... ....
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence 999988 9999999999999999999999999999999999999999999999999999999999999986543 3446
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhc
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L 249 (416)
.....|||.|||||+..+.+|+ ..+|+||||||+|||.+|++||...+...+.+.|.......|+..|..+.+||..+|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence 6777899999999999999997 889999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHhHHhcCcccccCC
Q 014909 250 DPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 250 ~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
.+||.+|+|..+++.|||.+...
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred hcChhhcccHHHHhcChHHhhhh
Confidence 99999999999999999998643
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-53 Score=413.07 Aligned_cols=259 Identities=36% Similarity=0.707 Sum_probs=237.5
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
....+++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred CCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 34567899999999999999999999999999999999987655444556789999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
.|+||||++||+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-- 170 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-- 170 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC--
Confidence 999999999999999999988999999999999999999999999999999999999999999999999999875422
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll 245 (416)
...+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..+...+|.+++..+++||
T Consensus 171 ---~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 246 (329)
T PTZ00263 171 ---RTFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLV 246 (329)
T ss_pred ---CcceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHH
Confidence 12356899999999999887774 88999999999999999999999988888888888888889999999999999
Q ss_pred HHhcCCCCCCCCC-----HhHHhcCccccc
Q 014909 246 ARILDPNPMTRIT-----IPEILEDEWFKK 270 (416)
Q Consensus 246 ~~~L~~dP~~R~t-----~~eil~h~~~~~ 270 (416)
++||+.||.+|++ +++++.||||..
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 9999999999997 799999999975
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-54 Score=414.52 Aligned_cols=259 Identities=31% Similarity=0.509 Sum_probs=227.6
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCC-E
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKT-K 85 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~-~ 85 (416)
..+.+|.+++.||.|+||.||+|+...+|+.||||.+++....-++. - -.||+..|++|+ |||||++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~-nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-M-NLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-H-HHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 46789999999999999999999999999999999997765443332 2 248999999999 999999999998887 9
Q ss_pred EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
+|+|||||+. .|+++++.. ..+++..++.|+.||++||+|+|.+|++|||+||||||+..+..+||+|||+|+...
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~-- 161 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR-- 161 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc--
Confidence 9999999975 999999765 469999999999999999999999999999999999999999999999999998543
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC---------------
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------------- 229 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~--------------- 229 (416)
....++.++.|.+|+|||++...++++.+.|||++|||++|+.+-++.|.+.+..+.+.+|...
T Consensus 162 -SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 162 -SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred -cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 4556778899999999999999999999999999999999999999999999988777766321
Q ss_pred ----ccCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 230 ----EFTCP-----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 230 ----~~~~~-----------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
.+.+| +..+.++.+||.+||..||++|||+.++|+||||+...
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 12222 23688999999999999999999999999999999654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-53 Score=403.11 Aligned_cols=254 Identities=33% Similarity=0.665 Sum_probs=232.4
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999998765444445677899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875422 12
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~ 250 (416)
...+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+......+|..+++.+++||++||+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 346799999999999887764 8899999999999999999999998888888888888888899999999999999999
Q ss_pred CCCCCCCC-----HhHHhcCccccc
Q 014909 251 PNPMTRIT-----IPEILEDEWFKK 270 (416)
Q Consensus 251 ~dP~~R~t-----~~eil~h~~~~~ 270 (416)
.||.+|++ ++++++||||..
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccC
Confidence 99999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=410.31 Aligned_cols=262 Identities=32% Similarity=0.515 Sum_probs=229.4
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--C
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--T 84 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~ 84 (416)
....+.|+.++.||+|+||.||+|++..+|+.||+|.+..+.. +++...-..|||.||++|+||||++|.+...+. .
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 4566779999999999999999999999999999999987653 344566788999999999999999999998876 7
Q ss_pred EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
.+|+|+|||+. +|.-++... -.+++.+++.|+.||+.||+|||++||.|||||.+|||||.+|.+||+|||||+++..
T Consensus 192 siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 192 SIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred eEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 89999999987 888777763 4899999999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc----------cCC
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----------FTC 233 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~----------~~~ 233 (416)
.. ...++..+-|++|+|||.+.+...++.++|+||+||||.||++|++.|.+.+..++..+|.... ..+
T Consensus 271 ~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 271 SG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 43 3346777889999999999998777899999999999999999999999999888887774321 111
Q ss_pred C-------------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 234 P-------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 234 ~-------------------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
| ..++..+.+|+..||..||.+|.|+.++|+|+||...
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 1 1258889999999999999999999999999999543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-52 Score=411.26 Aligned_cols=257 Identities=41% Similarity=0.753 Sum_probs=235.5
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 88 (416)
-..|++.+.||+|.||.||.++++.+|+.+|+|++.+.........+.+.+|+.+|+++. |||||.+++++++...+|+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 347999999999999999999999999999999999887765545678999999999998 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC----CCeEEeecccccccccc
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY----GNLKVSDFGLSALSQQV 164 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~----~~vkl~DFGla~~~~~~ 164 (416)
|||+|.||+|++.|... .++|..+..++.|++.|++|||+.||+||||||+|+|+... +.+|++|||+|.....
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~- 191 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP- 191 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-
Confidence 99999999999999887 59999999999999999999999999999999999999643 4799999999986543
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC--CC--CCHH
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--PW--LSFT 240 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~--~s~~ 240 (416)
.....+.||||.|+|||++...+|. ..+||||+||++|.|++|.+||.+.+....+.++..+.+.++ +| +|..
T Consensus 192 --~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 192 --GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred --CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 4567889999999999999988885 889999999999999999999999999888889988876553 44 7999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 241 ARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
+++||++||..||.+|+|+.++|+|||++..
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 9999999999999999999999999999865
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-53 Score=420.15 Aligned_cols=264 Identities=43% Similarity=0.796 Sum_probs=249.5
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
...++.|.+.++||+|.|++|.+|++..++..||||++++...... ..+.+.+|+.+|+.|+|||||+++.+..+...+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 5678999999999999999999999999999999999998776544 445599999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+||||+.+|++++++.+++++.+..++.+|.|+++|++|||+++|+|||||++||||+.+-++||+|||++..+. .
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~ 207 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---Y 207 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---c
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998775 3
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~ 246 (416)
...+.+.||+++|.|||++.+..|+++.+|+||+|++||.|+.|.+||++.+...+......+.+.+|-.+|.++.+||+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLR 287 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHH
Confidence 56788999999999999999999999999999999999999999999999999999888889999999999999999999
Q ss_pred HhcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 247 RILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
++|..+|.+|+++++|++|+|....+..
T Consensus 288 k~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HhhccCccccCCHHHhhhhcccchhhhh
Confidence 9999999999999999999999876543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-54 Score=386.13 Aligned_cols=260 Identities=36% Similarity=0.648 Sum_probs=232.8
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhh-----hcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-----LKHKMAEQIKREVATMKLVK-HPNVVRLYEVMG 81 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~-----~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~ 81 (416)
....+|.-.+.||+|..+.|.++.++.+|+.+|+|++..... ......+.-.+|+.||+++. ||||+++.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 356688889999999999999999999999999999964221 12345677889999999995 999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccc
Q 014909 82 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (416)
Q Consensus 82 ~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~ 161 (416)
++..+++|+|.|+.|+|||++.+...++|..++.+++||++|++|||.++|+||||||+|||++++-++||+|||+|...
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999855
Q ss_pred ccccCCCCcccccCCcccccchhhccC-----CCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCC--C
Q 014909 162 QQVRDDGLLHTTCGTPNYVAPEVLNDR-----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC--P 234 (416)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPEvl~~~-----~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~--~ 234 (416)
. .+..+...||||.|.|||.+... +.++..+|+|+||||+|.+|.|.+||......-+...|..+.+.+ |
T Consensus 174 ~---~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 174 E---PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred C---CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 4 34567788999999999998643 222578999999999999999999999999999999999887654 6
Q ss_pred CC--CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 235 PW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 235 ~~--~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.| +|.++++||.+||+.||.+|+|++|+|.||||.+
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 66 7899999999999999999999999999999964
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-52 Score=405.45 Aligned_cols=252 Identities=35% Similarity=0.620 Sum_probs=228.2
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 96 (416)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765544455677889999999999999999999999999999999999999
Q ss_pred chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCC
Q 014909 97 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (416)
Q Consensus 97 ~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt 176 (416)
+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence 9999999888999999999999999999999999999999999999999999999999999864221 12233456899
Q ss_pred cccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014909 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256 (416)
Q Consensus 177 ~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R 256 (416)
+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+......+|..+++++.+||++||+.||++|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 999999999887774 8899999999999999999999998888888888888888889999999999999999999999
Q ss_pred C-----CHhHHhcCcccccC
Q 014909 257 I-----TIPEILEDEWFKKD 271 (416)
Q Consensus 257 ~-----t~~eil~h~~~~~~ 271 (416)
| ++.++++||||...
T Consensus 238 ~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-53 Score=392.17 Aligned_cols=262 Identities=29% Similarity=0.469 Sum_probs=224.8
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-----CCE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-----KTK 85 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~ 85 (416)
.+|...+.||+|+||.|+.|.++.+|+.||||.+... +......++..||+++|+.++|+||+.+++++.. -..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 4566689999999999999999999999999998643 3445567889999999999999999999999865 457
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+|+|+|+|. .+|...|+.+..++++.++.++.||+.||+|+|+.||+||||||.|+|++.++.+||||||+|+......
T Consensus 101 vYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 101 VYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred eEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 999999995 5898888887779999999999999999999999999999999999999999999999999999765443
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc---------------
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--------------- 230 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~--------------- 230 (416)
.....+..+.|.+|.|||++.....++.+.||||+|||+.||++|++.|.+.+...+.+.|...-
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 44556778899999999999876655799999999999999999999999987665555442211
Q ss_pred --------cCCC--------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 231 --------FTCP--------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 231 --------~~~~--------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
+..| +..++.+.+|+.+||..||.+|+|++|+|+|||+.....|
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 1111 3478999999999999999999999999999999876544
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-52 Score=406.61 Aligned_cols=259 Identities=32% Similarity=0.613 Sum_probs=234.9
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCC-CeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETG-EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
.....++|++.+.||+|+||.||+|.+..++ ..||+|.+.+.........+.+.+|+.+++.++||||+++++++.+..
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 3456789999999999999999999876554 689999998766555555678899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
..|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence 9999999999999999999988999999999999999999999999999999999999999999999999999875422
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHH
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 244 (416)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+...+|+.+++.+.++
T Consensus 184 ----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 258 (340)
T PTZ00426 184 ----RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258 (340)
T ss_pred ----CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 2245689999999999987766 48899999999999999999999998888888888888888899999999999
Q ss_pred HHHhcCCCCCCCC-----CHhHHhcCccccc
Q 014909 245 IARILDPNPMTRI-----TIPEILEDEWFKK 270 (416)
Q Consensus 245 l~~~L~~dP~~R~-----t~~eil~h~~~~~ 270 (416)
|++||+.||.+|+ +++++++||||..
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999996 8999999999975
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-51 Score=403.98 Aligned_cols=258 Identities=32% Similarity=0.592 Sum_probs=224.8
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||+|+||+||+|.+..+++.||+|++.+...........+++|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998766555555678899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC----
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~---- 166 (416)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875322100
Q ss_pred -----------------------------CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCC
Q 014909 167 -----------------------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217 (416)
Q Consensus 167 -----------------------------~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~ 217 (416)
.......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0011345899999999999887775 8899999999999999999999988
Q ss_pred chHHHHHHhhcC--ccCCCCC--CCHHHHHHHHHhcCCCCC---CCCCHhHHhcCccccc
Q 014909 218 NLMNLYKKISAA--EFTCPPW--LSFTARKLIARILDPNPM---TRITIPEILEDEWFKK 270 (416)
Q Consensus 218 ~~~~~~~~i~~~--~~~~~~~--~s~~~~~ll~~~L~~dP~---~R~t~~eil~h~~~~~ 270 (416)
+....+.++... ...+|+. +++++++||.+|+. +|. .||+++||++||||..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 888877777653 3445543 78999999999875 444 4689999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-52 Score=372.34 Aligned_cols=258 Identities=31% Similarity=0.485 Sum_probs=224.6
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
.+|...+.||+|+||.||+|++..+|+.||||.+...+.. .+......|||+.|+.++||||+.++++|...+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 5788999999999999999999999999999999876543 334566789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 91 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
||++. +|...|+.. ..++..+++.|+.+++.||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+..... .
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~--~ 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR--I 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc--c
Confidence 99986 898888764 3689999999999999999999999999999999999999999999999999998765433 3
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc------------------
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------------------ 231 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~------------------ 231 (416)
....+-|.+|+|||.+.+...++..+||||.|||+.||+-|.+-|.+.+..++...|...-.
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 34447899999999999877778999999999999999999999999988777766643210
Q ss_pred ----CCC------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 232 ----TCP------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 232 ----~~~------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
+.| +-.+.++.+|+.+||..||.+|+|+.|+|+|+||+...
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 111 12477899999999999999999999999999999743
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-51 Score=397.41 Aligned_cols=250 Identities=36% Similarity=0.621 Sum_probs=226.4
Q ss_pred EeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014909 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (416)
Q Consensus 19 LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 98 (416)
||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999876544445567788999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCCcc
Q 014909 99 FDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178 (416)
Q Consensus 99 ~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 178 (416)
.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence 99999888999999999999999999999999999999999999999999999999999874322 1222345689999
Q ss_pred cccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-
Q 014909 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI- 257 (416)
Q Consensus 179 y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~- 257 (416)
|+|||++.+..+. .++||||+||++|+|++|..||.+.+....+..+......+|..+++++.+||.+||+.||.+||
T Consensus 159 y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 9999999887775 88999999999999999999999988888888888888888999999999999999999999997
Q ss_pred --CHhHHhcCcccccC
Q 014909 258 --TIPEILEDEWFKKD 271 (416)
Q Consensus 258 --t~~eil~h~~~~~~ 271 (416)
++.+++.||||...
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 57999999999863
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-52 Score=390.77 Aligned_cols=264 Identities=28% Similarity=0.480 Sum_probs=236.6
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
...+..|++++.||+|.-|+||+|....++..+|+|+++++.........+++.|..||+.++||.++.||..++++...
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 45567889999999999999999999999999999999999888777788999999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc-
Q 014909 87 FIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ- 163 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~- 163 (416)
|++||||+||+|....+++ +.+++..+++|+..++.||+|||..|||+||||||||||-++|++.|+||.|+.....
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999999988764 5799999999999999999999999999999999999999999999999998632100
Q ss_pred ----------------------------c---c-C---------------------CCCcccccCCcccccchhhccCCC
Q 014909 164 ----------------------------V---R-D---------------------DGLLHTTCGTPNYVAPEVLNDRGY 190 (416)
Q Consensus 164 ----------------------------~---~-~---------------------~~~~~~~~gt~~y~aPEvl~~~~~ 190 (416)
. . . +....+.+||-.|+|||++.+.+.
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 0 001224579999999999999888
Q ss_pred CCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCC--CCCHHHHHHHHHhcCCCCCCCCC----HhHHhc
Q 014909 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP--WLSFTARKLIARILDPNPMTRIT----IPEILE 264 (416)
Q Consensus 191 ~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~s~~~~~ll~~~L~~dP~~R~t----~~eil~ 264 (416)
. .++|.|+|||.+||||.|..||.+.+..+.+.+|......+|. .+|..++|||+++|.+||.+|.. +.||.+
T Consensus 313 g-sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 313 G-SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred C-chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 5 8999999999999999999999999999999999888777775 47899999999999999999998 999999
Q ss_pred CcccccC
Q 014909 265 DEWFKKD 271 (416)
Q Consensus 265 h~~~~~~ 271 (416)
||||+.-
T Consensus 392 HpFF~gV 398 (459)
T KOG0610|consen 392 HPFFEGV 398 (459)
T ss_pred CccccCC
Confidence 9999864
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-51 Score=398.20 Aligned_cols=251 Identities=35% Similarity=0.635 Sum_probs=226.9
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 96 (416)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765544555677889999999999999999999999999999999999999
Q ss_pred chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCC
Q 014909 97 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (416)
Q Consensus 97 ~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt 176 (416)
+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence 9999998888899999999999999999999999999999999999999999999999999864221 12233456899
Q ss_pred cccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014909 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256 (416)
Q Consensus 177 ~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R 256 (416)
+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++++.+||++||+.||.+|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 99999999987776 48899999999999999999999988888888888778888899999999999999999999999
Q ss_pred C-----CHhHHhcCccccc
Q 014909 257 I-----TIPEILEDEWFKK 270 (416)
Q Consensus 257 ~-----t~~eil~h~~~~~ 270 (416)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCCCHHHHhcCCCcCC
Confidence 7 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-52 Score=406.70 Aligned_cols=255 Identities=29% Similarity=0.515 Sum_probs=226.9
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
-...|.....||+|+.|.||.|....+++.||||.++.....+ .+.+.+|+.+|+..+|+|||++++.|.-.+.+|+
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 3457888899999999999999999999999999998876443 4678999999999999999999999988899999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
||||++||+|.|.+.. ..++|.++..+.+++++||+|||.+||+|||||.+|||++.+|.+||+|||+|........
T Consensus 348 VMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred EEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 9999999999887765 5599999999999999999999999999999999999999999999999999986654322
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhh-cC--ccCCCCCCCHHHHHHH
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS-AA--EFTCPPWLSFTARKLI 245 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~-~~--~~~~~~~~s~~~~~ll 245 (416)
.-.+.+|||+|||||++....|. +++||||||++++||+-|++||-..+.......|. .+ .+..|..+|+.+++||
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG-~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL 503 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFL 503 (550)
T ss_pred ccccccCCCCccchhhhhhcccC-ccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHH
Confidence 44678999999999999998884 99999999999999999999998766554444443 33 4566778999999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCccccc
Q 014909 246 ARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.+||+.||.+|+++.|+|+||||+.
T Consensus 504 ~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 504 DRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHhhcchhcCCCHHHHhcChhhhh
Confidence 9999999999999999999999954
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=385.63 Aligned_cols=263 Identities=33% Similarity=0.516 Sum_probs=228.1
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
....+.|++...||.|..++||+|++..+++.||||+++.++.... .+.+++|+..|+.++||||++++..|..+..+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 4567889999999999999999999999999999999999886554 78899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
|+||.||.+|++++.+... ..++|..+..++++++.||.|||.+|.+|||||+.||||+.+|.|||+|||.+......
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999999999874 46999999999999999999999999999999999999999999999999987654332
Q ss_pred cCC-CCc-ccccCCcccccchhhcc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC------
Q 014909 165 RDD-GLL-HTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP------ 234 (416)
Q Consensus 165 ~~~-~~~-~~~~gt~~y~aPEvl~~--~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~------ 234 (416)
+.. ... .+..|||+|||||++.. .+|+ .|+||||||++..||.+|..||..-....+.-.-.++.++.+
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence 211 111 56799999999999543 4675 899999999999999999999998777765543333433322
Q ss_pred ----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 235 ----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 235 ----~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
..++..++.++..||+.||.+|||++++|+|+||++.-
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 12677899999999999999999999999999998643
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-51 Score=395.55 Aligned_cols=251 Identities=35% Similarity=0.646 Sum_probs=226.0
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (416)
+.||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876544444566777888888876 699999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence 99999999888999999999999999999999999999999999999999999999999999864321 1223345689
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~ 255 (416)
|+.|+|||++.+..+. .++||||+||++|+|++|+.||...+....+..+.......|.+++.++.+||++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999877664 789999999999999999999999998888888888888889999999999999999999999
Q ss_pred CCCH------hHHhcCccccc
Q 014909 256 RITI------PEILEDEWFKK 270 (416)
Q Consensus 256 R~t~------~eil~h~~~~~ 270 (416)
||++ +++++||||..
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCC
Confidence 9998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-51 Score=395.76 Aligned_cols=251 Identities=35% Similarity=0.631 Sum_probs=226.6
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 96 (416)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++.+...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765544445677889999999999999999999999999999999999999
Q ss_pred chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCC
Q 014909 97 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (416)
Q Consensus 97 ~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt 176 (416)
+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence 9999998888899999999999999999999999999999999999999999999999999864221 12223456899
Q ss_pred cccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014909 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256 (416)
Q Consensus 177 ~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R 256 (416)
+.|+|||++.+..+. .++|||||||++|+|++|+.||...+.......+......+|..+++++.+||.+||+.||.+|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 999999999877774 8899999999999999999999988888888888777888888999999999999999999999
Q ss_pred C-----CHhHHhcCccccc
Q 014909 257 I-----TIPEILEDEWFKK 270 (416)
Q Consensus 257 ~-----t~~eil~h~~~~~ 270 (416)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 8 8999999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=393.29 Aligned_cols=256 Identities=31% Similarity=0.564 Sum_probs=230.0
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCC-CcceEEEEEEeCCEEEEEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP-NVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lV~ 90 (416)
+|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.+++.++|+ +|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876554444567788899999999764 6888999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence 9999999999999888999999999999999999999999999999999999999999999999999864221 12233
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~ 250 (416)
...+||+.|+|||++.+..+. .++||||+||++|+|++|+.||.+.+....+..+......+|..++.++.+|+++||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 456899999999999887774 8899999999999999999999998888888888888888889999999999999999
Q ss_pred CCCCCCCCH-----hHHhcCccccc
Q 014909 251 PNPMTRITI-----PEILEDEWFKK 270 (416)
Q Consensus 251 ~dP~~R~t~-----~eil~h~~~~~ 270 (416)
.||.+|++. +++++||||..
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=395.96 Aligned_cols=255 Identities=32% Similarity=0.568 Sum_probs=226.6
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998766544455677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875432 33
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc--cCCCC------CCCHHHH
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPP------WLSFTAR 242 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~--~~~~~------~~s~~~~ 242 (416)
...+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+.... ...|. .++.++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 456899999999999887665 88999999999999999999999888777666554322 22222 3589999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 243 KLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
+||.+||..+|.+||+++++++||||...
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=400.40 Aligned_cols=259 Identities=34% Similarity=0.621 Sum_probs=225.4
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
.+|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++.+.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765544555677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC---
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--- 167 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~--- 167 (416)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998643221100
Q ss_pred ---------------------------------CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCC
Q 014909 168 ---------------------------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214 (416)
Q Consensus 168 ---------------------------------~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf 214 (416)
....+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence 011235799999999999887775 8899999999999999999999
Q ss_pred CCCchHHHHHHhhcCc--cCCCC--CCCHHHHHHHHHhcCCCCCCCCC---HhHHhcCcccccC
Q 014909 215 DDSNLMNLYKKISAAE--FTCPP--WLSFTARKLIARILDPNPMTRIT---IPEILEDEWFKKD 271 (416)
Q Consensus 215 ~~~~~~~~~~~i~~~~--~~~~~--~~s~~~~~ll~~~L~~dP~~R~t---~~eil~h~~~~~~ 271 (416)
...+.......+.... ..+|. .+++++++||++||. +|.+|++ ++++++||||+..
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9888777766665432 33343 368999999999997 9999998 9999999999753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=401.24 Aligned_cols=258 Identities=32% Similarity=0.536 Sum_probs=222.3
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
.|++++.||+|+||+||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++.+.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999987665555567789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC-----
Q 014909 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD----- 166 (416)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~----- 166 (416)
|++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 999999999999888999999999999999999999999999999999999999999999999999753311000
Q ss_pred ----------------------------------------CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHH
Q 014909 167 ----------------------------------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFV 206 (416)
Q Consensus 167 ----------------------------------------~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ 206 (416)
.....+.+||+.|+|||++.+..+. .++|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHHH
Confidence 0011245799999999999887775 88999999999999
Q ss_pred HhhCCCCCCCCchHHHHHHhhc--CccCCCC--CCCHHHHHHHHHhc--CCCCCCCCCHhHHhcCccccc
Q 014909 207 LLAGYLPFDDSNLMNLYKKISA--AEFTCPP--WLSFTARKLIARIL--DPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 207 ml~G~~Pf~~~~~~~~~~~i~~--~~~~~~~--~~s~~~~~ll~~~L--~~dP~~R~t~~eil~h~~~~~ 270 (416)
|++|..||...+......++.. .....|+ .+++++.+||.+|+ ..+|..|+++++++.||||..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 9999999998776665555543 2344444 47999999999966 455556999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=393.57 Aligned_cols=251 Identities=33% Similarity=0.594 Sum_probs=226.5
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (416)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|..+++.+ +||||+++++++.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876554444566777899998866 799999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
|+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence 99999999888999999999999999999999999999999999999999999999999999864322 2223345689
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~ 255 (416)
|+.|+|||++.+..+. .++|||||||++|+|++|+.||...+....+..+.......|.+++.++.+||++||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 9999999999887774 889999999999999999999999998888999988888889999999999999999999999
Q ss_pred CC-------CHhHHhcCccccc
Q 014909 256 RI-------TIPEILEDEWFKK 270 (416)
Q Consensus 256 R~-------t~~eil~h~~~~~ 270 (416)
|+ +++++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCC
Confidence 99 8999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-50 Score=401.11 Aligned_cols=258 Identities=34% Similarity=0.572 Sum_probs=223.1
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
..|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999998765545556678999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC----
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~---- 166 (416)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..+.....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999753211000
Q ss_pred -----------------------------------------CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHH
Q 014909 167 -----------------------------------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205 (416)
Q Consensus 167 -----------------------------------------~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~ 205 (416)
.....+.+||+.|+|||++.+..|. .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence 0011235799999999999888875 8899999999999
Q ss_pred HHhhCCCCCCCCchHHHHHHhhcC--ccCCC--CCCCHHHHHHHHHhcCCCCCCCCC---HhHHhcCccccc
Q 014909 206 VLLAGYLPFDDSNLMNLYKKISAA--EFTCP--PWLSFTARKLIARILDPNPMTRIT---IPEILEDEWFKK 270 (416)
Q Consensus 206 ~ml~G~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~~~~ll~~~L~~dP~~R~t---~~eil~h~~~~~ 270 (416)
+|++|++||.+.+......++... ....| ..+++++.+||.+|+ .+|.+|++ ++++++||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 999999999988776655555432 23333 357999999999987 59999997 999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=401.26 Aligned_cols=258 Identities=33% Similarity=0.589 Sum_probs=222.7
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++++.||+|+||.||+|.+..+++.||||++.+.........+.+++|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998765545555678999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC---
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--- 167 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~--- 167 (416)
||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998632110000
Q ss_pred ------------------------------------------CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHH
Q 014909 168 ------------------------------------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205 (416)
Q Consensus 168 ------------------------------------------~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~ 205 (416)
......+||+.|+|||++.+..+. .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchhhh
Confidence 000135799999999999887774 8899999999999
Q ss_pred HHhhCCCCCCCCchHHHHHHhhcC--ccCCCC--CCCHHHHHHHHHhcCCCCCCC---CCHhHHhcCccccc
Q 014909 206 VLLAGYLPFDDSNLMNLYKKISAA--EFTCPP--WLSFTARKLIARILDPNPMTR---ITIPEILEDEWFKK 270 (416)
Q Consensus 206 ~ml~G~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~ll~~~L~~dP~~R---~t~~eil~h~~~~~ 270 (416)
+|++|.+||.+.+....+..+... ...+|. .++.++.+||.+||. +|.+| +|+.+++.||||..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999988877777666542 334444 378999999999998 66665 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=394.83 Aligned_cols=251 Identities=35% Similarity=0.629 Sum_probs=226.5
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 96 (416)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998766544455677889999999999999999999999999999999999999
Q ss_pred chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 97 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 97 ~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~-~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence 999999888889999999999999999999997 7999999999999999999999999999864321 1223345679
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~ 255 (416)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||++||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 9999999999887774 889999999999999999999999888888888888888888899999999999999999999
Q ss_pred CC-----CHhHHhcCccccc
Q 014909 256 RI-----TIPEILEDEWFKK 270 (416)
Q Consensus 256 R~-----t~~eil~h~~~~~ 270 (416)
|+ ++.++++||||..
T Consensus 238 R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCC
Confidence 97 8999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-50 Score=390.74 Aligned_cols=251 Identities=31% Similarity=0.612 Sum_probs=223.0
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (416)
+.||+|+||.||+|.+..+|+.||+|++.+..............|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999999876543333455677788888754 899999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence 99999998888899999999999999999999999999999999999999999999999999863211 1223345789
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~ 255 (416)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+.......|.+++.++++||++||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999887775 889999999999999999999999888888888887888889999999999999999999999
Q ss_pred CCCH-hHHhcCccccc
Q 014909 256 RITI-PEILEDEWFKK 270 (416)
Q Consensus 256 R~t~-~eil~h~~~~~ 270 (416)
||++ +++++||||..
T Consensus 238 R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 238 RLGVVGNIRGHPFFKT 253 (316)
T ss_pred cCCChHHHHcCCCcCC
Confidence 9998 58999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-50 Score=384.07 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=220.6
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
.|++.+.||+|+||.||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999987655444444567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 92 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
|+++|+|.+.+... ..+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||++..... ...
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCe
Confidence 99999998887543 3689999999999999999999999999999999999999999999999999875422 222
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH----HHHHHhhcCccCCCCCCCHHHHHHH
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----NLYKKISAAEFTCPPWLSFTARKLI 245 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~s~~~~~ll 245 (416)
....+||+.|+|||++.+..+. .++||||+||++|+|++|+.||...+.. .....+.......+..++.++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 3456799999999999887775 8899999999999999999999875432 2333344445566777999999999
Q ss_pred HHhcCCCCCCCCC-----HhHHhcCccccc
Q 014909 246 ARILDPNPMTRIT-----IPEILEDEWFKK 270 (416)
Q Consensus 246 ~~~L~~dP~~R~t-----~~eil~h~~~~~ 270 (416)
++||+.||.+||+ ++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 9999999999997 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=390.75 Aligned_cols=254 Identities=30% Similarity=0.547 Sum_probs=225.5
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHH---hcCCCCCcceEEEEEEeCCEEEEE
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM---KLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
|++.+.||+|+||.||+|.+..+++.||||++.+.........+.+.+|+.++ +.++||||+++++++.+....|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999999999999999999876544444456777777765 466799999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
|||++||+|...+.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... ....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCc
Confidence 999999999988764 5799999999999999999999999999999999999999999999999999864222 1222
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhc
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L 249 (416)
....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.......+.......|..++.++.+||++||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLL 236 (324)
T ss_pred ccccccCccccCHhHhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 3456899999999999887664 889999999999999999999999888888888888888888899999999999999
Q ss_pred CCCCCCCC-----CHhHHhcCccccc
Q 014909 250 DPNPMTRI-----TIPEILEDEWFKK 270 (416)
Q Consensus 250 ~~dP~~R~-----t~~eil~h~~~~~ 270 (416)
+.||.+|| ++.++++||||..
T Consensus 237 ~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 237 RRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred hcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 99999999 7999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-52 Score=381.07 Aligned_cols=261 Identities=33% Similarity=0.614 Sum_probs=245.7
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
...++.|...+.||+|.||+|.+++.+.+++.||||+++++-+...+....-..|-.+|+..+||.+..+...|++.+.+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 45788999999999999999999999999999999999998888777788888999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+||||+.||+|+-++.+...++|+.+++|-..|++||.|||+++|+.||||.+|+|+|++|++||+|||+++. ....
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE--~I~~ 321 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE--EIKY 321 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh--cccc
Confidence 99999999999999999988999999999999999999999999999999999999999999999999999874 3334
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~ 246 (416)
.....+.||||.|.|||++....|. .++|.|.+||++|||++|++||...+...++..|......+|..+|++++.||.
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYg-raVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLs 400 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYG-RAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLS 400 (516)
T ss_pred cceeccccCChhhcCchhhcccccc-ceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHH
Confidence 5567789999999999999988884 899999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCC-----CHhHHhcCccccc
Q 014909 247 RILDPNPMTRI-----TIPEILEDEWFKK 270 (416)
Q Consensus 247 ~~L~~dP~~R~-----t~~eil~h~~~~~ 270 (416)
.+|.+||.+|. .+.||+.|+||..
T Consensus 401 GLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 401 GLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 99999999998 4899999999985
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-50 Score=383.08 Aligned_cols=255 Identities=29% Similarity=0.450 Sum_probs=214.1
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
.+++|++.+.||.|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+....|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 467899999999999999999999999999999999754321 223567799999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 89 VLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
||||+++ +|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~--~~ 157 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV--PT 157 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC--CC
Confidence 9999986 8998887654 579999999999999999999999999999999999999999999999999875332 12
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC------------------
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------ 229 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~------------------ 229 (416)
.......||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 22345678999999999876544468999999999999999999999887655443332110
Q ss_pred -ccCC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 230 -EFTC-----------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 230 -~~~~-----------~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
...+ .+.++.++++||++||+.||.+|||++|+++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0011 12367899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-50 Score=389.27 Aligned_cols=256 Identities=31% Similarity=0.559 Sum_probs=229.5
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
+|++.+.||+|+||.||+|.+..+++.||+|++.+..............|..++..+ +||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 488999999999999999999999999999999876544444456677888888877 5899999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
||++||+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999864321 12233
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~ 250 (416)
...+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+....+..+......+|..++.++.+|+.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 456899999999999987775 8899999999999999999999999888888888888888888999999999999999
Q ss_pred CCCCCCCCH-----hHHhcCccccc
Q 014909 251 PNPMTRITI-----PEILEDEWFKK 270 (416)
Q Consensus 251 ~dP~~R~t~-----~eil~h~~~~~ 270 (416)
.||.+|++. .++++||||..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999999984 89999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-50 Score=388.53 Aligned_cols=251 Identities=33% Similarity=0.647 Sum_probs=222.5
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhc-CCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL-VKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (416)
+.||+|+||.||+|.+..+++.||+|++.+.........+.+..|..++.. .+||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999987654444445556677777765 4799999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC--CCCccccccC
Confidence 99999998888999999999999999999999999999999999999999999999999999874322 1233445689
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~ 255 (416)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+......+|.+++.++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999887764 889999999999999999999999888888888887778888999999999999999999999
Q ss_pred CCCHh-HHhcCccccc
Q 014909 256 RITIP-EILEDEWFKK 270 (416)
Q Consensus 256 R~t~~-eil~h~~~~~ 270 (416)
||++. ++++||||..
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 238 RLGVDGDIRQHPFFRG 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 99864 8889999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-50 Score=390.95 Aligned_cols=251 Identities=32% Similarity=0.592 Sum_probs=220.7
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (416)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876655555567788999999988 699999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
|+|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCccccccC
Confidence 99999998888999999999999999999999999999999999999999999999999999863211 2223345689
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCC---------chHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---------NLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~s~~~~~ll~ 246 (416)
|+.|+|||++.+..++ .++||||+||++|+|++|+.||... .....++.+.......|..++.++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999887775 8899999999999999999999632 12234556666777888999999999999
Q ss_pred HhcCCCCCCCCC------HhHHhcCccccc
Q 014909 247 RILDPNPMTRIT------IPEILEDEWFKK 270 (416)
Q Consensus 247 ~~L~~dP~~R~t------~~eil~h~~~~~ 270 (416)
+||+.||.+|+| ++++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999997 789999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=399.53 Aligned_cols=258 Identities=34% Similarity=0.557 Sum_probs=222.5
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765544445677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC----
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~---- 166 (416)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+.....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999753211000
Q ss_pred -------------------------------------CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh
Q 014909 167 -------------------------------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 209 (416)
Q Consensus 167 -------------------------------------~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~ 209 (416)
.......+||+.|+|||++.+..+. .++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence 0011235799999999999887775 88999999999999999
Q ss_pred CCCCCCCCchHHHHHHhhcC--ccCCCC--CCCHHHHHHHHHhcCCCCCCCC---CHhHHhcCccccc
Q 014909 210 GYLPFDDSNLMNLYKKISAA--EFTCPP--WLSFTARKLIARILDPNPMTRI---TIPEILEDEWFKK 270 (416)
Q Consensus 210 G~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~ll~~~L~~dP~~R~---t~~eil~h~~~~~ 270 (416)
|+.||.+.+.......+... ....|. .+++++.+||.+|+ .+|.+|+ |+.++++||||+.
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 99999988776665555432 233333 47999999999987 5999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=395.76 Aligned_cols=258 Identities=34% Similarity=0.644 Sum_probs=228.3
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998766555455678899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc-----
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR----- 165 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~----- 165 (416)
||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999987544322
Q ss_pred ----------------------CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHH
Q 014909 166 ----------------------DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY 223 (416)
Q Consensus 166 ----------------------~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~ 223 (416)
.........||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 00123345799999999999887764 8999999999999999999999988877777
Q ss_pred HHhhc--CccCCCCC--CCHHHHHHHHHhcCCCCCCCCC-HhHHhcCccccc
Q 014909 224 KKISA--AEFTCPPW--LSFTARKLIARILDPNPMTRIT-IPEILEDEWFKK 270 (416)
Q Consensus 224 ~~i~~--~~~~~~~~--~s~~~~~ll~~~L~~dP~~R~t-~~eil~h~~~~~ 270 (416)
.++.. .....|.. +++++.+||.+||. ||.+|++ ++++++||||..
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 77665 34444444 59999999999997 9999999 999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-50 Score=396.14 Aligned_cols=264 Identities=32% Similarity=0.549 Sum_probs=228.6
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
.....++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 34567899999999999999999999999999999999987554444445668899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999999998865 468999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCCcccccCCcccccchhhccCC---CCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc--cCCCC--CCC
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPP--WLS 238 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~---~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s 238 (416)
.......+||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+....+.++.... ..+|. .+|
T Consensus 197 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (370)
T cd05596 197 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEIS 275 (370)
T ss_pred -cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCC
Confidence 11224568999999999987542 34588999999999999999999999988887887776532 44454 479
Q ss_pred HHHHHHHHHhcCCCCCC--CCCHhHHhcCcccccC
Q 014909 239 FTARKLIARILDPNPMT--RITIPEILEDEWFKKD 271 (416)
Q Consensus 239 ~~~~~ll~~~L~~dP~~--R~t~~eil~h~~~~~~ 271 (416)
.++.+||++||+.+|.+ |+|++++++||||+..
T Consensus 276 ~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 99999999999999998 9999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=387.16 Aligned_cols=252 Identities=34% Similarity=0.634 Sum_probs=226.7
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (416)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876554445566778899999888 699999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence 99999999888999999999999999999999999999999999999999999999999999864221 1222345679
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~ 255 (416)
|+.|+|||++.+..+. .++||||+||++|+|++|+.||.+.+....+..+.......|..++.++.+||++||+.||++
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 9999999999887775 889999999999999999999999888888888888888888899999999999999999999
Q ss_pred CCCH-----hHHhcCcccccC
Q 014909 256 RITI-----PEILEDEWFKKD 271 (416)
Q Consensus 256 R~t~-----~eil~h~~~~~~ 271 (416)
|||+ .+++.||||+..
T Consensus 238 R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCCC
Confidence 9999 999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=386.41 Aligned_cols=251 Identities=31% Similarity=0.606 Sum_probs=222.3
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhc-CCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL-VKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (416)
+.||+|+||+||+|.+..+++.||||++.+..............|..+++. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999987654333344566778888875 4899999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence 99999998888899999999999999999999999999999999999999999999999999864221 1222345679
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~ 255 (416)
|+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+....+..+.......|.+++.++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 9999999999887774 889999999999999999999999888888888877777788899999999999999999999
Q ss_pred CCCHh-HHhcCccccc
Q 014909 256 RITIP-EILEDEWFKK 270 (416)
Q Consensus 256 R~t~~-eil~h~~~~~ 270 (416)
||++. ++++||||..
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 238 RLGVKGDIRQHPFFRE 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 99996 8999999976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-50 Score=395.36 Aligned_cols=258 Identities=33% Similarity=0.619 Sum_probs=225.2
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
+.|++.+.||+|+||.||+|.+..+++.||+|++.+...........+++|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999998765545555678899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC----
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~---- 166 (416)
||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999864322110
Q ss_pred -----------------------------CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCC
Q 014909 167 -----------------------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217 (416)
Q Consensus 167 -----------------------------~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~ 217 (416)
.....+.+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 0011245799999999999888775 8899999999999999999999988
Q ss_pred chHHHHHHhhcC--ccCCCCC--CCHHHHHHHHHhcCCCCCCCC---CHhHHhcCccccc
Q 014909 218 NLMNLYKKISAA--EFTCPPW--LSFTARKLIARILDPNPMTRI---TIPEILEDEWFKK 270 (416)
Q Consensus 218 ~~~~~~~~i~~~--~~~~~~~--~s~~~~~ll~~~L~~dP~~R~---t~~eil~h~~~~~ 270 (416)
+....+.++... ...+|+. ++.++++||.+|+. ||.+|+ +++++++||||..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 887777776542 3344443 78999999999875 999998 4899999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-50 Score=388.24 Aligned_cols=252 Identities=35% Similarity=0.641 Sum_probs=224.5
Q ss_pred eEEeecCceEEEEEEEC---CCCCeEEEEEeechhhhc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014909 17 RTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLK-HKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (416)
+.||+|+||.||+|.+. .+++.||+|++.+..... ......+.+|+.+|+.++||||+++++.+..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999864 478899999998754322 23346678999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCccc
Q 014909 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 172 (416)
Q Consensus 93 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 172 (416)
++|++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... .......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~ 159 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTHT 159 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCcccc
Confidence 99999999999888899999999999999999999999999999999999999999999999999864322 2223345
Q ss_pred ccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCC
Q 014909 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252 (416)
Q Consensus 173 ~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~d 252 (416)
.+||+.|+|||++.+..+. .++|||||||++|+|++|+.||...+.......+..+....|+.+++++.+||++||+.|
T Consensus 160 ~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 238 (323)
T cd05584 160 FCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238 (323)
T ss_pred cCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccC
Confidence 6899999999999877664 889999999999999999999999888888888888888889999999999999999999
Q ss_pred CCCCC-----CHhHHhcCcccccC
Q 014909 253 PMTRI-----TIPEILEDEWFKKD 271 (416)
Q Consensus 253 P~~R~-----t~~eil~h~~~~~~ 271 (416)
|++|| +++++++||||...
T Consensus 239 p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 239 PSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HhHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=380.63 Aligned_cols=255 Identities=29% Similarity=0.435 Sum_probs=213.8
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||+|+||.||+|++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 4799999999999999999999999999999999765332 234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
||++++.+..+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-cccc
Confidence 999998776655555679999999999999999999999999999999999999999999999999987643211 1223
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-------------------c
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-------------------F 231 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~-------------------~ 231 (416)
....||+.|+|||++.+..+. .++|||||||++|+|++|++||.+.+.......+.... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 345789999999999887764 88999999999999999999998765543322221100 0
Q ss_pred CCC-------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 232 TCP-------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 232 ~~~-------------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
..| ..+|.++.+||++||+.||++|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 011 1267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-50 Score=388.53 Aligned_cols=251 Identities=36% Similarity=0.619 Sum_probs=222.1
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (416)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++.+.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999999999999998765444334455555655 56889999999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence 99999999888999999999999999999999999999999999999999999999999999864221 1223345689
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~ 255 (416)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+.......++.++.++.+||++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 9999999999887775 789999999999999999999999888888888888877888889999999999999999999
Q ss_pred CCCH----hHHhcCccccc
Q 014909 256 RITI----PEILEDEWFKK 270 (416)
Q Consensus 256 R~t~----~eil~h~~~~~ 270 (416)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9997 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=394.43 Aligned_cols=263 Identities=33% Similarity=0.579 Sum_probs=226.3
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
....++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 44568999999999999999999999999999999999875544444456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~- 196 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG- 196 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-
Confidence 999999999999998865 468999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcccccCCcccccchhhccCC---CCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC--ccCCCC--CCCH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPP--WLSF 239 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~---~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~ 239 (416)
.....+.+||+.|+|||++.+.+ +.+.++||||+||++|+|++|..||...+....+.++... .+.+|. .++.
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 276 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISK 276 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCH
Confidence 11224668999999999997643 3458899999999999999999999988887777777543 344454 4699
Q ss_pred HHHHHHHHhcCCCCCC--CCCHhHHhcCcccccC
Q 014909 240 TARKLIARILDPNPMT--RITIPEILEDEWFKKD 271 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~--R~t~~eil~h~~~~~~ 271 (416)
.+++|+.+||..+|.+ |+|+.++++||||+..
T Consensus 277 ~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 277 HAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 9999999999866654 8999999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=382.56 Aligned_cols=258 Identities=27% Similarity=0.445 Sum_probs=211.4
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+....|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence 357899999999999999999999999999999999754321 123457789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
||||+. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~ 157 (303)
T cd07869 81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PS 157 (303)
T ss_pred EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--CC
Confidence 999996 4787777654 5689999999999999999999999999999999999999999999999999864322 12
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH-HHHHHhhc--Ccc-------------
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISA--AEF------------- 231 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~-~~~~~i~~--~~~------------- 231 (416)
......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.... .....+.. +..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 23345678999999999876555568899999999999999999999875332 22222110 000
Q ss_pred --------CCC---------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 232 --------TCP---------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 232 --------~~~---------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
..| ...+.++.+||++||+.||.+|||+.++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 000 0135678999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=385.10 Aligned_cols=256 Identities=31% Similarity=0.563 Sum_probs=228.6
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 90 (416)
.|++.+.||+|+||.||+|.+..+|+.||+|++.+.........+.+..|+.+++.+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998765544445667888999998886 577889999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999864321 12223
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~ 250 (416)
...+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+.....+.+.......|..++.++.+|+.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 456799999999999887764 8899999999999999999999998888888888888888888999999999999999
Q ss_pred CCCCCCCC-----HhHHhcCccccc
Q 014909 251 PNPMTRIT-----IPEILEDEWFKK 270 (416)
Q Consensus 251 ~dP~~R~t-----~~eil~h~~~~~ 270 (416)
.||.+|++ .+++++||||..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCC
Confidence 99999997 478999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=386.58 Aligned_cols=258 Identities=31% Similarity=0.584 Sum_probs=222.2
Q ss_pred CEEEEeEEeecCceEEEEEEEC---CCCCeEEEEEeechhhh-cHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 86 (416)
+|++.+.||+|+||.||+|++. .+++.||+|++.+.... .....+.+.+|+.+++.++ ||||+++++++.....+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4899999999999999999874 47889999999865432 2234567889999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~- 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE- 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCC----chHHHHHHhhcCccCCCCCCCHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS----NLMNLYKKISAAEFTCPPWLSFTAR 242 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~~~~ 242 (416)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... ........+......+|..+++.+.
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 122335689999999999987654568899999999999999999999643 2334445566666777888999999
Q ss_pred HHHHHhcCCCCCCCC-----CHhHHhcCccccc
Q 014909 243 KLIARILDPNPMTRI-----TIPEILEDEWFKK 270 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~-----t~~eil~h~~~~~ 270 (416)
+||.+||+.||++|| +++++++||||+.
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999999999999 8889999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=387.46 Aligned_cols=251 Identities=32% Similarity=0.598 Sum_probs=219.6
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (416)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876555555567788999988776 799999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence 99999998888999999999999999999999999999999999999999999999999999864322 1222345689
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCC---------CchHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD---------SNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~---------~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~ 246 (416)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.. .........+......+|..++..+.+||+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9999999999887774 889999999999999999999952 112234555666777888899999999999
Q ss_pred HhcCCCCCCCCC------HhHHhcCccccc
Q 014909 247 RILDPNPMTRIT------IPEILEDEWFKK 270 (416)
Q Consensus 247 ~~L~~dP~~R~t------~~eil~h~~~~~ 270 (416)
+||+.||++||+ +.++++||||+.
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999998 579999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=371.96 Aligned_cols=261 Identities=31% Similarity=0.396 Sum_probs=224.9
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTK 85 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~ 85 (416)
..++.|+.+..|++|+||.||+|+++.+++.||+|.++.++ ...+.--.-.|||.+|.+.+|||||.+-++... -+.
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 35678999999999999999999999999999999998765 333444456699999999999999999998753 467
Q ss_pred EEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
+|+|||||+. +|...+..-+ ++...+++.++.|+++|++|||.+.|+||||||+|+|++..|.+||+|||+|+.++..
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999999986 8999888755 8999999999999999999999999999999999999999999999999999976543
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc--------------
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-------------- 230 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~-------------- 230 (416)
-...+..+-|.+|+|||.+.+...++++.|+||+|||+.||+++++.|.+.+..++..+|...-
T Consensus 231 --~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 231 --LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred --cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 2345666789999999999997777799999999999999999999999998887777763210
Q ss_pred -----cCCCC-----------C--CCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 231 -----FTCPP-----------W--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 231 -----~~~~~-----------~--~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
..++. + +|....+|++.+|..||.+|.|++|.|+|+||....
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 11111 1 458899999999999999999999999999998754
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=388.35 Aligned_cols=258 Identities=29% Similarity=0.519 Sum_probs=223.8
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
.+|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46999999999999999999999999999999998766544555677899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 91 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........ ..
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc-ee
Confidence 999999999999876 6899999999999999999999999999999999999999999999999999875432111 12
Q ss_pred cccccCCcccccchhhcc-----CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc--cCC--CCCCCHH
Q 014909 170 LHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTC--PPWLSFT 240 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~-----~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~--~~~--~~~~s~~ 240 (416)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+.++.... ..+ .+.++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 234579999999999873 2233578999999999999999999999887777666664432 223 3457999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 241 ARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
+.+||++||. ||.+|||++++++||||..
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 9999999998 9999999999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=385.80 Aligned_cols=251 Identities=36% Similarity=0.608 Sum_probs=221.4
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (416)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++++...+..|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999998765443334455556655 56789999999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence 99999999888999999999999999999999999999999999999999999999999999864221 1223345689
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~ 255 (416)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+.......++..+..+.++|++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 9999999999887775 789999999999999999999999888888888887777778889999999999999999999
Q ss_pred CCCH----hHHhcCccccc
Q 014909 256 RITI----PEILEDEWFKK 270 (416)
Q Consensus 256 R~t~----~eil~h~~~~~ 270 (416)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCCCCCCHHHHhcCCCcCC
Confidence 9987 58999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-49 Score=382.82 Aligned_cols=251 Identities=35% Similarity=0.592 Sum_probs=221.6
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (416)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|.. +++.++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999998765444434455556654 67889999999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
|+|...+.....+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence 99999998888899999999999999999999999999999999999999999999999999864221 1223345689
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~ 255 (416)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+......+|+..+.++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 9999999999887775 789999999999999999999999888888888888888888889999999999999999999
Q ss_pred CCCH----hHHhcCccccc
Q 014909 256 RITI----PEILEDEWFKK 270 (416)
Q Consensus 256 R~t~----~eil~h~~~~~ 270 (416)
|+++ .++++|+||..
T Consensus 238 R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCCCCCHHHHhCCCCcCC
Confidence 9975 49999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-51 Score=390.04 Aligned_cols=256 Identities=29% Similarity=0.477 Sum_probs=227.8
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
..|+..+.||+|+||.||+|.+..+++.||||+++.+.... .++.+++|+.+|..+++|||.++|+.+..+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 45888899999999999999999999999999999876544 4788999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
|||.||++.+.++....+.|..+..++++++.|+.|||+++.+|||||+.|||+..+|.+||+|||.+...... ....
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~--~~rr 168 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT--VKRR 168 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech--hhcc
Confidence 99999999999999887899999999999999999999999999999999999999999999999998755432 2223
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhc
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARIL 249 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ll~~~L 249 (416)
.+..|||.||||||+...+|+ .++||||||++.+||++|.+||.....+.....|.... +.....+|+.+++|+..||
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence 788999999999999988887 89999999999999999999999877754444443332 2223358999999999999
Q ss_pred CCCCCCCCCHhHHhcCcccccC
Q 014909 250 DPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 250 ~~dP~~R~t~~eil~h~~~~~~ 271 (416)
++||+.||++.++|+|+|+++.
T Consensus 248 ~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred hcCcccCcCHHHHhhhHHHHhc
Confidence 9999999999999999999874
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=387.38 Aligned_cols=250 Identities=33% Similarity=0.585 Sum_probs=219.3
Q ss_pred EeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC---CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014909 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (416)
Q Consensus 19 LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (416)
||+|+||.||+|++..+++.||+|++.+..............|..++..+ +||||+++++.+.+...+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999876544443445556677777655 699999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence 99999999888999999999999999999999999999999999999999999999999999864322 2223446789
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCC-CCHHHHHHHHHhcCCCCC
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW-LSFTARKLIARILDPNPM 254 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-~s~~~~~ll~~~L~~dP~ 254 (416)
|+.|+|||++.+....+.++|||||||++|+|++|..||...+....+..+..+...+|.. ++.++.+||++||+.||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 9999999999765544688999999999999999999999988888888887777777654 799999999999999999
Q ss_pred CCC----CHhHHhcCccccc
Q 014909 255 TRI----TIPEILEDEWFKK 270 (416)
Q Consensus 255 ~R~----t~~eil~h~~~~~ 270 (416)
+|| ++.++++||||..
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HCCCCCCCHHHHhcCccccC
Confidence 998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-49 Score=382.21 Aligned_cols=251 Identities=31% Similarity=0.592 Sum_probs=220.4
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (416)
+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.++.++ +||||+++++.+.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999887655555667788999999888 599999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence 99999998888999999999999999999999999999999999999999999999999999864221 1223346789
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCC-------chHHHHHHhhcCccCCCCCCCHHHHHHHHHh
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-------NLMNLYKKISAAEFTCPPWLSFTARKLIARI 248 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~ 248 (416)
|+.|+|||++.+..+. .++|||||||++|+|++|..||... .....++.+......+|..++..+.++|++|
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999887774 8999999999999999999999532 2234455566666778888999999999999
Q ss_pred cCCCCCCCCC------HhHHhcCccccc
Q 014909 249 LDPNPMTRIT------IPEILEDEWFKK 270 (416)
Q Consensus 249 L~~dP~~R~t------~~eil~h~~~~~ 270 (416)
|+.||.+|++ ++++++||||..
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 9999999998 569999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=387.74 Aligned_cols=264 Identities=34% Similarity=0.578 Sum_probs=226.2
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
.....++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34567899999999999999999999999999999999987554444455678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 9999999999999998865 468999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCCcccccCCcccccchhhccCC---CCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc--cCCC--CCCC
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCP--PWLS 238 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~---~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~s 238 (416)
.....+.+||+.|+|||++.+.. +.+.++|||||||++|+|++|..||...+....+.++.... ..+| ..++
T Consensus 197 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (371)
T cd05622 197 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275 (371)
T ss_pred -cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence 11234568999999999997543 34588999999999999999999999988887787776532 3334 3589
Q ss_pred HHHHHHHHHhcCCCCCC--CCCHhHHhcCcccccC
Q 014909 239 FTARKLIARILDPNPMT--RITIPEILEDEWFKKD 271 (416)
Q Consensus 239 ~~~~~ll~~~L~~dP~~--R~t~~eil~h~~~~~~ 271 (416)
..+++||.+||..++.+ |+++++|++||||+..
T Consensus 276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 99999999999855544 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-49 Score=382.63 Aligned_cols=251 Identities=36% Similarity=0.621 Sum_probs=220.3
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (416)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|.. +++.++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999998765433333344445544 56889999999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence 99999999888899999999999999999999999999999999999999999999999999864321 2223445689
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~ 255 (416)
|+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+..+.......++.++..+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999887775 889999999999999999999999888888888877777778889999999999999999999
Q ss_pred CCCHh----HHhcCccccc
Q 014909 256 RITIP----EILEDEWFKK 270 (416)
Q Consensus 256 R~t~~----eil~h~~~~~ 270 (416)
|+++. ++++|+||..
T Consensus 238 R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCCCHHHHhcCcccCC
Confidence 99876 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=382.02 Aligned_cols=257 Identities=30% Similarity=0.492 Sum_probs=210.3
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----CEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-----TKI 86 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~ 86 (416)
+|++.+.||+|+||.||+|.+..+|+.||||.+..... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 69999999999999999999999999999999875322 222345688999999999999999999987543 358
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+||||+. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 58999998888899999999999999999999999999999999999999999999999999875432211
Q ss_pred -CCCcccccCCcccccchhhcc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhc---------------
Q 014909 167 -DGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--------------- 228 (416)
Q Consensus 167 -~~~~~~~~gt~~y~aPEvl~~--~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~--------------- 228 (416)
.......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|++||.+.+.......+..
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 112245679999999999875 344 5899999999999999999999987654332211100
Q ss_pred -----------CccCC-----CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 229 -----------AEFTC-----PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 229 -----------~~~~~-----~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
..... .+.+++.+.+||.+||+.||++|||++++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 00000 12367889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=383.30 Aligned_cols=250 Identities=35% Similarity=0.629 Sum_probs=222.7
Q ss_pred eEEeecCceEEEEEEEC---CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEecc
Q 014909 17 RTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV 93 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 93 (416)
+.||+|+||.||++.+. .+|+.||+|++.+..... .....+.+|+.++++++||||+++++++.++..+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 67999999999999863 578999999998755332 23456778999999999999999999999999999999999
Q ss_pred CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccc
Q 014909 94 TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 173 (416)
Q Consensus 94 ~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 173 (416)
++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC--CCCceecc
Confidence 9999999998888899999999999999999999999999999999999999999999999999875332 11233456
Q ss_pred cCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCC
Q 014909 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253 (416)
Q Consensus 174 ~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP 253 (416)
+||+.|+|||++.+..+. .++|||||||++|+|++|+.||...+.......+.......|..+++++.+||++||+.||
T Consensus 159 ~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P 237 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237 (318)
T ss_pred cCChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 899999999999877664 8899999999999999999999998888888888888888899999999999999999999
Q ss_pred CCCCC-----HhHHhcCccccc
Q 014909 254 MTRIT-----IPEILEDEWFKK 270 (416)
Q Consensus 254 ~~R~t-----~~eil~h~~~~~ 270 (416)
.+||+ +++++.||||..
T Consensus 238 ~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 238 ANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred hHcCCCCCCCHHHHhCCCCcCC
Confidence 99999 778999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=370.57 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=222.5
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCC----
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMGSKT---- 84 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~---- 84 (416)
+..|..++.||+|+||+||+|+++.+|+.||+|.+..+... ++.-....+|+.+|+.|+|+| |+++++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45677788899999999999999999999999999876432 334456789999999999999 999999998877
Q ss_pred --EEEEEEeccCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccc
Q 014909 85 --KIFIVLEFVTGGELFDKIVNHG----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (416)
Q Consensus 85 --~~~lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla 158 (416)
.+|+|+||++. +|..++.... .++...++.+++||+.||+|||++||+||||||.||||++.|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999976 9999998755 5888899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC---------
Q 014909 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------- 229 (416)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~--------- 229 (416)
+.+.. .........+|..|+|||++.+...++...||||+|||++||++++..|.+.+..++...|...
T Consensus 168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 85543 2334667789999999999999866678999999999999999999999998887776665321
Q ss_pred ---------ccCCCCC------------CCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 230 ---------EFTCPPW------------LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 230 ---------~~~~~~~------------~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
...++.| .+++..+++.+||+.+|.+|.|++.+|.||||....
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 1122222 245899999999999999999999999999998653
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=378.55 Aligned_cols=259 Identities=29% Similarity=0.534 Sum_probs=220.3
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||+|+||.||++.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998755444445677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 91 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-Ccc
Confidence 99999999999976 4579999999999999999999999999999999999999999999999999986443211 111
Q ss_pred cccccCCcccccchhhcc----CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc--cCCC---CCCCHH
Q 014909 170 LHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCP---PWLSFT 240 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~----~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~--~~~~---~~~s~~ 240 (416)
....+||+.|+|||++.. ....+.++||||+||++|+|++|+.||.+.+..+.+..+.... ..+| +.++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 233579999999999973 2334578999999999999999999999888777766664432 2333 347999
Q ss_pred HHHHHHHhcCCCCCC--CCCHhHHhcCccccc
Q 014909 241 ARKLIARILDPNPMT--RITIPEILEDEWFKK 270 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~--R~t~~eil~h~~~~~ 270 (416)
+++||++||..++++ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 999999999765544 889999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=371.64 Aligned_cols=249 Identities=29% Similarity=0.451 Sum_probs=214.2
Q ss_pred EeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014909 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (416)
Q Consensus 19 LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 98 (416)
||+|+||+||++.+..+++.||+|.+.+.........+.+..|+.+++.++||||+++++++......|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999876544444456778999999999999999999999999999999999999999
Q ss_pred HHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCccccc
Q 014909 99 FDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (416)
Q Consensus 99 ~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 174 (416)
.+.+.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... ........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC--CccccccC
Confidence 887743 356999999999999999999999999999999999999999999999999998654321 12233457
Q ss_pred CCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch----HHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 014909 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (416)
Q Consensus 175 gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~ 250 (416)
||+.|+|||++.+..++ .++|||||||++|+|++|+.||..... ......+.......|+.++.++.+|+.+||+
T Consensus 159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 99999999999987775 789999999999999999999986542 2333444444556677799999999999999
Q ss_pred CCCCCCC-----CHhHHhcCccccc
Q 014909 251 PNPMTRI-----TIPEILEDEWFKK 270 (416)
Q Consensus 251 ~dP~~R~-----t~~eil~h~~~~~ 270 (416)
.||++|| +++++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhc
Confidence 9999999 8899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=379.87 Aligned_cols=250 Identities=28% Similarity=0.480 Sum_probs=216.7
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCe-EEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-EE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEP-VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-KI 86 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~-vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~ 86 (416)
......+.+.||.|+||+||.|... |+. ||||++......... .+.+.+|+.+|++++|||||++++++.++. ..
T Consensus 39 ~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~ 115 (362)
T KOG0192|consen 39 DPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSL 115 (362)
T ss_pred ChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence 3445566677999999999999985 455 999999876655544 788999999999999999999999999887 79
Q ss_pred EEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC-cEeecCCCCcEEeccCC-CeEEeecccccccc
Q 014909 87 FIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRG-VYHRDLKPENLLLDAYG-NLKVSDFGLSALSQ 162 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~al~~LH~~g-ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~ 162 (416)
++||||+++|+|.+++.. ...++...+..++.||+.||.|||+++ ||||||||+|||++.++ ++||+|||+++...
T Consensus 116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999999999999988 578999999999999999999999999 99999999999999998 99999999998654
Q ss_pred cccCCCCcccccCCcccccchhhc--cCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHh--hcCccCCCCCCC
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLN--DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTCPPWLS 238 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~--~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~~s 238 (416)
... .......||+.|||||++. ...|+ .++||||+|+++|||+||+.||.+.........+ ....+.+|..++
T Consensus 196 ~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~ 272 (362)
T KOG0192|consen 196 ISK--TSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECP 272 (362)
T ss_pred ccc--ccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCC
Confidence 321 2233468999999999999 45675 9999999999999999999999988875554444 334566677799
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 239 FTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 239 ~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+.+..|+.+||+.||.+||++.+|+.
T Consensus 273 ~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 273 PHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999999999999975
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=370.03 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=220.1
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
.|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++.++||||+++++.+.+++..|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999998999999999986554444444567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 92 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
|+.||+|.+.+... ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCc
Confidence 99999999888653 4699999999999999999999999999999999999999999999999999875432 222
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHH----HHHhhcCccCCCCCCCHHHHHHH
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL----YKKISAAEFTCPPWLSFTARKLI 245 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~s~~~~~ll 245 (416)
....+|++.|+|||++.+..+. .++||||+||++|+|++|..||.+.+.... ...+.......+..++..+.+|+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 3455799999999999876664 789999999999999999999987655332 23334444556667899999999
Q ss_pred HHhcCCCCCCCC-----CHhHHhcCccccc
Q 014909 246 ARILDPNPMTRI-----TIPEILEDEWFKK 270 (416)
Q Consensus 246 ~~~L~~dP~~R~-----t~~eil~h~~~~~ 270 (416)
.+||+.||.+|| +++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-48 Score=375.91 Aligned_cols=256 Identities=23% Similarity=0.406 Sum_probs=219.0
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
..++|++.+.||+|+||.||+|++..++..+|+|++..+. .....+.+.+|+.+|+.++||||+++++++.+.+..++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4578999999999999999999999999999999997642 23345779999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~-givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
||||++||+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----
Confidence 999999999999999888899999999999999999999986 699999999999999999999999999864422
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhc-------------------
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA------------------- 228 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~------------------- 228 (416)
.......||+.|+|||++.+..+. .++|||||||++|+|++|+.||...+...+...+..
T Consensus 157 ~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 157 SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred cccccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 223455799999999999887764 899999999999999999999986655433222110
Q ss_pred ---------------------------Cc-cCC-CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 229 ---------------------------AE-FTC-PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 229 ---------------------------~~-~~~-~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
.. ... ...+++++++||.+||+.||++|||++++++||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 00 011 11367899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-50 Score=362.75 Aligned_cols=255 Identities=37% Similarity=0.675 Sum_probs=221.7
Q ss_pred cccCEEEE-eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe----
Q 014909 9 RVGKYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS---- 82 (416)
Q Consensus 9 ~~~~y~~~-~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~---- 82 (416)
..++|.+. +.||-|-.|+|-.+.++.+|+.+|+|++.- ....++|+++.-.. .|||||.++++|++
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 45567664 579999999999999999999999998742 24567888877666 49999999999864
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc---CCCeEEeeccc
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDFGL 157 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~---~~~vkl~DFGl 157 (416)
...+.+|||.++||+||+.|..++. ++|.+|..+++||..|+.|||+.+|.||||||||+|.+. |..+||+|||+
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 5678999999999999999998765 999999999999999999999999999999999999965 45699999999
Q ss_pred ccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc----hHHHHHHhhcCccCC
Q 014909 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTC 233 (416)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~----~~~~~~~i~~~~~~~ 233 (416)
|+... ....+.+.|-||+|+|||++....|+ ..+|+||+|||+|.||+|++||.... ...+..+|..+.+.|
T Consensus 211 AK~t~---~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 211 AKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred ccccC---CCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 98543 24567899999999999999888886 88999999999999999999997543 346778898898877
Q ss_pred CC--C--CCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCCCC
Q 014909 234 PP--W--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275 (416)
Q Consensus 234 ~~--~--~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~~ 275 (416)
|. | +|..++++|+.+|..+|.+|.|+++++.|||+.....-|
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp 332 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVP 332 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCC
Confidence 64 5 899999999999999999999999999999998765443
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=393.49 Aligned_cols=265 Identities=31% Similarity=0.504 Sum_probs=229.1
Q ss_pred ccccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
++.....++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.++..++|+||+++++.+...
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 34456678999999999999999999999999999999999876543 33456788999999999999999999877533
Q ss_pred C--------EEEEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeE
Q 014909 84 T--------KIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (416)
Q Consensus 84 ~--------~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vk 151 (416)
. .+++||||+++|+|.+.+... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence 2 478999999999999988652 4689999999999999999999999999999999999999999999
Q ss_pred EeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc
Q 014909 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 231 (416)
Q Consensus 152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~ 231 (416)
|+|||+++............+.+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.......+..+..
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~ 262 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 9999998765433233334567899999999999887775 899999999999999999999998888777776655543
Q ss_pred -CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 232 -TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 232 -~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
..|+.+++++.+|+.+||+.||.+||++.++++|||++.
T Consensus 263 ~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 263 DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 467789999999999999999999999999999999875
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=374.47 Aligned_cols=259 Identities=27% Similarity=0.510 Sum_probs=220.6
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998655444445566889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 91 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-Ccce
Confidence 99999999999987 467999999999999999999999999999999999999999999999999998643221 1112
Q ss_pred cccccCCcccccchhhcc----CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc--cCCCC---CCCHH
Q 014909 170 LHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPP---WLSFT 240 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~----~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~s~~ 240 (416)
....+||+.|+|||++.. ....+.++|||||||++|+|++|+.||...+....+.++.... ..+|. .++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 234689999999999863 2334588999999999999999999999888877777775442 23333 47999
Q ss_pred HHHHHHHhcCCCCCC--CCCHhHHhcCccccc
Q 014909 241 ARKLIARILDPNPMT--RITIPEILEDEWFKK 270 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~--R~t~~eil~h~~~~~ 270 (416)
+++||++||..+|.+ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999765554 789999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-48 Score=390.10 Aligned_cols=252 Identities=28% Similarity=0.390 Sum_probs=206.3
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 83 (416)
..++|++++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 3457999999999999999999999999999999885432 2245799999999999999999886432
Q ss_pred ---CEEEEEEeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC-CeEEeec
Q 014909 84 ---TKIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDF 155 (416)
Q Consensus 84 ---~~~~lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~-~vkl~DF 155 (416)
..+++||||+++ +|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 247799999986 6766654 346799999999999999999999999999999999999999765 6999999
Q ss_pred ccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC------
Q 014909 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------ 229 (416)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~------ 229 (416)
|+|..... .......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+......++...
T Consensus 216 Gla~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99975432 222335678999999999877554468999999999999999999999987655444333210
Q ss_pred -----------cc------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 230 -----------EF------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 230 -----------~~------------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
.. .+|...+.++.+||.+||+.||.+|||+.|+++||||..-
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 00 1234468899999999999999999999999999999753
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=382.12 Aligned_cols=254 Identities=20% Similarity=0.313 Sum_probs=209.6
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
+...++|++.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.+++.++||||+++++++......
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 345578999999999999999999999999999999743 23467899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
++|||++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|...... .
T Consensus 159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~ 236 (391)
T PHA03212 159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-N 236 (391)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-c
Confidence 99999996 589999988888999999999999999999999999999999999999999999999999998643221 1
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc-------hHHHHHHh-------------
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-------LMNLYKKI------------- 226 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~-------~~~~~~~i------------- 226 (416)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.... .......+
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred ccccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 122345689999999999988777 489999999999999999998874321 01111111
Q ss_pred -------------hcCc----cCCCCC-----CCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 227 -------------SAAE----FTCPPW-----LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 227 -------------~~~~----~~~~~~-----~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
.... ...|.| ++.++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 0000 011111 466899999999999999999999999999998643
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-49 Score=366.15 Aligned_cols=250 Identities=32% Similarity=0.492 Sum_probs=211.5
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--C---EE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--T---KI 86 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~---~~ 86 (416)
.|+-.+.+|.|+||.||.|....+++.||||.+-.++.. --+|+.+|+.++|||||++..+|... + ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 588899999999999999999999999999987554322 23799999999999999999888532 2 34
Q ss_pred EEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC-CCeEEeeccccccc
Q 014909 87 FIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALS 161 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~-~~vkl~DFGla~~~ 161 (416)
.+||||++. +|.+.++. +.+++.-.++-|..||++||+|||+.||+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 689999986 89888874 5789999999999999999999999999999999999999986 99999999999876
Q ss_pred ccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC------------
Q 014909 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------ 229 (416)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~------------ 229 (416)
.. +....+...|..|+|||.+.+...++.+.||||+|||+.||+-|++-|.+.+..++...|...
T Consensus 177 ~~---~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VK---GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred cc---CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 54 233356667999999999998777779999999999999999999999998876665544211
Q ss_pred -----ccCCC------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 230 -----EFTCP------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 230 -----~~~~~------------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
+..+| ...++++.+|+.++|..+|.+|.++.|++.||||..-.
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 11111 23689999999999999999999999999999998543
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=364.27 Aligned_cols=254 Identities=37% Similarity=0.724 Sum_probs=231.2
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
.+|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++++++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998766555555678999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
||+++++|.+++...+.+++..+..++.||+.||.|||++|++|+||+|.||+++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999999998889999999999999999999999999999999999999999999999999998754321 3
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~ 250 (416)
...+|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+..+....|..++..+.++|.+||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 34578999999999987665 47899999999999999999999988877777777777888888899999999999999
Q ss_pred CCCCCCC-----CHhHHhcCccccc
Q 014909 251 PNPMTRI-----TIPEILEDEWFKK 270 (416)
Q Consensus 251 ~dP~~R~-----t~~eil~h~~~~~ 270 (416)
.||.+|+ +++++++||||..
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred CCHHHccCcccCCHHHHHcCccccc
Confidence 9999999 9999999999965
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=369.31 Aligned_cols=258 Identities=28% Similarity=0.454 Sum_probs=214.6
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
.+++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 467899999999999999999999999999999998754322 223457789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 89 VLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
||||+++ +|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 158 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP--T 158 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC--c
Confidence 9999986 7888776543 5899999999999999999999999999999999999999999999999998653221 1
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC------------------
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------ 229 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~------------------ 229 (416)
.......+|+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 22234578999999999876554568999999999999999999999877654433322110
Q ss_pred -ccCC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 230 -EFTC-----------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 230 -~~~~-----------~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
.... .+.+++++++||.+||+.||.+|||++|+++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 0111 12368899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=373.52 Aligned_cols=259 Identities=29% Similarity=0.496 Sum_probs=220.7
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998755444444567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 91 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
||++||+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-cee
Confidence 99999999999987 4679999999999999999999999999999999999999999999999999987543211 111
Q ss_pred cccccCCcccccchhhccC----CCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc--cCCCC---CCCHH
Q 014909 170 LHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPP---WLSFT 240 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~----~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~s~~ 240 (416)
....+||+.|+|||++.+. +..+.++||||+||++|+|++|+.||...+....+.++.... +.+|+ .++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 2345799999999998752 223578999999999999999999999888777777665432 33343 36899
Q ss_pred HHHHHHHhcCCCCCC--CCCHhHHhcCccccc
Q 014909 241 ARKLIARILDPNPMT--RITIPEILEDEWFKK 270 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~--R~t~~eil~h~~~~~ 270 (416)
+++||.+||..++++ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999999876655 568999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-49 Score=381.69 Aligned_cols=258 Identities=30% Similarity=0.505 Sum_probs=236.7
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE-EE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK-IF 87 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~ 87 (416)
.+++|..++.+|+|+||.+++++++..++.|++|.++........ .....+|+.++++++|||||.+++.|..++. .+
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 467899999999999999999999999999999999987755443 4578899999999999999999999988887 99
Q ss_pred EEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 88 IVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
|||+||+||+|.+.|...+ -++|+.+..||.|++.|+.|||+++|.|||||+.||+++.++.|||+|||+|+.....
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~- 159 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE- 159 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc-
Confidence 9999999999999998754 5899999999999999999999999999999999999999999999999999976542
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKL 244 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 244 (416)
.....+..|||.||.||++.+.+|. .++|||||||++|||++-+.+|.+.+...+..+|..+. .+.|..+|.+++.|
T Consensus 160 -~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 160 -DSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL 237 (426)
T ss_pred -hhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence 2356788999999999999999996 99999999999999999999999999999999998876 56778899999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 245 IARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
|+.||.++|..||++.++|.+|....
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhChhhhh
Confidence 99999999999999999999988764
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=389.15 Aligned_cols=257 Identities=28% Similarity=0.466 Sum_probs=223.5
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCC-CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSET-GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+++|+.+|+.++||||+++++++...+..|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 44599999999999999999998877 7889999875432 3334678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 89 VLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
||||++||+|.+++.. ..++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999987753 346899999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc-CCCCCCCHHHHH
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARK 243 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~ 243 (416)
.......+.+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.......+..+.. ..|..++.++.+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHH
Confidence 222234566899999999999887664 889999999999999999999998888777777665544 345678999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 244 LIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
||.+||..||++||++++++.|+|++.
T Consensus 302 li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999999999999999999974
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=376.48 Aligned_cols=259 Identities=27% Similarity=0.459 Sum_probs=211.7
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC---
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--- 84 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 84 (416)
..+++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 357899999999999999999999999999999999975432 2334567889999999999999999999986543
Q ss_pred ---EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccc
Q 014909 85 ---KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (416)
Q Consensus 85 ---~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~ 161 (416)
..|+||||+.+ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 57999999976 5666664 35889999999999999999999999999999999999999999999999998643
Q ss_pred ccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhc-------------
Q 014909 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA------------- 228 (416)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~------------- 228 (416)
.. ........||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 174 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 174 CT---NFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred cc---CccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 21 2233456789999999999887775 789999999999999999999987664433221110
Q ss_pred ---------CccC---------CCC-----------CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 229 ---------AEFT---------CPP-----------WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 229 ---------~~~~---------~~~-----------~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
.... ++. ..+..+++||.+||+.||++|||+.|+|+||||...+.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 0000 111 135789999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=360.27 Aligned_cols=253 Identities=35% Similarity=0.656 Sum_probs=215.2
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (416)
|++++.||+|+||.||+|.+..+++.||+|++......... .....+|+.+++.++||||+++++++.+....++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999887654432 33445699999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCccc
Q 014909 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 172 (416)
Q Consensus 93 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 172 (416)
+.+++|.+++...+.+++..+..++.||+.||++||++|++|+||||+||+++.++.++|+|||.+... .........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence 999999999998889999999999999999999999999999999999999999999999999998643 122334456
Q ss_pred ccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc---hHHHHHHhhcCccCCCC----CCCHHHHHHH
Q 014909 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEFTCPP----WLSFTARKLI 245 (416)
Q Consensus 173 ~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~---~~~~~~~i~~~~~~~~~----~~s~~~~~ll 245 (416)
.++|+.|+|||++......+.++||||||+++|+|++|..||.... ......+........+. ..+..+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 7889999999999833444699999999999999999999999873 22333333222221111 1248999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCccc
Q 014909 246 ARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
.+||+.||++|||+.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=380.05 Aligned_cols=257 Identities=27% Similarity=0.446 Sum_probs=215.7
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-----EE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-----KI 86 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 86 (416)
+|++.+.||+|+||.||+|.+..+|+.||||.+.... ........+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4788999999999999999999999999999986532 22234567889999999999999999999998776 79
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+||||+. ++|.+.+.....+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++...... .
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-~ 157 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-E 157 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC-c
Confidence 99999997 588888888888999999999999999999999999999999999999999999999999998754322 1
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhc------------------
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA------------------ 228 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~------------------ 228 (416)
........+|+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 22233456899999999998765556899999999999999999999988765544433321
Q ss_pred -----Ccc---------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 229 -----AEF---------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 229 -----~~~---------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
... ......++++.+||.+||+.||.+|||+.++++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 001 1223457899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=377.39 Aligned_cols=258 Identities=29% Similarity=0.467 Sum_probs=215.2
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
...+++|+.++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++|+||+++++++...+.+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 345778999999999999999999999999999999986543 233457789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+||||+.+|+|.+. ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~-- 221 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-- 221 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--
Confidence 999999999998642 34678888999999999999999999999999999999999999999999998764321
Q ss_pred CCCcccccCCcccccchhhcc----CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH---HHHHHhh-cCccCCCCCCC
Q 014909 167 DGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---NLYKKIS-AAEFTCPPWLS 238 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~----~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~---~~~~~i~-~~~~~~~~~~s 238 (416)
........||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||...... .....+. ......+..++
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS 301 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence 122345679999999999853 234557899999999999999999999743322 2222222 22334556789
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 239 FTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 239 ~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
.++++||.+||+.||++|||+.|+++||||.+..
T Consensus 302 ~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 302 REFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 9999999999999999999999999999998753
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=364.42 Aligned_cols=252 Identities=32% Similarity=0.457 Sum_probs=206.9
Q ss_pred cCEEEEeEEeecCceEEEEEEECC-CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC---CCCCcceEEEEEE-----
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMG----- 81 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~----- 81 (416)
.+|++.+.||+|+||.||+|.+.. ++..||+|.+....... .......+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 379999999999999999999864 46889999987543222 2234556777777766 6999999999875
Q ss_pred eCCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 82 SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 82 ~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
....+++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456899999997 4898888753 458999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc--------
Q 014909 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-------- 231 (416)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~-------- 231 (416)
.... ........||+.|+|||++.+..+. .++||||+||++|+|++|.+||.+.+......++.....
T Consensus 159 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 159 IYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eccC---CcccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 5432 2233456799999999999877764 789999999999999999999998776655554432100
Q ss_pred -------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 232 -------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 232 -------------------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
...+.++..+++|+.+||+.||++|||+.++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0113467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=355.92 Aligned_cols=257 Identities=28% Similarity=0.528 Sum_probs=221.3
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
+.|.+.+.||+|++|.||.|.+..+++.||+|.+....... ......+.+|+.++++++||||+++++++.+....|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46999999999999999999999999999999987543221 2234678999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
||||++|++|.+.+...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987543221111
Q ss_pred -CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhc--CccCCCCCCCHHHHHHH
Q 014909 169 -LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--AEFTCPPWLSFTARKLI 245 (416)
Q Consensus 169 -~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~ll 245 (416)
......|++.|+|||++.+..+ +.++||||+|+++|+|++|+.||...+.......+.. .....|..++..+.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 1134568899999999988765 4899999999999999999999987666554444333 23456667899999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCccc
Q 014909 246 ARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
++||..+|.+|||+.++++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-47 Score=369.15 Aligned_cols=257 Identities=24% Similarity=0.412 Sum_probs=217.1
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
.-++|++.+.||+|+||.||+|.+..++..+|+|++.... .......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 4578999999999999999999999999999999987642 23345678999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~-givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
||||++||+|.+++...+.+++..+..++.|++.||.|||+. +++||||||+|||++.+|.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---- 156 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh----
Confidence 999999999999999888899999999999999999999985 799999999999999999999999999864422
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHh---------------------
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--------------------- 226 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i--------------------- 226 (416)
......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||...........+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 157 SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred hccccCCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 122345789999999999876664 8899999999999999999999865443222111
Q ss_pred -----------------------hcC-ccCCC-CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 227 -----------------------SAA-EFTCP-PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 227 -----------------------~~~-~~~~~-~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
... ....+ ..++.++++||.+||+.||++|||+.|++.||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 000 01111 13578899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-49 Score=408.28 Aligned_cols=264 Identities=31% Similarity=0.532 Sum_probs=236.7
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
.+..-++|++++.||+|+||.|.+++++.+++.||+|++++-...+.....-++.|-.+|..-+.+.|++++..|+++.+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 35667899999999999999999999999999999999988555545556779999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+|+||||++||+|..++.+.+++||+.|++|+..|+-||..||+.|+|||||||+|||||.+|++||+|||.|-.....+
T Consensus 150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999886554321
Q ss_pred CCCCcccccCCcccccchhhcc----CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC--ccCCC--CCC
Q 014909 166 DDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCP--PWL 237 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~----~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~ 237 (416)
.-.....+|||.|+|||++.. .+.+|..+|.||+||++|||+.|..||...+....|.+|... .+.+| ..+
T Consensus 230 -~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~V 308 (1317)
T KOG0612|consen 230 -TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDV 308 (1317)
T ss_pred -cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccccc
Confidence 223456799999999999963 255689999999999999999999999999999999999765 67788 559
Q ss_pred CHHHHHHHHHhcCCCCCCCCC---HhHHhcCcccccC
Q 014909 238 SFTARKLIARILDPNPMTRIT---IPEILEDEWFKKD 271 (416)
Q Consensus 238 s~~~~~ll~~~L~~dP~~R~t---~~eil~h~~~~~~ 271 (416)
|.++++||.+++. +|+.|.. +++|..||||...
T Consensus 309 SeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 309 SEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred CHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 9999999999885 7888888 9999999999864
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=361.20 Aligned_cols=255 Identities=28% Similarity=0.435 Sum_probs=216.4
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+++++.+.+.+..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999987654444445667889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 92 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
|++|++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---Ccc
Confidence 99999999988653 3589999999999999999999999999999999999999999999999999864322 122
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH---HHHH-HhhcCccCCCCCCCHHHHHHH
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---NLYK-KISAAEFTCPPWLSFTARKLI 245 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~---~~~~-~i~~~~~~~~~~~s~~~~~ll 245 (416)
.....||+.|+|||++.+..+. .++||||+||++|+|++|..||...... .... .........+..+++++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 2345799999999999877764 8899999999999999999999864321 1111 112222345566899999999
Q ss_pred HHhcCCCCCCCCC-----HhHHhcCccccc
Q 014909 246 ARILDPNPMTRIT-----IPEILEDEWFKK 270 (416)
Q Consensus 246 ~~~L~~dP~~R~t-----~~eil~h~~~~~ 270 (416)
++||+.||.+||| ++++++||||..
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=374.32 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=211.9
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 83 (416)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 56899999999999999999999999999999999976432 223356788999999999999999999987543
Q ss_pred -CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 84 -~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
...|+||||+.+ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 457999999976 67777653 48899999999999999999999999999999999999999999999999987542
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc------------
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------ 230 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~------------ 230 (416)
. ........||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+....+.++....
T Consensus 178 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 178 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred C---CCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 2 2233456789999999999887775 88999999999999999999998876655444332110
Q ss_pred ----------cC--------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 231 ----------FT--------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 231 ----------~~--------------------~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
.. .+...+..+++||.+||+.||.+|||++++|+||||...+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 326 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 326 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence 00 00113467899999999999999999999999999976443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=372.10 Aligned_cols=258 Identities=26% Similarity=0.444 Sum_probs=211.6
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC----
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK---- 83 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 83 (416)
...++|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 357899999999999999999999999999999999876432 233456788999999999999999999988643
Q ss_pred --CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccc
Q 014909 84 --TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (416)
Q Consensus 84 --~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~ 161 (416)
...|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357999999976 67666643 5889999999999999999999999999999999999999999999999998753
Q ss_pred ccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC------------
Q 014909 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------ 229 (416)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~------------ 229 (416)
.. ........||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 170 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 170 GT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred CC---ccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 22 2233456799999999999887775 8899999999999999999999877654333221100
Q ss_pred ----------c-----cC---------------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 230 ----------E-----FT---------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 230 ----------~-----~~---------------~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
. .. .+...+.++++||.+||+.||++|||+.|+|+||||...+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 0 00 01123567899999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-47 Score=385.16 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=203.8
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCC------CCcceEEEEEEeC
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH------PNVVRLYEVMGSK 83 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~~~ 83 (416)
.++|++.+.||+|+||+||+|.+..+++.||||+++... ........|+.+++.++| ++++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 478999999999999999999999999999999996432 123445667777776654 5588999988764
Q ss_pred -CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCcEEeccCC-------------
Q 014909 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYG------------- 148 (416)
Q Consensus 84 -~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~-~givHrDlkp~NILl~~~~------------- 148 (416)
..+|+|||++ |++|.+++...+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5789999988 67899999888899999999999999999999998 5999999999999998765
Q ss_pred ---CeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHH
Q 014909 149 ---NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK 225 (416)
Q Consensus 149 ---~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~ 225 (416)
.+||+|||++.... ......+||+.|+|||++.+..|. .++|||||||++|+|++|++||.+.+..+....
T Consensus 283 ~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 49999999875321 223456899999999999988775 889999999999999999999987765443332
Q ss_pred hhcCccCCC-----------------------C-------------------CCCHHHHHHHHHhcCCCCCCCCCHhHHh
Q 014909 226 ISAAEFTCP-----------------------P-------------------WLSFTARKLIARILDPNPMTRITIPEIL 263 (416)
Q Consensus 226 i~~~~~~~~-----------------------~-------------------~~s~~~~~ll~~~L~~dP~~R~t~~eil 263 (416)
+......+| + ..++.+.+||.+||+.||.+|||++|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 211100000 0 0135577999999999999999999999
Q ss_pred cCcccccCC
Q 014909 264 EDEWFKKDY 272 (416)
Q Consensus 264 ~h~~~~~~~ 272 (416)
+||||.+.+
T Consensus 437 ~Hp~~~~~~ 445 (467)
T PTZ00284 437 THPYVLKYY 445 (467)
T ss_pred cCccccccC
Confidence 999998754
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=358.49 Aligned_cols=248 Identities=28% Similarity=0.443 Sum_probs=208.6
Q ss_pred EeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014909 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (416)
Q Consensus 19 LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 98 (416)
||+|+||.||++.+..+|+.||+|.+.............+..|+.+++.++||||+++++.+.++...|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765544333345566799999999999999999999999999999999999999
Q ss_pred HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCC
Q 014909 99 FDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (416)
Q Consensus 99 ~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt 176 (416)
.+.+.... .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++..... ........||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---CceeeccCCC
Confidence 98886543 588999999999999999999999999999999999999999999999999875432 1223345789
Q ss_pred cccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch----HHHHHHhhcCccCCC-CCCCHHHHHHHHHhcCC
Q 014909 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFTCP-PWLSFTARKLIARILDP 251 (416)
Q Consensus 177 ~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~----~~~~~~i~~~~~~~~-~~~s~~~~~ll~~~L~~ 251 (416)
+.|+|||++.+..+ +.++||||+||++|+|++|..||..... ..............+ ..++.++++|+++||+.
T Consensus 158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999999988776 4889999999999999999999976432 233333333333322 35799999999999999
Q ss_pred CCCCCCCH----hHHhcCccccc
Q 014909 252 NPMTRITI----PEILEDEWFKK 270 (416)
Q Consensus 252 dP~~R~t~----~eil~h~~~~~ 270 (416)
||.+||++ ++++.||||+.
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcC
Confidence 99999999 67889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=354.97 Aligned_cols=257 Identities=32% Similarity=0.622 Sum_probs=224.0
Q ss_pred CEEE-EeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEE
Q 014909 12 KYEV-GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 12 ~y~~-~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV 89 (416)
-|++ .+.||+|+||.|--+.+..+|..||||++++... ....++.+|++++.+.+ |+||++++++|+++..+|+|
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc---hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 3444 4679999999999999999999999999988632 34678999999999996 99999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCC---eEEeecccccccccccC
Q 014909 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRD 166 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~---vkl~DFGla~~~~~~~~ 166 (416)
||-+.||.|...|.++..++|.+|.++.++|+.||.|||.+||.||||||+|||-...+. +|||||.+..-....++
T Consensus 155 fEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred EecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 999999999999999999999999999999999999999999999999999999976544 89999998764332221
Q ss_pred -----CCCcccccCCcccccchhhc----cCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc---------------hHHH
Q 014909 167 -----DGLLHTTCGTPNYVAPEVLN----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---------------LMNL 222 (416)
Q Consensus 167 -----~~~~~~~~gt~~y~aPEvl~----~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~---------------~~~~ 222 (416)
...+.+.||+..|||||+.. ...++..++|.||||||||.||+|++||.+.. ...+
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 22345779999999999963 22344589999999999999999999996531 4578
Q ss_pred HHHhhcCccCCCC--C--CCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 223 YKKISAAEFTCPP--W--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 223 ~~~i~~~~~~~~~--~--~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
+..|+.+.+.+|. | +|.++++|++.+|..|+.+|.++.++++|||++.-
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 8999999999986 3 89999999999999999999999999999999864
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=361.22 Aligned_cols=257 Identities=27% Similarity=0.457 Sum_probs=215.0
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
.+++|++.+.||.|+||.||+|.+..+++.||+|.+....... ....+.+|+.+++.++||||+++++++..+...|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 5788999999999999999999999999999999987543222 23457789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
||||+++ +|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 82 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~ 158 (301)
T cd07873 82 VFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--T 158 (301)
T ss_pred EEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC--C
Confidence 9999975 888887654 46899999999999999999999999999999999999999999999999998653321 1
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC------------------
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------ 229 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~------------------ 229 (416)
.......+++.|+|||++.+....+.++|||||||++|+|++|++||...+.......+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 22234567899999999876555568999999999999999999999887765443332110
Q ss_pred -ccCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 230 -EFTCP-----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 230 -~~~~~-----------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
....| +.+++.+.+||.+||+.||.+|||++|+++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 00111 246888999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=370.38 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=211.5
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 83 (416)
..++|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 457899999999999999999999999999999999764322 22345677999999999999999999987543
Q ss_pred -CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 84 -~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
..+|++||++ |++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 4579999998 678887765 4679999999999999999999999999999999999999999999999999987542
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc------------
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------ 230 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~------------ 230 (416)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 170 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred C-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 2 23456789999999999875555689999999999999999999998766544333321110
Q ss_pred -----------cCCC--------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 231 -----------FTCP--------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 231 -----------~~~~--------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
...+ ...++.+.+||.+||+.||.+|||+.++++||||.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 0011 125667899999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=359.57 Aligned_cols=251 Identities=30% Similarity=0.464 Sum_probs=205.4
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC---CCCCcceEEEEEEe-----C
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMGS-----K 83 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~-----~ 83 (416)
+|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 6999999999999999999999999999999987543221 1233456777777665 69999999998864 3
Q ss_pred CEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~ 161 (416)
..++++|||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 568999999985 888888763 35899999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-----------
Q 014909 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----------- 230 (416)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~----------- 230 (416)
.. ........||+.|+|||++.+..+. .++||||+||++|+|++|.+||.+.+......++....
T Consensus 159 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SC---QMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cC---cccCCCccccccccCchHhhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 32 1223345789999999999877664 88999999999999999999998776554443332100
Q ss_pred -------c---------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 231 -------F---------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 231 -------~---------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
+ ...+.++..+.+||.+||+.||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0112467789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=356.49 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=220.0
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
.|+..+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+.+|+.++|+||+.+++.+..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999987655444445667889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 92 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
|+++++|.+.+... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---CCc
Confidence 99999998888653 3699999999999999999999999999999999999999999999999999864322 122
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHH----HHHhhcCccCCCCCCCHHHHHHH
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL----YKKISAAEFTCPPWLSFTARKLI 245 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~s~~~~~ll 245 (416)
.....|++.|+|||++.+..+. .++|+||+||++|+|++|..||........ ...+.......++.++.++.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 2345799999999999877664 789999999999999999999987655432 23334444455667899999999
Q ss_pred HHhcCCCCCCCCC-----HhHHhcCcccccC
Q 014909 246 ARILDPNPMTRIT-----IPEILEDEWFKKD 271 (416)
Q Consensus 246 ~~~L~~dP~~R~t-----~~eil~h~~~~~~ 271 (416)
.+||+.||.+||+ +.+++.|+||+..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999 8899999999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=347.01 Aligned_cols=253 Identities=25% Similarity=0.505 Sum_probs=218.6
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CCEEEEEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KTKIFIVL 90 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lV~ 90 (416)
+|++.+.||.|++|.||++.+..+++.||+|.+...... ....+.+.+|+.+++.++|||++++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 599999999999999999999999999999999765432 2235678899999999999999999998764 45689999
Q ss_pred eccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 91 EFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 91 E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
||+++++|.+++... ..+++.++..++.|++.|+++||++|++||||||+||+++.++.++|+|||++...... ..
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~--~~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--CD 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc--CC
Confidence 999999999998763 45899999999999999999999999999999999999999999999999998765332 22
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc-CCCCCCCHHHHHHHHH
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIAR 247 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~ll~~ 247 (416)
......|++.|+|||++.+..+. .++||||+||++|+|++|+.||...+.......+..+.. ..+..+++.+.+|+.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 33456789999999999877664 789999999999999999999988776666555544433 4556789999999999
Q ss_pred hcCCCCCCCCCHhHHhcCccc
Q 014909 248 ILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 248 ~L~~dP~~R~t~~eil~h~~~ 268 (416)
||+.||.+|||+.++++||||
T Consensus 237 ~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=377.74 Aligned_cols=248 Identities=31% Similarity=0.481 Sum_probs=214.4
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-C-----CCcceEEEEEEeCCE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-H-----PNVVRLYEVMGSKTK 85 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h-----pnIv~l~~~~~~~~~ 85 (416)
+|++.+.||+|+||+|-+|.+..|++.||||+++... ....+...|+.+|..|+ | -|+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 8999999999999999999999999999999997643 34677888999999997 4 489999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC--CeEEeeccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG--NLKVSDFGLSALS 161 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~--~vkl~DFGla~~~ 161 (416)
.|||+|.+.. +|+++|+.+. +++...++.+++||+.||.+||..||||+|||||||||...+ .+||+|||.|...
T Consensus 263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999999965 9999999875 689999999999999999999999999999999999997643 6999999998754
Q ss_pred ccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccC---------
Q 014909 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT--------- 232 (416)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~--------- 232 (416)
. ....+.+.+..|+||||+.+.+|+ .+.||||||||++||++|.+.|.+.+..+++..|......
T Consensus 342 ~-----q~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 342 S-----QRVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred C-----CcceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 3 223488899999999999999997 8899999999999999999999999887776665321110
Q ss_pred -------------------------------------------CCCC-----------CCHHHHHHHHHhcCCCCCCCCC
Q 014909 233 -------------------------------------------CPPW-----------LSFTARKLIARILDPNPMTRIT 258 (416)
Q Consensus 233 -------------------------------------------~~~~-----------~s~~~~~ll~~~L~~dP~~R~t 258 (416)
.|+. -...+.+||++||..||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 1100 0234689999999999999999
Q ss_pred HhHHhcCccccc
Q 014909 259 IPEILEDEWFKK 270 (416)
Q Consensus 259 ~~eil~h~~~~~ 270 (416)
..++|+||||..
T Consensus 496 p~qal~Hpfl~~ 507 (586)
T KOG0667|consen 496 PAQALNHPFLTG 507 (586)
T ss_pred HHHHhcCccccc
Confidence 999999999984
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=350.47 Aligned_cols=256 Identities=30% Similarity=0.522 Sum_probs=220.0
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhh------cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL------KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~------~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
+|.+.+.||.|+||.||+|.+..+++.+|+|.+...... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 588999999999999999999888999999988654322 22345678999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
.++||||+++++|.+++...+.+++..+..++.|++.||+|||++|++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999987554211
Q ss_pred CC----CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC-ccCCCCCCCHH
Q 014909 166 DD----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (416)
Q Consensus 166 ~~----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 240 (416)
.. .......|++.|+|||.+.+..+. .++|+|||||++|+|++|+.||...+.......+... ....|..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 11 111234688999999999877664 7899999999999999999999887665444444333 34556678999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 241 ARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
+.++|++||+.||.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=366.80 Aligned_cols=252 Identities=22% Similarity=0.386 Sum_probs=204.9
Q ss_pred ccCEEEEeEEeecCceEEEEEEEC-----CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 83 (416)
-++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 468999999999999999999752 345789999987532 222356788999999999 899999999988654
Q ss_pred -CEEEEEEeccCCCchHHHHHhC---------------------------------------------------------
Q 014909 84 -TKIFIVLEFVTGGELFDKIVNH--------------------------------------------------------- 105 (416)
Q Consensus 84 -~~~~lV~E~~~gg~L~~~i~~~--------------------------------------------------------- 105 (416)
..+|+||||+++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999998753
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCCcccc
Q 014909 106 -----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180 (416)
Q Consensus 106 -----~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 180 (416)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...............+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 237778889999999999999999999999999999999999999999999987543211111122334567899
Q ss_pred cchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHH-HHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 014909 181 APEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN-LYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRI 257 (416)
Q Consensus 181 aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~-~~~~i~~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~ 257 (416)
|||++.+..+. .++|||||||++|+|++ |..||.+..... ....+..+ ....|...++++.+|+.+||+.||.+||
T Consensus 244 aPE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 244 APESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred CcHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 99999877764 88999999999999997 999998765433 33333333 3445667899999999999999999999
Q ss_pred CHhHHhc
Q 014909 258 TIPEILE 264 (416)
Q Consensus 258 t~~eil~ 264 (416)
|+.++++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=350.49 Aligned_cols=253 Identities=28% Similarity=0.567 Sum_probs=224.6
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999987665554567889999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcc
Q 014909 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (416)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 171 (416)
|+.|++|.+++....++++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++..... .....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~---~~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC---Ccccc
Confidence 999999999998877899999999999999999999999999999999999999999999999999875432 22334
Q ss_pred cccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch---HHHHHHhhcCccCCCCCCCHHHHHHHHHh
Q 014909 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---MNLYKKISAAEFTCPPWLSFTARKLIARI 248 (416)
Q Consensus 172 ~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~s~~~~~ll~~~ 248 (416)
...|+..|+|||++.+..+ +.++|+||||+++|+|++|..||...+. ..............|+.++..+.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 5678899999999987665 4889999999999999999999987763 33333333355667778899999999999
Q ss_pred cCCCCCCCCCH--hHHhcCccc
Q 014909 249 LDPNPMTRITI--PEILEDEWF 268 (416)
Q Consensus 249 L~~dP~~R~t~--~eil~h~~~ 268 (416)
|..||.+||++ +|+++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-46 Score=352.49 Aligned_cols=253 Identities=29% Similarity=0.459 Sum_probs=209.4
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
+|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++.++...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999999999999999875432 22234678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 92 FVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 92 ~~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
|++ ++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.+|.+||+|||++...... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VR 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--cc
Confidence 998 4888887643 46899999999999999999999999999999999999999999999999998754321 12
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC------------------c
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------E 230 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~------------------~ 230 (416)
......+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 2234567899999999876554458899999999999999999999876543222111000 0
Q ss_pred -----------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 231 -----------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 231 -----------~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
......+++++.+||++||+.||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00122368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=361.54 Aligned_cols=261 Identities=31% Similarity=0.473 Sum_probs=233.8
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
++.....|+.-+.||+|+||.|+-++.+.||+.||.|.+++..+..........+|-.+|.+++.+.||.+-..|++++.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 45566778899999999999999999999999999999998887776666778899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
+++||..|+||+|.-+|-..+ .++|..+++|+.+|+.||++||+.+||+|||||+|||+|+.|+++|+|+|+|....
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~- 338 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP- 338 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC-
Confidence 999999999999988888776 79999999999999999999999999999999999999999999999999998543
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch----HHHHHHhhcCccCCCCCCCH
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFTCPPWLSF 239 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~ 239 (416)
........+||..|||||++.+..|+ ...|.|||||+||+|+.|+.||..... .+.-+.+.......|..+|+
T Consensus 339 --~g~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ 415 (591)
T KOG0986|consen 339 --EGKPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSE 415 (591)
T ss_pred --CCCccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCH
Confidence 34455666999999999999988875 888999999999999999999976433 24445566666778889999
Q ss_pred HHHHHHHHhcCCCCCCCCC-----HhHHhcCccccc
Q 014909 240 TARKLIARILDPNPMTRIT-----IPEILEDEWFKK 270 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t-----~~eil~h~~~~~ 270 (416)
++++|.+.+|.+||.+|.. ++++.+||||+.
T Consensus 416 eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 416 EAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 9999999999999999985 679999999986
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=360.29 Aligned_cols=247 Identities=27% Similarity=0.431 Sum_probs=194.6
Q ss_pred EeEEeecCceEEEEEEEC--CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCEEEEEEe
Q 014909 16 GRTIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLE 91 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E 91 (416)
++.||+|+||.||+|.+. .+++.||+|.+..... ...+.+|+.+|+.++||||+++++++.+ ...+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999975 3678899999865432 3456789999999999999999999854 567899999
Q ss_pred ccCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEe----ccCCCeEEeecccc
Q 014909 92 FVTGGELFDKIVNH---------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLS 158 (416)
Q Consensus 92 ~~~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl----~~~~~vkl~DFGla 158 (416)
|+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9965 888877532 258999999999999999999999999999999999999 45678999999999
Q ss_pred cccccccC-CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH---------HHHHHhhc
Q 014909 159 ALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---------NLYKKISA 228 (416)
Q Consensus 159 ~~~~~~~~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~---------~~~~~i~~ 228 (416)
........ .......+||+.|+|||++.+....+.++||||+||++|+|++|++||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 76533211 122345678999999999987655568999999999999999999999643310 11111100
Q ss_pred ----------------------------CccCC----------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 229 ----------------------------AEFTC----------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 229 ----------------------------~~~~~----------~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
..... ....+.++.+||++||+.||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00000 01135678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=355.38 Aligned_cols=254 Identities=25% Similarity=0.424 Sum_probs=215.6
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||+|+||.||+|.+..++..+|+|.+.... ......++.+|+.++++++||||+++++.+.+++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 46999999999999999999999999999999987542 2334567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~-~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
||++|++|.+++...+.+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++..... ..
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----cc
Confidence 999999999999988889999999999999999999998 5999999999999999999999999998864322 22
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC--------------------
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------------------- 229 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~-------------------- 229 (416)
....+|++.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 345678999999999877665 47899999999999999999999765543332222111
Q ss_pred -----------------ccCCCC-CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 230 -----------------EFTCPP-WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 230 -----------------~~~~~~-~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
....|. .++.++.+|+.+||..||++|||+.++++||||.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 011111 257889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=353.88 Aligned_cols=259 Identities=32% Similarity=0.619 Sum_probs=222.8
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
.+|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+.+++..|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999998765444445677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC----
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~---- 166 (416)
||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999998763211000
Q ss_pred ---------CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC---
Q 014909 167 ---------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--- 234 (416)
Q Consensus 167 ---------~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~--- 234 (416)
........|+..|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+.......+.......|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 001112467889999999887666 5889999999999999999999998877777776655543333
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCC---HhHHhcCccccc
Q 014909 235 PWLSFTARKLIARILDPNPMTRIT---IPEILEDEWFKK 270 (416)
Q Consensus 235 ~~~s~~~~~ll~~~L~~dP~~R~t---~~eil~h~~~~~ 270 (416)
..++.++.++|++||+.||++||+ +.++++||||..
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 247899999999999999999998 799999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=356.14 Aligned_cols=260 Identities=32% Similarity=0.552 Sum_probs=225.5
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 37999999999999999999999999999999998766554445678999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC-
Q 014909 91 EFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD- 167 (416)
Q Consensus 91 E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~- 167 (416)
||+.|++|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 56899999999999999999999999999999999999999999999999997643221100
Q ss_pred --------------------------CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHH
Q 014909 168 --------------------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 221 (416)
Q Consensus 168 --------------------------~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~ 221 (416)
.......||..|+|||++.+..+ +.++||||||+++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 01123468889999999987766 488999999999999999999999888777
Q ss_pred HHHHhhcCccCCCCC--CCHHHHHHHHHhcCCCCCCCCC----HhHHhcCcccccC
Q 014909 222 LYKKISAAEFTCPPW--LSFTARKLIARILDPNPMTRIT----IPEILEDEWFKKD 271 (416)
Q Consensus 222 ~~~~i~~~~~~~~~~--~s~~~~~ll~~~L~~dP~~R~t----~~eil~h~~~~~~ 271 (416)
.+..+.......+.. ++..+.++|.+||..||++||| +++++.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 777666555555544 6899999999999999999999 9999999999863
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=342.60 Aligned_cols=253 Identities=29% Similarity=0.480 Sum_probs=221.5
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
.|++.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++.++||||+++++.+.+.+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 488999999999999999999999999999999765433 3345778899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 92 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
|++|++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNF 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--cch
Confidence 99999999999774 57899999999999999999999999999999999999999999999999998754332 122
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccC-CCCCCCHHHHHHHHHh
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARI 248 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~ll~~~ 248 (416)
....+|++.|+|||++.+..+. .++|+|||||++++|++|+.||...+.......+...... .+..++.++.+++.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 3445789999999999877764 8899999999999999999999988877766666555433 3446889999999999
Q ss_pred cCCCCCCCCCHhHHhcCccc
Q 014909 249 LDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 249 L~~dP~~R~t~~eil~h~~~ 268 (416)
|+.+|++||++.++++|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=346.45 Aligned_cols=255 Identities=27% Similarity=0.473 Sum_probs=216.7
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhh---hcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV---LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
+|++.+.||.|+||.||+|.+ .+++.+|+|.+..... ........+.+|+.+++.++|+||+++++++.+....|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999987 4788999999875432 122334678999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc---
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR--- 165 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~--- 165 (416)
+|||++|++|.+++.+.+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987542211
Q ss_pred -CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC---ccCCCCCCCHHH
Q 014909 166 -DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTA 241 (416)
Q Consensus 166 -~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~ 241 (416)
.........|+..|+|||++.+..+. .++|||||||++|+|++|..||...+.......+... ....+..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 11223345789999999999877664 8899999999999999999999876554433333222 234566689999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 242 RKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
.++|++||+.+|.+||++.++++||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=354.29 Aligned_cols=253 Identities=33% Similarity=0.529 Sum_probs=208.9
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
+|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+....|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 58999999999999999999999999999999976432 22234567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 92 FVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 92 ~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
|+.+ +|.+++.. .+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...... ....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 156 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VRCY 156 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC--CCCc
Confidence 9975 78777765 467999999999999999999999999999999999999999999999999998754321 1222
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCC-CCCchHHHHHHhhcC----------------c---
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAA----------------E--- 230 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf-~~~~~~~~~~~i~~~----------------~--- 230 (416)
....+++.|+|||++.+....+.++|||||||++|+|++|..|| .+.+....+..+... .
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 34567899999999877554468999999999999999998885 444433333322110 0
Q ss_pred c----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 231 F----------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 231 ~----------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
. ...+.+++++.+||.+||+.||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112368899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=348.83 Aligned_cols=255 Identities=30% Similarity=0.478 Sum_probs=212.7
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999999875432 2223456789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
||++++.|...+.....+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc--ccc
Confidence 999998888877777789999999999999999999999999999999999999999999999999987543321 122
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC---------------c----c
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---------------E----F 231 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~---------------~----~ 231 (416)
....++..|+|||++.+....+.++||||+|+++|+|++|..||.+.+..+....+... . .
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 33467889999999876554468899999999999999999999876654332222110 0 0
Q ss_pred CCC------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 232 TCP------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 232 ~~~------------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
..| +.++..+.+|+.+||+.||++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 001 2357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=368.62 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=207.6
Q ss_pred ccCEEEEeEEeecCceEEEEEEEC--CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
-.+|++++.||.|+||.||+|... .++..||+|.+.... ...+|+.+|+.++||||+++++++......|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 357999999999999999999764 356789999886432 3458999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
+|||++. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 9999996 589999977788999999999999999999999999999999999999999999999999998754432222
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH---HHHHHhhc----------------
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---NLYKKISA---------------- 228 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~---~~~~~i~~---------------- 228 (416)
.......||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.... ..+..+..
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred ccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 223356799999999999887775 7899999999999999999999764321 11111100
Q ss_pred -------------CccCCCC-----CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 229 -------------AEFTCPP-----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 229 -------------~~~~~~~-----~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
..+..|+ .++.++.+||++||..||++|||+.++|.||||.+.
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0011111 246788999999999999999999999999999864
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=347.67 Aligned_cols=254 Identities=30% Similarity=0.421 Sum_probs=212.6
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+++|+.+++.++||||+++++.+......|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 34679999999999999999999999999999999875432 123568899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~ 161 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--IA 161 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc--cc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998754321 11
Q ss_pred CcccccCCcccccchhhcc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC-----CCCCHHH
Q 014909 169 LLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP-----PWLSFTA 241 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~--~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~~~ 241 (416)
......|++.|+|||.+.. ....+.++||||+||++|+|++|..||...........+....+..+ ..++..+
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence 1234578899999999853 22224789999999999999999999976544333323322222222 2367899
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCcc
Q 014909 242 RKLIARILDPNPMTRITIPEILEDEW 267 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h~~ 267 (416)
.+||++||..||++|||+++|++|+|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=351.34 Aligned_cols=260 Identities=28% Similarity=0.485 Sum_probs=221.3
Q ss_pred cccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
.++....+|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+....
T Consensus 14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 3456678999999999999999999999999999999998765432 2466889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
..|+||||++|++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 99999999999999998865 56899999999999999999999999999999999999999999999999988753321
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC---ccCCCCCCCHHH
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTA 241 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~ 241 (416)
........|++.|+|||.+.+..+ +.++||||+||++|+|++|+.||...+.......+... ....+..++..+
T Consensus 170 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (296)
T cd06654 170 --QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (296)
T ss_pred --ccccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHH
Confidence 112234578999999999987666 48899999999999999999999877654333222222 223355688999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
.+|+.+||..||.+|||+.++++||||...
T Consensus 247 ~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=346.13 Aligned_cols=257 Identities=31% Similarity=0.520 Sum_probs=215.8
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhh-------cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-------KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~-------~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
+|.+.+.||.|+||.||+|.+..+|+.+|+|.+...... .....+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 689999999999999999999989999999988643221 1123467889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
..++||||++|++|.+++...+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998754332
Q ss_pred cCCCCcccccCCcccccchhhccCC-CCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC--ccCCCC----CC
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPP----WL 237 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~-~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~--~~~~~~----~~ 237 (416)
..........|+..|+|||++.... ..+.++|+||||+++|+|++|..||...........+... ...++. .+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 2222233457889999999987654 2357899999999999999999999766554433332221 222232 35
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 238 SFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 238 s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
+.++.++|.+||.++|++|||++++++|||+
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=349.20 Aligned_cols=253 Identities=30% Similarity=0.457 Sum_probs=213.2
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+...+..|+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 34689999999999999999999999999999999875432 224567889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
||||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~ 161 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IA 161 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--cc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999998654321 11
Q ss_pred CcccccCCcccccchhhc---cCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC-----CCCCHH
Q 014909 169 LLHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP-----PWLSFT 240 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~---~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~~ 240 (416)
......|++.|+|||++. ...+ +.++|+||+||++|+|++|..||...................+ ..++..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred ccccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 223457899999999984 2334 4789999999999999999999976544333222222222222 236788
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCcc
Q 014909 241 ARKLIARILDPNPMTRITIPEILEDEW 267 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~eil~h~~ 267 (416)
+.+++.+||..||++|||++++++|||
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=345.81 Aligned_cols=248 Identities=35% Similarity=0.688 Sum_probs=220.2
Q ss_pred EeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014909 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (416)
Q Consensus 19 LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 98 (416)
||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.++...|++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999876655555567899999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCCcc
Q 014909 99 FDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178 (416)
Q Consensus 99 ~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 178 (416)
.+++.+...+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++....... ......|++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 9999888889999999999999999999999999999999999999999999999999987543321 2234578999
Q ss_pred cccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc--hHHHHHHhh--cCccCCCCCCCHHHHHHHHHhcCCCCC
Q 014909 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN--LMNLYKKIS--AAEFTCPPWLSFTARKLIARILDPNPM 254 (416)
Q Consensus 179 y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~--~~~~~~~i~--~~~~~~~~~~s~~~~~ll~~~L~~dP~ 254 (416)
|+|||.+.+..++ .++|+||+|+++|+|++|..||.... ....+..+. ......|...+.++.++|.+||..||+
T Consensus 158 ~~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999998876664 78999999999999999999998776 556666655 445667777899999999999999999
Q ss_pred CCCC-----HhHHhcCccccc
Q 014909 255 TRIT-----IPEILEDEWFKK 270 (416)
Q Consensus 255 ~R~t-----~~eil~h~~~~~ 270 (416)
+||+ ++|+++||||+.
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHHhcChhhhC
Confidence 9999 999999999975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=343.76 Aligned_cols=256 Identities=30% Similarity=0.491 Sum_probs=218.8
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||.|+||.||+|.+..++..+|+|++....... ....+.+|+.+++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999997654322 4678999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 91 EFVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 91 E~~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
|+++|++|.+.+... ..+++..+..++.||+.||+|||++|++||||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 45899999999999999999999999999999999999999999999999998765432222
Q ss_pred --CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc-CCC-----CCCCH
Q 014909 168 --GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCP-----PWLSF 239 (416)
Q Consensus 168 --~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~-~~~-----~~~s~ 239 (416)
.......|+..|+|||++......+.++|+|||||++|+|++|+.||...+....+.+...... ..+ ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 1234457899999999988763445889999999999999999999988766655554433322 111 24678
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 240 TARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
.+.+++.+||..||++|||+.++++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=350.35 Aligned_cols=257 Identities=32% Similarity=0.467 Sum_probs=219.7
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
.++|++.+.||.|+||.||+|.+..+++.+|+|++.... ....+.+.+|+.+++.++||||+++++.+.++...|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 357999999999999999999998899999999986542 33456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
|||+++++|.+++... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~ 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQ 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc--cc
Confidence 9999999999998764 46999999999999999999999999999999999999999999999999987643321 11
Q ss_pred CcccccCCcccccchhhccC----CCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc---cCCCCCCCHHH
Q 014909 169 LLHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTA 241 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~----~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~ 241 (416)
......|++.|+|||++... ...+.++|||||||++|+|++|++||...+......++.... ...|..++.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 22345789999999998532 122468999999999999999999998877666665655443 23455688999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
.++|.+||+.+|.+||++.++++||||...
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=375.33 Aligned_cols=254 Identities=29% Similarity=0.478 Sum_probs=224.7
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
.|.|+..||.|+||+||+|.++.++-.-|.|+|... .....+.+.-||.||..++||+||++++.|.-.+.+|++.|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 588999999999999999999999888899998643 34457888899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 92 FVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 92 ~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
||.||-....+.. ...+++++++.+.+|++.||.|||+++|+|||||..|||++-+|.++|+|||.+..... .-..-
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkR 187 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKR 187 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--HHhhh
Confidence 9999998877665 45799999999999999999999999999999999999999999999999999764222 12234
Q ss_pred ccccCCcccccchhhc-----cCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccC---CCCCCCHHHH
Q 014909 171 HTTCGTPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT---CPPWLSFTAR 242 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~-----~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~---~~~~~s~~~~ 242 (416)
++..|||+||||||+. ..+|+ .++||||||++|.+|..+.+|...-+.+..+.+|....++ -|..++..+.
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~ 266 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFS 266 (1187)
T ss_pred ccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHH
Confidence 6789999999999974 46776 8999999999999999999999999999888888766543 3667899999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 243 KLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
|||.+||.+||..||++.++++||||...
T Consensus 267 DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 267 DFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 99999999999999999999999999853
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=350.08 Aligned_cols=258 Identities=29% Similarity=0.489 Sum_probs=221.0
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
.+....+|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+.....
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDE 90 (296)
T ss_pred cCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCce
Confidence 34455679999999999999999999999999999999875432 234678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+|+|+||+++++|..++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~- 168 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE- 168 (296)
T ss_pred EEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc-
Confidence 9999999999999998865 46899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC---ccCCCCCCCHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTAR 242 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~ 242 (416)
........|++.|+|||.+.+..+. .++|||||||++|+|++|+.||...+.......+... ....+..+++.+.
T Consensus 169 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (296)
T cd06655 169 -QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFR 246 (296)
T ss_pred -cccCCCcCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHH
Confidence 1122345789999999999876664 7899999999999999999999887765444333322 2234556889999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 243 KLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
+||++||..||.+|||+.++++||||+.
T Consensus 247 ~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 247 DFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred HHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 9999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=357.52 Aligned_cols=254 Identities=24% Similarity=0.398 Sum_probs=206.2
Q ss_pred EEeEEeec--CceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014909 15 VGRTIGEG--TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (416)
Q Consensus 15 ~~~~LG~G--~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (416)
+++.||+| +|++||++.++.+|+.||+|.++..... ......+++|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 7899999999999999999999765432 33456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC----
Q 014909 93 VTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (416)
Q Consensus 93 ~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~---- 166 (416)
+++|+|.+++..+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999999998753 4589999999999999999999999999999999999999999999999986432211110
Q ss_pred -CCCcccccCCcccccchhhccC--CCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccC-----------
Q 014909 167 -DGLLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT----------- 232 (416)
Q Consensus 167 -~~~~~~~~gt~~y~aPEvl~~~--~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~----------- 232 (416)
........++..|+|||++.+. .+ +.++||||+||++|+|++|+.||..............+..+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred cccccccccceecccChHHhhcccCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 1112234577889999999763 34 58899999999999999999999865443322221111100
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 233 -----------------------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 233 -----------------------------------~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
....+++.+.+||++||+.||++|||++++++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 01124678999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=356.25 Aligned_cols=261 Identities=31% Similarity=0.561 Sum_probs=240.1
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 85 (416)
..+..+|.++..||+|+||+|-+|..+.+.+.||||+++++-+.+.+..+--..|-++|... +-|.+++++..|++-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 56778899999999999999999999999999999999988777666666666777888776 47899999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+|+||||+.||+|.-.|+.-+++.|..|..|+..|+-||-+||++||++||||.+||++|.+|++||+|||+++. ...
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE--ni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc--ccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999863 333
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll 245 (416)
......+.||||.|+|||++..++|. ..+|.||+||+||||++|++||++.+..++++.|......+|..+|.++.++.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYg-ksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAIC 581 (683)
T ss_pred CCcceeeecCCCcccccceEEecccc-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHH
Confidence 44456788999999999999999984 89999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCH-----hHHhcCccccc
Q 014909 246 ARILDPNPMTRITI-----PEILEDEWFKK 270 (416)
Q Consensus 246 ~~~L~~dP~~R~t~-----~eil~h~~~~~ 270 (416)
+..|.+.|.+|... ++|..||||+.
T Consensus 582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 582 KGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHhhcCCccccCCCCccccchhhCcchhh
Confidence 99999999999853 68999999985
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=347.20 Aligned_cols=255 Identities=31% Similarity=0.498 Sum_probs=215.1
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
+|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 599999999999999999999999999999999765432 2345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 92 FVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 92 ~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
|+ +++|.+++.. ...+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........ ...
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccc
Confidence 99 9999998865 35699999999999999999999999999999999999999999999999999876543211 223
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC-------------------cc
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------------------EF 231 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~-------------------~~ 231 (416)
....|+..|+|||++.+....+.++||||+||++|+|++|.+||.+.+....+..+... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 45678999999999876655568999999999999999999999876655444332210 00
Q ss_pred C-----------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 014909 232 T-----------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (416)
Q Consensus 232 ~-----------~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~ 269 (416)
. ..+..+..+.+||++||+.||.+|||+++++.||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 0123568899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=348.11 Aligned_cols=257 Identities=34% Similarity=0.657 Sum_probs=229.4
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV 89 (416)
.+|++.+.||+|+||.||+|.+..+++.||+|++.++..........+.+|+.++++++ ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998766555555678899999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC--
Q 014909 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-- 167 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~-- 167 (416)
|||+++++|.+.+...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999999999998889999999999999999999999999999999999999999999999999998755432211
Q ss_pred ----------------CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc
Q 014909 168 ----------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 231 (416)
Q Consensus 168 ----------------~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~ 231 (416)
.......|+..|+|||++....+ +.++||||||++++++++|..||...+....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 12233467899999999887655 4789999999999999999999998887777777777777
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCH----hHHhcCccc
Q 014909 232 TCPPWLSFTARKLIARILDPNPMTRITI----PEILEDEWF 268 (416)
Q Consensus 232 ~~~~~~s~~~~~ll~~~L~~dP~~R~t~----~eil~h~~~ 268 (416)
..|..+++.+.+||.+||+.||.+|||+ +++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 8888899999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=350.17 Aligned_cols=255 Identities=29% Similarity=0.462 Sum_probs=215.0
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... ...+.+.+|+.+++.++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999999899999999986544322 34567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
||++++.|.........+++..+..++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++...... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC--cccc
Confidence 99999998887777667999999999999999999999999999999999999999999999999998754332 1223
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-------------------c
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-------------------F 231 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~-------------------~ 231 (416)
....++..|+|||++.+....+.++||||+|+++|+|++|.+||...+.......+.... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 345688999999998765555688999999999999999999998766443333222100 0
Q ss_pred ------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 232 ------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 232 ------------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
..++.++..+.+|+.+||+.+|++||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0123468889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=349.90 Aligned_cols=261 Identities=33% Similarity=0.480 Sum_probs=218.1
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhh--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+|++.+.||.|+||.||+|.+..+++.||||.+...... .......+..|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999989999999999765433 122345677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 90 LEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
|||+ +++|.+++.... .+++..+..++.||++||.|||++|++|+||+|+||+++.+|.++|+|||++...... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP--NR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC--Cc
Confidence 9999 889999998766 7999999999999999999999999999999999999999999999999998754332 12
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc------------------
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------------ 230 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~------------------ 230 (416)
......+++.|+|||.+.+....+.++||||+||++|+|++|.+||.+.+....+.++....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 22334578899999998665445689999999999999999999998776554444432110
Q ss_pred -----cC-----CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCCCC
Q 014909 231 -----FT-----CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275 (416)
Q Consensus 231 -----~~-----~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~~ 275 (416)
.. .....+..+.+||.+||+.||++|||+.+++.||||.....+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 00 0122467899999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=348.72 Aligned_cols=240 Identities=16% Similarity=0.244 Sum_probs=209.2
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CCEEEEEEec
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----KTKIFIVLEF 92 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~ 92 (416)
..||+|++|.||+|.. +|+.||||.+...........+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999998 688999999987654444456788999999999999999999999876 4578999999
Q ss_pred cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcc
Q 014909 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (416)
Q Consensus 93 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~-givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 171 (416)
++||+|.+++...+.+++.....++.|++.||.|||+. +++||||||+|||+++++.+||+|||++..... ...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~-----~~~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS-----PPF 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc-----ccc
Confidence 99999999999888899999999999999999999984 999999999999999999999999999875422 123
Q ss_pred cccCCcccccchhhcc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhc--CccCCCCCCCHHHHHHHHH
Q 014909 172 TTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--AEFTCPPWLSFTARKLIAR 247 (416)
Q Consensus 172 ~~~gt~~y~aPEvl~~--~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~ll~~ 247 (416)
...||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+....+..+.. ..+..|...++.+.+|+.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4568999999999976 445 5899999999999999999999998887777776643 3445565789999999999
Q ss_pred hcCCCCCCCCCHhHHhc
Q 014909 248 ILDPNPMTRITIPEILE 264 (416)
Q Consensus 248 ~L~~dP~~R~t~~eil~ 264 (416)
||+.||++|||+.++++
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 99999999999999985
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=348.29 Aligned_cols=249 Identities=30% Similarity=0.464 Sum_probs=205.3
Q ss_pred EEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHH---hcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014909 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM---KLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (416)
Q Consensus 18 ~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 94 (416)
.||+|+||.||++.+..+++.+|+|.+.+.............+|..++ ...+||||+.+++.+...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999999765443322223334444433 34479999999999999999999999999
Q ss_pred CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCccccc
Q 014909 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (416)
Q Consensus 95 gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 174 (416)
||+|.+++...+.+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||++...... ......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----CccCcC
Confidence 9999999988889999999999999999999999999999999999999999999999999998643321 223457
Q ss_pred CCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch---HHHHHHhhcCccCCCCCCCHHHHHHHHHhcCC
Q 014909 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---MNLYKKISAAEFTCPPWLSFTARKLIARILDP 251 (416)
Q Consensus 175 gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~ 251 (416)
||+.|+|||.+......+.++||||+||++|+|++|..||..... ..............|+.++.++.++|++||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 999999999986433335889999999999999999999975432 22222222334456777899999999999999
Q ss_pred CCCCCC-----CHhHHhcCccccc
Q 014909 252 NPMTRI-----TIPEILEDEWFKK 270 (416)
Q Consensus 252 dP~~R~-----t~~eil~h~~~~~ 270 (416)
||.+|+ |+.++++||||+.
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccC
Confidence 999999 6999999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=345.53 Aligned_cols=257 Identities=26% Similarity=0.481 Sum_probs=216.6
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhh---hcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV---LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
+|+..+.||+|+||.||+|.+..+++.||+|++..... ......+.+++|+.++++++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 48889999999999999999999999999999975432 122345789999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC-CeEEeecccccccccccC-
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRD- 166 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~~- 166 (416)
||||++|++|.+++...+++++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998876 599999999865433211
Q ss_pred -CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHH---Hhh--cCccCCCCCCCHH
Q 014909 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK---KIS--AAEFTCPPWLSFT 240 (416)
Q Consensus 167 -~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~---~i~--~~~~~~~~~~s~~ 240 (416)
........||..|+|||++.+..+. .++||||+|+++|+|++|..||.......... .+. ......|+.++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 1112234688999999999876664 78999999999999999999997554322222 221 2234456678999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 014909 241 ARKLIARILDPNPMTRITIPEILEDEWFK 269 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~eil~h~~~~ 269 (416)
+.+++.+||..+|++|||+.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=339.99 Aligned_cols=253 Identities=30% Similarity=0.596 Sum_probs=220.2
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
+|++.+.||+|+||.||.+.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++.+......|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 699999999999999999999999999999999765432 2235678999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 92 FVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 92 ~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
|+++++|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--EL 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hh
Confidence 999999999987643 57899999999999999999999999999999999999999999999999987543211 11
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc-CCCCCCCHHHHHHHHHh
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARI 248 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~ll~~~ 248 (416)
.....|++.|+|||++.+..+. .++|+|||||++|+|++|..||...+.......+..+.. ..+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCCC-CccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 2234688999999999876654 789999999999999999999988877777666655543 35566899999999999
Q ss_pred cCCCCCCCCCHhHHhcCccc
Q 014909 249 LDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 249 L~~dP~~R~t~~eil~h~~~ 268 (416)
|+.+|++||++.++++||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=347.21 Aligned_cols=255 Identities=29% Similarity=0.489 Sum_probs=216.5
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (416)
|++.+.||+|+||.||+|.+..++..+|+|.+.... ....+.+.+|+.+++.++||||+++++.+......|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 788899999999999999999999999999986543 23356788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcc
Q 014909 93 VTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (416)
Q Consensus 93 ~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 171 (416)
+++++|...+.. ..++++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...... .....
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 161 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRD 161 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc--ccccc
Confidence 999999887765 457999999999999999999999999999999999999999999999999998643221 12234
Q ss_pred cccCCcccccchhhcc-----CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc---cCCCCCCCHHHHH
Q 014909 172 TTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARK 243 (416)
Q Consensus 172 ~~~gt~~y~aPEvl~~-----~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~ 243 (416)
...|++.|+|||++.. ..+ +.++||||+||++|+|++|.+||...+.......+.... ...|..++.++.+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD 240 (282)
T ss_pred cccccccccCHhhccccCCCCCCC-CccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence 4578999999999842 223 468999999999999999999998877655555443332 2345568899999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 244 LIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
||.+||+.||.+||++.++++||||.....
T Consensus 241 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 241 FLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred HHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 999999999999999999999999987543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=350.53 Aligned_cols=258 Identities=29% Similarity=0.481 Sum_probs=219.4
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
+....+|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+......
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 45668999999999999999999999999999999999754322 246688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+||||++|++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~-- 168 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 168 (297)
T ss_pred EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC--
Confidence 999999999999998865 56899999999999999999999999999999999999999999999999998654321
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC---ccCCCCCCCHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARK 243 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~ 243 (416)
........|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+... ....|..++..+.+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD 247 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHH
Confidence 112234578999999999987666 48899999999999999999999876543332222211 12234567889999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 244 LIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
|+.+||..||++||+++++++||||...
T Consensus 248 li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhccc
Confidence 9999999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=341.07 Aligned_cols=257 Identities=28% Similarity=0.528 Sum_probs=215.6
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhh--hcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKI 86 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 86 (416)
..|++.+.||+|+||.||.|.+..++..||||.+..... ......+.+.+|+.+++.++||||+++++.+.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 479999999999999999999999999999999864321 122345788999999999999999999998866 3578
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|++|||++|++|.+++...+.+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 89999999999999998888899999999999999999999999999999999999999999999999999875432211
Q ss_pred -CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC--ccCCCCCCCHHHHH
Q 014909 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARK 243 (416)
Q Consensus 167 -~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~ 243 (416)
........|+..|+|||++.+..+ +.++|||||||++|+|++|+.||...........+... ....|+.++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 112234568999999999987666 48899999999999999999999876554444433322 23345667889999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCcccc
Q 014909 244 LIARILDPNPMTRITIPEILEDEWFK 269 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~h~~~~ 269 (416)
+|++|+. +|++||+++++++|||++
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=339.39 Aligned_cols=251 Identities=31% Similarity=0.473 Sum_probs=216.2
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||.|+||.||+|.+..+++.+|+|++...... ..+.+.+|+.+++.++||||+++++.+.+...+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 5799999999999999999999989999999999765322 4578899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 91 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AK 157 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hc
Confidence 999999999998876 789999999999999999999999999999999999999999999999999987543311 12
Q ss_pred cccccCCcccccchhhccC---CCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccC-----CCCCCCHHH
Q 014909 170 LHTTCGTPNYVAPEVLNDR---GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-----CPPWLSFTA 241 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~---~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~s~~~ 241 (416)
.....|+..|+|||.+... .++ .++|+|||||++|+|++|..||...+.......+....+. .+..++.++
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF 236 (262)
T ss_pred cccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence 2345788999999998765 554 7899999999999999999999887655444444333222 223357889
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCcc
Q 014909 242 RKLIARILDPNPMTRITIPEILEDEW 267 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h~~ 267 (416)
.+|+++||..||..|||+.+++.|+|
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 237 HDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=386.76 Aligned_cols=262 Identities=29% Similarity=0.463 Sum_probs=217.0
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--C
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--K 83 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~ 83 (416)
....+++|++++.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+|+.++|||||++++++.+ .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 456788999999999999999999999999999999999765433 3345778899999999999999999998854 4
Q ss_pred CEEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-------CcEeecCCCCcEEecc------
Q 014909 84 TKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSR-------GVYHRDLKPENLLLDA------ 146 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~~-------givHrDlkp~NILl~~------ 146 (416)
..+|+||||+++|+|.++|.. .+.+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 679999999999999998875 35799999999999999999999985 4999999999999964
Q ss_pred -----------CCCeEEeecccccccccccCCCCcccccCCcccccchhhccC-CCCCChhhHHHHHHHHHHHhhCCCCC
Q 014909 147 -----------YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPF 214 (416)
Q Consensus 147 -----------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~-~~~~~~~DIwSlGvil~~ml~G~~Pf 214 (416)
.+.+||+|||++..... .......+||+.|+|||++.+. ...+.++||||||||||+|++|..||
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 23489999999875432 2233456799999999998643 23358999999999999999999999
Q ss_pred CCCchH-HHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 215 DDSNLM-NLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 215 ~~~~~~-~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
...+.. .+...+........+..+.++.+||.+||..+|.+||++.++|.|||+...
T Consensus 244 ~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 244 HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 865544 333344333222234578999999999999999999999999999999744
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=345.13 Aligned_cols=250 Identities=23% Similarity=0.385 Sum_probs=210.3
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++.+......++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36889999999999999999999999999999987542 2234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
||+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++..... ...
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~ 150 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIA 150 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----ccc
Confidence 99999988654 4578999999999999999999999999999999999999999999999999875422 223
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch-------HHHHHHhhcCc-cCC-CCCCCHHH
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-------MNLYKKISAAE-FTC-PPWLSFTA 241 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~-------~~~~~~i~~~~-~~~-~~~~s~~~ 241 (416)
...+||+.|+|||++.+..+ +.++|+||+||++|+|++|..||..... ......+.... ... ....++++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229 (279)
T ss_pred cCCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence 45689999999999987766 4889999999999999999999965321 12222222221 111 23478899
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
.+|+.+||+.||.+||+++++++||||...
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=342.08 Aligned_cols=256 Identities=27% Similarity=0.497 Sum_probs=214.9
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhh--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCEEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--KHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKIF 87 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~ 87 (416)
.|++.+.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++.+.. ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 689999999999999999999999999999998754321 22345678999999999999999999998865 46789
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc-C
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR-D 166 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-~ 166 (416)
++|||+++++|.+.+...+.+++.....++.|++.||+|||++|++||||||+||+++.++.+||+|||++....... .
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 999999999999999888889999999999999999999999999999999999999999999999999987543211 1
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhc--CccCCCCCCCHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--AEFTCPPWLSFTARKL 244 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~l 244 (416)
........|+..|+|||.+.+..+. .++||||+||++|+|++|+.||...........+.. ....+|..+++.+++|
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241 (266)
T ss_pred CCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence 1122335688999999999876654 789999999999999999999987655544433322 2344566788999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCcccc
Q 014909 245 IARILDPNPMTRITIPEILEDEWFK 269 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~h~~~~ 269 (416)
+ +||..+|++||+++++++||||+
T Consensus 242 i-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 242 L-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred H-HHhcCChhhCcCHHHHhcCcccc
Confidence 9 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=346.47 Aligned_cols=248 Identities=31% Similarity=0.479 Sum_probs=213.1
Q ss_pred EeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014909 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (416)
Q Consensus 19 LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 98 (416)
||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++.+...+..|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999875544444455677899999999999999999999999999999999999999
Q ss_pred HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCC
Q 014909 99 FDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (416)
Q Consensus 99 ~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt 176 (416)
.+++.... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..... ........++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 99998766 799999999999999999999999999999999999999999999999999875432 2222345678
Q ss_pred cccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch----HHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCC
Q 014909 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252 (416)
Q Consensus 177 ~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~d 252 (416)
..|+|||++.+..+ +.++||||+||++|+|++|+.||..... ..+...+.......|+.+++.+.++|++||+.|
T Consensus 158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 89999999987665 4789999999999999999999976543 233333333445566678999999999999999
Q ss_pred CCCCC-----CHhHHhcCccccc
Q 014909 253 PMTRI-----TIPEILEDEWFKK 270 (416)
Q Consensus 253 P~~R~-----t~~eil~h~~~~~ 270 (416)
|.+|| ++.+++.||||..
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhc
Confidence 99999 8888999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=346.63 Aligned_cols=250 Identities=30% Similarity=0.458 Sum_probs=209.0
Q ss_pred EEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHH---HHHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014909 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE---VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (416)
Q Consensus 18 ~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E---i~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 94 (416)
.||+|+||.||+|.+..+++.||+|++.+..............| +..++...||||+++++.+.+.+..|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999986543322222223333 344555689999999999999999999999999
Q ss_pred CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCccccc
Q 014909 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (416)
Q Consensus 95 gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 174 (416)
||+|.+++...+.+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||++..... ......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~----~~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc----cCCcCcC
Confidence 999999998888899999999999999999999999999999999999999999999999999864432 1223557
Q ss_pred CCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCC---chHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCC
Q 014909 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251 (416)
Q Consensus 175 gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~ 251 (416)
|++.|+|||++.+....+.++||||+||++|+|++|..||... ........+.......|..+|.++.+++.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 9999999999975433358899999999999999999999876 3334444444445666777899999999999999
Q ss_pred CCCCCC-----CHhHHhcCcccccC
Q 014909 252 NPMTRI-----TIPEILEDEWFKKD 271 (416)
Q Consensus 252 dP~~R~-----t~~eil~h~~~~~~ 271 (416)
+|.+|| ++.++++||||+..
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccCC
Confidence 999999 99999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=368.72 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=204.9
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
..+|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+.+|++++|||||++++++......++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 457999999999999999999999999999999632 12356899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
||++. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 99996 5888888664 469999999999999999999999999999999999999999999999999987654322222
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCC--------chHHHHHHhhcCcc---------
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS--------NLMNLYKKISAAEF--------- 231 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~--------~~~~~~~~i~~~~~--------- 231 (416)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|..|+... ....+.+.+.....
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 23346799999999999887775 8999999999999999987654321 11222222222111
Q ss_pred --------------------CCCCC-----CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 232 --------------------TCPPW-----LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 232 --------------------~~~~~-----~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
..+.| ++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 11112 4568999999999999999999999999999974
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=344.14 Aligned_cols=253 Identities=28% Similarity=0.426 Sum_probs=211.2
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe-----
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS----- 82 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----- 82 (416)
.-+.|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++++ +||||+++++.+..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 45789999999999999999999999999999999875431 235678899999998 69999999999865
Q ss_pred -CCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 83 -KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 83 -~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
...+|++|||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||++++++.++|+|||++.
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 34689999999999999998864 368999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCCcccccCCcccccchhhcc-----CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc--cC
Q 014909 160 LSQQVRDDGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FT 232 (416)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~-----~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~--~~ 232 (416)
..... ........|++.|+|||++.. ..+ +.++||||+||++|+|++|..||...........+.... ..
T Consensus 160 ~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06637 160 QLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 236 (272)
T ss_pred ecccc--cccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC
Confidence 54321 122345679999999999863 234 478999999999999999999998665544433332221 12
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 233 CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 233 ~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
.+..++.++.+|+.+||..||.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 233478899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=346.72 Aligned_cols=254 Identities=30% Similarity=0.490 Sum_probs=216.1
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
+.|++.+.||.|+||.||+|.+..+++.+|+|++.... ....+.+.+|+.+++.++||||+++++.+..+..+|+||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 67999999999999999999999999999999987542 334677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 91 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
||++|++|...+.. ...+++..+..++.||+.|+.|||++|++||||||+||+++.++.+||+|||++...... ...
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~ 166 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQR 166 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc--ccc
Confidence 99999999887754 457899999999999999999999999999999999999999999999999987643221 112
Q ss_pred cccccCCcccccchhhcc-----CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc---cCCCCCCCHHH
Q 014909 170 LHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTA 241 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~-----~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~ 241 (416)
.....+++.|+|||++.+ ..+ +.++|||||||++|+|++|..||...+......++.... ...+..++.++
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF 245 (292)
T ss_pred cceecCCccccCceeeccccccCCCC-CchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHH
Confidence 234568899999999853 223 468999999999999999999998776655554443332 23345678899
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 242 RKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.+||.+||..||++||+++++++||||..
T Consensus 246 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 246 RDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred HHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 99999999999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=344.58 Aligned_cols=255 Identities=27% Similarity=0.488 Sum_probs=220.8
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++.+.+....|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 478999999999999999999999999999999976532 223567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
||+++++|.+++... ++++..+..++.|++.|+.|||++|++|+||+|+||++++++.++|+|||++....... ...
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~ 155 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKR 155 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--ccc
Confidence 999999999998865 89999999999999999999999999999999999999999999999999987654321 122
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-cCCCCC-CCHHHHHHHHHh
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPW-LSFTARKLIARI 248 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~-~s~~~~~ll~~~ 248 (416)
....|++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+.... ...+.. ++.++.+++.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence 34578899999999987775 489999999999999999999998776655555444432 233344 788999999999
Q ss_pred cCCCCCCCCCHhHHhcCcccccC
Q 014909 249 LDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 249 L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
|..||++|||++++++||||.+.
T Consensus 235 l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 235 LNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred hhCChhhCcCHHHHhhChhhcCC
Confidence 99999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=349.95 Aligned_cols=261 Identities=32% Similarity=0.443 Sum_probs=215.3
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKI 86 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 86 (416)
.+++|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.++++++||||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 5788999999999999999999999999999999987543222 2234466899999999999999999998654 578
Q ss_pred EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
|+||||+.+ +|.+.+.. ...+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999975 78887765 3578999999999999999999999999999999999999999999999999987654321
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC----------------
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---------------- 229 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~---------------- 229 (416)
.......+++.|+|||++.+....+.++||||+||++|+|++|.+||.+.+....+..+...
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 163 --KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred --CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 12233346788999999876554468899999999999999999999988776655544321
Q ss_pred ---ccCC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 230 ---EFTC-----------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 230 ---~~~~-----------~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
.+.. ..+.++++.+||.+||+.||++|||+++++.||||+...-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 0111 1235889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=345.74 Aligned_cols=254 Identities=22% Similarity=0.368 Sum_probs=216.6
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCC-----CeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETG-----EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
.+++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 4678999999999999999999876554 679999986443 233456789999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC
Q 014909 84 TKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~ 147 (416)
...|++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 9999999999999999999764 457888999999999999999999999999999999999999
Q ss_pred CCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHh
Q 014909 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (416)
Q Consensus 148 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i 226 (416)
+.++|+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..+....+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999998754322222223345678899999999876664 88999999999999998 99999988877777776
Q ss_pred hcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 227 SAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 227 ~~~~-~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.... ...|..++.++.+|+.+||+.||.+||++.+|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5543 34566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=336.24 Aligned_cols=253 Identities=30% Similarity=0.541 Sum_probs=221.7
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
+|++.+.||.|+||.||.+++..+++.+++|.+....... .....+.+|+.++++++||||+++++++.+....+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999987654333 345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 92 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
|+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SM 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--cc
Confidence 99999999999775 468999999999999999999999999999999999999999999999999987543322 12
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccC-CCCCCCHHHHHHHHHh
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARI 248 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~ll~~~ 248 (416)
.....|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+.......+..+... .++.++.++.+++.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 3456789999999999876654 7899999999999999999999988777777666555443 3455789999999999
Q ss_pred cCCCCCCCCCHhHHhcCccc
Q 014909 249 LDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 249 L~~dP~~R~t~~eil~h~~~ 268 (416)
|..+|.+||++.++++|||+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=345.02 Aligned_cols=255 Identities=29% Similarity=0.488 Sum_probs=207.8
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
.+++|++.+.||+|++|.||+|.+..+++.||||.+....... ....+.+|+.+++.++||||+++++++.+....|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 5689999999999999999999999899999999987543221 22446689999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
||||+.+ +|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~ 157 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--S 157 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC--C
Confidence 9999985 899888764 46899999999999999999999999999999999999999999999999998643221 1
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc-hHHHHHHhhcC-----------------
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAA----------------- 229 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~-~~~~~~~i~~~----------------- 229 (416)
.......+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.. .......+...
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 112234578899999998765444588999999999999999999997655 22222211100
Q ss_pred --c--cC---------CCCCCC--HHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 230 --E--FT---------CPPWLS--FTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 230 --~--~~---------~~~~~s--~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
. .. ..+.++ .++.+++.+||+.||++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 00 001234 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=337.33 Aligned_cols=254 Identities=28% Similarity=0.494 Sum_probs=218.8
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhh--hcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+|+..+.||+|+||.||+|.+..+++.||+|.+..... ......+.+.+|+.+++.++||||+++++++.+....|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 58888999999999999999988899999999875432 1233457789999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
|||+++++|.+++...+.+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence 9999999999999888889999999999999999999999999999999999999999999999999987543221 2
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhc--CccCCCCCCCHHHHHHHHH
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--AEFTCPPWLSFTARKLIAR 247 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~ll~~ 247 (416)
.....|++.|+|||.+......+.++|+||+||++|+|++|..||...........+.. .....|+.+++++.+++++
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 34567899999999987655235889999999999999999999987665444333332 2334566789999999999
Q ss_pred hcCCCCCCCCCHhHHhcCccc
Q 014909 248 ILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 248 ~L~~dP~~R~t~~eil~h~~~ 268 (416)
||+.+|.+||++.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=343.38 Aligned_cols=260 Identities=28% Similarity=0.423 Sum_probs=215.6
Q ss_pred ccccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 014909 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS 82 (416)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 82 (416)
..++...++|++.+.||+|+||.||+|.+..+++.+|+|++..... ....+.+|+.+++++ +|||++++++++..
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 4566778999999999999999999999999999999999865321 235677899999998 79999999999865
Q ss_pred C-----CEEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEe
Q 014909 83 K-----TKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (416)
Q Consensus 83 ~-----~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~ 153 (416)
. ...|+||||++|++|.+++.. ...+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence 3 468999999999999998753 4578999999999999999999999999999999999999999999999
Q ss_pred ecccccccccccCCCCcccccCCcccccchhhccCC----CCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC
Q 014909 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG----YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 229 (416)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~----~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~ 229 (416)
|||++....... .......|+..|+|||++.... ..+.++|||||||++|+|++|+.||...........+...
T Consensus 171 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 248 (291)
T cd06639 171 DFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN 248 (291)
T ss_pred ecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC
Confidence 999987543211 1123456899999999986432 1257899999999999999999999876655444444333
Q ss_pred c---cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 014909 230 E---FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (416)
Q Consensus 230 ~---~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~ 269 (416)
. ...+...+..+.+||.+||+.||++||++.++++||||+
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2 223445678899999999999999999999999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=359.21 Aligned_cols=247 Identities=28% Similarity=0.408 Sum_probs=200.1
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
..+|++.+.||+|+||.||+|.+..++..||+|+.... ....|+.+++.++||||+++++++......|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 35799999999999999999999999999999985432 234689999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 90 LEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
|||+.+ +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 136 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~ 211 (357)
T PHA03209 136 LPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---AP 211 (357)
T ss_pred EEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cc
Confidence 999965 88888765 45799999999999999999999999999999999999999999999999999864322 12
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCC-CCCCCCchH----------HHHHHhhcC---ccCCC
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY-LPFDDSNLM----------NLYKKISAA---EFTCP 234 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~-~Pf~~~~~~----------~~~~~i~~~---~~~~~ 234 (416)
......||+.|+|||++.+..+. .++||||+||++|+|+++. .+|...... .+...+... ...+|
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 23346799999999999887775 8899999999999999854 444432110 111111100 00011
Q ss_pred ------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 235 ------------------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 235 ------------------------------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
..++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 124667888999999999999999999999999974
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=346.40 Aligned_cols=256 Identities=25% Similarity=0.434 Sum_probs=216.6
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.++++++||||+++++.+...+..|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 46899999999999999999999999999999986532 2233567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 91 EFVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 91 E~~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~al~~LH~-~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
||++|++|..++... ..+++..+..++.||+.||.|||+ .|++||||||+||+++.++.+||+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--- 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence 999999998888763 379999999999999999999997 5999999999999999999999999999864321
Q ss_pred CCCcccccCCcccccchhhccCCC-----CCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHH---hhc-CccCCCCCC
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGY-----DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK---ISA-AEFTCPPWL 237 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~-----~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~---i~~-~~~~~~~~~ 237 (416)
.......|++.|+|||.+.+... .+.++|||||||++|+|++|..||........... +.. .....|+.+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 156 -SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred -CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 22344578899999999865332 25789999999999999999999976554443332 222 234556668
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 238 s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
+.++.+||.+||+.+|++||++++++.||||....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=348.34 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=204.5
Q ss_pred ccCEEEEeEEeecCceEEEEEEECC----------------CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCc
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSE----------------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~----------------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 73 (416)
-++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++++++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence 4689999999999999999998532 34479999987543 23345678899999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEe
Q 014909 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-------------------RMKEDEARRYFQQLINAVDYCHSRGVYH 134 (416)
Q Consensus 74 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-------------------~l~e~~~~~~~~qll~al~~LH~~givH 134 (416)
+++++++.+.+..|+||||+++|+|.+++.... .++...+..++.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999886532 3567788999999999999999999999
Q ss_pred ecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh--CCC
Q 014909 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA--GYL 212 (416)
Q Consensus 135 rDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~--G~~ 212 (416)
|||||+|||++.++.+||+|||++................++..|+|||++....+ +.++|||||||++|+|++ |..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999875432211112233456788999999987666 489999999999999986 678
Q ss_pred CCCCCchHHHHHHhhc--------CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHh
Q 014909 213 PFDDSNLMNLYKKISA--------AEFTCPPWLSFTARKLIARILDPNPMTRITIPEIL 263 (416)
Q Consensus 213 Pf~~~~~~~~~~~i~~--------~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil 263 (416)
||...+.......+.. .....|+.++..+.+|+.+||+.||.+|||+.+|.
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 8887665544433211 12234566889999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=341.26 Aligned_cols=256 Identities=31% Similarity=0.471 Sum_probs=213.4
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC-
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT- 84 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~- 84 (416)
+...++|++.+.||+|++|.||+|.+..+++.+|+|++..... ..+.+.+|+.+++++ +||||+++++.+....
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 3456899999999999999999999998999999999876432 246788999999999 6999999999986544
Q ss_pred -----EEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeec
Q 014909 85 -----KIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (416)
Q Consensus 85 -----~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DF 155 (416)
.+|+||||+++++|.+++.. +..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCC
Confidence 58999999999999998865 357999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCcccccCCcccccchhhccCC----CCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-
Q 014909 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG----YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE- 230 (416)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~----~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~- 230 (416)
|++...... ........|++.|+|||++.... ..+.++|||||||++|+|++|..||...........+....
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 235 (275)
T cd06608 158 GVSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP 235 (275)
T ss_pred ccceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC
Confidence 998754321 12234457899999999985422 22478999999999999999999998765554444443332
Q ss_pred --cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 231 --FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 231 --~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
...+..++.++++||.+||..||++|||+.++++|||+
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 12223367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=337.03 Aligned_cols=249 Identities=31% Similarity=0.556 Sum_probs=216.5
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
+|++.+.||.|+||.||++.+..+++.||+|.++.... ....+.+.+|+.+++.++||||+++++.+.+...+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999875432 2245778899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 92 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
|+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||++++++.++|+|||++...... ...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAY 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--ccc
Confidence 99999999988653 45899999999999999999999999999999999999999999999999998754332 112
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc-CCCCCCCHHHHHHHHHh
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARI 248 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~ll~~~ 248 (416)
.....|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.. ..|..++..+.+||.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 234568999999999987666 4889999999999999999999998887777666655544 35566899999999999
Q ss_pred cCCCCCCCCCHhHHhcC
Q 014909 249 LDPNPMTRITIPEILED 265 (416)
Q Consensus 249 L~~dP~~R~t~~eil~h 265 (416)
|+.||++|||+.+++.-
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=362.09 Aligned_cols=253 Identities=22% Similarity=0.356 Sum_probs=206.8
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCC-----CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS 82 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 82 (416)
..++|++++.||+|+||.||+|++... +..||+|++..... ......+.+|+.+++.+ +||||+++++.+..
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 345799999999999999999986443 35799999975432 22356788999999999 89999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhC---------------------------------------------------------
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNH--------------------------------------------------------- 105 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~--------------------------------------------------------- 105 (416)
....|+||||+++|+|.+++...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 99999999999999999988642
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCccc
Q 014909 106 -------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 172 (416)
Q Consensus 106 -------------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 172 (416)
.++++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||++..............
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 2467888999999999999999999999999999999999999999999999875432211111122
Q ss_pred ccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHH-HHhhcC-ccCCCCCCCHHHHHHHHHhc
Q 014909 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLY-KKISAA-EFTCPPWLSFTARKLIARIL 249 (416)
Q Consensus 173 ~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~-~~i~~~-~~~~~~~~s~~~~~ll~~~L 249 (416)
..+++.|+|||++.+..+. .++|||||||++|+|++ |+.||........+ ..+..+ ....|.+.++++.+++.+||
T Consensus 274 ~~~~~~y~aPE~~~~~~~~-~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 352 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCW 352 (374)
T ss_pred CCCccceeCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHc
Confidence 3355679999999876664 89999999999999997 99999876544333 223222 34566778999999999999
Q ss_pred CCCCCCCCCHhHHhc
Q 014909 250 DPNPMTRITIPEILE 264 (416)
Q Consensus 250 ~~dP~~R~t~~eil~ 264 (416)
+.||.+|||+.++++
T Consensus 353 ~~dp~~RPs~~~l~~ 367 (374)
T cd05106 353 NLEPTERPTFSQISQ 367 (374)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=335.75 Aligned_cols=252 Identities=30% Similarity=0.508 Sum_probs=219.0
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
+|++.+.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++.+......++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 6999999999999999999999999999999998654333 345779999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC-CeEEeecccccccccccCCC
Q 014909 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 92 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~~~~ 168 (416)
|++|++|.+++... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .+||+|||++..... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~---~~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KS 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC---Cc
Confidence 99999999999764 3589999999999999999999999999999999999998654 579999999875432 12
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHHHH
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIAR 247 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll~~ 247 (416)
......|++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+.......+... ....+..++.++.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 2234578999999999987665 47899999999999999999999988776666655444 334566789999999999
Q ss_pred hcCCCCCCCCCHhHHhcCccc
Q 014909 248 ILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 248 ~L~~dP~~R~t~~eil~h~~~ 268 (416)
||..||++|||+.++++||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=344.68 Aligned_cols=256 Identities=32% Similarity=0.497 Sum_probs=215.7
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 479999999999999999999999999999999875432 2334577899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
||++++.+.........+++..+..++.||+.||.|||++|++|+||+|+||++++++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 9999977777676667799999999999999999999999999999999999999999999999999876543221 133
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC---------------------
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------------------- 229 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~--------------------- 229 (416)
....+++.|+|||++.+....+.++||||+|+++|+|++|..||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 44678899999999987734458999999999999999999999876554333222110
Q ss_pred c-----------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 230 E-----------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 230 ~-----------~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
. ...+..++.++.+||++||..+|++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 01233458899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=337.01 Aligned_cols=256 Identities=31% Similarity=0.557 Sum_probs=217.9
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++...+.+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 699999999999999999999989999999999866543 3457889999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC-C-
Q 014909 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-L- 169 (416)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~-~- 169 (416)
|+++++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 99999999999887789999999999999999999999999999999999999999999999999987654322111 1
Q ss_pred cccccCCcccccchhhccCC--CCCChhhHHHHHHHHHHHhhCCCCCCCCch-HHHHHHhh-cCccCCCCCC--CHHHHH
Q 014909 170 LHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKIS-AAEFTCPPWL--SFTARK 243 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~--~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~-~~~~~~i~-~~~~~~~~~~--s~~~~~ 243 (416)
.....+++.|+|||++.+.. ..+.++||||+|+++|+|++|..||..... ......+. ......|.+. ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 22457889999999997654 135789999999999999999999976532 22222222 2234455554 899999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 244 LIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
||.+||+.+|.+|||+.+++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=340.25 Aligned_cols=251 Identities=34% Similarity=0.649 Sum_probs=221.2
Q ss_pred EeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014909 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (416)
Q Consensus 19 LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 98 (416)
||.|+||.||++.+..+|+.+|+|++...........+.+.+|+.++++++||||+++++.+......|++|||++|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999989999999999876554445678899999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC------CCCccc
Q 014909 99 FDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD------DGLLHT 172 (416)
Q Consensus 99 ~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~------~~~~~~ 172 (416)
.+++...+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 99998878899999999999999999999999999999999999999999999999999875432211 112234
Q ss_pred ccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCC--CHHHHHHHHHhcC
Q 014909 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL--SFTARKLIARILD 250 (416)
Q Consensus 173 ~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--s~~~~~ll~~~L~ 250 (416)
..++..|+|||.+....+ +.++||||||+++|+|++|..||........+..+..+....|... +..+.+++++||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 568889999999987665 4789999999999999999999998888887877776666666655 8999999999999
Q ss_pred CCCCCCCCH---hHHhcCccccc
Q 014909 251 PNPMTRITI---PEILEDEWFKK 270 (416)
Q Consensus 251 ~dP~~R~t~---~eil~h~~~~~ 270 (416)
.+|++|||+ .++++||||+.
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=354.40 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=212.0
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 83 (416)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 46789999999999999999999999999999999865432 233456678899999999999999999988643
Q ss_pred -CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 84 -~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
...|+||||+.+ +|.+.+... +++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999975 888877654 8999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc------------
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------ 230 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~------------ 230 (416)
. ........|++.|+|||++.+..+. .++|||||||++|+|++|+.||...+....+.++....
T Consensus 170 ~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred C---CCCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 2223445689999999999887775 88999999999999999999998766444333321100
Q ss_pred ----------c--------------CC-------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 231 ----------F--------------TC-------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 231 ----------~--------------~~-------~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
. .. +...+..+++||.+||+.||++|||+.|+|.||||+.++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 0 00 11235578999999999999999999999999999876654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=344.97 Aligned_cols=253 Identities=30% Similarity=0.486 Sum_probs=210.0
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
.|++.+.||.|++|.||+|.+..+|+.||||.+..... .......+.+|+.++++++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999999875432 22234578899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 92 FVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 92 ~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
|+. ++|.+++.. ...+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--ccc
Confidence 996 588888865 356899999999999999999999999999999999999999999999999998754321 122
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC------------------cc
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------EF 231 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~------------------~~ 231 (416)
.....+++.|+|||++.+....+.++|||||||++|+|++|+.||...+......++... ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 234467889999999877665568899999999999999999999876654332221110 00
Q ss_pred C-----------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 232 T-----------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 232 ~-----------~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
. ..+.++++++++|.+||+.||++|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0 112367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=359.00 Aligned_cols=263 Identities=27% Similarity=0.426 Sum_probs=215.7
Q ss_pred cccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC
Q 014909 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSK 83 (416)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 83 (416)
.+...-..|++.+.||+|+.++||++...+. +.||+|.+.... .+......+.+||.+|.+|+ |.+||++|++-..+
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d 432 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD 432 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence 3456667899999999999999999998654 456666554433 34556888999999999996 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRM-KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l-~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
+.+|+||||-+ .+|...|...... +....+.|+.|++.|+.++|.+||||.||||.|+|+-+ |.+||+|||+|....
T Consensus 433 ~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 433 GYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred ceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 99999999875 4899988876654 44689999999999999999999999999999999966 899999999998776
Q ss_pred cccCCCCcccccCCcccccchhhccCCCC----------CChhhHHHHHHHHHHHhhCCCCCCCCc-hHHHHHHhhcC--
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYD----------GSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAA-- 229 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~----------~~~~DIwSlGvil~~ml~G~~Pf~~~~-~~~~~~~i~~~-- 229 (416)
....+-...+.+||+.|||||.+....+. +.++||||||||||+|+.|++||..-. ...-+..|...
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~ 590 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNH 590 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCc
Confidence 65555566788999999999999754432 578999999999999999999997532 22333344433
Q ss_pred ccCCCCCCCHH-HHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 230 EFTCPPWLSFT-ARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 230 ~~~~~~~~s~~-~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
++.+|..-+.. +.++++.||..||++|||+.++|+|||+...
T Consensus 591 ~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 591 EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 33555544433 9999999999999999999999999999753
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=358.73 Aligned_cols=240 Identities=27% Similarity=0.459 Sum_probs=210.4
Q ss_pred EEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEecc
Q 014909 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV 93 (416)
Q Consensus 14 ~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 93 (416)
++++.||+|-||+||+|.... ...||+|.+...... .+.+.+|+.+|++|+|+|||++++++..+..+||||||+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHhcCCccceEEEEEEcC-CCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 456789999999999999854 347999998754322 356779999999999999999999999988999999999
Q ss_pred CCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcc
Q 014909 94 TGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (416)
Q Consensus 94 ~gg~L~~~i~~--~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 171 (416)
+.|+|.+++.. ...+...+...++.||++||+||+++++|||||-..||||++++.+||+|||+|+... ++...
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~----d~~Y~ 359 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG----DDEYT 359 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC----CCcee
Confidence 99999999997 4568999999999999999999999999999999999999999999999999998322 22222
Q ss_pred cccC---CcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHHH
Q 014909 172 TTCG---TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIA 246 (416)
Q Consensus 172 ~~~g---t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll~ 246 (416)
...| ...|.|||.+....+. .+||||||||+|+||+| |+.||.+.+..+....+..+ ..+.|+.+|+++.+++.
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~ 438 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMK 438 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHH
Confidence 2222 3579999999988875 89999999999999998 99999999999999998877 57888999999999999
Q ss_pred HhcCCCCCCCCCHhHHh
Q 014909 247 RILDPNPMTRITIPEIL 263 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil 263 (416)
.||..+|++|||++.+.
T Consensus 439 ~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 439 SCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHhhCCcccCCCHHHHH
Confidence 99999999999998664
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=346.87 Aligned_cols=261 Identities=28% Similarity=0.398 Sum_probs=209.6
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT- 84 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 84 (416)
....+++|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.++++++||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 456788999999999999999999999999999999998654322 222345678999999999999999999986543
Q ss_pred -------EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecc
Q 014909 85 -------KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (416)
Q Consensus 85 -------~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFG 156 (416)
..|+||||+.+ +|.+.+... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 86 PYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred cccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCC
Confidence 46999999975 787777654 378999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCC--CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc---
Q 014909 157 LSALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF--- 231 (416)
Q Consensus 157 la~~~~~~~~~--~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~--- 231 (416)
++......... .......++..|+|||.+.+....+.++||||+|+++|+|++|..||.+.+.......+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 98754332211 1223446788999999987654445889999999999999999999987665433322211000
Q ss_pred ----------------CCC-------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 232 ----------------TCP-------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 232 ----------------~~~-------------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
..| ...+..+.+||.+||..||.+|||++++++||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 001 1135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=335.99 Aligned_cols=253 Identities=34% Similarity=0.577 Sum_probs=219.3
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE--eCCEEEEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG--SKTKIFIV 89 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lV 89 (416)
+|++.+.||.|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++.+. .....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 589999999999999999999999999999998765432 334577889999999999999999999775 35678999
Q ss_pred EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCcEeecCCCCcEEeccCCCeEEeecccccc
Q 014909 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCH-----SRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH-----~~givHrDlkp~NILl~~~~~vkl~DFGla~~ 160 (416)
|||+++++|.+++.. ..++++..++.++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999876 357899999999999999999999 99999999999999999999999999999886
Q ss_pred cccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc-CCCCCCCH
Q 014909 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSF 239 (416)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~ 239 (416)
..... .......|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.....+.+..+.. ..+..++.
T Consensus 160 ~~~~~--~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 160 LGHDS--SFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred ccCCc--ccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 54321 11334578999999999987665 4889999999999999999999998877777777665544 45566889
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 240 TARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
.+.+++.+||+.+|++|||+.+|++|||+
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=349.59 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=193.2
Q ss_pred EeEEeecCceEEEEEEECC--CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE--eCCEEEEEEe
Q 014909 16 GRTIGEGTFAKVKFARNSE--TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG--SKTKIFIVLE 91 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lV~E 91 (416)
+..||+|+||.||+|.+.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++. ....+|+|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 4679999999999999754 567899999865432 345778999999999999999999884 4567899999
Q ss_pred ccCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEe----ccCCCeEEeecccc
Q 014909 92 FVTGGELFDKIVNH---------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLS 158 (416)
Q Consensus 92 ~~~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl----~~~~~vkl~DFGla 158 (416)
|+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9875 787777532 248899999999999999999999999999999999999 45678999999999
Q ss_pred cccccccC-CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH---------HHHHHhhc
Q 014909 159 ALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---------NLYKKISA 228 (416)
Q Consensus 159 ~~~~~~~~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~---------~~~~~i~~ 228 (416)
........ ........||+.|+|||++.+....+.++||||+||++|+|++|.+||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 76533211 112334578999999999987655568999999999999999999999753211 00000000
Q ss_pred ----------------------------Ccc----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 229 ----------------------------AEF----------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 229 ----------------------------~~~----------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
... ......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=336.73 Aligned_cols=250 Identities=28% Similarity=0.487 Sum_probs=215.7
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||.|+||.||+|.+..+++.+|+|.+..... .+.+.+|+.+++.++||||+++++.+.+....|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 579999999999999999999998899999999875432 577999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 91 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....... ..
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~ 155 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AK 155 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--cc
Confidence 99999999999875 4568999999999999999999999999999999999999999999999999987543321 12
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC---ccCCCCCCCHHHHHHHH
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIA 246 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~ll~ 246 (416)
.....|+..|+|||++.+..++ .++||||+|+++|+|++|+.||...+.......+... ....+..++.++.+++.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred cccccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence 2345588999999999877664 8899999999999999999999876654433333221 22334457889999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccc
Q 014909 247 RILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~h~~~ 268 (416)
+||+.||++|||+.++++||||
T Consensus 235 ~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=341.02 Aligned_cols=249 Identities=31% Similarity=0.526 Sum_probs=205.6
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC--CEEEEE
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSK--TKIFIV 89 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~lV 89 (416)
|++.+.||+|+||.||+|.+..+++.||+|.+.+..... ......+|+.+++++. ||||+++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL--EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc--hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 788999999999999999999999999999987543221 1223457888898885 99999999999887 889999
Q ss_pred EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
|||+.+ +|.+.+... ..+++..+..++.|++.||+|||++|++||||+|+||+++. +.+||+|||++..... ..
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~---~~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS---KP 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc---CC
Confidence 999975 888887763 57899999999999999999999999999999999999999 9999999999875432 12
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC------------------c
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------E 230 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~------------------~ 230 (416)
......+++.|+|||++....+.+.++||||+||++|+|++|..||.+.+..+....+... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 2234568899999998766555568999999999999999999999887655443333210 1
Q ss_pred cCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 231 FTCP-----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 231 ~~~~-----------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
+..| +.++.++.+||.+||++||++|||++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111 2367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=338.41 Aligned_cols=251 Identities=20% Similarity=0.295 Sum_probs=211.3
Q ss_pred ccCEEEEeEEeecCceEEEEEEEC---CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
..+|++.+.||+|+||.||+|.+. ..+..||+|.+..... ......+.+|+.+++.++||||+++++++..++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 467999999999999999999765 3467899999876432 23356788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+|++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999998774 578999999999999999999999999999999999999999999999999865432111
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (416)
........++..|+|||++.+..+. .++||||+||++|++++ |..||.+.+.......+..+ ..+.|..++..+.+
T Consensus 162 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd05064 162 -IYTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ 239 (266)
T ss_pred -hhcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 0111123456789999999877664 89999999999999775 99999988877777766554 33456668999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhc
Q 014909 244 LIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~ 264 (416)
++.+||+.+|.+||++++|++
T Consensus 240 li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 240 LMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=345.85 Aligned_cols=256 Identities=32% Similarity=0.420 Sum_probs=213.7
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKI 86 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 86 (416)
.+++|++.+.||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.++++++||||+++++++... ...
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 357899999999999999999999999999999999765432 22345677899999999999999999998877 899
Q ss_pred EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
|+||||+.+ +|.+.+.... .+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999999985 8988887644 58999999999999999999999999999999999999999999999999987544321
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc---------------
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--------------- 230 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~--------------- 230 (416)
.......+++.|+|||.+.+....+.++||||+|+++|+|++|..||...+......++....
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 161 --KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred --cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 223345678899999998765555688999999999999999999998776655444332110
Q ss_pred ----------------cCCCCC-CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 231 ----------------FTCPPW-LSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 231 ----------------~~~~~~-~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
..++.. +++.+.+||++||+.||++|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 112222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=337.37 Aligned_cols=247 Identities=34% Similarity=0.596 Sum_probs=210.5
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHH-hcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (416)
+.||.|+||.||+|.+..+++.||+|++.+...........+..|..++ ...+|||++++++++...+.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999765433333334445555544 455899999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 99999998888899999999999999999999999999999999999999999999999998864322 234568
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCC----CCCCCHHHHHHHHHhcCC
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----PPWLSFTARKLIARILDP 251 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~----~~~~s~~~~~ll~~~L~~ 251 (416)
++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+....+..+....... +..++.++.+++.+||+.
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 899999999987765 589999999999999999999999888777776665544332 235789999999999999
Q ss_pred CCCCCC---CHhHHhcCccccc
Q 014909 252 NPMTRI---TIPEILEDEWFKK 270 (416)
Q Consensus 252 dP~~R~---t~~eil~h~~~~~ 270 (416)
||++|| +++|++.||||.+
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhc
Confidence 999999 4579999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=359.29 Aligned_cols=252 Identities=22% Similarity=0.386 Sum_probs=206.3
Q ss_pred cCEEEEeEEeecCceEEEEEEE-----CCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 014909 11 GKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 84 (416)
++|++++.||+|+||.||+|.. ..++..||+|++..... ....+.+.+|+.+++.+ +||||+++++++.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 4799999999999999999974 34567899999865432 22356788999999999 8999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCC----------------------------------------------------------
Q 014909 85 KIFIVLEFVTGGELFDKIVNHG---------------------------------------------------------- 106 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~---------------------------------------------------------- 106 (416)
..|+||||++||+|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999986432
Q ss_pred -----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 107 -----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 107 -----------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 367788899999999999999999999999999999999999999999999875433211111
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchH-HHHHHhhcC-ccCCCCCCCHHHHHHHH
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM-NLYKKISAA-EFTCPPWLSFTARKLIA 246 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~-~~~~~i~~~-~~~~~~~~s~~~~~ll~ 246 (416)
.....++..|+|||++.+..+. .++|||||||++|+|++ |..||...... ...+.+..+ ....|...+.++.+|+.
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 351 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMK 351 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHH
Confidence 1223456679999999877764 88999999999999997 99999876543 333334333 23345667899999999
Q ss_pred HhcCCCCCCCCCHhHHhcC
Q 014909 247 RILDPNPMTRITIPEILED 265 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~h 265 (416)
+||+.||++|||+.++++.
T Consensus 352 ~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 352 SCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHccCChhHCcCHHHHHHH
Confidence 9999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=341.52 Aligned_cols=254 Identities=27% Similarity=0.412 Sum_probs=205.4
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+...... .....+.+|+.+++.++|+||+++++++.++...|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 47899999999999999999999999999999998654321 2234567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 90 LEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
|||+. ++|.+.+.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ..
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~ 158 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP--SQ 158 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC--CC
Confidence 99996 577666654 356889999999999999999999999999999999999999999999999998753321 11
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH-HHHHHhhcC-c----------------
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAA-E---------------- 230 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~-~~~~~i~~~-~---------------- 230 (416)
......+++.|+|||++.+....+.++|||||||++|+|++|..||...+.. +....+... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 2234567899999999876544457899999999999999999999765432 221111100 0
Q ss_pred ------cCCCC---------CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 231 ------FTCPP---------WLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 231 ------~~~~~---------~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
...+. ..+.++.+++.+||..||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=340.73 Aligned_cols=257 Identities=30% Similarity=0.532 Sum_probs=217.5
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCEEEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 88 (416)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++ |||++++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4788899999999999999999999999999987542 2223567889999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
||||++|++|.+++.. +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--S 156 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--c
Confidence 9999999999998866 579999999999999999999999999999999999999999999999999987654322 2
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc-CCCCC-CCHHHHHHHH
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPW-LSFTARKLIA 246 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~-~s~~~~~ll~ 246 (416)
......|+..|+|||.+.+....+.++|+|||||++|+|++|..||...........+..... .++.. ++.++.+++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence 223457899999999987654445889999999999999999999988766554444333322 22222 7789999999
Q ss_pred HhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 247 RILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
+||+.||++||++.+++.||||+....
T Consensus 237 ~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 237 ACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred HHcCCCcccCcCHHHHhhChHhhcccc
Confidence 999999999999999999999987553
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-47 Score=363.01 Aligned_cols=261 Identities=32% Similarity=0.592 Sum_probs=242.5
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
...+...+++.+||-|+||.|-++........+|+|++++..+.+....+.+..|-.||...+.|.||++|-.|.+...+
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 45677888999999999999999988765556999999998888888889999999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+.||-|-||+|+..+...+.+.+..+++|...+++|++|||++||++|||||+|++++.+|-+||.|||+|+... .
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~---~ 572 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG---S 572 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc---c
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998554 4
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC--ccCCCCCCCHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKL 244 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~l 244 (416)
+....+.||||.|+|||++.+++++ .++|.||||+++||||+|.+||.+.+.+..|..|..+ ...+|..++..+.+|
T Consensus 573 g~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL 651 (732)
T ss_pred CCceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence 5566789999999999999999997 8899999999999999999999999999999988776 467889999999999
Q ss_pred HHHhcCCCCCCCCC-----HhHHhcCcccccC
Q 014909 245 IARILDPNPMTRIT-----IPEILEDEWFKKD 271 (416)
Q Consensus 245 l~~~L~~dP~~R~t-----~~eil~h~~~~~~ 271 (416)
|+++...+|..|.. +.+|.+|.||...
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 99999999999986 8999999999753
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=340.76 Aligned_cols=257 Identities=30% Similarity=0.456 Sum_probs=212.4
Q ss_pred cccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEE--
Q 014909 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG-- 81 (416)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~-- 81 (416)
.+....++|++.+.||+|+||.||+|.+..+++.+|+|++..... ....+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 345677899999999999999999999999999999999864321 235678899999999 6999999999873
Q ss_pred ---eCCEEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEee
Q 014909 82 ---SKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSD 154 (416)
Q Consensus 82 ---~~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~D 154 (416)
+....|+||||++|++|.+.+.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEcc
Confidence 45679999999999999988753 34689999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCcccccCCcccccchhhcc-----CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC
Q 014909 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 229 (416)
Q Consensus 155 FGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~-----~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~ 229 (416)
||++...... ........|++.|+|||++.. ..+ +.++||||+||++|+|++|+.||...........+...
T Consensus 168 fg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 244 (286)
T cd06638 168 FGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244 (286)
T ss_pred CCceeecccC--CCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence 9998754321 112234578999999999853 223 47899999999999999999999876654444333222
Q ss_pred ---ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 230 ---EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 230 ---~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
....|..++..+.+|+.+||+.||++|||+.++++|+||
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 122344568899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=341.29 Aligned_cols=255 Identities=27% Similarity=0.430 Sum_probs=211.0
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEE----
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG---- 81 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~---- 81 (416)
....+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++++ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 12 RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred cChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 446689999999999999999999999999999999986543 2245678899999988 6999999999984
Q ss_pred --eCCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccc
Q 014909 82 --SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (416)
Q Consensus 82 --~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGl 157 (416)
....+|++|||+++|+|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence 356789999999999999988763 4588999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCcccccCCcccccchhhcc-----CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc-
Q 014909 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF- 231 (416)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~-----~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~- 231 (416)
+...... ........|++.|+|||++.. ..+ +.++|||||||++|+|++|..||...........+.....
T Consensus 168 ~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 244 (282)
T cd06636 168 SAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP 244 (282)
T ss_pred hhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCC
Confidence 8754321 122345678999999999863 234 4689999999999999999999977654433333322211
Q ss_pred C-CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 232 T-CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 232 ~-~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
. .+..++.++.+||++||+.||.+|||+.++++||||
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 1 123478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=358.58 Aligned_cols=247 Identities=32% Similarity=0.673 Sum_probs=217.9
Q ss_pred EeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014909 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (416)
.+.||+|.||+||-|+++.+|+.||||+|++.++...+ ..++++|+.||+.+.||+||.+--.+++.+.+++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 47899999999999999999999999999987765543 47899999999999999999999999999999999999987
Q ss_pred CchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC---CeEEeecccccccccccCCCCc
Q 014909 96 GELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 96 g~L~~~i~~--~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~---~vkl~DFGla~~~~~~~~~~~~ 170 (416)
+....|-. .+++++...++++.||+.||.|||-+||+|+||||||||+.... .+||||||+|++... ....
T Consensus 648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ksFR 723 (888)
T KOG4236|consen 648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KSFR 723 (888)
T ss_pred -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch---hhhh
Confidence 55555533 47899999999999999999999999999999999999997653 599999999997654 3345
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC--CC--CCHHHHHHHH
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--PW--LSFTARKLIA 246 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~--~s~~~~~ll~ 246 (416)
.+.+|||.|.|||++..++|. ...|+||+|||+|.-|.|..||.... ++..+|+...+.+| || +|+++.+||+
T Consensus 724 rsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn 800 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLIN 800 (888)
T ss_pred hhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHH
Confidence 678999999999999999997 77899999999999999999998543 34455666666555 45 8999999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccccc
Q 014909 247 RILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.+|+..-.+|.|++..+.|||++.
T Consensus 801 ~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 801 NLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred HHHHHHHHHhcchHhhccchhhhc
Confidence 999999999999999999999975
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=342.10 Aligned_cols=255 Identities=29% Similarity=0.425 Sum_probs=208.4
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCE----
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTK---- 85 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~---- 85 (416)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999999876432 2223456888999999995 6999999999877665
Q ss_pred -EEEEEeccCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc-CCCeEEeecccc
Q 014909 86 -IFIVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLS 158 (416)
Q Consensus 86 -~~lV~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~-~~~vkl~DFGla 158 (416)
.|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 788887653 35799999999999999999999999999999999999998 889999999998
Q ss_pred cccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc--------
Q 014909 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-------- 230 (416)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~-------- 230 (416)
...... ........+++.|+|||++.+....+.++||||+|+++|+|++|..||.+.+......++....
T Consensus 159 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 744221 1122334678899999998765444589999999999999999999998776554443332110
Q ss_pred ---------cCC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 014909 231 ---------FTC-----------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (416)
Q Consensus 231 ---------~~~-----------~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~ 269 (416)
... .+.++.++.+||.+||..||.+||++.+++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 000 124788999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=347.74 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=219.0
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (416)
|.+++.||+|+||.||+|+|+.+|+.+|||.+..+. ..+.+.+||.||++++.|+||++|+.+.....+|+||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 667889999999999999999999999999986543 467899999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcc
Q 014909 93 VTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (416)
Q Consensus 93 ~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 171 (416)
|..|+..|.++. +++++|+++..+++..+.||+|||...-+|||||..|||++.+|+.||+|||.|...... -....
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRN 187 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRN 187 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhhC
Confidence 999999998875 468999999999999999999999999999999999999999999999999998643221 11235
Q ss_pred cccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC---ccCCCCCCCHHHHHHHHHh
Q 014909 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIARI 248 (416)
Q Consensus 172 ~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~ll~~~ 248 (416)
+..|||.|||||++..-+|+ .++||||||+...||..|++||.+-..+...--|... .+.-|..+|.++.+|+++|
T Consensus 188 TVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred ccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence 67899999999999999998 7899999999999999999999876655333222211 1233445789999999999
Q ss_pred cCCCCCCCCCHhHHhcCcccccCC
Q 014909 249 LDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 249 L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
|.++|++|.|+-++++|||.+...
T Consensus 267 LiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 267 LIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred hcCCHHHHHHHHHHhhhhhhcCCC
Confidence 999999999999999999998653
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=359.94 Aligned_cols=258 Identities=33% Similarity=0.544 Sum_probs=224.8
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
.-|..+++||-|+||+|.++...++...||+|.+++...........++.|-.||..-+.+.||+||..|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 34888999999999999999999999999999999988888888899999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC-
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL- 169 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~- 169 (416)
+|++||++..++.+-+-+.|+.|++|+..|..|+++.|+.|+|||||||+|||||.+|++||+|||||+-+....+...
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999976543221111
Q ss_pred ---------------------------------------cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhC
Q 014909 170 ---------------------------------------LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 210 (416)
Q Consensus 170 ---------------------------------------~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G 210 (416)
.+..+||+.|+|||++...+|. ..+|.||.|||||+|+.|
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhhC
Confidence 1134799999999999999886 889999999999999999
Q ss_pred CCCCCCCchHHHHHHhhc--CccCCC--CCCCHHHHHHHHHhcCCCCCCCCC---HhHHhcCccccc
Q 014909 211 YLPFDDSNLMNLYKKISA--AEFTCP--PWLSFTARKLIARILDPNPMTRIT---IPEILEDEWFKK 270 (416)
Q Consensus 211 ~~Pf~~~~~~~~~~~i~~--~~~~~~--~~~s~~~~~ll~~~L~~dP~~R~t---~~eil~h~~~~~ 270 (416)
++||...+..+...++.. ....+| ..+|.++.+||.++. -+++.|.. ++++..||||+.
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence 999988776554444432 223333 458999999999865 56788874 678999999985
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=341.43 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=214.7
Q ss_pred cccCEEEEeEEeecCceEEEEEEECC-----CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... ....+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 35679999999999999999998753 357899999875432 22457899999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCC
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHG--------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~--------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~ 149 (416)
...|+||||++|++|.+++...+ .+++..+..++.||+.|+.|||++|++||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999997643 3788899999999999999999999999999999999999999
Q ss_pred eEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhc
Q 014909 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA 228 (416)
Q Consensus 150 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~ 228 (416)
+||+|||++................+++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 999999998643221111122334567889999999887764 78999999999999998 9999988887777777766
Q ss_pred CccC-CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 229 AEFT-CPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 229 ~~~~-~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+... .+..++..+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6543 34568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=349.32 Aligned_cols=260 Identities=28% Similarity=0.466 Sum_probs=210.4
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----C
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-----T 84 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 84 (416)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 468999999999999999999999999999999986422 223456678899999999999999999887544 3
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
..|++|||+.+ +|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 58999999975 88877754 67999999999999999999999999999999999999999999999999998754322
Q ss_pred cC-CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhc---------------
Q 014909 165 RD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--------------- 228 (416)
Q Consensus 165 ~~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~--------------- 228 (416)
.. .......+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 11223457899999999986544446899999999999999999999987654332221110
Q ss_pred C-----------cc-----CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 229 A-----------EF-----TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 229 ~-----------~~-----~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
. .. ...+..+.++.+||.+||+.||.+|||+.++++||||.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0 00 011345788999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=339.54 Aligned_cols=253 Identities=27% Similarity=0.454 Sum_probs=216.9
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||.|+||.||+|.+..+++.+|+|.+..... ......+.+|+.+++.++||||+++++.+......|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468889999999999999999999999999999876532 234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 91 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~-~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence 999999999999876 789999999999999999999999 999999999999999999999999999986543211
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc-----hHHHHHHhhcC-ccCCCCC-CCHHH
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-----LMNLYKKISAA-EFTCPPW-LSFTA 241 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~-----~~~~~~~i~~~-~~~~~~~-~s~~~ 241 (416)
.....|+..|+|||.+.+..+. .++||||+|+++|+|++|..||.... .....+.+... ....+.. ++.++
T Consensus 156 -~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 156 -AKTFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred -hhcccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 1226788999999999887664 88999999999999999999997542 22333333322 2333444 78899
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 242 RKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.++|.+||..||.+|||+.+++.||||++
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=335.58 Aligned_cols=252 Identities=31% Similarity=0.538 Sum_probs=212.9
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+++|++.+.||+|+||.||+|.+..+++.||||.+.............+.+|+.+++.++||||+++++++.+.+..|++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 47899999999999999999999999999999998764444445567788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
|||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999988753 3458999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc--hHHHHHHhhcCccC-CC-CCCCHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN--LMNLYKKISAAEFT-CP-PWLSFTA 241 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~--~~~~~~~i~~~~~~-~~-~~~s~~~ 241 (416)
.......|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||.... .......+.....+ .+ ...+..+
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08228 161 --TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237 (267)
T ss_pred --HHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 122345688999999999877664 78999999999999999999996543 23444444433322 22 3477899
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 014909 242 RKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.+++.+||..+|++||++.++++
T Consensus 238 ~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 238 RELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHHHHCCCCcccCcCHHHHHH
Confidence 99999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=339.38 Aligned_cols=252 Identities=32% Similarity=0.512 Sum_probs=211.1
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
+|++.+.||.|++|.||+|.+..+|+.||||.+..... ......+.+|+.+++.++||||+++++.+.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999876432 2224567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 92 FVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 92 ~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
|+++ +|.+++...+ .+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++...... ..
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~~ 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VN 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--cc
Confidence 9986 8888876543 5899999999999999999999999999999999999999999999999998754321 11
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc------------------
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------------ 230 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~------------------ 230 (416)
......+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 22345678999999998765555689999999999999999999998877655444332110
Q ss_pred cC-----------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 231 FT-----------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 231 ~~-----------~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
.. ..+..+..+.+++.+||+.||.+||++.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 112457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=345.07 Aligned_cols=257 Identities=29% Similarity=0.485 Sum_probs=216.9
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 34555678999999999999999899999999986533 233567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
||+++++|.+++.. +.+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++...... ....
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~ 175 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKR 175 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc--cccC
Confidence 99999999988754 57999999999999999999999999999999999999999999999999998643321 1222
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc---cCCCCCCCHHHHHHHHH
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIAR 247 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~ll~~ 247 (416)
....|++.|+|||.+.+..+. .++||||+|+++|+|++|+.||...+.......+.... ...+...+..+.+++.+
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred ceeecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence 345789999999999876664 78999999999999999999998876655544443321 12223478899999999
Q ss_pred hcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 248 ILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 248 ~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
||..||.+|||++++++||||.....|
T Consensus 255 ~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 255 MLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HccCChhHCcCHHHHhhChhhhccCCc
Confidence 999999999999999999999876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=345.24 Aligned_cols=256 Identities=29% Similarity=0.428 Sum_probs=206.5
Q ss_pred CEEEEeEEeecCceEEEEEEECC--CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CEEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSE--TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKIF 87 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 87 (416)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 8999999999874322233456678899999999999999999999988 8899
Q ss_pred EEEeccCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc----CCCeEEeecccc
Q 014909 88 IVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA----YGNLKVSDFGLS 158 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~----~~~vkl~DFGla 158 (416)
+||||+.+ +|.+.+... ..+++..++.++.||+.||+|||++|++||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 677766432 36899999999999999999999999999999999999999 899999999998
Q ss_pred cccccccC-CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHH---------HHHHh--
Q 014909 159 ALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---------LYKKI-- 226 (416)
Q Consensus 159 ~~~~~~~~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~---------~~~~i-- 226 (416)
........ .......++|+.|+|||++.+....+.++|||||||++|+|++|+.||.+..... ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 76533222 1122345788999999998765544588999999999999999999997544221 00000
Q ss_pred ------------------------hcCccCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 227 ------------------------SAAEFTCP-----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 227 ------------------------~~~~~~~~-----------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
......++ ...+.++.+++.+||+.||++|||+.++++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00000111 1456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=340.06 Aligned_cols=255 Identities=29% Similarity=0.477 Sum_probs=218.3
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
+.|+..+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++.+.+....|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 468888999999999999999998999999999875432 234578899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
||++|++|.+++.. +++++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--ccc
Confidence 99999999998875 579999999999999999999999999999999999999999999999999986543211 122
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhc
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARIL 249 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll~~~L 249 (416)
....++..|+|||++.+..+ +.++|+|||||++|+|++|..||...........+... ....+..++.++.+++.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence 33468889999999987665 48899999999999999999999877665554444333 22334457889999999999
Q ss_pred CCCCCCCCCHhHHhcCcccccC
Q 014909 250 DPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 250 ~~dP~~R~t~~eil~h~~~~~~ 271 (416)
+.+|++||++.++++||||...
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 238 NKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ccCcccCcCHHHHHhChHhhhc
Confidence 9999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=341.34 Aligned_cols=257 Identities=25% Similarity=0.404 Sum_probs=217.9
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
...+|++.+.||+|+||+||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++.+......|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 3567999999999999999999999999999999987543 23346788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~-~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
||||+++++|.+++...+.+++..++.++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++.....
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~---- 156 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN---- 156 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----
Confidence 99999999999999888889999999999999999999997 6999999999999999999999999998764322
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH-----------HHHHHhhcC-ccCCCC
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-----------NLYKKISAA-EFTCPP 235 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~-----------~~~~~i~~~-~~~~~~ 235 (416)
......+|+..|+|||++.+..+. .++||||+||++|+|++|..||...... .....+... ...++.
T Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd06620 157 SIADTFVGTSTYMSPERIQGGKYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235 (284)
T ss_pred hccCccccCcccCCHHHHccCCCC-ccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence 112345789999999999876554 7899999999999999999999865431 222333222 222233
Q ss_pred C-CCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 236 W-LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 236 ~-~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
. ++.++.+|+.+||+.||++|||+.|+++|+||.+..
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 3 778999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=338.40 Aligned_cols=248 Identities=25% Similarity=0.451 Sum_probs=206.5
Q ss_pred cccccCEEEEeEE--eecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 014909 7 KRRVGKYEVGRTI--GEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (416)
Q Consensus 7 ~~~~~~y~~~~~L--G~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 83 (416)
....++|++.+.+ |+|+||.||++.+..++..+|+|++....... .|+.....+ +||||+++++.+...
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 3456678887777 99999999999999999999999987643221 122222222 699999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC-CeEEeecccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQ 162 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~-~vkl~DFGla~~~~ 162 (416)
+..|+||||++|++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 99999999999999999998888999999999999999999999999999999999999999988 99999999886432
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHH----HHHHhhcCccCCCCCCC
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKISAAEFTCPPWLS 238 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~s 238 (416)
. .....|+..|+|||++.+..+. .++||||+|+++|+|++|..||....... .+..........++.+|
T Consensus 162 ~------~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T PHA03390 162 T------PSCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVS 234 (267)
T ss_pred C------CccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccC
Confidence 2 1234689999999999887775 88999999999999999999998554322 11112233345556689
Q ss_pred HHHHHHHHHhcCCCCCCCCC-HhHHhcCcccc
Q 014909 239 FTARKLIARILDPNPMTRIT-IPEILEDEWFK 269 (416)
Q Consensus 239 ~~~~~ll~~~L~~dP~~R~t-~~eil~h~~~~ 269 (416)
+.+.+||.+||+.||.+||+ ++++|+||||.
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 235 KNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 99999999999999999996 69999999996
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=332.59 Aligned_cols=253 Identities=32% Similarity=0.575 Sum_probs=217.2
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
+|++.+.||+|+||.||+|.+..+|..+|+|.+....... ...+.+.+|+.+++.++||||+++++.+.+....|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 5899999999999999999999999999999997654322 234678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCC-eEEeecccccccccccCCC
Q 014909 92 FVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 92 ~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~-vkl~DFGla~~~~~~~~~~ 168 (416)
|+++++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||++++++. +||+|||.+...... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--ME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC--cc
Confidence 999999999987644 4799999999999999999999999999999999999998864 699999998754321 12
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHHHHHHHH
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIAR 247 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ll~~ 247 (416)
......|++.|+|||++.+..+. .++|+||||+++++|++|..||...+.......+.... ...++.++.++.++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 22345689999999998876664 88999999999999999999998877666555544433 23455678999999999
Q ss_pred hcCCCCCCCCCHhHHhcCccc
Q 014909 248 ILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 248 ~L~~dP~~R~t~~eil~h~~~ 268 (416)
||..+|++|||+.++++||||
T Consensus 237 ~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 237 LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=339.51 Aligned_cols=258 Identities=31% Similarity=0.459 Sum_probs=211.3
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+++|++.+.||+|++|.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 46899999999999999999999999999999998654322 22346688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc-CCCeEEeecccccccccccC
Q 014909 90 LEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~~~ 166 (416)
|||+++ +|.+.+.... .+++..+..++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-- 156 (294)
T PLN00009 80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-- 156 (294)
T ss_pred Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--
Confidence 999965 7888876544 3578889999999999999999999999999999999985 457999999998654321
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC--c--------------
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--E-------------- 230 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~--~-------------- 230 (416)
........|++.|+|||++.+....+.++||||+||++|+|++|..||...+......++... .
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 112234467899999999876544458899999999999999999999876655444332110 0
Q ss_pred -----c--------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 231 -----F--------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 231 -----~--------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
. ...+.+++.+.+++.+||+.||++||++.++++||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 0123468889999999999999999999999999999753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=362.45 Aligned_cols=244 Identities=34% Similarity=0.602 Sum_probs=215.4
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 87 (416)
....|.+...+|.|+||.|..+.+..+++.+++|++.++. .+..+|+.++... +||||+++++++.+....|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 5678999999999999999999999999999999998762 2344677666555 6999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEe-ccCCCeEEeecccccccccccC
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL-DAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl-~~~~~vkl~DFGla~~~~~~~~ 166 (416)
+|||++.|+.|.+.|....... .++..|++||+.|+.|||++||+||||||+|||+ +..|+++|+|||.+.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~--- 468 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER--- 468 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch---
Confidence 9999999999999998866555 7888999999999999999999999999999999 5889999999999875432
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH-HHHHHhhcCccCCCCCCCHHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCPPWLSFTARKLI 245 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~s~~~~~ll 245 (416)
...+.|-|..|.|||++...+|+ +++||||||++||+||+|+.||...... ++...+..+.+. .++|.++++||
T Consensus 469 --~~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl 543 (612)
T KOG0603|consen 469 --SCDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLL 543 (612)
T ss_pred --hhcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHH
Confidence 15667889999999999988886 9999999999999999999999865544 666677555444 88999999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCccc
Q 014909 246 ARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
++||+.||.+|+++.+++.||||
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=349.40 Aligned_cols=261 Identities=25% Similarity=0.421 Sum_probs=214.1
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE----eCCEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG----SKTKI 86 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~~~ 86 (416)
.+|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+|+.++||||+++++++. .....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999875432 2234567888999999999999999998875 34578
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.+|.+||+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999996 58999998878899999999999999999999999999999999999999999999999999875432211
Q ss_pred --CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhc----------------
Q 014909 167 --DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---------------- 228 (416)
Q Consensus 167 --~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~---------------- 228 (416)
........|+..|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 11223457899999999987644446889999999999999999999987654332221110
Q ss_pred ---------C-ccCC-----CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 229 ---------A-EFTC-----PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 229 ---------~-~~~~-----~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
. .... .+..+.++.++|++||+.||.+|||+.+++.||||.+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 0 0000 1336889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=328.53 Aligned_cols=255 Identities=30% Similarity=0.551 Sum_probs=220.7
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CEEEEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKIFIV 89 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV 89 (416)
+|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999989999999999765532 33467899999999999999999999999988 899999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
+||+++++|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99999999999998887999999999999999999999999999999999999999999999999999876544322112
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc-hHHHHHHhh--cCccCCCCCCCHHHHHHHH
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKIS--AAEFTCPPWLSFTARKLIA 246 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~-~~~~~~~i~--~~~~~~~~~~s~~~~~ll~ 246 (416)
.....++..|+|||.+....+ +.++||||+|+++|+|++|..||.... .......+. ......|...+..+.+++.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 345678999999999987665 488999999999999999999998765 223333333 2334556678999999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccc
Q 014909 247 RILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~h~~~ 268 (416)
+||..||++||++.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=363.16 Aligned_cols=252 Identities=28% Similarity=0.496 Sum_probs=218.6
Q ss_pred EEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCc
Q 014909 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGE 97 (416)
Q Consensus 18 ~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 97 (416)
.||+|.||+||.|++..+.-.+|||-+.... ....+-+..||.+.++|+|.|||+++|.+..++.+-++||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 6999999999999999999999999986433 2346779999999999999999999999999999999999999999
Q ss_pred hHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc-CCCeEEeecccccccccccCCCCcccc
Q 014909 98 LFDKIVNH-GRM--KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTT 173 (416)
Q Consensus 98 L~~~i~~~-~~l--~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~~ 173 (416)
|.++++.. |++ +|..+-+|.+||++||.|||.+.|+|||||-+|+|++. .|.+||+|||.++..... +....+.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC--Ccccccc
Confidence 99999876 566 88999999999999999999999999999999999976 589999999998765443 3345678
Q ss_pred cCCcccccchhhccC-CCCCChhhHHHHHHHHHHHhhCCCCCCCC--chHHHHH-HhhcCccCCCCCCCHHHHHHHHHhc
Q 014909 174 CGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDS--NLMNLYK-KISAAEFTCPPWLSFTARKLIARIL 249 (416)
Q Consensus 174 ~gt~~y~aPEvl~~~-~~~~~~~DIwSlGvil~~ml~G~~Pf~~~--~~~~~~~-~i~~~~~~~~~~~s~~~~~ll~~~L 249 (416)
.||..|||||++... ..+|.++|||||||++.||.||++||..- ....+++ .+....+++|..+|.+++.||.+|+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 899999999999642 23369999999999999999999999753 3334444 2445567788889999999999999
Q ss_pred CCCCCCCCCHhHHhcCcccccCCCC
Q 014909 250 DPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 250 ~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
.+||..||++.++|++||++...+.
T Consensus 817 epd~~~R~sA~~LL~DpFlq~~~kk 841 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQDPFLQHNNKK 841 (1226)
T ss_pred CCCcccCccHHHhccCcccccCCCC
Confidence 9999999999999999999977543
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=338.88 Aligned_cols=252 Identities=32% Similarity=0.480 Sum_probs=210.0
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (416)
|++.+.||.|++|.||+|.+..+|..||+|++...... ......+.+|+.+++.++|||++++++++.+.+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 67889999999999999999999999999999765422 22345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 93 VTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 93 ~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
++ ++|.+++.... .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence 95 58999987765 7899999999999999999999999999999999999999999999999998644321 1122
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC---------------------
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------------------- 229 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~--------------------- 229 (416)
....+++.|+|||++.+....+.++||||||+++|+|++|++||...+......++...
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 33457889999999876544458899999999999999999999876654333222110
Q ss_pred --c------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 230 --E------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 230 --~------~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
. ....+.++..+.++|.+||+.||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 01123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=337.96 Aligned_cols=259 Identities=21% Similarity=0.289 Sum_probs=213.0
Q ss_pred cccCEEEEeEEeecCceEEEEEEECC-----CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
.-++|++.+.||+|+||.||+|.++. .+..||+|.+..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34689999999999999999997642 345799999865432 22234578899999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEe
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHG----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~ 153 (416)
...|+||||+++|+|.+++...+ ..+...+..++.||+.||.|||++||+||||||+||+++.++.++|+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999999997532 24567888999999999999999999999999999999999999999
Q ss_pred ecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-cc
Q 014909 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EF 231 (416)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~ 231 (416)
|||+++...............++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999874332111111222345678999999987666 489999999999999998 89999987777766655444 34
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc------Cccccc
Q 014909 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILE------DEWFKK 270 (416)
Q Consensus 232 ~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~------h~~~~~ 270 (416)
..+...++.+.+++.+||+.||++|||+.++++ ||||..
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 456667899999999999999999999999986 888864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=338.10 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=212.0
Q ss_pred ccCEEEEeEEeecCceEEEEEEEC-----CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
-.+|.+.+.||+|+||.||++.+. .++..+|+|.+.... ......+.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 457999999999999999999853 345668999886532 234567899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeE
Q 014909 85 KIFIVLEFVTGGELFDKIVNHG-------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~-------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vk 151 (416)
..|+||||+++++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+||++++++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 9999999999999999997543 489999999999999999999999999999999999999999999
Q ss_pred EeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc
Q 014909 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE 230 (416)
Q Consensus 152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~ 230 (416)
|+|||++................+++.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999998754322111122334467789999999876664 78999999999999998 999999887777777776655
Q ss_pred c-CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 231 F-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 231 ~-~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
. ..+..++.++.+|+.+||+.||.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3 345568899999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=330.84 Aligned_cols=247 Identities=40% Similarity=0.721 Sum_probs=222.8
Q ss_pred EeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014909 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (416)
Q Consensus 19 LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 98 (416)
||+|+||.||.+.+..+++.+|+|++.+...........+.+|+.+++.++||||+++++.+.++...|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999988999999999887665555677899999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCCcc
Q 014909 99 FDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178 (416)
Q Consensus 99 ~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 178 (416)
.+++.....+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++....... .......|+..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 9999988889999999999999999999999999999999999999999999999999987543321 22345578899
Q ss_pred cccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014909 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT 258 (416)
Q Consensus 179 y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t 258 (416)
|+|||.+.+... +.++|+||||+++|+|++|..||...+.......+......+|..++..+.+++++||..||++||+
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999987665 4789999999999999999999988877777777777777888888999999999999999999999
Q ss_pred H---hHHhcCccc
Q 014909 259 I---PEILEDEWF 268 (416)
Q Consensus 259 ~---~eil~h~~~ 268 (416)
+ +++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=336.07 Aligned_cols=255 Identities=28% Similarity=0.475 Sum_probs=218.7
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
-|++.+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++.+..+...|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 37788999999999999999988999999999865432 2235678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcc
Q 014909 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (416)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 171 (416)
|+++++|.+++.. ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~ 159 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRN 159 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhhc
Confidence 9999999988865 568999999999999999999999999999999999999999999999999886543211 1123
Q ss_pred cccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhcC
Q 014909 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILD 250 (416)
Q Consensus 172 ~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll~~~L~ 250 (416)
...|+..|+|||.+.+.... .++|+||+||++|+|++|..||...........+... ....+..++.++.+++.+||+
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 238 (277)
T ss_pred cccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 35688999999999776554 7899999999999999999999877665555555433 233556688999999999999
Q ss_pred CCCCCCCCHhHHhcCcccccCC
Q 014909 251 PNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 251 ~dP~~R~t~~eil~h~~~~~~~ 272 (416)
.+|.+||++.++++||||.+..
T Consensus 239 ~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 239 KEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred CChhhCcCHHHHHhCHHHhhhh
Confidence 9999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=327.63 Aligned_cols=253 Identities=30% Similarity=0.532 Sum_probs=221.7
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+.+.+|+.++++++|||++++++++.+....|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999989999999999876533 2346789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcc
Q 014909 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (416)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 171 (416)
|+++++|.+++.....+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........ ...
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--ccc
Confidence 999999999999888999999999999999999999999999999999999999999999999999876543221 124
Q ss_pred cccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHh-hcCccCCCCCCCHHHHHHHHHhcC
Q 014909 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI-SAAEFTCPPWLSFTARKLIARILD 250 (416)
Q Consensus 172 ~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i-~~~~~~~~~~~s~~~~~ll~~~L~ 250 (416)
...|+..|+|||.+.+..+ +.++||||+|+++|+|++|..||...+......++ .......++.++..+.+++.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 4578999999999877664 58899999999999999999999876654433333 344455667789999999999999
Q ss_pred CCCCCCCCHhHHhcCccc
Q 014909 251 PNPMTRITIPEILEDEWF 268 (416)
Q Consensus 251 ~dP~~R~t~~eil~h~~~ 268 (416)
.+|++|||+.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=342.65 Aligned_cols=253 Identities=22% Similarity=0.361 Sum_probs=209.8
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCe--EEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEP--VALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~--vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 83 (416)
...+.+|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 34678999999999999999999999877765 466665432 2233456788999999999 899999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~ 147 (416)
+.+|+||||+++++|.+++...+ .+++..++.++.||+.|++|||++|++||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 99999999999999999997543 47889999999999999999999999999999999999999
Q ss_pred CCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHh
Q 014909 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (416)
Q Consensus 148 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i 226 (416)
+.+||+|||++....... ......++..|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+.......+
T Consensus 161 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 161 YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred CcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 999999999986322110 1111234567999999977665 488999999999999998 99999887777666666
Q ss_pred hcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 227 SAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 227 ~~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
... ....+..+++++.+|+.+||+.+|++||++++++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 237 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 443 223444578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=393.30 Aligned_cols=259 Identities=32% Similarity=0.529 Sum_probs=226.2
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
=+|+-+..||.|.||.||.|.+..+|+..|+|-+...... ......+.+|..++..++|||+|++|++-.+.+..||.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3688889999999999999999999999999988765443 345678999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc--CCC
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR--DDG 168 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~--~~~ 168 (416)
|||+||+|.+.+...+-.+|...+.|..|++.|++|||++|||||||||+||+++.+|.+|++|||.|....... -.+
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 999999999999988888999999999999999999999999999999999999999999999999987544321 123
Q ss_pred CcccccCCcccccchhhccCC--CCCChhhHHHHHHHHHHHhhCCCCCCCCch--HHHHHHhhcCccCCCCCCCHHHHHH
Q 014909 169 LLHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSNL--MNLYKKISAAEFTCPPWLSFTARKL 244 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~--~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~--~~~~~~i~~~~~~~~~~~s~~~~~l 244 (416)
.+....|||.|||||++.+.. ..+-++||||||||+.||+||+.||..-+. .-+|.--....+++|..+|++.++|
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dF 1473 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDF 1473 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHH
Confidence 456789999999999998643 234688999999999999999999986443 3444444445678888899999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 245 IARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
|.+||..||++|+++.|+++|.|-+.
T Consensus 1474 le~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1474 LEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HHHHHhcCchhhhHHHHHHHhhcccc
Confidence 99999999999999999999999764
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=340.69 Aligned_cols=256 Identities=26% Similarity=0.389 Sum_probs=215.2
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
..+|.+.+.||+|+||.||+|.+..+++.||+|.+...........+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 45699999999999999999999989999999998755444444557789999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 90 LEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
|||+.| +|.+.+.. ...+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~----- 167 (307)
T cd06607 94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP----- 167 (307)
T ss_pred HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC-----
Confidence 999975 67676654 45799999999999999999999999999999999999999999999999998864322
Q ss_pred CcccccCCcccccchhhcc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-cCC-CCCCCHHHHHH
Q 014909 169 LLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTC-PPWLSFTARKL 244 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~--~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~-~~~-~~~~s~~~~~l 244 (416)
.....|++.|+|||++.+ ....+.++||||+|+++|+|++|..||...+.......+.... ... +..++..+.++
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (307)
T cd06607 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNF 246 (307)
T ss_pred -CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence 234568899999999852 2233578999999999999999999998877655444443322 222 22367899999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 245 IARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
|.+||..||++||++.+++.||||....
T Consensus 247 i~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 247 VDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 9999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=336.24 Aligned_cols=255 Identities=25% Similarity=0.441 Sum_probs=206.3
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHH-HhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT-MKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
.+|++.+.||+|+||.||+|.+..+|+.||+|.+........ ...+..|+.+ ++.++||||+++++.+......|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 369999999999999999999999999999999876532221 2344456554 6777899999999999999999999
Q ss_pred EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~~-givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
|||++| +|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 999974 77776654 34689999999999999999999998 999999999999999999999999999875432
Q ss_pred cCCCCcccccCCcccccchhhcc----CCCCCChhhHHHHHHHHHHHhhCCCCCCCCc--hHHHHHHhhcCccCCC-CCC
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSN--LMNLYKKISAAEFTCP-PWL 237 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~----~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~--~~~~~~~i~~~~~~~~-~~~ 237 (416)
........|+..|+|||++.+ ..+ +.++|+||+||++|+|++|+.||.... .......+.......| ..+
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd06617 157 --SVAKTIDAGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF 233 (283)
T ss_pred --ccccccccCCccccChhhcCCccccccc-CccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence 112233568899999999864 233 478999999999999999999997532 2233333333333333 347
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 238 s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
|.++.+||.+||..+|++||+++++++||||.+..
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 89999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=332.68 Aligned_cols=251 Identities=27% Similarity=0.452 Sum_probs=208.6
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (416)
......||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|+||
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 334468999999999999999899999999886543 22356788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc-CCCeEEeecccccccccccCCC
Q 014909 93 VTGGELFDKIVNH-GRM--KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 93 ~~gg~L~~~i~~~-~~l--~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~~~~~ 168 (416)
+++++|.+.+... ..+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++...... ..
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~ 164 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NP 164 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC--CC
Confidence 9999999999764 445 88889999999999999999999999999999999986 679999999998754321 12
Q ss_pred CcccccCCcccccchhhccCC-CCCChhhHHHHHHHHHHHhhCCCCCCCCchH--HHHHH-hhcCccCCCCCCCHHHHHH
Q 014909 169 LLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLM--NLYKK-ISAAEFTCPPWLSFTARKL 244 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~-~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~--~~~~~-i~~~~~~~~~~~s~~~~~l 244 (416)
......|++.|+|||.+.... ..+.++||||+|+++|+|++|..||...... ..+.. ........|..+++++.+|
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence 233446899999999986543 2358899999999999999999999764322 22211 2223345677789999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCccc
Q 014909 245 IARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
+++||+.+|.+|||+.+++.||||
T Consensus 245 i~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 245 ILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=336.20 Aligned_cols=254 Identities=19% Similarity=0.276 Sum_probs=209.9
Q ss_pred cccCEEEEeEEeecCceEEEEEEECC-----CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
.-++|++.+.||+|+||.||.|.+.. ++..||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34679999999999999999998642 356799999864322 22345688999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEe
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHG----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~ 153 (416)
...++||||+++|+|.+++.... .++...+..++.|++.||.|||+.|++||||||+||++++++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999999987532 25677889999999999999999999999999999999999999999
Q ss_pred ecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc-c
Q 014909 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-F 231 (416)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~-~ 231 (416)
|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999864322111111123356788999999987666 488999999999999998 799999887776666554443 3
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 232 ~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
..+...+..+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5566788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=330.94 Aligned_cols=245 Identities=27% Similarity=0.451 Sum_probs=204.0
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 96 (416)
+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++......|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36899999999999999999999999876432 2334577899999999999999999999999999999999999999
Q ss_pred chHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 97 ELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 97 ~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
+|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++................+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 9999997644 689999999999999999999999999999999999999999999999999864322110000111123
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCC
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNP 253 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll~~~L~~dP 253 (416)
+..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+... ....+...+..+.+|+.+||+.||
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 456999999987666 478999999999999997 99999876665555444332 345566688999999999999999
Q ss_pred CCCCCHhHHhc
Q 014909 254 MTRITIPEILE 264 (416)
Q Consensus 254 ~~R~t~~eil~ 264 (416)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=335.87 Aligned_cols=254 Identities=30% Similarity=0.494 Sum_probs=216.6
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
.|...+.||+|++|.||++.+..+++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++...+..|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 3455579999999999999998899999999986433 2234568899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcc
Q 014909 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (416)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 171 (416)
|++|++|.+++.. +++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... .....
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~~ 173 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRK 173 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Ccccc
Confidence 9999999999877 67999999999999999999999999999999999999999999999999987643321 11223
Q ss_pred cccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCC---CCCCCHHHHHHHHHh
Q 014909 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC---PPWLSFTARKLIARI 248 (416)
Q Consensus 172 ~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~---~~~~s~~~~~ll~~~ 248 (416)
...|++.|+|||.+.+..+. .++||||+||++|+|++|..||...+.......+....... +..++..+.+|+++|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cccCCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence 45689999999999877664 78999999999999999999998877666666555443222 223788999999999
Q ss_pred cCCCCCCCCCHhHHhcCcccccCC
Q 014909 249 LDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 249 L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
|+.+|++|||+.++++||||.+..
T Consensus 253 l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 253 LVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred cccChhhCcCHHHHccCcccccCC
Confidence 999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=336.70 Aligned_cols=254 Identities=19% Similarity=0.327 Sum_probs=212.0
Q ss_pred cccCEEEEeEEeecCceEEEEEEEC----CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNS----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
.+..|++.+.||+|+||.||+|.+. .++..+|+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4578999999999999999999853 456789999987532 2234567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC
Q 014909 85 KIFIVLEFVTGGELFDKIVNH-----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~-----------------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~ 147 (416)
..|+||||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999998532 237888899999999999999999999999999999999999
Q ss_pred CCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHh
Q 014909 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (416)
Q Consensus 148 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i 226 (416)
+.+||+|||+++...............++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999875433222222334456778999999987666 489999999999999998 99999887666555555
Q ss_pred hcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 227 SAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 227 ~~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
... ....+..+++.+.+++.+||+.||.+||++.+|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 443 344566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=342.96 Aligned_cols=253 Identities=22% Similarity=0.356 Sum_probs=210.3
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCe----EEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEP----VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
...+|++.+.||+|+||.||+|.+..+++. ||+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 346799999999999999999998666654 8999986432 233456788999999999999999999998764
Q ss_pred EEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
..++++||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 5789999999999999998753 688999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHH
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 241 (416)
...........++..|+|||.+.+..+. .++|||||||++|+|++ |..||.+.........+... ..+.|+.++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 240 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 2221112223446789999999877765 89999999999999997 99999887766554444333 345567789999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 242 RKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.+++.+||..||.+|||+.+++.+
T Consensus 241 ~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 241 YMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=330.33 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=214.8
Q ss_pred eEEeecCceEEEEEEECCC---CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEecc
Q 014909 17 RTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV 93 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 93 (416)
+.||+|+||.||+|.+... +..||+|++....... ..+.+.+|+.+++.++||||+++++++.+...+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 8899999997654322 4678999999999999999999999999999999999999
Q ss_pred CCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 94 TGGELFDKIVNH---------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 94 ~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999885 77999999999999999999999999999999999999999999999999998765443
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHH
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 242 (416)
..........+++.|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+..+ ....|..+|.++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 22122344567889999999987655 488999999999999998 69999998877777777643 3456778899999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcC
Q 014909 243 KLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t~~eil~h 265 (416)
+++.+||..||++|||+.+++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=329.77 Aligned_cols=256 Identities=27% Similarity=0.491 Sum_probs=216.2
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhh--hcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKI 86 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 86 (416)
.+|++.+.||+|+||.||+|.+..+++.||+|.+..... ........+++|+.++++++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 479999999999999999999999999999998864321 1233457899999999999999999999998664 568
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
+++|||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999875432211
Q ss_pred -CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC--ccCCCCCCCHHHHH
Q 014909 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARK 243 (416)
Q Consensus 167 -~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~ 243 (416)
........|+..|+|||.+.+..+. .++|+|||||++|+|++|+.||..........++... ....|..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 1112345689999999999876654 7899999999999999999999877655544444322 34467778999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 244 LIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
++.+||+ +|.+||++.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=341.17 Aligned_cols=255 Identities=29% Similarity=0.476 Sum_probs=215.7
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
+.|+..+.||+|+||.||+|.+..++..||+|.+..... ....+.+.+|+.+++.++||||+++++.+......|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 346777889999999999999998999999999875432 224577999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
||+++++|.+++.. +.+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~~ 158 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKR 158 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc--chhh
Confidence 99999999998865 57899999999999999999999999999999999999999999999999998754321 1112
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhc
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARIL 249 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ll~~~L 249 (416)
....|+..|+|||.+.+..+. .++|+|||||++|+|++|..||...........+.... ...+...+.++.+++.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred hcccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence 334688999999999877664 78999999999999999999998665544444333322 2333457889999999999
Q ss_pred CCCCCCCCCHhHHhcCcccccC
Q 014909 250 DPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 250 ~~dP~~R~t~~eil~h~~~~~~ 271 (416)
+.+|++||++.++++||||...
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 238 NKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred cCCcccCcCHHHHHHhHHHHHH
Confidence 9999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=329.92 Aligned_cols=255 Identities=30% Similarity=0.513 Sum_probs=220.8
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
.+|++.+.||.|++|.||+|.+..+++.||+|++...... .....+.+|+..++.++||||+++++++......|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3689999999999999999999999999999998765432 34677999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~-~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
||+++++|.+++.....+++..+..++.|++.|++|||+ .|++||||+|+||+++.++.++|+|||++....... ..
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--DQ 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC--Cc
Confidence 999999999999888889999999999999999999999 999999999999999999999999999987553321 11
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCC---chHHHHHHhhcC-ccCCCCC-CCHHHHHH
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAA-EFTCPPW-LSFTARKL 244 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~---~~~~~~~~i~~~-~~~~~~~-~s~~~~~l 244 (416)
.....++..|+|||.+....+ +.++|+||||+++|+|++|..||... ........+... ....+.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 234568899999999887655 48899999999999999999999876 344444444432 3344445 78999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 245 IARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
|.+||..+|++|||+.++++|||++.
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=327.18 Aligned_cols=253 Identities=35% Similarity=0.612 Sum_probs=221.9
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
+|++.+.||.|+||.||++.+..+++.||+|.+...... ......+.+|+.+++.++|||++++++.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 589999999999999999999989999999999765432 2345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 92 FVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 92 ~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
|+++++|.+.+... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999998774 679999999999999999999999999999999999999999999999999987654322
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHHH
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIA 246 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll~ 246 (416)
......+|++.|+|||.+.+..+. .++|+||+|+++++|++|..||...+........... ....|..++..+.+++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 233456789999999998877664 7899999999999999999999888776666655444 33455578899999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccc
Q 014909 247 RILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~h~~~ 268 (416)
+||..+|++|||+.++++||||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=346.16 Aligned_cols=259 Identities=30% Similarity=0.435 Sum_probs=212.9
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----C
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-----T 84 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 84 (416)
..+|.+.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 35799999999999999999999999999999998754322 22345677899999999999999999987644 3
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
..|+||||+. ++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 5899999996 589999988888999999999999999999999999999999999999999999999999998754321
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhc----------------
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---------------- 228 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~---------------- 228 (416)
........++..|+|||.+......+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 162 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 162 --GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred --cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 12234456889999999987644456889999999999999999999987654322221110
Q ss_pred --------C----c---cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 229 --------A----E---FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 229 --------~----~---~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
. . ....+.+++++.+||++||+.||++|||++++++||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 0 0 011235788999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=339.85 Aligned_cols=260 Identities=28% Similarity=0.483 Sum_probs=218.8
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
++...++|.+.+.||+|+||.||++.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+.....
T Consensus 14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 90 (293)
T cd06647 14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDE 90 (293)
T ss_pred ccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc
Confidence 3556789999999999999999999998889999999986432 2234678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
.|+|+||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~- 168 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE- 168 (293)
T ss_pred EEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc-
Confidence 9999999999999998875 45889999999999999999999999999999999999999999999999987654322
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhc-Cc--cCCCCCCCHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA-AE--FTCPPWLSFTAR 242 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~-~~--~~~~~~~s~~~~ 242 (416)
........|++.|+|||.+....+ +.++|+|||||++|++++|+.||...+.......+.. .. ...+..++..++
T Consensus 169 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 246 (293)
T cd06647 169 -QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 246 (293)
T ss_pred -ccccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHH
Confidence 112234568899999999987666 4789999999999999999999987665433322221 11 222334678899
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 243 KLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
+++++||..+|.+||++.+++.||||+...
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 247 DFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=343.96 Aligned_cols=259 Identities=27% Similarity=0.407 Sum_probs=213.9
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-- 84 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 84 (416)
....++|++.+.||+|+||.||+|.+..++..||||.+.+.. ........+.+|+.+|+.++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 345678999999999999999999999999999999986542 22334567889999999999999999999987653
Q ss_pred ----EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccc
Q 014909 85 ----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (416)
Q Consensus 85 ----~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~ 160 (416)
.+++||||+ |++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 468999999 6788877754 6799999999999999999999999999999999999999999999999999874
Q ss_pred cccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc---------
Q 014909 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF--------- 231 (416)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~--------- 231 (416)
... ......+++.|+|||.+.+....+.++|+|||||++|+|++|..||...+....+.++.....
T Consensus 168 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 168 TDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred ccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 322 123446789999999987644456889999999999999999999987765444333221110
Q ss_pred ----------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 232 ----------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 232 ----------------------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
...+.+++.+.++|.+||+.||.+|||+.+++.||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 112357888999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=334.84 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=211.2
Q ss_pred cccCEEEEeEEeecCceEEEEEEECC-----CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34679999999999999999999976 67889999886432 222345688899999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC---CeEEe
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHG-------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVS 153 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~-------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~---~vkl~ 153 (416)
...|+||||++|++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+||+++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999999997653 488999999999999999999999999999999999998765 59999
Q ss_pred ecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-cc
Q 014909 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EF 231 (416)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~ 231 (416)
|||++................++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999875422111111112233568999999987766 489999999999999997 99999987776666555433 34
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 232 ~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
..|..++..+.+++.+||+.||++|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5567789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=333.37 Aligned_cols=252 Identities=31% Similarity=0.547 Sum_probs=213.0
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+++|++.+.||+|+||.||+|.+..++..+|||.+.............+.+|+.+++.++||||+++++.+..++..+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 46899999999999999999999989999999998765544444557888999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
|||++|++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC-
Confidence 999999999998863 346899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch--HHHHHHhhcCccC-C-CCCCCHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL--MNLYKKISAAEFT-C-PPWLSFTA 241 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~--~~~~~~i~~~~~~-~-~~~~s~~~ 241 (416)
.......+|++.|+|||.+.+..+. .++|+||||+++|+|++|..||.+... ......+...... . +..++..+
T Consensus 160 -~~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08229 160 -TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237 (267)
T ss_pred -CcccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence 1223445789999999999877664 789999999999999999999976443 2334444333222 2 23578899
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 014909 242 RKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.+++.+||+.||++|||+.+|++
T Consensus 238 ~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 238 RQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=331.26 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=213.3
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCC---CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
.++|++.+.||+|+||.||+|.+..+ ...||||.+.... .......+.+|+.+++.++||||+++++.+......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 36799999999999999999998654 4579999986543 233456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
|++|||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999998764 478999999999999999999999999999999999999999999999999988654211
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (416)
.........+++.|+|||.+.+..+. .++||||||+++|+|++ |..||...........+... ....+...+..+.+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11111223446789999999877664 88999999999999997 99999887777776666554 33445668999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcC
Q 014909 244 LIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~h 265 (416)
|+.+||+.+|++||++.+++++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=339.31 Aligned_cols=256 Identities=23% Similarity=0.394 Sum_probs=212.7
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECC-------CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEE
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLY 77 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 77 (416)
.....++|.+++.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++.+ +||||++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 34456899999999999999999998643 23569999997542 222356788899999999 799999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCc
Q 014909 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141 (416)
Q Consensus 78 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~N 141 (416)
+++......|+||||+++|+|.+++.... .++...+..++.|++.||+|||++|++||||||+|
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 99999999999999999999999997642 47888999999999999999999999999999999
Q ss_pred EEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchH
Q 014909 142 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM 220 (416)
Q Consensus 142 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~ 220 (416)
|+++.++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 9999999999999999875432111111112234578999999987666 488999999999999998 99999888777
Q ss_pred HHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 221 NLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 221 ~~~~~i~~~~-~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.....+.... ...|..++.++.+|+.+||..+|++|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 250 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 7766665543 3556678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=372.82 Aligned_cols=254 Identities=22% Similarity=0.403 Sum_probs=207.9
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+++|++.+.||+|+||.||+|.+..+|+.||+|++...........+++.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 58999999999999999999999999999999999765444444567889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccc
Q 014909 90 LEFVTGGELFDKIVNH-----------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~-----------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla 158 (416)
|||++||+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999988642 23456678899999999999999999999999999999999999999999998
Q ss_pred cccccccC----------------CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHH
Q 014909 159 ALSQQVRD----------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL 222 (416)
Q Consensus 159 ~~~~~~~~----------------~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~ 222 (416)
........ .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+....
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 76521110 001123479999999999988776 4899999999999999999999987554433
Q ss_pred HHHhhc-CccCC--CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 223 YKKISA-AEFTC--PPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 223 ~~~i~~-~~~~~--~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
...... ..... ...+++.+.+++.+||..||++|++..+.+.
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 222111 11111 1247889999999999999999987665553
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=335.15 Aligned_cols=259 Identities=30% Similarity=0.560 Sum_probs=218.2
Q ss_pred CEEEEeEEeecCceEEEEEEEC---CCCCeEEEEEeechhhhc-HHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLK-HKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 86 (416)
.|++.+.||.|+||.||.|.+. .+|..||+|++....... ....+.+.+|+.+++.+ +||||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999875 478999999997644322 22346788999999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||+|+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE- 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCcccccCCcccccchhhccC-CCCCChhhHHHHHHHHHHHhhCCCCCCCCc----hHHHHHHhhcCccCCCCCCCHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPPWLSFTA 241 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~-~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~ 241 (416)
.......+|+..|+|||.+... ...+.++||||+|+++|+|++|..||.... .......+.......|..+++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence 1222345789999999998753 233578999999999999999999997432 23444444445556677789999
Q ss_pred HHHHHHhcCCCCCCCC-----CHhHHhcCcccccC
Q 014909 242 RKLIARILDPNPMTRI-----TIPEILEDEWFKKD 271 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~-----t~~eil~h~~~~~~ 271 (416)
.+++++||+.||++|| ++++++.||||.+.
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 9999999999999997 89999999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=356.69 Aligned_cols=254 Identities=28% Similarity=0.421 Sum_probs=221.8
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (416)
|.=.+.||.|+||-||.|++..+.+.||||.+.-+.......-+.|.+|+..|++++|||+|.+.+.|..+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 44567899999999999999999999999999876655555668899999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcc
Q 014909 93 VTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (416)
Q Consensus 93 ~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 171 (416)
|-| +-.|.+.-+ +++.|.++..|..+.+.||+|||+++.||||||..|||+++.|.|||+|||.|.+..+ ..
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------An 180 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------AN 180 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc------hh
Confidence 976 777877654 5799999999999999999999999999999999999999999999999999886543 45
Q ss_pred cccCCcccccchhhcc---CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-cCCC-CCCCHHHHHHHH
Q 014909 172 TTCGTPNYVAPEVLND---RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCP-PWLSFTARKLIA 246 (416)
Q Consensus 172 ~~~gt~~y~aPEvl~~---~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~-~~~~-~~~s~~~~~ll~ 246 (416)
+.+|||+||||||+.. ..|+ -++||||||++..++.-.++|+-..+.+.....|..+. +..+ +.+|..++.|+.
T Consensus 181 sFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd 259 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 259 (948)
T ss_pred cccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHH
Confidence 7899999999999863 4465 68999999999999999999988888776655565443 3333 237889999999
Q ss_pred HhcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 247 RILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
.||++-|..|||.+++|.|+|....-.+
T Consensus 260 ~CLqKipqeRptse~ll~H~fv~R~Rp~ 287 (948)
T KOG0577|consen 260 SCLQKIPQERPTSEELLKHRFVLRERPP 287 (948)
T ss_pred HHHhhCcccCCcHHHHhhcchhccCCCc
Confidence 9999999999999999999999876443
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=340.05 Aligned_cols=253 Identities=30% Similarity=0.519 Sum_probs=215.0
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (416)
|.....||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+..+...|++|||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 4456689999999999999998999999999875432 2246688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCccc
Q 014909 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 172 (416)
Q Consensus 93 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 172 (416)
+++++|.+.+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ......
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~ 176 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKS 176 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--cccccc
Confidence 999999887654 67899999999999999999999999999999999999999999999999998644321 112234
Q ss_pred ccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc---cCCCCCCCHHHHHHHHHhc
Q 014909 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIARIL 249 (416)
Q Consensus 173 ~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~ll~~~L 249 (416)
.+|++.|+|||++.+..+ +.++||||+||++|+|++|+.||...+.......+.... ...+..++..+.++|++||
T Consensus 177 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 255 (297)
T cd06659 177 LVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML 255 (297)
T ss_pred eecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence 678999999999987766 488999999999999999999998776655555443322 2223457889999999999
Q ss_pred CCCCCCCCCHhHHhcCcccccCC
Q 014909 250 DPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 250 ~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
+.+|.+||++.++++||||.+..
T Consensus 256 ~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 256 TREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred cCCcccCcCHHHHhhChhhccCC
Confidence 99999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=329.87 Aligned_cols=249 Identities=25% Similarity=0.378 Sum_probs=213.3
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
...|.+.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+|+.+++.++||||+++++++.....++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 4569999999999999999999999999999999865421 245688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 90 LEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
|||+++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||++++++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999999998764 35899999999999999999999999999999999999999999999999998754321111
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHH
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll 245 (416)
......++..|+|||.+.+..+. .++|||||||++|+|++ |..||.+.+....+..+... ....|..++.++.+++
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELM 238 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 11122345679999999877664 78999999999999998 99999988877777776554 4455677899999999
Q ss_pred HHhcCCCCCCCCCHhHHhc
Q 014909 246 ARILDPNPMTRITIPEILE 264 (416)
Q Consensus 246 ~~~L~~dP~~R~t~~eil~ 264 (416)
.+||+.||++|||+.++++
T Consensus 239 ~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 239 RACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHccCCcccCCCHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=345.27 Aligned_cols=257 Identities=28% Similarity=0.435 Sum_probs=208.5
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK------ 83 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 83 (416)
.++|.+.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 4789999999999999999999999999999999876543 2356788999999999999999999876543
Q ss_pred --------CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc-CCCeEEee
Q 014909 84 --------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSD 154 (416)
Q Consensus 84 --------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~-~~~vkl~D 154 (416)
...|+||||+++ +|.+.+.. +.+++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 358999999974 88887754 57999999999999999999999999999999999999975 55789999
Q ss_pred cccccccccccC-CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc---
Q 014909 155 FGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--- 230 (416)
Q Consensus 155 FGla~~~~~~~~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~--- 230 (416)
||++........ ........|+..|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999875432211 1122334678999999988654445588999999999999999999998766543333221110
Q ss_pred ----------------------c-----CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 231 ----------------------F-----TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 231 ----------------------~-----~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
. ...+.++.++.+||.+||+.||.+|||+.+++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0 0123467889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=344.31 Aligned_cols=265 Identities=29% Similarity=0.392 Sum_probs=216.1
Q ss_pred cccCEEE-EeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHH-----------HHHHHHHHHHHHhcCCCCCcceE
Q 014909 9 RVGKYEV-GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-----------MAEQIKREVATMKLVKHPNVVRL 76 (416)
Q Consensus 9 ~~~~y~~-~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~hpnIv~l 76 (416)
..++|.. .+.||.|+||.||+|.+..+++.||||++......... ....+.+|+.+++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 4567764 57799999999999999999999999998754322210 11247789999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecc
Q 014909 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (416)
Q Consensus 77 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFG 156 (416)
++++......|+||||+. |+|.+++.....+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 999999999999999997 5899999888889999999999999999999999999999999999999999999999999
Q ss_pred ccccccccc------------CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHH
Q 014909 157 LSALSQQVR------------DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK 224 (416)
Q Consensus 157 la~~~~~~~------------~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~ 224 (416)
++....... .........+++.|+|||.+.+....+.++|||||||++|+|++|.+||.+.+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 987543110 01122334578899999999765555689999999999999999999998877655444
Q ss_pred HhhcCc--c--------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 225 KISAAE--F--------------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 225 ~i~~~~--~--------------------------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
.+.... . ...+..+..+.++|.+||+.+|++|||+++++.||||+....+
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 332100 0 0012357889999999999999999999999999999876443
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=345.56 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=215.3
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE--
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK-- 85 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 85 (416)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 456789999999999999999999999999999999875432 22334667889999999999999999988766554
Q ss_pred ----EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccc
Q 014909 86 ----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (416)
Q Consensus 86 ----~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~ 161 (416)
.|+|+||+ |++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 5699888875 57999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc----------
Q 014909 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------- 231 (416)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~---------- 231 (416)
.. ......+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 169 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 169 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cc-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 32 134457889999999987644456899999999999999999999987766554444322110
Q ss_pred ---------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 232 ---------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 232 ---------------------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
......++.+.+||++||+.||++|||+.++++||||.+...+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 0012358899999999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=337.23 Aligned_cols=260 Identities=24% Similarity=0.421 Sum_probs=216.7
Q ss_pred cccccccccCEEEEeEEeecCceEEEEEEECCC-----CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceE
Q 014909 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRL 76 (416)
Q Consensus 3 ~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l 76 (416)
.++....-++|++.+.||+|+||.||++.+... ...+|+|.+..... ......+.+|+.+++++ +||||+++
T Consensus 4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~ 81 (293)
T cd05053 4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINL 81 (293)
T ss_pred CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 345566778999999999999999999987643 36799999875432 22346688999999999 79999999
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCC
Q 014909 77 YEVMGSKTKIFIVLEFVTGGELFDKIVN----------------HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPE 140 (416)
Q Consensus 77 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~----------------~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~ 140 (416)
++++......|++|||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+
T Consensus 82 ~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~ 161 (293)
T cd05053 82 LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAAR 161 (293)
T ss_pred EEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccccee
Confidence 9999999999999999999999999864 245889999999999999999999999999999999
Q ss_pred cEEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCch
Q 014909 141 NLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNL 219 (416)
Q Consensus 141 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~ 219 (416)
||+++.++.+||+|||++................++..|+|||++.+..+. .++|||||||++|+|++ |..||...+.
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 999999999999999998754432111112223345789999998776664 88999999999999997 9999998887
Q ss_pred HHHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 220 MNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 220 ~~~~~~i~~~~-~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
...+..+.... ...|...+.++.+|+.+||..||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 241 EELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 77777665543 34566688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=327.80 Aligned_cols=252 Identities=31% Similarity=0.554 Sum_probs=213.5
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+++|++.+.||+|+||.||+|.+..+|+.||+|.+...........+.+.+|+.++++++|+||+++++.+......++|
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 36899999999999999999999989999999998765444444567899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~- 159 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC-
Confidence 999999999998864 245899999999999999999999999999999999999999999999999998654321
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc--hHHHHHHhhcCcc-CCCC-CCCHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN--LMNLYKKISAAEF-TCPP-WLSFTA 241 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~--~~~~~~~i~~~~~-~~~~-~~s~~~ 241 (416)
........|++.|+|||.+.+..+. .++|||||||++|+|++|..||.... .......+..+.. ..|. .++..+
T Consensus 160 -~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08224 160 -TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL 237 (267)
T ss_pred -CcccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence 1222345789999999999877764 78999999999999999999996543 2334444433322 2333 578899
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 014909 242 RKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.++|.+||..+|++|||+.+|++
T Consensus 238 ~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 238 RDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=331.93 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=208.2
Q ss_pred EEEEeEEeecCceEEEEEEECCC---CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE----
Q 014909 13 YEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK---- 85 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~---- 85 (416)
|++++.||+|+||.||.|....+ +..||+|.+...... ......+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 57889999999999999987643 478999998764332 3345678999999999999999999998765443
Q ss_pred --EEEEEeccCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccc
Q 014909 86 --IFIVLEFVTGGELFDKIVNH------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (416)
Q Consensus 86 --~~lV~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGl 157 (416)
.+++|||+++|+|..++... ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999888542 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCC
Q 014909 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPP 235 (416)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~ 235 (416)
+................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+..+ ....|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 875433221112223345678999999877666 488999999999999999 99999887777666665543 445667
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 236 WLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 236 ~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.++.++.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=331.89 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=206.3
Q ss_pred EEEEeEEeecCceEEEEEEECCCCC--eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe------CC
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------KT 84 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~ 84 (416)
|.+++.||+|+||.||+|.+..++. .+|+|.+..... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3577899999999999999877665 689999876432 23346778899999999999999999997642 23
Q ss_pred EEEEEEeccCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNH------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla 158 (416)
..+++|||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 578999999999999887432 34889999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc-cCCCCC
Q 014909 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPW 236 (416)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~ 236 (416)
................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+......+..+..+. ...++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 75432211111223346778999999987766 489999999999999999 899998877777776666543 345666
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 237 LSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 237 ~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
++..+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=331.76 Aligned_cols=253 Identities=21% Similarity=0.286 Sum_probs=212.8
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCC-----CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
...+|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 456899999999999999999987643 3789999986543 222346688999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEe
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHG----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~ 153 (416)
...|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999999986532 36778899999999999999999999999999999999999999999
Q ss_pred ecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-cc
Q 014909 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EF 231 (416)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~ 231 (416)
|||+++...............++..|+|||.+.+..+ +.++|||||||++|++++ |..||.+.+.......+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence 9999875433222122334457889999999977665 488999999999999998 99999887777666665543 34
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 232 ~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
..|..++..+.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 566778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=334.85 Aligned_cols=252 Identities=24% Similarity=0.374 Sum_probs=211.9
Q ss_pred cccCEEEEeEEeecCceEEEEEEEC-----CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
..++|.+.+.||+|+||.||+|.+. .++..+++|.+..... ...+.+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 4678999999999999999999854 3455689998865432 2346688999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~ 147 (416)
...++||||+++++|.+++..++ .+++..++.++.||+.||+|||++|++||||||+||+++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999997643 37899999999999999999999999999999999999999
Q ss_pred CCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHh
Q 014909 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (416)
Q Consensus 148 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i 226 (416)
+.++|+|||++................|++.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999998654322111122344567899999999876664 78999999999999998 99999887777776666
Q ss_pred hcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 227 SAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 227 ~~~~~-~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
..+.. ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 55543 334557899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=338.87 Aligned_cols=258 Identities=26% Similarity=0.427 Sum_probs=207.9
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe------
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------ 82 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 82 (416)
.+++|++.+.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 3789999999999999999999999999999999987543222 123456789999999999999999988743
Q ss_pred --CCEEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 83 --KTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 83 --~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
...+|+||||+.+ +|...+.. ...+++..+..++.||++||+|||++|++||||||+||++++++.++|+|||++.
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 3357999999976 67666654 4579999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCC---------CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc
Q 014909 160 LSQQVRDD---------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230 (416)
Q Consensus 160 ~~~~~~~~---------~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~ 230 (416)
........ .......|++.|+|||.+.+....+.++||||+||++|+|++|++||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 54332111 111233578889999998765444688999999999999999999999877665544432210
Q ss_pred c-----------------------CCC-------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 231 F-----------------------TCP-------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 231 ~-----------------------~~~-------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
. ..+ ..+++.+.+||.+||+.||.+|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 000 1244678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=333.43 Aligned_cols=253 Identities=33% Similarity=0.500 Sum_probs=211.5
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CEEEEEE
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKIFIVL 90 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV~ 90 (416)
|++.+.||.|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|||++++++++... ...|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999999999999998654 2333456788999999999999999999999888 8999999
Q ss_pred eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 91 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
||+++ +|.+.+... ..+++..+..++.||+.||+|||+.|++|+||+|+||++++++.+||+|||++........ ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence 99975 888888765 5799999999999999999999999999999999999999999999999999876543221 12
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc------------------
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------------------ 231 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~------------------ 231 (416)
.....++..|+|||.+.+....+.++||||||+++|+|++|+.||...+.......+.....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 23446788999999887654446899999999999999999999988776554443322100
Q ss_pred -----CC-------CCC-CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 232 -----TC-------PPW-LSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 232 -----~~-------~~~-~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
.. ... .+..+.+++++||..||.+||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00 011 38889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=350.76 Aligned_cols=255 Identities=22% Similarity=0.354 Sum_probs=207.8
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCC-----CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVM 80 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~ 80 (416)
...-++|++++.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+|+++. ||||+++++++
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 34456888999999999999999987432 3469999996543 2233567899999999996 99999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhC-------------------------------------------------------
Q 014909 81 GSKTKIFIVLEFVTGGELFDKIVNH------------------------------------------------------- 105 (416)
Q Consensus 81 ~~~~~~~lV~E~~~gg~L~~~i~~~------------------------------------------------------- 105 (416)
.+....|+||||+++|+|.+++...
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 9999999999999999999988642
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEe
Q 014909 106 -----------------------------------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL 144 (416)
Q Consensus 106 -----------------------------------------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl 144 (416)
..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 136778889999999999999999999999999999999
Q ss_pred ccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchH-HH
Q 014909 145 DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM-NL 222 (416)
Q Consensus 145 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~-~~ 222 (416)
+.++.+||+|||++................+++.|+|||++.+..+. .++|||||||++|+|++ |..||...... ..
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~ 349 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence 99999999999998754332221122334567889999999876664 89999999999999997 99999875443 33
Q ss_pred HHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 223 YKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 223 ~~~i~~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+..+..+ ....+..++.++.+++.+||+.||++|||+.++.+
T Consensus 350 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 350 YNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 3333333 33445668899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=305.97 Aligned_cols=257 Identities=34% Similarity=0.510 Sum_probs=217.2
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
.+|.-.+.||+|.||+|++|++..+++.||+|.++.... +++.-....+||.+++.++|.|||+++++..++..+.+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 356667889999999999999999999999999987653 3344566789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 91 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
|||.. +|..+... ++.+..+.++.++.|++.||.|||++++.||||||.|+||+.+|.+|++|||+|+-++-.- .-
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv--rc 157 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RC 157 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--Ee
Confidence 99975 78777765 5779999999999999999999999999999999999999999999999999998665321 12
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHh-hCCCCCCCCchHHHHHHhhcCc--c---------CCC---
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL-AGYLPFDDSNLMNLYKKISAAE--F---------TCP--- 234 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml-~G~~Pf~~~~~~~~~~~i~~~~--~---------~~~--- 234 (416)
....+-|..|.+|.++.+...++...|+||.|||+.|+. +|.+.|++.+..+...+|...- + ..|
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 334467899999999998776678899999999999998 5999999998887777663210 0 011
Q ss_pred ---------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 235 ---------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 235 ---------------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
|.++..-++|++++|.-+|.+|++++++++||||...
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 1134567899999999999999999999999999753
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=344.29 Aligned_cols=260 Identities=28% Similarity=0.433 Sum_probs=218.5
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-----EE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-----KI 86 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 86 (416)
+|++.+.||+|+||.||+|.+..+++.||||.+.... ......+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 6999999999999999999999899999999987543 22334577899999999999999999999987765 78
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|++|||+.+ +|.+.+.....+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999985 8999998878899999999999999999999999999999999999999999999999999886543221
Q ss_pred -CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccC-------------
Q 014909 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT------------- 232 (416)
Q Consensus 167 -~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~------------- 232 (416)
........+++.|+|||++.+....+.++|+||+|+++|+|++|..||.+.+..+.+..+......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 012344568899999999987734458899999999999999999999887766555544321100
Q ss_pred ------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 233 ------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 233 ------------------~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
..+.++.++.+||.+||+.+|++|||+++++.||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 11236788999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=337.48 Aligned_cols=259 Identities=30% Similarity=0.499 Sum_probs=211.5
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-- 84 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 84 (416)
...+++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 34678999999999999999999999999999999999764322 223456778999999999999999999987654
Q ss_pred --------EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeec
Q 014909 85 --------KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (416)
Q Consensus 85 --------~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DF 155 (416)
.+|+||||+++ +|.+.+... ..+++..+..++.||+.||+|||++||+||||||+||++++++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 79999999987 677776653 46899999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc--c--
Q 014909 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--F-- 231 (416)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~--~-- 231 (416)
|++........ .......++..|+|||.+.+....+.++||||+||++|+|++|++||...+.......+.... .
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 161 GLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred cccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99875433211 122233567889999998765444688999999999999999999998766554443332210 0
Q ss_pred --------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 232 --------------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 232 --------------------------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
.....++..+.+++.+||+.||++|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0011367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=345.86 Aligned_cols=252 Identities=23% Similarity=0.393 Sum_probs=204.2
Q ss_pred cCEEEEeEEeecCceEEEEEEECC-----CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe-C
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS-K 83 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~-~ 83 (416)
++|++.+.||+|+||.||+|.... +++.||+|++..... ....+.+.+|+.+++++ +||||+++++++.. .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 489999999999999999997533 457899999875432 22346678899999999 79999999998764 4
Q ss_pred CEEEEEEeccCCCchHHHHHhC----------------------------------------------------------
Q 014909 84 TKIFIVLEFVTGGELFDKIVNH---------------------------------------------------------- 105 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~---------------------------------------------------------- 105 (416)
..++++|||+++++|.+++...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 6789999999999999988642
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCCcccccc
Q 014909 106 ---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182 (416)
Q Consensus 106 ---~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 182 (416)
.++++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++................++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 25788899999999999999999999999999999999999999999999998754322111112234456789999
Q ss_pred hhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHH-HHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCH
Q 014909 183 EVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN-LYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITI 259 (416)
Q Consensus 183 Evl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~-~~~~i~~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~ 259 (416)
|++.+..+. .++|||||||++|+|++ |..||.+....+ ....+... ....|...++++.+++.+||+.+|++||++
T Consensus 245 E~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 323 (337)
T cd05054 245 ESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTF 323 (337)
T ss_pred HHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 999887775 78999999999999997 999998754333 23333332 234455678999999999999999999999
Q ss_pred hHHhcC
Q 014909 260 PEILED 265 (416)
Q Consensus 260 ~eil~h 265 (416)
.++++|
T Consensus 324 ~ell~~ 329 (337)
T cd05054 324 SELVEI 329 (337)
T ss_pred HHHHHH
Confidence 999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=331.28 Aligned_cols=254 Identities=30% Similarity=0.446 Sum_probs=210.0
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFI 88 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~l 88 (416)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|+.+++.++||||+++++++.+ ...+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 479999999999999999999999999999999875432 2345778999999999999999999998854 457899
Q ss_pred EEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 89 VLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
||||++|++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999887653 346899999999999999999999999999999999999999999999999998643321
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc-----hHHHHHHhhcCc-cCCC----
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-----LMNLYKKISAAE-FTCP---- 234 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~-----~~~~~~~i~~~~-~~~~---- 234 (416)
......++..|+|||.+.+..++ .++|||||||++|+|++|..||.... ..+....+.... ...+
T Consensus 159 ----~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 159 ----LAGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ----ccccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 12244678899999999877665 78999999999999999999998652 223333333211 1111
Q ss_pred --CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 235 --PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 235 --~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
..+++.+.+||.+||..||.+|||+.|+++||||++.
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 1246789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=352.77 Aligned_cols=237 Identities=23% Similarity=0.400 Sum_probs=209.3
Q ss_pred EEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014909 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (416)
Q Consensus 15 ~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 94 (416)
-.+.||.|+.|.||+|+. .++.||||.++. .-..+|+-|++|+|||||.+.++|.....++||||||.
T Consensus 128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhhccCcccceeeeec--cCceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 357899999999999997 478899997642 22357889999999999999999999999999999999
Q ss_pred CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCccccc
Q 014909 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (416)
Q Consensus 95 gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 174 (416)
.|.|+..++....++......|..+|+.|+.|||.+.|||||||.-||||+.+..|||+|||.+..... .......+
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~---~STkMSFa 272 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD---KSTKMSFA 272 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh---hhhhhhhh
Confidence 999999999999999999999999999999999999999999999999999999999999998875432 23345679
Q ss_pred CCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC--ccCCCCCCCHHHHHHHHHhcCCC
Q 014909 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKLIARILDPN 252 (416)
Q Consensus 175 gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~ll~~~L~~d 252 (416)
||..|||||++.+.+.. .++|||||||||||||||..||.+-+...++.-+... ..+.|..++..++-||+.||+-.
T Consensus 273 GTVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sK 351 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSK 351 (904)
T ss_pred hhHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcC
Confidence 99999999999988875 9999999999999999999999987766655444433 34667889999999999999999
Q ss_pred CCCCCCHhHHhcCcc
Q 014909 253 PMTRITIPEILEDEW 267 (416)
Q Consensus 253 P~~R~t~~eil~h~~ 267 (416)
|..||++.+||.|-=
T Consensus 352 pRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 352 PRNRPSFRQILLHLD 366 (904)
T ss_pred CCCCccHHHHHHHHh
Confidence 999999999999843
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=368.24 Aligned_cols=151 Identities=31% Similarity=0.629 Sum_probs=141.8
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
.+++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++.....+|+
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 46899999999999999999999999999999999987665555566789999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
||||+.|++|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=364.42 Aligned_cols=246 Identities=31% Similarity=0.521 Sum_probs=206.5
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEE-EEe------C
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEV-MGS------K 83 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~-~~~------~ 83 (416)
++++.+.|.+|+|+.||+|.+...|..||+|.+-.. ++...+.+++||.+|++|+ |+|||.+++. ... .
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 568899999999999999999988899999988643 5567889999999999997 9999999993 211 2
Q ss_pred CEEEEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~al~~LH~~g--ivHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
-.++|.||||.||.|-|++.. ..+|+|.++.+||.|+++||.+||... |||||||-|||||+.+|+.||||||.|+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 357899999999999999985 356999999999999999999999998 9999999999999999999999999986
Q ss_pred ccccccCC--CC--c---ccccCCcccccchhhc---cCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC
Q 014909 160 LSQQVRDD--GL--L---HTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 229 (416)
Q Consensus 160 ~~~~~~~~--~~--~---~~~~gt~~y~aPEvl~---~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~ 229 (416)
-.-..... +. . -...-|+.|+|||++. +.+. ++|+|||+|||+||-|+....||++... ..|..+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng 269 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNG 269 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEec
Confidence 32221110 00 0 1124689999999984 4444 5999999999999999999999987633 246778
Q ss_pred ccCCCC--CCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 230 EFTCPP--WLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 230 ~~~~~~--~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.|.+|+ .+|..+.+||+.||++||++||++.+++.+
T Consensus 270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 888887 489999999999999999999999998853
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=334.66 Aligned_cols=253 Identities=20% Similarity=0.282 Sum_probs=211.0
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCC----------------CeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETG----------------EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~----------------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn 72 (416)
..++|++++.||+|+||.||+|.+...+ ..||+|.+..... ....+.+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 3568999999999999999999876543 4589999875432 234678899999999999999
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCchHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCc
Q 014909 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141 (416)
Q Consensus 73 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-----------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~N 141 (416)
|+++++++..+...+++|||+++++|.+++.... .+++..++.++.|++.||+|||++|++||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999998765 68999999999999999999999999999999999
Q ss_pred EEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh--CCCCCCCCch
Q 014909 142 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA--GYLPFDDSNL 219 (416)
Q Consensus 142 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~--G~~Pf~~~~~ 219 (416)
|+++.++.++|+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999875432222222234456788999999887655 488999999999999998 7889987666
Q ss_pred HHHHHHhhcC--------ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 220 MNLYKKISAA--------EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 220 ~~~~~~i~~~--------~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
...+..+... ....++.++.++.+|+.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 6555544321 12344567899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=327.36 Aligned_cols=244 Identities=23% Similarity=0.346 Sum_probs=205.2
Q ss_pred EEeecCceEEEEEEE--CCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014909 18 TIGEGTFAKVKFARN--SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (416)
Q Consensus 18 ~LG~G~fg~V~~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (416)
.||+|+||.||+|.. ..++..+|+|++.... ......+.+.+|+.+++.++||||+++++++. ....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999964 4567899999986543 23345678899999999999999999999875 4567899999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC-CCccccc
Q 014909 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTC 174 (416)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~~ 174 (416)
|+|.+++.....+++..+..++.|++.||+|||++|++||||||.||+++.++.+||+|||++......... .......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 999999988888999999999999999999999999999999999999999999999999998754322110 0112234
Q ss_pred CCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCC
Q 014909 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPN 252 (416)
Q Consensus 175 gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ll~~~L~~d 252 (416)
+++.|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+..+. ...|..+++++.+||.+||+.|
T Consensus 160 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 4678999999876655 478999999999999998 999999877776666666543 4567779999999999999999
Q ss_pred CCCCCCHhHHhc
Q 014909 253 PMTRITIPEILE 264 (416)
Q Consensus 253 P~~R~t~~eil~ 264 (416)
|++||++++|.+
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=334.98 Aligned_cols=259 Identities=24% Similarity=0.419 Sum_probs=216.1
Q ss_pred ccccccccCEEEEeEEeecCceEEEEEEEC-------CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcce
Q 014909 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNS-------ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75 (416)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~ 75 (416)
++......+|++.+.||+|+||.||+|++. ..+..||+|.+..... ......+.+|+.+++.+ +||||++
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~ 85 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIIN 85 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchh
Confidence 455667789999999999999999999753 2345799999875421 22356789999999999 7999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCC
Q 014909 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 139 (416)
Q Consensus 76 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp 139 (416)
+++++......|+||||+++|+|.+++... ..++...+..++.||+.||.|||++|++||||||
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 999999999999999999999999999763 2467788899999999999999999999999999
Q ss_pred CcEEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCc
Q 014909 140 ENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSN 218 (416)
Q Consensus 140 ~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~ 218 (416)
+||+++.++.+||+|||++................+++.|+|||++.+..+. .++||||||+++|+|++ |..||.+.+
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999998755432222222334567789999999876664 78999999999999998 899999888
Q ss_pred hHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 219 LMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 219 ~~~~~~~i~~~~-~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.......+.... ...+..++.++.+|+.+||..+|++|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 877777765543 34456688999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=326.16 Aligned_cols=248 Identities=25% Similarity=0.434 Sum_probs=209.4
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
..+|++.+.||+|+||.||+|.... +..+|+|.+...... ...+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 3568999999999999999998754 567999988654321 35688899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
|||+++|+|.+++... +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........ .
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-T 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-e
Confidence 9999999999998753 4689999999999999999999999999999999999999999999999998874322111 1
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHHHHHHH
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIA 246 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ll~ 246 (416)
......++..|+|||++.+..+. .++||||||+++|+|++ |+.||...+.......+..+. ...|...+..+.+++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMY 235 (256)
T ss_pred ccCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 11122345689999999877664 78999999999999999 999999888777777776553 3345567889999999
Q ss_pred HhcCCCCCCCCCHhHHhc
Q 014909 247 RILDPNPMTRITIPEILE 264 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~ 264 (416)
+||+.||++|||++++++
T Consensus 236 ~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 236 SCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=341.57 Aligned_cols=259 Identities=27% Similarity=0.410 Sum_probs=210.5
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC----
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK---- 83 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 83 (416)
..-++|++.+.||+|+||.||+|.+..+++.||+|.+.+.... ....+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 3458899999999999999999999999999999998764322 22346688899999999999999999988543
Q ss_pred --CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccc
Q 014909 84 --TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (416)
Q Consensus 84 --~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~ 161 (416)
...|++++++ |++|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+||++++++.+||+|||++...
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 3478899887 6789887754 56999999999999999999999999999999999999999999999999998743
Q ss_pred ccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-----------
Q 014909 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----------- 230 (416)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~----------- 230 (416)
.. ......|++.|+|||++.+....+.++||||+||++|+|++|+.||...+.......+....
T Consensus 171 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 171 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred cc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 21 22345788999999998764444588999999999999999999998765544333221100
Q ss_pred ------------cCCC--------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 231 ------------FTCP--------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 231 ------------~~~~--------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
...| ...++++.+||.+||+.||.+|||+.+++.||||.+...+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~ 309 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence 0000 1257889999999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=334.59 Aligned_cols=253 Identities=21% Similarity=0.339 Sum_probs=213.2
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCC-----CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
.+.+|++.+.||.|+||.||+|.+..+ ++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 456788999999999999999987543 5789999987543 233457788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC
Q 014909 84 TKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~ 147 (416)
...++++||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998532 247888899999999999999999999999999999999999
Q ss_pred CCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHh
Q 014909 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (416)
Q Consensus 148 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i 226 (416)
+.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999875432222222233456789999999987666 478999999999999998 99999988777777777
Q ss_pred hcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 227 SAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 227 ~~~~~-~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
..... ..|..++..+.+|+.+||+.+|.+||++.+|+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 240 RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 65543 456678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=333.73 Aligned_cols=249 Identities=22% Similarity=0.360 Sum_probs=207.8
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCC--eEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 87 (416)
++|++.+.||+|+||.||+|....++. .+++|.+... ......+.+.+|+.+++++ +||||+++++++......|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 679999999999999999999877665 4688877532 1223356788999999999 7999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeE
Q 014909 88 IVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vk 151 (416)
+||||+++++|.+++.... .+++..++.++.||+.||+|||++|++||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997642 478899999999999999999999999999999999999999999
Q ss_pred EeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-
Q 014909 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA- 229 (416)
Q Consensus 152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~- 229 (416)
|+|||++....... .......+..|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+...
T Consensus 160 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 160 IADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred ECCcCCCcccccee---ccCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 99999986322110 01112234579999999877664 88999999999999997 99999988877777766554
Q ss_pred ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 230 EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 230 ~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
....|..++.++.+|+.+||+.+|.+|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 234556689999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=329.75 Aligned_cols=252 Identities=22% Similarity=0.364 Sum_probs=209.8
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCC----eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
...+|++.+.||+|+||.||+|.+..+++ .||+|++.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 45689999999999999999999877766 48999986543 23345678899999999999999999999875 4
Q ss_pred EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
..+++|||+++|+|.+.+... +.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 578999999999999999764 5699999999999999999999999999999999999999999999999999876543
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHH
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 241 (416)
...........+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...........+... ....++..+.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHH
Confidence 2111111223456789999999877765 88999999999999998 99999877666555555443 334556789999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 014909 242 RKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.+++.+||..||++||++.+++.
T Consensus 241 ~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 241 YMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=334.25 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=212.6
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
.|...+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++|||++++++++.+....|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 36677889999999999999999999999999976554444455778899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 92 FVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 92 ~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
|+.| +|.+.+.. ..++++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++.... ..
T Consensus 102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~~ 174 (313)
T cd06633 102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------PA 174 (313)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------CC
Confidence 9975 77777765 4578999999999999999999999999999999999999999999999999875321 22
Q ss_pred ccccCCcccccchhhcc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccC--CCCCCCHHHHHHHH
Q 014909 171 HTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT--CPPWLSFTARKLIA 246 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~--~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~ll~ 246 (416)
....|+..|+|||++.. ....+.++|||||||++|+|++|..||...+.......+.....+ ..+.++..+.+|+.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 254 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVD 254 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 34578999999999852 233347899999999999999999999877665544444333221 12346788999999
Q ss_pred HhcCCCCCCCCCHhHHhcCcccccC
Q 014909 247 RILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
+||+.+|.+||++.+++.||||...
T Consensus 255 ~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 255 YCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHccCChhhCcCHHHHhcCcccCCC
Confidence 9999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=320.71 Aligned_cols=249 Identities=33% Similarity=0.554 Sum_probs=213.9
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
.|++.+.||+|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++||||+++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999998999999999976543 245788999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 92 FVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 92 ~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
|++|++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999998876 5799999999999999999999999999999999999999999999999999875443211 3
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC-ccCCC--CCCCHHHHHHHHH
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-EFTCP--PWLSFTARKLIAR 247 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~-~~~~~--~~~s~~~~~ll~~ 247 (416)
....|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+... ....+ ..++..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 45678999999999987664 48899999999999999999999877544333333222 22222 2248899999999
Q ss_pred hcCCCCCCCCCHhHHhcCcc
Q 014909 248 ILDPNPMTRITIPEILEDEW 267 (416)
Q Consensus 248 ~L~~dP~~R~t~~eil~h~~ 267 (416)
||+.||++|||+.++++|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=329.10 Aligned_cols=248 Identities=23% Similarity=0.404 Sum_probs=212.7
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
-.+|++.+.||.|+||.||+|.+.. +..+|+|++..... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4579999999999999999999987 88999999876532 2345688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 90 LEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
|||+++++|.+++... ..++...+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-- 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-- 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc--
Confidence 9999999999999763 468999999999999999999999999999999999999999999999999987543211
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHH
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll 245 (416)
.......++..|+|||++....+. .++||||||+++|+|++ |+.||...+..+.+..+... ....+...++++.+++
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence 111233456789999999876664 78999999999999998 89999888777776666543 3455667899999999
Q ss_pred HHhcCCCCCCCCCHhHHhc
Q 014909 246 ARILDPNPMTRITIPEILE 264 (416)
Q Consensus 246 ~~~L~~dP~~R~t~~eil~ 264 (416)
.+||+.||.+|||+.++++
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 238 LECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=335.55 Aligned_cols=254 Identities=24% Similarity=0.405 Sum_probs=210.9
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECC-------CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEV 79 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 79 (416)
..-++|.+++.||+|+||.||+|.+.. ....+|+|.+..... ......+.+|+.+++.+ +||||++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 345789999999999999999998632 345799999875332 23356788999999999 59999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEE
Q 014909 80 MGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 143 (416)
Q Consensus 80 ~~~~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NIL 143 (416)
+.....+|++|||+++|+|.+++... ..++...+..++.||+.||.|||++|++||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 99999999999999999999999753 24788889999999999999999999999999999999
Q ss_pred eccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHH
Q 014909 144 LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNL 222 (416)
Q Consensus 144 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~ 222 (416)
++.++.+||+|||++................++..|+|||++.+..+. .++|||||||++|+|++ |..||.+.+....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcC-ccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999998754322111112223345689999999876664 88999999999999999 9999998877777
Q ss_pred HHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 223 YKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 223 ~~~i~~~~-~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+..+.... ...|..++.++.+|+.+||+.||++|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 246 FKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 76665543 3456668889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=360.29 Aligned_cols=260 Identities=25% Similarity=0.406 Sum_probs=196.1
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCC-CCeEEEEE--------------eechhhhcHHHHHHHHHHHHHHhcCCCCCc
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSET-GEPVALKI--------------LDKEKVLKHKMAEQIKREVATMKLVKHPNV 73 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~-~~~vaiK~--------------i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 73 (416)
..++|++++.||+|+||+||+|..+.. +...++|. +.+...........+.+|+.+|+.++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 457899999999999999999876432 22222221 111111122345678899999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC
Q 014909 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (416)
Q Consensus 74 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~ 148 (416)
+++++++.+.+..|+|+|++.+ +|++++... .......++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 9999999999999999999964 777776542 2344677889999999999999999999999999999999999
Q ss_pred CeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCC-CCCCCc--h-HHHHH
Q 014909 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL-PFDDSN--L-MNLYK 224 (416)
Q Consensus 149 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~-Pf~~~~--~-~~~~~ 224 (416)
.+||+|||++....... .......+||+.|+|||++.+..+. .++|||||||++|+|++|.. ||.... . ..+..
T Consensus 305 ~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 305 KIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999997653321 1122346799999999999887775 88999999999999999875 443321 1 11111
Q ss_pred Hhhc---------------------Ccc-----CCC-----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 225 KISA---------------------AEF-----TCP-----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 225 ~i~~---------------------~~~-----~~~-----~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
.+.. ..+ .++ ..++.++.++|.+||+.||.+|||+.|+|.||||...
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 1110 000 000 1245678889999999999999999999999999764
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=341.17 Aligned_cols=254 Identities=20% Similarity=0.328 Sum_probs=203.1
Q ss_pred eEEeec--CceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014909 17 RTIGEG--TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (416)
Q Consensus 17 ~~LG~G--~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 94 (416)
..||.| +||+||+|.+..+|+.||+|++....... ...+.+++|+.+++.++||||+++++++..++..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 345666 99999999999999999999987654322 345789999999999999999999999999999999999999
Q ss_pred CCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC----
Q 014909 95 GGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG---- 168 (416)
Q Consensus 95 gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~---- 168 (416)
+++|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99999998764 358999999999999999999999999999999999999999999999998654322111110
Q ss_pred -CcccccCCcccccchhhccCC-CCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc---------------
Q 014909 169 -LLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF--------------- 231 (416)
Q Consensus 169 -~~~~~~gt~~y~aPEvl~~~~-~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~--------------- 231 (416)
......++..|+|||++.+.. ..+.++||||+||++|+|++|.+||.................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 111234567899999997642 235889999999999999999999987654433322211110
Q ss_pred --------------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 232 --------------------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 232 --------------------------------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
..+..++..+.+||++||+.||++|||+.++++||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0111256789999999999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=318.70 Aligned_cols=258 Identities=26% Similarity=0.406 Sum_probs=210.0
Q ss_pred cccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE---
Q 014909 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG--- 81 (416)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--- 81 (416)
++...-.+|++.+.||.|+|+.|+++++..+++.||+|.+.... .+..+...+|+...++++||||++++++..
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 34556789999999999999999999999999999999997654 334678999999999999999999987653
Q ss_pred --eCCEEEEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCcEEeccCCCeEEe
Q 014909 82 --SKTKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVS 153 (416)
Q Consensus 82 --~~~~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~al~~LH~~g--ivHrDlkp~NILl~~~~~vkl~ 153 (416)
.....|+++.|...|+|.+.|... ..++|.++..||.+|++||++||+.. .+||||||.|||+++.+..+|.
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence 334599999999999999998763 26999999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccccCCCC-------cccccCCcccccchhhccCCC--CCChhhHHHHHHHHHHHhhCCCCCCCCchH--HH
Q 014909 154 DFGLSALSQQVRDDGL-------LHTTCGTPNYVAPEVLNDRGY--DGSTADLWSCGVILFVLLAGYLPFDDSNLM--NL 222 (416)
Q Consensus 154 DFGla~~~~~~~~~~~-------~~~~~gt~~y~aPEvl~~~~~--~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~--~~ 222 (416)
|||.++.....-.+.. ......|.+|+|||.+.-+.+ .+.++|||||||+||+|+.|..||+..-.. .+
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 9999875432211110 112345889999999875433 358899999999999999999999742111 11
Q ss_pred HHHhhcCccCCCC--CCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 223 YKKISAAEFTCPP--WLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 223 ~~~i~~~~~~~~~--~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
...+..+.+.+|. .+|+.+.+||+.||++||.+||++.+++.+
T Consensus 252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1223444555543 389999999999999999999999999863
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=333.75 Aligned_cols=254 Identities=22% Similarity=0.358 Sum_probs=209.0
Q ss_pred ccccCEEEEeEEeecCceEEEEEEE-----CCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG 81 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 81 (416)
...++|.+.+.||+|+||.||+|.+ ..++..||+|.+..... ....+.+.+|+.+++++ +||||+++++.+.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 3445799999999999999999975 23456899999875432 23456789999999999 7999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 82 SKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 82 ~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
..+..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++|++|+||||+|||++.++.++|+|||++.
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999999997643 38999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHh-hcC-ccCCCCC
Q 014909 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAA-EFTCPPW 236 (416)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i-~~~-~~~~~~~ 236 (416)
...............+++.|+|||.+.+..+. .++||||+||++|+|++ |..||........+.+. ..+ ....+..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH 268 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCC
Confidence 54322111111223457889999999877664 88999999999999998 99999876655444333 222 2334566
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 237 ~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.++.+.+|+.+||+.+|++|||+.++++
T Consensus 269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 269 APAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 8899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=333.46 Aligned_cols=255 Identities=22% Similarity=0.328 Sum_probs=206.1
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV 89 (416)
.+|+..+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. ||||+++++++..+...+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4567788999999999999999999999999998764322 34567889999999996 99999999999999999999
Q ss_pred EeccCCCchHH---HHH--hCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 90 LEFVTGGELFD---KIV--NHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 90 ~E~~~gg~L~~---~i~--~~~~l~e~~~~~~~~qll~al~~LH~~-givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
|||+.+ ++.+ .+. ....+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999865 4443 322 236799999999999999999999975 999999999999999999999999999864322
Q ss_pred ccCCCCcccccCCcccccchhhccC--CCCCChhhHHHHHHHHHHHhhCCCCCCCCchH-HHHHHhhcCc-cCC----CC
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAE-FTC----PP 235 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~--~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~-~~~~~i~~~~-~~~----~~ 235 (416)
........|++.|+|||++.+. ...+.++||||+||++|+|++|+.||...... .....+.... ... +.
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 161 ---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred ---CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 1222345689999999999765 23458899999999999999999999765421 2222222221 111 12
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 236 ~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
.++.++.+|+.+||+.||++|||+++++.||||+..
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 378899999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=324.45 Aligned_cols=248 Identities=22% Similarity=0.370 Sum_probs=209.1
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
-++|++.+.||+|++|.||+|.+. +++.||+|.+..... ..+.+.+|+.++++++||||+++++++......|++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 467999999999999999999975 456799999875432 245688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 90 LEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
|||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999999997654 6899999999999999999999999999999999999999999999999998765421111
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHH
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll 245 (416)
......++..|+|||++.+..+ +.++||||||+++|+|++ |+.||.+.+.......+... ....+...+..+.+++
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM 237 (261)
T ss_pred -ccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 0111122457999999887666 478999999999999999 99999987777666666544 2345566889999999
Q ss_pred HHhcCCCCCCCCCHhHHhc
Q 014909 246 ARILDPNPMTRITIPEILE 264 (416)
Q Consensus 246 ~~~L~~dP~~R~t~~eil~ 264 (416)
.+||+.+|.+||++.++++
T Consensus 238 ~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 238 LDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHhhcCcccCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=342.56 Aligned_cols=261 Identities=31% Similarity=0.438 Sum_probs=213.3
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe--CC
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS--KT 84 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~--~~ 84 (416)
...++|++.+.||+|+||.||+|.+..+|+.+|+|.+..... .......+.+|+.+++++ +||||+++++++.. ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 346789999999999999999999998999999998865322 222345677899999999 99999999998864 34
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
..|+||||+.+ +|..++... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 83 DIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred eEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 68999999975 999888765 7899999999999999999999999999999999999999999999999998755432
Q ss_pred cCC---CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-----------
Q 014909 165 RDD---GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----------- 230 (416)
Q Consensus 165 ~~~---~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~----------- 230 (416)
... .......||+.|+|||++.+....+.++||||||+++|+|++|+.||.+........++....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 211 223345689999999998765555688999999999999999999998766544333221110
Q ss_pred ----------------c----CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 231 ----------------F----TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 231 ----------------~----~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
. ...+.++.++.+||.+||+.||++|||+.++++|||+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0 0112368899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=333.99 Aligned_cols=254 Identities=27% Similarity=0.405 Sum_probs=215.2
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
.|...+.||+|+||.||+|.+..++..||+|.+.............+.+|+.+++.++|||++++++++.+....|+|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 37888999999999999999999999999999976544444556789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 92 FVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 92 ~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
|+.| +|.+.+.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++..... .
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~ 178 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------A 178 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------c
Confidence 9976 77777654 45689999999999999999999999999999999999999999999999998764322 2
Q ss_pred ccccCCcccccchhhcc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc-CC-CCCCCHHHHHHHH
Q 014909 171 HTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TC-PPWLSFTARKLIA 246 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~--~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~-~~-~~~~s~~~~~ll~ 246 (416)
....|++.|+|||.+.. ....+.++||||+||++|+|++|..||...+.......+..... .. +..++..+++|+.
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 258 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 258 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHH
Confidence 34578999999999842 23335789999999999999999999987766655555544332 22 2347889999999
Q ss_pred HhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 247 RILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
+||+.+|.+||++.++++|+|+....
T Consensus 259 ~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 259 SCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHccCCcccCcCHHHHHhChhhhccC
Confidence 99999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=329.60 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=210.4
Q ss_pred cccCEEEEeEEeecCceEEEEEEEC-----CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
...+|.+.+.||+|+||.||++... .++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 3457889999999999999999743 346689999876432 33457899999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHG---------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~---------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~ 148 (416)
...|++|||+++++|.+++...+ .+++..+..++.||+.|++|||++|++||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999999999999997653 478899999999999999999999999999999999999999
Q ss_pred CeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhh
Q 014909 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS 227 (416)
Q Consensus 149 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~ 227 (416)
.+||+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |.+||...........+.
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 9999999998644321111112233457889999999877765 88999999999999998 999998777666665554
Q ss_pred cC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 228 AA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 228 ~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.+ ....|..+++.+.+|+.+||+.||.+||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 44 34456678999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=326.71 Aligned_cols=261 Identities=31% Similarity=0.581 Sum_probs=237.3
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 85 (416)
..-+..|.+.+.||+|+|++|.+++++++.+.||+|+++++-....+.+..++.|-.+...- +||.+|.++..|++++.
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 45677899999999999999999999999999999999998887777788899998888766 69999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+++|.||++||+|.-.+++..+++|+.|++|...|+.||.|||++||+.||||.+|+|+|..|++||+|+|+++. ...
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke--~l~ 403 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GLG 403 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc--CCC
Confidence 999999999999998899999999999999999999999999999999999999999999999999999999874 334
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCC--------CchHHHHHHhhcCccCCCCCC
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD--------SNLMNLYKKISAAEFTCPPWL 237 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~--------~~~~~~~~~i~~~~~~~~~~~ 237 (416)
......+.||||.|+|||++.+..| +..+|.|+|||+++||++|+.||+- .+..-+++-|....+.+|..+
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsl 482 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSL 482 (593)
T ss_pred CCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccccee
Confidence 5556788999999999999999888 5999999999999999999999962 223456777888889999999
Q ss_pred CHHHHHHHHHhcCCCCCCCCC------HhHHhcCccccc
Q 014909 238 SFTARKLIARILDPNPMTRIT------IPEILEDEWFKK 270 (416)
Q Consensus 238 s~~~~~ll~~~L~~dP~~R~t------~~eil~h~~~~~ 270 (416)
|-.+..+++..|++||..|.. +.++..|+||+.
T Consensus 483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 999999999999999999974 789999999984
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=325.21 Aligned_cols=248 Identities=24% Similarity=0.421 Sum_probs=208.1
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
.+|++.+.||+|+||.||+|.+. ++..+|+|++...... ...+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 46889999999999999999886 4667999998654321 345778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 91 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
||++|++|.+++... ..+++..+..++.||+.|++|||++|++||||||+||+++.++.+||+|||++........ ..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TS 157 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-cc
Confidence 999999999999764 4689999999999999999999999999999999999999999999999999875422110 01
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHHHH
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIAR 247 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll~~ 247 (416)
.....++..|+|||.+.+..+. .++||||||+++|+|++ |..||...+.......+... ....|...+..+.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 1112234579999999877664 78999999999999998 89999887776666666544 345566689999999999
Q ss_pred hcCCCCCCCCCHhHHhcC
Q 014909 248 ILDPNPMTRITIPEILED 265 (416)
Q Consensus 248 ~L~~dP~~R~t~~eil~h 265 (416)
||..+|++|||+.++++.
T Consensus 237 cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=322.37 Aligned_cols=251 Identities=29% Similarity=0.483 Sum_probs=219.6
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
+|++.+.||+|+||.||++.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999997654332 335667889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 92 FVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 92 ~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999998866 356899999999999999999999999999999999999999999999999998765432
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc-CCCCCCCHHHHHHHH
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIA 246 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~ll~ 246 (416)
......|++.|+|||.+.+..+. .++|+||+|+++|+|++|+.||...+.......+....+ ..+..++.++++++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 33345789999999999877664 789999999999999999999998887766666555443 344568899999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccc
Q 014909 247 RILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~h~~~ 268 (416)
+||..+|++|||+.++++||++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 235 SMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=330.44 Aligned_cols=257 Identities=29% Similarity=0.485 Sum_probs=220.0
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
.....|++.+.||+|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++||||+++++.+......|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 345678999999999999999999998899999999975432 3567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
+++||++|++|.+++.... .++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 9999999999999998876 89999999999999999999999999999999999999999999999999876433211
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-cC--CCCCCCHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FT--CPPWLSFTARK 243 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~-~~--~~~~~s~~~~~ 243 (416)
.......+++.|+|||++.+..++ .++|+|||||++|+|++|..||...+.......+.... .. .+..++.++.+
T Consensus 171 -~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (286)
T cd06614 171 -SKRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKD 248 (286)
T ss_pred -hhhccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHH
Confidence 122344678899999999877664 88999999999999999999998776655444443322 12 22237889999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 244 LIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
+|.+||+.+|.+|||+.++++||||.+.
T Consensus 249 li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 249 FLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred HHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 9999999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=324.93 Aligned_cols=249 Identities=20% Similarity=0.352 Sum_probs=209.3
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
..++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++.+.+....|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 4568999999999999999999975 466799998865332 24678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 89 VLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
+|||+++++|.+++... ..++...+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999999998753 4688899999999999999999999999999999999999999999999999875432111
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 244 (416)
.......++..|+|||.+....+ +.++|||||||++|+|++ |..||...........+... ..+.+..++.++.++
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (261)
T cd05072 159 -TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDI 236 (261)
T ss_pred -eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11122345678999999987665 478999999999999998 99999887776666665544 233344578999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc
Q 014909 245 IARILDPNPMTRITIPEILE 264 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~ 264 (416)
+.+||..+|++|||++++++
T Consensus 237 i~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 237 MKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=324.07 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=208.8
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
.++|++.+.||+|+||.||+|.... +..+|+|.+..... ..+.+.+|+.++++++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4679999999999999999998754 45699999875432 135688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
|||+.+|+|.+++... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++........ .
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T 156 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence 9999999999999764 4689999999999999999999999999999999999999999999999998864422111 1
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHHHHHHH
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIA 246 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ll~ 246 (416)
......++..|+|||.+.+..+. .++|||||||++|+|++ |..||...+.......+.... ...+...+..+.+++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred ecCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 11122345679999999876664 78999999999999998 999998877776666665543 3345557899999999
Q ss_pred HhcCCCCCCCCCHhHHhcC
Q 014909 247 RILDPNPMTRITIPEILED 265 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~h 265 (416)
+||+.||.+|||+.+++.+
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHcCCCcccCCCHHHHHHh
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=329.61 Aligned_cols=259 Identities=32% Similarity=0.558 Sum_probs=216.5
Q ss_pred CEEEEeEEeecCceEEEEEEEC---CCCCeEEEEEeechhhhc-HHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLK-HKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 86 (416)
.|++.+.||+|+||.||+|.+. .++..||||++.+..... ......+.+|+.+++++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 467889999997654322 23456788999999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+||||+++|+|.+++.....+++..++.++.|++.||.|||+.|++||||+|.||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE- 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc-
Confidence 9999999999999999887889999999999999999999999999999999999999999999999999987543321
Q ss_pred CCCcccccCCcccccchhhccCC-CCCChhhHHHHHHHHHHHhhCCCCCCCCc----hHHHHHHhhcCccCCCCCCCHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPPWLSFTA 241 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~-~~~~~~DIwSlGvil~~ml~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~ 241 (416)
.......+|++.|+|||.+.+.. ..+.++||||||+++|+|++|..||.... .....+.+.......|..++.++
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 11123356899999999987643 23578999999999999999999996432 23334444555566777789999
Q ss_pred HHHHHHhcCCCCCCCCC---HhHHhcCcccccC
Q 014909 242 RKLIARILDPNPMTRIT---IPEILEDEWFKKD 271 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t---~~eil~h~~~~~~ 271 (416)
.++|.+||+.||++||| +.++|+||||+..
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 99999999999999998 5677999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=330.64 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=208.5
Q ss_pred CEEEEeEEeecCceEEEEEEECC-----CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
+|++.+.||+|+||.||+|.+.. ....+|+|.+..... ......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 235689998865432 22356788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcE
Q 014909 87 FIVLEFVTGGELFDKIVNH------------------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENL 142 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NI 142 (416)
|++|||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999988642 2477889999999999999999999999999999999
Q ss_pred EeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHH
Q 014909 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 221 (416)
Q Consensus 143 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~ 221 (416)
|+++++.+||+|||++...............+++..|+|||.+.+..+. .++||||||+++|+|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-hHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999998754322211112334567789999998776664 88999999999999998 999999887777
Q ss_pred HHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 222 LYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 222 ~~~~i~~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.+..+... ....|..++.++.+++.+||+.||.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 66655443 33446668999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=338.69 Aligned_cols=253 Identities=28% Similarity=0.439 Sum_probs=207.7
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK------ 83 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 83 (416)
..+|.+.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 4799999999999999999999998999999999876432 222345688999999999999999999998654
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
..+|+||||+.+ +|...+ ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 93 ~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 357999999964 676654 34689999999999999999999999999999999999999999999999999864321
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-------------
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------- 230 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~------------- 230 (416)
......|++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+....+..+....
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 170 -----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred -----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 12345678999999998764444588999999999999999999999876544433322110
Q ss_pred ----------cCC--------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 231 ----------FTC--------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 231 ----------~~~--------~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
..+ .+..+..+.+||.+||+.||.+||++++++.||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000 12367789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=336.14 Aligned_cols=260 Identities=28% Similarity=0.416 Sum_probs=208.8
Q ss_pred CEEEEeEEeecCceEEEEEEECCC--CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe----CC
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSET--GEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS----KT 84 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----~~ 84 (416)
+|++.+.||+|+||.||++.+..+ +..||+|.+.... ......+.+.+|+.+++++ +||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999887 8899999986432 2222356678899999999 59999999987532 35
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
.+|++|||+. ++|.+.+.....+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6889999986 589999988888999999999999999999999999999999999999999999999999998754322
Q ss_pred cC--CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC-------------
Q 014909 165 RD--DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------- 229 (416)
Q Consensus 165 ~~--~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~------------- 229 (416)
.. ........||+.|+|||++.+....+.++||||+||++|+|++|.+||...+.......+...
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 112234578999999999866433358999999999999999999999876543322221110
Q ss_pred ---------------ccC---CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 230 ---------------EFT---CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 230 ---------------~~~---~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
... ..+..+..+.+|+.+||+.||.+|||+.+++.|||+.+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~ 300 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD 300 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence 000 11235789999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=328.30 Aligned_cols=248 Identities=31% Similarity=0.518 Sum_probs=204.4
Q ss_pred EEEeEEeecCceEEEEEEEC----CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 14 EVGRTIGEGTFAKVKFARNS----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 14 ~~~~~LG~G~fg~V~~a~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
++.+.||.|+||.||+|... ..+..|+||.+... ......+.+.+|+..+++++||||+++++++......++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 57899999999999999987 34678999999543 2333468899999999999999999999999988889999
Q ss_pred EeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 90 LEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
|||+++|+|.+++... ..++......++.||+.||.|||+++++|+||+|.|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999986 67999999999999999999999999999999999999999999999999998755221111
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHHHHHH
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLI 245 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ll 245 (416)
.......+...|+|||.+.+..+ +.++||||||+++|||++ |+.||.+.+......++..+. ...|..++..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 12233456778999999987665 489999999999999999 789999888777777765543 345667899999999
Q ss_pred HHhcCCCCCCCCCHhHHhc
Q 014909 246 ARILDPNPMTRITIPEILE 264 (416)
Q Consensus 246 ~~~L~~dP~~R~t~~eil~ 264 (416)
.+||..||++|||+.+|++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=325.70 Aligned_cols=264 Identities=30% Similarity=0.434 Sum_probs=213.9
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCC----CeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CC
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETG----EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KT 84 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~ 84 (416)
...|++++.||+|+||.||+|..+.++ ..+|||.+..++- ..+.....-||+.+++.++||||+.+..++.+ +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 457999999999999999999665543 3689999876542 22345667899999999999999999999877 88
Q ss_pred EEEEEEeccCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC----CCeEEeec
Q 014909 85 KIFIVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY----GNLKVSDF 155 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~----~~vkl~DF 155 (416)
.+|+++||++. +|...|.-+ ..++...++.++.||++|+.|||++=|+||||||.|||+..+ |.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999987 899888654 358999999999999999999999999999999999999887 89999999
Q ss_pred ccccccccccCCC-CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch---------HHHHHH
Q 014909 156 GLSALSQQVRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---------MNLYKK 225 (416)
Q Consensus 156 Gla~~~~~~~~~~-~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~---------~~~~~~ 225 (416)
|+|+++...-..- ..+..+-|.+|+|||.+.+...++++.|||+.|||+.||++-++.|.+... .+...+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999876532211 234456788999999999988888999999999999999999998865321 122223
Q ss_pred hhcC--cc---------CCCCC--------------------------CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 226 ISAA--EF---------TCPPW--------------------------LSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 226 i~~~--~~---------~~~~~--------------------------~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
|... .+ ..|.| -++.+.+||.+||+.||.+|+|++++|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 2211 00 11111 25568999999999999999999999999999
Q ss_pred ccCCCCC
Q 014909 269 KKDYKPP 275 (416)
Q Consensus 269 ~~~~~~~ 275 (416)
.....||
T Consensus 341 ~~d~lpp 347 (438)
T KOG0666|consen 341 TEDPLPP 347 (438)
T ss_pred ccCCCCC
Confidence 9887664
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=331.73 Aligned_cols=252 Identities=30% Similarity=0.498 Sum_probs=212.8
Q ss_pred EeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014909 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (416)
...||+|+||.||++.+..+++.||||.+.... ......+.+|+.+++.++||||+++++.+...+..|+||||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 367999999999999999999999999985432 22356788999999999999999999999999999999999999
Q ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 96 g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
++|.+++. ...+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++...... ........|
T Consensus 102 ~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~ 178 (292)
T cd06657 102 GALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLVG 178 (292)
T ss_pred CcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc--ccccccccc
Confidence 99988765 457899999999999999999999999999999999999999999999999987643221 112234568
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC---ccCCCCCCCHHHHHHHHHhcCCC
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIARILDPN 252 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~ll~~~L~~d 252 (416)
++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...........+... .......+++.+.+++.+||+.|
T Consensus 179 ~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (292)
T cd06657 179 TPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257 (292)
T ss_pred CccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence 999999999876665 47899999999999999999999877665544444322 12223447889999999999999
Q ss_pred CCCCCCHhHHhcCcccccCCCC
Q 014909 253 PMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 253 P~~R~t~~eil~h~~~~~~~~~ 274 (416)
|.+||++.+++.||||.+...+
T Consensus 258 P~~R~~~~~ll~~~~~~~~~~~ 279 (292)
T cd06657 258 PAQRATAAELLKHPFLAKAGPP 279 (292)
T ss_pred cccCcCHHHHhcChHHhccCCC
Confidence 9999999999999999987644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=329.50 Aligned_cols=252 Identities=33% Similarity=0.503 Sum_probs=211.6
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (416)
|++.+.||+|++|.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++.++...|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999999999999998765432 23456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcc
Q 014909 93 VTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (416)
Q Consensus 93 ~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 171 (416)
+++ +|.+.+.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 976 88887766 3589999999999999999999999999999999999999999999999999987554322 1223
Q ss_pred cccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-------------------cC
Q 014909 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-------------------FT 232 (416)
Q Consensus 172 ~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~-------------------~~ 232 (416)
...++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+..+.+.++.... ..
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 34578899999999876344689999999999999999999998877655444332110 00
Q ss_pred -----------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 233 -----------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 233 -----------~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
..+.++.++.+||.+||++||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 112367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=324.00 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=211.0
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCC---eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
.+.|++.+.||+|+||.||+|.+..++. .||||++.... .......+.+|+.+++.++||||+++++++.+....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4679999999999999999999877664 59999987542 233457799999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
++||||+++++|.+++... +.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999988763 568999999999999999999999999999999999999999999999999987543322
Q ss_pred CCCCccccc---CCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHH
Q 014909 166 DDGLLHTTC---GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (416)
Q Consensus 166 ~~~~~~~~~---gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 240 (416)
......... ++..|+|||.+.+..+. .++||||+||++|+|++ |..||...+.......+... ..+.+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 111111111 24579999999877774 78999999999999886 99999887777666666443 23445567899
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 241 ARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+.+++.+||..+|++||++++++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=326.63 Aligned_cols=252 Identities=19% Similarity=0.327 Sum_probs=207.1
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCC----eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
..++|++.+.||+|+||.||+|....+++ .+++|.+.... .......+..|+.+++.++||||+++++++. ..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence 34689999999999999999999877776 46777765322 1223467888999999999999999999875 45
Q ss_pred EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
..++++||+++|+|.+++... +.+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 578899999999999999764 5789999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHH
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTA 241 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~ 241 (416)
...........++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+.........+..+. ...+...+.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV 240 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHH
Confidence 2221222344567789999999876664 89999999999999998 999998876665555554443 33345578899
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 014909 242 RKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.+++.+||..||++|||+.++++
T Consensus 241 ~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 241 YMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=323.73 Aligned_cols=247 Identities=23% Similarity=0.380 Sum_probs=206.7
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
.++|++.+.||+|+||.||+|.+..+ ..||+|++...... .+.+.+|+.+++.++||||+++++.+. ....|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence 46799999999999999999998665 45999998754321 346889999999999999999999875 4568999
Q ss_pred EeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 90 LEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~-~ 157 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y 157 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc-c
Confidence 9999999999999763 358899999999999999999999999999999999999999999999999987543221 1
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHH
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll 245 (416)
.......++..|+|||++.+..+ +.++||||+||++|+|++ |..||.+.........+... ....+..++..+.+|+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 236 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 236 (262)
T ss_pred ccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 11223446678999999887666 488999999999999999 99999887766666665443 2344556889999999
Q ss_pred HHhcCCCCCCCCCHhHHhc
Q 014909 246 ARILDPNPMTRITIPEILE 264 (416)
Q Consensus 246 ~~~L~~dP~~R~t~~eil~ 264 (416)
.+||++||++||++.++++
T Consensus 237 ~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 237 CQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHccCCcccCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=322.07 Aligned_cols=244 Identities=24% Similarity=0.349 Sum_probs=204.4
Q ss_pred eEEeecCceEEEEEEECCCC---CeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEecc
Q 014909 17 RTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV 93 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 93 (416)
+.||+|+||.||+|....++ ..+|+|.+..+... ...+.+.+|+.+++.++||||+++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999876544 78999999765533 34567889999999999999999999876 45689999999
Q ss_pred CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC-Cccc
Q 014909 94 TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHT 172 (416)
Q Consensus 94 ~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~-~~~~ 172 (416)
++|+|.+++.....+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 999999999988889999999999999999999999999999999999999999999999999987553321110 0111
Q ss_pred ccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhcC
Q 014909 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILD 250 (416)
Q Consensus 173 ~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ll~~~L~ 250 (416)
..++..|+|||.+.+..+. .++|||||||++|+|++ |.+||...+.......+.... ...|..++..+.+++.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCCC-ccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 2234679999999876664 88999999999999998 999998877766666665443 35566789999999999999
Q ss_pred CCCCCCCCHhHHhc
Q 014909 251 PNPMTRITIPEILE 264 (416)
Q Consensus 251 ~dP~~R~t~~eil~ 264 (416)
.||++||++.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=336.00 Aligned_cols=259 Identities=24% Similarity=0.416 Sum_probs=213.2
Q ss_pred ccccccccCEEEEeEEeecCceEEEEEEECCC-------CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcce
Q 014909 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSET-------GEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75 (416)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~-------~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~ 75 (416)
++-...-.+|++++.||+|+||.||+|.+... +..||+|.+.... .....+.+.+|+.+++++ +||||++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 33444556899999999999999999986432 2368999886432 223356788999999999 7999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCC
Q 014909 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 139 (416)
Q Consensus 76 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp 139 (416)
+++++......|++|||+++|+|.+++.... .++...+..++.|++.||.|||++|++||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 9999999999999999999999999987532 367788889999999999999999999999999
Q ss_pred CcEEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCc
Q 014909 140 ENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSN 218 (416)
Q Consensus 140 ~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~ 218 (416)
+|||++.++.+||+|||+++...............++..|+|||++.+..+. .++|||||||++|+|++ |..||.+.+
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999998754332111112223345679999999877665 78999999999999998 999999888
Q ss_pred hHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 219 LMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 219 ~~~~~~~i~~~~-~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.......+.... ...|...+.++.+|+.+||+.+|.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 242 VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 777777665543 34556688999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=330.80 Aligned_cols=252 Identities=20% Similarity=0.288 Sum_probs=204.6
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCC--------------CeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcce
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETG--------------EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~--------------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~ 75 (416)
-.+|++.+.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 358999999999999999999875432 358999987542 2334567899999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCchHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEE
Q 014909 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHG------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 143 (416)
Q Consensus 76 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NIL 143 (416)
+++++......|+||||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999886532 3678889999999999999999999999999999999
Q ss_pred eccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh--CCCCCCCCchHH
Q 014909 144 LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA--GYLPFDDSNLMN 221 (416)
Q Consensus 144 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~--G~~Pf~~~~~~~ 221 (416)
++.++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+...
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999875432111111223345678999999887666 589999999999999988 778998766555
Q ss_pred HHHHhhc--------CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 222 LYKKISA--------AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 222 ~~~~i~~--------~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
....+.. .....++..++.+.+|+.+||+.||++|||+++|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 4433211 112335567899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=328.31 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=211.5
Q ss_pred cccCEEEEeEEeecCceEEEEEEECC-----CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 35689999999999999999998753 57789999987543 223456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHG----------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~----------------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~N 141 (416)
...|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999997432 36788889999999999999999999999999999
Q ss_pred EEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchH
Q 014909 142 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM 220 (416)
Q Consensus 142 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~ 220 (416)
|+++.++.++|+|||++................++..|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999998643322111112233456779999999877764 88999999999999997 88999887777
Q ss_pred HHHHHhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 221 NLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 221 ~~~~~i~~~~~-~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+....+..+.. ..|..++.++.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 76666655543 346678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=339.67 Aligned_cols=253 Identities=23% Similarity=0.399 Sum_probs=203.8
Q ss_pred ccCEEEEeEEeecCceEEEEEEE-----CCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe-
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS- 82 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~- 82 (416)
-++|++.+.||+|+||.||+|.+ ..+++.||||++..... ......+.+|+.++.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 35899999999999999999984 34678899999975432 22356788999999999 68999999998754
Q ss_pred CCEEEEEEeccCCCchHHHHHhCC--------------------------------------------------------
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNHG-------------------------------------------------------- 106 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~~-------------------------------------------------------- 106 (416)
...+++||||+++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 456899999999999999986531
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 107 -----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 107 -----------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
.++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++................+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 356778889999999999999999999999999999999999999999999875422111111122345
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchH-HHHHHhhc-CccCCCCCCCHHHHHHHHHhcCCC
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM-NLYKKISA-AEFTCPPWLSFTARKLIARILDPN 252 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~-~~~~~i~~-~~~~~~~~~s~~~~~ll~~~L~~d 252 (416)
++.|+|||++.+..+. .++||||||+++|+|++ |..||...... .....+.. .....|.+.++++.+++.+||+.|
T Consensus 244 ~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 244 PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred CcceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 6789999999877664 88999999999999996 99999875433 22233322 234556778999999999999999
Q ss_pred CCCCCCHhHHhcC
Q 014909 253 PMTRITIPEILED 265 (416)
Q Consensus 253 P~~R~t~~eil~h 265 (416)
|++|||+.+|++|
T Consensus 323 p~~Rps~~eil~~ 335 (343)
T cd05103 323 PSQRPTFSELVEH 335 (343)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=326.74 Aligned_cols=250 Identities=31% Similarity=0.464 Sum_probs=206.3
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC---CCCCcceEEEEEEeCCE----
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMGSKTK---- 85 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~---- 85 (416)
|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++++ +||||+++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7889999999999999999998899999999975433 222334566788777666 59999999999988776
Q ss_pred -EEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 86 -IFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 86 -~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
+|++|||+.+ +|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999985 8988887643 58999999999999999999999999999999999999999999999999987643
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-----cC-----
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-----FT----- 232 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~-----~~----- 232 (416)
.. .......++..|+|||++.+..+. .++|+||+||++|+|++|.+||.+.+..+...++.... ..
T Consensus 159 ~~---~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 FE---MALTSVVVTLWYRAPEVLLQSSYA-TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred CC---cccccccccccccChHHhccCCCC-CcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 22 222344578899999999877664 78999999999999999999999877665555442210 00
Q ss_pred -----------------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 233 -----------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 233 -----------------~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
..+.+++.+.++|.+||+.||++||++++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 001246778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=324.45 Aligned_cols=252 Identities=25% Similarity=0.403 Sum_probs=212.7
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCC----eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
..++|++.+.||+|+||.||+|.+..+|+ .+|+|.+..... ......+.+|+.+++.++||||+++++++.+ .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45789999999999999999999876665 589998875532 3345678899999999999999999999887 7
Q ss_pred EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 899999999999999999874 4689999999999999999999999999999999999999999999999999876543
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHH
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTA 241 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~ 241 (416)
...........++..|+|||.+....+. .++|+|||||++|++++ |..||.+....+....+..+. ...|...+.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 2111111222345689999998766664 78999999999999998 999999888777776665543 45566688999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 014909 242 RKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.+++.+||..||..|||+.++++
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=320.35 Aligned_cols=244 Identities=25% Similarity=0.458 Sum_probs=210.7
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
...+|++.+.||.|+||.||+|... |+.||+|.+..... ..+++.+|+.+++.++||||+++++++.+....|+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 3568999999999999999999874 78899999975432 35778899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 89 VLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~-- 155 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-- 155 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc--
Confidence 999999999999998765 6999999999999999999999999999999999999999999999999998754221
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 244 (416)
.....++..|+|||.+....+ +.++||||||+++|+|++ |..||...+.......+... ....|..+++.+.++
T Consensus 156 ---~~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (256)
T cd05039 156 ---QDSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKV 231 (256)
T ss_pred ---cccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHH
Confidence 112344567999999876655 478999999999999997 99999888777666655443 334556689999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc
Q 014909 245 IARILDPNPMTRITIPEILE 264 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~ 264 (416)
|.+||..+|++|||+.++++
T Consensus 232 i~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 232 MKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHhccChhhCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=323.36 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=209.7
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCC---eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
.++|++.+.||+|+||.||+|.+..++. .+|+|.+..... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4689999999999999999999865443 699999865432 22356789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
|+||||+++++|.+++... +.++...+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999765 468999999999999999999999999999999999999999999999999987554321
Q ss_pred CCCC-cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHH
Q 014909 166 DDGL-LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (416)
Q Consensus 166 ~~~~-~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 242 (416)
.... .....++..|+|||.+.+..+ +.++|+|||||++|++++ |..||.+.+.......+... ..+.+..+++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 1110 111223568999999987666 489999999999999886 99999887766666666544 2333445788999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhc
Q 014909 243 KLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+++.+||+.+|.+||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=331.28 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=211.9
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
..|...+.||+|+||.||+|++..+++.+|+|.+.............+.+|+.+++.++|||++++++++......|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34778899999999999999999999999999987543333444567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 91 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
||+.| +|.+.+.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------ 167 (308)
T cd06634 95 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 167 (308)
T ss_pred EccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC------
Confidence 99974 77777654 45689999999999999999999999999999999999999999999999998865322
Q ss_pred cccccCCcccccchhhcc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc-CC-CCCCCHHHHHHH
Q 014909 170 LHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TC-PPWLSFTARKLI 245 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~--~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~-~~-~~~~s~~~~~ll 245 (416)
.....|++.|+|||.+.+ ....+.++|||||||++|+|++|..||...+.......+..... .. +..++..+.+||
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHH
Confidence 234568899999999853 22234789999999999999999999987655444333333322 22 235788999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 246 ARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
++||+.+|.+||+++++++|||+...
T Consensus 248 ~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 248 DSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHhhCCcccCCCHHHHhhCcccccc
Confidence 99999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=332.56 Aligned_cols=258 Identities=27% Similarity=0.437 Sum_probs=210.5
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CCEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KTKIF 87 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~ 87 (416)
..++|++.+.||.|+||.||+|.+..+++.||+|.+.+... .....+.+.+|+.+++.++||||+++++++.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 45789999999999999999999999999999999865432 22345678899999999999999999999865 56789
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
++|||+ +++|.+.+.. ..+++..+..++.||++||+|||++|++||||+|.||+++.++.++|+|||++.....
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---- 160 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----
Confidence 999998 4588877754 5688999999999999999999999999999999999999999999999999874321
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhc-------------------
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA------------------- 228 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~------------------- 228 (416)
......+++.|+|||++.+....+.++||||+||++|+|++|+.||........+..+..
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 161 -QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred -CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 223456788999999987644445899999999999999999999987654322211110
Q ss_pred -----C--ccCC-----CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 229 -----A--EFTC-----PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 229 -----~--~~~~-----~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
. .... .+.++..+.++|++||+.+|++|||+++++.||||.....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 0 0011 13467899999999999999999999999999999865544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=322.46 Aligned_cols=248 Identities=23% Similarity=0.377 Sum_probs=207.2
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
..++|++.+.||+|+||.||+|.+. .+..+|+|.+...... .+.+.+|+.++++++|||++++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 3468999999999999999999875 4667999998764432 346889999999999999999999875 456899
Q ss_pred EEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 89 VLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
+|||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999999998763 3589999999999999999999999999999999999999999999999999875432111
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 244 (416)
.......++..|+|||.+.+..+ +.++||||||+++|+|++ |.+||.+.+.......+... ..+.+...+..+.+|
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05070 158 -TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL 235 (260)
T ss_pred -ccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 11112234567999999877665 478999999999999999 99999887777666666543 345566788999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc
Q 014909 245 IARILDPNPMTRITIPEILE 264 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~ 264 (416)
+.+||.+||++|||++++.+
T Consensus 236 i~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 236 MLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=343.88 Aligned_cols=255 Identities=21% Similarity=0.337 Sum_probs=208.6
Q ss_pred ccccCEEEEeEEeecCceEEEEEEEC-----CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMG 81 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~ 81 (416)
....+|.+++.||+|+||.||+|.+. .++..||+|++..... ....+.+.+|+.+|.++. ||||+++++++.
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 44567889999999999999999864 3456899999975432 223457889999999997 999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhCC-------------------------------------------------------
Q 014909 82 SKTKIFIVLEFVTGGELFDKIVNHG------------------------------------------------------- 106 (416)
Q Consensus 82 ~~~~~~lV~E~~~gg~L~~~i~~~~------------------------------------------------------- 106 (416)
.....|+||||+++|+|.+++...+
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999986532
Q ss_pred -------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEE
Q 014909 107 -------------------------------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 143 (416)
Q Consensus 107 -------------------------------------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NIL 143 (416)
.++...+..++.||+.||+|||+.|++||||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 2566678889999999999999999999999999999
Q ss_pred eccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHH
Q 014909 144 LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNL 222 (416)
Q Consensus 144 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~ 222 (416)
+++++.+||+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||........
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 99999999999999875432211112223467889999999987666 488999999999999998 8999987554443
Q ss_pred H-HHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 223 Y-KKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 223 ~-~~i~~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
. ..+..+ ....|..++.++.+|+.+||..+|.+||++++|++.
T Consensus 351 ~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 351 FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3 333333 344566789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=328.37 Aligned_cols=251 Identities=20% Similarity=0.307 Sum_probs=203.6
Q ss_pred cCEEEEeEEeecCceEEEEEEECC----------------CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcc
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSE----------------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~----------------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv 74 (416)
++|++.+.||+|+||.||++.+.. ++..+|+|++.... .......+.+|+.+++.++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 579999999999999999986432 34468999987542 233457789999999999999999
Q ss_pred eEEEEEEeCCEEEEEEeccCCCchHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEE
Q 014909 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 143 (416)
Q Consensus 75 ~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-----------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NIL 143 (416)
++++++......|+||||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 99999999999999999999999999987643 3667789999999999999999999999999999999
Q ss_pred eccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh--CCCCCCCCchHH
Q 014909 144 LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA--GYLPFDDSNLMN 221 (416)
Q Consensus 144 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~--G~~Pf~~~~~~~ 221 (416)
++.++.++|+|||++................+++.|+|||+.....+ +.++|||||||++|+|++ |..||...+...
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999875432211111222344678999999877666 489999999999999998 789998766554
Q ss_pred HHHHhh--------cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 222 LYKKIS--------AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 222 ~~~~i~--------~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
...... ......|..++..+.+|+.+||+.||++||++.+|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 433221 1123345567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=327.63 Aligned_cols=252 Identities=32% Similarity=0.519 Sum_probs=211.5
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (416)
|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+....|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999998654 2233456778899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcc
Q 014909 93 VTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (416)
Q Consensus 93 ~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 171 (416)
+++ +|.+++... ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... .....
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~~ 156 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYT 156 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC--ccccC
Confidence 985 899999876 57999999999999999999999999999999999999999999999999998754332 11233
Q ss_pred cccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC------------------ccCC
Q 014909 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------EFTC 233 (416)
Q Consensus 172 ~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~------------------~~~~ 233 (416)
...++..|+|||.+.+....+.++|||||||++|+|++|..||...+....+.++... ...+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 4456788999999877634468899999999999999999999887655444333210 0011
Q ss_pred C-----------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 234 P-----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 234 ~-----------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
+ +.++..+.++|++||..||++||++++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1 1247789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=319.58 Aligned_cols=243 Identities=24% Similarity=0.450 Sum_probs=206.6
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEE-EeCCEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM-GSKTKIF 87 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~ 87 (416)
...+|++.+.||+|+||.||++... |..||+|.+.... ..+.+.+|+.+++.++|||++++++++ ......|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 4568999999999999999999864 7789999986432 245688999999999999999999975 4567799
Q ss_pred EEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 88 IVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
++|||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-- 154 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 154 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc--
Confidence 9999999999999997654 478999999999999999999999999999999999999999999999999864322
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (416)
......++..|+|||++.+..+. .++|||||||++|+|++ |+.||...+.......+... ....++.+++.+.+
T Consensus 155 ---~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd05082 155 ---TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYD 230 (256)
T ss_pred ---cCCCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 11233456789999999876664 78999999999999997 99999987777666666444 33445678999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhc
Q 014909 244 LIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~ 264 (416)
++.+||+.+|++|||+.++++
T Consensus 231 li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 231 VMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=326.82 Aligned_cols=250 Identities=32% Similarity=0.482 Sum_probs=207.3
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEEEe
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 91 (416)
|++.+.||+|+||.||+|....+++.||||.+....... ......+|+..+++++ ||||+++++++.+++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 788999999999999999999899999999986543211 1233457899999999 9999999999999999999999
Q ss_pred ccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 92 FVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 92 ~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
|+ +|+|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~---~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS---RPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC---CCC
Confidence 99 779999887764 789999999999999999999999999999999999999999999999999875432 222
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC-------------------c
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------------------E 230 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~-------------------~ 230 (416)
.....|+..|+|||++.+....+.++|+||||+++++|++|++||...+......++... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 334568899999999865444458899999999999999999999877655444332210 0
Q ss_pred cC-----------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 231 FT-----------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 231 ~~-----------~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
.. ..+..+..+.+||++||+.||++|||++|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 012236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=323.61 Aligned_cols=253 Identities=28% Similarity=0.501 Sum_probs=212.5
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhh--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+|.+.+.||+|+||.||++.+..++..+++|++...... .......+.+|+.+++.++||||+++++.+.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 699999999999999999999887777778776543221 122345577899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
|||+++++|.+.+.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~-- 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG-- 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC--
Confidence 999999999988864 356899999999999999999999999999999999999975 6799999999875432
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKL 244 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 244 (416)
.........|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+.......+..+. ...+..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 12223345688999999998776665 78999999999999999999998777666655554443 34455688999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCccc
Q 014909 245 IARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
|.+||..||++||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=319.63 Aligned_cols=248 Identities=24% Similarity=0.376 Sum_probs=206.2
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
..++|.+.+.||+|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 356899999999999999999988654 4599998865432 2356788999999999999999999885 456899
Q ss_pred EEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 89 VLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
+|||+.+++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE- 156 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-
Confidence 999999999999997643 47899999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 244 (416)
........++..|+|||.+.+..+ +.++||||||+++|+|++ |.+||.+.........+... ....+...+..+.++
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHEL 235 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence 111122345678999999887665 488999999999999999 99999987776666665544 334456688999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc
Q 014909 245 IARILDPNPMTRITIPEILE 264 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~ 264 (416)
+++||.+||++||+++++++
T Consensus 236 i~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 236 MKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=319.20 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=210.6
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
--++|++.+.||+|+||.||+|.+. ++..||||.+..... ..+.+.+|+.+++.++||||+++++++.+....++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 3468999999999999999999975 457799999875432 23568899999999999999999999999899999
Q ss_pred EEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 89 VLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
||||+++++|.+++.... .++...+..++.|++.|+.|||++|++|+||||+||+++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999999997643 689999999999999999999999999999999999999999999999999875432111
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 244 (416)
.......++..|+|||.+.+..+ +.++||||+|+++|+|++ |+.||.+.+.......+... ....|...+.++.++
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05034 159 -TAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL 236 (261)
T ss_pred -hhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11112234568999999987665 588999999999999998 99999887777777766544 334556678999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc
Q 014909 245 IARILDPNPMTRITIPEILE 264 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~ 264 (416)
+.+||+.+|++||+++++++
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=318.14 Aligned_cols=244 Identities=25% Similarity=0.377 Sum_probs=205.9
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 96 (416)
+.||+|+||.||+|.+.. ++.||+|.+...... .....+.+|+.++++++||||+++++++.+....|+||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999977 999999998765432 34567899999999999999999999999999999999999999
Q ss_pred chHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 97 ELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 97 ~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++................+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999998663 4689999999999999999999999999999999999999999999999999875432111111112234
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCC
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNP 253 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll~~~L~~dP 253 (416)
+..|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+... ....|...+..+.+++.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999887665 488999999999999998 89999887766666665443 344566788999999999999999
Q ss_pred CCCCCHhHHhc
Q 014909 254 MTRITIPEILE 264 (416)
Q Consensus 254 ~~R~t~~eil~ 264 (416)
++|||+.++++
T Consensus 237 ~~Rp~~~ell~ 247 (251)
T cd05041 237 ENRPSFSEIYN 247 (251)
T ss_pred hhCcCHHHHHH
Confidence 99999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=315.40 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=212.3
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 86 (416)
..+...+++..||.|+.|.|++++.+.+|...|||.+.+.. +.+..+++...+.++..-+ +|+||+.+++|-.+...
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 34445667788999999999999999999999999998754 3344677888888776665 89999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~-~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
++.||.|.. .+..++.. .++++|..+-.+...++.||.||.. +||+|||+||+|||+|+.|++||||||++...-
T Consensus 167 ~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv-- 243 (391)
T KOG0983|consen 167 FICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-- 243 (391)
T ss_pred HHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee--
Confidence 999999854 33333332 4679999999999999999999975 599999999999999999999999999987543
Q ss_pred cCCCCcccccCCcccccchhhcc---CCCCCChhhHHHHHHHHHHHhhCCCCCCCCch-HHHHHHhhcCccCC-CC--CC
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLND---RGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAEFTC-PP--WL 237 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~---~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~-~~~~~~i~~~~~~~-~~--~~ 237 (416)
+........|.+.|||||.+.- ..|+ ..+||||||+.++||.||..||.+.+. .+...++...+++. |. .+
T Consensus 244 -dSkAhtrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gF 321 (391)
T KOG0983|consen 244 -DSKAHTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGF 321 (391)
T ss_pred -cccccccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCc
Confidence 2334456689999999999863 3455 889999999999999999999998543 36666666554433 22 38
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 238 s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
|+.+.+|+..||++|+.+||...++|+|||+...
T Consensus 322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 322 SPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred CHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 9999999999999999999999999999999764
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=322.36 Aligned_cols=242 Identities=23% Similarity=0.384 Sum_probs=200.9
Q ss_pred eEEeecCceEEEEEEECCCCC--eEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEecc
Q 014909 17 RTIGEGTFAKVKFARNSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFV 93 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 93 (416)
+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++++ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999988775 46888776322 223456788999999999 7999999999999999999999999
Q ss_pred CCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccc
Q 014909 94 TGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (416)
Q Consensus 94 ~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGl 157 (416)
++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999997543 478899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCC
Q 014909 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPP 235 (416)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~ 235 (416)
+...... ........+..|+|||++....+ +.++|||||||++|+|++ |..||.+.+....+..+... ....+.
T Consensus 159 ~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred ccccchh---hhccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 7532211 01112234567999999977666 488999999999999997 99999887777766666543 234455
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 236 WLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 236 ~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.++.++.+|+.+||..||.+|||+.+++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 67899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=320.45 Aligned_cols=229 Identities=29% Similarity=0.429 Sum_probs=194.6
Q ss_pred cCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHH
Q 014909 22 GTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDK 101 (416)
Q Consensus 22 G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~ 101 (416)
|++|.||+|.+..+++.||+|.+.+... ..+|...+....||||+++++++.+....|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976431 22344445556799999999999999999999999999999999
Q ss_pred HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCCccccc
Q 014909 102 IVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181 (416)
Q Consensus 102 i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 181 (416)
+.....+++..+..++.|++.||+|||++|++||||||+||+++.++.++++|||.+..... ......++..|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCccccC
Confidence 98888899999999999999999999999999999999999999999999999998754332 1233456788999
Q ss_pred chhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH--
Q 014909 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI-- 259 (416)
Q Consensus 182 PEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~-- 259 (416)
||.+.+..+ +.++|+||+|+++|+|++|+.||....... ........|+++++.+.+||.+||+.||++||++
T Consensus 151 PE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 999877666 478999999999999999999886432211 0112345778899999999999999999999985
Q ss_pred ---hHHhcCccc
Q 014909 260 ---PEILEDEWF 268 (416)
Q Consensus 260 ---~eil~h~~~ 268 (416)
+++++||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=319.12 Aligned_cols=243 Identities=23% Similarity=0.357 Sum_probs=201.3
Q ss_pred EEeecCceEEEEEEEC--CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014909 18 TIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (416)
Q Consensus 18 ~LG~G~fg~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 95 (416)
.||+|+||.||+|.+. ..+..||+|++.... .....+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999765 345679999987543 23345678999999999999999999998864 578999999999
Q ss_pred CchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC-Ccccc
Q 014909 96 GELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTT 173 (416)
Q Consensus 96 g~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~-~~~~~ 173 (416)
++|.+++.. ...+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++.......... .....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999999875 4578999999999999999999999999999999999999999999999999987543221111 11112
Q ss_pred cCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCC
Q 014909 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDP 251 (416)
Q Consensus 174 ~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll~~~L~~ 251 (416)
.+++.|+|||.+....+ +.++|||||||++|+|++ |..||...........+..+ ....|+..++++.+++.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 33578999999887666 478999999999999996 99999987776666655543 3566777899999999999999
Q ss_pred CCCCCCCHhHHhc
Q 014909 252 NPMTRITIPEILE 264 (416)
Q Consensus 252 dP~~R~t~~eil~ 264 (416)
||++||++.+|.+
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999965
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=322.25 Aligned_cols=254 Identities=19% Similarity=0.285 Sum_probs=210.8
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECC----CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSE----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS- 82 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 82 (416)
..-.+|++.+.||+|+||.||+|.+.. ++..||+|.+.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345789999999999999999999875 35789999886432 33346778899999999999999999998765
Q ss_pred CCEEEEEEeccCCCchHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEee
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNH--------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSD 154 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~--------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~D 154 (416)
+...++++||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 57789999999999999998753 3588999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccC
Q 014909 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFT 232 (416)
Q Consensus 155 FGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~ 232 (416)
||+++...............++..|+|||++.+..+ +.++|||||||++|++++ |++||...+.......+..+ ...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA 239 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence 999875432111111123345678999999987666 488999999999999998 99999987777766655543 233
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 233 CPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 233 ~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.+..+++++.+++.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 45567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=319.11 Aligned_cols=248 Identities=22% Similarity=0.361 Sum_probs=207.3
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
.-.+|++++.||+|+||.||+|... +++.||+|.+...... ...+.+|+.+++.++||||+++++++. .+..|+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 3467999999999999999999865 5778999998754432 356889999999999999999999874 456899
Q ss_pred EEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 89 VLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
+|||+.+++|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999999998753 3689999999999999999999999999999999999999999999999999875432111
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 244 (416)
.......++..|+|||++....+ +.++||||||+++|+|++ |++||.+.+.......+... ....+...+.++.++
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05067 158 -TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL 235 (260)
T ss_pred -ccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11122345678999999987665 488999999999999998 99999988777666665444 234455678899999
Q ss_pred HHHhcCCCCCCCCCHhHHhc
Q 014909 245 IARILDPNPMTRITIPEILE 264 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~ 264 (416)
+.+||+.+|++|||+++++.
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHccCChhhCCCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=318.55 Aligned_cols=244 Identities=27% Similarity=0.446 Sum_probs=205.6
Q ss_pred eEEeecCceEEEEEEECC-CCC--eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEecc
Q 014909 17 RTIGEGTFAKVKFARNSE-TGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV 93 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~-~~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 93 (416)
+.||+|++|.||+|.+.. ++. .||||.+...... ...+.+.+|+.++++++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999876543 456789999999999999999999999988 8999999999
Q ss_pred CCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC-CCc
Q 014909 94 TGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLL 170 (416)
Q Consensus 94 ~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~ 170 (416)
++++|.+.+.... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999999998754 6899999999999999999999999999999999999999999999999998765332111 111
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC--ccCCCCCCCHHHHHHHHH
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKLIAR 247 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~ll~~ 247 (416)
....++..|+|||.+.+..+. .++|||||||++|+|++ |..||...+..+....+... ....+...+..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 234577899999999877664 78999999999999998 99999887776666655432 233445678999999999
Q ss_pred hcCCCCCCCCCHhHHhc
Q 014909 248 ILDPNPMTRITIPEILE 264 (416)
Q Consensus 248 ~L~~dP~~R~t~~eil~ 264 (416)
||..+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=323.02 Aligned_cols=250 Identities=25% Similarity=0.377 Sum_probs=199.8
Q ss_pred cCE-EEEeEEeecCceEEEEEE----ECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--C
Q 014909 11 GKY-EVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--K 83 (416)
Q Consensus 11 ~~y-~~~~~LG~G~fg~V~~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~ 83 (416)
++| ++.+.||+|+||+||++. ...++..||+|++..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 466 899999999999998865 335678899999875432 2235678899999999999999999998765 3
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
...|++|||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 468999999999999999876 4699999999999999999999999999999999999999999999999999875433
Q ss_pred ccCC-CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH--HH-------------HHHhh
Q 014909 164 VRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM--NL-------------YKKIS 227 (416)
Q Consensus 164 ~~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~--~~-------------~~~i~ 227 (416)
.... .......++..|+|||.+.+..+ +.++||||||+++|+|++|..||...... .. ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 2111 11122345678999999987666 48999999999999999999998653311 11 00111
Q ss_pred c-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 228 A-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 228 ~-~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
. ...+.|..++..+.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 122345567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=317.13 Aligned_cols=248 Identities=26% Similarity=0.420 Sum_probs=211.0
Q ss_pred EEEEeEEeecCceEEEEEEECCCC----CeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETG----EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
+++.+.||.|+||.||+|.+..++ ..||+|.+..... ......+..|+.+++.++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 357789999999999999998766 8899999965432 2246788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 89 VLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
+|||+++++|.+.+..... +++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976554 99999999999999999999999999999999999999999999999999875543211
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKL 244 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 244 (416)
.. .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |.+||...+.......+.... ...+...+.++.++
T Consensus 159 ~~-~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 159 YK-KKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL 236 (258)
T ss_pred cc-cccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 11 111236789999999966555 489999999999999998 899999887777777665543 34556689999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc
Q 014909 245 IARILDPNPMTRITIPEILE 264 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~ 264 (416)
+.+||..||++|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=323.71 Aligned_cols=239 Identities=23% Similarity=0.316 Sum_probs=197.8
Q ss_pred eEEeecCceEEEEEEECCCCC-------eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 17 RTIGEGTFAKVKFARNSETGE-------PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~-------~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+.||+|+||.||+|.+...+. .+|+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 368999999999999865543 38888876432 23456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCC--------eEEeecccccc
Q 014909 90 LEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--------LKVSDFGLSAL 160 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~--------vkl~DFGla~~ 160 (416)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997654 5899999999999999999999999999999999999987765 69999998764
Q ss_pred cccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhC-CCCCCCCchHHHHHHhhcCccCCCCCCCH
Q 014909 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAAEFTCPPWLSF 239 (416)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 239 (416)
... .....+++.|+|||++.+....+.++|||||||++|+|++| .+||...+...... ........|...+.
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPAPKWT 230 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCCCCcH
Confidence 321 23456889999999998755446889999999999999998 57776555443322 23344556666788
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 240 TARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
++.+|+.+||+.||++|||+++|++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=318.65 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=209.5
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCC---eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
...|+..+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 3578999999999999999999876554 69999986542 222356788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
|+||||+++++|.+++... +.+++..+..++.|++.|++|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999998764 578999999999999999999999999999999999999999999999999987543321
Q ss_pred CCCCc-ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHHH
Q 014909 166 DDGLL-HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTAR 242 (416)
Q Consensus 166 ~~~~~-~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 242 (416)
..... .....++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+.... .+.+...+.++.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 240 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 11111 11123457999999987666 488999999999999997 999998877777766665442 233334788999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhc
Q 014909 243 KLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+++.+||+.+|++||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=321.38 Aligned_cols=251 Identities=23% Similarity=0.370 Sum_probs=211.1
Q ss_pred cCEEEEeEEeecCceEEEEEEECC-----CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
.+|++.+.||.|+||.||+|+... +.+.+|+|.+.... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 679999999999999999999754 34679999886533 22245778999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecc
Q 014909 86 IFIVLEFVTGGELFDKIVNHG---------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~---------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFG 156 (416)
.|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.++++|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999999998765 68999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCcc--CC
Q 014909 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF--TC 233 (416)
Q Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~~--~~ 233 (416)
++...... .........++..|+|||.+.+..+. .++||||||+++|+|++ |..||...........+..... ..
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 163 LSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred cccccCcc-cccccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence 87643211 11122334567789999998876654 78999999999999998 8999987766666666654443 33
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 234 PPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 234 ~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
+..++..+.+++.+||+.||.+|||+.+++.+
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 45688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=325.07 Aligned_cols=261 Identities=26% Similarity=0.412 Sum_probs=209.9
Q ss_pred cccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC
Q 014909 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSK 83 (416)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 83 (416)
......+.|++.+.||+|+||.||+|.+..+++.||||.+.+.... .....+.+|+.++.... ||||+++++++.+.
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 3456788999999999999999999999988999999999754322 22455666777666664 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCcEEeccCCCeEEeeccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~-~givHrDlkp~NILl~~~~~vkl~DFGla~~~ 161 (416)
...|++|||+.+ .|.+.+.. ...+++..+..++.|++.||+|||+ .||+||||+|+||+++.++.+||+|||++...
T Consensus 87 ~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 87 SDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred CeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999999999864 67666655 4578999999999999999999997 59999999999999999999999999998654
Q ss_pred ccccCCCCcccccCCcccccchhhccCC---CCCChhhHHHHHHHHHHHhhCCCCCCCCch-HHHHHHhhcCc-cCCCC-
Q 014909 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAE-FTCPP- 235 (416)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~---~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~-~~~~~~i~~~~-~~~~~- 235 (416)
... .......+++.|+|||.+.+.. ..+.++||||||+++|+|++|+.||..... .+....+.... ...+.
T Consensus 166 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T cd06618 166 VDS---KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN 242 (296)
T ss_pred cCC---CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCC
Confidence 321 1223346788999999987543 234789999999999999999999976432 23333333222 22222
Q ss_pred -CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 236 -WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 236 -~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
.++.++.+|+.+||..||.+||++++++.||||...
T Consensus 243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 368899999999999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=313.30 Aligned_cols=243 Identities=25% Similarity=0.430 Sum_probs=203.1
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 96 (416)
+.||+|+||.||+|... ++..+|+|.+.... .......+.+|+.+++.++||||+++++++......++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999865 68889999987543 2233456889999999999999999999999999999999999999
Q ss_pred chHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC
Q 014909 97 ELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (416)
Q Consensus 97 ~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 175 (416)
+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ........+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence 999988754 468899999999999999999999999999999999999999999999999986432211 111112244
Q ss_pred CcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCC
Q 014909 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNP 253 (416)
Q Consensus 176 t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll~~~L~~dP 253 (416)
+..|+|||++.+..+ +.++||||+|+++|+|++ |..||...........+... ....+..++..+.+++.+||+.+|
T Consensus 157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 567999999977655 478999999999999998 99999887766665555544 335566789999999999999999
Q ss_pred CCCCCHhHHhc
Q 014909 254 MTRITIPEILE 264 (416)
Q Consensus 254 ~~R~t~~eil~ 264 (416)
++||++.++++
T Consensus 236 ~~Rp~~~~l~~ 246 (250)
T cd05085 236 ENRPKFSELQK 246 (250)
T ss_pred ccCCCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=314.55 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=210.1
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
..+|++.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 457999999999999999999885 4678999998754332 34678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
|||+++++|.+++... +.+++..+..++.|++.|++|||++|++||||||+||+++.++.+||+|||++........ .
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 156 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-T 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-c
Confidence 9999999999998764 4689999999999999999999999999999999999999999999999999864422111 1
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHHH
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIA 246 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll~ 246 (416)
......++..|+|||.+.+..+. .++||||||+++|+|++ |..||...........+..+ ....|...+..+.+|+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ 235 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 11223345689999999876664 78999999999999998 99999988877777776554 33345567899999999
Q ss_pred HhcCCCCCCCCCHhHHhcC
Q 014909 247 RILDPNPMTRITIPEILED 265 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~h 265 (416)
+||+.+|++|||+.+++++
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 236 HCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHcccChhhCCCHHHHHHh
Confidence 9999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=343.02 Aligned_cols=255 Identities=27% Similarity=0.518 Sum_probs=220.0
Q ss_pred ccCE-EEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhh-cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE--
Q 014909 10 VGKY-EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK-- 85 (416)
Q Consensus 10 ~~~y-~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 85 (416)
-|+| +....||+|+|-+||+|.+..+|-.||--.+....+. .+...+++..|+.+|+.|+|||||++|+.+.+...
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 3455 3456899999999999999999999986555444433 34557899999999999999999999999987655
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCcEEeccC-CCeEEeecccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAY-GNLKVSDFGLSALSQ 162 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~g--ivHrDlkp~NILl~~~-~~vkl~DFGla~~~~ 162 (416)
+.+|.|++.+|+|..|+.+.++++...++.|++||+.||.|||++. |+|||||-+||+|+.+ |.|||+|+|||++..
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 8899999999999999999999999999999999999999999995 9999999999999875 899999999999765
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCC-chHHHHHHhhcCccC--CCCCCCH
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKISAAEFT--CPPWLSF 239 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~-~~~~~~~~i~~~~~~--~~~~~s~ 239 (416)
.. ......|||.|||||++. ..|+ ..+||||||+.+.||+|+..||... +..++|+++..+..+ +..--++
T Consensus 198 ~s----~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP 271 (632)
T KOG0584|consen 198 KS----HAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP 271 (632)
T ss_pred cc----ccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH
Confidence 42 233478999999999987 4676 8999999999999999999999864 566888888877532 2223478
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 240 TARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
++++||.+||.. .+.|+|+.|+|+||||...
T Consensus 272 evr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 272 EVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 999999999999 9999999999999999875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=342.08 Aligned_cols=251 Identities=22% Similarity=0.382 Sum_probs=215.5
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
...+...++..||+|.||+||+|.+-. .||||+++......+ ..+.+++|+..+++-+|.||+-+.|++..+.. .
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 345667888999999999999999843 499999988765544 68999999999999999999999999988777 9
Q ss_pred EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 88 IVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
||..+|+|.+|+.+|.-. .++.....+.|++||++||.|||.++|+|||||..||++.+++.|||+|||+++.......
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 999999999999998653 4688899999999999999999999999999999999999999999999999987666555
Q ss_pred CCCcccccCCcccccchhhcc---CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCC-----CCCCC
Q 014909 167 DGLLHTTCGTPNYVAPEVLND---RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-----PPWLS 238 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~---~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~s 238 (416)
........|...|||||++.. .+| +..+||||+||++|||+||.+||...+...++-.+..+.... ....+
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~p 622 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCP 622 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCH
Confidence 556677789999999999974 345 588999999999999999999999766666555555553221 12356
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 239 FTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 239 ~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.++++|+..||..+++.||.+.+||.
T Consensus 623 k~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 623 KAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHhcCcccCccHHHHHH
Confidence 79999999999999999999999986
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=327.15 Aligned_cols=248 Identities=21% Similarity=0.389 Sum_probs=198.3
Q ss_pred CceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHH
Q 014909 23 TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI 102 (416)
Q Consensus 23 ~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i 102 (416)
++|.||.+++..+++.||+|++..... .......+.+|+.+++.++||||+++++++......|++|||+++|+|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 445667777777899999999986532 2334678999999999999999999999999999999999999999999998
Q ss_pred HhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC-----CCCcccccC
Q 014909 103 VNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-----DGLLHTTCG 175 (416)
Q Consensus 103 ~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-----~~~~~~~~g 175 (416)
... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+........ ........+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 763 4689999999999999999999999999999999999999999999999998764322111 112234457
Q ss_pred CcccccchhhccC--CCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHH-HHhhcCc----------------------
Q 014909 176 TPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY-KKISAAE---------------------- 230 (416)
Q Consensus 176 t~~y~aPEvl~~~--~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~-~~i~~~~---------------------- 230 (416)
+..|+|||++... .+ +.++||||+||++|+|++|..||......... .++....
T Consensus 171 ~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (314)
T cd08216 171 NLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249 (314)
T ss_pred cccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccc
Confidence 8899999998753 34 47899999999999999999999875543322 2221100
Q ss_pred -----------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 231 -----------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 231 -----------~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
...+..++.++.+|+.+||..||++|||++++++||||+.-.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000112356789999999999999999999999999998543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=324.65 Aligned_cols=253 Identities=23% Similarity=0.370 Sum_probs=208.0
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCC----eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
..++|+..+.||+|+||.||+|.+..+|. .||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 45678999999999999999999887776 468888865432 22345688999999999999999999998754
Q ss_pred EEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 4679999999999999987754 689999999999999999999999999999999999999999999999999876543
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHH
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 241 (416)
...........++..|+|||.+.+..+. .++|||||||++|+|++ |..||.+.........+... ....++..+..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDV 240 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 2221122234457789999999876664 88999999999999997 99999877655544444333 234455678999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 242 RKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.+++.+||..+|++||+++++++.
T Consensus 241 ~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 241 YMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=317.99 Aligned_cols=239 Identities=22% Similarity=0.292 Sum_probs=194.3
Q ss_pred eEEeecCceEEEEEEECCC------------CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 17 RTIGEGTFAKVKFARNSET------------GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~------------~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
+.||+|+||.||+|..... ...+|+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3689999999999985322 2358899876543 234567888999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCC-------eEEeecc
Q 014909 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-------LKVSDFG 156 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~-------vkl~DFG 156 (416)
..++||||+++|+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998888753 56899999999999999999999999999999999999987664 8999999
Q ss_pred cccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHh-hCCCCCCCCchHHHHHHhhcCccCCCC
Q 014909 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL-AGYLPFDDSNLMNLYKKISAAEFTCPP 235 (416)
Q Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml-~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 235 (416)
++..... .....|+..|+|||.+......+.++|||||||++|+|+ .|..||......... ...........
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~ 230 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT 230 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC
Confidence 8764321 123457889999999875444468899999999999997 599999876544332 22233333333
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 236 WLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 236 ~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
..+.++.+|+.+||+.||.+||++.+|+++
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 456789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=318.78 Aligned_cols=245 Identities=22% Similarity=0.272 Sum_probs=192.6
Q ss_pred eEEeecCceEEEEEEECC--CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014909 17 RTIGEGTFAKVKFARNSE--TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 94 (416)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 369999999999996532 44578888875432 23335668889999999999999999999999999999999999
Q ss_pred CCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 95 GGELFDKIVNHG-----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 95 gg~L~~~i~~~~-----~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
+|+|.+++.... ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999999997643 246778899999999999999999999999999999999999999999999864322111111
Q ss_pred cccccCCcccccchhhccC------CCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHh-hcCccC-----CCCC
Q 014909 170 LHTTCGTPNYVAPEVLNDR------GYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFT-----CPPW 236 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~------~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i-~~~~~~-----~~~~ 236 (416)
.....+++.|+|||++... ...+.++|||||||++|+|++ |..||...........+ ...... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 1233456789999998532 233578999999999999998 89999877655444433 332222 2335
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 237 ~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
++....+++..|+ .||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888999999998 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=316.88 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=207.9
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCC---CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
.-.+|++.+.||+|+||.||+|.+... ...||||....... ....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 445799999999999999999987543 34689998865431 2345678999999999999999999999875 45
Q ss_pred EEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
.|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 789999999999999998744 5899999999999999999999999999999999999999999999999998754322
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHH
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 242 (416)
.. .......+++.|+|||.+....+. .++|||||||++|+|++ |..||...+.......+..+ ....|+.++..+.
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05056 161 SY-YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 238 (270)
T ss_pred cc-eecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence 11 111122345689999998776664 88999999999999986 99999888776666655544 3455677899999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhc
Q 014909 243 KLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+++.+||..+|++|||+.+++.
T Consensus 239 ~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 239 SLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=319.31 Aligned_cols=245 Identities=24% Similarity=0.356 Sum_probs=202.9
Q ss_pred eEEeecCceEEEEEEECCCC------CeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 17 RTIGEGTFAKVKFARNSETG------EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
+.||+|+||.||+|.+.... +.+|||.+..... ......+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999876533 6799998864321 223567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC-----CeEEeecccc
Q 014909 91 EFVTGGELFDKIVNH-------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-----NLKVSDFGLS 158 (416)
Q Consensus 91 E~~~gg~L~~~i~~~-------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~-----~vkl~DFGla 158 (416)
||+++++|.+++... ..+++..+..++.|++.||+|||+++++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999998642 3478899999999999999999999999999999999999887 8999999998
Q ss_pred cccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCC
Q 014909 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPW 236 (416)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 236 (416)
................++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+... .+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 65432211112223355788999999987666 589999999999999998 99999887766666655443 3455667
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 237 ~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
++..+.+|+.+||..+|.+||+++++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=320.10 Aligned_cols=238 Identities=24% Similarity=0.292 Sum_probs=193.4
Q ss_pred EEeecCceEEEEEEECCC------------------------CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCc
Q 014909 18 TIGEGTFAKVKFARNSET------------------------GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73 (416)
Q Consensus 18 ~LG~G~fg~V~~a~~~~~------------------------~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 73 (416)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 599999999999974321 2358999986543 2234668889999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC----
Q 014909 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---- 148 (416)
Q Consensus 74 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~---- 148 (416)
+++++++.+....|+||||+++|+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999988865 45789999999999999999999999999999999999998654
Q ss_pred ---CeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHh-hCCCCCCCCchHHHHH
Q 014909 149 ---NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL-AGYLPFDDSNLMNLYK 224 (416)
Q Consensus 149 ---~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml-~G~~Pf~~~~~~~~~~ 224 (416)
.+|++|||++..... .....++..|+|||.+.+....+.++|||||||++|+|+ +|..||..........
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 389999998753211 123457889999999876444468999999999999985 7999998765544322
Q ss_pred HhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 225 KISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 225 ~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.. ......|...++.+.++|.+||+.+|++|||+.+++++
T Consensus 233 ~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 FY-EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HH-HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22 22334455567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=317.86 Aligned_cols=245 Identities=20% Similarity=0.232 Sum_probs=193.1
Q ss_pred eEEeecCceEEEEEEEC--CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014909 17 RTIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 94 (416)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.+++.++||||+++++.+.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999864 3456799998865432 2234568889999999999999999999999999999999999
Q ss_pred CCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 95 GGELFDKIVNHG-----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 95 gg~L~~~i~~~~-----~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
+|+|.+++.... ..++..++.++.|++.|++|||++|++||||||+||+++.++++||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999999987532 356778889999999999999999999999999999999999999999999864322111111
Q ss_pred cccccCCcccccchhhccCC------CCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHH-hhcCccCC-----CCC
Q 014909 170 LHTTCGTPNYVAPEVLNDRG------YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKK-ISAAEFTC-----PPW 236 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~------~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~-i~~~~~~~-----~~~ 236 (416)
.....|++.|+|||++.+.. ..+.++||||+|+++|+|++ |..||........... +....... ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 23346788999999986432 12578999999999999996 9999987665544332 22222211 123
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 237 ~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.+..+.+++++|+ .+|++|||+++|+.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=313.31 Aligned_cols=248 Identities=22% Similarity=0.363 Sum_probs=206.7
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
..++|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+.+++.++|+||+++++.+.. ...|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 4678999999999999999999865 456699998865321 24678899999999999999999999887 77899
Q ss_pred EEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 89 VLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
+|||+++++|.+++... ..++...+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 156 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE- 156 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC-
Confidence 99999999999999763 357888899999999999999999999999999999999999999999999987543211
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKL 244 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 244 (416)
........++..|+|||++....+ +.++|+|||||++|++++ |..||...+.......+.... ...+...+.++.++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI 235 (260)
T ss_pred cccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHH
Confidence 111122335567999999987655 478999999999999998 999999877776666655442 33455688999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc
Q 014909 245 IARILDPNPMTRITIPEILE 264 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~ 264 (416)
+.+||+.+|++||++.++++
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 236 MMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 99999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=337.77 Aligned_cols=249 Identities=27% Similarity=0.431 Sum_probs=213.3
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCC---e-EEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGE---P-VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~---~-vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
+-.+.+.||+|+||.||+|..+..+. . ||||....+..........+.+|+++|++++|||||++||+......+|
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34556899999999999998765322 3 8999988644445566888999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 88 IVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
+|||+|+||+|.+++.+.+. ++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||+++....
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~--- 314 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ--- 314 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc---
Confidence 99999999999999999874 99999999999999999999999999999999999999999999999999874321
Q ss_pred CCCcccc-cCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc--cCCCCCCCHHHH
Q 014909 167 DGLLHTT-CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE--FTCPPWLSFTAR 242 (416)
Q Consensus 167 ~~~~~~~-~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~~ 242 (416)
....... .-...|+|||.+....| +.++||||+||++||+++ |..||.+....+...+|.... .+.|...+.++.
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~ 393 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELA 393 (474)
T ss_pred eeeccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHH
Confidence 1111111 23568999999998766 489999999999999998 899999999999999885443 345566788999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhc
Q 014909 243 KLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.++.+|+..||+.|||+.++.+
T Consensus 394 ~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 394 KVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHhccCChhhccCHHHHHH
Confidence 9999999999999999999965
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=317.57 Aligned_cols=265 Identities=29% Similarity=0.436 Sum_probs=217.5
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE------
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG------ 81 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~------ 81 (416)
..++.|+-...||+|.||+|++|+.+.+|+.||+|++-.+. .+++.-....+|+.+|..|+|+|++.+++++.
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 35678888899999999999999999999999998764322 23344456779999999999999999998774
Q ss_pred --eCCEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccc
Q 014909 82 --SKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (416)
Q Consensus 82 --~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla 158 (416)
+...+|+||.+|+. +|+-.+... .+++..+++.++.++++||.|+|++.|+|||+||+|+||+.+|.+||+|||++
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 34569999999986 888888665 57999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC--CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC--ccC--
Q 014909 159 ALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFT-- 232 (416)
Q Consensus 159 ~~~~~~~~~--~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~--~~~-- 232 (416)
+.+...... ...+..+-|.+|.+||.+.+...++++.|||..|||+.+|.+|.+-+.+.+.......|... .++
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 765432211 12334566999999999998777789999999999999999999999988776665555321 110
Q ss_pred ------------------CCC-------------CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 233 ------------------CPP-------------WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 233 ------------------~~~-------------~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
.|. .-++++.+|+.+||..||.+|+++++++.|.||.++..|
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 110 025688999999999999999999999999999987654
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=319.96 Aligned_cols=251 Identities=25% Similarity=0.410 Sum_probs=201.2
Q ss_pred CEEEEeEEeecCceEEEEEEE----CCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CE
Q 014909 12 KYEVGRTIGEGTFAKVKFARN----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TK 85 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 85 (416)
-|++.+.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 368899999999999999974 4568899999986543 233456799999999999999999999998765 67
Q ss_pred EEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
.|+||||++|++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 899999999999999987653 5899999999999999999999999999999999999999999999999998754332
Q ss_pred cCC-CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch---------------HHHHHHhhc
Q 014909 165 RDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---------------MNLYKKISA 228 (416)
Q Consensus 165 ~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~---------------~~~~~~i~~ 228 (416)
... .......|+..|+|||++.+..+. .++|||||||++|+|+++..|+..... ......+..
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 111 112234567789999999876664 789999999999999998776532110 111111111
Q ss_pred -CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 229 -AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 229 -~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
...+.+..++..+.+|+.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1233455688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=358.65 Aligned_cols=258 Identities=32% Similarity=0.520 Sum_probs=208.7
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEE-------
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM------- 80 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~------- 80 (416)
+....|+..+.||+||||.||+++++-+|..||||.|.... .......+.+|+..+.+|+|||||++|..+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 45667888899999999999999999999999999998765 333467799999999999999999998543
Q ss_pred --------------------------------------------------E---------------------e-------
Q 014909 81 --------------------------------------------------G---------------------S------- 82 (416)
Q Consensus 81 --------------------------------------------------~---------------------~------- 82 (416)
. +
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0 0
Q ss_pred --------------------------C--------CEEEEEEeccCCCchHHHHHhCCCC-CHHHHHHHHHHHHHHHHHH
Q 014909 83 --------------------------K--------TKIFIVLEFVTGGELFDKIVNHGRM-KEDEARRYFQQLINAVDYC 127 (416)
Q Consensus 83 --------------------------~--------~~~~lV~E~~~gg~L~~~i~~~~~l-~e~~~~~~~~qll~al~~L 127 (416)
+ ..+||-||||+...|.++|..+... ..+.++++|+||++||.|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 0 2378999999987777777765544 4788999999999999999
Q ss_pred HhCCcEeecCCCCcEEeccCCCeEEeecccccccc----c------------ccCCCCcccccCCcccccchhhccCC--
Q 014909 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ----Q------------VRDDGLLHTTCGTPNYVAPEVLNDRG-- 189 (416)
Q Consensus 128 H~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPEvl~~~~-- 189 (416)
|+.|+|||||||.||++++++.|||+|||+|+... . .......+..+||-.|+|||++.+..
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999999998621 0 01112345678999999999998766
Q ss_pred CCCChhhHHHHHHHHHHHhhCCCCCCCCc-hHHHHHHhhcCccCCCCCC----CHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 190 YDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAAEFTCPPWL----SFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 190 ~~~~~~DIwSlGvil~~ml~G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~----s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.+..|+|||||||||+||+. ||...- .......+..+.++.|+.+ -+....+|++||+.||++|||+.|+|+
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 23489999999999999984 565432 2345556666666666322 346789999999999999999999999
Q ss_pred Cccccc
Q 014909 265 DEWFKK 270 (416)
Q Consensus 265 h~~~~~ 270 (416)
+.||..
T Consensus 871 s~llpp 876 (1351)
T KOG1035|consen 871 SELLPP 876 (1351)
T ss_pred ccCCCc
Confidence 999963
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=316.65 Aligned_cols=250 Identities=24% Similarity=0.393 Sum_probs=204.7
Q ss_pred EEEEeEEeecCceEEEEEEEC---CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-----
Q 014909 13 YEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----- 84 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----- 84 (416)
|++.+.||+|+||.||+|... .+++.||||++..+.. .....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678899999999999999864 3578899999975432 2334577889999999999999999999875432
Q ss_pred -EEEEEEeccCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccc
Q 014909 85 -KIFIVLEFVTGGELFDKIVNH------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (416)
Q Consensus 85 -~~~lV~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGl 157 (416)
..++++||+.+|+|.+++... ..++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 347899999999998877532 2478899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCC
Q 014909 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPP 235 (416)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~ 235 (416)
+................+++.|++||.+....+. .++|||||||++|+|++ |.+||.+.+....+..+... ....++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 8754321111112233456789999999877664 78999999999999999 99999887777666655443 344556
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 236 WLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 236 ~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
..+..+.+++.+||+.+|+.|||+.++++
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 78899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=312.25 Aligned_cols=242 Identities=26% Similarity=0.452 Sum_probs=204.6
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
.+.+|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++... ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 457899999999999999999864 67889999986532 235688999999999999999999998654 4799
Q ss_pred EEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 89 VLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
+|||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999997654 5889999999999999999999999999999999999999999999999998643221
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKL 244 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 244 (416)
......+..|+|||.+.+..+. .++|+|||||++|+|++ |.+||...+.......+..+. ...+..++..+.++
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVL 229 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcC-chhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHH
Confidence 1223345789999998876664 78999999999999997 999999887776666655442 33445678999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc
Q 014909 245 IARILDPNPMTRITIPEILE 264 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~ 264 (416)
+.+||+.+|++||+++++++
T Consensus 230 i~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 230 MTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=316.58 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=199.5
Q ss_pred cCEEEEeEEeecCceEEEEEEE----CCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CC
Q 014909 11 GKYEVGRTIGEGTFAKVKFARN----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KT 84 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~ 84 (416)
.+|++.+.||+|+||.||.|.. ..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4789999999999999999973 4578899999986543 2335678999999999999999999998643 45
Q ss_pred EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
.+++||||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 689999999999999999764 4689999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCC-cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHH----------------HHHHh
Q 014909 164 VRDDGL-LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----------------LYKKI 226 (416)
Q Consensus 164 ~~~~~~-~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~----------------~~~~i 226 (416)
...... .....++..|+|||++.+..+ +.++|||||||++|+|++|..|+....... +...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 111100 111223456999999987666 488999999999999999987765432210 11111
Q ss_pred hc-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 227 SA-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 227 ~~-~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.. ...+.+..++.++.+|+.+||..+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11 123345568899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=312.07 Aligned_cols=245 Identities=24% Similarity=0.349 Sum_probs=197.4
Q ss_pred eEEeecCceEEEEEEECC---CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE-eCCEEEEEEec
Q 014909 17 RTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG-SKTKIFIVLEF 92 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lV~E~ 92 (416)
+.||+|+||.||+|.+.. .+..+|+|.+.... .....+.+.+|+.+++.++||||+++++++. .+...+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998653 34579999875422 2234567889999999999999999999765 45668999999
Q ss_pred cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC--CC
Q 014909 93 VTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--GL 169 (416)
Q Consensus 93 ~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~--~~ 169 (416)
+.+|+|.+++... ...+...+..++.||+.||+|||+.|++||||||+|||++.++.+||+|||++......... ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9999999999764 34677788899999999999999999999999999999999999999999998643221110 11
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHHHHHHHH
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIAR 247 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ll~~ 247 (416)
.....+++.|+|||.+.+..+. .++|||||||++|+|++ |.+||...+.......+..+. ...+..++..+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 1233456789999999876664 88999999999999999 577887776666665554443 33455578999999999
Q ss_pred hcCCCCCCCCCHhHHhc
Q 014909 248 ILDPNPMTRITIPEILE 264 (416)
Q Consensus 248 ~L~~dP~~R~t~~eil~ 264 (416)
||..+|++||++.++++
T Consensus 238 cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 238 CWHPKPEMRPTFSELVS 254 (262)
T ss_pred HcCCChhhCCCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=312.46 Aligned_cols=236 Identities=21% Similarity=0.269 Sum_probs=193.4
Q ss_pred eEEeecCceEEEEEEECCCC----------CeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 17 RTIGEGTFAKVKFARNSETG----------EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~----------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
+.||+|+||.||+|.+..++ ..+++|++..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46999999999999998766 3478887754331 15678899999999999999999999887 778
Q ss_pred EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC-------CeEEeecccc
Q 014909 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-------NLKVSDFGLS 158 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~-------~vkl~DFGla 158 (416)
++||||+++|+|.+++.... .++...+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998766 799999999999999999999999999999999999999887 7999999998
Q ss_pred cccccccCCCCcccccCCcccccchhhccC-CCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCccCCCCC
Q 014909 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTCPPW 236 (416)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~-~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 236 (416)
..... .....++..|+|||++.+. ...+.++|||||||++|+|++ |..||...+......... .....+..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~ 228 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP 228 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC
Confidence 75322 2234567889999999875 244588999999999999999 688887765433322222 12222222
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 237 ~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.+..+.+++.+||..+|.+|||+.++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3478999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=346.99 Aligned_cols=249 Identities=24% Similarity=0.398 Sum_probs=214.3
Q ss_pred cCEEEEeEEeecCceEEEEEEECC-----CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
..-.+.+.||+|+||+||+|+... ..+.||||.++... ..++.++++||+++|..++|||||+|+|++..++.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 345677899999999999998643 34579999997543 33467899999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeE
Q 014909 86 IFIVLEFVTGGELFDKIVNHG----------R----MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~----------~----l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vk 151 (416)
+|+|+|||..|||..++..++ . ++..+...++.||+.||.||-++.+|||||-..|+||.++-.||
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEE
Confidence 999999999999999997542 2 77889999999999999999999999999999999999999999
Q ss_pred EeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc
Q 014909 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE 230 (416)
Q Consensus 152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~ 230 (416)
|+|||+++.......-.......-...|||||.|....+. .+|||||+||+|||+++ |..||.+.+..+..+.|..+.
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~ 722 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ 722 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence 9999999753321111111111224689999999998885 88999999999999997 999999999999999988775
Q ss_pred -cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHH
Q 014909 231 -FTCPPWLSFTARKLIARILDPNPMTRITIPEI 262 (416)
Q Consensus 231 -~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~ei 262 (416)
...|..++.++.+|+..||+.+|++||++.||
T Consensus 723 lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 723 LLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 57788899999999999999999999999998
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=311.90 Aligned_cols=250 Identities=29% Similarity=0.513 Sum_probs=209.2
Q ss_pred CEEEEeEEeecCceEEEEEEECC-CCCeEEEEEeechhh-------hcHHHHHHHHHHHHHHhc-CCCCCcceEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKV-------LKHKMAEQIKREVATMKL-VKHPNVVRLYEVMGS 82 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~-~~~~vaiK~i~~~~~-------~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~ 82 (416)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.++++ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 688999998864321 223345667788888865 799999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCcEEeccCCCeEEeeccc
Q 014909 83 KTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~-~givHrDlkp~NILl~~~~~vkl~DFGl 157 (416)
.+..|++|||++|++|.+.+.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999888743 3468999999999999999999996 7899999999999999999999999999
Q ss_pred ccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCC-CC-
Q 014909 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PP- 235 (416)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~-~~- 235 (416)
+...... .......|+..|+|||.+.+..+ +.++||||||+++|+|++|+.||...+.......+....... +.
T Consensus 161 ~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPE---SKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred eeecccc---cccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 8754332 13345678999999999987665 589999999999999999999998877766666655444332 22
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 236 WLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 236 ~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.+++.+.+++.+||+.||++||++.|+..+
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 578999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=315.05 Aligned_cols=255 Identities=16% Similarity=0.193 Sum_probs=193.9
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCC---CCeEEEEEeechhhh--cHHH------HHHHHHHHHHHhcCCCCCcce
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVL--KHKM------AEQIKREVATMKLVKHPNVVR 75 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~---~~~vaiK~i~~~~~~--~~~~------~~~~~~Ei~il~~l~hpnIv~ 75 (416)
...-++|++.+.||+|+||.||+|.+..+ +..+|+|+....... .+.. ......+...+..+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 33446899999999999999999998877 667888865432211 0000 011223344566778999999
Q ss_pred EEEEEEeCC----EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeE
Q 014909 76 LYEVMGSKT----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (416)
Q Consensus 76 l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vk 151 (416)
+++...... ..+++||++.. ++.+.+......++..+..++.|++.||+|||++||+||||||+|||++.++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEE
Confidence 998765443 45788888754 6666666655678999999999999999999999999999999999999999999
Q ss_pred EeecccccccccccC-----CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch-HH----
Q 014909 152 VSDFGLSALSQQVRD-----DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MN---- 221 (416)
Q Consensus 152 l~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~-~~---- 221 (416)
|+|||+|+....... ........||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+... ..
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 999999876532111 111233579999999999988777 4899999999999999999999987632 11
Q ss_pred ----HHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 222 ----LYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 222 ----~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
....+..+...+ +..+..+.++++.|+..+|++||+++++++
T Consensus 246 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 246 AKCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hHHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 223333333332 346789999999999999999999999975
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=313.85 Aligned_cols=251 Identities=24% Similarity=0.404 Sum_probs=204.1
Q ss_pred cCEEEEeEEeecCceEEEEEEEC----CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CC
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNS----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KT 84 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~ 84 (416)
..|++.+.||+|+||.||+|... .++..||+|++...... ...+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 56888999999999999999864 34789999999765432 345789999999999999999999999877 66
Q ss_pred EEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
..+++|||+++++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 8999999999999999997754 689999999999999999999999999999999999999999999999999876542
Q ss_pred ccCC-CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHH---------------HHHHhh
Q 014909 164 VRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---------------LYKKIS 227 (416)
Q Consensus 164 ~~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~---------------~~~~i~ 227 (416)
.... .......++..|+|||.+.+..+ +.++||||||+++|+|++|..||....... ....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 1111 11112344567999999987665 478999999999999999999987543211 112222
Q ss_pred c-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 228 A-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 228 ~-~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
. .....+..++.++.+|+.+||+.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2 123344567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=310.76 Aligned_cols=245 Identities=18% Similarity=0.248 Sum_probs=192.3
Q ss_pred eEEeecCceEEEEEEECCC--CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014909 17 RTIGEGTFAKVKFARNSET--GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 94 (416)
+.||+|+||.||+|..... ...+++|.+..... ....+.+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999975432 33566777654332 2335778999999999999999999999999999999999999
Q ss_pred CCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 95 GGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 95 gg~L~~~i~~~----~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
+|+|.+++... ...++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999999764 24667788899999999999999999999999999999999999999999987532111111122
Q ss_pred ccccCCcccccchhhccCC------CCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-c-----cCCCCCC
Q 014909 171 HTTCGTPNYVAPEVLNDRG------YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-E-----FTCPPWL 237 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~------~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~-----~~~~~~~ 237 (416)
...+|++.|+|||++.... ..+.++|||||||++|+|++ |..||...+..+.+..+... . ...+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3457889999999985321 12468999999999999996 68899876666555543222 1 2233447
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 238 SFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 238 s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
++.+.+++..|+ .+|++||+++++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 889999999999 67999999999965
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=320.52 Aligned_cols=252 Identities=31% Similarity=0.489 Sum_probs=204.6
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCC--CC----cceEEEEEEe
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH--PN----VVRLYEVMGS 82 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pn----Iv~l~~~~~~ 82 (416)
..++|.+.+++|+|+||+|-.+.+..++..||||+++.-. ...+..+-|+.+++++.+ |+ +|.+.++|+-
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 3578999999999999999999999999999999986422 234556779999999942 33 6778888999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc--------------
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-------------- 146 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~-------------- 146 (416)
.+++++|+|.+ |-++++++.++. +++.+.++.+.+||+.+|+|||+.+++|.||||||||+.+
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999999998 559999998865 6899999999999999999999999999999999999831
Q ss_pred ------CCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH
Q 014909 147 ------YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220 (416)
Q Consensus 147 ------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~ 220 (416)
+-.++++|||.|+.-.. .-.+.+.|..|.|||++.+-++. .++||||+||||+|+.+|...|...+..
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred eeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccCCcH
Confidence 23589999999875432 12456789999999999999996 8999999999999999999999865533
Q ss_pred H---HHHHhhcC------------------ccCCCCC-------------------------CCHHHHHHHHHhcCCCCC
Q 014909 221 N---LYKKISAA------------------EFTCPPW-------------------------LSFTARKLIARILDPNPM 254 (416)
Q Consensus 221 ~---~~~~i~~~------------------~~~~~~~-------------------------~s~~~~~ll~~~L~~dP~ 254 (416)
+ +-+.|... ....|.. -..++.+||++||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 3 22332211 0110100 012478999999999999
Q ss_pred CCCCHhHHhcCcccccC
Q 014909 255 TRITIPEILEDEWFKKD 271 (416)
Q Consensus 255 ~R~t~~eil~h~~~~~~ 271 (416)
+|+|+.|+|.||||...
T Consensus 396 ~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 396 RRITLREALSHPFFARL 412 (415)
T ss_pred ccccHHHHhcCHHhhcC
Confidence 99999999999999753
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=347.11 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=213.6
Q ss_pred cCEEEEeEEeecCceEEEEEEECCC-CC----eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSET-GE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~-~~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
..-++.+.||+|+||.||.|..... |. .||||.+.+ ..+.+....+.+|..+|+.++|||||+++|++-+...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 4567889999999999999987653 22 378887764 3455667889999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccc
Q 014909 86 IFIVLEFVTGGELFDKIVNH-------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~-------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla 158 (416)
.++++|||.||+|..+|++. ..++..+...++.||+.|+.||+++++|||||...|+||+....|||+|||+|
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999999886 24888999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHH-HhhcCccCCCCC
Q 014909 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYK-KISAAEFTCPPW 236 (416)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~-~i~~~~~~~~~~ 236 (416)
+........+......-...|||||.+....+ +.++|||||||+|||+++ |..||.+.+..+... -...++...|+.
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~ 928 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSY 928 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCC
Confidence 83221111000000112357999999998666 589999999999999998 999999988877666 556678889999
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 237 ~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
++..+.++|..||+.+|+.||++..|++
T Consensus 929 CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 929 CPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CChHHHHHHHHHccCChhhCccHHHHHh
Confidence 9999999999999999999999999997
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=307.27 Aligned_cols=255 Identities=29% Similarity=0.478 Sum_probs=213.7
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK------ 83 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 83 (416)
-.+|.-.+.+|.|+- .|..|.+.-.++.||+|.+..+. ......++..+|..+|..++|+||++++.++...
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 457888999999999 88899999999999999988773 3344568889999999999999999999999654
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
...|+||||+.. +|...+. -.+.-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+|...+.
T Consensus 94 ~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 94 QEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence 358999999976 7877776 4467788999999999999999999999999999999999999999999999975332
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-------------
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------- 230 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~------------- 230 (416)
.-..+..+.|..|.|||++.+.+|. +.+||||+|||+.||++|...|.+.+..+.|.++...-
T Consensus 171 ---~~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 171 ---DFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred ---ccccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 2355677899999999999998865 88999999999999999999999887766665543210
Q ss_pred --------------cC----CCC-----------CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 231 --------------FT----CPP-----------WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 231 --------------~~----~~~-----------~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
.. +|. .-+..+++|+.+||..||++|.+++++|.|||++-++.
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~ 318 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYD 318 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecc
Confidence 00 111 11345899999999999999999999999999985543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=293.52 Aligned_cols=250 Identities=26% Similarity=0.480 Sum_probs=206.4
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC--CE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSK--TK 85 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~ 85 (416)
..++|++.+.+|+|.|++|+.|.+..+++.++||++.+-+ .+.+++|+.||+.|. ||||++++++..++ ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 5678999999999999999999999999999999986543 567999999999998 99999999998765 45
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC-CCeEEeecccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQV 164 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~-~~vkl~DFGla~~~~~~ 164 (416)
..+|+||++..+...+- ..++..+++.|+.||+.||.||||.||+|||+||.|++||.. -.++|+|+|+|.+...
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp- 185 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP- 185 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC-
Confidence 67999999886654333 458889999999999999999999999999999999999875 5699999999987654
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCC-CCchHHHHHHhhc-------------Cc
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD-DSNLMNLYKKISA-------------AE 230 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~-~~~~~~~~~~i~~-------------~~ 230 (416)
.......+.+..|--||.+..-..+....|+|||||+|..|+..+.||- +.+..++.-+|.. -.
T Consensus 186 --~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 186 --GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred --CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 2334566788999999999876655689999999999999999999984 3333333333211 00
Q ss_pred cCCC-------------C-----------CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 231 FTCP-------------P-----------WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 231 ~~~~-------------~-----------~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
...+ + ..++++.+||.++|..|...|+|+.|++.||||..
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 1111 1 25799999999999999999999999999999974
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=318.71 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=200.2
Q ss_pred ccccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
.++......|.-...||+|+||.||+|.... |..||||.+....... ..++.+|+.++.+++|||+|+|+|+|.+.
T Consensus 68 ~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~ 143 (361)
T KOG1187|consen 68 DELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEG 143 (361)
T ss_pred HHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecC
Confidence 4455666788888999999999999999864 4889999876543221 34599999999999999999999999998
Q ss_pred C-EEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cEeecCCCCcEEeccCCCeEEeeccc
Q 014909 84 T-KIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRG---VYHRDLKPENLLLDAYGNLKVSDFGL 157 (416)
Q Consensus 84 ~-~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~g---ivHrDlkp~NILl~~~~~vkl~DFGl 157 (416)
+ ..+||+||++.|+|.+++.... .+++....+|+.+++.||+|||... |+||||||+|||+|++.+.||+|||+
T Consensus 144 ~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGL 223 (361)
T KOG1187|consen 144 GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGL 223 (361)
T ss_pred CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccC
Confidence 8 5999999999999999998765 8899999999999999999999864 99999999999999999999999999
Q ss_pred ccccccccCCCCcccc-cCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc---h---HHHH-HHhhcC
Q 014909 158 SALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---L---MNLY-KKISAA 229 (416)
Q Consensus 158 a~~~~~~~~~~~~~~~-~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~---~---~~~~-~~i~~~ 229 (416)
|...... .....+. .||..|+|||.+.... .+.++||||+||+|.|+++|+.|.+... . .... ..+..+
T Consensus 224 a~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~-lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 224 AKLGPEG--DTSVSTTVMGTFGYLAPEYASTGK-LTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred cccCCcc--ccceeeecCCCCccCChhhhccCC-cCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 9643221 2222223 8999999999997643 4589999999999999999998887532 1 1111 112221
Q ss_pred c------cCCC-CCCC--HH---HHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 230 E------FTCP-PWLS--FT---ARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 230 ~------~~~~-~~~s--~~---~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
. ..+. ...+ .. +..+..+|++.+|..||++.++++
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1 1111 1122 22 456778999999999999999754
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=330.56 Aligned_cols=202 Identities=34% Similarity=0.570 Sum_probs=177.1
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT---- 84 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 84 (416)
..+-|...+.||+||||.||+++++.+|..||||.+++....+ ..+..-+|+++|++++|||||+++++-++..
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r--~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR--PRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccc--hHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 3467888999999999999999999999999999998755333 3677889999999999999999999876544
Q ss_pred --EEEEEEeccCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc--CCC--eEEeec
Q 014909 85 --KIFIVLEFVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--YGN--LKVSDF 155 (416)
Q Consensus 85 --~~~lV~E~~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~--~~~--vkl~DF 155 (416)
.-.+|||||.||+|+..+.+. .+++|.+...++..+..||.|||.+||+||||||.||++-. +|. .||+||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 457999999999999999763 47999999999999999999999999999999999999843 343 799999
Q ss_pred ccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCC
Q 014909 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 215 (416)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~ 215 (416)
|.|+-.. ++....+..||+.|.+||++..+.+++..+|.||+||++|+++||.+||.
T Consensus 169 G~Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 169 GAARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred cccccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 9998543 45578889999999999999876666799999999999999999999995
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=335.39 Aligned_cols=257 Identities=18% Similarity=0.252 Sum_probs=180.3
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCC----CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEE---
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSET----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEV--- 79 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~--- 79 (416)
....++|.+.+.||+|+||.||+|.+..+ +..||+|.+...... +....+ .++...+.++..+...
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 34678999999999999999999999988 899999987643211 111111 1112222222222211
Q ss_pred ---EEeCCEEEEEEeccCCCchHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCcEeec
Q 014909 80 ---MGSKTKIFIVLEFVTGGELFDKIVNHGR--------------------MKEDEARRYFQQLINAVDYCHSRGVYHRD 136 (416)
Q Consensus 80 ---~~~~~~~~lV~E~~~gg~L~~~i~~~~~--------------------l~e~~~~~~~~qll~al~~LH~~givHrD 136 (416)
......+++||||+.+++|.+++..... ..+..+..++.||+.||+|||++||+|||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 2456789999999999999998875321 12345678999999999999999999999
Q ss_pred CCCCcEEecc-CCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCC---------------------CCCh
Q 014909 137 LKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY---------------------DGST 194 (416)
Q Consensus 137 lkp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~---------------------~~~~ 194 (416)
|||+|||++. ++.+||+|||+|+..... ........+||+.|+|||.+....+ .+.+
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 9999999986 589999999999754321 1223345689999999997643221 1245
Q ss_pred hhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCC---------------------CCCCCHHHHHHHHHhcCCCC
Q 014909 195 ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC---------------------PPWLSFTARKLIARILDPNP 253 (416)
Q Consensus 195 ~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~---------------------~~~~s~~~~~ll~~~L~~dP 253 (416)
+||||+||+||+|+++..|++... ......+....... ....+....+||.+||+.||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 699999999999999887765321 11111111111100 01122345689999999999
Q ss_pred CCCCCHhHHhcCcccccCC
Q 014909 254 MTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 254 ~~R~t~~eil~h~~~~~~~ 272 (416)
.+|||+.++|+||||+...
T Consensus 439 ~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 439 RQRISAKAALAHPYFDREG 457 (566)
T ss_pred ccCCCHHHHhCCcCcCCCC
Confidence 9999999999999998643
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=317.05 Aligned_cols=264 Identities=30% Similarity=0.454 Sum_probs=221.4
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcH----HHHHHHHHHHHHHhcCCCCCcceEEEEEE-eC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH----KMAEQIKREVATMKLVKHPNVVRLYEVMG-SK 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~ 83 (416)
.-++|-+...||+|+|++||+|.+...+.+||+|+-...+.|+. ...+...+|..|.+.|.||.||++|+++. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 45678899999999999999999999999999999877665554 34567789999999999999999999996 55
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--CcEeecCCCCcEEec---cCCCeEEeecccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR--GVYHRDLKPENLLLD---AYGNLKVSDFGLS 158 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~--givHrDlkp~NILl~---~~~~vkl~DFGla 158 (416)
+.+|-|+|||+|.+|.-+++.+.-++|.+|+.|+-||+.||.||... -|+|-||||.|||+- ..|.+||+|||++
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 67899999999999999999999999999999999999999999976 599999999999994 3578999999999
Q ss_pred cccccccCCC-----CcccccCCcccccchhhcc---CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH-HHHHH--h-
Q 014909 159 ALSQQVRDDG-----LLHTTCGTPNYVAPEVLND---RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKK--I- 226 (416)
Q Consensus 159 ~~~~~~~~~~-----~~~~~~gt~~y~aPEvl~~---~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~-~~~~~--i- 226 (416)
++++....+. ......||-+|.+||.+.- .+-.+.++||||+|||+|.++.|+.||...... ++++. |
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 9876543331 2344579999999998753 344568899999999999999999999865432 33221 2
Q ss_pred hcCccCCC--CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 227 SAAEFTCP--PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 227 ~~~~~~~~--~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
...+..+| |-+|.++++||++||+..-+.|..+.++-.||+|..+.
T Consensus 701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~ 748 (775)
T KOG1151|consen 701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI 748 (775)
T ss_pred cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence 22334444 56999999999999999999999999999999997643
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=299.50 Aligned_cols=249 Identities=24% Similarity=0.420 Sum_probs=203.4
Q ss_pred EeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014909 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 94 (416)
...||.|+||+|++..++.+|+..|||.++...... ...++..|.. +|+.-++||||++|+....++..|+-||+|+
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~k--eq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEK--EQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchH--HHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 457999999999999999999999999998766533 3566777777 4556679999999999999999999999996
Q ss_pred CCchHHHH-----HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 95 GGELFDKI-----VNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 95 gg~L~~~i-----~~~~~l~e~~~~~~~~qll~al~~LH~-~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
- +|..+- .....++|+..-.+....+.||.||.. ..|+|||+||+|||++..|.+||||||++.... +.-
T Consensus 147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv---~Si 222 (361)
T KOG1006|consen 147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV---DSI 222 (361)
T ss_pred h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH---HHH
Confidence 4 442221 234579999999999999999999975 489999999999999999999999999986432 222
Q ss_pred CcccccCCcccccchhhcc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCCch-HHHHHHhhcCccCC---CC---CCCH
Q 014909 169 LLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAEFTC---PP---WLSF 239 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~--~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~-~~~~~~i~~~~~~~---~~---~~s~ 239 (416)
..+...|..+|||||.+.. .+|+ .++|+||||++|||+.||..|+.+.+. .+....+..+.++. +. .+|.
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~ 301 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF 301 (361)
T ss_pred HhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence 3345678999999999964 4565 899999999999999999999987654 34444444444322 22 2788
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 240 TARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
.+..+|..||.+|-+.||...+++++||++..
T Consensus 302 ~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 302 SMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred HHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 99999999999999999999999999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=290.62 Aligned_cols=240 Identities=47% Similarity=0.833 Sum_probs=208.4
Q ss_pred CceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHH
Q 014909 23 TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI 102 (416)
Q Consensus 23 ~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i 102 (416)
+||.||+|.+..+++.+|+|++........ .+.+.+|+..+++++|+||+++++.+......++++||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999998999999999976543221 578999999999999999999999999999999999999999999999
Q ss_pred HhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCCcccccc
Q 014909 103 VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182 (416)
Q Consensus 103 ~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 182 (416)
.....++...+..++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||.+...... .......++..|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG---GLLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc---cccccccCCcCCCCH
Confidence 87767999999999999999999999999999999999999999999999999998765432 133456788999999
Q ss_pred hhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCC-CchHHHHHHhhcCccCCCCC---CCHHHHHHHHHhcCCCCCCCCC
Q 014909 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPW---LSFTARKLIARILDPNPMTRIT 258 (416)
Q Consensus 183 Evl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~---~s~~~~~ll~~~L~~dP~~R~t 258 (416)
|.+....+. .++||||+|+++++|++|..||.. .+.......+.......+.. ++.++.+++.+||..+|++||+
T Consensus 156 E~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 999876665 699999999999999999999987 55555555555544433332 8899999999999999999999
Q ss_pred HhHHhcCccc
Q 014909 259 IPEILEDEWF 268 (416)
Q Consensus 259 ~~eil~h~~~ 268 (416)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=326.10 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=221.2
Q ss_pred cccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEE--
Q 014909 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMG-- 81 (416)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~-- 81 (416)
..+..-+.|++.++||.|.+|+||+++++.+++..|+|++..... .-+.++.|+++++.+. |||++.+|+++.
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 345567889999999999999999999999999999999876432 3467888999999885 999999999985
Q ss_pred ---eCCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecc
Q 014909 82 ---SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (416)
Q Consensus 82 ---~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFG 156 (416)
.++.+|||||||.||+.-|+++.. .++.|+.+..|++.++.|+.+||++.++|||||=.|||++.+|.|||+|||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeee
Confidence 467899999999999999998763 579999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCcccccCCcccccchhhccC-----CCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-
Q 014909 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE- 230 (416)
Q Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~-----~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~- 230 (416)
.+...... -+.-.+..|||.|||||++... .|+ ..+|+||||++..||..|.+|+-+.......-+|....
T Consensus 169 vSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP 245 (953)
T KOG0587|consen 169 VSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 245 (953)
T ss_pred eeeeeecc--cccccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC
Confidence 98765442 2344678999999999999653 343 68999999999999999999998877765444443332
Q ss_pred c--CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 231 F--TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 231 ~--~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
+ .-|..++.++.+||..||.+|-.+||+..++|+|||+..
T Consensus 246 PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 246 PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 1 223447899999999999999999999999999999984
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=313.20 Aligned_cols=262 Identities=19% Similarity=0.257 Sum_probs=190.2
Q ss_pred ccccCEEEEeEEeecCceEEEEEEEC----------------CCCCeEEEEEeechhhhcH-----------HHHHHHHH
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNS----------------ETGEPVALKILDKEKVLKH-----------KMAEQIKR 60 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~----------------~~~~~vaiK~i~~~~~~~~-----------~~~~~~~~ 60 (416)
...++|.+.+.||+|+||.||+|... ..++.||||.+........ ...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 35678999999999999999999752 2356799999864321100 01122334
Q ss_pred HHHHHhcCCCCCc-----ceEEEEEEe--------CCEEEEEEeccCCCchHHHHHhCC---------------------
Q 014909 61 EVATMKLVKHPNV-----VRLYEVMGS--------KTKIFIVLEFVTGGELFDKIVNHG--------------------- 106 (416)
Q Consensus 61 Ei~il~~l~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~i~~~~--------------------- 106 (416)
|+..+.+++|.++ +++++++.. ....|+||||+++++|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6677777766554 566666542 356899999999999999886421
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCCcccccch
Q 014909 107 ---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183 (416)
Q Consensus 107 ---~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 183 (416)
.++...++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++....... ........+|+.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeChh
Confidence 23556788999999999999999999999999999999999999999999986433211 11111234589999999
Q ss_pred hhccCC--------------------CC-CChhhHHHHHHHHHHHhhCCC-CCCCCc-----------hHHHHHHhhcCc
Q 014909 184 VLNDRG--------------------YD-GSTADLWSCGVILFVLLAGYL-PFDDSN-----------LMNLYKKISAAE 230 (416)
Q Consensus 184 vl~~~~--------------------~~-~~~~DIwSlGvil~~ml~G~~-Pf~~~~-----------~~~~~~~i~~~~ 230 (416)
++.... |. ..+.||||+||++|+|++|.+ ||.+.. ....+..+....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 986422 11 124799999999999999986 775421 112223333344
Q ss_pred cCCCC--CCCHHHHHHHHHhcCCCC---CCCCCHhHHhcCccccc
Q 014909 231 FTCPP--WLSFTARKLIARILDPNP---MTRITIPEILEDEWFKK 270 (416)
Q Consensus 231 ~~~~~--~~s~~~~~ll~~~L~~dP---~~R~t~~eil~h~~~~~ 270 (416)
+.++. ..++.+.+|+.+||..+| .+|+|++|+|+||||..
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 44443 478999999999999866 68999999999999965
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=311.13 Aligned_cols=253 Identities=27% Similarity=0.432 Sum_probs=213.1
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCC------CCcceEEEEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH------PNVVRLYEVMG 81 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~ 81 (416)
..-++|.+....|+|-||+|..|.+...|+.||||+|..... +.+.=.+|+.||++|+. -|.++|+-.|.
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 345689999999999999999999999999999999986543 45666789999999963 47899999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC-CCeEEeeccc
Q 014909 82 SKTKIFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGL 157 (416)
Q Consensus 82 ~~~~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~-~~vkl~DFGl 157 (416)
..+++|||+|-+.- .|.+.+++.+ +|....++.|++||+-||..|...||+|.||||+|||+++. ..+||||||.
T Consensus 505 hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 505 HKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 99999999998864 8888888754 68889999999999999999999999999999999999986 4589999999
Q ss_pred ccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCC-
Q 014909 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW- 236 (416)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~- 236 (416)
|..... ...+.+.-+..|.|||++.+.+|+ .+.|+||+||.|||+.||+..|++.+...++........++|..
T Consensus 584 A~~~~e----neitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 584 ASFASE----NEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred cccccc----ccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 875432 234455567889999999999998 88999999999999999999999988777665443322222210
Q ss_pred ----------------------------------------------------CC-------HHHHHHHHHhcCCCCCCCC
Q 014909 237 ----------------------------------------------------LS-------FTARKLIARILDPNPMTRI 257 (416)
Q Consensus 237 ----------------------------------------------------~s-------~~~~~ll~~~L~~dP~~R~ 257 (416)
++ ..+++||.+||..||++|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 11 2478999999999999999
Q ss_pred CHhHHhcCccccc
Q 014909 258 TIPEILEDEWFKK 270 (416)
Q Consensus 258 t~~eil~h~~~~~ 270 (416)
|+.++|+||||..
T Consensus 739 t~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 739 TVNQALKHPFITE 751 (752)
T ss_pred CHHHHhcCCcccC
Confidence 9999999999974
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=309.04 Aligned_cols=244 Identities=27% Similarity=0.466 Sum_probs=207.9
Q ss_pred EEEEeEEeecCceEEEEEEECCC--CC--eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 13 YEVGRTIGEGTFAKVKFARNSET--GE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~--~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
.++.+.||.|-||.||.|..... |+ .||||..+.+. ..+..+.+..|..+|+.++|||||+++|++.. ...|+
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 34456899999999999986532 33 48899887643 23347889999999999999999999999965 57899
Q ss_pred EEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 89 VLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
|||+++-|+|..+++.++ .++......|..||+.||.|||+.+.+||||-..|||+.....|||+|||+++.... +
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed---~ 544 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED---D 544 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc---c
Confidence 999999999999998865 688899999999999999999999999999999999999999999999999986543 3
Q ss_pred CCcccccCC--cccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHH
Q 014909 168 GLLHTTCGT--PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (416)
Q Consensus 168 ~~~~~~~gt--~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (416)
.......|. ..|||||-++-..+. .++|||-|||.+||++. |..||.+-...+..-.+..+ ..++|+.+++.+..
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYs 623 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYS 623 (974)
T ss_pred chhhccccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHH
Confidence 333333443 469999999887775 88999999999999885 99999987777766666665 57899999999999
Q ss_pred HHHHhcCCCCCCCCCHhHHh
Q 014909 244 LIARILDPNPMTRITIPEIL 263 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil 263 (416)
|+.+||..+|.+||++.+|.
T Consensus 624 lmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 624 LMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHHhccCcccCCcHHHHH
Confidence 99999999999999987764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=308.61 Aligned_cols=206 Identities=30% Similarity=0.569 Sum_probs=187.9
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHH-----HHHHHHHHHHhcCC---CCCcceEEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA-----EQIKREVATMKLVK---HPNVVRLYE 78 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~-----~~~~~Ei~il~~l~---hpnIv~l~~ 78 (416)
..++..|...+.||.|+||+|++|.++.+...|+||.|.++++...... -.+-.||.||..++ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 4567789999999999999999999999999999999999887543332 33668999999997 999999999
Q ss_pred EEEeCCEEEEEEecc-CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccc
Q 014909 79 VMGSKTKIFIVLEFV-TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (416)
Q Consensus 79 ~~~~~~~~~lV~E~~-~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGl 157 (416)
+|++++.+|++||-. +|-+||++|.....++|.++..+|+|++.|+++||+.||+|||||-||+.++.+|.+||+|||.
T Consensus 637 fFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 637 FFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred eeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 999999999999975 4579999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCC
Q 014909 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216 (416)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~ 216 (416)
|... .+++.+...||..|.|||++.+..|.|.+-|||++|++||.++...-||..
T Consensus 717 aa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 8754 456788999999999999999999999999999999999999998888853
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=310.60 Aligned_cols=255 Identities=26% Similarity=0.431 Sum_probs=215.4
Q ss_pred cCEEEEeEEeecCceEEEEEEECC-CCC--eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSE-TGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~-~~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
++..+.+.||+|+||.|+.|.++. +|+ .||||++....... ....+.+|+.+|.+|+|||+|+||++..+ ..+.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 345667899999999999998875 333 58999998665443 57889999999999999999999999987 7889
Q ss_pred EEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+|||++++|+|.+.+.+. ..+.......|+.||+.||.||.+++.|||||-..|+|+-....||||||||.+-.....
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999999999873 357888899999999999999999999999999999999999999999999988654422
Q ss_pred CCCCc-ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHH
Q 014909 166 DDGLL-HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (416)
Q Consensus 166 ~~~~~-~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 242 (416)
+.... ....-...|+|||.+....+. .++|+|++||++|||++ |+.||.+.....++++|..+ ..+-|+.+|+++.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY 345 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY 345 (1039)
T ss_pred cceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence 11100 011123479999999988775 89999999999999997 99999999999999988755 4677889999999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCcccc
Q 014909 243 KLIARILDPNPMTRITIPEILEDEWFK 269 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t~~eil~h~~~~ 269 (416)
+++..||..+|..|||+..|.+.-+..
T Consensus 346 ~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 346 QIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHhccCCccccccHHHHHHhHHHH
Confidence 999999999999999999997544443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=288.97 Aligned_cols=257 Identities=25% Similarity=0.438 Sum_probs=211.9
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-----EE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-----KI 86 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 86 (416)
+.+..+.||-|+||.||.+.+..+|+.||+|.+..- ..+-...+++.+|+++|..++|.|++..+++..... .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 345678999999999999999999999999988532 223334588999999999999999999999876543 47
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|++.|++.. +|...|.....++.+.++-+++||+.||+|||+.||.||||||.|+|++.|..+||||||+|+..+...
T Consensus 133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~- 210 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD- 210 (449)
T ss_pred HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh-
Confidence 889999975 888888888899999999999999999999999999999999999999999999999999998754422
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhc------------------
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA------------------ 228 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~------------------ 228 (416)
....+..+-|-+|.|||++.+...++.+.||||.|||+.|++..+..|...+..+..+.|..
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 22334456688999999999877777899999999999999999999987776555444321
Q ss_pred -----CccCCCC-----------CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 229 -----AEFTCPP-----------WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 229 -----~~~~~~~-----------~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
+....|. .-..++..++.+||..||++|++..+++.|++....
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 1111121 123468899999999999999999999999998654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=288.51 Aligned_cols=129 Identities=29% Similarity=0.521 Sum_probs=114.6
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-----C---CCcceEEEEEE-
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-----H---PNVVRLYEVMG- 81 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----h---pnIv~l~~~~~- 81 (416)
++|.+.+.||.|-|++||+|.+..+.+.||+|+.+... ...+....||.+|++++ | .+||+|++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 79999999999999999999999999999999987543 35567789999999884 3 36999999986
Q ss_pred ---eCCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCcEEe
Q 014909 82 ---SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLL 144 (416)
Q Consensus 82 ---~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~-givHrDlkp~NILl 144 (416)
++.++++|+|+. |..|..+|... +.++...++.|++|++.||.|||.. ||+|.||||+|||+
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 467899999999 66899988874 5799999999999999999999975 99999999999998
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=297.21 Aligned_cols=241 Identities=26% Similarity=0.419 Sum_probs=211.3
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (416)
..+...||-|.||.||.|.++.-.-.||||.++.+.. ..+.+..|+.+|+.++|||+|+++++|..+..+|||.||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 3556789999999999999998888899999864432 357899999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 93 VTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 93 ~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
|..|.|.+++++.. .++.-....++.||.+|++||..+++|||||-..|+|+.++..||++||||++++.. ..+
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg----DTY 420 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG----DTY 420 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC----Cce
Confidence 99999999998754 367777788899999999999999999999999999999999999999999997643 222
Q ss_pred ccccC---CcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHH
Q 014909 171 HTTCG---TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245 (416)
Q Consensus 171 ~~~~g---t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll 245 (416)
+...| ...|.|||-+....+. .++|||+|||+|||+.| |-.||.+-+..+.|..+..+ ...-|..+++.+.+|+
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLM 499 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELM 499 (1157)
T ss_pred ecccCccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHH
Confidence 33334 3479999999887775 89999999999999997 99999999998888877665 4566888999999999
Q ss_pred HHhcCCCCCCCCCHhHH
Q 014909 246 ARILDPNPMTRITIPEI 262 (416)
Q Consensus 246 ~~~L~~dP~~R~t~~ei 262 (416)
+.||+.+|..||++.||
T Consensus 500 raCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 500 RACWNWSPSDRPSFAEI 516 (1157)
T ss_pred HHHhcCCcccCccHHHH
Confidence 99999999999999998
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=308.67 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=218.0
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCC---eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
..-.|.+.||.|.||+|++|+.+..|+ .||||.++.-.. +.....+..|+.||-+++||||++|.++........
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc--HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 345788999999999999999887764 699999975432 335678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 88 IVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
||.|||++|+|..+++.+ ++++..+...+++.|++|++||-+.|.|||||-..|||++.+..+|++|||+++..+...
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~- 785 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP- 785 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC-
Confidence 999999999999999874 678888999999999999999999999999999999999999999999999999765433
Q ss_pred CCCcccccC--CcccccchhhccCCCCCChhhHHHHHHHHHHHh-hCCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHH
Q 014909 167 DGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL-AGYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (416)
Q Consensus 167 ~~~~~~~~g--t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml-~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 242 (416)
.....+.-| ...|.|||.|....+. .++||||+||++||.+ .|..||-+.+..+..+.|..+ ..+.|..++..+.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~ 864 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALY 864 (996)
T ss_pred CccccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHH
Confidence 223333333 3579999999988875 8999999999999866 599999999988888888766 4566667999999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhc
Q 014909 243 KLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.|+..||++|-.+||.+.+|+.
T Consensus 865 qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 865 QLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HHHHHHHHHHhhcCCCHHHHHH
Confidence 9999999999999999999986
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=295.47 Aligned_cols=252 Identities=20% Similarity=0.322 Sum_probs=206.6
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
+..+++.||+|-||+|.++.-. .+..||+|+++.... ......+.+||++|.+|+|||||+++++|..++.+++|+|
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred heehhhhhcCcccceeEEEEec-CceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 3567899999999999999874 368899999987543 3346889999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 92 FVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 92 ~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
|++.|+|.+++.++.. +.......++.||++||+||.+.+++||||.|.|+|++.++++||+|||+++-.........
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 9999999999998743 34455667999999999999999999999999999999999999999999874322111111
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHh--hCCCCCCCCchHHHHHHhhc--------CccCCCCCCCH
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL--AGYLPFDDSNLMNLYKKISA--------AEFTCPPWLSF 239 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml--~G~~Pf~~~~~~~~~~~i~~--------~~~~~~~~~s~ 239 (416)
-...+-...|||||.+....+. .++|+|++|+++||++ +...||...+..+....... .....|+-++.
T Consensus 696 qgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~ 774 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQ 774 (807)
T ss_pred ecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcH
Confidence 1122335689999999877774 8999999999999876 58999988776665554321 12355777899
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 014909 240 TARKLIARILDPNPMTRITIPEILEDEWFK 269 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~h~~~~ 269 (416)
.+.+|+-+|+..+-.+|||++++ |.+|+
T Consensus 775 ~lyelml~Cw~~es~~RPsFe~l--h~~lq 802 (807)
T KOG1094|consen 775 GLYELMLRCWRRESEQRPSFEQL--HLFLQ 802 (807)
T ss_pred HHHHHHHHHhchhhhcCCCHHHH--HHHHH
Confidence 99999999999999999999999 55554
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=329.39 Aligned_cols=237 Identities=19% Similarity=0.305 Sum_probs=186.7
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
..|...+.||+|+||.||+|.+..++..||||.+..... ....|+.++++++|||||++++++.+....|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 445667789999999999999988999999999864321 1234688999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH---SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH---~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
||+++|+|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 99999999999953 888999999999999999999 6799999999999999998888776 665432211
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch----HHHHHHhhcC--------ccCCCC
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAA--------EFTCPP 235 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~----~~~~~~i~~~--------~~~~~~ 235 (416)
.....||+.|+|||++.+..+. .++||||+||++|||++|+.||+.... ...+.+.... ....+.
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --CCCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 1234688999999999887775 899999999999999999999964211 1111110000 000000
Q ss_pred ------CCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 236 ------WLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 236 ------~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
....++.+++.+||+.||++|||+.|+++.
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 112356789999999999999999999863
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.41 Aligned_cols=247 Identities=30% Similarity=0.454 Sum_probs=195.8
Q ss_pred EeEEeecCceE-EEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEEEecc
Q 014909 16 GRTIGEGTFAK-VKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFV 93 (416)
Q Consensus 16 ~~~LG~G~fg~-V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 93 (416)
.+.+|.|+-|+ ||+|.. .|+.||||.+-.+ ......+||..|+.-+ |||||++|+.-.+....||..|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 35789999986 788886 5789999976432 3466889999999885 999999999999999999999999
Q ss_pred CCCchHHHHHhCCC----CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc---CC--CeEEeecccccccccc
Q 014909 94 TGGELFDKIVNHGR----MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YG--NLKVSDFGLSALSQQV 164 (416)
Q Consensus 94 ~gg~L~~~i~~~~~----l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~---~~--~vkl~DFGla~~~~~~ 164 (416)
.. +|.++++.++. ......+....|+++||++||+.+|+||||||.||||+. ++ .++|+|||+|+.....
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 75 99999987521 111456889999999999999999999999999999976 33 5899999999865443
Q ss_pred cCC-CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCccCCC---CCCCH
Q 014909 165 RDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTCP---PWLSF 239 (416)
Q Consensus 165 ~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~~~~~---~~~s~ 239 (416)
... ....+..||-+|+|||++..... ..++||+|+||++|+.++ |..||.+.-..+ ..|..+.+... +.-..
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLPDC 741 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCchH
Confidence 221 22456679999999999987655 368999999999998887 599998653322 23444443322 22223
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
++.+||.+||+++|..||++.++|.||+|+...+.
T Consensus 742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekr 776 (903)
T KOG1027|consen 742 EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKR 776 (903)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHH
Confidence 89999999999999999999999999999976543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=302.37 Aligned_cols=256 Identities=28% Similarity=0.443 Sum_probs=223.2
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
-.+|++...+|+|+||.||+|+++.+++..|+|+++.+... ...-++.||-+++..+|||||.+++.+-..+..|+.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d---d~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD---DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc---cccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 45799999999999999999999999999999999876533 356788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
||||.||+|.+.-.-.++++|.++....+..+.|++|||+.|-+|||||-.|||+++.|.+|++|||.+...... -..
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~K 168 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAK 168 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh--hhh
Confidence 999999999998888899999999999999999999999999999999999999999999999999987644321 122
Q ss_pred cccccCCcccccchhhc---cCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCC-----CCCHHH
Q 014909 170 LHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-----WLSFTA 241 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~---~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~-----~~s~~~ 241 (416)
.....|||+|||||+-. ..+| ...+|||++|+...|+---++|-.+...+.....+....+..|. .+++.+
T Consensus 169 rksfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhcccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 35678999999999963 3455 48999999999999998888887776666655556666665553 378899
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
-+|++.+|.++|++|||++.+|.|||....
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 999999999999999999999999999754
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=291.78 Aligned_cols=247 Identities=24% Similarity=0.383 Sum_probs=211.6
Q ss_pred EEEeEEeecCceEEEEEEECCCCC----eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 14 EVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 14 ~~~~~LG~G~fg~V~~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+..+.||+|+||+||+|.....|+ +||||++..... ......+.+|+-+|.+++|||++++++++.... ..||
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 445789999999999998765554 689999876543 234678999999999999999999999997766 8899
Q ss_pred EeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 90 LEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
++|+++|.|.|+++.++ .+.......|..||++||.|||.++++||||-..|||+..-.++||.|||+|+........-
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 99999999999998764 68889999999999999999999999999999999999999999999999999876543332
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHHH
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIA 246 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll~ 246 (416)
......-.+.|||=|.+....|. .++||||+||.+||++| |..|+.+....++...+..+ +...|+..+.++..++.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mv 934 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMV 934 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHH
Confidence 22222334679999999888775 89999999999999997 99999998888777666554 47889999999999999
Q ss_pred HhcCCCCCCCCCHhHHhc
Q 014909 247 RILDPNPMTRITIPEILE 264 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~ 264 (416)
+||..|++.||+++++-.
T Consensus 935 kCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 935 KCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHhccCcccCccHHHHHH
Confidence 999999999999998753
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=251.38 Aligned_cols=207 Identities=23% Similarity=0.445 Sum_probs=168.2
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHh-cCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
..-+..||+|++|.|-+.++..+|+..|+|.+...-. ....+++.+|+.+.. ...+|.+|.+|+.+.....+|+.||
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 3445689999999999999999999999999875432 234566777887654 4579999999999999999999999
Q ss_pred ccCCCchHH----HHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 92 FVTGGELFD----KIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 92 ~~~gg~L~~----~i~~~~~l~e~~~~~~~~qll~al~~LH~~-givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
.|.. +|.. .+...+.++|..+-+++..++.||.|||++ .++|||+||+||||+.+|++|+||||++.....
T Consensus 126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d--- 201 (282)
T KOG0984|consen 126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD--- 201 (282)
T ss_pred Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh---
Confidence 9975 6643 344567899999999999999999999987 899999999999999999999999999875432
Q ss_pred CCCcccccCCcccccchhhcc----CCCCCChhhHHHHHHHHHHHhhCCCCCCCC-chHHHHHHh
Q 014909 167 DGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKI 226 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~----~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~-~~~~~~~~i 226 (416)
.-..+...|..+|||||.+.. .+|+ -++||||||+.++||.+++.||+.. +..++..++
T Consensus 202 SiAkt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 202 SIAKTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred hhHHHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 222233678899999999853 3565 8999999999999999999999754 333444443
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.32 Aligned_cols=247 Identities=25% Similarity=0.420 Sum_probs=206.7
Q ss_pred EEEeEEeecCceEEEEEEECC-------CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCE
Q 014909 14 EVGRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTK 85 (416)
Q Consensus 14 ~~~~~LG~G~fg~V~~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 85 (416)
.+.+.||+|+||.|++|.-.. ....||||.+...... ...+.+..|+.+|+.+. ||||+.+++.+.....
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 466699999999999996331 1346999998765433 45688999999999995 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCC
Q 014909 86 IFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~ 149 (416)
.++|+||+..|+|.++++..+ .++..+...+..||+.|++||++..++||||-..|||++++..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV 456 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence 999999999999999998765 3888999999999999999999999999999999999999999
Q ss_pred eEEeecccccccccccCCCCcccccCCc--ccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCc-hHHHHHH
Q 014909 150 LKVSDFGLSALSQQVRDDGLLHTTCGTP--NYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSN-LMNLYKK 225 (416)
Q Consensus 150 vkl~DFGla~~~~~~~~~~~~~~~~gt~--~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~-~~~~~~~ 225 (416)
+||+|||+|+........ ......|+. .|||||.+....| +.++||||+||+|||+++ |..||.+-. ..++++.
T Consensus 457 ~kIaDFGlar~~~~~~~y-~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~ 534 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYY-RTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF 534 (609)
T ss_pred EEEccccceeccCCCCce-EecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence 999999999843221111 112223333 4999999998666 489999999999999998 999999855 5566766
Q ss_pred hhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 226 ISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 226 i~~~~-~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+..+. ...|..++.+..++++.|++.+|++||++.++.+
T Consensus 535 l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 535 LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 76664 5778889999999999999999999999999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=275.95 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=202.1
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECC---CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSK 83 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 83 (416)
.....|.+++.||.|+|+.||+|.+.. ....||+|.+.... ...++.+|++.|..+. +.||+++.+.+..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 345678999999999999999998877 78899999986543 2466899999999996 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC-CCeEEeecccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQ 162 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~-~~vkl~DFGla~~~~ 162 (416)
+...+||||++..+..++... ++..+++.|++.++.||.++|++||+||||||.|+|.+.. +.-.|+|||+|...+
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 999999999998776666643 6788999999999999999999999999999999999864 778999999986211
Q ss_pred ccc-------------------------------CCCCc-----------ccccCCcccccchhhccCCCCCChhhHHHH
Q 014909 163 QVR-------------------------------DDGLL-----------HTTCGTPNYVAPEVLNDRGYDGSTADLWSC 200 (416)
Q Consensus 163 ~~~-------------------------------~~~~~-----------~~~~gt~~y~aPEvl~~~~~~~~~~DIwSl 200 (416)
... ..+.. ....||++|.|||++...+-.++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 000 00000 123599999999999988888899999999
Q ss_pred HHHHHHHhhCCCCCCCCchH-----HH---------HH------H--hhc-Cc-------------------cCCC----
Q 014909 201 GVILFVLLAGYLPFDDSNLM-----NL---------YK------K--ISA-AE-------------------FTCP---- 234 (416)
Q Consensus 201 Gvil~~ml~G~~Pf~~~~~~-----~~---------~~------~--i~~-~~-------------------~~~~---- 234 (416)
|||+..++++..||-..... ++ .+ + +.. .. ....
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 99999999999999532210 00 00 0 000 00 0000
Q ss_pred ------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 235 ------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 235 ------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
..++..+.+|+.+||..||.+|+|++++|+||||..
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 114568999999999999999999999999999983
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=269.81 Aligned_cols=245 Identities=25% Similarity=0.432 Sum_probs=191.4
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHh--cCCCCCcceEEEEEEe----CC
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK--LVKHPNVVRLYEVMGS----KT 84 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~--~l~hpnIv~l~~~~~~----~~ 84 (416)
.+-++.+.||+|-||+||+|... |+.||||++.... .....+|.+|.+ .|+|+||+.+++.-.. -.
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 45789999999999999999985 7899999997532 344667777765 5699999999976422 24
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeecCCCCcEEeccCCCeEEeecc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR--------GVYHRDLKPENLLLDAYGNLKVSDFG 156 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~--------givHrDlkp~NILl~~~~~vkl~DFG 156 (416)
.+|||.+|.+.|+|+|++.+ ..++.+.+.+++..+++||+|||.. .|.|||||..|||+.++|.+-|+|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 58999999999999999998 6799999999999999999999963 49999999999999999999999999
Q ss_pred cccccccccC--CCCcccccCCcccccchhhccCC----CCC-ChhhHHHHHHHHHHHhhC----------CCCCCC---
Q 014909 157 LSALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRG----YDG-STADLWSCGVILFVLLAG----------YLPFDD--- 216 (416)
Q Consensus 157 la~~~~~~~~--~~~~~~~~gt~~y~aPEvl~~~~----~~~-~~~DIwSlGvil~~ml~G----------~~Pf~~--- 216 (416)
||-......+ +-..+..+||..|||||++...- +.+ ..+||||||.|+||++.. ++||.+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9976544321 22446789999999999996532 111 358999999999998752 688864
Q ss_pred --CchHHHHHHh--hcCccCCCC-CCCHH----HHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 217 --SNLMNLYKKI--SAAEFTCPP-WLSFT----ARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 217 --~~~~~~~~~i--~~~~~~~~~-~~s~~----~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
++.+++.+-+ .+..+.+|. |-|.+ +..+++.||..||.-|.|+--|.+
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 4444554432 333455554 44433 457889999999999999876654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=273.13 Aligned_cols=246 Identities=23% Similarity=0.324 Sum_probs=195.0
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhc--CCCCCcceEEEEEEeCC--
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL--VKHPNVVRLYEVMGSKT-- 84 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~-- 84 (416)
.+...++.+.||+|.||.||+|.. +++.||||++.... .+.++.|-.|.+. ++|+||+++++.-....
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 355667889999999999999987 46999999997543 4556666666664 47999999998876544
Q ss_pred --EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---------CCcEeecCCCCcEEeccCCCeEEe
Q 014909 85 --KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS---------RGVYHRDLKPENLLLDAYGNLKVS 153 (416)
Q Consensus 85 --~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~---------~givHrDlkp~NILl~~~~~vkl~ 153 (416)
.++||+||.+.|+|.+++..+ .++.....+++..+++||+|||+ -.|+|||||..|||+..+++.-|+
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 899999999999999999875 48999999999999999999996 359999999999999999999999
Q ss_pred ecccccccccccCCCCcccccCCcccccchhhccCCCC-----CChhhHHHHHHHHHHHhhCC------------CCCC-
Q 014909 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD-----GSTADLWSCGVILFVLLAGY------------LPFD- 215 (416)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~-----~~~~DIwSlGvil~~ml~G~------------~Pf~- 215 (416)
|||+|-.+......+.....+||..|||||++.+.-.. -.+.||||+|.|||||++.- +||.
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 99999988776666666678999999999999764322 13589999999999998742 3443
Q ss_pred ----CCchHHHHHHh--hcCccCCCCC-----CCHHHHHHHHHhcCCCCCCCCCHhHHh
Q 014909 216 ----DSNLMNLYKKI--SAAEFTCPPW-----LSFTARKLIARILDPNPMTRITIPEIL 263 (416)
Q Consensus 216 ----~~~~~~~~~~i--~~~~~~~~~~-----~s~~~~~ll~~~L~~dP~~R~t~~eil 263 (416)
.++..++...+ .+.++.+|.. --.-+++.+..||+.||+.|.|+.=+.
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 23334444333 3344555542 134578999999999999999986553
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=260.74 Aligned_cols=253 Identities=25% Similarity=0.442 Sum_probs=200.9
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEE-EEeCCEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEV-MGSKTKI 86 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~-~~~~~~~ 86 (416)
..+.|.+.+.||+|.||++.++.|+.+++.+++|.+.++.. ..+.+.+|...--.|. |.||+.-|++ |++.+.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 45789999999999999999999999999999999987653 3577888888766665 8999998875 6778888
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc--CCCeEEeecccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~--~~~vkl~DFGla~~~~~~ 164 (416)
.++|||++.|+|..-+.. .++-|.....++.|+++|+.|+|+++++|||||.+||||-. .-.+||||||+++..+
T Consensus 98 vF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g-- 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG-- 174 (378)
T ss_pred EEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC--
Confidence 999999999999988766 45899999999999999999999999999999999999933 3479999999876432
Q ss_pred cCCCCcccccCCcccccchhhccCC----CCCChhhHHHHHHHHHHHhhCCCCCCCCchH----HHHHHhhc-CccCCCC
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRG----YDGSTADLWSCGVILFVLLAGYLPFDDSNLM----NLYKKISA-AEFTCPP 235 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~----~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~----~~~~~i~~-~~~~~~~ 235 (416)
.......-+..|.|||+..... ...+.+|||.||+|+|.+++|.+||...... -.+.++.. .....|.
T Consensus 175 ---~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 175 ---TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred ---ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 2223334567899999875321 1135689999999999999999999854322 12222222 2333443
Q ss_pred ---CCCHHHHHHHHHhcCCCCCCC---CCHhHHhcCcccccC
Q 014909 236 ---WLSFTARKLIARILDPNPMTR---ITIPEILEDEWFKKD 271 (416)
Q Consensus 236 ---~~s~~~~~ll~~~L~~dP~~R---~t~~eil~h~~~~~~ 271 (416)
.+|+.+..+.++-|.++|++| .++.......|....
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 379999999999999999999 566666677776543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=246.64 Aligned_cols=213 Identities=43% Similarity=0.786 Sum_probs=187.1
Q ss_pred EeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 014909 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (416)
Q Consensus 19 LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 98 (416)
||+|++|.||++....+++.+++|++....... ....+.+|+..++.++|++|+++++++......+++||++.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997654321 356799999999999999999999999999999999999999999
Q ss_pred HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc-CCCeEEeecccccccccccCCCCcccccCC
Q 014909 99 FDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (416)
Q Consensus 99 ~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~~~gt 176 (416)
.+++... ..++...+..++.+++.++++||+.|++|+||+|.||+++. ++.++|+|||.+........ ......++
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9999875 47899999999999999999999999999999999999999 89999999999875433211 13345678
Q ss_pred cccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014909 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256 (416)
Q Consensus 177 ~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R 256 (416)
..|++||.+......+.++|+||+|+++++| ..+.+++.+|++.||++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 8999999997752445889999999999999 578999999999999999
Q ss_pred CCHhHHhcCc
Q 014909 257 ITIPEILEDE 266 (416)
Q Consensus 257 ~t~~eil~h~ 266 (416)
|++.++++|+
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=250.34 Aligned_cols=220 Identities=45% Similarity=0.755 Sum_probs=188.0
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (416)
|.+.+.||.|++|.||++.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++.+......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999988999999999865433 2467889999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcc
Q 014909 93 VTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (416)
Q Consensus 93 ~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 171 (416)
+++++|.+.+..... +++..+..++.|++.++.+||++|++|+||+|.||+++.++.++|+|||++....... .....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-ccccc
Confidence 999999999988766 8999999999999999999999999999999999999999999999999987654322 11234
Q ss_pred cccCCcccccchhh-ccCCCCCChhhHHHHHHHHHHHhhCCCCCCC--CchHHHHHHhhcCccCCCCC
Q 014909 172 TTCGTPNYVAPEVL-NDRGYDGSTADLWSCGVILFVLLAGYLPFDD--SNLMNLYKKISAAEFTCPPW 236 (416)
Q Consensus 172 ~~~gt~~y~aPEvl-~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~--~~~~~~~~~i~~~~~~~~~~ 236 (416)
...++..|++||.+ ....+. .++|+||||+++++|++|+.||.. .+...+.+.+..+.+...+|
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 224 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWEW 224 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcccccc
Confidence 55788899999998 444554 689999999999999999999987 44447777777766554443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.91 Aligned_cols=261 Identities=30% Similarity=0.514 Sum_probs=213.7
Q ss_pred cCE-EEEeEEeecCceEEEEEEECCCCCeEEEEEeec---hhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 11 GKY-EVGRTIGEGTFAKVKFARNSETGEPVALKILDK---EKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 11 ~~y-~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~---~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
..| .....+|.|++|.|+.+......+.++.|.+.. ...........+..|..+-..+.|||++..+..+.....+
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 445 456789999999999888877777666665542 1112222334488889999999999998887777666666
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
+-+||||++ +|+..+...+.+...++..++.||+.||+|+|+.||.||||||+|++++.+|.+||+|||.+..+.....
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 667999999 9999999988999999999999999999999999999999999999999999999999999998876655
Q ss_pred C--CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHH--HHHh-------hcCccCCCC
Q 014909 167 D--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL--YKKI-------SAAEFTCPP 235 (416)
Q Consensus 167 ~--~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~--~~~i-------~~~~~~~~~ 235 (416)
. ......+|+.+|+|||++.+..|+....||||+|++++.|.+|+.||......+. +... ..+...+..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 5 4566789999999999999999999999999999999999999999986544322 1111 111112223
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 236 ~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
.++...+.+|.+||++||.+|+|+++|++.+||+.-.
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred hchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 3788899999999999999999999999999998643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=294.89 Aligned_cols=200 Identities=18% Similarity=0.253 Sum_probs=146.3
Q ss_pred CCC-CCcceEEEEE-------EeCCEEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCC
Q 014909 68 VKH-PNVVRLYEVM-------GSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138 (416)
Q Consensus 68 l~h-pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlk 138 (416)
++| +||+++++.+ .....++++|||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 345 5777777766 2234678889988 5599999975 3469999999999999999999999999999999
Q ss_pred CCcEEeccCC-------------------CeEEeecccccccccccC--------------CCCcccccCCcccccchhh
Q 014909 139 PENLLLDAYG-------------------NLKVSDFGLSALSQQVRD--------------DGLLHTTCGTPNYVAPEVL 185 (416)
Q Consensus 139 p~NILl~~~~-------------------~vkl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~aPEvl 185 (416)
|+||||+..| .+|++|||+++....... .......+||+.|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 9999996544 455666666543211000 0001124689999999999
Q ss_pred ccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 186 ~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.+..| +.++|||||||+||||++|..|+..... ....+..... ..+....+...+++.+||++||.+||++.|+++
T Consensus 188 ~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 188 NGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred ccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 88877 4899999999999999999998764321 1111111111 111113456789999999999999999999999
Q ss_pred CcccccC
Q 014909 265 DEWFKKD 271 (416)
Q Consensus 265 h~~~~~~ 271 (416)
||||...
T Consensus 265 h~~~~~~ 271 (793)
T PLN00181 265 SEFINEP 271 (793)
T ss_pred chhhhhh
Confidence 9999763
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-28 Score=232.30 Aligned_cols=256 Identities=36% Similarity=0.621 Sum_probs=213.6
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCC-CcceEEEEEEeCCEEEEEEe
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP-NVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lV~E 91 (416)
|.+.+.||.|+||.||.+.+. ..+++|.+.............+.+|+.+++.+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999987 78999999876655444578899999999999988 79999999988888999999
Q ss_pred ccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC-CeEEeecccccccccccCC
Q 014909 92 FVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 92 ~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~~~ 167 (416)
++.++++.+.+.... .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998777765 799999999999999999999999999999999999999988 6999999998754432222
Q ss_pred C----CcccccCCcccccchhhccC--CCCCChhhHHHHHHHHHHHhhCCCCCCCCch----HHHHHHhhcCccC-CCCC
Q 014909 168 G----LLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFT-CPPW 236 (416)
Q Consensus 168 ~----~~~~~~gt~~y~aPEvl~~~--~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~----~~~~~~i~~~~~~-~~~~ 236 (416)
. .....+||+.|+|||.+.+. .+.....|+||+|++++++++|..||..... ......+...... ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 1 34677899999999999874 4556889999999999999999999887763 3444444444333 2222
Q ss_pred CC--------HHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 237 LS--------FTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 237 ~s--------~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
.. ..+.+++.+++..+|..|.+..+...++|....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 21 478999999999999999999999988776654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-30 Score=225.99 Aligned_cols=159 Identities=21% Similarity=0.250 Sum_probs=128.9
Q ss_pred CchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCccccc
Q 014909 96 GELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (416)
Q Consensus 96 g~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 174 (416)
|+|.+++... .++++..++.++.|++.||.|||+++ ||+|||++.++.+|+ ||++..... ....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~-------~~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP-------EQSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-------ccCC
Confidence 6899999874 46999999999999999999999999 999999999999999 999875432 1236
Q ss_pred CCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH-HHHHHhhcCccC-------CCCCCCH--HHHHH
Q 014909 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFT-------CPPWLSF--TARKL 244 (416)
Q Consensus 175 gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~-~~~~~i~~~~~~-------~~~~~s~--~~~~l 244 (416)
||+.|+|||++.+..|. .++||||+||++|+|++|+.||...... .....+...... .+..++. ++.++
T Consensus 66 g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 89999999999888775 8999999999999999999999765432 223332221111 1122333 69999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 245 IARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
+.+||..||.+||++.++++|+|+..
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999999863
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=241.24 Aligned_cols=173 Identities=22% Similarity=0.226 Sum_probs=137.6
Q ss_pred ccccccccCEEEEeEEeecCceEEEEEEECC-CCCeEEEEEeechhh--hcHHHHHHHHHHHHHHhcCCCCCcce-EEEE
Q 014909 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVKHPNVVR-LYEV 79 (416)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~-~~~~vaiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~-l~~~ 79 (416)
++++...++|.+.+.||+|+||+||+|.+.. +++.+|||.+..... ........+.+|+.+|+.++|+|++. +++.
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 4567788999999999999999999999876 678889998753311 12234567999999999999999985 5442
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecC-CCCcEEeccCCCeEEeecccc
Q 014909 80 MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL-KPENLLLDAYGNLKVSDFGLS 158 (416)
Q Consensus 80 ~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDl-kp~NILl~~~~~vkl~DFGla 158 (416)
...|+||||++|++|.. +.. .. ...++.|+++||.|||++||+|||| ||+|||++.++.+||+|||+|
T Consensus 91 ----~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred ----CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 45799999999999963 211 11 1468899999999999999999999 999999999999999999999
Q ss_pred cccccccCCCC------cccccCCcccccchhhcc
Q 014909 159 ALSQQVRDDGL------LHTTCGTPNYVAPEVLND 187 (416)
Q Consensus 159 ~~~~~~~~~~~------~~~~~gt~~y~aPEvl~~ 187 (416)
+.......... ..+.++++.|+|||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 87654332222 245678899999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=230.89 Aligned_cols=252 Identities=19% Similarity=0.240 Sum_probs=205.1
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCC-----CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE-eC
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG-SK 83 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~ 83 (416)
-.++++.-.+-+|.||.||.|+.++. .+.|-+|.+... ..+-....+..|...+..+.|||+....++.. +.
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 34677788899999999999976643 234566665432 22334577888999999999999999999864 45
Q ss_pred CEEEEEEeccCCCchHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeec
Q 014909 84 TKIFIVLEFVTGGELFDKIVNH--------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~--------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DF 155 (416)
...++++.+..-|.|..++... ..++..+...++.|+..|++|||++||+|.||-..|++||+.-.+||+|=
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 6678888888889999988721 24677778889999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCC
Q 014909 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTC 233 (416)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~ 233 (416)
.+++..-+....-.-+.......|||||.+....|. .++|+|||||+||||+| |+.|+.+-++.++..-+..+ +...
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQ 519 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQ 519 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecC
Confidence 998754433222222333345689999999988886 88999999999999997 99999999999888877766 4566
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 234 PPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 234 ~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
|-.++.++..++.-||..+|++||+++++..
T Consensus 520 P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 520 PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 7789999999999999999999999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=256.75 Aligned_cols=240 Identities=35% Similarity=0.599 Sum_probs=209.6
Q ss_pred EEeecCceEEEEEEE---CCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEEEecc
Q 014909 18 TIGEGTFAKVKFARN---SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFV 93 (416)
Q Consensus 18 ~LG~G~fg~V~~a~~---~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 93 (416)
.+|.|+||.|+++.. .+.|+.+|+|+..+......... .-..|-.++...+ ||.+|+++..++++...|+++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 379999999998653 35678899999987665443322 5667778888887 999999999999999999999999
Q ss_pred CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccc
Q 014909 94 TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 173 (416)
Q Consensus 94 ~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 173 (416)
.||+|+..+.....+.+...+.+...++-|++++|+.||+|||+|++||+++.+|++++.|||+++..-.. ...
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~------~~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE------KIA 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh------hhc
Confidence 99999999988888999999999999999999999999999999999999999999999999998754321 122
Q ss_pred cCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCC
Q 014909 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253 (416)
Q Consensus 174 ~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP 253 (416)
|||..|||||++. ++. ..+|.||+|+++|+|++|..||.. +....|....+.+|..++..+++++..++..+|
T Consensus 154 cgt~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccchhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 9999999999998 444 778999999999999999999988 566677778889999999999999999999999
Q ss_pred CCCCC-----HhHHhcCcccccC
Q 014909 254 MTRIT-----IPEILEDEWFKKD 271 (416)
Q Consensus 254 ~~R~t-----~~eil~h~~~~~~ 271 (416)
..|.. +.+|++|+||+..
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred HHHhccCcchhHHHhccchheee
Confidence 99985 5799999999853
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-26 Score=221.59 Aligned_cols=249 Identities=27% Similarity=0.334 Sum_probs=192.8
Q ss_pred CEEEEeEEeecCceEEEEEEECCCC-CeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCC----CCcceEEEEE-EeCCE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETG-EPVALKILDKEKVLKHKMAEQIKREVATMKLVKH----PNVVRLYEVM-GSKTK 85 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----pnIv~l~~~~-~~~~~ 85 (416)
+|.+.+.||+|+||.||++.+..++ ..+|+|+......... ..+..|+.++..+.. +++..+++.. .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999998764 5789998765432221 257888999988873 6899999998 57888
Q ss_pred EEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC-----CCeEEeecccc
Q 014909 86 IFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-----GNLKVSDFGLS 158 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~-----~~vkl~DFGla 158 (416)
-|+||+.+ |.+|.++.... +.++...+..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 67999977544 579999999999999999999999999999999999999765 35999999999
Q ss_pred cccccccCCC-------C-cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH---HHHHHhh
Q 014909 159 ALSQQVRDDG-------L-LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---NLYKKIS 227 (416)
Q Consensus 159 ~~~~~~~~~~-------~-~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~---~~~~~i~ 227 (416)
+.+......+ . .....||..|+++.++.+... +.+.|+||++.++.+++.|.+||...... ..+.+..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8332211111 1 123459999999999988766 58899999999999999999999765532 2222222
Q ss_pred cCccC--CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 228 AAEFT--CPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 228 ~~~~~--~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
..... .....+.+...+...+-..+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22111 223355677777777777888899988777653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=241.20 Aligned_cols=221 Identities=32% Similarity=0.615 Sum_probs=177.0
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
.-..|..++++..|+||-||+++|+.+.+.+|+| +++.+.. +++ ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-------lRn---ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-------LRN---ILTFAGNPFVV-------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-------hhc---cccccCCccee--------------
Confidence 3457999999999999999999999999999994 4443321 111 44444555554
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC-
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD- 167 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~- 167 (416)
|+-...++.-++++.+. +.+++|||+-||+|||+||+|++|+.-|++|+.|||++..--.....
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 45566666666676654 78999999999999999999999999999999999997642111000
Q ss_pred ------------CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCC
Q 014909 168 ------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 235 (416)
Q Consensus 168 ------------~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 235 (416)
-.-...||||.|+||||+...+| +.++|.|++|+|+|+++-|..||.+.+.++++..........|.
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 01123499999999999999888 59999999999999999999999999999999887776665554
Q ss_pred C---CCHHHHHHHHHhcCCCCCCCC---CHhHHhcCccccc
Q 014909 236 W---LSFTARKLIARILDPNPMTRI---TIPEILEDEWFKK 270 (416)
Q Consensus 236 ~---~s~~~~~ll~~~L~~dP~~R~---t~~eil~h~~~~~ 270 (416)
. +.+++++++.++|+.+|..|. .+-++.+|+||+.
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 3 788999999999999999997 4678889999985
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8e-28 Score=249.29 Aligned_cols=260 Identities=34% Similarity=0.605 Sum_probs=222.5
Q ss_pred ccCEEEEeEEeecCceEEEEEEECC-CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 87 (416)
...|.+.+.||+|+|+.|-++.+.. +...+|+|.+.... .......++..|..+.+.+. |+|++.+++...+....+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 5679999999999999999988754 34567777776543 23345677888999999998 999999999999999999
Q ss_pred EEEeccCCCchHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCcEeecCCCCcEEeccCC-CeEEeeccccccccc
Q 014909 88 IVLEFVTGGELFDKI-VNHG-RMKEDEARRYFQQLINAVDYCH-SRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQ 163 (416)
Q Consensus 88 lV~E~~~gg~L~~~i-~~~~-~l~e~~~~~~~~qll~al~~LH-~~givHrDlkp~NILl~~~~-~vkl~DFGla~~~~~ 163 (416)
++++|..|+++++.+ ..+. ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ +++++|||+|+.+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 7766 7889999999999999999999 99999999999999999999 999999999998776
Q ss_pred -ccCCCCcccccC-CcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHH-HHhhc--CccCCCCC--
Q 014909 164 -VRDDGLLHTTCG-TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY-KKISA--AEFTCPPW-- 236 (416)
Q Consensus 164 -~~~~~~~~~~~g-t~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~-~~i~~--~~~~~~~~-- 236 (416)
.+........|| ++.|+|||...+..|.++..|+||+|+++..+++|..||......... ..... ......+|
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 556667778899 999999999998889999999999999999999999999876544321 11111 22223333
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 237 ~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
++..+.+++.++|..+|..|.+++++..+||+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 7899999999999999999999999999999987
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-25 Score=194.56 Aligned_cols=245 Identities=22% Similarity=0.312 Sum_probs=191.3
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCC-CCcceEEEEEEeCCEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNVVRLYEVMGSKTKI 86 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~ 86 (416)
...++|.+++.||+|+||.+|+|.+..+|+.||||+-.... . ..++..|..+.+.|++ .+|..+..+..+...-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-K----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-C----CcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 46789999999999999999999999999999999865432 2 2357788899998974 7788888888888888
Q ss_pred EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC---CCeEEeecccccccc
Q 014909 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGLSALSQ 162 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~---~~vkl~DFGla~~~~ 162 (416)
.+||++. |.+|.++..- ...++...+.-++-|++.-++|+|.++++||||||+|.|+.-+ ..+.|+|||+|+.+.
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999998 6688776643 3568999999999999999999999999999999999998543 458999999998765
Q ss_pred cccCCC-----CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch---HHHHHHhhcCccCCC
Q 014909 163 QVRDDG-----LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---MNLYKKISAAEFTCP 234 (416)
Q Consensus 163 ~~~~~~-----~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~---~~~~~~i~~~~~~~~ 234 (416)
...... .-....||..|.+--.+.+... +..-|+-|+|.+|..+.-|.+||.+-.. .+-+.+|.......|
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 433221 1234579999998777766544 3678999999999999999999997543 344566665555444
Q ss_pred -----CCCCHHHHHHHHHhcCCCCCCCCCH
Q 014909 235 -----PWLSFTARKLIARILDPNPMTRITI 259 (416)
Q Consensus 235 -----~~~s~~~~~ll~~~L~~dP~~R~t~ 259 (416)
..+|.++.-.+.-|-..--++-|..
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 3467777777777765555555553
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=200.50 Aligned_cols=142 Identities=21% Similarity=0.274 Sum_probs=113.6
Q ss_pred EeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHH-----------------------HHHHHHHHHHHHhcCCCCC
Q 014909 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-----------------------MAEQIKREVATMKLVKHPN 72 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~hpn 72 (416)
...||+|+||.||+|.+. +|+.||||+++........ ......+|+.+++.+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999997 8999999999765321110 0123456999999998887
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeecCCCCcEEeccCCCeE
Q 014909 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC-HSRGVYHRDLKPENLLLDAYGNLK 151 (416)
Q Consensus 73 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~L-H~~givHrDlkp~NILl~~~~~vk 151 (416)
+.....+... ..++||||++|+++...+...+++++..+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 7544433222 2389999999988766655567899999999999999999999 799999999999999998 48899
Q ss_pred Eeeccccccc
Q 014909 152 VSDFGLSALS 161 (416)
Q Consensus 152 l~DFGla~~~ 161 (416)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=202.60 Aligned_cols=174 Identities=14% Similarity=0.190 Sum_probs=136.0
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHH------HHHHHHHHhcCCCCCcceEEEEEEe
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQ------IKREVATMKLVKHPNVVRLYEVMGS 82 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~------~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (416)
.-++|++.+.||.|+||.||++.. ++..+|||++..+....+..... +++|+..+.++.||||..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 347899999999999999999755 46689999998765545444444 5799999999999999999988654
Q ss_pred C--------CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEee
Q 014909 83 K--------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSD 154 (416)
Q Consensus 83 ~--------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~D 154 (416)
. ...+++|||++|.+|.+.. .+++ ....+++.+|..||+.|++|||+||+||+++.+| ++|+|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 3 3578999999999997763 2333 2466999999999999999999999999999988 99999
Q ss_pred cccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHh
Q 014909 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 208 (416)
Q Consensus 155 FGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml 208 (416)
||.+........ . ........|. .++|+||||+.+..+.
T Consensus 178 fg~~~~~~e~~a---~-----------d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKA---K-----------DRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhh---H-----------HHHHHHhHhc-ccccccceeEeehHHH
Confidence 998764321110 0 1133445666 7899999999887553
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=198.43 Aligned_cols=215 Identities=25% Similarity=0.414 Sum_probs=177.4
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 87 (416)
---.|++++.||+|+||..+.|.+.-++++||||.-.... ...+++.|....+.|. .++|...|.+...+.+-.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 3347999999999999999999999999999999754322 2467889999999886 799999999988888889
Q ss_pred EEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC-----CeEEeeccccccc
Q 014909 88 IVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-----NLKVSDFGLSALS 161 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~-----~vkl~DFGla~~~ 161 (416)
+|||+. |.+|.|+..- ..+++...+..++.|++.-++|+|++.+|.|||||+|+||...+ .+-|+|||+|+.+
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 999998 5577776654 35799999999999999999999999999999999999996543 4899999999875
Q ss_pred ccccCC-----CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCC---chHHHHHHhhcCc
Q 014909 162 QQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAAE 230 (416)
Q Consensus 162 ~~~~~~-----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~---~~~~~~~~i~~~~ 230 (416)
...... +...+..||..||+--...+.... ..-|+-|||-+++.+|-|.+||.+- +..+-|++|....
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQS-RRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhh-hhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 443221 123456899999998888887664 7889999999999999999999874 4446677775443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-26 Score=238.66 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=186.6
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechh--hhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEK--VLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
.|...+.||++-|=+|.+|++.+ |. |+||++-+.. +.-....+ ..+|++ ....+|||.+++.-+..+....|+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~q-rL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQ-RLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHH-HHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 78899999999999999999854 55 8999986644 11122223 334555 5667899999999998888999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC-
Q 014909 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG- 168 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~- 168 (416)
-+|... +|+|.+....-+..-+.+.|+.||+.||.-||..||+|+|||.|||||+..+-+.|+||..-+......++.
T Consensus 100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 999976 999999887778889999999999999999999999999999999999999999999998654322211111
Q ss_pred ----CcccccCCcccccchhhccCC----------CCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHh-hcCccC
Q 014909 169 ----LLHTTCGTPNYVAPEVLNDRG----------YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFT 232 (416)
Q Consensus 169 ----~~~~~~gt~~y~aPEvl~~~~----------~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i-~~~~~~ 232 (416)
..++...-.+|+|||.+.... ..+++.||||+||+++|+++ |++||.-.........- ...+..
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 223344456899999986522 13567899999999999997 89999632221111000 000000
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 233 CPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 233 ~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
...--+..++.||..|++.||++|.++++.|+.
T Consensus 259 Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 259 LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 001124578999999999999999999999974
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=193.15 Aligned_cols=142 Identities=21% Similarity=0.259 Sum_probs=115.1
Q ss_pred EeEEeecCceEEEEEEECCCCCeEEEEEeechhhhc-----------------------HHHHHHHHHHHHHHhcCCCCC
Q 014909 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-----------------------HKMAEQIKREVATMKLVKHPN 72 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~-----------------------~~~~~~~~~Ei~il~~l~hpn 72 (416)
.+.||+|+||+||+|.+. +|+.||||+++...... .......++|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 89999999998652110 001234578999999999999
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCcEEeccCCCeE
Q 014909 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLK 151 (416)
Q Consensus 73 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~-~givHrDlkp~NILl~~~~~vk 151 (416)
|.....+.... .|+||||++|+++........++++..+..++.|++.++.++|+ +||+||||||+||+++ ++.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 86555443332 48999999998665443445678899999999999999999999 9999999999999999 79999
Q ss_pred Eeeccccccc
Q 014909 152 VSDFGLSALS 161 (416)
Q Consensus 152 l~DFGla~~~ 161 (416)
|+|||+|...
T Consensus 158 liDFG~a~~~ 167 (190)
T cd05145 158 IIDVSQAVEL 167 (190)
T ss_pred EEEcccceec
Confidence 9999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=201.15 Aligned_cols=235 Identities=26% Similarity=0.320 Sum_probs=153.3
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCC----------CCcceEEEEEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH----------PNVVRLYEVMG 81 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----------pnIv~l~~~~~ 81 (416)
....++.||.|+++.||.+.+..+|+.+|+|++...........+.+++|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 56788999999999999999999999999999876553334456777777765555432 12333333321
Q ss_pred ---------eC---C-----EEEEEEeccCCCchHHHHHh---CCCC---CHHHH-HHHHHHHHHHHHHHHhCCcEeecC
Q 014909 82 ---------SK---T-----KIFIVLEFVTGGELFDKIVN---HGRM---KEDEA-RRYFQQLINAVDYCHSRGVYHRDL 137 (416)
Q Consensus 82 ---------~~---~-----~~~lV~E~~~gg~L~~~i~~---~~~l---~e~~~-~~~~~qll~al~~LH~~givHrDl 137 (416)
.. . +.+++|+-+.+ +|.+.+.. .... ....+ ..+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 23677887754 88776542 2222 12233 345589999999999999999999
Q ss_pred CCCcEEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCC-------CCCChhhHHHHHHHHHHHhhC
Q 014909 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG-------YDGSTADLWSCGVILFVLLAG 210 (416)
Q Consensus 138 kp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~-------~~~~~~DIwSlGvil~~ml~G 210 (416)
+|+|++++.+|.++|+||+.....+. .......+..|.+||...... ..+.+.|.|+||+++|.|.||
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999987653322 111134567899999875421 125788999999999999999
Q ss_pred CCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014909 211 YLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256 (416)
Q Consensus 211 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R 256 (416)
.+||........... .--.+. .+++.++.||+.+|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~~---~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW---DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG---GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc---cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999987644321110 111233 788999999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-23 Score=183.25 Aligned_cols=191 Identities=17% Similarity=0.202 Sum_probs=143.3
Q ss_pred EEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHH-HHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEEEe
Q 014909 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 14 ~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~-~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 91 (416)
.+...|++|+||+|+++.. .+.+++.+.+.....+.... ...+++|+.+|++|. |++|++++++ ...|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4668899999999997775 57778877776554332221 235889999999995 5889999886 34799999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecC-CCCcEEeccCCCeEEeecccccccccccCC-CC
Q 014909 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL-KPENLLLDAYGNLKVSDFGLSALSQQVRDD-GL 169 (416)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDl-kp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~ 169 (416)
|+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|......... ..
T Consensus 79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 9999998754321 1 2357899999999999999999999 799999999999999999999854432110 00
Q ss_pred ----------cccccCCcccccchhhccC-CCCCChhhHHHHHHHHHHHhhCCCCCCCC
Q 014909 170 ----------LHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDS 217 (416)
Q Consensus 170 ----------~~~~~gt~~y~aPEvl~~~-~~~~~~~DIwSlGvil~~ml~G~~Pf~~~ 217 (416)
..-...++.|++|+...-. ...-...+.++.|+-+|.++|+.+|+-+.
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0112368889999875432 11124678899999999999999987543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-24 Score=199.29 Aligned_cols=190 Identities=26% Similarity=0.387 Sum_probs=143.2
Q ss_pred CCCCcceEEEEEE---------------------------eCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHH
Q 014909 69 KHPNVVRLYEVMG---------------------------SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121 (416)
Q Consensus 69 ~hpnIv~l~~~~~---------------------------~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll 121 (416)
+|||||++..+|. .+..+|+||..++. +|..++..+ ..+....+-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 5999999987652 34579999999875 888888763 466778888999999
Q ss_pred HHHHHHHhCCcEeecCCCCcEEe--ccCC--CeEEeeccccccccccc----CCCCcccccCCcccccchhhccCC----
Q 014909 122 NAVDYCHSRGVYHRDLKPENLLL--DAYG--NLKVSDFGLSALSQQVR----DDGLLHTTCGTPNYVAPEVLNDRG---- 189 (416)
Q Consensus 122 ~al~~LH~~givHrDlkp~NILl--~~~~--~vkl~DFGla~~~~~~~----~~~~~~~~~gt~~y~aPEvl~~~~---- 189 (416)
+|+.|||.+||.|||+|.+|||+ |+++ .+.++|||++---+..+ ...-.-..-|.-.-||||+....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999998 3443 48999999864221111 011112345788899999986432
Q ss_pred -CCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHH--hhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHh
Q 014909 190 -YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK--ISAAEFTCPPWLSFTARKLIARILDPNPMTRITIP 260 (416)
Q Consensus 190 -~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~--i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~ 260 (416)
.+-.++|.|++|.+.||+++..-||.....+.+-.. -...-+..|..+++.+++|+..+|+.||++|++..
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 112579999999999999999999987543321111 11223456777999999999999999999999854
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-23 Score=187.70 Aligned_cols=244 Identities=20% Similarity=0.361 Sum_probs=196.4
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
..++...+...|.....|+.|+|+.. |..+++|++...... ......+..|.-.|+.+.||||+.+++.+.++.+..
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 44556667778899999999999985 455778888654432 234567888999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCcEEeccCCCeEEe--eccccccc
Q 014909 88 IVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVS--DFGLSALS 161 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~al~~LH~~g--ivHrDlkp~NILl~~~~~vkl~--DFGla~~~ 161 (416)
++..|++.|+|+..+..... ++..++.+++.+++.|++|||+.. |----|....++||++-+.+|+ |--++.
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf-- 341 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-- 341 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--
Confidence 99999999999999987543 677889999999999999999974 4344688999999998776654 322211
Q ss_pred ccccCCCCcccccCCcccccchhhccCCCC--CChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHH--hhcCccCCCCCC
Q 014909 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYD--GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK--ISAAEFTCPPWL 237 (416)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~--~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~--i~~~~~~~~~~~ 237 (416)
+. ....-+|.||+||.+...+.+ -.++|+|||++++||+.|...||.+-+.++.--+ +......+||.+
T Consensus 342 qe-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgi 414 (448)
T KOG0195|consen 342 QE-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGI 414 (448)
T ss_pred ec-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCc
Confidence 11 122347899999999876644 2468999999999999999999998877754433 345578899999
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHh
Q 014909 238 SFTARKLIARILDPNPMTRITIPEIL 263 (416)
Q Consensus 238 s~~~~~ll~~~L~~dP~~R~t~~eil 263 (416)
|.....|++-|++.||.+||.++.|+
T Consensus 415 s~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 415 SRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred cHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999999999988774
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-22 Score=181.63 Aligned_cols=133 Identities=20% Similarity=0.273 Sum_probs=107.8
Q ss_pred EeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-----CCCCcceEEEEEEeCC---EEE
Q 014909 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-----KHPNVVRLYEVMGSKT---KIF 87 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~---~~~ 87 (416)
.+.||+|+||.||. ++.++.. +||++..... ...+.+.+|+.+++.+ +||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46899999999995 7776665 7999876432 2346789999999999 5799999999998874 434
Q ss_pred -EEEec--cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCcEeecCCCCcEEeccC----CCeEEeeccc
Q 014909 88 -IVLEF--VTGGELFDKIVNHGRMKEDEARRYFQQLINAV-DYCHSRGVYHRDLKPENLLLDAY----GNLKVSDFGL 157 (416)
Q Consensus 88 -lV~E~--~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al-~~LH~~givHrDlkp~NILl~~~----~~vkl~DFGl 157 (416)
+|||| +.+|+|.+++.. +.+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 557999999976 456666 35678888777 99999999999999999999743 3799999553
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.9e-22 Score=182.43 Aligned_cols=144 Identities=19% Similarity=0.250 Sum_probs=115.6
Q ss_pred CEEEEeEEeecCceEEEEEE-ECCCCCeEEEEEeechhhhc---------------------HHHHHHHHHHHHHHhcCC
Q 014909 12 KYEVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLK---------------------HKMAEQIKREVATMKLVK 69 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~-~~~~~~~vaiK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~ 69 (416)
-|.+.+.||+|+||.||+|. +..+|+.||+|++....... ......+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47899999999999999999 66789999999997543110 011234678999999997
Q ss_pred CCC--cceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-cEeecCCCCcEEecc
Q 014909 70 HPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG-VYHRDLKPENLLLDA 146 (416)
Q Consensus 70 hpn--Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~g-ivHrDlkp~NILl~~ 146 (416)
+.+ +.++++. ...|+||||+.|++|.........+....+..++.||+.++.+||++| ++||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 633 3444442 235899999999888766544556777778899999999999999999 99999999999999
Q ss_pred CCCeEEeecccccc
Q 014909 147 YGNLKVSDFGLSAL 160 (416)
Q Consensus 147 ~~~vkl~DFGla~~ 160 (416)
++.++|+|||.|..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999998764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=208.25 Aligned_cols=240 Identities=22% Similarity=0.310 Sum_probs=182.6
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
.+...+|.|.+.||+|+||+||.|.+.. |+.||+|+=.....+.--...+++..++ .+. -+.|..+...+.-.+.-
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~--~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQM--LPSIMHISSAHVFQNAS 769 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hhh--hcchHHHHHHHccCCcc
Confidence 3455689999999999999999999977 9999999987777665433333333333 111 24555565555566777
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc-------CCCeEEeeccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-------YGNLKVSDFGLSA 159 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~-------~~~vkl~DFGla~ 159 (416)
++|+||.+.|+|.+++...+.+++..+..+..|++..|++||..+|||+||||+|.||.. +--++|+|||.|-
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 899999999999999998899999999999999999999999999999999999999942 2348999999987
Q ss_pred ccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc-----CCC
Q 014909 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-----TCP 234 (416)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~-----~~~ 234 (416)
.+....+.......++|-.+-.+|+..+.++. ..+|.|.++.+++.||.|+.- + ...+.. .++
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y~----------q-~~~g~~~~~~~~~~ 917 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKYM----------E-VKNGSSWMVKTNFP 917 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHHH----------H-hcCCcceeccccch
Confidence 66655555567778999999999999999995 999999999999999998532 1 111111 122
Q ss_pred CCC-CHHHHHHHHHhcCCCCCCCCCHhHH
Q 014909 235 PWL-SFTARKLIARILDPNPMTRITIPEI 262 (416)
Q Consensus 235 ~~~-s~~~~~ll~~~L~~dP~~R~t~~ei 262 (416)
.++ -.-.-+|+..+|+.|-..=|.+.++
T Consensus 918 Ry~~~~~W~~~F~~lLN~~~~~~p~l~~l 946 (974)
T KOG1166|consen 918 RYWKRDMWNKFFDLLLNPDCDTLPNLQEL 946 (974)
T ss_pred hhhhHHHHHHHHHHHhCcCcccchhHHHH
Confidence 222 2335678888888554444554444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6e-20 Score=167.47 Aligned_cols=137 Identities=24% Similarity=0.330 Sum_probs=115.5
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhc-----HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-----HKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
+.||+|++|.||+|.. .|..+++|+........ ......+.+|+.++..+.|++|.....++.+....+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 67789999865432211 1123568899999999999999887777777788899999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccc
Q 014909 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (416)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~ 160 (416)
|++|++|.+.+..... ....++.+++.+|.++|+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998865432 7888999999999999999999999999999999 78999999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=163.80 Aligned_cols=133 Identities=20% Similarity=0.249 Sum_probs=108.3
Q ss_pred EEeecCceEEEEEEECCCCCeEEEEEeechhhh-----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014909 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (416)
Q Consensus 18 ~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (416)
.||+|+||.||+|.. +|..+++|........ ......++.+|+.+++.+.|+++....-+.......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 5778999986543211 111246788999999999988765555555566677999999
Q ss_pred cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccc
Q 014909 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (416)
Q Consensus 93 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~ 160 (416)
++|++|.+.+..... .++.|++.+|.+||+.|++|+|++|+||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988765321 7899999999999999999999999999999 79999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=164.41 Aligned_cols=139 Identities=22% Similarity=0.330 Sum_probs=109.8
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcH-------------------HHHHHHHHHHHHHhcCCCCC
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH-------------------KMAEQIKREVATMKLVKHPN 72 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~-------------------~~~~~~~~Ei~il~~l~hpn 72 (416)
.|.+.+.||+|+||.||++.+. +|+.||||++........ .......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888999999999999999875 799999999875331000 01124678999999998874
Q ss_pred --cceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCe
Q 014909 73 --VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (416)
Q Consensus 73 --Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~v 150 (416)
+...++ ....++||||++|++|...... ..+..++.+++.++.++|+.|++||||||+||++++++.+
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 444443 2345899999999988664321 3456788999999999999999999999999999999999
Q ss_pred EEeeccccccc
Q 014909 151 KVSDFGLSALS 161 (416)
Q Consensus 151 kl~DFGla~~~ 161 (416)
+|+|||++...
T Consensus 165 ~liDfg~~~~~ 175 (198)
T cd05144 165 YIIDWPQMVST 175 (198)
T ss_pred EEEECCccccC
Confidence 99999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-20 Score=185.42 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=168.0
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCC---CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEE-------E
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE-------V 79 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-------~ 79 (416)
.+.+.+.+..+.++++.+.......+ .+-++-+..+.. +........+++..+....|.+..-+.+ .
T Consensus 243 ~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d---~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~ 319 (516)
T KOG1033|consen 243 SGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD---SLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFES 319 (516)
T ss_pred cccccccccccccccCCchhhhhcccchhhhhccchhhhcc---chhhhhhhhhhhhheeccccCCcccccCCCCchhhh
Confidence 34455556666666666655443222 222333322221 1122344556666666555444433333 1
Q ss_pred E-----EeCCEEEEEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeE
Q 014909 80 M-----GSKTKIFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (416)
Q Consensus 80 ~-----~~~~~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vk 151 (416)
+ ....+.|+.|++|.-.+|.++|.... ..+...+..++.|+..|++| +|.+|||+||.||+...++.+|
T Consensus 320 ~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 320 SKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred ccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhh
Confidence 1 11335899999999999999997543 35677889999999999999 9999999999999999999999
Q ss_pred Eeeccccccccccc----CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHh
Q 014909 152 VSDFGLSALSQQVR----DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (416)
Q Consensus 152 l~DFGla~~~~~~~----~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i 226 (416)
|.|||+.+-..... .........||+.||+||.+.+..|. .++||||||+||+|++. =..+|.. ......+
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~ 472 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQFER---IATLTDI 472 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHHHH---HHhhhhh
Confidence 99999987544322 11123456899999999999998885 99999999999999986 2233221 1222233
Q ss_pred hcCccCCCCCC-CHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 227 SAAEFTCPPWL-SFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 227 ~~~~~~~~~~~-s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
..+.++...+. .+....|+.+||.+.|.+||++.+.--|+|.
T Consensus 473 r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 473 RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 33433311222 3456799999999999999988777777765
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.4e-19 Score=177.66 Aligned_cols=200 Identities=23% Similarity=0.360 Sum_probs=157.0
Q ss_pred HhcCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCc-EeecCCCCcE
Q 014909 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGV-YHRDLKPENL 142 (416)
Q Consensus 65 l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~gi-vHrDlkp~NI 142 (416)
|+.+.|.|+.++++.+.++...++|.+||.-|+|.|.+.. ..+++..-...++++|+.||.|||+..| .|+.|++.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678899999999999999999999999999999999987 3467777778889999999999998866 9999999999
Q ss_pred EeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCC------CCChhhHHHHHHHHHHHhhCCCCCCC
Q 014909 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY------DGSTADLWSCGVILFVLLAGYLPFDD 216 (416)
Q Consensus 143 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~------~~~~~DIwSlGvil~~ml~G~~Pf~~ 216 (416)
++|....+||+|||+..+..............-..-|.|||.+..... .+.+.||||+|++++|+++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999876532111111112223457999999986422 24568999999999999999999976
Q ss_pred Cc----hHHHHHHhhc-CccCCCCC------CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 217 SN----LMNLYKKISA-AEFTCPPW------LSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 217 ~~----~~~~~~~i~~-~~~~~~~~------~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.. ..+....+.. +...+-|. ..+++..+++.|+..+|..||++++|-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 32 2344444544 33222222 3457899999999999999999999864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.2e-19 Score=182.03 Aligned_cols=138 Identities=20% Similarity=0.226 Sum_probs=112.1
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhh-----hcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-----LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~-----~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
.|...+.||+|+||.||++..... .+++|+...... ......+++.+|+.+++.++|++++....+..+....
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 345678999999999999987543 344544322111 1112346788999999999999999888777777788
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~ 160 (416)
++||||++|++|.+.+. ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998875 356789999999999999999999999999999 678999999999874
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-18 Score=155.65 Aligned_cols=137 Identities=24% Similarity=0.405 Sum_probs=100.2
Q ss_pred EeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHH---------------------HHHHHHHHHhcCCCCC--
Q 014909 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE---------------------QIKREVATMKLVKHPN-- 72 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~---------------------~~~~Ei~il~~l~hpn-- 72 (416)
.+.||+|+||.||+|.+. +++.||||++............ ....|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999986 7899999998764322111111 1245666666665443
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCchHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCcEEeccCCCe
Q 014909 73 VVRLYEVMGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNL 150 (416)
Q Consensus 73 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~-~i~~~~~l~e~~~~~~~~qll~al~~LH~-~givHrDlkp~NILl~~~~~v 150 (416)
+.+.++. ...++||||++|+.+.. .+... ... ..++.++.+++.++.++|+ .||+||||||+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4555543 23589999999954321 12111 111 6788999999999999999 9999999999999999 8999
Q ss_pred EEeecccccc
Q 014909 151 KVSDFGLSAL 160 (416)
Q Consensus 151 kl~DFGla~~ 160 (416)
+|+|||.+..
T Consensus 154 ~liDfg~a~~ 163 (187)
T cd05119 154 YIIDVPQAVE 163 (187)
T ss_pred EEEECccccc
Confidence 9999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.3e-19 Score=185.41 Aligned_cols=265 Identities=26% Similarity=0.435 Sum_probs=214.9
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
+...+.+.+.+.+-+|+++.+..+.-..+|...++|+..+.........+.++.+-.++-...+|-++...-.+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 45678889999999999999999998888888888876543332222234444444444444567777665556667889
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc-
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR- 165 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~- 165 (416)
+++|+|+.|++|..++...+..+++.++.++..+..+++|||+..+.|||++|.|+|+..+|+.+++|||.........
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998432211100
Q ss_pred ---C-------------------------CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCC
Q 014909 166 ---D-------------------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217 (416)
Q Consensus 166 ---~-------------------------~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~ 217 (416)
. ........||+.|.+||.+.+... +..+|.|+.|+++++.++|.+||+..
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0 011223468999999999998776 48899999999999999999999999
Q ss_pred chHHHHHHhhcCccCCCC---CCCHHHHHHHHHhcCCCCCCCCCHh---HHhcCcccccCC
Q 014909 218 NLMNLYKKISAAEFTCPP---WLSFTARKLIARILDPNPMTRITIP---EILEDEWFKKDY 272 (416)
Q Consensus 218 ~~~~~~~~i~~~~~~~~~---~~s~~~~~ll~~~L~~dP~~R~t~~---eil~h~~~~~~~ 272 (416)
.....++.|.......|. ..+.++++++.+.|..+|.+|..+. +...|+||+...
T Consensus 1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence 999999988777665554 4799999999999999999999988 899999998654
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.9e-17 Score=152.78 Aligned_cols=137 Identities=20% Similarity=0.295 Sum_probs=104.6
Q ss_pred eEEe-ecCceEEEEEEECCCCCeEEEEEeechhh----h------cHHHHHHHHHHHHHHhcCCCCCc--ceEEEEEEeC
Q 014909 17 RTIG-EGTFAKVKFARNSETGEPVALKILDKEKV----L------KHKMAEQIKREVATMKLVKHPNV--VRLYEVMGSK 83 (416)
Q Consensus 17 ~~LG-~G~fg~V~~a~~~~~~~~vaiK~i~~~~~----~------~~~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~~ 83 (416)
..|| .|+.|+||.+... +..+++|.+..... . ......++.+|+.++..++|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4566 7777888877763 67899998864321 1 11223668899999999998885 6777664332
Q ss_pred -CE---EEEEEeccCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccc
Q 014909 84 -TK---IFIVLEFVTG-GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (416)
Q Consensus 84 -~~---~~lV~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla 158 (416)
.. .++|||+++| .+|.+.+.. ..+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 2599999998 688887754 4566543 678999999999999999999999999999999999999987
Q ss_pred cc
Q 014909 159 AL 160 (416)
Q Consensus 159 ~~ 160 (416)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 63
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.1e-17 Score=141.09 Aligned_cols=132 Identities=23% Similarity=0.305 Sum_probs=112.5
Q ss_pred EEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCC--CCcceEEEEEEeCCEEEEEEec
Q 014909 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH--PNVVRLYEVMGSKTKIFIVLEF 92 (416)
Q Consensus 15 ~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~ 92 (416)
+.+.||+|.++.||++.... ..+++|.+..... ...+.+|+.+++.++| +++++++......+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45789999999999999854 6799999865432 3568899999999976 5899999988888899999999
Q ss_pred cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CcEeecCCCCcEEeccCCCeEEeecccccc
Q 014909 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR---GVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (416)
Q Consensus 93 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~---givHrDlkp~NILl~~~~~vkl~DFGla~~ 160 (416)
++|+.+... +......++.+++.+++++|.. +++|+|++|+||++++.+.++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999877543 5566677899999999999985 799999999999999989999999998763
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.3e-17 Score=161.22 Aligned_cols=254 Identities=19% Similarity=0.218 Sum_probs=193.5
Q ss_pred CEEEEeEEee--cCceEEEEEEE--CCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEE
Q 014909 12 KYEVGRTIGE--GTFAKVKFARN--SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 12 ~y~~~~~LG~--G~fg~V~~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 86 (416)
.+.+.+.+|. |.+|.||.+.. ..++..+|+|.-.... ........-.+|+...+.++ |+|.++.+..++..+..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 4567788999 99999999998 8899999999733221 11112233446777777775 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCcEeecCCCCcEEeccC-CCeEEeecccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLIN----AVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSAL 160 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~----al~~LH~~givHrDlkp~NILl~~~-~~vkl~DFGla~~ 160 (416)
|+-+|+|. .+|..+...... +++..++.++.+..+ ||.++|+.+++|-|+||+||++..+ ...+++|||+...
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence 99999996 688888877655 899999999999999 9999999999999999999999998 8899999999876
Q ss_pred cccccCCCCc---ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc--cCCCC
Q 014909 161 SQQVRDDGLL---HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPP 235 (416)
Q Consensus 161 ~~~~~~~~~~---~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~--~~~~~ 235 (416)
.......... ...-|...|++||...+. .+...||+|+|.++.+..+|..+....... .|..+.... ..+-.
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQLRQGYIPLEFCE 349 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCC-CccccccccCchhhhc
Confidence 5443322211 122577889999998753 357899999999999988876665432110 011111111 11122
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 236 ~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
..+.++...+..|++.+|..|++.+.++.|++...
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 34667777999999999999999999999999874
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.9e-16 Score=158.13 Aligned_cols=146 Identities=19% Similarity=0.385 Sum_probs=101.1
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhc-------------------------------HHHHHH
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-------------------------------HKMAEQ 57 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~-------------------------------~~~~~~ 57 (416)
.+..|.. +.||+|++|+||.|+.+.+|+.||||+.++.-... .+..+.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456776 78999999999999998889999999997542100 012233
Q ss_pred HHHHHH------HHhcCC----CCCcceEEEEEEe-CCEEEEEEeccCCCchHHH--HHhCC----CCCHHHHHHHHHHH
Q 014909 58 IKREVA------TMKLVK----HPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDK--IVNHG----RMKEDEARRYFQQL 120 (416)
Q Consensus 58 ~~~Ei~------il~~l~----hpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~--i~~~~----~l~e~~~~~~~~ql 120 (416)
+.+|+. .+.++. +.+.+.+-.++.+ ....++||||+.|+.+.+. +...+ .+.+..+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 333333 333332 3333443344432 3456799999999999764 33333 35556666677776
Q ss_pred HHHHHHHHhCCcEeecCCCCcEEeccCC----CeEEeecccccccc
Q 014909 121 INAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSALSQ 162 (416)
Q Consensus 121 l~al~~LH~~givHrDlkp~NILl~~~~----~vkl~DFGla~~~~ 162 (416)
+ ..|++|+|+||.||+++.+| .++++|||++....
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 5 59999999999999999988 99999999987543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.6e-14 Score=145.78 Aligned_cols=142 Identities=21% Similarity=0.336 Sum_probs=97.0
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhc-------------------------------HHHHH------HHH
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-------------------------------HKMAE------QIK 59 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~-------------------------------~~~~~------~~~ 59 (416)
+.||+|++|+||+|+.. +|+.||||+.++.-... .+... .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999975 68999999986531100 00001 244
Q ss_pred HHHHHHhcCC----CCCcceEEEEE-EeCCEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 014909 60 REVATMKLVK----HPNVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLIN-AVDYCHSRGV 132 (416)
Q Consensus 60 ~Ei~il~~l~----hpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~-al~~LH~~gi 132 (416)
+|...+.++. |.+-+.+-.++ ...+..++||||++|++|.+..... ... ....++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence 4555555542 32222322222 2234568999999999998876432 122 22345556655 4678999999
Q ss_pred EeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 133 vHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
+|+|+||.||+++.+|.++++|||++....
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999987543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=7.9e-14 Score=141.00 Aligned_cols=171 Identities=18% Similarity=0.339 Sum_probs=132.0
Q ss_pred EEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCC
Q 014909 29 FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM 108 (416)
Q Consensus 29 ~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l 108 (416)
.|..+.++.+|.|.+.+.+.. .....+++-++-|+.++||||+++++.++..+.+|+|.|.+. -|..++.+.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-- 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--
Confidence 355667889999999876553 345678888999999999999999999999999999999985 4566666533
Q ss_pred CHHHHHHHHHHHHHHHHHHH-hCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhcc
Q 014909 109 KEDEARRYFQQLINAVDYCH-SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND 187 (416)
Q Consensus 109 ~e~~~~~~~~qll~al~~LH-~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~ 187 (416)
.......+.||+.||.||| +.+++|++|.-..|+++..|..||++|.++........ ......---.|..|+.+..
T Consensus 103 -~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 103 -KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCc
Confidence 6677778899999999997 56899999999999999999999999998764432221 1111111224666776543
Q ss_pred CCCCCChhhHHHHHHHHHHHhhCCC
Q 014909 188 RGYDGSTADLWSCGVILFVLLAGYL 212 (416)
Q Consensus 188 ~~~~~~~~DIwSlGvil~~ml~G~~ 212 (416)
.. -..|.|-|||++++++.|..
T Consensus 180 s~---~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 180 SE---WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred cc---cchhhhhHHHHHHHHhCccc
Confidence 33 24699999999999999933
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.4e-13 Score=123.14 Aligned_cols=142 Identities=15% Similarity=0.228 Sum_probs=104.6
Q ss_pred EeEEeecCceEEEEEEECC------CCCeEEEEEeechhh--------h-----------cHHHH----HHHHHHHHHHh
Q 014909 16 GRTIGEGTFAKVKFARNSE------TGEPVALKILDKEKV--------L-----------KHKMA----EQIKREVATMK 66 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~------~~~~vaiK~i~~~~~--------~-----------~~~~~----~~~~~Ei~il~ 66 (416)
...||.|--+.||.|.... .+..+|||+...... . +.... ...++|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998654 357899998752110 0 01112 23448999999
Q ss_pred cCCC--CCcceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeecCCCCcEE
Q 014909 67 LVKH--PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC-HSRGVYHRDLKPENLL 143 (416)
Q Consensus 67 ~l~h--pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~L-H~~givHrDlkp~NIL 143 (416)
++.. -++.+++++ ...++||||+.++.+.....++..+++..+..++.|++.+|..+ |+.|++|+||+|.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9863 456666764 45789999998755533222334566677788899999999999 8999999999999999
Q ss_pred eccCCCeEEeecccccccc
Q 014909 144 LDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 144 l~~~~~vkl~DFGla~~~~ 162 (416)
++ ++.+.|+|||.|-...
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 97 4789999999876443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.8e-15 Score=146.42 Aligned_cols=253 Identities=21% Similarity=0.172 Sum_probs=190.4
Q ss_pred ccccCEEEEeEEeecCceEEEEEEEC-CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNS-ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 85 (416)
...++|..+..||.|.|+.|+..... .++..|++|..........+.+. -..|+.+...+ .|.++++++..+.....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCcccccc
Confidence 35678999999999999999987755 67788999987654433322222 22455555555 49999999988888888
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC-CCeEEeecccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQV 164 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~-~~vkl~DFGla~~~~~~ 164 (416)
.|+-.|||.++++...+.....+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||.++.+.-
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~- 419 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF- 419 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce-
Confidence 88999999999887777555668899999999999999999999999999999999999886 7889999998763111
Q ss_pred cCCCCcccccCCcccc-cchhhccCCCCCChhhHHHHHHHHHHHhhCCC-CCCCCchHHHHHHhhcCccCCCCCCCHHHH
Q 014909 165 RDDGLLHTTCGTPNYV-APEVLNDRGYDGSTADLWSCGVILFVLLAGYL-PFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~-aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~-Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~ 242 (416)
......+.-.+. .+|++........++|++|||.-+.+.++|.. ++.+ ..+..|..+.....+..+..+.
T Consensus 420 ----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~----~~~~~i~~~~~p~~~~~~~~~q 491 (524)
T KOG0601|consen 420 ----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG----VQSLTIRSGDTPNLPGLKLQLQ 491 (524)
T ss_pred ----ecccccccccccccchhhccccccccccccccccccccccccCcccCccc----ccceeeecccccCCCchHHhhh
Confidence 011122233344 35555544444589999999999999988753 3332 2334455666666666668899
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 243 KLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.+.+.|+.+++..|+.+.++..|+=|..
T Consensus 492 ~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 492 VLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hhhhhhcCCccccchhhhhhcccchhhh
Confidence 9999999999999999999988876643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.49 E-value=1e-13 Score=121.61 Aligned_cols=127 Identities=20% Similarity=0.287 Sum_probs=96.8
Q ss_pred EeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcc-eEEEEEEeCCEEEEEEeccC
Q 014909 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV-RLYEVMGSKTKIFIVLEFVT 94 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~lV~E~~~ 94 (416)
++.|+.|.++.||++... +..|++|+...... ......+|+.+++.+.+.+++ +++.... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999874 77899999764421 123467899999988765544 4555433 33579999999
Q ss_pred CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----EeecCCCCcEEeccCCCeEEeeccccc
Q 014909 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV-----YHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 95 gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~gi-----vHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
|.++.+. ......++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9877543 11123467899999999999985 9999999999999 6789999999865
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.2e-13 Score=126.96 Aligned_cols=202 Identities=15% Similarity=0.257 Sum_probs=141.7
Q ss_pred HhcCCCCCcceEEEEEEeC-----CEEEEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cE
Q 014909 65 MKLVKHPNVVRLYEVMGSK-----TKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRG--VY 133 (416)
Q Consensus 65 l~~l~hpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~al~~LH~~g--iv 133 (416)
+-.+-|.|||+++.++.+. ....++.||+..|+|..++++. ..+....-.+|.-||++||.|||+.. |+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 3445699999999988654 3478999999999999999763 35888888999999999999999985 99
Q ss_pred eecCCCCcEEeccCCCeEEeecccccccccccC--CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCC
Q 014909 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211 (416)
Q Consensus 134 HrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~ 211 (416)
|+++....|++..+|-+|+.----...-..... ........|-+.|.|||.=.-... +.++|||++|....+|..|.
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAILE 279 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHhe
Confidence 999999999999999888753221111111000 111122346788999997443333 36789999999999998876
Q ss_pred CCCC-CCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 212 LPFD-DSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 212 ~Pf~-~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.--. ..+....-..+...-+.. -...-++++.+||+..|..||++.+++-||-+-.
T Consensus 280 iq~tnseS~~~~ee~ia~~i~~l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIANVIIGL---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred eccCCCcceeehhhhhhhheeec---cCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 5422 222111111221111111 1123467899999999999999999999998754
|
|
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.7e-13 Score=97.62 Aligned_cols=60 Identities=58% Similarity=0.935 Sum_probs=48.6
Q ss_pred ccccchhhhhhcCCCCCCCCCCccccc--ccccceeEecCCHHHHHHHHHHhcccCCcEEEe
Q 014909 308 PVAMNAFELISLSKGLNLGNLFDAEQD--FKRETRFTSRCPANEIINKIEEAAKPLGFDVHK 367 (416)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (416)
|..+|||++|++|+|+||++||+..+. .++.+||+|+.|+++|+++||++++.+||.|++
T Consensus 2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 2 PKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp -EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 678999999999999999999986643 578999999999999999999999999999975
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.9e-11 Score=106.38 Aligned_cols=135 Identities=21% Similarity=0.266 Sum_probs=102.0
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcH-----HHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH-----KMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
..+++|+-+.++.+... |..+++|.=-+.....+ -...+..+|+.++.++.--+|.-.+=+..++....++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999998653 44466665333222222 223667789999998876666555555567778889999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccc
Q 014909 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (416)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~ 161 (416)
|++|..|.+.+... ...+++.+-.-+.-||..||+|+||.++||++... .+.++|||++...
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~s 141 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFS 141 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCccccc
Confidence 99998888888775 24577778888899999999999999999999874 4999999998743
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.9e-11 Score=104.77 Aligned_cols=146 Identities=23% Similarity=0.266 Sum_probs=109.9
Q ss_pred EEeEEeecCceEEEEEEECCCCCeEEEEEeechh-----hhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEK-----VLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 15 ~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~-----~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
....|-+|+-+.|+.+.. .|+...||.=.... ....-...+.++|+.++.++.--+|.-..-++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567889999999999886 57887888543322 22233347788999999988765665555556666777899
Q ss_pred EeccCC-CchHHHHHhCC-CCCHHHH-HHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCC---eEEeecccccccc
Q 014909 90 LEFVTG-GELFDKIVNHG-RMKEDEA-RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQ 162 (416)
Q Consensus 90 ~E~~~g-g~L~~~i~~~~-~l~e~~~-~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~---vkl~DFGla~~~~ 162 (416)
|||++| .++.+++.... .-.++.. ..++++|-+.+.-||.++++|+||..+||++..+|. +.++|||++....
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~ 167 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVSR 167 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhccc
Confidence 999988 46777776643 2233333 688999999999999999999999999999977653 5899999987543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.4e-11 Score=111.05 Aligned_cols=140 Identities=21% Similarity=0.319 Sum_probs=106.8
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCC--CcceEEEEEEeC---CEEEEEEe
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP--NVVRLYEVMGSK---TKIFIVLE 91 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~---~~~~lV~E 91 (416)
+.||.|..+.||++.... |+.+++|+....... .....+.+|+.+++.+.+. ++.+++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 678999999999998743 678999997654321 1245688999999999763 456777776554 26789999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 014909 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS------------------------------------------ 129 (416)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~------------------------------------------ 129 (416)
|++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999887665432 356777777778888888888873
Q ss_pred --------------CCcEeecCCCCcEEecc--CCCeEEeecccccc
Q 014909 130 --------------RGVYHRDLKPENLLLDA--YGNLKVSDFGLSAL 160 (416)
Q Consensus 130 --------------~givHrDlkp~NILl~~--~~~vkl~DFGla~~ 160 (416)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24699999999999998 56689999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.5e-10 Score=112.73 Aligned_cols=211 Identities=20% Similarity=0.245 Sum_probs=157.1
Q ss_pred ceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE----eCCEEEEEEeccCC-Cch
Q 014909 24 FAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG----SKTKIFIVLEFVTG-GEL 98 (416)
Q Consensus 24 fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~~~~lV~E~~~g-g~L 98 (416)
-.+.|++....+|..|++|.++..+.... ...-.-+..++++.|+|||++.+++. .+..+.+|++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 45789999999999999999854433222 23334577889999999999999986 34578999999987 577
Q ss_pred HHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 99 FDKIVN---------------HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 99 ~~~i~~---------------~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
.++--. +.+.+|..+|.|+.||..||.++|+.|..-+-|.|.+||++.+-+++|+..|...+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 765422 23478999999999999999999999999999999999999988899987776554432
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCC-CCCCchHHH-HHHhhcCccCCCCCCCHHH
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNL-YKKISAAEFTCPPWLSFTA 241 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~P-f~~~~~~~~-~~~i~~~~~~~~~~~s~~~ 241 (416)
.. + |-+... .+-|.=-||.++..|.||..- |........ ...| -+.+|.++
T Consensus 446 d~---------~-------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------~~~yS~D~ 498 (655)
T KOG3741|consen 446 DP---------T-------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------TTTYSTDL 498 (655)
T ss_pred CC---------C-------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------hhhhhHHH
Confidence 11 0 112221 346999999999999999644 222222222 2222 23478899
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 242 RKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
+++|.-+...++.. -++.+++.+
T Consensus 499 rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 499 RNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHhcCccc-ccHHHHHHH
Confidence 99999999999887 588888864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.5e-10 Score=100.12 Aligned_cols=127 Identities=24% Similarity=0.364 Sum_probs=84.8
Q ss_pred EEEEEEECCCCCeEEEEEeechh-----------------------hhcHHHHHHHHHHHHHHhcCCCC--CcceEEEEE
Q 014909 26 KVKFARNSETGEPVALKILDKEK-----------------------VLKHKMAEQIKREVATMKLVKHP--NVVRLYEVM 80 (416)
Q Consensus 26 ~V~~a~~~~~~~~vaiK~i~~~~-----------------------~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~ 80 (416)
.||.|... +|..+|+|+..... .+........++|...|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999884 57799999875311 11122346788999999999865 466776553
Q ss_pred EeCCEEEEEEeccC--CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCcEeecCCCCcEEeccCCCeEEeeccc
Q 014909 81 GSKTKIFIVLEFVT--GGELFDKIVNHGRMKEDEARRYFQQLINAVDY-CHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (416)
Q Consensus 81 ~~~~~~~lV~E~~~--gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~-LH~~givHrDlkp~NILl~~~~~vkl~DFGl 157 (416)
...+||||+. |..+..+... .++......++.+++..+.. +|+.|++|+||.+.||+++++ .+.++|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2469999998 6555443322 12245567788888886665 579999999999999999886 999999998
Q ss_pred ccc
Q 014909 158 SAL 160 (416)
Q Consensus 158 a~~ 160 (416)
+..
T Consensus 153 av~ 155 (188)
T PF01163_consen 153 AVD 155 (188)
T ss_dssp EEE
T ss_pred cee
Confidence 764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.4e-11 Score=122.56 Aligned_cols=153 Identities=20% Similarity=0.344 Sum_probs=114.7
Q ss_pred HHHHHHHHHHhC-CcEeecCCCCcEEeccCCCeEEeecccccccccccC-------CCCcccccCCcccccchhhccCCC
Q 014909 119 QLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-------DGLLHTTCGTPNYVAPEVLNDRGY 190 (416)
Q Consensus 119 qll~al~~LH~~-givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-------~~~~~~~~gt~~y~aPEvl~~~~~ 190 (416)
+...|+.|+|.. ++||++|.|++|.++.+|.+||+.|+++........ ........-...|.|||.+.. ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 444999999976 899999999999999999999999998754332111 011111234568999999987 44
Q ss_pred CCChhhHHHHHHHHHHHh-hCCCCCCCCchHHHHHH----hhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 191 DGSTADLWSCGVILFVLL-AGYLPFDDSNLMNLYKK----ISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 191 ~~~~~DIwSlGvil~~ml-~G~~Pf~~~~~~~~~~~----i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.+.++|++|+||++|.+. .|+.-+...+....+.. ...+....+..+++++++=|.++|..++.-||++.+++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 468999999999999998 56666655433322221 1222344556789999999999999999999999999999
Q ss_pred cccccCC
Q 014909 266 EWFKKDY 272 (416)
Q Consensus 266 ~~~~~~~ 272 (416)
|||....
T Consensus 266 ~ff~D~~ 272 (700)
T KOG2137|consen 266 PFFSDPG 272 (700)
T ss_pred cccCCch
Confidence 9998653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=5.7e-09 Score=98.45 Aligned_cols=133 Identities=17% Similarity=0.097 Sum_probs=93.6
Q ss_pred eEEEEEEECCCCCeEEEEEeechhhhc---H-----HHHHHHHHHHHHHhcCCCCCc--ceEEEEEEe-----CCEEEEE
Q 014909 25 AKVKFARNSETGEPVALKILDKEKVLK---H-----KMAEQIKREVATMKLVKHPNV--VRLYEVMGS-----KTKIFIV 89 (416)
Q Consensus 25 g~V~~a~~~~~~~~vaiK~i~~~~~~~---~-----~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~-----~~~~~lV 89 (416)
..|..+.. .|+.|.||......... . .-.....+|...+.++..-+| ..+..+.+. ....++|
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 33555443 56789999764322110 0 001147789988888753333 334444432 2357899
Q ss_pred EeccCCC-chHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc-------CCCeEEeeccccc
Q 014909 90 LEFVTGG-ELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-------YGNLKVSDFGLSA 159 (416)
Q Consensus 90 ~E~~~gg-~L~~~i~~--~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~-------~~~vkl~DFGla~ 159 (416)
||++++. +|.+++.. ....++.....++.+++..+.-||..||+|+|++|.|||++. ++.+.++||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999986 78888753 345667788899999999999999999999999999999975 4679999999775
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.5e-09 Score=97.52 Aligned_cols=137 Identities=22% Similarity=0.328 Sum_probs=105.1
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeech------------h-------hhcHHHHHHHHHHHHHHhcCCCC--
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKE------------K-------VLKHKMAEQIKREVATMKLVKHP-- 71 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~------------~-------~~~~~~~~~~~~Ei~il~~l~hp-- 71 (416)
+.++..||-|--|.||.|.+. .|.++|||.=+.- . .+..-.....++|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 356789999999999999986 5889999963210 0 01111235678999999999754
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeE
Q 014909 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (416)
Q Consensus 72 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vk 151 (416)
.|.+.+++ +...+||||++|-.|... +++...+..++..|+.-+.-+-..|++|+|+++-||+++++|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 67777764 456799999999777542 224556666777888888777799999999999999999999999
Q ss_pred Eeeccccc
Q 014909 152 VSDFGLSA 159 (416)
Q Consensus 152 l~DFGla~ 159 (416)
++||-.+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99998654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.9e-08 Score=96.09 Aligned_cols=236 Identities=19% Similarity=0.222 Sum_probs=150.9
Q ss_pred EEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhc-CCCCCcceEEEE------EEeCC-E
Q 014909 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL-VKHPNVVRLYEV------MGSKT-K 85 (416)
Q Consensus 14 ~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~------~~~~~-~ 85 (416)
..++.||+|+-+.+|-.-... ..+.|++....... ..+ ....|.. -.||-+-.-+.+ ..+.+ .
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~---~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAA---QAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchhh---chhheeecCCCchH---HHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 356889999999999654321 23678887654321 111 1222332 346644331111 11222 3
Q ss_pred EEEEEeccCCCchHHHH-Hh---CC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccc
Q 014909 86 IFIVLEFVTGGELFDKI-VN---HG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i-~~---~~---~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla 158 (416)
+-+.|..++|..--..+ .. .. ....+-+.+..+.|+.+.+.||..|.+-+|+.++|+|+++++.|.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 77899998885322222 11 11 2556778889999999999999999999999999999999999999985532
Q ss_pred cccccccCCCCcccccCCcccccchhhccCCC----CCChhhHHHHHHHHHHHhhC-CCCCCCCch----HHHHH-Hhhc
Q 014909 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY----DGSTADLWSCGVILFVLLAG-YLPFDDSNL----MNLYK-KISA 228 (416)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~----~~~~~DIwSlGvil~~ml~G-~~Pf~~~~~----~~~~~-~i~~ 228 (416)
.+- ..+....-.+|.+.|.+||.-.-... .+...|.|.||+++|++|.| +.||.+-.. ...++ .|..
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 221 12233345679999999998652211 13568999999999999875 999976321 11111 2222
Q ss_pred Ccc-----------CC---CCC--CCHHHHHHHHHhcCC--CCCCCCCHhH
Q 014909 229 AEF-----------TC---PPW--LSFTARKLIARILDP--NPMTRITIPE 261 (416)
Q Consensus 229 ~~~-----------~~---~~~--~s~~~~~ll~~~L~~--dP~~R~t~~e 261 (416)
+.+ +. +|| +++++..|..+|+.. ++.-|||++.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 211 11 123 688999999999865 4678999764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.9e-08 Score=90.32 Aligned_cols=106 Identities=19% Similarity=0.365 Sum_probs=84.1
Q ss_pred HHHHHHHHHHHhcCCCCC--cceEEEEEEeC----CEEEEEEeccCCC-chHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 014909 55 AEQIKREVATMKLVKHPN--VVRLYEVMGSK----TKIFIVLEFVTGG-ELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127 (416)
Q Consensus 55 ~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~i~~~~~l~e~~~~~~~~qll~al~~L 127 (416)
..+..+|...+..|..-+ +.+.+++.... ...++|+|+++|. +|.+++......+......++.++...+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 346778888887775333 34455554432 3458999999984 7888887755577788889999999999999
Q ss_pred HhCCcEeecCCCCcEEeccCC---CeEEeecccccc
Q 014909 128 HSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSAL 160 (416)
Q Consensus 128 H~~givHrDlkp~NILl~~~~---~vkl~DFGla~~ 160 (416)
|.+||+|+|++|.|||++.++ .+.++||+-+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 799999997653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.8e-10 Score=116.21 Aligned_cols=245 Identities=20% Similarity=0.215 Sum_probs=172.2
Q ss_pred cccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCC-cceEEEEEEeC
Q 014909 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMGSK 83 (416)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~ 83 (416)
+...+...|...+.+++|+++++++.+...+...+ .+++... ...+-++++|.+++||| .+..++-++.+
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E 306 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGE 306 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcc
Confidence 34445556777788999999999999877655444 6666433 34567889999999999 88888888888
Q ss_pred CEEEEEEeccCCC-chHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccc
Q 014909 84 TKIFIVLEFVTGG-ELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (416)
Q Consensus 84 ~~~~lV~E~~~gg-~L~~~i-~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~ 161 (416)
+..+++|+++.++ +-.... ...-.+.+.+...+.+.-+.+++++|+.--+||| ||+.++ +..|..||+.....
T Consensus 307 ~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 307 DYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred cccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCccc
Confidence 9999999999887 211111 1111233444455666778899999998878998 887766 77899999986643
Q ss_pred ccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC------C
Q 014909 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP------P 235 (416)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~------~ 235 (416)
... ....+..+|+.++|||+.....++ ...|.||+|+--.+|.-|.+|-..+... ...+..+ +..| .
T Consensus 382 ~~~---~~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~~~~g~~-p~s~~L~~~~a 454 (829)
T KOG0576|consen 382 TRT---MKPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPAV--LPMIGNG-PNSPMLTDKSA 454 (829)
T ss_pred Ccc---cccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCccc--cCCCCCC-CCccccchhhh
Confidence 321 134567899999999999888887 6779999998878888888776442110 0001000 0011 1
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 236 ~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
|-...-+++...|+..-|..|+...+++.|.+|..
T Consensus 455 w~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 455 WSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred cCcccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 22222235788899999999999999999988875
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.1e-07 Score=85.96 Aligned_cols=139 Identities=17% Similarity=0.273 Sum_probs=92.0
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHH------HHHHHHHHHhcCC---CCCcceEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE------QIKREVATMKLVK---HPNVVRLYEVM 80 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~------~~~~Ei~il~~l~---hpnIv~l~~~~ 80 (416)
-++|.+.+.+-......|.+..- +|+.+++|.........+.... ...+++..+..+. -.....++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 46788888888888888877664 5788999988754432222111 1223333333332 23333333332
Q ss_pred E-----eCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeec
Q 014909 81 G-----SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (416)
Q Consensus 81 ~-----~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DF 155 (416)
+ -....+++|||++|.+|.+... +++ .+...+.+++.-||+.|++|+|..|.|++++++ .+++.||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 2 2244568999999988765432 333 244677888999999999999999999999865 4999999
Q ss_pred cccc
Q 014909 156 GLSA 159 (416)
Q Consensus 156 Gla~ 159 (416)
+..+
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 8543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.3e-07 Score=83.51 Aligned_cols=138 Identities=17% Similarity=0.194 Sum_probs=98.3
Q ss_pred eecCceEEEEEEECCCCCeEEEEEeechhh--hc-HHHHHHHHHHHHHHhcCCCCC--cceEE--EEEEeC--CEEEEEE
Q 014909 20 GEGTFAKVKFARNSETGEPVALKILDKEKV--LK-HKMAEQIKREVATMKLVKHPN--VVRLY--EVMGSK--TKIFIVL 90 (416)
Q Consensus 20 G~G~fg~V~~a~~~~~~~~vaiK~i~~~~~--~~-~~~~~~~~~Ei~il~~l~hpn--Iv~l~--~~~~~~--~~~~lV~ 90 (416)
|+|+.|-|+..... |+.+-+|.-..... .. +.-...+.+|+..++.|..-+ +.+.. +....+ -.-+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 56889999987653 44677886541111 11 223467889999998886322 44443 111122 2357999
Q ss_pred eccCC-CchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCC--eEEeeccccc
Q 014909 91 EFVTG-GELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--LKVSDFGLSA 159 (416)
Q Consensus 91 E~~~g-g~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~--vkl~DFGla~ 159 (416)
|-+.| -+|.+++... .+.++.....++.++...+.-||+.|+.|+|+.+.||+++.+|. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97765 5787777653 34577777899999999999999999999999999999987777 9999998554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.2e-07 Score=84.66 Aligned_cols=133 Identities=15% Similarity=0.169 Sum_probs=84.2
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCC--cceEEEEEEeCCEEEEEEeccC
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEVMGSKTKIFIVLEFVT 94 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~lV~E~~~ 94 (416)
..||+|..+.||+. .+..+++|...... ....+.+|..+++.+..-+ +.+.+++....+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 56899999999973 24567899876422 2345789999999886443 4677888878888899999999
Q ss_pred CCc-hH--------------HHH-------HhC--CCCCHHH-HHHHHHHH----------HHH-HHHHH----hCCcEe
Q 014909 95 GGE-LF--------------DKI-------VNH--GRMKEDE-ARRYFQQL----------INA-VDYCH----SRGVYH 134 (416)
Q Consensus 95 gg~-L~--------------~~i-------~~~--~~l~e~~-~~~~~~ql----------l~a-l~~LH----~~givH 134 (416)
|.. +. ..+ ..- ...+... ...+..++ ... ..+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 11 111 100 0011000 00111111 111 11222 125789
Q ss_pred ecCCCCcEEeccCCCeEEeeccccc
Q 014909 135 RDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 135 rDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
+|+.|.||++++++ +.++||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999999765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.7e-07 Score=84.41 Aligned_cols=147 Identities=18% Similarity=0.221 Sum_probs=100.6
Q ss_pred cccCEEEEe---EEeecCceEEEEEEECCCCCeEEEEEeechhhhcH---------------------HHHHHHHHHHHH
Q 014909 9 RVGKYEVGR---TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---------------------KMAEQIKREVAT 64 (416)
Q Consensus 9 ~~~~y~~~~---~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~---------------------~~~~~~~~Ei~i 64 (416)
...+..+.. .|+.|--+.||+|.. .++..+|+|++......-. .......+|..-
T Consensus 43 L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~N 121 (268)
T COG1718 43 LLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRN 121 (268)
T ss_pred HhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHH
Confidence 334444444 556677778999986 4578899999864322111 112446678888
Q ss_pred HhcCC--CCCcceEEEEEEeCCEEEEEEeccCCCch-HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCC
Q 014909 65 MKLVK--HPNVVRLYEVMGSKTKIFIVLEFVTGGEL-FDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPE 140 (416)
Q Consensus 65 l~~l~--hpnIv~l~~~~~~~~~~~lV~E~~~gg~L-~~~i~~~~~l~e~~~~~~~~qll~al~~LH~-~givHrDlkp~ 140 (416)
|+++. +=.+.+.+.+.. -.+||||+..... .-.+. +.++...++..+..++++.+.-|-. .|+||+||+.-
T Consensus 122 L~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEy 196 (268)
T COG1718 122 LKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEY 196 (268)
T ss_pred HHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhh
Confidence 88875 344556666543 3599999965311 11111 1234444789999999999999877 89999999999
Q ss_pred cEEeccCCCeEEeecccccccc
Q 014909 141 NLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 141 NILl~~~~~vkl~DFGla~~~~ 162 (416)
|||+. +|.+.|+|||-|....
T Consensus 197 NiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 197 NILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred heEEE-CCeEEEEECccccccC
Confidence 99999 7899999999876543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.7e-07 Score=83.06 Aligned_cols=137 Identities=20% Similarity=0.323 Sum_probs=82.8
Q ss_pred EeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCC--cceEEEEE---EeCCEEEEEE
Q 014909 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEVM---GSKTKIFIVL 90 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~---~~~~~~~lV~ 90 (416)
++.|+.|..+.||.+.... ..+++|+.... .....+.+|..+++.+...+ +.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4789999999999999865 48999997654 23567888999988886333 45666543 2334579999
Q ss_pred eccCCCchHH----------------HHH---hC----CCCCHHH------HHHH---------------HHHHHH-HHH
Q 014909 91 EFVTGGELFD----------------KIV---NH----GRMKEDE------ARRY---------------FQQLIN-AVD 125 (416)
Q Consensus 91 E~~~gg~L~~----------------~i~---~~----~~l~e~~------~~~~---------------~~qll~-al~ 125 (416)
++++|..+.. .+. .. ....... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987766 111 11 0111000 0000 111222 233
Q ss_pred HHHh-------CCcEeecCCCCcEEec-cCCCeEEeeccccc
Q 014909 126 YCHS-------RGVYHRDLKPENLLLD-AYGNLKVSDFGLSA 159 (416)
Q Consensus 126 ~LH~-------~givHrDlkp~NILl~-~~~~vkl~DFGla~ 159 (416)
.+++ ..++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3332 4699999999999999 55666799999764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.3e-07 Score=96.57 Aligned_cols=136 Identities=24% Similarity=0.381 Sum_probs=88.2
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhc-------------------------------HHHHH------HHH
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-------------------------------HKMAE------QIK 59 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~-------------------------------~~~~~------~~~ 59 (416)
+.|+.++-|+||.|+... |+.||||+.++.-... .+..+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 678999999999999864 9999999986421100 00111 133
Q ss_pred HHHHHHhcCC-----CCCcceEEEEEEeCCEEEEEEeccCCCchHHH--HHhCCCCC-----HHHHHHHHHHHHHHHHHH
Q 014909 60 REVATMKLVK-----HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDK--IVNHGRMK-----EDEARRYFQQLINAVDYC 127 (416)
Q Consensus 60 ~Ei~il~~l~-----hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~--i~~~~~l~-----e~~~~~~~~qll~al~~L 127 (416)
+|...+.+++ .|+|.=..=+++-.+.-.++|||+.|-.+.+. +.. .+.+ +.-+..++.|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~------ 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLL------ 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHH------
Confidence 4444444442 23332221222234556799999999888776 444 3344 222333333333
Q ss_pred HhCCcEeecCCCCcEEeccCCCeEEeeccccccc
Q 014909 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (416)
Q Consensus 128 H~~givHrDlkp~NILl~~~~~vkl~DFGla~~~ 161 (416)
..|++|.|.+|.||+++.+|.+.+.|||+....
T Consensus 283 -~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 283 -RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred -hcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 489999999999999999999999999987643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.57 E-value=8.8e-07 Score=95.53 Aligned_cols=205 Identities=18% Similarity=0.193 Sum_probs=147.1
Q ss_pred HHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE----EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 014909 55 AEQIKREVATMKLVKHPNVVRLYEVMGSKTKI----FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130 (416)
Q Consensus 55 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~----~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~ 130 (416)
+....-|+..+..+.|+|++.++.+-...... .+..+++++-++...+..-+.++....+.+..+++.|+.|+|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 34455677788888999999999887544332 34457899999999999989999999999999999999999999
Q ss_pred CcEeecCCCC---cEEeccCCCeEEe--ecccccccccccCCCCcccccCCcccccchhhccCCCCC-ChhhHHHHHHHH
Q 014909 131 GVYHRDLKPE---NLLLDAYGNLKVS--DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG-STADLWSCGVIL 204 (416)
Q Consensus 131 givHrDlkp~---NILl~~~~~vkl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~-~~~DIwSlGvil 204 (416)
...|.-|... +-..+..+.+.++ ||+.+..... ........-+..+.|||......+.. ...|+|++|..+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d---~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD---NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCC---cccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 7666655555 4445566667777 8887664432 22223334466788888887655541 236999999999
Q ss_pred HHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 205 FVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 205 ~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
..+..|..+-........+ .+.....+..+++.+|+.-++++|+++.+++.|+|.+.+
T Consensus 383 ~~~~~~~~i~~~~~~~~~~---------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAVPVSL---------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhhhcCcccccccchhhh---------hccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 9998876553211111000 011111267889999999999999999999999999854
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.33 E-value=6.5e-06 Score=90.06 Aligned_cols=80 Identities=19% Similarity=0.336 Sum_probs=57.4
Q ss_pred EeEEeecCceEEEEEEECCCC--CeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCc--ceEEEEEEeC---CEEE
Q 014909 16 GRTIGEGTFAKVKFARNSETG--EPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNV--VRLYEVMGSK---TKIF 87 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~--~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnI--v~l~~~~~~~---~~~~ 87 (416)
.+.|+.|.+..+|+......+ ..+++|......... ....+.+|+.+|+.+. |+++ .+++.++.+. ...|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 577899999999998765432 467788764432111 1346889999999996 6665 7777777654 4578
Q ss_pred EEEeccCCCc
Q 014909 88 IVLEFVTGGE 97 (416)
Q Consensus 88 lV~E~~~gg~ 97 (416)
+||||++|..
T Consensus 121 lVME~v~G~~ 130 (822)
T PLN02876 121 YIMEYLEGRI 130 (822)
T ss_pred EEEEecCCcc
Confidence 9999999854
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.31 E-value=5.4e-06 Score=77.24 Aligned_cols=133 Identities=16% Similarity=0.114 Sum_probs=81.9
Q ss_pred EeecCc-eEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEEEeccCCC
Q 014909 19 IGEGTF-AKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (416)
Q Consensus 19 LG~G~f-g~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg 96 (416)
|-.|.. +.||++... +..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 444555 789998753 4678899875432 235678888888874 333557777777667789999999997
Q ss_pred chHHHHH----------------hCCCCCH-----H-HHHHHHHH-----------------------HHHHHHHHH---
Q 014909 97 ELFDKIV----------------NHGRMKE-----D-EARRYFQQ-----------------------LINAVDYCH--- 128 (416)
Q Consensus 97 ~L~~~i~----------------~~~~l~e-----~-~~~~~~~q-----------------------ll~al~~LH--- 128 (416)
.|..... .-..++. . .....+.+ +...+..|-
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 6653210 0000100 0 00000000 111122221
Q ss_pred ----hCCcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 129 ----SRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 129 ----~~givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
...++|+|+.|.|||+++++.+.|+||+.|.
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2348999999999999997778899999765
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.1e-07 Score=104.30 Aligned_cols=256 Identities=16% Similarity=0.073 Sum_probs=167.4
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KT 84 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~ 84 (416)
.+..|++.=.+|.|.++.-...+.+..+ +.+|+...-.... +...+-+..|..-++...|+++...+.-... ..
T Consensus 1227 ~~e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1227 AMEHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred HhhhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence 3445566555666655543322222222 4555543221111 1112233344445566789998887766543 34
Q ss_pred EEEEEEeccCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC-----CcEeecCCCCcEEeccCCCeEEeec
Q 014909 85 KIFIVLEFVTGGELFDKIVNHG----RMKEDEARRYFQQLINAVDYCHSR-----GVYHRDLKPENLLLDAYGNLKVSDF 155 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~al~~LH~~-----givHrDlkp~NILl~~~~~vkl~DF 155 (416)
..|.+++|+.+|.+++.|.+.- .+.+..+.....+.+.+..-+|+. -.+|++||+-|.+|..+-++|+.++
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence 5789999999999999987642 345555555556668888888864 2789999999999999999999999
Q ss_pred ccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-cCCC
Q 014909 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCP 234 (416)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~-~~~~ 234 (416)
|+.++..+ .........+++.|++|++...-.+. .++|+|+.|+-+|+...|..||-......+...+.... ...+
T Consensus 1385 gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe 1461 (2724)
T KOG1826|consen 1385 GLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIE 1461 (2724)
T ss_pred ccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCccccccccccc
Confidence 99884332 22234456788999999999887775 56999999999999999988886444434333343333 2333
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 014909 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (416)
Q Consensus 235 ~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~ 269 (416)
...|.++-.....+|-..-..||.-..++.-+.|-
T Consensus 1462 ~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1462 KLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred ccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 33455555556666666667888887777766554
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.12 E-value=4.8e-05 Score=68.51 Aligned_cols=130 Identities=19% Similarity=0.290 Sum_probs=93.0
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhh-------------hcHHHHHHHHHHHHHHhcCC------CCCcceEE
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKV-------------LKHKMAEQIKREVATMKLVK------HPNVVRLY 77 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~-------------~~~~~~~~~~~Ei~il~~l~------hpnIv~l~ 77 (416)
..||+|+.-.||. |.. ....+||+...... .......+..+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~--HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEE--CCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 5699999999984 433 44578999987650 01112355666666655555 78899999
Q ss_pred EEEEeCCEEEEEEeccCC------CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC---
Q 014909 78 EVMGSKTKIFIVLEFVTG------GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG--- 148 (416)
Q Consensus 78 ~~~~~~~~~~lV~E~~~g------g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~--- 148 (416)
|+.+++.-.-+|+|.+.. .+|.+++.. +.+++ .+...+-+-..||-+++|+.+|++|.||++...+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999998643 357777754 44666 3444455566788999999999999999996532
Q ss_pred -CeEEee
Q 014909 149 -NLKVSD 154 (416)
Q Consensus 149 -~vkl~D 154 (416)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 477887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.6e-05 Score=73.70 Aligned_cols=73 Identities=11% Similarity=0.094 Sum_probs=45.7
Q ss_pred EeEEeecCce-EEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCC---CcceEEEEEEeC---CEEEE
Q 014909 16 GRTIGEGTFA-KVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP---NVVRLYEVMGSK---TKIFI 88 (416)
Q Consensus 16 ~~~LG~G~fg-~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~~~---~~~~l 88 (416)
++.|+.|+.. .||.. +..+++|+..... ....+.+|..+++.+... -+.+.++..... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567777776 48875 2347788754321 245788999999887532 234444443322 23588
Q ss_pred EEeccCCCch
Q 014909 89 VLEFVTGGEL 98 (416)
Q Consensus 89 V~E~~~gg~L 98 (416)
+|++++|.++
T Consensus 72 l~~~i~G~~l 81 (235)
T cd05155 72 VYRWLEGETA 81 (235)
T ss_pred EEEeecCCCC
Confidence 9999998665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.7e-05 Score=67.83 Aligned_cols=128 Identities=20% Similarity=0.311 Sum_probs=91.4
Q ss_pred EEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcce-EEEEEEeCCEEEEEEecc
Q 014909 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR-LYEVMGSKTKIFIVLEFV 93 (416)
Q Consensus 15 ~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~-l~~~~~~~~~~~lV~E~~ 93 (416)
..+.||+|.+|.||++... |..+|+|+-..+. ....+..|+++|..+...++-+ +|.+-. .++.|||+
T Consensus 26 v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i 94 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYI 94 (201)
T ss_pred hhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhh
Confidence 4578999999999999974 5689999865433 2567889999999998777654 444422 34559999
Q ss_pred CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCC-CCcEEeccCCCeEEeecccccc
Q 014909 94 TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK-PENLLLDAYGNLKVSDFGLSAL 160 (416)
Q Consensus 94 ~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlk-p~NILl~~~~~vkl~DFGla~~ 160 (416)
.|-.|.+.-... . +.-+..++++---|-..||-|..|. |...+|-.++.+.|+||..|+.
T Consensus 95 ~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 998876654321 1 2233455566455677899999987 5555555556999999998874
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=3.3e-05 Score=79.07 Aligned_cols=139 Identities=24% Similarity=0.334 Sum_probs=84.2
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhc----------------------------HHHHHHH------HHHH
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK----------------------------HKMAEQI------KREV 62 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~----------------------------~~~~~~~------~~Ei 62 (416)
+.||.-+.|+|++|+.+. |+.||||+-++.-... .+..+.+ .+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 689999999999999876 9999999865411100 0011112 2222
Q ss_pred HH----HhcCCCCC------cceEEEEEEeCCEEEEEEeccCCCchHH--HHHhCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 014909 63 AT----MKLVKHPN------VVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSR 130 (416)
Q Consensus 63 ~i----l~~l~hpn------Iv~l~~~~~~~~~~~lV~E~~~gg~L~~--~i~~~~~l~e~~~~~~~~qll~al~~LH~~ 130 (416)
+- .+.+.|-+ |.++|-. -...-.|+||||+|..+.| .|.+.+ ++...+...+.+... .-+=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~--~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYL--EQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHH--HHHHhc
Confidence 22 22333444 3333322 2345679999999976644 455544 444332222222211 122357
Q ss_pred CcEeecCCCCcEEecc----CCCeEEeeccccccc
Q 014909 131 GVYHRDLKPENLLLDA----YGNLKVSDFGLSALS 161 (416)
Q Consensus 131 givHrDlkp~NILl~~----~~~vkl~DFGla~~~ 161 (416)
|++|.|=+|.||+++. ++.+.+-|||+....
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 8999999999999984 567999999987643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.06 E-value=6.8e-05 Score=67.19 Aligned_cols=128 Identities=23% Similarity=0.275 Sum_probs=91.0
Q ss_pred cCEEEEeEEeecCc-eEEEEEEECCCCCeEEEEEeec---h-------hhhc-H-------HHHHHHHHHHHHHhcCC--
Q 014909 11 GKYEVGRTIGEGTF-AKVKFARNSETGEPVALKILDK---E-------KVLK-H-------KMAEQIKREVATMKLVK-- 69 (416)
Q Consensus 11 ~~y~~~~~LG~G~f-g~V~~a~~~~~~~~vaiK~i~~---~-------~~~~-~-------~~~~~~~~Ei~il~~l~-- 69 (416)
..++.++.||.|+- |.||+++. .|+.||+|++.. . .... . ....-+..|....-+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67899999999999 99999987 578999999321 0 0000 0 12345677777766664
Q ss_pred -CCCc--ceEEEEEEeC------------------CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 014909 70 -HPNV--VRLYEVMGSK------------------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128 (416)
Q Consensus 70 -hpnI--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH 128 (416)
+.++ |+++++..-. ....||.||++... .++. .=+.+|++-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 5566 9999987211 12467888877643 2222 34567888889999
Q ss_pred hCCcEeecCCCCcEEeccCCCeEEeecccc
Q 014909 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (416)
Q Consensus 129 ~~givHrDlkp~NILl~~~~~vkl~DFGla 158 (416)
..||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999985 3489999964
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00017 Score=71.72 Aligned_cols=80 Identities=19% Similarity=0.243 Sum_probs=55.5
Q ss_pred EeEEeecCceEEEEEEECCCCCeEEEEEeechhhh--c--HHHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCEEEE
Q 014909 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--K--HKMAEQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~--~--~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 88 (416)
.+.||.|.+..||++.....++.++||.-...... . +-..++...|...|+.+. ..++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46799999999999998654468999985321100 0 113466778888888763 3457777776 4466789
Q ss_pred EEeccCCCc
Q 014909 89 VLEFVTGGE 97 (416)
Q Consensus 89 V~E~~~gg~ 97 (416)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00015 Score=64.92 Aligned_cols=99 Identities=20% Similarity=0.309 Sum_probs=79.4
Q ss_pred HHHHHHHhcCCC-CCcceEEEEEEeCCEEEEEEeccCCCchHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 014909 59 KREVATMKLVKH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDK---IVNHGRMKEDEARRYFQQLINAVDYCHS---RG 131 (416)
Q Consensus 59 ~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~---i~~~~~l~e~~~~~~~~qll~al~~LH~---~g 131 (416)
..|.-+|+.+.+ +++.+++|++.. ++|.||...+++... +..-...+.....+++.++++.+.+++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 368889999986 699999999853 568899987766421 1112346788899999999999999997 45
Q ss_pred cEeecCCCCcEEeccCCCeEEeeccccccc
Q 014909 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (416)
Q Consensus 132 ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 161 (416)
+.-.|++|+|+-++++|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 777999999999999999999999976543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.96 E-value=8.6e-05 Score=68.63 Aligned_cols=75 Identities=20% Similarity=0.335 Sum_probs=49.1
Q ss_pred EeEEeecCceEEEEEEECC-CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEEEEEecc
Q 014909 16 GRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFV 93 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~ 93 (416)
++.|..|-...+|++.... .++.|++|+...... ..-...+|+.+++.+...++ .+++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4678888889999987543 356789998754321 11234578889988864333 44444332 1 3799999
Q ss_pred CCCch
Q 014909 94 TGGEL 98 (416)
Q Consensus 94 ~gg~L 98 (416)
+|..+
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.89 E-value=5.8e-05 Score=72.40 Aligned_cols=136 Identities=21% Similarity=0.173 Sum_probs=82.8
Q ss_pred EeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCC--cceEEEE------EEeCCEEE
Q 014909 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEV------MGSKTKIF 87 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~------~~~~~~~~ 87 (416)
.+.|..|....+|+.... +..+++|+.... ....+..|+.+++.+.+.+ +.+++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 567888888899998652 346899987641 1345777888888775332 4444431 23345678
Q ss_pred EEEeccCCCchHH----H----------HHhC-CCCC--------HHHH------------HHHHHHHHHHHHHHHh---
Q 014909 88 IVLEFVTGGELFD----K----------IVNH-GRMK--------EDEA------------RRYFQQLINAVDYCHS--- 129 (416)
Q Consensus 88 lV~E~~~gg~L~~----~----------i~~~-~~l~--------e~~~------------~~~~~qll~al~~LH~--- 129 (416)
+++++++|..+.. . +... ..+. .... ......+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999866421 0 1100 0000 0000 0011112334444443
Q ss_pred ----CCcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 130 ----RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 130 ----~givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
.+++|+|+.|.||++++++.+.|.||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999987777899999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.86 E-value=5.1e-05 Score=71.25 Aligned_cols=133 Identities=14% Similarity=0.185 Sum_probs=78.0
Q ss_pred EEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEEEEEeccCCC
Q 014909 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFVTGG 96 (416)
Q Consensus 18 ~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~gg 96 (416)
.+..|-.+.+|+.. .+++.+++|....... ...-...+|..+++.+...++ .+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 35668888899887 3566788997643211 110135678899988864433 34444332 36899999986
Q ss_pred chHH----------HH-------HhCC----CCC-HHHHHHHHHHHH---------HHHHHHHh--------CCcEeecC
Q 014909 97 ELFD----------KI-------VNHG----RMK-EDEARRYFQQLI---------NAVDYCHS--------RGVYHRDL 137 (416)
Q Consensus 97 ~L~~----------~i-------~~~~----~l~-e~~~~~~~~qll---------~al~~LH~--------~givHrDl 137 (416)
.+.. .+ .... +++ ...+..+..++. ..+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 5421 11 1100 111 112223332221 11222221 25899999
Q ss_pred CCCcEEeccCCCeEEeecccccc
Q 014909 138 KPENLLLDAYGNLKVSDFGLSAL 160 (416)
Q Consensus 138 kp~NILl~~~~~vkl~DFGla~~ 160 (416)
.|.||++++++ +.++||+.|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00052 Score=66.05 Aligned_cols=78 Identities=15% Similarity=0.149 Sum_probs=55.0
Q ss_pred EEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCC---CCcceEEEEEEe---CCEEE
Q 014909 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH---PNVVRLYEVMGS---KTKIF 87 (416)
Q Consensus 14 ~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~---~~~~~ 87 (416)
.-.+.||.|..+.||...... + .+.+|... ... ....+..|...|+.+.- -.+.++++++.. .+..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~-~~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMAR-SFS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEec-ccc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 345789999999999986532 3 46778743 210 12467889999988853 357778877654 36689
Q ss_pred EEEeccCCCch
Q 014909 88 IVLEFVTGGEL 98 (416)
Q Consensus 88 lV~E~~~gg~L 98 (416)
+|||+++|+.+
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00021 Score=69.06 Aligned_cols=138 Identities=22% Similarity=0.243 Sum_probs=80.6
Q ss_pred EEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCC--cceEEEE------EEeCCEE
Q 014909 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEV------MGSKTKI 86 (416)
Q Consensus 15 ~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~------~~~~~~~ 86 (416)
..+.++.|....+|++.. .+| .+++|+..... . .+.+..|+.++..|...+ +.+++.. ....+..
T Consensus 26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred eccccCCccccceEEEEe-CCC-cEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 356777888889998864 334 57889875421 1 234556677777664222 3344332 1224567
Q ss_pred EEEEeccCCCchH----H-------H---HHhC-CCCC--------HHH-----HH----------HHHHHHHHHHHHHH
Q 014909 87 FIVLEFVTGGELF----D-------K---IVNH-GRMK--------EDE-----AR----------RYFQQLINAVDYCH 128 (416)
Q Consensus 87 ~lV~E~~~gg~L~----~-------~---i~~~-~~l~--------e~~-----~~----------~~~~qll~al~~LH 128 (416)
+++++|++|.++. . . +... ..++ ... .. .....+...++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 8999999985431 0 0 1110 0010 000 00 01112334455554
Q ss_pred h-------CCcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 129 S-------RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 129 ~-------~givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
. .+++|+|+.+.||++++++.+.|.||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2 689999999999999998877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00083 Score=65.16 Aligned_cols=136 Identities=18% Similarity=0.194 Sum_probs=74.0
Q ss_pred EeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCC--cceEEE------EEEeCCEEE
Q 014909 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYE------VMGSKTKIF 87 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~------~~~~~~~~~ 87 (416)
.+.|+.|....+|..... +| .+++|++.. . . .+.+..|+.+++.|...+ +.+.+. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~--~-~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFER--L-T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEeC-CC-cEEEEEecc--C-C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 355677887899988753 33 688998751 1 1 223444556555553211 223332 122355678
Q ss_pred EEEeccCCCchH-----------HHH---Hh-CCCC--------C--H--HHH-----------HHHHHHHH-HHHHHHH
Q 014909 88 IVLEFVTGGELF-----------DKI---VN-HGRM--------K--E--DEA-----------RRYFQQLI-NAVDYCH 128 (416)
Q Consensus 88 lV~E~~~gg~L~-----------~~i---~~-~~~l--------~--e--~~~-----------~~~~~qll-~al~~LH 128 (416)
++++|++|..+. ..+ .. ...+ . . ... ...+.+.+ ..++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999986431 111 10 0000 0 0 000 01111111 1122222
Q ss_pred -------hCCcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 129 -------SRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 129 -------~~givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
..|++|+|+.|.||+++.+...-|+||+.+.
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2489999999999999866556899999764
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0007 Score=65.58 Aligned_cols=142 Identities=21% Similarity=0.282 Sum_probs=96.4
Q ss_pred EEeEEeecCceEEEEEEECCCCCeEEEEEeechhh----------------------hcHHH-HHHHHHHHHHHhcCCCC
Q 014909 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV----------------------LKHKM-AEQIKREVATMKLVKHP 71 (416)
Q Consensus 15 ~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~----------------------~~~~~-~~~~~~Ei~il~~l~hp 71 (416)
+-..|..|--+.||.|... +|..+|||++.-+-. ....+ .-...+|+.-|++++..
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4456778888999999874 578899998742110 00111 23456788888888755
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeecCCCCcEEeccCCCe
Q 014909 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC-HSRGVYHRDLKPENLLLDAYGNL 150 (416)
Q Consensus 72 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~L-H~~givHrDlkp~NILl~~~~~v 150 (416)
+|.-.--+.. ....|||+++....--.-.-++..++...+..+.+|++.-+.-| |..++||.||+--|+|+-+ |.+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~l 303 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GKL 303 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CEE
Confidence 5322111111 22458999985422111112245688889999999999999887 5669999999999999965 899
Q ss_pred EEeecccccc
Q 014909 151 KVSDFGLSAL 160 (416)
Q Consensus 151 kl~DFGla~~ 160 (416)
.|+|-+-+--
T Consensus 304 yiIDVSQSVE 313 (520)
T KOG2270|consen 304 YIIDVSQSVE 313 (520)
T ss_pred EEEEcccccc
Confidence 9999886643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00087 Score=64.48 Aligned_cols=75 Identities=17% Similarity=0.221 Sum_probs=48.9
Q ss_pred EeEEeecCceEEEEEEECC------CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEEE
Q 014909 16 GRTIGEGTFAKVKFARNSE------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFI 88 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~l 88 (416)
++.|..|-...||++.... +++.+++|+...... ......+|..+++.+...++ .+++..+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3566677778899887543 257899999754321 12356788888888864333 345555432 35
Q ss_pred EEeccCCCch
Q 014909 89 VLEFVTGGEL 98 (416)
Q Consensus 89 V~E~~~gg~L 98 (416)
|+||++|..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 8999988665
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.001 Score=64.06 Aligned_cols=140 Identities=22% Similarity=0.282 Sum_probs=88.2
Q ss_pred EEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCC--CcceEEEEEEeCC--EEEEE
Q 014909 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP--NVVRLYEVMGSKT--KIFIV 89 (416)
Q Consensus 14 ~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~~--~~~lV 89 (416)
.+++.+..|..-.+|..... ++.+++. ... ............+|..+|+.+.-- -+...++.+.++. ..|.|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 34444544444456655543 7888888 332 122223456778899999887532 2334455555554 67999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHH-HHHHHHHHHHHh---------------------------------------
Q 014909 90 LEFVTGGELFDKIVNHGRMKEDEARRYF-QQLINAVDYCHS--------------------------------------- 129 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~-~qll~al~~LH~--------------------------------------- 129 (416)
|+|++|..+.+.. .+......+. ..+.+.|+-||+
T Consensus 104 ~~~veGe~~~~~~-----~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 104 MEWVEGEVVWSAL-----PPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred EEEecceeccCcC-----CcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 9999985432211 1111112222 366666666665
Q ss_pred -------------------CCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 130 -------------------RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 130 -------------------~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
..++|+|+.+.|++++..+-+-+.||+++.+-+
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 359999999999999998889999999987543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.47 E-value=9.5e-05 Score=70.31 Aligned_cols=136 Identities=20% Similarity=0.265 Sum_probs=96.5
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhh-------------------hcHHHHHHHHHHHHHHhcCCC--
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-------------------LKHKMAEQIKREVATMKLVKH-- 70 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~-------------------~~~~~~~~~~~Ei~il~~l~h-- 70 (416)
=|.+++.||-|--+.||.+-+. .|++.++|+=+.-.. |-.-..-...+|...|+.|..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3567899999999999999884 588889986432110 000011235578888888853
Q ss_pred CCcceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCe
Q 014909 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (416)
Q Consensus 71 pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~v 150 (416)
--|.+.+++ +..++|||++.|-.|...-. ...+..+...++.-+--|-.+|+||+|..--||++++++.+
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i 241 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI 241 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence 224444443 56789999999876643221 12344566777777888999999999999999999999999
Q ss_pred EEeecccc
Q 014909 151 KVSDFGLS 158 (416)
Q Consensus 151 kl~DFGla 158 (416)
+++||--+
T Consensus 242 ~vIDFPQm 249 (465)
T KOG2268|consen 242 VVIDFPQM 249 (465)
T ss_pred EEeechHh
Confidence 99999753
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0017 Score=63.51 Aligned_cols=77 Identities=14% Similarity=0.138 Sum_probs=50.6
Q ss_pred EEeecCceEEEEEEECCCCCeEEEEEeechhhh----cHHHHHHHHHHHHHHhcCC--CC-CcceEEEEEEeCCEEEEEE
Q 014909 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVL----KHKMAEQIKREVATMKLVK--HP-NVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 18 ~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~----~~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lV~ 90 (416)
.||.|....||++.+...++.|+||.-..--.. -+-...+..-|...|+... .| .+.++|.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999998644468999964321110 0123466778888887764 35 45555543 556667999
Q ss_pred eccCCC
Q 014909 91 EFVTGG 96 (416)
Q Consensus 91 E~~~gg 96 (416)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00092 Score=67.29 Aligned_cols=163 Identities=21% Similarity=0.283 Sum_probs=105.5
Q ss_pred HHHHHHHHHHhcCCCCCcceEEEEEEeC-CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEe
Q 014909 56 EQIKREVATMKLVKHPNVVRLYEVMGSK-TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134 (416)
Q Consensus 56 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givH 134 (416)
.++.-...+++.+.|+|...++++.... ....+|||++. .+|.+....+. +-.... + .+|+.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~-------~-------~~~~~~ 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDESL-------L-------AHGVLH 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchhhh-------c-------ccccce
Confidence 3455667788999999999999987543 45789999995 48998887644 221111 0 223322
Q ss_pred ecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCC
Q 014909 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214 (416)
Q Consensus 135 rDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf 214 (416)
- | .++.+| -+++ . | |- ..++++||||+|.++.++.-|...|
T Consensus 91 ~-----~-------~~~~td-~~~t-------~-----------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 91 L-----N-------IIYITD-HFLT-------K-----------Y--PS------PIGPKSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred e-----h-------hhhccc-cccc-------c-----------C--CC------CCCcchhhhhHHHHHHHHHHhhHHH
Confidence 2 2 223333 1100 0 0 10 1124899999999999999998887
Q ss_pred CCCchHHHHHHhhcCccCCC------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 215 DDSNLMNLYKKISAAEFTCP------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 215 ~~~~~~~~~~~i~~~~~~~~------------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
......+....+..-..... -.++....+++.+|+-..|..||...++++++-|...+.
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~ 202 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYK 202 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHh
Confidence 76555444444322111100 114666788999999999999999999999999987654
|
|
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.00042 Score=46.81 Aligned_cols=35 Identities=20% Similarity=0.394 Sum_probs=29.7
Q ss_pred CcceEEEEEEEEEc-CCeEEEEEEEcCCCccceecC
Q 014909 382 KGNLNVATEVFQVA-PSLHMVEVRKAKGDTLEFHKV 416 (416)
Q Consensus 382 ~~~l~~~~~~~~~~-~~~~~v~~~~~~gd~~e~~~~ 416 (416)
+..+.|.++|+++. .+++.|+|+|.+||.+.|+++
T Consensus 2 ~~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~l 37 (47)
T PF02149_consen 2 KEVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDL 37 (47)
T ss_dssp CC-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHH
T ss_pred CcceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHH
Confidence 34689999999998 899999999999999999863
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0044 Score=60.90 Aligned_cols=136 Identities=16% Similarity=0.226 Sum_probs=79.7
Q ss_pred EeEEeecCceEEEEEEECC----CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcc-eEEEEEEeCCEEEEEE
Q 014909 16 GRTIGEGTFAKVKFARNSE----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV-RLYEVMGSKTKIFIVL 90 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~lV~ 90 (416)
+..|-.|-.-.+|++.... +++.|++|+..... ....+ ..+|..+++.+..-++. ++++.+... .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 3455558888999987432 34679999876532 12233 36788888888644443 556655332 578
Q ss_pred eccCCCchHHH----------H-------HhCC----C-C-CHHHHHHHHHHH-----------------HHHHHHH---
Q 014909 91 EFVTGGELFDK----------I-------VNHG----R-M-KEDEARRYFQQL-----------------INAVDYC--- 127 (416)
Q Consensus 91 E~~~gg~L~~~----------i-------~~~~----~-l-~e~~~~~~~~ql-----------------l~al~~L--- 127 (416)
+|++|..|... + .... . . ....+..++.++ ...+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 88877655311 1 1100 0 1 112222333221 1111122
Q ss_pred -H----hCCcEeecCCCCcEEecc-CCCeEEeeccccc
Q 014909 128 -H----SRGVYHRDLKPENLLLDA-YGNLKVSDFGLSA 159 (416)
Q Consensus 128 -H----~~givHrDlkp~NILl~~-~~~vkl~DFGla~ 159 (416)
. ...++|+|+++.||++++ ++.+.++||..|.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 236899999999999986 4689999999765
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0081 Score=59.89 Aligned_cols=77 Identities=14% Similarity=0.116 Sum_probs=51.9
Q ss_pred EEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhc-H---HHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCEEE
Q 014909 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-H---KMAEQIKREVATMKLVK---HPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 15 ~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~-~---~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~ 87 (416)
-.+.||.|....||+..+. +..++||.-....... . ....+...|...|+.+. ...+.+++.+.. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3678999999999998873 4568899754211100 0 12455566777777664 247778888766 4467
Q ss_pred EEEeccCC
Q 014909 88 IVLEFVTG 95 (416)
Q Consensus 88 lV~E~~~g 95 (416)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0069 Score=57.60 Aligned_cols=30 Identities=23% Similarity=0.407 Sum_probs=25.3
Q ss_pred CcEeecCCCCcEEeccCCC-eEEeecccccc
Q 014909 131 GVYHRDLKPENLLLDAYGN-LKVSDFGLSAL 160 (416)
Q Consensus 131 givHrDlkp~NILl~~~~~-vkl~DFGla~~ 160 (416)
.++|+|++|.||++++++. .-|.||+.+.+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 56999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.018 Score=55.46 Aligned_cols=29 Identities=34% Similarity=0.574 Sum_probs=25.4
Q ss_pred CCcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 130 ~givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57999999999999988 678999999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.0088 Score=59.35 Aligned_cols=78 Identities=18% Similarity=0.247 Sum_probs=53.0
Q ss_pred EeEEeecCceEEEEEEECCCCCeEEEEEeechhhh--c-HHHHHHHHHHHHHHhcCC--CC-CcceEEEEEEeCCEEEEE
Q 014909 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--K-HKMAEQIKREVATMKLVK--HP-NVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~--~-~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lV 89 (416)
.+.||.|.-.-||++.+...++.|+||.-..--.. + +-..++..-|..+|+... .| .+.++|.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 57899999999999998544567999864321110 0 123577788889888774 45 45556654 55667789
Q ss_pred EeccCC
Q 014909 90 LEFVTG 95 (416)
Q Consensus 90 ~E~~~g 95 (416)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999865
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.048 Score=52.65 Aligned_cols=29 Identities=17% Similarity=0.170 Sum_probs=26.9
Q ss_pred CcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 131 givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
+++|+|+.+.|+|+++++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.019 Score=56.17 Aligned_cols=135 Identities=18% Similarity=0.254 Sum_probs=77.5
Q ss_pred eEEeecCceEEEEEEECCC---CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEEEEEec
Q 014909 17 RTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEF 92 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~ 92 (416)
+.|..|-...+|++..... +..|++|+...... . .-.-.+|..+++.+..-++ .++++++..+ +|.+|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~f 91 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---Y-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSF 91 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---e-EechHHHHHHHHHHHhcCCCCceeEEeCCc----Eeehh
Confidence 4455577788998875432 34789998754321 1 1223578888888875554 3556555322 58888
Q ss_pred cCCCchHH----------HH-------HhCC-C----C-CHHHHHHHHHHH----------------------HHHHHHH
Q 014909 93 VTGGELFD----------KI-------VNHG-R----M-KEDEARRYFQQL----------------------INAVDYC 127 (416)
Q Consensus 93 ~~gg~L~~----------~i-------~~~~-~----l-~e~~~~~~~~ql----------------------l~al~~L 127 (416)
++|..|.. .+ .... + . ....+..|+.++ ..-+..+
T Consensus 92 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 171 (330)
T PLN02421 92 INARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVEL 171 (330)
T ss_pred hcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHH
Confidence 87755411 11 1100 0 1 112233333222 1112222
Q ss_pred H----hC----CcEeecCCCCcEEecc-CCCeEEeeccccc
Q 014909 128 H----SR----GVYHRDLKPENLLLDA-YGNLKVSDFGLSA 159 (416)
Q Consensus 128 H----~~----givHrDlkp~NILl~~-~~~vkl~DFGla~ 159 (416)
. +. -.+|+|+.|.|||+++ ++.++++||..|.
T Consensus 172 ~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 172 KEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1 12 2799999999999975 4789999999775
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.0097 Score=54.04 Aligned_cols=31 Identities=32% Similarity=0.582 Sum_probs=22.0
Q ss_pred CCcEeecCCCCcEEe-ccCCCeEEeecccccc
Q 014909 130 RGVYHRDLKPENLLL-DAYGNLKVSDFGLSAL 160 (416)
Q Consensus 130 ~givHrDlkp~NILl-~~~~~vkl~DFGla~~ 160 (416)
..++|+||.|.||++ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 359999999999999 8889999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.026 Score=53.95 Aligned_cols=75 Identities=15% Similarity=0.185 Sum_probs=47.5
Q ss_pred EEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCEEEEEE
Q 014909 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 14 ~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV~ 90 (416)
+-.+.+|.|....+|... .+++.+.+|+-... ....+..|..-|+.|. .-.+.+.+.+....+..|++|
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 445778999999999887 56788999987622 1244677888887773 445778888887777779999
Q ss_pred eccCCC
Q 014909 91 EFVTGG 96 (416)
Q Consensus 91 E~~~gg 96 (416)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.042 Score=54.76 Aligned_cols=76 Identities=17% Similarity=0.238 Sum_probs=45.5
Q ss_pred EEeEEeecCceEEEEEEECCC-CCe-----EEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEE
Q 014909 15 VGRTIGEGTFAKVKFARNSET-GEP-----VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIF 87 (416)
Q Consensus 15 ~~~~LG~G~fg~V~~a~~~~~-~~~-----vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~ 87 (416)
-++.|..|-...+|++..... +.. |.+++... .....-.-.+|+.+++.+...++ .++++.+.. +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence 345566688899999875432 222 44443211 11112224578999999975544 456666542 5
Q ss_pred EEEeccCCCch
Q 014909 88 IVLEFVTGGEL 98 (416)
Q Consensus 88 lV~E~~~gg~L 98 (416)
++.||++|..|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 89999998665
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.071 Score=52.76 Aligned_cols=61 Identities=18% Similarity=0.199 Sum_probs=42.6
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHH-HHHhCCcEeecCCCCcEEeccC
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD-YCHSRGVYHRDLKPENLLLDAY 147 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~-~LH~~givHrDlkp~NILl~~~ 147 (416)
..++-+|..|-++..++.. ...+|.....+..-...|+- -+--.+.+|.|+.|.||++--+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 3466678888888777765 44566566666655555543 3445689999999999999554
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.33 Score=54.63 Aligned_cols=30 Identities=33% Similarity=0.488 Sum_probs=25.7
Q ss_pred CCcEeecCCCCcEEeccCC--CeE-Eeeccccc
Q 014909 130 RGVYHRDLKPENLLLDAYG--NLK-VSDFGLSA 159 (416)
Q Consensus 130 ~givHrDlkp~NILl~~~~--~vk-l~DFGla~ 159 (416)
.++||+|+.+.|||++.++ .+. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 5799999999999999875 555 99999765
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.083 Score=51.56 Aligned_cols=84 Identities=25% Similarity=0.354 Sum_probs=60.2
Q ss_pred CCcceEEEEE-EeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCcEEeccCC
Q 014909 71 PNVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYG 148 (416)
Q Consensus 71 pnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~-givHrDlkp~NILl~~~~ 148 (416)
++..+.+-+- ......|++|++. |+.|. .+ ..-..+++..+|.+.+..++-+..+ ..-|||+.-.||||+ +|
T Consensus 285 ~~~e~~~vv~~de~~y~yl~~kdh-gt~is-~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G 358 (488)
T COG5072 285 VFLETLKVVSLDETLYLYLHFKDH-GTPIS-II---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG 358 (488)
T ss_pred hhhhcceEEecCCceEEEEEEecC-Cceee-ee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC
Confidence 3433433333 2344567888876 44442 22 2234567788899988888887765 689999999999999 89
Q ss_pred CeEEeecccccc
Q 014909 149 NLKVSDFGLSAL 160 (416)
Q Consensus 149 ~vkl~DFGla~~ 160 (416)
++-|+||-+|+.
T Consensus 359 nvtLIDfklsRl 370 (488)
T COG5072 359 NVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEeeeeec
Confidence 999999999984
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.97 E-value=0.61 Score=45.39 Aligned_cols=71 Identities=20% Similarity=0.106 Sum_probs=41.9
Q ss_pred cCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCC--cceEE---E--EEEeCCEEEEEEeccC
Q 014909 22 GTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLY---E--VMGSKTKIFIVLEFVT 94 (416)
Q Consensus 22 G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~---~--~~~~~~~~~lV~E~~~ 94 (416)
+.-..||.... .++..+++|+.+.... ....+..|...+..|.... ++... + +...++..+.++++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 34456888765 3466799998764321 1345667777777664211 22211 1 1223466788999998
Q ss_pred CCc
Q 014909 95 GGE 97 (416)
Q Consensus 95 gg~ 97 (416)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 753
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=94.89 E-value=0.16 Score=48.45 Aligned_cols=74 Identities=12% Similarity=0.111 Sum_probs=43.6
Q ss_pred eecCceEEEEEEECC----CC----CeEEEEEeechhhhcH--HHHHHHHHHHHHHhcCC-------------CCCcceE
Q 014909 20 GEGTFAKVKFARNSE----TG----EPVALKILDKEKVLKH--KMAEQIKREVATMKLVK-------------HPNVVRL 76 (416)
Q Consensus 20 G~G~fg~V~~a~~~~----~~----~~vaiK~i~~~~~~~~--~~~~~~~~Ei~il~~l~-------------hpnIv~l 76 (416)
|.|-.|.+|++.-.. ++ ..+.||.......... .....+.+|+...+.+- ...+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 667778888765422 22 3588998763222221 12356777877665441 1234566
Q ss_pred EEEEEeCCEEEEEEecc
Q 014909 77 YEVMGSKTKIFIVLEFV 93 (416)
Q Consensus 77 ~~~~~~~~~~~lV~E~~ 93 (416)
+.....+....||||-+
T Consensus 82 ~~~~~~~~~~~lvlEDL 98 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDL 98 (294)
T ss_pred EEeccCCCceeeehhhh
Confidence 66665555788999865
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 416 | ||||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-77 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-76 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-75 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-75 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-75 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-75 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-74 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-73 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-66 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-65 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-65 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-64 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-64 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-63 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-63 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-63 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-63 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-61 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-60 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-57 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-57 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-56 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-56 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-56 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-53 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-51 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-51 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-51 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-51 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-51 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-51 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-51 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-51 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-51 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-51 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-51 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-51 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-51 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-51 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-51 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-51 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-51 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-50 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-50 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-50 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-50 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-50 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-50 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-50 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-50 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-50 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-50 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-50 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-50 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-50 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-50 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-50 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-50 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-50 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-50 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-50 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-50 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-50 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-50 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-50 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-50 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-50 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-50 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-50 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-50 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-50 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-50 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-50 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-50 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-49 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-49 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-49 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-49 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-49 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-49 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-49 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-47 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-47 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-47 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-47 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-47 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-46 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-46 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-46 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-46 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-46 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-46 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-46 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-45 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-45 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-45 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-45 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-45 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-45 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-45 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-45 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-44 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-44 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-44 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-44 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-44 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-43 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-43 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-42 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-42 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-42 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-42 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-42 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-42 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-42 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-41 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-41 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-41 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-41 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-41 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-41 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-41 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-41 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-41 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-41 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-41 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-41 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-41 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-41 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-41 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-41 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-41 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-41 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-41 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-41 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-41 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-41 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-41 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-41 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-41 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-41 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-41 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-41 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-41 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-41 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-41 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-41 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-41 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-41 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-41 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-41 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-41 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-41 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-41 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-41 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-41 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-41 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-41 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-40 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-40 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-40 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-40 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-40 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-40 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-40 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-40 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-40 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-40 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-40 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-40 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-40 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-40 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-40 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-40 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-40 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-40 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-40 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-40 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-40 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-40 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-40 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-39 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-39 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-39 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-39 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-39 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-39 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-39 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-39 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-39 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-39 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-39 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-39 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-39 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-39 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-39 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-39 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-39 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-39 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-39 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-39 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-39 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-39 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-39 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-39 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-39 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-39 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-39 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-38 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-38 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-38 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-38 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-38 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-38 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-38 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-38 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-38 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-38 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-38 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-38 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-38 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-37 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-37 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-37 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-37 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-37 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-37 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-37 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-37 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-37 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-37 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-37 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-37 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-37 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-37 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-37 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-37 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-37 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-37 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-37 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-36 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-36 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-36 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-36 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-36 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-36 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-36 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-36 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-36 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-36 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-36 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-36 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-36 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-35 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-35 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-35 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-35 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-35 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-35 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-35 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-34 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-34 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-34 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-34 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-34 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-34 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-34 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-33 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-33 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-33 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-33 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-33 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-33 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-32 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-32 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-32 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-31 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-31 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-31 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-31 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-31 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-31 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-31 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-31 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-31 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-31 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-31 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-31 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-31 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-30 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-30 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-30 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-30 | ||
| 2ehb_D | 143 | The Structure Of The C-Terminal Domain Of The Prote | 5e-30 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-30 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-29 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-29 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-29 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-29 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-29 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-28 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-28 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-28 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-28 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-28 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-28 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-27 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-27 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-27 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-27 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-27 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-27 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-27 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-27 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-27 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-27 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-27 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-27 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-27 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-27 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-26 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-26 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-26 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-26 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-26 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-26 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-26 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-26 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-26 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-26 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-26 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-26 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-26 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-25 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-25 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-25 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-25 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-25 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-25 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-25 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-25 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-25 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-24 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-24 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-24 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-24 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-24 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-24 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-24 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-24 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-24 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-24 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-24 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-24 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-24 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-24 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-24 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-24 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-24 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-24 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-24 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-24 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-24 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-24 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-24 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-24 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-24 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-24 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-24 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-24 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-24 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-24 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-24 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-24 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-24 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-24 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-24 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-24 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-24 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-24 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-24 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-24 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-24 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-24 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-24 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-24 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-24 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-24 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-24 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-24 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-24 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-24 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-24 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-24 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-24 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-24 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-24 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-24 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-24 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-23 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-23 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-23 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-23 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-23 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-23 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-23 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-23 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-23 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-23 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-23 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-23 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-23 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-23 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-23 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-23 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-23 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-23 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-22 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-22 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-22 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-22 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-22 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-22 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-22 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-22 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-22 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-21 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-21 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-21 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-20 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-20 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-20 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-20 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-20 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-20 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-19 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-19 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-19 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-19 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-19 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-19 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-19 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-19 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-19 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-19 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-19 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-19 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-19 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-19 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-19 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-19 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-19 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-19 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-19 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-19 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-19 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-19 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-19 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-19 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-19 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-19 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-19 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-19 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-19 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-19 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-19 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-19 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-18 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-18 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-18 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-18 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-18 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-18 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-18 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-18 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-18 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-18 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-18 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-18 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-18 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-18 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-18 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-18 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-18 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-18 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-18 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-18 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-18 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-18 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-18 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-18 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-18 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-18 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-18 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-18 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-18 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-18 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-18 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-18 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-18 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-18 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-18 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-18 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-18 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-18 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-18 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-18 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-18 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-18 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-18 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-18 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-18 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-18 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-18 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-18 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-18 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-18 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-18 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-17 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-17 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-17 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-17 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-17 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-17 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-17 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-17 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-17 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-17 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-17 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-17 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-17 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-17 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-17 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-17 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-17 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-17 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-17 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-17 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-17 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-17 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-17 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-17 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-17 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-17 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-17 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-17 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-17 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-17 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-17 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-17 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-17 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-17 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-17 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-17 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-17 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-17 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-17 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-17 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-17 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-16 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-16 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-16 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-16 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-16 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-16 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-16 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-16 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-16 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 6e-16 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-15 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-15 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-15 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-15 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-15 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-15 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-15 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-15 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-15 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-15 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-15 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-15 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-15 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-15 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-15 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-15 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-15 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-15 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-13 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-13 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-13 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-13 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-13 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-13 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-13 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-12 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-12 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-11 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-11 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-11 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-11 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-11 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-11 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-11 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-11 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-11 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-11 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-11 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 9e-11 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-10 | ||
| 2zfd_B | 123 | The Crystal Structure Of Plant Specific Calcium Bin | 2e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 6e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 7e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 7e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 7e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 7e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 7e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 7e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 7e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 8e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 8e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 9e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-10 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-09 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-09 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-09 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 5e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-09 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 6e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-08 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 6e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-07 |
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2EHB|D Chain D, The Structure Of The C-Terminal Domain Of The Protein Kinase Atsos2 Bound To The Calcium Sensor Atsos3 Length = 143 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2ZFD|B Chain B, The Crystal Structure Of Plant Specific Calcium Binding Protein Atcbl2 In Complex With The Regulatory Domain Of Atcipk14 Length = 123 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 566 bits (1460), Expect = 0.0
Identities = 152/472 (32%), Positives = 243/472 (51%), Gaps = 63/472 (13%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ + ++G Y +G T+G GTF KVK ++ TG VA+KIL+++K+ + +I+RE
Sbjct: 7 QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE 66
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
+ +KL +HP++++LY+V+ + + IF+V+E+V+GGELFD I +GR+ E E+RR FQQ++
Sbjct: 67 IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL 126
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+ VDYCH V HRDLKPEN+LLDA+ N K++DFGLS + + D L T+CG+PNY A
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAA 183
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PEV++ R Y G D+WS GVIL+ LL G LPFDD ++ L+KKI F P +L+ +
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSV 243
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLD--DVEAVFKDSEEHH 299
L+ +L +PM R TI +I E EWFK+D +F E + D EA+ + E+
Sbjct: 244 ISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFE 303
Query: 300 VTEQK--------EEQPVAMNAFELI---------------------------------- 317
+E++ Q A+ LI
Sbjct: 304 CSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHP 363
Query: 318 ------------SLSKGLNLGNLFDAEQDFKRETRFTS---RCPANEIINKIEEAAKPLG 362
+ L Q ++ + N+I+ ++ A K L
Sbjct: 364 ERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLD 423
Query: 363 FDVHKKN-YKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEF 413
++ N Y +R+ ++ +++QV ++++ R + LE
Sbjct: 424 YEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 515 bits (1328), Expect = 0.0
Identities = 133/278 (47%), Positives = 191/278 (68%), Gaps = 3/278 (1%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
S+ + ++G Y +G T+G GTF KVK + TG VA+KIL+++K+ + +IKRE
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
+ +KL +HP++++LY+V+ + T F+V+E+V+GGELFD I HGR++E EARR FQQ++
Sbjct: 62 IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL 121
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+AVDYCH V HRDLKPEN+LLDA+ N K++DFGLS + + D L T+CG+PNY A
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAA 178
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PEV++ R Y G D+WSCGVIL+ LL G LPFDD ++ L+KKI F P +L+ +
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSV 238
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
L+ +L +P+ R TI +I E EWFK+D +F E
Sbjct: 239 ATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPE 276
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 510 bits (1315), Expect = 0.0
Identities = 135/326 (41%), Positives = 204/326 (62%), Gaps = 12/326 (3%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA 63
KR +G Y + T+GEG+F KVK A + +T + VALK + ++ + K M +++RE++
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINA 123
+KL++HP++++LY+V+ + T I +V+E+ GGELFD IV RM EDE RR+FQQ+I A
Sbjct: 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
++YCH + HRDLKPENLLLD N+K++DFGLS + + D L T+CG+PNY APE
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPE 177
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243
V+N + Y G D+WSCG++L+V+L G LPFDD + NL+KK+++ + P +LS A+
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQS 237
Query: 244 LIARILDPNPMTRITIPEILEDEWFKKDYKPPVF-EEKKDTNLDDVEAVFKDSEEHHVTE 302
LI R++ +PM RITI EI D WF + + E+ + D V K E +E
Sbjct: 238 LIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSE 297
Query: 303 Q-------KEEQPVAMNAFELISLSK 321
+E A+ L+ ++
Sbjct: 298 DYIVEALRSDENNEVKEAYNLLHENQ 323
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 510 bits (1315), Expect = 0.0
Identities = 121/351 (34%), Positives = 181/351 (51%), Gaps = 17/351 (4%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
I +Y+ + IG G F + R+ T E VA+K +++ + E ++RE
Sbjct: 11 LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQRE 66
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
+ + ++HPN+VR EV+ + T + I++E+ +GGEL+++I N GR EDEAR +FQQL+
Sbjct: 67 IINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL 126
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
+ V YCHS + HRDLK EN LLD LK+ DFG S S +T GTP Y
Sbjct: 127 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTVGTPAY 183
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK----ISAAEFTCPP 235
+APEVL + YDG AD+WSCGV L+V+L G PF+D Y+K I + +++ P
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD 243
Query: 236 --WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT-NLDDVEAVF 292
+S LI+RI +P TRI+IPEI WF K+ + E + E
Sbjct: 244 DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPM 303
Query: 293 KDSEEHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTS 343
+ + + P N ++ L+L + D + D + E S
Sbjct: 304 QSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDDMD-DFDSESEIDIDS 353
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 507 bits (1307), Expect = 0.0
Identities = 108/308 (35%), Positives = 163/308 (52%), Gaps = 9/308 (2%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M+ P + +++ +T+GEG + +V+ A N T E VA+KI+D ++ + E IK+
Sbjct: 1 MAVPFV----EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKK 54
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ K++ H NVV+ Y ++ LE+ +GGELFD+I M E +A+R+F QL
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ V Y H G+ HRD+KPENLLLD NLK+SDFGL+ + + + LL+ CGT YV
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPW--L 237
APE+L R + D+WSCG++L +LAG LP+D S+ Y + PW +
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEE 297
L+ +IL NP RITIP+I +D W+ K K + +
Sbjct: 235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHI 294
Query: 298 HHVTEQKE 305
+
Sbjct: 295 QSNLDFSP 302
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 504 bits (1301), Expect = 0.0
Identities = 108/276 (39%), Positives = 160/276 (57%), Gaps = 9/276 (3%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M+ P + +++ +T+GEG + +V+ A N T E VA+KI+D ++ + E IK+
Sbjct: 1 MAVPFV----EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKK 54
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ K++ H NVV+ Y ++ LE+ +GGELFD+I M E +A+R+F QL
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ V Y H G+ HRD+KPENLLLD NLK+SDFGL+ + + + LL+ CGT YV
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPW--L 237
APE+L R + D+WSCG++L +LAG LP+D S+ Y + PW +
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273
L+ +IL NP RITIP+I +D W+ K K
Sbjct: 235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 497 bits (1282), Expect = e-178
Identities = 91/303 (30%), Positives = 156/303 (51%), Gaps = 12/303 (3%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-MAEQIKREVATMK 66
+ +GKY +G +GEG++ KVK +SET A+KIL K+K+ + +K+E+ ++
Sbjct: 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 67 LVKHPNVVRLYEVMG--SKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLIN 122
++H NV++L +V+ K K+++V+E+ G E+ D + R +A YF QLI+
Sbjct: 62 RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLID 120
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
++Y HS+G+ H+D+KP NLLL G LK+S G++ D T+ G+P + P
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 183 EVLND-RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
E+ N + G D+WS GV L+ + G PF+ N+ L++ I + P
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDS-----E 296
L+ +L+ P R +I +I + WF+K + P + D + + E
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLE 300
Query: 297 EHH 299
+ H
Sbjct: 301 DLH 303
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 479 bits (1236), Expect = e-171
Identities = 93/271 (34%), Positives = 139/271 (51%), Gaps = 3/271 (1%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
R +Y GR +G+G FAK +++T E A KI+ K +LK E++ E++ +
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ H +VV + +F+VLE L + + E EAR Y +Q++ Y
Sbjct: 71 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
H V HRDLK NL L+ +K+ DFGL+ + D CGTPNY+APEVL+
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLS 188
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246
+G+ D+WS G I++ LL G PF+ S L Y +I E++ P ++ A LI
Sbjct: 189 KKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 247
Query: 247 RILDPNPMTRITIPEILEDEWFKKDYKPPVF 277
++L +P R TI E+L DE+F Y P
Sbjct: 248 KMLQTDPTARPTINELLNDEFFTSGYIPARL 278
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 477 bits (1231), Expect = e-170
Identities = 93/269 (34%), Positives = 139/269 (51%), Gaps = 3/269 (1%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
R +Y GR +G+G FAK +++T E A KI+ K +LK E++ E++ +
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ H +VV + +F+VLE L + + E EAR Y +Q++ Y
Sbjct: 97 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
H V HRDLK NL L+ +K+ DFGL+ + D CGTPNY+APEVL+
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLS 214
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246
+G+ D+WS G I++ LL G PF+ S L Y +I E++ P ++ A LI
Sbjct: 215 KKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 273
Query: 247 RILDPNPMTRITIPEILEDEWFKKDYKPP 275
++L +P R TI E+L DE+F Y P
Sbjct: 274 KMLQTDPTARPTINELLNDEFFTSGYIPA 302
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 475 bits (1225), Expect = e-170
Identities = 90/277 (32%), Positives = 152/277 (54%), Gaps = 4/277 (1%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA 63
I ++ ++VG +G+G+FA V A + TG VA+K++DK+ + K M ++++ EV
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLIN 122
+KHP+++ LY +++VLE GE+ + N E+EAR + Q+I
Sbjct: 64 IHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT 123
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ Y HS G+ HRDL NLLL N+K++DFGL+ + +T CGTPNY++P
Sbjct: 124 GMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISP 181
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242
E+ + G +D+WS G + + LL G PFD + N K+ A++ P +LS A+
Sbjct: 182 EIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAK 240
Query: 243 KLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
LI ++L NP R+++ +L+ + ++ +E
Sbjct: 241 DLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 469 bits (1209), Expect = e-166
Identities = 119/298 (39%), Positives = 182/298 (61%), Gaps = 4/298 (1%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
S + +G Y + +TIG+G FAKVK AR+ TG VA+KI+DK + L +++ RE
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFRE 64
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
V MK++ HPN+V+L+EV+ ++ +++++E+ +GGE+FD +V HGRMKE EAR F+Q++
Sbjct: 65 VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV 124
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+AV YCH + + HRDLK ENLLLDA N+K++DFG S + G L CG P Y A
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN---EFTVGGKLDAFCGAPPYAA 181
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PE+ + YDG D+WS GVIL+ L++G LPFD NL L +++ ++ P ++S
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDC 241
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHH 299
L+ R L NP+ R T+ +I++D W ++ + + LD + D
Sbjct: 242 ENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGM 299
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 461 bits (1189), Expect = e-164
Identities = 94/283 (33%), Positives = 163/283 (57%), Gaps = 8/283 (2%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
PK K + +++GR +G+G F V AR + +ALK+L K ++ K + Q++RE
Sbjct: 5 EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRRE 64
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
+ ++HPN++R+Y + +I+++LEF GEL+ ++ HGR E + + ++L
Sbjct: 65 IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELA 124
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+A+ YCH R V HRD+KPENLL+ G LK++DFG S + +R T CGT +Y+
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLP 180
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PE++ + +D DLW GV+ + L G PFD + +++I + PP+LS +
Sbjct: 181 PEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGS 239
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYK---PPVFEEKK 281
+ LI+++L +P R+ + ++E W K + + PPV++ +
Sbjct: 240 KDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQ 282
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 460 bits (1186), Expect = e-163
Identities = 95/298 (31%), Positives = 157/298 (52%), Gaps = 32/298 (10%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-------- 53
++ +Y + IG+G++ VK A N A+K+L K+K+++
Sbjct: 4 GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 54 ---------------MAEQIKREVATMKLVKHPNVVRLYEVMG--SKTKIFIVLEFVTGG 96
EQ+ +E+A +K + HPNVV+L EV+ ++ +++V E V G
Sbjct: 64 RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 97 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156
+ + + + ED+AR YFQ LI ++Y H + + HRD+KP NLL+ G++K++DFG
Sbjct: 124 PVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPF 214
+S + D LL T GTP ++APE L++ + + G D+W+ GV L+ + G PF
Sbjct: 183 VSNEFK--GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240
Query: 215 DDSNLMNLYKKISAAEFTCP--PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
D +M L+ KI + P P ++ + LI R+LD NP +RI +PEI W +
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 453 bits (1167), Expect = e-161
Identities = 99/280 (35%), Positives = 158/280 (56%), Gaps = 5/280 (1%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA 63
K + + +E+GR +G+G F V AR ++ +ALK+L K ++ K + Q++REV
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINA 123
++HPN++RLY T+++++LE+ G ++ ++ + E Y +L NA
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+ YCHS+ V HRD+KPENLLL + G LK++DFG S + R CGT +Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPE 177
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243
++ R +D DLWS GV+ + L G PF+ + YK+IS EFT P +++ AR
Sbjct: 178 MIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 244 LIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 283
LI+R+L NP R + E+LE W + P + K++
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKES 276
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 444 bits (1144), Expect = e-156
Identities = 81/319 (25%), Positives = 144/319 (45%), Gaps = 15/319 (4%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE----- 56
KY +G G F V A + E + V +K + KEKVL+ E
Sbjct: 15 LAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG 74
Query: 57 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF-VTGGELFDKIVNHGRMKEDEARR 115
++ E+A + V+H N++++ ++ ++ +V+E +G +LF I H R+ E A
Sbjct: 75 KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
F+QL++AV Y + + HRD+K EN+++ +K+ DFG +A + L +T CG
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY---LERGKLFYTFCG 191
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 235
T Y APEVL Y G ++WS GV L+ L+ PF + ++ A P
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPY 245
Query: 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDS 295
+S L++ +L P P R T+ +++ D W + + ++ ++ E+ +
Sbjct: 246 LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSA 305
Query: 296 EEHHVTEQKEEQPVAMNAF 314
+ +
Sbjct: 306 ASLEMGNRSLSDVAQAQEL 324
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 434 bits (1119), Expect = e-153
Identities = 83/297 (27%), Positives = 134/297 (45%), Gaps = 17/297 (5%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQ 57
+ + +Y+VG +G G F V PVA+K ++K+++ +
Sbjct: 33 APGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR 92
Query: 58 IKREVATMKLVKH--PNVVRLYEVMGSKTKIFIVLEFVTG-GELFDKIVNHGRMKEDEAR 114
+ EV +K V V+RL + ++LE +LFD I G ++E+ AR
Sbjct: 93 VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 152
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTT 173
+F Q++ AV +CH+ GV HRD+K EN+L+D G LK+ DFG AL + D +
Sbjct: 153 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDF 208
Query: 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 233
GT Y PE + Y G +A +WS G++L+ ++ G +PF+ ++I +
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFF 262
Query: 234 PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEA 290
+S + LI L P R T EI W + P E +L +
Sbjct: 263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPS 319
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 434 bits (1118), Expect = e-153
Identities = 86/287 (29%), Positives = 133/287 (46%), Gaps = 19/287 (6%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQ--- 57
+ +Y +G +G+G F V VA+K++ + +VL
Sbjct: 21 PGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT 80
Query: 58 IKREVATMKLV----KHPNVVRLYEVMGSKTKIFIVLEF-VTGGELFDKIVNHGRMKEDE 112
EVA + V HP V+RL + ++ +VLE + +LFD I G + E
Sbjct: 81 CPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP 140
Query: 113 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLH 171
+R +F Q++ A+ +CHSRGV HRD+K EN+L+D G K+ DFG AL D
Sbjct: 141 SRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH----DEPYT 196
Query: 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 231
GT Y PE ++ Y A +WS G++L+ ++ G +PF+ ++I AE
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAEL 250
Query: 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFE 278
P +S LI R L P P +R ++ EIL D W + +
Sbjct: 251 HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN 297
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 409 bits (1052), Expect = e-142
Identities = 66/325 (20%), Positives = 130/325 (40%), Gaps = 50/325 (15%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-------- 53
+ + + Y + RT+ +G F K+ + + ALK +K + K +
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNND 79
Query: 54 ------MAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR 107
+ K E+ + +K+ + ++ + +++I+ E++ +
Sbjct: 80 KISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV 139
Query: 108 MK--------EDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
+ + + ++N+ Y H+ + + HRD+KP N+L+D G +K+SDFG S
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDD- 216
D + + GT ++ PE ++ Y+G+ D+WS G+ L+V+ +PF
Sbjct: 200 EYMV----DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255
Query: 217 SNLMNLYKKISAAEFTCP-------------------PWLSFTARKLIARILDPNPMTRI 257
+L+ L+ I P +LS + L NP RI
Sbjct: 256 ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315
Query: 258 TIPEILEDEWFKKDYKPPVFEEKKD 282
T + L+ EW + E K+
Sbjct: 316 TSEDALKHEWLADTNIEDLREFSKE 340
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-117
Identities = 81/303 (26%), Positives = 133/303 (43%), Gaps = 36/303 (11%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
R +E +G+G F +V ARN+ A+K + + + I EV +
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLAS 58
Query: 68 VKHPNVVRLYEV-------------MGSKTKIFIVLEFVTGGELFDKIVNHGRMK-EDEA 113
+ H VVR Y + K+ +FI +E+ G L+D I + + DE
Sbjct: 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118
Query: 114 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ---------- 163
R F+Q++ A+ Y HS+G+ HRDLKP N+ +D N+K+ DFGL+ +
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 164 --VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 221
L + GT YVA EVL+ G+ D++S G+I F ++ Y +N
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVN 236
Query: 222 LYKKISAAEFTCPPWL----SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVF 277
+ KK+ + PP +K+I ++D +P R +L W ++ V
Sbjct: 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVI 296
Query: 278 EEK 280
+E
Sbjct: 297 KEA 299
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-113
Identities = 100/311 (32%), Positives = 162/311 (52%), Gaps = 21/311 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMK 66
+Y + +T+G G +VK A +T + VA+KI+ K K + A ++ E+ +K
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ HP ++++ ++ +IVLE + GGELFDK+V + R+KE + YF Q++ AV Y
Sbjct: 71 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 127 CHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
H G+ HRDLKPEN+LL + +K++DFG S + + + L+ T CGTP Y+APE
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPE 186
Query: 184 VLNDRGYD--GSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAA--EFTCPPW-- 236
VL G D WS GVILF+ L+GY PF + ++L +I++ F W
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246
Query: 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 296
+S A L+ ++L +P R T E L W + + F++ + ++
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLL--SEENESTALPQVL 304
Query: 297 EHHVTEQKEEQ 307
T +K +
Sbjct: 305 AQPSTSRKRPR 315
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 341 bits (875), Expect = e-111
Identities = 87/450 (19%), Positives = 152/450 (33%), Gaps = 55/450 (12%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
S + G +E+ +G G F V + +TGE VA+K +E K++ E+ E
Sbjct: 5 SPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLE 62
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKI------FIVLEFVTGGELFDKIVNHGR---MKEDE 112
+ MK + HPNVV EV K+ + +E+ GG+L + +KE
Sbjct: 63 IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP 122
Query: 113 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDDGL 169
R + +A+ Y H + HRDLKPEN++L K+ D G ++++ L
Sbjct: 123 IRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG---YAKELDQGEL 179
Query: 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISA 228
GT Y+APE+L + Y T D WS G + F + G+ PF + + + K+
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238
Query: 229 AEFTCPPWLSFT-----------------------ARKLIARILDPNPMTRITIPEILED 265
+ + +L + R T P+
Sbjct: 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV 298
Query: 266 EWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQPVAMNAFELISLSKGLNL 325
F+ + +V T E N + G+
Sbjct: 299 GCFQ---------ALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPE 349
Query: 326 GN--LFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGFDVHKKNYKMRLENMKAGRKG 383
L A + ++ + + + L F + E +
Sbjct: 350 EEQELLQASGLALNSAQPLTQYVIDCTVIDGRQGEGDLIFLFDNRK--TVYEPQISLPAH 407
Query: 384 NLNVATEVFQVAPSLHMVEVRKAKGDTLEF 413
+V+ + L +R+ G +
Sbjct: 408 PESVSIVLQDPKRPLTYTHLRRVWGQIWQT 437
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 323 bits (831), Expect = e-110
Identities = 103/271 (38%), Positives = 145/271 (53%), Gaps = 15/271 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + TIG G++ +VK A T A K + K V + ++ K+E+ MK + HP
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHP 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N++RLYE T I++V+E TGGELF+++V+ +E +A R + +++AV YCH
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
V HRDLKPEN L LK+ DFGL+A + ++ T GTP YV+P+VL
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPYYVSPQVLE-G 182
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y G D WS GV+++VLL GY PF + KI F W +S A L
Sbjct: 183 LY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
I R+L +P RIT + LE EWF+K
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = e-110
Identities = 100/279 (35%), Positives = 159/279 (56%), Gaps = 12/279 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y+V +G+G F+ V+ + TG A KI++ +K L + ++++RE + ++HP
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHP 65
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+VRL++ + ++ ++V + VTGGELF+ IV E +A QQ++ ++ YCHS G
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 132 VYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HR+LKPENLLL + +K++DFG L+ +V D H GTP Y++PEVL
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFG---LAIEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y D+W+CGVIL++LL GY PF D + LY +I A ++ P W ++ A+ L
Sbjct: 183 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 283
I +L NP RIT + L+ W + ++DT
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDT 280
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 327 bits (840), Expect = e-109
Identities = 97/276 (35%), Positives = 153/276 (55%), Gaps = 21/276 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMK 66
+Y + +T+G G +VK A +T + VA++I+ K K + A ++ E+ +K
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ HP ++++ ++ +IVLE + GGELFDK+V + R+KE + YF Q++ AV Y
Sbjct: 196 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 127 CHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
H G+ HRDLKPEN+LL + +K++DFG S + + + L+ T CGTP Y+APE
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPE 311
Query: 184 VLND---RGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAA--EFTCPPW- 236
VL GY D WS GVILF+ L+GY PF + ++L +I++ F W
Sbjct: 312 VLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 370
Query: 237 -LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271
+S A L+ ++L +P R T E L W + +
Sbjct: 371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = e-108
Identities = 92/275 (33%), Positives = 143/275 (52%), Gaps = 20/275 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-----LKHKMAEQIKREVATMK 66
KY+ IG G + V+ + TG A+KI++ ++ E +RE ++
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 67 LVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
V HP+++ L + S + +F+V + + GELFD + + E E R + L+ AV
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
+ H+ + HRDLKPEN+LLD +++SDFG S + L CGTP Y+APE+L
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELCGTPGYLAPEIL 271
Query: 186 ------NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW- 236
GY G DLW+CGVILF LLAG PF + + + I +F+ P W
Sbjct: 272 KCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330
Query: 237 -LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
S T + LI+R+L +P R+T + L+ +F++
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = e-108
Identities = 91/282 (32%), Positives = 140/282 (49%), Gaps = 21/282 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK------HKMAEQIKREVATM 65
YE +G G + V+ + T + A+KI+D ++ E +EV +
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 66 KLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
+ V HPN+++L + + T F+V + + GELFD + + E E R+ + L+ +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
H + HRDLKPEN+LLD N+K++DFG S Q+ L CGTP+Y+APE+
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFG---FSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 185 L------NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW 236
+ N GY G D+WS GVI++ LLAG PF M + + I + +F P W
Sbjct: 195 IECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253
Query: 237 --LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
S T + L++R L P R T E L +F++ V
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-108
Identities = 69/289 (23%), Positives = 128/289 (44%), Gaps = 19/289 (6%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+ + + Y + + IG G +KV N E + A+K ++ E+ ++ + +
Sbjct: 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRN 75
Query: 61 EVATMKLVKHPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 118
E+A + ++ + ++RLY+ + I++V+E +L + + E + Y++
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWK 134
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
++ AV H G+ H DLKP N L+ G LK+ DFG++ Q + + GT N
Sbjct: 135 NMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 179 YVAPEVLNDRGYD----------GSTADLWSCGVILFVLLAGYLPFDD--SNLMNLYKKI 226
Y+ PE + D +D+WS G IL+ + G PF + + L+ I
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253
Query: 227 -SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274
E P + ++ L +P RI+IPE+L + + P
Sbjct: 254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 316 bits (812), Expect = e-106
Identities = 98/271 (36%), Positives = 155/271 (57%), Gaps = 12/271 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y+V +G+G F+ V+ + TG A KI++ +K L + ++++RE + ++HP
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHP 88
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+VRL++ + ++ ++V + VTGGELF+ IV E +A QQ++ ++ YCHS G
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 132 VYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HR+LKPENLLL + +K++DFGL+ +V D H GTP Y++PEVL
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y D+W+CGVIL++LL GY PF D + LY +I A ++ P W ++ A+ L
Sbjct: 206 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
I +L NP RIT + L+ W +
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWICNRERVA 295
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 312 bits (803), Expect = e-105
Identities = 96/270 (35%), Positives = 147/270 (54%), Gaps = 15/270 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G G F++V + TG+ ALK + K + ++ E+A +K +KH
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS---LENEIAVLKKIKHE 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V L ++ S T ++V++ V+GGELFD+I+ G E +A QQ+++AV Y H G
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPENLL + + ++DFGLS ++ +G++ T CGTP YVAPEVL +
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLS----KMEQNGIMSTACGTPGYVAPEVLAQK 182
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y D WS GVI ++LL GY PF + L++KI EF P W +S +A+
Sbjct: 183 PY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKP 274
I +L+ +P R T + L W +
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWIDGNTAL 271
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 311 bits (799), Expect = e-105
Identities = 83/269 (30%), Positives = 138/269 (51%), Gaps = 17/269 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ R +G G F V +G +K ++K++ EQI+ E+ +K + HP
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM--EQIEAEIEVLKSLDHP 80
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVDYC 127
N+++++EV ++IV+E GGEL ++IV + E +Q++NA+ Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 128 HSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
HS+ V H+DLKPEN+L + +K+ DFGL+ L + D GT Y+APEV
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEV 197
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW-LSFTA 241
R D+WS GV+++ LL G LPF ++L + +K + E + L+ A
Sbjct: 198 FK-RDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKK 270
L+ ++L +P R + ++L EWFK+
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = e-105
Identities = 59/307 (19%), Positives = 114/307 (37%), Gaps = 50/307 (16%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ + +G+G A V R+ +TG+ A+K+ + L+ + RE +K + H N
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKN 68
Query: 73 VVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYC 127
+V+L+ + T +++EF G L+ + + E E + ++ +++
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 128 HSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
G+ HR++KP N++ D K++DFG + ++ DD + GT Y+ P+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPD 185
Query: 184 VLNDRGYD-------GSTADLWSCGVILFVLLAGYLPFDDS----NLMNLYKKISAAEFT 232
+ G+T DLWS GV + G LPF + KI + +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 233 C-------------------------PPWLSFTARKLIARILDPNPMTRITIPEILEDEW 267
L ++A IL+ + + +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 268 FKKDYKP 274
Sbjct: 306 DILHRGN 312
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-105
Identities = 94/267 (35%), Positives = 150/267 (56%), Gaps = 13/267 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y + +G+G+F +V ++ T + A+K+++K K+K I REV +K + HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHP 81
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+++L+E++ + +IV E TGGELFD+I+ R E +A R +Q+ + + Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPEN+LL + ++K+ DFGLS + + + GT Y+APEVL
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVLR-G 197
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y D+WS GVIL++LL+G PF N ++ K++ F P W +S A+ L
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 245 IARILDPNPMTRITIPEILEDEWFKKD 271
I ++L +P RIT + LE W +K
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 314 bits (805), Expect = e-104
Identities = 73/350 (20%), Positives = 143/350 (40%), Gaps = 21/350 (6%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ I + Y + + IG G +KV N E + A+K ++ E+ ++ + + E
Sbjct: 47 ANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNE 104
Query: 62 VATMKLVKHPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 119
+A + ++ + ++RLY+ + I++V+E +L + + E + Y++
Sbjct: 105 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKN 163
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
++ AV H G+ H DLKP N L+ G LK+ DFG++ Q + + G NY
Sbjct: 164 MLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNY 222
Query: 180 VAPEVLNDRGYD----------GSTADLWSCGVILFVLLAGYLPFDD--SNLMNLYKKI- 226
+ PE + D +D+WS G IL+ + G PF + + L+ I
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282
Query: 227 SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLD 286
E P + ++ L +P RI+IPE+L + + P + +
Sbjct: 283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP--VNQMAKGTTE 340
Query: 287 DVEAVFKDSEEHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFK 336
+++ V + + + S + F+ ++ K
Sbjct: 341 EMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK 390
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 312 bits (800), Expect = e-104
Identities = 71/288 (24%), Positives = 127/288 (44%), Gaps = 19/288 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + + IG G +KV N E + A+K ++ E+ ++ + + E+A + ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 67
Query: 72 N--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+ ++RLY+ + I++V+E +L + + E + Y++ ++ AV H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
G+ H DLKP N L+ G LK+ DFG++ Q + + GT NY+ PE + D
Sbjct: 127 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 190 YD----------GSTADLWSCGVILFVLLAGYLPFDD--SNLMNLYKKISA-AEFTCPPW 236
+D+WS G IL+ + G PF + + L+ I E P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTN 284
+ ++ L +P RI+IPE+L + + P K T
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 293
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 310 bits (795), Expect = e-103
Identities = 64/358 (17%), Positives = 128/358 (35%), Gaps = 50/358 (13%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ + +G+G A V R+ +TG+ A+K+ + L+ + RE +K + H N
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKN 68
Query: 73 VVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYC 127
+V+L+ + T +++EF G L+ + + E E + ++ +++
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 128 HSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
G+ HR++KP N++ D K++DFG + ++ DD + GT Y+ P+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPD 185
Query: 184 VLNDRGYD-------GSTADLWSCGVILFVLLAGYLPFDD----SNLMNLYKKISAAEFT 232
+ G+T DLWS GV + G LPF + KI + +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 233 -------------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 267
L ++A IL+ + + +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 268 FKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQPVAMNAFELISLSKGLNL 325
+ + ++ ++ + + ELI + L L
Sbjct: 306 DILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVL 363
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 306 bits (785), Expect = e-101
Identities = 97/271 (35%), Positives = 151/271 (55%), Gaps = 11/271 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y++ +G+G F+ V+ G+ A I++ +K+ ++++RE +L+KHP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH-QKLEREARICRLLKHP 70
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+VRL++ + + +++ + VTGGELF+ IV E +A QQ++ AV +CH G
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
V HR+LKPENLLL +K++DFGL+ + + GTP Y++PEVL
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--EQQAWFGFAGTPGYLSPEVLRKD 188
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y G DLW+CGVIL++LL GY PF D + LY++I A +F P W ++ A+ L
Sbjct: 189 PY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
I ++L NP RIT E L+ W
Sbjct: 248 INKMLTINPSKRITAAEALKHPWISHRSTVA 278
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = e-100
Identities = 93/278 (33%), Positives = 147/278 (52%), Gaps = 19/278 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLVK 69
YE+ IG+G F+ V+ N ETG+ A+KI+D K E +KRE + ++K
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVD 125
HP++V L E S +++V EF+ G +L +IV E A Y +Q++ A+
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 126 YCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTPNYVA 181
YCH + HRD+KP +LL + +K+ FG++ Q+ + G + GTP+++A
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI---QLGESGLVAGGRVGTPHFMA 201
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--L 237
PEV+ Y G D+W CGVILF+LL+G LPF + L++ I + W +
Sbjct: 202 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHI 259
Query: 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
S +A+ L+ R+L +P RIT+ E L W K+ +
Sbjct: 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYA 297
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 300 bits (771), Expect = e-100
Identities = 96/268 (35%), Positives = 146/268 (54%), Gaps = 17/268 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+EV +G G + V + T +P ALK+L K + ++ E+ + + HP
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHP 108
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+++L E+ + T+I +VLE VTGGELFD+IV G E +A +Q++ AV Y H G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPENLL LK++DFG LS+ V L+ T CGTP Y APE+L
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFG---LSKIVEHQVLMKTVCGTPGYCAPEILRGC 225
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAA--EFTCPPW--LSFTARK 243
Y G D+WS G+I ++LL G+ PF D+ ++++I F P W +S A+
Sbjct: 226 AY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284
Query: 244 LIARILDPNPMTRITIPEILEDEWFKKD 271
L+ +++ +P R+T + L+ W
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPWVTGK 312
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 7e-99
Identities = 88/276 (31%), Positives = 141/276 (51%), Gaps = 22/276 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKH 70
YEV IG G+++ K + T A+KI+DK K E+ + + +H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQH 75
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
PN++ L +V +++V E + GGEL DKI+ E EA + V+Y H++
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 131 GVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
GV HRDLKP N+L ++++ DFG + + ++GLL T C T N+VAPEVL
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVLE 193
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---LYKKISAA--EFTCPPW--LSF 239
+GYD + D+WS GV+L+ +L GY PF + + +I + + W +S
Sbjct: 194 RQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252
Query: 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
TA+ L++++L +P R+T +L W + P
Sbjct: 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP 288
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 297 bits (761), Expect = 1e-98
Identities = 94/312 (30%), Positives = 142/312 (45%), Gaps = 53/312 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVK 69
KY + IG+G++ V+ A ++T A+KI++K K+ + K E+IK EV MK +
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK-------------------- 109
HPN+ RLYEV + I +V+E GG L DK+
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 110 --------------------EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL--DAY 147
E +Q+ +A+ Y H++G+ HRD+KPEN L +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 148 GNLKVSDFGLSAL--SQQVRDDGLLHTTCGTPNYVAPEVLN--DRGYDGSTADLWSCGVI 203
+K+ DFGLS + + T GTP +VAPEVLN + Y G D WS GV+
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWSAGVL 265
Query: 204 LFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW--LSFTARKLIARILDPNPMTRITI 259
L +LL G +PF N + ++ + F P + LS AR L++ +L+ N R
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325
Query: 260 PEILEDEWFKKD 271
L+ W +
Sbjct: 326 MRALQHPWISQF 337
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 2e-98
Identities = 94/276 (34%), Positives = 151/276 (54%), Gaps = 15/276 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA---EQIKREVATMKLV 68
YE+G +G G FA V+ R TG+ A K + K ++ + E+I+REV ++ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
+HPN++ L+++ +KT + ++LE V+GGELFD + + EDEA ++ +Q+++ V Y H
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 129 SRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
S+ + H DLKPEN++L +K+ DFG ++ ++ GTP +VAPE+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG---IAHKIEAGNEFKNIFGTPEFVAPEI 182
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFT 240
+N G AD+WS GVI ++LL+G PF ISA +F + S
Sbjct: 183 VNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
A+ I R+L +P R+TI + LE W K + V
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = 1e-97
Identities = 97/289 (33%), Positives = 158/289 (54%), Gaps = 17/289 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y + +G+G+F +V ++ T + A+K+++K K+K I REV +K + HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHP 81
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+++L+E++ + +IV E TGGELFD+I+ R E +A R +Q+ + + Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPEN+LL + ++K+ DFG LS + + + GT Y+APEVL
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFG---LSTCFQQNTKMKDRIGTAYYIAPEVLR-G 197
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW--LSFTARKL 244
Y D+WS GVIL++LL+G PF N ++ K++ + F P W +S A+ L
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFK 293
I ++L +P RIT + LE W +K E ++L +E+
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKYSS----ETPTISDLPSLESAMT 301
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 2e-97
Identities = 98/283 (34%), Positives = 144/283 (50%), Gaps = 15/283 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA---EQIKREVATMKLV 68
Y+ G +G G FA VK R TG A K + K + + E I+REV+ +K +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
+HPNV+ L+EV +KT + ++LE V GGELFD + + E+EA + +Q++N V Y H
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 129 SRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
S + H DLKPEN++L +K+ DFG L+ ++ GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFT 240
+N G AD+WS GVI ++LL+G PF +SA EF + S
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 283
A+ I R+L +P R+TI + L+ W K K
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASA 290
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 6e-97
Identities = 97/272 (35%), Positives = 155/272 (56%), Gaps = 12/272 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y+ R +G+G+F +V ++ TG+ A+K++ K +V + E + REV +K + HP
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+++LYE K ++V E TGGELFD+I++ R E +A R +Q+++ + Y H
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPENLLL N+++ DFG LS + GT Y+APEVL+
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFG---LSTHFEASKKMKDKIGTAYYIAPEVLH-G 202
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW--LSFTARKL 244
Y D+WS GVIL++LL+G PF+ +N ++ KK+ + F P W +S +A+ L
Sbjct: 203 TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
I ++L P RI+ + L+ EW + K +
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQTYTKEQI 293
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 1e-96
Identities = 89/283 (31%), Positives = 146/283 (51%), Gaps = 15/283 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA---EQIKREVATMKLV 68
Y++G +G G FA VK R TG A K + K + + E+I+REV+ ++ V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
H NV+ L++V ++T + ++LE V+GGELFD + + E+EA + +Q+++ V+Y H
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 129 SRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
++ + H DLKPEN++L ++K+ DFG L+ ++ D GTP +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFT 240
+N G AD+WS GVI ++LL+G PF I++ +F + S
Sbjct: 190 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 283
A+ I ++L R+TI E L W ++
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESV 291
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 2e-96
Identities = 97/327 (29%), Positives = 158/327 (48%), Gaps = 35/327 (10%)
Query: 12 KYEVG---RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
Y++ + +GEG+F+ + + ++ + A+KI+ K ++E+ +KL
Sbjct: 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLC 62
Query: 69 K-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
+ HPN+V+L+EV + F+V+E + GGELF++I E EA ++L++AV +
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 128 HSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
H GV HRDLKPENLL + +K+ DFG + L D+ L T C T +Y APE+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPEL 180
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-------LMNLYKKISAA--EFTCPP 235
LN GYD S DLWS GVIL+ +L+G +PF + + + KKI F
Sbjct: 181 LNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239
Query: 236 W--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFK 293
W +S A+ LI +L +P R+ + + +EW + + L + +
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS------SNPLMTPDILGS 293
Query: 294 DSEEHHVTEQKEEQPVAMNAFELISLS 320
V + A N ++
Sbjct: 294 SG--AAVHTCVKATFHAFNKYKREGFC 318
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 6e-96
Identities = 90/283 (31%), Positives = 147/283 (51%), Gaps = 15/283 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA---EQIKREVATMKLV 68
Y++G +G G FA VK R TG A K + K + + E+I+REV+ ++ V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
HPN++ L++V ++T + ++LE V+GGELFD + + E+EA + +Q+++ V+Y H
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 129 SRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
++ + H DLKPEN++L ++K+ DFG L+ ++ D GTP +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFT 240
+N G AD+WS GVI ++LL+G PF I+A +F + S
Sbjct: 190 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 283
A+ I ++L R+TI E L W ++
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESV 291
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 4e-95
Identities = 92/287 (32%), Positives = 148/287 (51%), Gaps = 22/287 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA----------EQIKRE 61
Y R +G G + +V + A+K++ K + K + + E+I E
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
++ +K + HPN+++L++V K ++V EF GGELF++I+N + E +A +Q++
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156
Query: 122 NAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
+ + Y H + HRD+KPEN+LL ++ N+K+ DFG LS D L GT
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG---LSSFFSKDYKLRDRLGTAY 213
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW 236
Y+APEVL + Y D+WSCGVI+++LL GY PF N ++ KK+ + F W
Sbjct: 214 YIAPEVLK-KKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271
Query: 237 --LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKK 281
+S A++LI +L + R T E L W KK ++K
Sbjct: 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQK 318
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 5e-95
Identities = 93/271 (34%), Positives = 145/271 (53%), Gaps = 13/271 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y+ + +G G + +V R+ T A+KI+ K + ++ EVA +KL+ HP
Sbjct: 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEEVAVLKLLDHP 96
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+++LY+ K ++V+E GGELFD+I++ + E +A +Q+++ V Y H
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPENLLL + +K+ DFGLSA+ + + GT Y+APEVL +
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKMKERLGTAYYIAPEVLR-K 212
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW--LSFTARKL 244
Y D+WS GVILF+LLAGY PF + +K+ + F P W +S A+ L
Sbjct: 213 KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
I ++L + RI+ + LE W K+
Sbjct: 272 IKQMLQFDSQRRISAQQALEHPWIKEMCSKK 302
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 4e-93
Identities = 64/271 (23%), Positives = 126/271 (46%), Gaps = 15/271 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY + +G G F V + + + K + + + +K+E++ + + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSR 130
N++ L+E S ++ ++ EF++G ++F++I + E E Y Q+ A+ + HS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 131 GVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ H D++PEN++ + +K+ +FG ++Q++ P Y APEV
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFG---QARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
+ D+WS G +++VLL+G PF + + I A F + +S A
Sbjct: 179 VV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
+ R+L +R+T E L+ W K+ +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERV 268
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 281 bits (722), Expect = 6e-93
Identities = 81/286 (28%), Positives = 140/286 (48%), Gaps = 16/286 (5%)
Query: 12 KYEV-GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
Y + + +G G FA V+ + TG+ A K L K + +I E+A ++L K
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKS 87
Query: 71 -PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV--NHGRMKEDEARRYFQQLINAVDYC 127
P V+ L+EV + ++I ++LE+ GGE+F + + E++ R +Q++ V Y
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 128 HSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
H + H DLKP+N+LL G++K+ DFG +S+++ L GTP Y+APE+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG---MSRKIGHACELREIMGTPEYLAPEI 204
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFT 240
LN + D+W+ G+I ++LL PF + Y IS +++ + +S
Sbjct: 205 LNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLD 286
A I +L NP R T L W ++ +F ++ ++
Sbjct: 264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSS 309
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 283 bits (725), Expect = 8e-93
Identities = 49/311 (15%), Positives = 102/311 (32%), Gaps = 53/311 (17%)
Query: 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
+ ++ R G +G+ A + ETGE + + + +Q+K EV
Sbjct: 65 ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEV 124
Query: 63 ATMKL----------------------VKHPNVVRLYEVMGSKTKIFIVLEFV------- 93
++L VK P ++ V + ++++ F
Sbjct: 125 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 184
Query: 94 ----TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149
G L H + + Q+I + H G+ H L+P +++LD G
Sbjct: 185 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG 244
Query: 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG----------YDGSTADLWS 199
+ ++ F DG + + + PE+ R + D W+
Sbjct: 245 VFLTGFEHL------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298
Query: 200 CGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI 259
G++++ + LP + + I F + R L+ L R+
Sbjct: 299 LGLVIYWIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLP 354
Query: 260 PEILEDEWFKK 270
+ +E +++
Sbjct: 355 LQAMETPEYEQ 365
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 282 bits (722), Expect = 7e-92
Identities = 106/346 (30%), Positives = 157/346 (45%), Gaps = 39/346 (11%)
Query: 3 QPKIKRRVGKYEV-GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
Q K + Y+V + +G G KV N T E ALK+L + +RE
Sbjct: 53 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARRE 104
Query: 62 VATMK-LVKHPNVVRLYEV----MGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEAR 114
V + P++VR+ +V + + IV+E + GGELF +I + G E EA
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 164
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLH 171
+ + A+ Y HS + HRD+KPENLL LK++DFG +++ L
Sbjct: 165 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG---FAKETTSHNSLT 221
Query: 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKIS 227
T C TP YVAPEVL YD S D+WS GVI+++LL GY PF ++ + + +I
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280
Query: 228 AA--EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 283
EF P W +S + LI +L P R+TI E + W + K P T
Sbjct: 281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP------QT 334
Query: 284 NLDDVEAVFKDSEEHHVTEQKEEQPVAMNAF--ELISLSKGLNLGN 327
L + +D E +++ +A E I + K + N
Sbjct: 335 PLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASN 380
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 2e-91
Identities = 96/324 (29%), Positives = 150/324 (46%), Gaps = 40/324 (12%)
Query: 12 KYEVGR-TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVK 69
Y++ + +G G KV + TG+ ALK+L + ++EV +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASG 80
Query: 70 HPNVVRLYEV----MGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEARRYFQQLINA 123
P++V + +V K + I++E + GGELF +I G E EA + + A
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 124 VDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + HS + HRD+KPENLL + LK++DFG + + L T C TP YV
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA----KETTQNALQTPCYTPYYV 196
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAA--EFTCP 234
APEVL YD S D+WS GVI+++LL G+ PF + + ++I F P
Sbjct: 197 APEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255
Query: 235 PW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVF 292
W +S A++LI +L +P R+TI + + W + P T L +
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP------QTPLHTARVLQ 309
Query: 293 KDSEEHHVTEQKEEQPVAMNAFEL 316
+D + H E KEE A+ +
Sbjct: 310 EDKD--HWDEVKEEMTSALATMRV 331
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 2e-91
Identities = 84/294 (28%), Positives = 139/294 (47%), Gaps = 38/294 (12%)
Query: 12 KYEVGR-TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK- 69
Y++ +GEG A+V+ N T + A+KI++K+ + ++ REV + +
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQG 69
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
H NV+ L E + + ++V E + GG + I E EA Q + +A+D+ H+
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 130 RGVYHRDLKPENLLL---DAYGNLKVSDFGLSAL-----SQQVRDDGLLHTTCGTPNYVA 181
+G+ HRDLKPEN+L + +K+ DF L + L T CG+ Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 182 PEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN--------------- 221
PEV+ YD DLWS GVIL++LL+GY PF +
Sbjct: 190 PEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248
Query: 222 LYKKISAA--EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271
L++ I EF W +S A+ LI+++L + R++ ++L+ W +
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 5e-90
Identities = 74/271 (27%), Positives = 131/271 (48%), Gaps = 14/271 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y++ +G G F V TG K ++ L +K E++ M + HP
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHHP 108
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSR 130
++ L++ K ++ ++LEF++GGELFD+I +M E E Y +Q + + H
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 131 GVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ H D+KPEN++ + +K+ DFG L+ ++ D ++ T T + APE+++
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFG---LATKLNPDEIVKVTTATAEFAAPEIVDRE 225
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
G D+W+ GV+ +VLL+G PF + + + + EF + +S A+
Sbjct: 226 PV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
I +L P R+T+ + LE W K D+
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 315
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 1e-88
Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 14/289 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y++ +G G F V TG A K + E +++E+ TM +++HP
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHP 214
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSR 130
+V L++ ++ ++ EF++GGELF+K+ + H +M EDEA Y +Q+ + + H
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 131 GVYHRDLKPENLLL--DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
H DLKPEN++ LK+ DFG L+ + + T GT + APEV +
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFG---LTAHLDPKQSVKVTTGTAEFAAPEVAEGK 331
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
G D+WS GV+ ++LL+G PF N + + + + +S +
Sbjct: 332 PV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFK 293
I ++L +P TR+TI + LE W P + + + K
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIK 439
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 2e-88
Identities = 84/282 (29%), Positives = 140/282 (49%), Gaps = 16/282 (5%)
Query: 12 KYEVGRT--IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
Y V +T +G G F +V + TG +A KI+ + K E++K E++ M +
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLD 144
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCH 128
H N+++LY+ SK I +V+E+V GGELFD+I++ + E + + +Q+ + + H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 129 SRGVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
+ H DLKPEN+L +K+ DFG L+++ + L GTP ++APEV+N
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFG---LARRYKPREKLKVNFGTPEFLAPEVVN 261
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTAR 242
+ D+WS GVI ++LL+G PF N I A + + +S A+
Sbjct: 262 -YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320
Query: 243 KLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTN 284
+ I+++L RI+ E L+ W +K N
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKN 362
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 3e-88
Identities = 79/291 (27%), Positives = 126/291 (43%), Gaps = 34/291 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKH 70
+ V R + EG FA V A++ +G ALK L + + I +EV MK L H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGH 85
Query: 71 PNVVRLY-------EVMGSKTKIFIVLEFVTGGELFDKIVN---HGRMKEDEARRYFQQL 120
PN+V+ E + F++L + G+L + + G + D + F Q
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 121 INAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLSA-------LSQQVRDDGLLH 171
AV + H + + HRDLK ENLLL G +K+ DFG + S + L+
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 172 ---TTCGTPNYVAPEVLN--DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
T TP Y PE+++ G D+W+ G IL++L PF+D + +I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----RI 261
Query: 227 SAAEFTCPPWLSFTA--RKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
+++ PP + LI +L NP R++I E++ +
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 3e-87
Identities = 65/284 (22%), Positives = 116/284 (40%), Gaps = 23/284 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + +GEG F+ V G ALK + + + E+ +RE +L HP
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHP 86
Query: 72 NVVRLYEV----MGSKTKIFIVLEFVTGGELFDKI----VNHGRMKEDEARRYFQQLINA 123
N++RL G+K + +++L F G L+++I + ED+ +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-------SQQVRDDGLLHTTCGT 176
++ H++G HRDLKP N+LL G + D G S+Q T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 177 PNYVAPEVLNDRGYD--GSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAEFTC 233
+Y APE+ + + + D+WS G +L+ ++ G P+D + + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 234 PPWLSFT--ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
P + +L+ ++ +P R IP +L + P
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 5e-87
Identities = 82/289 (28%), Positives = 140/289 (48%), Gaps = 14/289 (4%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
K+R ++ G+ +GEG+F+ V AR T A+KIL+K ++K + RE
Sbjct: 21 PPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE 80
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
M + HP V+LY K++ L + GEL I G E R Y +++
Sbjct: 81 RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 140
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+A++Y H +G+ HRDLKPEN+LL+ +++++DFG + + ++ GT YV+
Sbjct: 141 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PE+L ++ ++DLW+ G I++ L+AG PF N +++KI E+ P A
Sbjct: 201 PELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 259
Query: 242 RKLIARILDPNPMTRITIP------EILEDEWFKK-------DYKPPVF 277
R L+ ++L + R+ + +F+ PP
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 308
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 3e-85
Identities = 87/274 (31%), Positives = 135/274 (49%), Gaps = 16/274 (5%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
R YEV TIG G++ + + R G+ + K LD + + + EV ++ +
Sbjct: 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLREL 62
Query: 69 KHPNVVRLYE--VMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLIN 122
KHPN+VR Y+ + + T ++IV+E+ GG+L I + + E+ R QL
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 123 AVDYCHSRG-----VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
A+ CH R V HRDLKP N+ LD N+K+ DFGL+ + D T GTP
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTP 180
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PPW 236
Y++PE +N Y+ +D+WS G +L+ L A PF + L KI +F P
Sbjct: 181 YYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239
Query: 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
S ++I R+L+ R ++ EILE+ +
Sbjct: 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 3e-83
Identities = 74/312 (23%), Positives = 123/312 (39%), Gaps = 44/312 (14%)
Query: 2 SQPKIKRRVGK-YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+ P ++ + + +G G+ V F S G PVA+K + + +
Sbjct: 5 NIPNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALM 57
Query: 61 EVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-------RMKEDE 112
E+ + + HPNV+R Y + ++I LE L D + + KE
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYN 116
Query: 113 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-------------AYGNLKVSDFGLSA 159
+Q+ + V + HS + HRDLKP+N+L+ + +SDFGL
Sbjct: 117 PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 160 L--SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD------GSTADLWSCGVILFVLL-AG 210
S Q L+ GT + APE+L + + D++S G + + +L G
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 211 YLPFDDSNLMN---LYKKISAAEFTCPPW--LSFTARKLIARILDPNPMTRITIPEILED 265
PF D + S E C L A LI++++D +P+ R T ++L
Sbjct: 237 KHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296
Query: 266 EWFKKDYKPPVF 277
F K F
Sbjct: 297 PLFWPKSKKLEF 308
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 8e-82
Identities = 76/262 (29%), Positives = 139/262 (53%), Gaps = 7/262 (2%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY + IGEG+F K +++E G +K ++ + + K E+ +REVA + +KHP
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMKHP 83
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKI--VNHGRMKEDEARRYFQQLINAVDYCHS 129
N+V+ E ++IV+++ GG+LF +I +ED+ +F Q+ A+ + H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
R + HRD+K +N+ L G +++ DFG++ + L GTP Y++PE+ ++
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKP 201
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PPWLSFTARKLIARI 248
Y+ + +D+W+ G +L+ L F+ ++ NL KI + F S+ R L++++
Sbjct: 202 YN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260
Query: 249 LDPNPMTRITIPEILEDEWFKK 270
NP R ++ ILE + K
Sbjct: 261 FKRNPRDRPSVNSILEKGFIAK 282
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 7e-81
Identities = 67/282 (23%), Positives = 114/282 (40%), Gaps = 33/282 (11%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
KR ++ IG G F +V A++ G+ +K + E+ +REV +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALA 59
Query: 67 LVKHPNVVRLYE----------------VMGSKTKIFIVLEFVTGGELFDKIV--NHGRM 108
+ H N+V +FI +EF G L I ++
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 109 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168
+ A F+Q+ VDY HS+ + +RDLKP N+ L +K+ DFGL +++DG
Sbjct: 120 DKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDG 176
Query: 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA 228
+ GT Y++PE ++ + Y DL++ G+IL LL +++ + +
Sbjct: 177 KRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD 233
Query: 229 AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
+ L+ ++L P R EIL K
Sbjct: 234 GII--SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 9e-80
Identities = 45/310 (14%), Positives = 87/310 (28%), Gaps = 47/310 (15%)
Query: 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
+ + K ++ + G + V R+ E E ALK+ E++
Sbjct: 54 DSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEAT 113
Query: 63 ATMKLVKHPNVVRLYEVMG--------------------------SKTKIFIVLEFVTG- 95
+ + + + +++ +
Sbjct: 114 FAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVD 173
Query: 96 ----GELFDKIVNHGRMKEDEARRYF-QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150
D + + A QLI S+G+ H P+NL + G L
Sbjct: 174 LELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRL 233
Query: 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD-GSTADLWSCGVILFVLLA 209
+ D + + Y E LN + W G+ ++ +
Sbjct: 234 MLGDVSAL-----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
Query: 210 GYLPFDDSN--LMNLYKKISAAE-------FTCPPWLSFTARKLIARILDPNPMTRITIP 260
+LPF + +K+ S F L + LI R L+ + R+
Sbjct: 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL 348
Query: 261 EILEDEWFKK 270
E +E F +
Sbjct: 349 EAMETPEFLQ 358
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 6e-79
Identities = 85/295 (28%), Positives = 124/295 (42%), Gaps = 57/295 (19%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHP 71
+ +G G KV N T E ALK+L + +REV + + P
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 71
Query: 72 NVVRLYEV----MGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEARRYFQQLINAVD 125
++VR+ +V + + IV+E + GGELF +I + G E EA + + A+
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 126 YCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
Y HS + HRD+KPENLL LK++DFG A
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AK 168
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKISAA--EFTCPPW 236
E YD S D+WS GVI+++LL GY PF ++ + + +I EF P W
Sbjct: 169 ETTG-EKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226
Query: 237 --LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVE 289
+S + LI +L P R+TI E + W + K P T L
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP------QTPLHTSR 275
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 7e-79
Identities = 66/287 (22%), Positives = 113/287 (39%), Gaps = 24/287 (8%)
Query: 7 KRRVGK--YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
VGK + +G G + + R VA+K + E REV
Sbjct: 18 VVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQL 70
Query: 65 MK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM-KEDEARRYFQQLIN 122
++ +HPNV+R + + +I +E L + + E QQ +
Sbjct: 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTS 129
Query: 123 AVDYCHSRGVYHRDLKPENLLL-----DAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGT 176
+ + HS + HRDLKP N+L+ +SDFGL L+ GT
Sbjct: 130 GLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
Query: 177 PNYVAPEVLNDRGYDGST--ADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTC 233
++APE+L++ + T D++S G + + +++ G PF S + A C
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249
Query: 234 PPW---LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVF 277
AR+LI +++ +P R + +L+ +F K F
Sbjct: 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQF 296
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 2e-78
Identities = 88/288 (30%), Positives = 150/288 (52%), Gaps = 20/288 (6%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ + ++ +++ +T+G G+F +V ++ E+G A+KILDK+KV+K K E E
Sbjct: 32 TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
++ V P +V+L + +++V+E+V GGE+F + GR E AR Y Q++
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+Y HS + +RDLKPENLL+D G ++V+DFG + R G T CGTP +A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALA 206
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PE++ +GY D W+ GV+++ + AGY PF + +Y+KI + + P S
Sbjct: 207 PEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 242 RKLIARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPP 275
+ L+ +L + R + +I +WF + + P
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 243 bits (624), Expect = 2e-78
Identities = 96/303 (31%), Positives = 167/303 (55%), Gaps = 27/303 (8%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA 63
PK + +++ RT+G G+F +V R+ G A+K+L KE V++ K E E
Sbjct: 1 PKYS--LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL 58
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINA 123
+ +V HP ++R++ +IF++++++ GGELF + R A+ Y ++ A
Sbjct: 59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA 118
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
++Y HS+ + +RDLKPEN+LLD G++K++DFG + + +T CGTP+Y+APE
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPE 173
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243
V++ + Y + D WS G++++ +LAGY PF DSN M Y+KI AE PP+ + +
Sbjct: 174 VVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 232
Query: 244 LIARILDPNPMTRI-----TIPEILEDEWFK---------KD----YKPPVFEEKKDT-N 284
L++R++ + R+ ++ WFK ++ Y+PP+ + + DT
Sbjct: 233 LLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQ 292
Query: 285 LDD 287
D
Sbjct: 293 FDK 295
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 6e-78
Identities = 48/302 (15%), Positives = 98/302 (32%), Gaps = 42/302 (13%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM 65
+ R G +G+ A + ETGE + + + +Q+K EV +
Sbjct: 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRL 132
Query: 66 KL----------------------VKHPNVVRLYEVMGSKTKIFIVLEFVT--------- 94
+L VK P ++ V + ++++ F
Sbjct: 133 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQ 192
Query: 95 --GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152
G L H + + Q+I + H G+ H L+P +++LD G + +
Sbjct: 193 TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFL 252
Query: 153 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST----ADLWSCGVILFVLL 208
+ F + + P A +L + + D W+ G+ ++ +
Sbjct: 253 TGFEH-LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
Query: 209 AGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268
LP D + + I + P R L+ L R+ + +E +
Sbjct: 312 CADLPNTDDAALGGSEWIFRSCKNIPQP----VRALLEGFLRYPKEDRLLPLQAMETPEY 367
Query: 269 KK 270
++
Sbjct: 368 EQ 369
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 7e-77
Identities = 64/261 (24%), Positives = 111/261 (42%), Gaps = 10/261 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++ +G G++ +V R+ E G A+K A ++ + K+ +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSR 130
VRL + +++ E G L G + E + Y + + A+ + HS+
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
G+ H D+KP N+ L G K+ DFGL ++ G G P Y+APE+L Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELLQG-SY 232
Query: 191 DGSTADLWSCGVILFVLLAGY-LPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249
+ AD++S G+ + + LP L + EF LS R ++ +L
Sbjct: 233 G-TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRSVLVMML 289
Query: 250 DPNPMTRITIPEILEDEWFKK 270
+P+P R T +L ++
Sbjct: 290 EPDPKLRATAEALLALPVLRQ 310
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 7e-77
Identities = 82/289 (28%), Positives = 137/289 (47%), Gaps = 15/289 (5%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+ + + + + IG G F++V A G PVALK + ++ K +
Sbjct: 22 LRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK 81
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----MKEDEARRY 116
E+ +K + HPNV++ Y ++ IVLE G+L I + + + E +Y
Sbjct: 82 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
F QL +A+++ HSR V HRD+KP N+ + A G +K+ D GL H+ GT
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGT 199
Query: 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAAEFTCP 234
P Y++PE +++ GY+ +D+WS G +L+ + A PF D NL +L KKI ++ P
Sbjct: 200 PYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--P 256
Query: 235 PW----LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
P S R+L+ ++P+P R + + + E
Sbjct: 257 PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEH 305
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 7e-74
Identities = 67/294 (22%), Positives = 114/294 (38%), Gaps = 31/294 (10%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
R + +E + +G G F V A+N A+K + + E++ REV +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAK 59
Query: 68 VKHPNVVRLYEV------------MGSKTKIFIVLEFVTGGELFDKIVNHGRMK---EDE 112
++HP +VR + K ++I ++ L D + ++
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 113 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL----------SQ 162
F Q+ AV++ HS+G+ HRDLKP N+ +KV DFGL
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL 222
+ GT Y++PE ++ Y D++S G+ILF LL Y +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELL--YPFSTQMERVRT 236
Query: 223 YKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
+ +F ++ +L P+PM R I+E+ F+ P
Sbjct: 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 4e-73
Identities = 75/289 (25%), Positives = 142/289 (49%), Gaps = 21/289 (7%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R IG+G+F KV + ++T + A+K ++K+K ++ + +E+ M+ ++HP +V L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ + +F+V++ + GG+L + + KE+ + + +L+ A+DY ++ + HRD
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR---GYDGS 193
+KP+N+LLD +G++ ++DF ++A + + + T GT Y+APE+ + R GY
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYMAPEMFSSRKGAGY-SF 196
Query: 194 TADLWSCGVILFVLLAGYLPF---DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250
D WS GV + LL G P+ ++ + T P S L+ ++L+
Sbjct: 197 AVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLE 256
Query: 251 PNPMTRI-TIPEILEDEWFK---------KDYKPPVFEEKKDTNLDDVE 289
PNP R + ++ + K P F K D
Sbjct: 257 PNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPG-FIPNKGRLNCDPT 304
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-71
Identities = 47/298 (15%), Positives = 106/298 (35%), Gaps = 36/298 (12%)
Query: 3 QPKIKRRVG--KYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMA 55
+PK + ++G V +GEG FA+V A +++ + LK+ + +
Sbjct: 55 KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG 114
Query: 56 EQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV-----NHGRMKE 110
Q+ +K ++ Y + +V E + G L + I M +
Sbjct: 115 TQLMER---LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171
Query: 111 DEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL-----------DAYGNLKVSDFGLSA 159
+ +++ ++ H + H D+KP+N +L D L + D G S
Sbjct: 172 GLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSN 218
+ + C T + E+L+++ ++ D + ++ +L G Y+ +
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEG 290
Query: 219 LMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE---DEWFKKDYK 273
+ + W + +L+ + ++L + F++ Y
Sbjct: 291 GECKPEGLFRRLPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 4e-68
Identities = 91/273 (33%), Positives = 142/273 (52%), Gaps = 17/273 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+GTF KV R TG A+KIL KE ++ E ++ +HP + L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ ++ V+E+ GGELF + E+ AR Y ++++A++Y HSR V +RD
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
+K ENL+LD G++K++DFGL + + D + T CGTP Y+APEVL D Y G D
Sbjct: 131 IKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 187
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256
W GV+++ ++ G LPF + + L++ I E P LS A+ L+A +L +P R
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 257 I-----TIPEILEDEWFK---------KDYKPP 275
+ E++E +F K PP
Sbjct: 248 LGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 4e-68
Identities = 91/273 (33%), Positives = 140/273 (51%), Gaps = 17/273 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVR 75
+ IG+G+F KV AR+ A+K+L K+ +LK K + I E + K VKHP +V
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + K++ VL+++ GGELF + E AR Y ++ +A+ Y HS + +R
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 163
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKPEN+LLD+ G++ ++DFGL + + + T CGTP Y+APEVL+ + Y T
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DRTV 220
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W G +L+ +L G PF N +Y I P ++ +AR L+ +L +
Sbjct: 221 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 280
Query: 256 RITIP----EILEDEWFK---------KDYKPP 275
R+ EI +F K PP
Sbjct: 281 RLGAKDDFMEIKSHVFFSLINWDDLINKKITPP 313
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 6e-68
Identities = 82/287 (28%), Positives = 146/287 (50%), Gaps = 16/287 (5%)
Query: 2 SQPKIKRRVG--KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK 59
+P ++ ++ + + + +G+G+F KV A +T + A+K L K+ VL E
Sbjct: 6 ERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM 65
Query: 60 REVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 118
E + L +HP + ++ +K +F V+E++ GG+L I + + A Y
Sbjct: 66 VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA 125
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
++I + + HS+G+ +RDLK +N+LLD G++K++DFG+ + + D +T CGTP+
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPD 183
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS 238
Y+APE+L + Y + D WS GV+L+ +L G PF + L+ I P WL
Sbjct: 184 YIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE 242
Query: 239 FTARKLIARILDPNPMTRI-TIPEILEDEWFK---------KDYKPP 275
A+ L+ ++ P R+ +I + F+ K+ PP
Sbjct: 243 KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPP 289
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 215 bits (551), Expect = 3e-67
Identities = 88/277 (31%), Positives = 146/277 (52%), Gaps = 21/277 (7%)
Query: 17 RTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLVKHPN 72
R +G+G + KV R + TG+ A+K+L K ++ K K E ++ VKHP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V L + K++++LE+++GGELF ++ G ED A Y ++ A+ + H +G+
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPEN++L+ G++K++DFGL S + D + HT CGT Y+APE+L G+
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKES--IHDGTVTHTFCGTIEYMAPEILMRSGH-N 199
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
D WS G +++ +L G PF N KI + PP+L+ AR L+ ++L N
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRN 259
Query: 253 PMTRI-----TIPEILEDEWFK---------KDYKPP 275
+R+ E+ +F+ + +PP
Sbjct: 260 AASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPP 296
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 5e-67
Identities = 88/276 (31%), Positives = 148/276 (53%), Gaps = 21/276 (7%)
Query: 17 RTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G+G+F KV + S+ + A+K+L K + K E + V HP +
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVNHPFI 88
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 133
V+L+ ++ K++++L+F+ GG+LF ++ E++ + Y +L A+D+ HS G+
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGS 193
+RDLKPEN+LLD G++K++DFGLS S + + ++ CGT Y+APEV+N RG+
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCGTVEYMAPEVVNRRGH-TQ 205
Query: 194 TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
+AD WS GV++F +L G LPF + I A+ P +LS A+ L+ + NP
Sbjct: 206 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNP 265
Query: 254 MTRI-----TIPEILEDEWFK---------KDYKPP 275
R+ + EI +F ++ PP
Sbjct: 266 ANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPP 301
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 3e-66
Identities = 97/302 (32%), Positives = 154/302 (50%), Gaps = 30/302 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YEV + IG G F +V+ R+ T + A+K+L K +++K + E M P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV+L+ +++V+E++ GG+L ++++ + E AR Y +++ A+D HS G
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGF 189
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL--HTTCGTPNYVAPEVLNDRGY 190
HRD+KP+N+LLD G+LK++DFG ++ +G++ T GTP+Y++PEVL +G
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 191 D---GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----FTCPPWLSFTARK 243
D G D WS GV L+ +L G PF +L+ Y KI + F +S A+
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 306
Query: 244 LIARILDPNPMTRIT---IPEILEDEWFK---------KDYKPPV---FEEKKDT-NLDD 287
LI L + R+ + EI +FK +D PV DT N DD
Sbjct: 307 LICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDD 365
Query: 288 VE 289
+E
Sbjct: 366 LE 367
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 5e-66
Identities = 91/275 (33%), Positives = 146/275 (53%), Gaps = 19/275 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
R +G+G+F KV AR ETG+ A+K+L K+ +L+ E E + L HP + +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + ++F V+EFV GG+L I R E AR Y ++I+A+ + H +G+ +R
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYR 148
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD G+ K++DFG+ + + + T CGTP+Y+APE+L + Y G
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEILQEMLY-GPAV 205
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W+ GV+L+ +L G+ PF+ N +L++ I E P WL A ++ + NP
Sbjct: 206 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTM 265
Query: 256 RI------TIPEILEDEWFK---------KDYKPP 275
R+ IL +FK + +PP
Sbjct: 266 RLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPP 300
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-65
Identities = 93/289 (32%), Positives = 151/289 (52%), Gaps = 18/289 (6%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
++PK + + ++E + +G+GTF KV + TG A+KIL KE ++ E
Sbjct: 139 AKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTE 198
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
++ +HP + L + ++ V+E+ GGELF + ED AR Y +++
Sbjct: 199 NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 258
Query: 122 NAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+A+DY HS + V +RDLK ENL+LD G++K++DFGL + ++D + T CGTP Y+
Sbjct: 259 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYL 316
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVL D Y G D W GV+++ ++ G LPF + + L++ I E P L
Sbjct: 317 APEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 375
Query: 241 ARKLIARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPP 275
A+ L++ +L +P R+ EI++ +F K PP
Sbjct: 376 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 424
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 2e-65
Identities = 81/274 (29%), Positives = 143/274 (52%), Gaps = 18/274 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+G+G+F KV + T E A+KIL K+ V++ E E + L K P + +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + +++ V+E+V GG+L I GR KE A Y ++ + + S+G+ +R
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 145
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N++LD+ G++K++DFG+ + + D T CGTP+Y+APE++ + Y G +
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMCKEN--IWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSV 202
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W+ GV+L+ +LAG PF+ + L++ I P +S A + ++ +P
Sbjct: 203 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 262
Query: 256 RI-----TIPEILEDEWFK---------KDYKPP 275
R+ +I E +F+ K+ +PP
Sbjct: 263 RLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP 296
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 3e-64
Identities = 90/337 (26%), Positives = 151/337 (44%), Gaps = 38/337 (11%)
Query: 7 KRRVGK--YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
+ R+ + +E+ + IG G F++V + +TG+ A+KI++K +LK + E
Sbjct: 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV 114
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINA 123
+ + +L+ + +++V+E+ GG+L + G R+ + AR Y +++ A
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA 174
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL--HTTCGTPNYVA 181
+D H G HRD+KP+N+LLD G+++++DFG ++R DG + GTP+Y++
Sbjct: 175 IDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVGTPDYLS 231
Query: 182 PEVLNDRGYD------GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTC 233
PE+L G G D W+ GV + + G PF + Y KI +
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291
Query: 234 P---PWLSFTARKLIARILDPNPMTRIT---IPEILEDEWFK-------KDYKPPV---F 277
P + AR I R+L P TR+ + +F +D PP F
Sbjct: 292 PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDF 350
Query: 278 EEKKDT-NLDDVEAVFKDSEEHHVTEQKEEQPVAMNA 313
E DT N D VE D V+ E
Sbjct: 351 EGATDTCNFDLVE----DGLTAMVSGGGETLSDIREG 383
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 4e-64
Identities = 85/284 (29%), Positives = 147/284 (51%), Gaps = 28/284 (9%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
R IG G++AKV R +T A+K++ KE V + + ++ E + HP +V
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ +++++F V+E+V GG+L + ++ E+ AR Y ++ A++Y H RG+ +R
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD+ G++K++D+G+ + +R T CGTPNY+APE+L Y G +
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 191
Query: 196 DLWSCGVILFVLLAGYLPF---------DDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246
D W+ GV++F ++AG PF D + L++ I + P LS A ++
Sbjct: 192 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 251
Query: 247 RILDPNPMTRI------TIPEILEDEWFK---------KDYKPP 275
L+ +P R+ +I +F+ K PP
Sbjct: 252 SFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPP 295
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 4e-64
Identities = 78/304 (25%), Positives = 140/304 (46%), Gaps = 32/304 (10%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ + IG G F +V + + A+KIL+K ++LK + E +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
+ L+ +++V+++ GG+L + R+ E+ AR Y +++ A+D H
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL--HTTCGTPNYVAPEVLND-- 187
HRD+KP+N+L+D G+++++DFG ++ +DG + GTP+Y++PE+L
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 188 ---RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTCPPW---LSF 239
Y G D WS GV ++ +L G PF +L+ Y KI F P +S
Sbjct: 253 GGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311
Query: 240 TARKLIARILDPNPMTRIT---IPEILEDEWFK-------KDYKPPV---FEEKKDT-NL 285
A+ LI R++ R+ I + + +F ++ + P DT N
Sbjct: 312 NAKDLIRRLICSRE-HRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNF 370
Query: 286 DDVE 289
D +
Sbjct: 371 DVDD 374
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 6e-63
Identities = 86/301 (28%), Positives = 153/301 (50%), Gaps = 30/301 (9%)
Query: 2 SQPKIKRRVG--KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK 59
K +G +++ R IG G++AKV R +T A++++ KE V + + ++
Sbjct: 41 ESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQ 100
Query: 60 REVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 118
E + HP +V L+ +++++F V+E+V GG+L + ++ E+ AR Y
Sbjct: 101 TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA 160
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
++ A++Y H RG+ +RDLK +N+LLD+ G++K++D+G+ + +R T CGTPN
Sbjct: 161 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPN 218
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF---------DDSNLMNLYKKISAA 229
Y+APE+L Y G + D W+ GV++F ++AG PF D + L++ I
Sbjct: 219 YIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277
Query: 230 EFTCPPWLSFTARKLIARILDPNPMTRI------TIPEILEDEWFK---------KDYKP 274
+ P LS A ++ L+ +P R+ +I +F+ K P
Sbjct: 278 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVP 337
Query: 275 P 275
P
Sbjct: 338 P 338
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 212 bits (540), Expect = 2e-62
Identities = 81/274 (29%), Positives = 143/274 (52%), Gaps = 18/274 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+G+G+F KV + T E A+KIL K+ V++ E E + L K P + +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + +++ V+E+V GG+L I GR KE A Y ++ + + S+G+ +R
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 466
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N++LD+ G++K++DFG+ + + D T CGTP+Y+APE++ + Y G +
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCKEN--IWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSV 523
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W+ GV+L+ +LAG PF+ + L++ I P +S A + ++ +P
Sbjct: 524 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 583
Query: 256 RI-----TIPEILEDEWFK---------KDYKPP 275
R+ +I E +F+ K+ +PP
Sbjct: 584 RLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP 617
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 2e-62
Identities = 83/284 (29%), Positives = 149/284 (52%), Gaps = 27/284 (9%)
Query: 17 RTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLVKH-P 71
+ +G G + KV R +TG+ A+K+L K ++ K K E + E ++ ++ P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+V L+ ++TK+ ++L+++ GGELF + R E E + Y +++ A+++ H G
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 179
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL--NDRG 189
+ +RD+K EN+LLD+ G++ ++DFGLS + + CGT Y+AP+++ D G
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSG 238
Query: 190 YDGSTADLWSCGVILFVLLAGYLPF----DDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245
+D + D WS GV+++ LL G PF + ++ + ++I +E P +S A+ LI
Sbjct: 239 HDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLI 297
Query: 246 ARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPP 275
R+L +P R+ EI E +F+ K P
Sbjct: 298 QRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP 341
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 3e-62
Identities = 76/316 (24%), Positives = 133/316 (42%), Gaps = 29/316 (9%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R +G G F +V + TG+ A K L+K+++ K K + E + V +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGV 132
+KT + +V+ + GG++ I N + +E A Y Q+++ +++ H R +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPEN+LLD GN+++SD GL+ + GTP ++APE+L Y
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMAPELLLGEEY-D 367
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKISAAEFTCPPWLSFTARKLIARI 248
+ D ++ GV L+ ++A PF L +++ T P S ++ +
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEAL 427
Query: 249 LDPNPMTRI-----TIPEILEDEWFK---------KDYKPPVF---EEKKDTNLDDVEAV 291
L +P R+ + + F+ PP N+ DV
Sbjct: 428 LQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVG-A 486
Query: 292 FKDSEEHHVTEQKEEQ 307
F + + E
Sbjct: 487 FSTVKGVAFEKADTEF 502
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 4e-62
Identities = 81/314 (25%), Positives = 141/314 (44%), Gaps = 33/314 (10%)
Query: 3 QPKIKRRVGK--YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-----HKMA 55
++ + + V R IG G F +V R ++TG+ A+K LDK+++ +
Sbjct: 179 NVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN 238
Query: 56 EQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR 115
E + ++ + P +V + + K+ +L+ + GG+L + HG E + R
Sbjct: 239 E--RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF 296
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
Y ++I +++ H+R V +RDLKP N+LLD +G++++SD GL+ H + G
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVG 352
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---LYKKISAAEFT 232
T Y+APEVL S+AD +S G +LF LL G+ PF + + +
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412
Query: 233 CPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFK---------KDYKP---P 275
P S R L+ +L + R+ E+ E +F+ + Y P P
Sbjct: 413 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP 472
Query: 276 VFEEKKDTNLDDVE 289
E + D+
Sbjct: 473 PRGEVNAADAFDIG 486
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-61
Identities = 79/304 (25%), Positives = 137/304 (45%), Gaps = 26/304 (8%)
Query: 7 KRRVGK--YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
++ V K + R +G+G F +V + TG+ A K L+K+++ K K E
Sbjct: 178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI 237
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM--KEDEARRYFQQLIN 122
++ V VV L +K + +VL + GG+L I + G+ E A Y ++
Sbjct: 238 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC 297
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
++ H + +RDLKPEN+LLD +G++++SD G L+ V + + GT Y+AP
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLG---LAVHVPEGQTIKGRVGTVGYMAP 354
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPPWLS 238
EV+ + Y + D W+ G +L+ ++AG PF + + + S
Sbjct: 355 EVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFS 413
Query: 239 FTARKLIARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPPVFEEKKDTN 284
AR L +++L +P R+ + E+ E FK +PP + +
Sbjct: 414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIY 473
Query: 285 LDDV 288
DV
Sbjct: 474 CKDV 477
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 6e-60
Identities = 54/284 (19%), Positives = 94/284 (33%), Gaps = 35/284 (12%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++ IG G F V G A+K K ++ A L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----MKEDEARRYFQQLINAVDYC 127
+VVR + + I E+ GG L D I + R KE E + Q+ + Y
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 128 HSRGVYHRDLKPENLLLDAYGNL-------------------KVSDFGLSALSQQVRDDG 168
HS + H D+KP N+ + K+ D G V
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH------VTRIS 185
Query: 169 LLHTTCGTPNYVAPEVLN-DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS 227
G ++A EVL + + AD+++ + + + + +I
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQW---HEIR 241
Query: 228 AAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
P LS +L+ ++ P+P R + +++
Sbjct: 242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 7e-56
Identities = 64/328 (19%), Positives = 114/328 (34%), Gaps = 72/328 (21%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILD-------KEKVLK------------- 51
+E + +G G F V A+N A+K + +EKV++
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 52 -----------------------------------HKMAEQIKREVATMKLVKHPNVVRL 76
+ ++ M N V
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDE---ARRYFQQLINAVDYCHSRGVY 133
+ K ++I ++ L D + +++ E F Q+ AV++ HS+G+
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD----------GLLHTTCGTPNYVAPE 183
HRDLKP N+ +KV DFGL Q ++ GT Y++PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF-TAR 242
++ Y D++S G+ILF LL Y + + + +F +
Sbjct: 247 QIHGNNYSHK-VDIFSLGLILFELL--YSFSTQMERVRIITDVRNLKFPLLFTQKYPQEH 303
Query: 243 KLIARILDPNPMTRITIPEILEDEWFKK 270
++ +L P+P R +I+E+ F+
Sbjct: 304 MMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 7e-56
Identities = 75/274 (27%), Positives = 128/274 (46%), Gaps = 15/274 (5%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
+G+GT+ V R+ +A+K + + + ++ + E+A K +KH N+V+
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEA--RRYFQQLINAVDYCHSRGV 132
I I +E V GG L + G +K++E Y +Q++ + Y H +
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 133 YHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN--DRG 189
HRD+K +N+L++ Y G LK+SDFG S + T GT Y+APE+++ RG
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRG 201
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEF--TCPPWLSFTARKLIA 246
Y + AD+WS G + + G PF + K+ + P +S A+ I
Sbjct: 202 YGKA-ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFIL 260
Query: 247 RILDPNPMTRITIPEILEDEWFKKDYKPPVFEEK 280
+ +P+P R ++L DE+ K K + K
Sbjct: 261 KCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPK 294
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 2e-54
Identities = 65/267 (24%), Positives = 112/267 (41%), Gaps = 22/267 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+G G+F +V ++ +TG A+K + E E+ + P
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV--------EELVACAGLSSPR 111
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V LY + + I +E + GG L I G + ED A Y Q + ++Y H+R +
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 133 YHRDLKPENLLLDAYGNL-KVSDFGLSALSQQVRDDGLLHTTC------GTPNYVAPEVL 185
H D+K +N+LL + G+ + DFG + ++ DGL + GT ++APEV+
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHAL---CLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTAR 242
+ D D+WS ++ +L G P+ L KI++ PP +
Sbjct: 229 MGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287
Query: 243 KLIARILDPNPMTRITIPEILEDEWFK 269
+ I L P+ R + E+
Sbjct: 288 QAIQEGLRKEPVHRASAMELRRKVGKA 314
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-52
Identities = 79/316 (25%), Positives = 137/316 (43%), Gaps = 62/316 (19%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVATMKLVK 69
KYE IGEG++ V RN +TG+ VA+K + ++ + K+A RE+ +K +K
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL---REIRMLKQLK 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCH 128
HPN+V L EV K ++ +V E+ + ++ + R + E + Q + AV++CH
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYV------A 181
HRD+KPEN+L+ + +K+ DFG + L+ + + V +
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY----YD-----DEVATRWYRS 170
Query: 182 PEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMNLYKKIS---------- 227
PE+L D Y D+W+ G + LL+G P S++ LY I
Sbjct: 171 PELLVGDTQY--GPPVDVWAIGCVFAELLSGVPLWP-GKSDVDQLY-LIRKTLGDLIPRH 226
Query: 228 ---------AAEFTCPPW------------LSFTARKLIARILDPNPMTRITIPEILEDE 266
+ P +S+ A L+ L +P R+T ++L
Sbjct: 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286
Query: 267 WFKKDYKPPVFEEKKD 282
+F+ + ++ D
Sbjct: 287 YFENIREIEDLAKEHD 302
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 8e-52
Identities = 67/272 (24%), Positives = 129/272 (47%), Gaps = 18/272 (6%)
Query: 11 GKYE-VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
G++ IG G+F V ++ET VA L K+ K ++ K E +K ++
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQ 83
Query: 70 HPNVVRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
HPN+VR Y + K I +V E +T G L + MK R + +Q++ +
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 126 YCHSRG--VYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ H+R + HRDLK +N+ + G++K+ D GL+ L + GTP ++AP
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAP 199
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAE--FTCPPWLSF 239
E+ + YD S D+++ G+ + + P+ + N +Y+++++ +
Sbjct: 200 EMY-EEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 240 TARKLIARILDPNPMTRITIPEILEDEWFKKD 271
+++I + N R +I ++L +F+++
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-51
Identities = 80/321 (24%), Positives = 132/321 (41%), Gaps = 70/321 (21%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----RE 61
+ + KYE +GEG++ V RN +TG VA+K + + + +K RE
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-------KMVKKIAMRE 74
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQ 119
+ +K ++H N+V L EV K + ++V EFV + + + ++Y Q
Sbjct: 75 IKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL--FPNGLDYQVVQKYLFQ 132
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPN 178
+IN + +CHS + HRD+KPEN+L+ G +K+ DFG + L+ + +
Sbjct: 133 IINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV----YD-----D 183
Query: 179 YV------APEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMNLYK--KI 226
V APE+L D Y A D+W+ G ++ + G P DS++ LY
Sbjct: 184 EVATRWYRAPELLVGDVKY--GKAVDVWAIGCLVTEMFMGEPLFP-GDSDIDQLYHIMMC 240
Query: 227 ----------------SAAEFTCPPW------------LSFTARKLIARILDPNPMTRIT 258
A P LS L + L +P R
Sbjct: 241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF 300
Query: 259 IPEILEDEWFKKDYKPPVFEE 279
E+L ++F+ D F +
Sbjct: 301 CAELLHHDFFQMDGFAERFSQ 321
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-50
Identities = 86/312 (27%), Positives = 127/312 (40%), Gaps = 58/312 (18%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVA 63
+K R +YE +GEG FA V AR+ T + VA+K L K + RE+
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLI 121
++ + HPN++ L + G K+ I +V +F+ + N + + Y +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTL 122
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS--------ALSQQVRDDGLLHTT 173
++Y H + HRDLKP NLLLD G LK++DFGL+ A + QV
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-------- 174
Query: 174 CGTPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMNLYK----- 224
T Y APE+L R Y D+W+ G IL LL +LP DS+L L +
Sbjct: 175 --TRWYRAPELLFGARMY--GVGVDMWAVGCILAELLLRVPFLP-GDSDLDQLTRIFETL 229
Query: 225 ---------KIS----AAEFTCP---------PWLSFTARKLIARILDPNPMTRITIPEI 262
+ F LI + NP RIT +
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 289
Query: 263 LEDEWFKKDYKP 274
L+ ++F P
Sbjct: 290 LKMKYFSNRPGP 301
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 5e-50
Identities = 79/326 (24%), Positives = 131/326 (40%), Gaps = 71/326 (21%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQI 58
+S + +Y +GEGT+ +V A ++ T E VA+K L+ E+ E +
Sbjct: 24 VSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-------EGV 76
Query: 59 K----REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 114
REV+ +K ++H N++ L V+ ++ ++ E+ +L + + + +
Sbjct: 77 PGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIK 135
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-----GNLKVSDFGLS--------ALS 161
+ QLIN V++CHSR HRDLKP+NLLL LK+ DFGL+ +
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195
Query: 162 QQVRDDGLLHTTCGTPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDD- 216
++ T Y PE+L R Y ST+ D+WS I +L P D
Sbjct: 196 HEII----------TLWYRPPEILLGSRHY--STSVDIWSIACIWAEMLMKTPLFPGDSE 243
Query: 217 ----------------------SNL---MNLYKKISAAEF--TCPPWLSFTARKLIARIL 249
+ L + K L L+ +L
Sbjct: 244 IDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAML 303
Query: 250 DPNPMTRITIPEILEDEWFKKDYKPP 275
+ +P+ RI+ LE +F + P
Sbjct: 304 EMDPVKRISAKNALEHPYFSHNDFDP 329
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 9e-50
Identities = 98/313 (31%), Positives = 142/313 (45%), Gaps = 72/313 (23%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----REVATM 65
KYE IGEGT+ V A+N ET E VALK LD + E + RE+ +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-------EGVPSSALREICLL 55
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINA 123
K +KH N+VRL++V+ S K+ +V EF + FD +G + + + + QL+
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKG 113
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS--------ALSQQVRDDGLLHTTCG 175
+ +CHSR V HRDLKP+NLL++ G LK+++FGL+ S +V
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV---------- 163
Query: 176 TPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAA-- 229
T Y P+VL + Y ST+ D+WS G I L P + L +I
Sbjct: 164 TLWYRPPDVLFGAKLY--STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK-RIFRLLG 220
Query: 230 ---EFTCP------------------------PWLSFTARKLIARILDPNPMTRITIPEI 262
E P P L+ T R L+ +L NP+ RI+ E
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
Query: 263 LEDEWFKKDYKPP 275
L+ +F D+ PP
Sbjct: 281 LQHPYF-SDFCPP 292
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 3e-49
Identities = 83/323 (25%), Positives = 131/323 (40%), Gaps = 77/323 (23%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----REV 62
+++ +G GT+A V N TG VALK LD E E RE+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--------EGTPSTAIREI 54
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG-----ELFDKIVNHGRMKEDEARRYF 117
+ MK +KH N+VRLY+V+ ++ K+ +V EF+ + ++ + + +
Sbjct: 55 SLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGT 176
QL+ + +CH + HRDLKP+NLL++ G LK+ DFGL+ A V +
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--------TFS 166
Query: 177 PN-----YVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDD----------- 216
Y AP+VL R Y ST+ D+WSCG IL ++ G P +
Sbjct: 167 SEVVTLWYRAPDVLMGSRTY--STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI 224
Query: 217 ------------SNL------------MNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
+ L +L + + L + +L N
Sbjct: 225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT---KEPLDGNLMDFLHGLLQLN 281
Query: 253 PMTRITIPEILEDEWFKKDYKPP 275
P R++ + L WF + Y
Sbjct: 282 PDMRLSAKQALHHPWFAEYYHHA 304
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-48
Identities = 88/317 (27%), Positives = 142/317 (44%), Gaps = 69/317 (21%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----R 60
+ + KY+ +GEGT+ V A++S G VALK LD E E I R
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAED-------EGIPSTAIR 68
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQ 118
E++ +K + HPN+V L +V+ S+ + +V EF+ ++ D+ N +++ + + Y
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLY 126
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTP 177
QL+ V +CH + HRDLKP+NLL+++ G LK++DFGL+ A VR T
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--------SYTH 178
Query: 178 N-----YVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDD------------ 216
Y AP+VL + Y ST+ D+WS G I ++ G P
Sbjct: 179 EVVTLWYRAPDVLMGSKKY--STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL 236
Query: 217 -----------SNLMNLYKKISAAEFTCP------PWLSFTARKLIARILDPNPMTRITI 259
L +K+ + F P L++ +L +P RI+
Sbjct: 237 GTPNPREWPQVQELPL-WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA 295
Query: 260 PEILEDEWFKKDYKPPV 276
+ + +F KD P +
Sbjct: 296 RDAMNHPYF-KDLDPQI 311
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-48
Identities = 82/320 (25%), Positives = 126/320 (39%), Gaps = 62/320 (19%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKRE 61
P +YE IG G + V AR+ +G VALK + + RE
Sbjct: 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE 61
Query: 62 VATMKLVK---HPNVVRLYEV-----MGSKTKIFIVLEFVTG--GELFDKIVNHGRMKED 111
VA ++ ++ HPNVVRL +V + K+ +V E V DK + +
Sbjct: 62 VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-PPPGLPAE 120
Query: 112 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-------ALSQQV 164
+ +Q + +D+ H+ + HRDLKPEN+L+ + G +K++DFGL+ AL+ V
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV 180
Query: 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMN 221
T Y APEVL Y +T D+WS G I + +S
Sbjct: 181 V----------TLWYRAPEVLLQSTY--ATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQ 227
Query: 222 LYK-----------------KISAAEFTCP---------PWLSFTARKLIARILDPNPMT 255
L K + F P + + +L+ +L NP
Sbjct: 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHK 287
Query: 256 RITIPEILEDEWFKKDYKPP 275
RI+ L+ + KD P
Sbjct: 288 RISAFRALQHSYLHKDEGNP 307
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 9e-48
Identities = 95/307 (30%), Positives = 140/307 (45%), Gaps = 69/307 (22%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----REVATM 65
KY IGEGT+ V A+N GE ALK L+KE E I RE++ +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-------EGIPSTTIREISIL 54
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINA 123
K +KH N+V+LY+V+ +K ++ +V E + +L D G ++ A+ + QL+N
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNG 112
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPN---- 178
+ YCH R V HRDLKP+NLL++ G LK++DFGL+ A VR T
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--------KYTHEIVTL 164
Query: 179 -YVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMNLYKKISAA---- 229
Y AP+VL + Y ST D+WS G I ++ G P S L +I
Sbjct: 165 WYRAPDVLMGSKKY--STTIDIWSVGCIFAEMVNGTPLFP-GVSEADQLM-RIFRILGTP 220
Query: 230 -EFTCP------------------------PWLSFTARKLIARILDPNPMTRITIPEILE 264
P L + L++++L +P RIT + LE
Sbjct: 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
Query: 265 DEWFKKD 271
+FK++
Sbjct: 281 HAYFKEN 287
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-47
Identities = 76/268 (28%), Positives = 134/268 (50%), Gaps = 15/268 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ IG+G+F +V ++ T + VA+KI+D E+ E I++E+ + P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 81
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
V + Y TK++I++E++ GG D ++ G + E + ++++ +DY HS
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYD 191
HRD+K N+LL +G +K++DFG++ Q+ D + T GTP ++APEV+ YD
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 197
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL----SFTARKLIAR 247
AD+WS G+ L G P + + M + I PP L S ++ +
Sbjct: 198 SK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVEA 253
Query: 248 ILDPNPMTRITIPEILEDEWFKKDYKPP 275
L+ P R T E+L+ ++ ++ K
Sbjct: 254 CLNKEPSFRPTAKELLKHKFILRNAKKT 281
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-47
Identities = 77/277 (27%), Positives = 125/277 (45%), Gaps = 28/277 (10%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ IG G+F V A G VA+KIL ++ + + REVA MK ++HPN+
Sbjct: 40 NIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHPNI 96
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ---QLINAVDYCHSR 130
V + + IV E+++ G L+ + G ++ + RR + ++Y H+R
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 131 G--VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HR+LK NLL+D +KV DFGLS L + + GTP ++APEVL D
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------TCPPWLSF 239
+ +D++S GVIL+ L P+ + +N + ++A F P +
Sbjct: 215 PSN-EKSDVYSFGVILWELATLQQPWGN---LNPAQVVAAVGFKCKRLEIPRNLNPQV-- 268
Query: 240 TARKLIARILDPNPMTRITIPEILED-EWFKKDYKPP 275
+I P R + I++ K PP
Sbjct: 269 --AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 5e-47
Identities = 85/322 (26%), Positives = 128/322 (39%), Gaps = 69/322 (21%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----RE 61
V KYE IG+GTF +V AR+ +TG+ VALK +++ EK E RE
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-------EGFPITALRE 66
Query: 62 VATMKLVKHPNVVRLYEVM--------GSKTKIFIVLEFV----TGGELFDKIVNHGRMK 109
+ ++L+KH NVV L E+ K I++V +F G L + +
Sbjct: 67 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFT 122
Query: 110 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDG 168
E +R Q L+N + Y H + HRD+K N+L+ G LK++DFGL+ A S
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 169 LLHTTC-GTPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--------------- 210
+T T Y PE+L +R Y DLW G I+ +
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDY--GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 240
Query: 211 -----------------YLP-FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
++ L+ K+ A LI ++L +
Sbjct: 241 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYV-RDPYALDLIDKLLVLD 299
Query: 253 PMTRITIPEILEDEWFKKDYKP 274
P RI + L ++F D P
Sbjct: 300 PAQRIDSDDALNHDFFWSDPMP 321
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 71/313 (22%), Positives = 122/313 (38%), Gaps = 72/313 (23%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----REVATM 65
Y +GEGT+A V ++ T VALK L+ E E REV+ +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--------EGAPCTAIREVSLL 54
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINA 123
K +KH N+V L++++ ++ + +V E++ + D + + + QL+
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRG 112
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS--------ALSQQVRDDGLLHTTCG 175
+ YCH + V HRDLKP+NLL++ G LK++DFGL+ +V
Sbjct: 113 LAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV---------- 162
Query: 176 TPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMNLYK------- 224
T Y P++L Y ST D+W G I + + G P + L+
Sbjct: 163 TLWYRPPDILLGSTDY--STQIDMWGVGCIFYEMATGRPLFP-GSTVEEQLHFIFRILGT 219
Query: 225 -------------KISAAEFTCP---------PWLSFTARKLIARILDPNPMTRITIPEI 262
+ + P L L+ ++L RI+ +
Sbjct: 220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA 279
Query: 263 LEDEWFKKDYKPP 275
++ +F +
Sbjct: 280 MKHPFFLSLGERI 292
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-46
Identities = 71/267 (26%), Positives = 113/267 (42%), Gaps = 37/267 (13%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
EV +G G F V A+ + VA+K ++ E K E+ + V HPN+
Sbjct: 11 EVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERK-----AFIVELRQLSRVNHPNI 63
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI---NAVDYCHSR 130
V+LY + +V+E+ GG L++ + + A + V Y HS
Sbjct: 64 VKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 131 ---GVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
+ HRDLKP NLLL A G LK+ DFG + Q + G+ ++APEV
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFE 176
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------TCPPWL 237
Y D++S G+IL+ ++ PFD+ + +I A P +
Sbjct: 177 GSNYS-EKCDVFSWGIILWEVITRRKPFDE--IGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 238 SFTARKLIARILDPNPMTRITIPEILE 264
L+ R +P R ++ EI++
Sbjct: 234 ----ESLMTRCWSKDPSQRPSMEEIVK 256
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 7e-46
Identities = 87/328 (26%), Positives = 133/328 (40%), Gaps = 74/328 (22%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNS-ETGEPVALK--ILDKEKVLKHKMAEQ 57
M + + R +YE IGEG + KV AR+ G VALK + + E
Sbjct: 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-------EG 53
Query: 58 IK----REVATMKLVK---HPNVVRLYEV-----MGSKTKIFIVLEFVTG--GELFDKIV 103
+ REVA ++ ++ HPNVVRL++V +TK+ +V E V DK+
Sbjct: 54 MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV- 112
Query: 104 NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS----- 158
+ + + QL+ +D+ HS V HRDLKP+N+L+ + G +K++DFGL+
Sbjct: 113 PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172
Query: 159 --ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAG--YLP 213
AL+ V T Y APEVL Y +T DLWS G I +
Sbjct: 173 QMALTSVVV----------TLWYRAPEVLLQSSY--ATPVDLWSVGCIFAEMFRRKPLFR 220
Query: 214 FDDSNLMNLYK-----------------KISAAEFTCP---------PWLSFTARKLIAR 247
S++ L K + F + + L+ +
Sbjct: 221 -GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK 279
Query: 248 ILDPNPMTRITIPEILEDEWFKKDYKPP 275
L NP RI+ L +F+ +
Sbjct: 280 CLTFNPAKRISAYSALSHPYFQDLERCK 307
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-45
Identities = 60/265 (22%), Positives = 119/265 (44%), Gaps = 24/265 (9%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
VG+ IG G+F V + + + VA+K+L + + K EV ++ +H N
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD----VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRG 131
++ + ++ IV ++ G L+ + + + + + +Q +DY H++
Sbjct: 82 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ HRDLK N+ L +K+ DFGL+ + G+ ++APEV+ + +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 192 GST--ADLWSCGVILFVLLAGYLPFDDSNLM----------NLYKKISAAEFTCPPWLSF 239
+ +D+++ G++L+ L+ G LP+ + N +L +S CP +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM-- 258
Query: 240 TARKLIARILDPNPMTRITIPEILE 264
++L+A L R + P IL
Sbjct: 259 --KRLMAECLKKKRDERPSFPRILA 281
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-45
Identities = 58/270 (21%), Positives = 115/270 (42%), Gaps = 29/270 (10%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
E+G IG+G F +V R + E VA++++D E+ + KREV + +H N
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE----VAIRLIDIER-DNEDQLKAFKREVMAYRQTRHEN 90
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRG 131
VV S + I+ G L+ + + ++ R+ Q+++ + Y H++G
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ H+DLK +N+ D G + ++DFGL + Q R + L G ++APE++
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 189 GYDGST--------ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI------SAAEFTCP 234
D +D+++ G I + L A PF + ++ + ++
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMG 269
Query: 235 PWLSFTARKLIARILDPNPMTRITIPEILE 264
+ ++ R T ++++
Sbjct: 270 KEI----SDILLFCWAFEQEERPTFTKLMD 295
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-45
Identities = 62/113 (54%), Positives = 81/113 (71%), Gaps = 1/113 (0%)
Query: 305 EEQPVAMNAFELISLSKGLNLGNLFDAEQDF-KRETRFTSRCPANEIINKIEEAAKPLGF 363
+E P+ MNAFE+I+LS+GLNL LFD QDF KR+TRF SR +EII IE A +GF
Sbjct: 1 DEGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGF 60
Query: 364 DVHKKNYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKV 416
H +N+K RLE + + + G L V E+++VAPSL MV+VRKA G+TLE+HK
Sbjct: 61 KSHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKF 113
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 9e-45
Identities = 66/279 (23%), Positives = 114/279 (40%), Gaps = 44/279 (15%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
G +G+G F + + ETGE + +K L + + +EV M+ ++HPNV
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNV 69
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG---------RMKEDEARRYFQQLINAV 124
++ V+ ++ + E++ GG L I + +D A +
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS--------GM 121
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL------------SQQVRDDGLLHT 172
Y HS + HRDL N L+ N+ V+DFGL+ L S + D +T
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF- 231
G P ++APE++N R YD D++S G++L ++ D + ++ F
Sbjct: 182 VVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240
Query: 232 ------TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
CPP + R D +P R + ++
Sbjct: 241 DRYCPPNCPPSF----FPITVRCCDLDPEKRPSFVKLEH 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-44
Identities = 77/271 (28%), Positives = 139/271 (51%), Gaps = 10/271 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ IGEG+ V AR +G VA+K++D K + E + EV M+ +H
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQHF 102
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
NVV +Y+ ++++++EF+ GG L D IV+ R+ E++ + ++ A+ Y H++G
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQG 161
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+K +++LL G +K+SDFG A Q +D + GTP ++APEV++ Y
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRSLYA 219
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIARI 248
D+WS G+++ ++ G P+ + + K++ + + +S R + R+
Sbjct: 220 TE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278
Query: 249 LDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
L +P R T E+L+ + + P
Sbjct: 279 LVRDPQERATAQELLDHPFLLQTGLPECLVP 309
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-44
Identities = 69/273 (25%), Positives = 117/273 (42%), Gaps = 34/273 (12%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKIL----DKEKVLKHKMAEQIKREVATMKLVK 69
E + IG+G F V R + VA+K L + + + ++ +REV M +
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCH 128
HPN+V+LY + +V+EFV G+L+ ++++ +K R + ++Y
Sbjct: 82 HPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 129 SRG--VYHRDLKPENLLLDAYG-----NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
++ + HRDL+ N+ L + KV+DFGLS S + G ++A
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMA 194
Query: 182 PEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--------F 231
PE + Y AD +S +IL+ +L G PFD+ + + E
Sbjct: 195 PETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253
Query: 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
CPP L R +I +P R I++
Sbjct: 254 DCPPRL----RNVIELCWSGDPKKRPHFSYIVK 282
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-44
Identities = 75/271 (27%), Positives = 133/271 (49%), Gaps = 10/271 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY IG+G V A + TG+ VA++ ++ ++ K E I E+ M+ K+P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNP 77
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V + ++++V+E++ GG L D +V M E + ++ + A+++ HS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+K +N+LL G++K++DFG A Q + T GTP ++APEV+ + Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIARI 248
D+WS G++ ++ G P+ + N + I+ E P LS R + R
Sbjct: 195 PK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 249 LDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
L+ + R + E+L+ ++ K
Sbjct: 254 LEMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 3e-44
Identities = 45/269 (16%), Positives = 98/269 (36%), Gaps = 36/269 (13%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ E ++ R G + +K+L + + E +++ HPNV
Sbjct: 13 NFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNV 69
Query: 74 VRLYEVM--GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD------ 125
+ + ++ ++ G L++ + D+++ + A+D
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQA----VKFALDMARGMA 125
Query: 126 YCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+ H+ + L ++++D ++S + Q P +VAPE
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPE 178
Query: 184 VLNDRGYDGST--ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------TCPP 235
L + D + AD+WS V+L+ L+ +PF D + M + K++ P
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238
Query: 236 WLSFTARKLIARILDPNPMTRITIPEILE 264
+ KL+ ++ +P R I+
Sbjct: 239 HV----SKLMKICMNEDPAKRPKFDMIVP 263
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-43
Identities = 69/264 (26%), Positives = 129/264 (48%), Gaps = 14/264 (5%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+Y++ +G G + V A ++ VA+K + K + ++ +REV + H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
N+V + +V ++V+E++ G L + I +HG + D A + Q+++ + + H
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTC--GTPNYVAPEVLND 187
+ HRD+KP+N+L+D+ LK+ DFG++ ALS+ L T GT Y +PE
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET----SLTQTNHVLGTVQYFSPEQAKG 186
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFD-DSNLMNLYKKISAAEFTCP----PWLSFTAR 242
D T D++S G++L+ +L G PF+ ++ + K I + + +
Sbjct: 187 EATDECT-DIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245
Query: 243 KLIARILDPNPMTR-ITIPEILED 265
+I R + + R TI E+ +D
Sbjct: 246 NVILRATEKDKANRYKTIQEMKDD 269
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-43
Identities = 80/290 (27%), Positives = 134/290 (46%), Gaps = 25/290 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YE+ IG G A V+ A + E VA+K ++ EK +++ +E+ M HPN
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM--DELLKEIQAMSQCHHPN 74
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFD--------KIVNHGRMKEDEARRYFQQLINAV 124
+V Y K ++++V++ ++GG + D G + E ++++ +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLL--HTTCGTPNYVA 181
+Y H G HRD+K N+LL G+++++DFG+SA L+ T GTP ++A
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 182 PEVL-NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYK---------KISAAE 230
PEV+ RGYD AD+WS G+ L G P+ M L + +
Sbjct: 195 PEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQD 253
Query: 231 FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEK 280
+ RK+I+ L +P R T E+L ++F+K +EK
Sbjct: 254 KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEK 303
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-43
Identities = 68/277 (24%), Positives = 117/277 (42%), Gaps = 21/277 (7%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT-MKLVKHP 71
E +G GT +V R +TG +A+K + + + ++I ++ +K P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHDCP 84
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-R 130
+V+ + + T +FI +E + K G + E + ++ A+ Y
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
GV HRD+KP N+LLD G +K+ DFG+S ++ DD + G Y+APE ++
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 191 DGST----ADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPWL------SF 239
AD+WS G+ L L G P+ + + K+ E PP L S
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE---PPLLPGHMGFSG 258
Query: 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
+ + L + R ++LE + K+ V
Sbjct: 259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-43
Identities = 66/265 (24%), Positives = 120/265 (45%), Gaps = 19/265 (7%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
++ + + G Y + R +G G V A ++ VALK++ + +++RE
Sbjct: 25 AESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQRE 84
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
T ++ P+VV +++ ++++ + + G +L + G + A +Q+
Sbjct: 85 ARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIG 144
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL-SALSQQVRDDGLLHT--TCGTPN 178
+A+D H+ G HRD+KPEN+L+ A + DFG+ SA + D+ L T GT
Sbjct: 145 SALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT----DEKLTQLGNTVGTLY 200
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS 238
Y+APE ++ AD+++ +L+ L G P+ L + I+ A P S
Sbjct: 201 YMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQA----IPRPS 255
Query: 239 FTARKL-------IARILDPNPMTR 256
+ IAR + NP R
Sbjct: 256 TVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-42
Identities = 77/299 (25%), Positives = 141/299 (47%), Gaps = 19/299 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++V +GEG++ V A + ETG+ VA+K + E L ++I +E++ M+ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-----QEIIKEISIMQQCDSP 84
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSR 130
+VV+ Y T ++IV+E+ G + D I + + + EDE Q + ++Y H
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
HRD+K N+LL+ G+ K++DFG++ Q +T GTP ++APEV+ + GY
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYK--KISAAEFTCPPWLSFTARKLIAR 247
+ AD+WS G+ + G P+ D + M ++ F P S + +
Sbjct: 203 NCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ 261
Query: 248 ILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEE 306
L +P R T ++L+ + + + + + + ++Q+EE
Sbjct: 262 CLVKSPEQRATATQLLQHPFVRSAKGVSILRDL-------INEAMDVKLKRQESQQREE 313
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-42
Identities = 77/277 (27%), Positives = 133/277 (48%), Gaps = 15/277 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+E+ +G+G F KV A+N ETG A K+++ + + E E+ + HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHP 76
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
+V+L K++I++EF GG + ++ + E + + +Q++ A+++ HS+
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV-----L 185
+ HRDLK N+L+ G+++++DFG+SA + ++ + GTP ++APEV +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYK--KISAAEFTCPPWLSFTAR 242
D YD AD+WS G+ L + P + N M L K K P S R
Sbjct: 195 KDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253
Query: 243 KLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
+ LD NP TR + ++LE + E
Sbjct: 254 DFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRE 290
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-42
Identities = 69/272 (25%), Positives = 115/272 (42%), Gaps = 36/272 (13%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA-EQIKREVATMKLVKHPN 72
+ IG G F KV A G+ VA+K + E +++E ++KHPN
Sbjct: 10 TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
++ L V + + +V+EF GG L + R+ D + Q+ ++Y H +
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 133 Y---HRDLKPENLLLDAYG--------NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
HRDLK N+L+ LK++DFGL+ + + G ++A
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMA 182
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------T 232
PEV+ + +D+WS GV+L+ LL G +PF ++ T
Sbjct: 183 PEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRG---IDGLAVAYGVAMNKLALPIPST 238
Query: 233 CPPWLSFTARKLIARILDPNPMTRITIPEILE 264
CP KL+ +P+P +R + IL+
Sbjct: 239 CPEPF----AKLMEDCWNPDPHSRPSFTNILD 266
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-41
Identities = 69/256 (26%), Positives = 116/256 (45%), Gaps = 12/256 (4%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+YE+G +G G ++V AR+ VA+K+L + + +RE + H
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 71 PNVVRLY---EVMGSKTKI-FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
P +V +Y E + +IV+E+V G L D + G M A A+++
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVL 185
H G+ HRD+KP N+++ A +KV DFG++ A++ GT Y++PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFD-DSNLMNLYKKISAAEFTCP----PWLSFT 240
D + D++S G +L+ +L G PF DS + Y+ + + P LS
Sbjct: 192 RGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSARHEGLSAD 249
Query: 241 ARKLIARILDPNPMTR 256
++ + L NP R
Sbjct: 250 LDAVVLKALAKNPENR 265
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-41
Identities = 36/110 (32%), Positives = 54/110 (49%), Gaps = 5/110 (4%)
Query: 308 PVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGFDVHK 367
MNAF++IS S G NL LF + + R RF S A ++ ++EE V K
Sbjct: 3 ARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAK 62
Query: 368 K-NYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEFHKV 416
K + M++E G+KGN + E+ Q+ L M+EVRK + +
Sbjct: 63 KETWGMKIE----GQKGNFAMVVEINQLTDELVMIEVRKRQRAAASGRDL 108
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 4e-41
Identities = 64/271 (23%), Positives = 110/271 (40%), Gaps = 11/271 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E +G G V + +G +A K++ E +K + QI RE+ + P
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 92
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG- 131
+V Y S +I I +E + GG L + GR+ E + +I + Y +
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
+ HRD+KP N+L+++ G +K+ DFG+S L + + + GT +Y++PE L Y
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-----SFVGTRSYMSPERLQGTHY 207
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250
+D+WS G+ L + G P + L + + R L+
Sbjct: 208 S-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG-DAAETPPRPRTPGRPLN 265
Query: 251 PNPMTRITIPEILEDEWFKKDYKPPVFEEKK 281
M I E + + PP
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGV 296
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-41
Identities = 59/224 (26%), Positives = 97/224 (43%), Gaps = 19/224 (8%)
Query: 11 GKYEVGRTIGEG--TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
G YE+ IG+G V AR TGE V ++ ++ E +M ++ E+ KL
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLF 83
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDY 126
HPN+V + ++++V F+ G D I H M E Q ++ A+DY
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC--------GTPN 178
H G HR +K ++L+ G + +S + + G
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNL---SMISHGQRQRVVHDFPKYSVKVLP 200
Query: 179 YVAPEVL--NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220
+++PEVL N +GYD +D++S G+ L G++PF D
Sbjct: 201 WLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPAT 243
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-41
Identities = 85/314 (27%), Positives = 130/314 (41%), Gaps = 73/314 (23%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + IG G+F V A+ ++GE VA+K KVL+ K + RE+ M+ + H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK-----KVLQDKRFKN--RELQIMRKLDHC 107
Query: 72 NVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLI 121
N+VRL S + +VL++V ++ ++ R K + Y QL
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPN- 178
++ Y HS G+ HRD+KP+NLLLD LK+ DFG + L + G PN
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------------GEPNV 214
Query: 179 -YV------APEV-LNDRGYDGSTA-DLWSCGVILFVLLAGYLPF--------------- 214
Y+ APE+ Y +++ D+WS G +L LL G F
Sbjct: 215 SYICSRYYRAPELIFGATDY--TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272
Query: 215 ------DDSNLMN-LYKKISAAEFTCPPWLSF-------TARKLIARILDPNPMTRITIP 260
+ MN Y + + PW A L +R+L+ P R+T
Sbjct: 273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 332
Query: 261 EILEDEWFKKDYKP 274
E +F + P
Sbjct: 333 EACAHSFFDELRDP 346
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-40
Identities = 75/279 (26%), Positives = 127/279 (45%), Gaps = 29/279 (10%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
G +E+ +G GT+ +V R+ +TG+ A+K++D + E+IK+E+ +K
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 70 HPNVVRLYE------VMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLI 121
H N+ Y G ++++V+EF G + D K +KE+ ++++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+ + H V HRD+K +N+LL +K+ DFG+SA Q R G +T GTP ++A
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 197
Query: 182 PEVL-----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 236
PEV+ D YD +DLWS G+ + G P D + M I P
Sbjct: 198 PEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---APR 253
Query: 237 L-----SFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
L S + I L N R ++++ + +
Sbjct: 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-40
Identities = 73/294 (24%), Positives = 128/294 (43%), Gaps = 26/294 (8%)
Query: 1 MSQPKIKRRVGK------YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM 54
+ P + K + R IG G+F V FAR+ E VA+K + ++
Sbjct: 38 LKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 97
Query: 55 AEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 114
+ I +EV ++ ++HPN ++ + ++V+E+ G V+ ++E E
Sbjct: 98 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA 157
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTT 173
+ + Y HS + HRD+K N+LL G +K+ DFG ++ ++ ++
Sbjct: 158 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSF 210
Query: 174 CGTPNYVAPEV---LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230
GTP ++APEV +++ YDG D+WS G+ L P + N M+ I+ E
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 269
Query: 231 FTCPPWL-----SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
P L S R + L P R T +L+ + ++ P V +
Sbjct: 270 ---SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 320
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-40
Identities = 95/359 (26%), Positives = 148/359 (41%), Gaps = 72/359 (20%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + IG G+F V A+ E+ E VA+K KVL+ K RE+ M++VKHP
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIK-----KVLQDK--RFKNRELQIMRIVKHP 92
Query: 72 NVVRLYEVMGS------KTKIFIVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQL 120
NVV L S + + +VLE+V E + H M + Y QL
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYV--PETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
+ ++ Y HS G+ HRD+KP+NLLLD G LK+ DFG + + + + C + Y
Sbjct: 151 LRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA--KILIAGEPNVSYIC-SRYY 207
Query: 180 VAPEV-LNDRGYDGSTA-DLWSCGVILFVLLAGYLPFD-DSNLMNLYKKI---------- 226
APE+ Y +T D+WS G ++ L+ G F +S + L + I
Sbjct: 208 RAPELIFGATNY--TTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265
Query: 227 ------SAAEFTCPPW------------LSFTARKLIARILDPNPMTRITIPEILEDEWF 268
+ E P A LI+R+L+ P R+T E L +F
Sbjct: 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325
Query: 269 KKDYK------------PPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQPVAMNAFE 315
+ + PP+F K+ L + H + + + ++ F+
Sbjct: 326 -DELRTGEARMPNGRELPPLFNWTKE-ELSVRPDLISRLVPQHAEAELLSRGIDVHNFQ 382
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-40
Identities = 66/257 (25%), Positives = 105/257 (40%), Gaps = 35/257 (13%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSE-TGEPVALKIL----DKEKVLKHKMAEQIKREVATM 65
G+YEV I G + A + G PV LK L D E E +
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAE------AQAMAMAERQFL 133
Query: 66 KLVKHPNVVRLYEV-----MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
V HP++V+++ +IV+E+V G L ++ EA Y ++
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEI 191
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL-SALSQQVRDDGLLHTTCGTPNY 179
+ A+ Y HS G+ + DLKPEN++L LK+ D G S ++ G L GTP +
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTE-EQLKLIDLGAVSRINS----FGYL---YGTPGF 243
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF 239
APE++ R D+++ G L L + + L + +
Sbjct: 244 QAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKT--YDSY-- 297
Query: 240 TARKLIARILDPNPMTR 256
+L+ R +DP+P R
Sbjct: 298 --GRLLRRAIDPDPRQR 312
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 64/285 (22%), Positives = 121/285 (42%), Gaps = 32/285 (11%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT-MKLVKHP 71
+ IG G + V + +G+ +A+K + + K +Q+ ++ M+ P
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST--VDEKEQKQLLMDLDVVMRSSDCP 81
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV------NHGRMKEDEARRYFQQLINAVD 125
+V+ Y + + +I +E ++ FDK + E+ + + A++
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 126 YCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
+ + HRD+KP N+LLD GN+K+ DFG+S Q+ D G Y+APE
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPER 196
Query: 185 L----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCPPWL-- 237
+ + +GYD +D+WS G+ L+ L G P+ N + + ++ + PP L
Sbjct: 197 IDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD---PPQLSN 252
Query: 238 ------SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
S + + L + R E+L+ + + V
Sbjct: 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-39
Identities = 66/281 (23%), Positives = 120/281 (42%), Gaps = 28/281 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHP 71
E +G G + V+ R+ +G+ +A+K + + + +++ ++ +M+ V P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRLLMDLDISMRTVDCP 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV-----NHGRMKEDEARRYFQQLINAVDY 126
V Y + + ++I +E + DK + ED + ++ A+++
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 127 CHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV- 184
HS V HRD+KP N+L++A G +K+ DFG+S + DD G Y+APE
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERI 181
Query: 185 ---LNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPWL--- 237
LN +GY +D+WS G+ + L P+D K++ P L
Sbjct: 182 NPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP---SPQLPAD 237
Query: 238 --SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
S ++ L N R T PE+++ +F
Sbjct: 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-38
Identities = 70/302 (23%), Positives = 133/302 (44%), Gaps = 58/302 (19%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKH 70
Y++ R +G G +++V A N E V +KIL K ++IKRE+ ++ L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGG 90
Query: 71 PNVVRLYEVM---GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
PN++ L +++ S+T + E V + ++ + + + R Y +++ A+DYC
Sbjct: 91 PNIITLADIVKDPVSRTPALVF-EHVNNTDF-KQLYQ--TLTDYDIRFYMYEILKALDYC 146
Query: 128 HSRGVYHRDLKPENLLLD-AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL- 185
HS G+ HRD+KP N+++D + L++ D+GL+ ++ + + + PE+L
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLV 203
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPF--------------------DDSNLMNLYKK 225
+ + YD S D+WS G +L ++ PF D + ++ Y
Sbjct: 204 DYQMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262
Query: 226 ISAAEF-------TCPPWLSF-----------TARKLIARILDPNPMTRITIPEILEDEW 267
F + W F A + ++L + +R+T E +E +
Sbjct: 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
Query: 268 FK 269
F
Sbjct: 323 FY 324
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-38
Identities = 70/346 (20%), Positives = 124/346 (35%), Gaps = 78/346 (22%)
Query: 3 QPKIKRRVGKYEV-GRTIGEGTFAKVKFARN--SETGEPVALKILDKEKVLKHKMAEQIK 59
+ +R +E G +G GT+ V A+ + + ALK ++ +
Sbjct: 12 SSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----- 66
Query: 60 REVATMKLVKHPNVVRLYEVMGSKT--KIFIVLEFV--------TGGELFDKIVNHGRMK 109
RE+A ++ +KHPNV+ L +V S K++++ ++ ++
Sbjct: 67 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 126
Query: 110 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN----LKVSDFGLSALSQQVR 165
+ Q+++ + Y H+ V HRDLKP N+L+ G +K++D G A
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF-ARLFNSP 185
Query: 166 DDGLLHTTCG--TPNYVAPEVL-NDRGYDGSTA-DLWSCGVIL----------------- 204
L T Y APE+L R Y + A D+W+ G I
Sbjct: 186 LKPLADLDPVVVTFWYRAPELLLGARHY--TKAIDIWAIGCIFAELLTSEPIFHCRQEDI 243
Query: 205 ----------------------------FVLLAGYLPFDDSNLMNLYKKISAAEF--TCP 234
+ + N Y S ++
Sbjct: 244 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHK 303
Query: 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP--PVFE 278
A L+ ++L +P+ RIT + ++D +F +D P VF
Sbjct: 304 VKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFA 349
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-37
Identities = 79/358 (22%), Positives = 148/358 (41%), Gaps = 65/358 (18%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+ + ++ + +++V R G+GTF V+ + TG VA+K KV++ R
Sbjct: 13 AADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK-----KVIQDPRFR--NR 65
Query: 61 EVATMKL---VKHPNVVRLYEVMGSKTK-------IFIVLEFVTGGELFDKIVNHGRMK- 109
E+ M+ + HPN+V+L + + + +V+E+V L N+ R +
Sbjct: 66 ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQV 124
Query: 110 ---EDEARRYFQQLINAVDYCH--SRGVYHRDLKPENLLLD-AYGNLKVSDFGLSALSQQ 163
+ + QLI ++ H S V HRD+KP N+L++ A G LK+ DFG + +
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA--KKL 182
Query: 164 VRDDGLLHTTCGTPNYVAPEV-LNDRGYDGSTA-DLWSCGVILFVLLAGYLPF------- 214
+ + C + Y APE+ ++ Y +TA D+WS G I ++ G F
Sbjct: 183 SPSEPNVAYIC-SRYYRAPELIFGNQHY--TTAVDIWSVGCIFAEMMLGEPIFRGDNSAG 239
Query: 215 --------------DDSNLMN-LYKKISAAEFTCPPW----------LSFTARKLIARIL 249
+ +N + + PW + A L++ +L
Sbjct: 240 QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALL 299
Query: 250 DPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQ 307
P R+ E L +F + P + + +L + F +E ++E ++ +
Sbjct: 300 QYLPEERMKPYEALCHPYF-DELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAK 356
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 54/296 (18%), Positives = 107/296 (36%), Gaps = 56/296 (18%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G+G + +V GE VA+KI + + + E+ +++H N+
Sbjct: 11 TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSR----DEKSWFRETELYNTVMLRHENI 64
Query: 74 VRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+ S T+++++ + G L+D + + R + + + + H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHI 123
Query: 130 R--------GVYHRDLKPENLLLDAYGNLKVSDFGLSAL--SQQVRDDGLLHTTCGTPNY 179
+ HRDLK +N+L+ G ++D GL+ + + D + GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 180 VAPEVLNDRGYDGST-----ADLWSCGVILFVLLAGY----------LPFDDSNLMN--- 221
+APEVL++ D+W+ G++L+ + PF D +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 222 -------LYKKI------SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
+ L+ KL+ NP R+T I +
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLA----KLMKECWYQNPSARLTALRIKK 295
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 42/253 (16%), Positives = 80/253 (31%), Gaps = 39/253 (15%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
G+Y + G + A ++ VAL +D + VL + ++ + +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
P V R+ +V+ ++ +V E++ GG L + V A R Q L A D H
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
GV P + + G++ ++ +
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA------- 179
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP-------PWLSFTARK 243
D+ G L+ LL P ++ + + P + F
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238
Query: 244 LIARILDPNPMTR 256
+ AR + + R
Sbjct: 239 VAARSVQGDGGIR 251
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-35
Identities = 84/351 (23%), Positives = 150/351 (42%), Gaps = 71/351 (20%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
+Y+ +G G + V A +++TG VA+K L + + + A++ RE+ +K +KH
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 71 PNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
NV+ L +V +++V + G +L + IV ++ +D + Q++ +
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---- 180
Y HS + HRDLKP NL ++ LK+ DFGL+ + D + YV
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTADEM-------TGYVATRW 194
Query: 181 --APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----------- 226
APE+ LN Y+ T D+WS G I+ LL G F ++ ++ K I
Sbjct: 195 YRAPEIMLNWMHYN-QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253
Query: 227 -------SAAEF--TCPPW--LSFT---------ARKLIARILDPNPMTRITIPEILEDE 266
SA + + ++F A L+ ++L + RIT + L
Sbjct: 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313
Query: 267 WFKKDYKP---PVFE------EKKDTNLDDV-EAVFKDSEEHHVTEQKEEQ 307
+F + + P PV + E +D +D+ + + +E+
Sbjct: 314 YFAQYHDPDDEPVADPYDQSLESRDLLIDEWKSLTYDEVISFVPPPLDQEE 364
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-35
Identities = 59/296 (19%), Positives = 121/296 (40%), Gaps = 56/296 (18%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++ + IG+G + +V + GE VA+K+ + + + E+ L++H N+
Sbjct: 40 QMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENI 93
Query: 74 VRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+ + GS T+++++ ++ G L+D + + + + ++ + + H+
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHT 152
Query: 130 R--------GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGTPNY 179
+ HRDLK +N+L+ G ++D GL+ + D +T GT Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 180 VAPEVLNDRGYDGST-----ADLWSCGVIL---------FVLLAGY-LPFDDSNLMN--- 221
+ PEVL++ AD++S G+IL ++ Y LP+ D +
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 222 -------LYKKI------SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
KK+ + C + KL+ NP +R+T + +
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMG----KLMTECWAHNPASRLTALRVKK 324
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 85/352 (24%), Positives = 144/352 (40%), Gaps = 71/352 (20%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
Y + +G G + V A + TG VA+K L + + ++ A++ RE+ +K ++H
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLKHMRH 83
Query: 71 PNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
NV+ L +V ++V+ F+ G +L K++ H ++ ED + Q++ +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---- 180
Y H+ G+ HRDLKP NL ++ LK+ DFGL+ R T YV
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQADSEMT-----GYVVTRW 190
Query: 181 --APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----------- 226
APEV LN Y T D+WS G I+ ++ G F S+ ++ K+I
Sbjct: 191 YRAPEVILNWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249
Query: 227 -------SAAEF--TCP-----------PWLSFTARKLIARILDPNPMTRITIPEILEDE 266
A + P S A L+ ++L + R+T E L
Sbjct: 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309
Query: 267 WFKKDYKP---PVFE------EKKDTNLDDV-EAVFKDSEEHHVTEQKEEQP 308
+F+ + P + + D LD+ +K+ Q +
Sbjct: 310 YFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARV 361
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 81/343 (23%), Positives = 145/343 (42%), Gaps = 66/343 (19%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
+Y IGEG + V A ++ VA+K K +H+ ++ RE+ + +H
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRH 84
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
N++ + +++ + T ++IV + + +L K++ + D + Q++ +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV----- 180
Y HS V HRDLKP NLLL+ +LK+ DFGL+ ++ D T YV
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWY 197
Query: 181 -APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI-------SAAEF 231
APE+ LN +GY + D+WS G IL +L+ F + ++ I S +
Sbjct: 198 RAPEIMLNSKGYT-KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256
Query: 232 TC---------------PPWLSFT---------ARKLIARILDPNPMTRITIPEILEDEW 267
C + + A L+ ++L NP RI + + L +
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316
Query: 268 FKKDYKP---PVFE-------EKKDTNLDDV-EAVFKDSEEHH 299
++ Y P P+ E E D + + E +F+++
Sbjct: 317 LEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQ 359
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 76/340 (22%), Positives = 126/340 (37%), Gaps = 86/340 (25%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY +G+T+G G+F V + E+G+ ALK KVL+ RE+ MK++ H
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALK-----KVLQD--PRYKNRELDIMKVLDHV 60
Query: 72 NVVRLYEVMGSKTK--------------------------------------IFIVLEFV 93
N+++L + + + +++E+V
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 94 TGGELFDKIVNHGRMK----EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-G 148
L + + R + Y QL AV + HS G+ HRD+KP+NLL+++
Sbjct: 121 -PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV-LNDRGYDGSTADLWSCGVILFVL 207
LK+ DFG + + + + + C + Y APE+ L Y + DLWS G + L
Sbjct: 180 TLKLCDFGSA--KKLIPSEPSVAYIC-SRFYRAPELMLGATEYT-PSIDLWSIGCVFGEL 235
Query: 208 LAGYLPF---------------------DDSNLMN-LYKKISAAEFTCPPWLSF------ 239
+ G F + MN Y ++ W
Sbjct: 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP 295
Query: 240 -TARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFE 278
A L+ +IL P RI E + +F +
Sbjct: 296 SLAIDLLEQILRYEPDLRINPYEAMAHPFF-DHLRNSYES 334
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 59/294 (20%), Positives = 114/294 (38%), Gaps = 52/294 (17%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +IG+G F +V + GE VA+KI + + + E+ +++H N+
Sbjct: 45 VLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENI 98
Query: 74 VRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+ + G+ T++++V ++ G LFD +N + + + + + + H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 130 R--------GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGTPNY 179
+ HRDLK +N+L+ G ++D GL+ D D + GT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 180 VAPEVLNDRGYDGST-----ADLWSCGVILFVLLAGY----------LPFDDSNLMN--- 221
+APEVL+D AD+++ G++ + + LP+ D +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 222 -------LYKK----ISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
+K I +C K++ N R+T I +
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVM--AKIMRECWYANGAARLTALRIKK 329
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 59/304 (19%), Positives = 112/304 (36%), Gaps = 46/304 (15%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+ + + ++ G F V + E VA+KI + K + Q +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVW--KAQLLNEYVAVKIFPIQ----DKQSWQNEY 67
Query: 61 EVATMKLVKHPNVVRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHG-------RMK 109
EV ++ +KH N+++ ++++ F G L D + + +
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIA 127
Query: 110 EDEAR--RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167
E AR Y + I + H + HRD+K +N+LL ++DFGL+ + +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 168 GLLHTTCGTPNYVAPEVLNDRGYDGST----ADLWSCGVILFVLLAGYLPFD---DSNLM 220
G H GT Y+APEVL D+++ G++L+ L + D D ++
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 221 NLYKKISAA-------EFTC-----PP----WLSFTARKLIARIL----DPNPMTRITIP 260
++I E P W ++ + D + R++
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 261 EILE 264
+ E
Sbjct: 308 CVGE 311
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 69/314 (21%), Positives = 119/314 (37%), Gaps = 54/314 (17%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
+Y + +G G V A +++ + VA+K + VL + RE+ ++ + H
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI----VLTDPQSVKHALREIKIIRRLDH 67
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGG--------ELFD----KIVNHGRMKEDEARRYFQ 118
N+V+++E++G E + ++ G + E+ AR +
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY 127
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLS-ALSQQVRDDGLLHTTCGT 176
QL+ + Y HS V HRDLKP NL ++ LK+ DFGL+ + G L T
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 177 PNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--------- 226
Y +P + L+ Y D+W+ G I +L G F ++ + + I
Sbjct: 188 KWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246
Query: 227 --------SAAEF--TCPPW--LSFT---------ARKLIARILDPNPMTRITIPEILED 265
+ T A + +IL +PM R+T E L
Sbjct: 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306
Query: 266 EWFKKDYKP---PV 276
+ P P+
Sbjct: 307 PYMSIYSFPMDEPI 320
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-33
Identities = 82/346 (23%), Positives = 139/346 (40%), Gaps = 68/346 (19%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
+++ +GEG + V A + TGE VA+K K + + A + RE+ +K KH
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFALRTLREIKILKHFKH 68
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
N++ ++ + + ++I+ E + +L ++++ + +D + + Q + AV
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL--SALSQQVRDDGLLHTTCGTPNYV--- 180
H V HRDLKP NLL+++ +LKV DFGL + G +V
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 181 ---APEV-LNDRGYDGSTADLWSCGVILFVLLAG--------YL------------PFDD 216
APEV L Y D+WSCG IL L Y P D
Sbjct: 187 WYRAPEVMLTSAKYS-RAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245
Query: 217 SNL--------------MNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPE 261
++L + +Y + F P ++ L+ R+L +P RIT E
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMF---PRVNPKGIDLLQRMLVFDPAKRITAKE 302
Query: 262 ILEDEWFKKDYKP---PVFEEKKDTNLDDVEAVFKDSEEHHVTEQK 304
LE + + + P P E + + D + +T +
Sbjct: 303 ALEHPYLQTYHDPNDEPEGEPIPPSFFEF------DHYKEALTTKD 342
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-33
Identities = 78/326 (23%), Positives = 139/326 (42%), Gaps = 65/326 (19%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
Y +G G + V A + +GE VA+K L + + ++ A++ RE+ +K ++H
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 71 PNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
NV+ L +V + ++V+ F+ +L + + E++ + Q++ +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKGL 139
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---- 180
Y HS GV HRDLKP NL ++ LK+ DFGL+ R T YV
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA------RHADAEMT-----GYVVTRW 188
Query: 181 --APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----------- 226
APEV L+ Y+ T D+WS G I+ +L G F + ++ +I
Sbjct: 189 YRAPEVILSWMHYN-QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247
Query: 227 -------SAAEF--TCPPW--LSFT---------ARKLIARILDPNPMTRITIPEILEDE 266
+A + + P FT A L+ ++L+ + R+T + L
Sbjct: 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307
Query: 267 WFKKDYKP---PVFEEKKDTNLDDVE 289
+F+ P ++ D +L+ +
Sbjct: 308 FFEPFRDPEEETEAQQPFDDSLEHEK 333
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-33
Identities = 73/356 (20%), Positives = 146/356 (41%), Gaps = 74/356 (20%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
+Y+ + IG G V A ++ VA+K L + +++ A++ RE+ MK V H
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 71 PNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMK-EDEARRYFQ-QLIN 122
N++ L V + ++IV+E + L I +M+ + E Y Q++
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI----QMELDHERMSYLLYQMLC 138
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ + HS G+ HRDLKP N+++ + LK+ DFG L++ ++ T Y AP
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAP 195
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI---------------- 226
EV+ GY D+WS G I+ ++ G + F ++ ++ + K+
Sbjct: 196 EVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 227 --------------------------SAAEFTCPPWLSFTARKLIARILDPNPMTRITIP 260
A+ + AR L++++L + RI++
Sbjct: 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314
Query: 261 EILEDEWFKK--------DYKPPVFE---EKKDTNLDDV-EAVFKDSEEHHVTEQK 304
E L+ + P + + ++++ +++ E ++K+ +
Sbjct: 315 EALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLEHHHHH 370
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 76/383 (19%), Positives = 145/383 (37%), Gaps = 85/383 (22%)
Query: 1 MSQPKIKRRVGKYEVGRT-------------IGEGTFAKVKFARNSETGEPVALKILDKE 47
MS+ K+ + EVG + IG G V A ++ VA+K L
Sbjct: 39 MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--S 96
Query: 48 KVLKHKM-AEQIKREVATMKLVKHPNVVRLYEVMGSKTK------IFIVLEFVTGGELFD 100
+ +++ A++ RE+ MK V H N++ L V + +++V+E + L
Sbjct: 97 RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-C 154
Query: 101 KIVNHGRMKEDEARRYFQ-QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159
+++ + E Y Q++ + + HS G+ HRDLKP N+++ + LK+ DFG
Sbjct: 155 QVIQMEL--DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG--- 209
Query: 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL 219
L++ ++ T Y APEV+ GY D+WS G I+ ++ + F +
Sbjct: 210 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDY 268
Query: 220 MNLYKKI------------------------------------------SAAEFTCPPWL 237
++ + K+ A+
Sbjct: 269 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK 328
Query: 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKK----DYKPPVFEEKKDTNLDDV----- 288
+ AR L++++L +P RI++ + L+ + + D LD+
Sbjct: 329 ASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIE 388
Query: 289 ---EAVFKDSEEHHVTEQKEEQP 308
E ++K+ +
Sbjct: 389 EWKELIYKEVMNSEEKTKNGVVK 411
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 42/228 (18%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK-ILDKEKVLKHKM-AEQIKREVATMKLVK 69
+YE+ IG G++ V A + VA+K IL V + + ++I RE+A + +
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR---VFEDLIDCKRILREIAILNRLN 110
Query: 70 HPNVVRLYEVMGSKT-----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ-QLINA 123
H +VV++ +++ K ++++VLE + K+ + + L+
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDF-KKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPN---- 178
V Y HS G+ HRDLKP N L++ ++KV DFGL+ + + L + +
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 179 --------------YV------APEV-LNDRGYDGSTA-DLWSCGVIL 204
+V APE+ L Y + A D+WS G I
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENY--TEAIDVWSIGCIF 274
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-31
Identities = 79/372 (21%), Positives = 139/372 (37%), Gaps = 90/372 (24%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMK-LVK 69
KYE+ + +G+G + V + + TGE VA+K + ++ A++ RE+ + L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI--FDAFQNSTDAQRTFREIMILTELSG 67
Query: 70 HPNVVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ-QLINAVDY 126
H N+V L V+ + +++V +++ +L ++ + E ++Y QLI + Y
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANIL-EPVHKQYVVYQLIKVIKY 124
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN-------- 178
HS G+ HRD+KP N+LL+A ++KV+DFGLS +R N
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 179 -----YV------APEV-LNDRGYDGSTADLWSCGVILFVLLAG---------------- 210
YV APE+ L Y D+WS G IL +L G
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYT-KGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 211 ----------------------YL---------PFDDSNLMNLYKKISAAEFTCPPWLSF 239
+ + + K + +
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYKP---PV--------FEEKKDTNLDDV 288
A L+ ++L NP RI+ + L+ + + P P + ++DD
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDY 363
Query: 289 -EAVFKDSEEHH 299
V+ +
Sbjct: 364 RNLVYSEISRRK 375
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 33/227 (14%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
Y + IG G++ V A + T + VA+K + ++ + + ++I RE+ + +K
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKS 84
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ-QLINAV 124
++RLY+++ ++IVLE +L K+ +E + L+
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDL-KKLFKTPIFLTEEHIKTILYNLLLGE 142
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP------- 177
++ H G+ HRDLKP N LL+ ++KV DFGL+ +D +++
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 178 -------NYV------APEV-LNDRGYDGSTADLWSCGVILFVLLAG 210
++V APE+ L Y + D+WS G I LL
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYT-KSIDIWSTGCIFAELLNM 248
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 71/347 (20%), Positives = 134/347 (38%), Gaps = 67/347 (19%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM--------AEQIKREVA 63
Y V R I G++ V +S G PVA+K + + +++ RE+
Sbjct: 23 PYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 64 TMKLVKHPNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMK-EDEARRYF 117
+ HPN++ L ++ + +++V E + +L ++++ R+ + +YF
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDL-AQVIHDQRIVISPQHIQYF 139
Query: 118 Q-QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
++ + H GV HRDL P N+LL ++ + DF L+++ D
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN---LAREDTADANKTHYVTH 196
Query: 177 PNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI-------SA 228
Y APE+ + +G+ D+WS G ++ + F S N KI
Sbjct: 197 RWYRAPELVMQFKGFT-KLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 229 AEFTC----------------PPWLSFT---------ARKLIARILDPNPMTRITIPEIL 263
+ P ++T A LIA++L+ NP RI+ + L
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315
Query: 264 EDEWFKKDYKP---PV-------FEEKKDTNLDDV-EAVFKDSEEHH 299
+F+ + P F+E + D+ + + E +
Sbjct: 316 RHPYFESLFDPLDLTEGLSERFHFDESVTD-VYDMHKIFTAEVERFN 361
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 47/217 (21%), Positives = 84/217 (38%), Gaps = 33/217 (15%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++ IG G + V + S PVA+K+ ++ ++ + + L++H N+
Sbjct: 16 KLLELIGRGRYGAVY--KGSLDERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNI 69
Query: 74 VRLY-----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
R + + +V+E+ G L + H + R + + Y H
Sbjct: 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLH 128
Query: 129 S---------RGVYHRDLKPENLLLDAYGNLKVSDFGLS------ALSQQVRDDGLLHTT 173
+ + HRDL N+L+ G +SDFGLS L + +D +
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 174 CGTPNYVAPEVLNDR------GYDGSTADLWSCGVIL 204
GT Y+APEVL D+++ G+I
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 35/229 (15%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK- 69
+Y + R +G G F+ V A++ VA+KI+ +K E + E+ ++ V
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVND 74
Query: 70 ----------HPNVVRLY---EVMGSKTK-IFIVLEFVTGGELFD--KIVNHGRMKEDEA 113
++++L G + +V E V G L K H +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYV 133
Query: 114 RRYFQQLINAVDYCHSR-GVYHRDLKPENLLLD------AYGNLKVSDFGLSALSQQVRD 166
++ +QL+ +DY H R G+ H D+KPEN+L++ +K++D G +
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-----Y 188
Query: 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 215
D + T Y +PEVL + AD+WS ++F L+ G F+
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFE 236
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 69/273 (25%), Positives = 115/273 (42%), Gaps = 25/273 (9%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+G IG G F +V R VA+K +E + A+ +E +K HPN+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAK-FLQEARILKQYSHPNI 174
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGV 132
VRL V K I+IV+E V GG+ + G ++ + ++Y S+
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY----VAPEVLNDR 188
HRDL N L+ LK+SDFG+S + DG+ + G APE LN
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMS----REEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 189 GYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA-----AEFTCPPWLSFTA 241
Y S+ D+WS G++L+ G P+ + + + + CP +
Sbjct: 291 RY--SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV---- 344
Query: 242 RKLIARILDPNPMTRITIPEILED-EWFKKDYK 273
+L+ + P R + I ++ + +K ++
Sbjct: 345 FRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 21/226 (9%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVK 69
+YEV + IG+G+F +V A + + + VALK++ EK + Q E+ + L K
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRK 152
Query: 70 HP-----NVVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLIN 122
NV+ + E + I + E + L++ K R++ ++
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYG--NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+D H + H DLKPEN+LL G +KV DFG S Q ++T + Y
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYR 266
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
APEV+ Y D+WS G IL LL GY + + +
Sbjct: 267 APEVILGARYGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACM 311
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-26
Identities = 54/235 (22%), Positives = 95/235 (40%), Gaps = 18/235 (7%)
Query: 15 VGRTIGEGTFAKVKFA--RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G G F VK + + + VA+KIL K + + +++ E M+ + +P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+VR+ + +V+E G L + + +K+ Q+ + Y
Sbjct: 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P-NYVAPEVLNDRG 189
HRDL N+LL K+SDFGLS + D+ P + APE +N
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 190 YDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
+ S+ D+WS GV+++ G P+ + + E CP +
Sbjct: 197 F--SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM 249
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 58/197 (29%), Positives = 87/197 (44%), Gaps = 13/197 (6%)
Query: 16 GRTIGEGTFAKVKFAR-NSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+G+G+F V+ ++ +G+ VA+K L + + + + + REV M + H N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
++RLY V+ + +V E G L D++ H G RY Q+ + Y S+
Sbjct: 83 LIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---APEVLNDR 188
HRDL NLLL +K+ DFGL Q +D APE L R
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ--NDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 189 GYDGSTA-DLWSCGVIL 204
+ S A D W GV L
Sbjct: 200 TF--SHASDTWMFGVTL 214
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 13/219 (5%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G G + +V + VA+K L KE E+ +E A MK +KHPN+
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KED---TMEVEEFLKEAAVMKEIKHPNL 278
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSRG 131
V+L V + +I+ EF+T G L D + R + Q+ +A++Y +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY--VAPEVLNDRG 189
HR+L N L+ +KV+DFG LS+ + D APE L
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFG---LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ +D+W+ GV+L+ + G P+ +L +Y+ +
Sbjct: 396 FS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 23/237 (9%)
Query: 16 GRTIGEGTFAKV---KFARNSETGE-PVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G G F V + E + PVA+K L +E E I E M V +P
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE-ILDEAYVMASVDNP 77
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
+V RL + + + ++ + + G L D + H + + Q+ ++Y R
Sbjct: 78 HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P-NYVAPEVLND 187
+ HRDL N+L+ ++K++DFGL+ L + + + G P ++A E +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKL---LGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 188 RGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
R Y + D+WS GV ++ ++ G P+D + + E C +
Sbjct: 194 RIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 23/228 (10%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+YE+ IG+G+F +V A + E VA+KI+ +K Q + EV ++L+
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNK 109
Query: 71 P------NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLIN 122
+V L + + +V E + L+D + N + + R++ QQ+
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 123 AVDYCHSR--GVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
A+ + + + H DLKPEN+LL +K+ DFG S Q ++ +
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRF 223
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
Y +PEVL YD + D+WS G IL + G F +N ++ KI
Sbjct: 224 YRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-23
Identities = 64/291 (21%), Positives = 122/291 (41%), Gaps = 53/291 (18%)
Query: 11 GKYEV-------GRTIGEGTFAKVKFAR-NSETGEPVALKIL-----DKEKVLKHKMAEQ 57
G E+ + +G G F VK + + VA+K++ +++ +
Sbjct: 1 GHMELKREEITLLKELGSGQFGVVKLGKWKGQY--DVAVKMIKEGSMSEDEFFQ------ 52
Query: 58 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRY 116
E TM + HP +V+ Y V + I+IV E+++ G L + + +HG+ ++ +
Sbjct: 53 ---EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM 109
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG- 175
+ + + S HRDL N L+D +KVSDFG +++ V DD + +
Sbjct: 110 CYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFG---MTRYVLDDQYVSSVGTK 166
Query: 176 -----TPNYVAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA 228
+ APEV + Y S+ D+W+ G++++ V G +P+D + K+S
Sbjct: 167 FPVKWS----APEVFHYFKY--SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220
Query: 229 AE-----FTCPPWLSFTARKLIARILDPNPMTRITIPEILE--DEWFKKDY 272
+ +++ P R T ++L + +KD
Sbjct: 221 GHRLYRPHLASDTI----YQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-23
Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 23/221 (10%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++ +TIG+G F V G VA+K + K A+ E + M ++H N+
Sbjct: 24 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-KNDA----TAQAFLAEASVMTQLRHSNL 76
Query: 74 VRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSR 130
V+L V + K ++IV E++ G L D + + GR ++ + A++Y
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---APEVLND 187
HRDL N+L+ KVSDFGL+ + +D G L P V APE L +
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------P--VKWTAPEALRE 188
Query: 188 RGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ + + +D+WS G++L+ + G +P+ L ++ ++
Sbjct: 189 KKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-23
Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 33/228 (14%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKIL-----DKEKVLKHKMAEQIKREVATMKLV 68
+ +G G + +V + VA+K L + E+ LK E A MK +
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---------EAAVMKEI 66
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDY 126
KHPN+V+L V + +I+ EF+T G L D + N + Q+ +A++Y
Sbjct: 67 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG------TPNYV 180
+ HRDL N L+ +KV+DFG LS+ + D T
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFG---LSRLMTGDTYTAHAGAKFPIKWT---- 179
Query: 181 APEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
APE L + S D+W+ GV+L+ + G P+ +L +Y+ +
Sbjct: 180 APESLAYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 64/337 (18%), Positives = 121/337 (35%), Gaps = 89/337 (26%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+ V R +G+GTF +V ++ + + A+K++ K K K E +K +++
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQN 90
Query: 71 -----PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINA 123
N+V+ + + ++ E G L++ I + ++ + Y +++ A
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYG-------------------------NLKVSDFGLS 158
++Y + H DLKPEN+LLD +K+ DFG
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-C 208
Query: 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY------- 211
A + T Y APEV+ + G+D S +D+WS G +L L G
Sbjct: 209 A----TFKSDYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHE 263
Query: 212 --------------LP--------------FDDSNLMNLY-------KKISAAEFTCPPW 236
+P + + + + L C P
Sbjct: 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL 323
Query: 237 LSFTARK----LIARILDPNPMTRITIPEILEDEWFK 269
+ + IL +P R + E+L+ ++ +
Sbjct: 324 YKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-23
Identities = 75/342 (21%), Positives = 119/342 (34%), Gaps = 95/342 (27%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETG-EPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+YE+ T+GEG F KV + + G VA+KI+ + E + E+ ++ +
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLN 69
Query: 70 HP------NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLI 121
V++ E I IV E + G +D I +G + D R+ Q+
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGN-------------------LKVSDFGLSALSQ 162
+V++ HS + H DLKPEN+L +KV DFG +
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 163 QVRDDGLLHTTCGTPNYV------APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216
+ H+T V APEV+ G+ D+WS G IL G+ F
Sbjct: 189 EH------HST-----LVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPT 236
Query: 217 SNLMNLYKKISAAEFTCPPWLSFTARK--------------------------------- 243
+ + P + RK
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296
Query: 244 -----------LIARILDPNPMTRITIPEILEDEWFKKDYKP 274
LI ++L+ +P RIT+ E L+ +F K
Sbjct: 297 SQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-23
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G+G F V+ R TGE VA+K L + +H +RE+ +K ++H
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHL--RDFEREIEILKSLQHD 71
Query: 72 NVVRLYEV--MGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCH 128
N+V+ V + + +++E++ G L D + H R+ + +Y Q+ ++Y
Sbjct: 72 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG--------TPNYV 180
++ HRDL N+L++ +K+ DFG L++ + D
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFG---LTKVLPQDKEFFKVKEPGESPIFWY---- 184
Query: 181 APEVLNDRGYDGSTA-DLWSCGVIL 204
APE L + + S A D+WS GV+L
Sbjct: 185 APESLTESKF--SVASDVWSFGVVL 207
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 8e-23
Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 17/220 (7%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G+G F +V N T VA+K L K + E +E MK ++H
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTT--RVAIKTL-KPGTMSP---EAFLQEAQVMKKLRHEK 240
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSR 130
+V+LY V+ S+ I+IV E+++ G L D + + Q+ + + Y
Sbjct: 241 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P-NYVAPEVLNDR 188
HRDL+ N+L+ KV+DFG L++ + D+ P + APE
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFG---LARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 189 GYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ +D+WS G++L + G +P+ + ++
Sbjct: 357 RFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 9e-23
Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 17/220 (7%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G+G F +V N T VA+K L + + E MK ++H
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEK 323
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSR 130
+V+LY V+ S+ I+IV E+++ G L D + + Q+ + + Y
Sbjct: 324 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P-NYVAPEVLNDR 188
HRDL+ N+L+ KV+DFG L++ + D+ P + APE
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFG---LARLIEDNEYTARQGAKFPIKWTAPEAALYG 439
Query: 189 GYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ +D+WS G++L + G +P+ + ++
Sbjct: 440 RFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 61/220 (27%), Positives = 105/220 (47%), Gaps = 21/220 (9%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++ +TIG+G F V G VA+K + K A+ E + M ++H N+
Sbjct: 196 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-KN----DATAQAFLAEASVMTQLRHSNL 248
Query: 74 VRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSR 130
V+L V + K ++IV E++ G L D + + GR ++ + A++Y
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRG 189
HRDL N+L+ KVSDFGL+ + +D G L P + APE L ++
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEALREKK 362
Query: 190 YDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ ST D+WS G++L+ + G +P+ L ++ ++
Sbjct: 363 F--STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 26/204 (12%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G+G F V+ R TGE VA+K L + +H +RE+ +K ++H
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHL--RDFEREIEILKSLQHD 102
Query: 72 NVVRLYEV-MGSKTK-IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCH 128
N+V+ V + + + +++E++ G L D + H R+ + +Y Q+ ++Y
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 162
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ------VRDDGLLHTTCGTP-NYVA 181
++ HRDL N+L++ +K+ DFGL+ + Q V++ G P + A
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES------PIFWYA 216
Query: 182 PEVLNDRGYDGSTA-DLWSCGVIL 204
PE L + + S A D+WS GV+L
Sbjct: 217 PESLTESKF--SVASDVWSFGVVL 238
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 15/224 (6%)
Query: 14 EVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+ + IG G +V + + PVA+K L K + + E + M H
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTE-RQRRDFLSEASIMGQFDH 109
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS 129
PN++RL V+ IV E++ G L + H G+ + + + + Y
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---APEVLN 186
G HRDL N+L+D+ KVSDFGLS + + D +TT G + APE +
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED--DPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 187 DRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA 228
R + S+A D+WS GV+++ VL G P+ + ++ +
Sbjct: 228 FRTF--SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 29/205 (14%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
R +GEG F KV N TGE VA+K L + +H+ K+E+ ++ + H
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR--SGWKQEIDILRTLYHE 93
Query: 72 NVVRLYEV-MGSKTK-IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
++++ + + +V+E+V G L D + H + + + QQ+ + Y H+
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHA 152
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQ-----QVRDDGLLHTTCGTPNYV--- 180
+ HRDL N+LLD +K+ DFGL+ A+ + +VR+DG P V
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------P--VFWY 204
Query: 181 APEVLNDRGYDGSTA-DLWSCGVIL 204
APE L + + A D+WS GV L
Sbjct: 205 APECLKEYKF--YYASDVWSFGVTL 227
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 25/204 (12%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
R +GEG F KV+ R TGE VA+K L E H +K+E+ ++ + H
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHE 83
Query: 72 NVVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCH 128
N+V+ + I +++EF+ G L + + + ++ + +Y Q+ +DY
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ------VRDDGLLHTTCGTP-NYVA 181
SR HRDL N+L+++ +K+ DFGL+ + V+DD P + A
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS------PVFWYA 197
Query: 182 PEVLNDRGYDGSTA-DLWSCGVIL 204
PE L + A D+WS GV L
Sbjct: 198 PECLMQSKF--YIASDVWSFGVTL 219
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-22
Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 46/240 (19%)
Query: 11 GKYEV-------GRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQ-IKRE 61
GK+ + + IG G F V ++ VA+K + +E M+E+ E
Sbjct: 1 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKD--KVAIKTI-RE----GAMSEEDFIEE 53
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQL 120
M + HP +V+LY V + I +V EF+ G L D + G + +
Sbjct: 54 AEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ Y V HRDL N L+ +KVSDFG +++ V DD Y
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG---MTRFVLDD----------QYT 160
Query: 181 ------------APEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
+PEV + Y S+ D+WS GV+++ V G +P+++ + + + I
Sbjct: 161 SSTGTKFPVKWASPEVFSFSRY--SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 23/237 (9%)
Query: 16 GRTIGEGTFAKV---KFARNSETGE-PVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G G F V + E + PVA+K L +E E I E M V +P
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE-ILDEAYVMASVDNP 77
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
+V RL + + + ++ + + G L D + H + + Q+ ++Y R
Sbjct: 78 HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P-NYVAPEVLND 187
+ HRDL N+L+ ++K++DFGL+ L + + + G P ++A E +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKL---LGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 188 RGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
R Y + D+WS GV ++ ++ G P+D + + E C +
Sbjct: 194 RIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 61/232 (26%), Positives = 92/232 (39%), Gaps = 20/232 (8%)
Query: 19 IGEGTFAKVKFAR-NSETGE-PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G F V+ + VA+K+L + E++ RE M + +P +VRL
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 75
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
V + +V+E GG L +V + Q+ + Y + HR
Sbjct: 76 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P-NYVAPEVLNDRGYDG 192
DL N+LL K+SDFGLS DD P + APE +N R +
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPECINFRKF-- 190
Query: 193 STA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
S+ D+WS GV ++ L G P+ + I + CPP L
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 242
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-22
Identities = 48/237 (20%), Positives = 101/237 (42%), Gaps = 23/237 (9%)
Query: 16 GRTIGEGTFAKV---KFARNSETGE-PVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G G F V + E+ + PV +K++ ++K + + + + + H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQA-VTDHMLAIGSLDHA 75
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
++VRL + + + +V +++ G L D + H G + + Q+ + Y
Sbjct: 76 HIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P-NYVAPEVLND 187
G+ HR+L N+LL + ++V+DFG++ L + D P ++A E ++
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADL---LPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 188 RGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
Y + D+WS GV ++ ++ G P+ L + + E C +
Sbjct: 192 GKY--THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDV 246
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIK---REVATMKLV 68
+G+G F V+ R TG VA+K L+H +Q + RE+ +K +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVK------QLQHSGPDQQRDFQREIQILKAL 81
Query: 69 KHPNVVRLYEV-MGSKTK-IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVD 125
+V+ V G + + +V+E++ G L D + H R+ Y Q+ ++
Sbjct: 82 HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ------VRDDGLLHTTCGTP-N 178
Y SR HRDL N+L+++ ++K++DFGL+ L VR+ G P
Sbjct: 142 YLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS------PIF 195
Query: 179 YVAPEVLNDRGYDGSTA-DLWSCGVIL 204
+ APE L+D + S D+WS GV+L
Sbjct: 196 WYAPESLSDNIF--SRQSDVWSFGVVL 220
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 70/343 (20%), Positives = 115/343 (33%), Gaps = 95/343 (27%)
Query: 11 GKYEVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+YE+ +GEGTF KV ++ VALKI+ K E + E+ +K +K
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIK 74
Query: 70 HP------NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLI 121
V + + + I E + G F+ + + R QL
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGN-------------------LKVSDFGLSALSQ 162
+A+ + H + H DLKPEN+L ++V+DFG +
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 163 QVRDDGLLHTTCGTPNYV------APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD- 215
+ HTT V PEV+ + G+ D+WS G ILF G+ F
Sbjct: 194 EH------HTT-----IVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQT 241
Query: 216 DSNL--------------MNLYKKISAAEF---TCPPWLSFTARK--------------- 243
N ++ + ++ W ++
Sbjct: 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML 301
Query: 244 -----------LIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
L+ R+L+ +P RIT+ E L +F
Sbjct: 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 7e-22
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 28/227 (12%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
E+GR IGEG F V N VA+K K + + +E TM+
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPAL--AVAIKTC-KNCTSDSVREKFL-QEALTMRQF 73
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYC 127
HP++V+L V+ ++ ++I++E T GEL + + Y QL A+ Y
Sbjct: 74 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG------TPNYVA 181
S+ HRD+ N+L+ + +K+ DFG LS+ + D + G A
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFG---LSRYMEDSTYYKASKGKLPIKWM----A 185
Query: 182 PEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
PE +N R + ++A D+W GV ++ +L+ G PF ++ +I
Sbjct: 186 PESINFRRF--TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 8e-22
Identities = 61/238 (25%), Positives = 107/238 (44%), Gaps = 22/238 (9%)
Query: 15 VGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ + +G G F +V + S+ VA+K L K + K E + M HP
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTE-KQRRDFLGEASIMGQFDHP 106
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
N++RL V+ + IV E++ G L + H + + + + + + Y
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTPNYV---APEVLN 186
G HRDL N+L+++ KVSDFG L + + DD +TT G + +PE +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFG---LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 187 DRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
R + ++A D+WS G++L+ V+ G P+ + + ++ K + CP L
Sbjct: 224 YRKF--TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 60/237 (25%), Positives = 98/237 (41%), Gaps = 52/237 (21%)
Query: 4 PKIKRRVGKYEV-------GRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHK 53
++K ++ + GR +G+G F V + + + VA+K+L K ++
Sbjct: 9 DELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASS 67
Query: 54 MAEQIKREVATMKLVKHPNVVRLYEV------MGSKTKIFIVLEFVTGGELFDKIVNHGR 107
E+ RE A MK HP+V +L V G ++L F+ G+L ++ R
Sbjct: 68 DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-R 126
Query: 108 MKEDEARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160
+ E+ Q L+ VD Y SR HRDL N +L + V+DFGLS
Sbjct: 127 IGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS-- 184
Query: 161 SQQVRDDGLLHTTCGTPNY-------------VAPEVLNDRGYDGSTADLWSCGVIL 204
R +++ +Y +A E L D Y +D+W+ GV +
Sbjct: 185 ----RK---IYSG----DYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTM 229
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 15 VGRTIGEGTFAKVKFAR-NSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+ IG G F +V + +G+ PVA+K L K + + + E M H
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVD-FLGEAGIMGQFSH 105
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS 129
N++RL V+ + I+ E++ G L + G + + + + Y +
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---APEVLN 186
HRDL N+L+++ KVSDFGLS + + D +TT G + APE ++
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEATYTTSGGKIPIRWTAPEAIS 223
Query: 187 DRGYDGSTA-DLWSCGVILF-VLLAGYLPFDD-SN 218
R + ++A D+WS G++++ V+ G P+ + SN
Sbjct: 224 YRKF--TSASDVWSFGIVMWEVMTYGERPYWELSN 256
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 95.8 bits (238), Expect = 2e-21
Identities = 59/232 (25%), Positives = 91/232 (39%), Gaps = 20/232 (8%)
Query: 19 IGEGTFAKVKFAR-NSETGE-PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G F V+ + VA+K+L + E++ RE M + +P +VRL
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 401
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
V + +V+E GG L +V + Q+ + Y + HR
Sbjct: 402 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---APEVLNDRGYDG 192
+L N+LL K+SDFGLS DD + APE +N R +
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPECINFRKF-- 516
Query: 193 STA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
S+ D+WS GV ++ L G P+ + I + CPP L
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 568
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 53/230 (23%), Positives = 98/230 (42%), Gaps = 37/230 (16%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKIL-----DKEKVLKHKMAEQIKREVATMKL 67
++ +G G F +V N T VA+K L + L E MK
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFLA---------EANLMKQ 64
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVD 125
++H +VRLY V+ ++ I+I+ E++ G L D + +K + Q+ +
Sbjct: 65 LQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG------TPNY 179
+ R HRDL+ N+L+ + K++DFG L++ + D+ T
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFG---LARLIEDNEYTAREGAKFPIKWT--- 177
Query: 180 VAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
APE +N + + D+WS G++L ++ G +P+ + + +
Sbjct: 178 -APEAINYGTF--TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 30/212 (14%)
Query: 11 GKYEVGRT-------IGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+Y + R +GEG F +V + + VA+K K+ L +K E+
Sbjct: 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMS 62
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQ 119
E MK + HP++V+L ++ + +I++E GEL + + +K Y Q
Sbjct: 63 EAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG---- 175
+ A+ Y S HRD+ N+L+ + +K+ DFG LS+ + D+ +
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG---LSRYIEDEDYYKASVTRLPI 178
Query: 176 --TPNYVAPEVLNDRGYDGSTA-DLWSCGVIL 204
+PE +N R + +TA D+W V +
Sbjct: 179 KWM----SPESINFRRF--TTASDVWMFAVCM 204
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 4e-21
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 18/220 (8%)
Query: 16 GRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
GR IGEG F V N VA+K K + +E TM+ H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAM--AVAIKTC-KNCTSDSVREK-FLQEALTMRQFDH 450
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS 129
P++V+L V+ ++ ++I++E T GEL + + Y QL A+ Y S
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-TP-NYVAPEVLND 187
+ HRD+ N+L+ + +K+ DFG LS+ + D + G P ++APE +N
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFG---LSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 188 RGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
R + S +D+W GV ++ +L+ G PF ++ +I
Sbjct: 567 RRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 39/230 (16%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQ-IKREVATMKLVKHP 71
+ +G G F VK+ + + VA+K++ KE M+E E M + H
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQY--DVAIKMI-KE----GSMSEDEFIEEAKVMMNLSHE 79
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
+V+LY V + IFI+ E++ G L + + R + + + + A++Y S+
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---------- 180
HRDL N L++ G +KVSDFG LS+ V DD Y
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFG---LSRYVLDD----------EYTSSVGSKFPVR 186
Query: 181 --APEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
PEVL + S+ D+W+ GV+++ + G +P++ + I
Sbjct: 187 WSPPEVLMYSKF--SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 49/200 (24%), Positives = 92/200 (46%), Gaps = 24/200 (12%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++ + +G G F +V A ++ VA+K + + E MK ++H +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKL 245
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSRG 131
V+L+ V+ +K I+I+ EF+ G L D + + K+ + + Q+ + + R
Sbjct: 246 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG------TPNYVAPEVL 185
HRDL+ N+L+ A K++DFG L++ + D+ T APE +
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFG---LARVIEDNEYTAREGAKFPIKWT----APEAI 357
Query: 186 NDRGYDGSTA-DLWSCGVIL 204
N + + D+WS G++L
Sbjct: 358 NFGSF--TIKSDVWSFGILL 375
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 73/372 (19%), Positives = 118/372 (31%), Gaps = 125/372 (33%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK- 69
G+Y V R +G G F+ V + + + + VA+K++ E E+ +K V+
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV----KSAEHYTETALDEIRLLKSVRN 92
Query: 70 ----HPN---VVRLY---EVMGSKTK-IFIVLEFVTGGELFD--KIVNHGRMKEDEARRY 116
PN VV+L ++ G I +V E V G L N+ + ++
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 117 FQQLINAVDYCHSR-GVYHRDLKPENLLL------------------------------- 144
QQ++ +DY H++ + H D+KPEN+LL
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 145 ------------------DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN-YVAPEVL 185
+K++D G + + T Y + EVL
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK--------------------- 224
GY+ + AD+WS + F L G F+ + +
Sbjct: 266 IGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 225 --KISAAEFT----------CPPWLSF---------------TARKLIARILDPNPMTRI 257
K S FT PW F + +L+ P R
Sbjct: 325 AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384
Query: 258 TIPEILEDEWFK 269
T E L W
Sbjct: 385 TAAECLRHPWLN 396
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-20
Identities = 59/238 (24%), Positives = 92/238 (38%), Gaps = 27/238 (11%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
I IG G F V N A+K L Q E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRI-TDIGEVSQFLTE 76
Query: 62 VATMKLVKHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQ 119
MK HPNV+ L + + S+ +VL ++ G+L + I N + + Q
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 136
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-------SQQVRDDGLLHT 172
+ + Y S+ HRDL N +LD +KV+DFGL+ S + L
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL-- 194
Query: 173 TCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
P V A E L + + + +D+WS GV+L+ ++ G P+ D N ++ +
Sbjct: 195 ----P--VKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 60/220 (27%), Positives = 88/220 (40%), Gaps = 46/220 (20%)
Query: 14 EVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+G+ +GEG F V + T VA+K + K + E+ E A MK H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95
Query: 71 PNVVRLYEV-----MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN-AV 124
PNV+RL V K ++L F+ G+L ++ R++ Q L+ V
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMV 154
Query: 125 D------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-----------D 167
D Y +R HRDL N +L + V+DFGLS +
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS------KKIYSGDYYRQGRI 208
Query: 168 GLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 204
+ P V A E L DR Y S +D+W+ GV +
Sbjct: 209 AKM------P--VKWIAIESLADRVYT-SKSDVWAFGVTM 239
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 66/300 (22%), Positives = 110/300 (36%), Gaps = 38/300 (12%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
I IG G F V N A+K L + Q E
Sbjct: 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NR-ITDIGEVSQFLTEG 141
Query: 63 ATMKLVKHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQL 120
MK HPNV+ L + + S+ +VL ++ G+L + I N + + Q+
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-------ALSQQVRDDGLLHTT 173
+ + S+ HRDL N +LD +KV+DFGL+ S + L
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL--- 258
Query: 174 CGTPNYV---APEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAA 229
P V A E L + + + +D+WS GV+L+ ++ G P+ D N ++ +
Sbjct: 259 ---P--VKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 312
Query: 230 E-----FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTN 284
CP L +++ + P R + E++ + + E N
Sbjct: 313 RRLLQPEYCPDPL----YEVMLKCWHPKAEMRPSFSELVSR--ISAIFSTFIGEHYVHVN 366
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 58/215 (26%), Positives = 87/215 (40%), Gaps = 37/215 (17%)
Query: 16 GRTIGEGTFAKVKFAR--NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKHPN 72
IGEG F +V AR A+K + KE K + E+ + L HPN
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRD-FAGELEVLCKLGHHPN 87
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY---------FQQLIN- 122
++ L + +++ +E+ G L D + ++ D A QQL++
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 123 AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
A D Y + HRDL N+L+ K++DFGLS R +
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS------RGQEVYVKKTMG 201
Query: 177 --PNYV---APEVLNDRGYDGSTA-DLWSCGVILF 205
P V A E LN Y +T D+WS GV+L+
Sbjct: 202 RLP--VRWMAIESLNYSVY--TTNSDVWSYGVLLW 232
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 52/222 (23%), Positives = 78/222 (35%), Gaps = 50/222 (22%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMK 66
+ R +G G F +V N + VA+K L E +++ E +
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV---CSEQDELDFLMEALIIS 88
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN-AVD 125
H N+VR V FI++E + GG+L + + L++ A D
Sbjct: 89 KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 126 ------YCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRD---------- 166
Y HRD+ N LL G K+ DFG++ RD
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRASYYRKG 202
Query: 167 -DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 204
+L P V PE + + T D WS GV+L
Sbjct: 203 GCAML------P--VKWMPPEAFMEGIFTSKT-DTWSFGVLL 235
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 50/222 (22%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMK 66
+ R +G+G+F V K E VA+K + E M E+I+ E + MK
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEA---ASMRERIEFLNEASVMK 83
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY---FQQLIN- 122
+VVRL V+ +++E +T G+L + + + ++I
Sbjct: 84 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143
Query: 123 AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---------- 166
A + Y ++ HRDL N ++ +K+ DFG++ RD
Sbjct: 144 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYETDYYRKG 197
Query: 167 -DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 204
GLL P V +PE L D + + +D+WS GV+L
Sbjct: 198 GKGLL------P--VRWMSPESLKDGVFT-TYSDVWSFGVVL 230
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 53/222 (23%), Positives = 78/222 (35%), Gaps = 50/222 (22%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMK 66
+ R +G G F +V N + VA+K L E +++ E +
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV---CSEQDELDFLMEALIIS 129
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN-AVD 125
H N+VR V FI+LE + GG+L + + L++ A D
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 126 ------YCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRD---------- 166
Y HRD+ N LL G K+ DFG++ RD
Sbjct: 190 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRAGYYRKG 243
Query: 167 -DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 204
+L P V PE + + S D WS GV+L
Sbjct: 244 GCAML------P--VKWMPPEAFMEGIFT-SKTDTWSFGVLL 276
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 44/214 (20%), Positives = 73/214 (34%), Gaps = 39/214 (18%)
Query: 14 EVGRTIGEGTFAKV-------KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
++G+GTF K+ V LK+LDK +E + M
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMS 67
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVD 125
+ H ++V Y V + +V EFV G L + + + +QL A+
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNL--------KVSDFGLSALSQQVRDDGLLHTTCGTP 177
+ + H ++ +N+LL + K+SD G +S V
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG---ISITVLPK---------- 174
Query: 178 NY-------VAPEVLNDRGYDGSTADLWSCGVIL 204
+ V PE + + D WS G L
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTL 208
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 30/208 (14%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
R IG+G F V + A+K L + + E RE M+ +
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRI--QCAIKSL-SRIT-EMQQVEAFLREGLLMRGL 79
Query: 69 KHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDY 126
HPNV+ L + + + ++L ++ G+L I + R + + Q+ ++Y
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-------SQQVRDDGLLHTTCGTPNY 179
+ HRDL N +LD +KV+DFGL+ S Q L P
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL------P-- 191
Query: 180 V---APEVLNDRGYDGSTADLWSCGVIL 204
V A E L + + +D+WS GV+L
Sbjct: 192 VKWTALESLQTYRFT-TKSDVWSFGVLL 218
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 62/239 (25%), Positives = 97/239 (40%), Gaps = 36/239 (15%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
+ VG+ IG G F +++ +N T E VA+K+ E + Q+ E K L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAP--QLHLEYRFYKQLGS 63
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ ++Y +VLE G +LFD QLI+ ++Y
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLEL-LGPSLEDLFDL--CDRTFSLKTVLMIAIQLISRMEY 120
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVS-----DFGLSALSQQVRD-DGLLH-------TT 173
HS+ + +RD+KPEN L+ GN DF L+++ D + H +
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA---LAKEYIDPETKKHIPYREHKSL 177
Query: 174 CGTPNYVAPEVLND-RGYDGSTA-DLWSCGVILFVLLAGYLP---FDDSNLMNLYKKIS 227
GT Y++ +N G + S DL + G + L G LP L Y+KI
Sbjct: 178 TGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 54/228 (23%), Positives = 89/228 (39%), Gaps = 51/228 (22%)
Query: 14 EVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-L 67
G+T+G G F KV A S+ VA+K+L L + A + E+ + L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA--LMSELKVLSYL 83
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL-----------FDKIVNHGRMKEDEARRY 116
H N+V L ++ E+ G+L + M++DE
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 117 FQQLI-------NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169
+ L+ + + S+ HRDL N+LL K+ DFG L++ +++D
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG---LARDIKNDS- 199
Query: 170 LHTTCGTPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
NYV APE + + Y +D+WS G+ L+
Sbjct: 200 --------NYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLW 238
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 52/222 (23%), Positives = 88/222 (39%), Gaps = 47/222 (21%)
Query: 16 GRTIGEGTFAKVKFA-----RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
G+T+G G F KV A + VA+K+L K + + E+ M L +
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALM-SELKIMSHLGQ 108
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY-------FQQLIN 122
H N+V L + ++ E+ G+L + + R+ E + + L++
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 123 -AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
+ + S+ HRD+ N+LL K+ DFGL+ RD
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA------RD------IMN 216
Query: 176 TPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
NY+ APE + D Y +D+WS G++L+
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLW 257
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 25/217 (11%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
K+ +GR IG G+F ++ N +T E VA+K+ E V Q+ E + L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHP--QLLYESKIYRILQG 61
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCH 128
+ + +V++ + G L D R + Q+IN V++ H
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 129 SRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRD-DGLLHTT-------CGTP 177
S+ HRD+KP+N L+ + + DFG L+++ RD H GT
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFG---LAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 178 NYVAPEVLNDRGYDGS-TADLWSCGVILFVLLAGYLP 213
Y + V G + S DL S G +L L G LP
Sbjct: 178 RYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 53/226 (23%), Positives = 84/226 (37%), Gaps = 54/226 (23%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+ +GEG F KV + VA+K L KE + +RE + ++
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQ--DFQREAELLTML 100
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGEL--------FDKIVNHGRMKEDEARRYFQQL 120
+H ++VR + V + +V E++ G+L D + G QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 121 IN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD------- 166
+ A Y HRDL N L+ +K+ DFG+S RD
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS------RDIYSTDYY 214
Query: 167 ----DGLLHTTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVIL 204
+L P + PE + R + +T D+WS GV+L
Sbjct: 215 RVGGRTML------P--IRWMPPESILYRKF--TTESDVWSFGVVL 250
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 32/236 (13%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
+Y +GR IG G+F + + GE VA+K+ E V Q+ E K +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHP--QLHIESKIYKMMQG 63
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ + +V+E + G +LF+ + Q+I+ ++Y
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEY 120
Query: 127 CHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDD-GLLHTT-------CG 175
HS+ HRD+KP+N L+ + + DFG L+++ RD H G
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG---LAKKYRDARTHQHIPYRENKNLTG 177
Query: 176 TPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAGYLP---FDDSNLMNLYKKIS 227
T Y + + G + S DL S G +L G LP + Y++IS
Sbjct: 178 TARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 5e-17
Identities = 52/227 (22%), Positives = 84/227 (37%), Gaps = 54/227 (23%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+GE F KV E + VA+K L K+K E + E +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREE-FRHEAMLRARL 69
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY---------FQQ 119
+HPNVV L V+ + ++ + + G+L + +V + +
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 120 LIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD------ 166
++ Y S V H+DL N+L+ N+K+SD GL R+
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF------REVYAADY 183
Query: 167 -----DGLLHTTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVIL 204
+ LL P + APE + + S D+WS GV+L
Sbjct: 184 YKLLGNSLL------P--IRWMAPEAIMYGKF--SIDSDIWSYGVVL 220
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 8e-17
Identities = 61/240 (25%), Positives = 99/240 (41%), Gaps = 61/240 (25%)
Query: 3 QPKIKRRVGKYEVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQ 57
IKRR + R +GEG F KV ++ VA+K L K+ +A +
Sbjct: 9 VQHIKRR--DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPT----LAAR 61
Query: 58 IK--REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---------KIVNHG 106
RE + ++H ++V+ Y V G + +V E++ G+L I+ G
Sbjct: 62 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121
Query: 107 RMKEDEARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159
+ ++ + Q+++ A Y S+ HRDL N L+ A +K+ DFG+S
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS- 180
Query: 160 LSQQVRD-----------DGLLHTTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVIL 204
RD +L P + PE + R + +T D+WS GVIL
Sbjct: 181 -----RDVYSTDYYRVGGHTML------P--IRWMPPESIMYRKF--TTESDVWSFGVIL 225
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 9e-17
Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 55/228 (24%)
Query: 16 GRTIGEGTFAKVKFAR-------NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-L 67
G+ +GEG F +V A VA+K+L K + +++ I E+ MK +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLI-SEMEMMKMI 131
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---------KIVNHGRMKEDEARRYFQ 118
KH N++ L +++++E+ + G L + ++ E + +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 119 QLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD----- 166
L++ A Y S+ HRDL N+L+ +K++DFGL+ RD
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA------RDIHHID 245
Query: 167 ------DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF 205
+G L P V APE L DR Y +D+WS GV+L+
Sbjct: 246 YYKKTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLW 284
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 55/230 (23%)
Query: 14 EVGRTIGEGTFAKVKFAR-------NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
+G+ +GEG F +V A + VA+K+L K+ + +++ + E+ MK
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEMEMMK 95
Query: 67 -LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---------KIVNHGRMKEDEARRY 116
+ KH N++ L +++++E+ + G L + ++ + E +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 117 FQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--- 166
F+ L++ Y S+ HRDL N+L+ +K++DFGL+ RD
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINN 209
Query: 167 --------DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF 205
+G L P V APE L DR Y +D+WS GV+++
Sbjct: 210 IDYYKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 250
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 58/231 (25%), Positives = 91/231 (39%), Gaps = 56/231 (24%)
Query: 16 GRTIGEGTF-----AKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
G+T+GEG F A + VA+K+L KE ++ + + E +K V H
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRD-LLSEFNVLKQVNH 85
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGEL-----------------FDKIVNHGRMKEDEA 113
P+V++LY + +++E+ G L + DE
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 114 RRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166
LI+ A Y + HRDL N+L+ +K+SDFGLS RD
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS------RD 199
Query: 167 DGLLHTTCGTPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
++ +YV A E L D Y + +D+WS GV+L+
Sbjct: 200 ---VYE---EDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 55/246 (22%), Positives = 92/246 (37%), Gaps = 34/246 (13%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
Y+VGR IGEG+F + N + VA+K E Q++ E T K L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEPRRSDAP--QLRDEYRTYKLLAG 64
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ +Y +V++ G +L D + +Q++ V
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDL-LGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQS 121
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLK-----VSDFGLSALSQQVRD-DGLLH-------TT 173
H + + +RD+KP+N L+ + V DFG + + RD H
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG---MVKFYRDPVTKQHIPYREKKNL 178
Query: 174 CGTPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAGYLP---FDDSNLMNLYKKISAA 229
GT Y++ + G + S DL + G + L G LP + Y++I
Sbjct: 179 SGTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236
Query: 230 EFTCPP 235
+ + P
Sbjct: 237 KQSTPL 242
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 38/223 (17%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G G F KV R G VA+K L +E+ ++ Q + EV + + H N++RL
Sbjct: 38 LGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLR- 93
Query: 79 VMG---SKTKIFIVLEFVTGG----ELFDKIVNHG------RMK--EDEAR--RYFQQLI 121
G + T+ +V ++ G L ++ + R + AR Y
Sbjct: 94 --GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH--- 148
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT---CGTPN 178
D+C + + HRD+K N+LLD V DFGL+ L D H T GT
Sbjct: 149 ---DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLM----DYKDTHVTTAVRGTIG 200
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 221
++APE L+ G D++ GV+L L+ G FD + L N
Sbjct: 201 HIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 3e-16
Identities = 61/237 (25%), Positives = 88/237 (37%), Gaps = 54/237 (22%)
Query: 8 RRVGKYEVGRTIGEGTFAKV-KFARNSETGEPVALKILDKEKVLK-HKMAEQIKREVATM 65
G +GEG F V K N VA+K L + ++ +Q +E+ M
Sbjct: 28 DERPISVGGNKMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVM 84
Query: 66 KLVKHPNVVRL-------------YEVM--GSKTKIFIVLEFVTGGELFDKIVNHG---- 106
+H N+V L Y M GS L L
Sbjct: 85 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGS-------LLDR----LSCLDGTPPLSWH 133
Query: 107 -RMK--EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163
R K + A +++ H HRD+K N+LLD K+SDFGL+ S+
Sbjct: 134 MRCKIAQGAAN--------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE- 184
Query: 164 VRDDGLLHTT---CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217
T GT Y+APE L RG +D++S GV+L ++ G D+
Sbjct: 185 --KFAQTVMTSRIVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEH 237
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 55/235 (23%), Positives = 85/235 (36%), Gaps = 62/235 (26%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
E R IGEG F +V E VA+K+L KE+ A+ +RE A M
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQAD-FQREAALMAEF 107
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGEL-----------------FDKIVNHGRMKED 111
+PN+V+L V + ++ E++ G+L D
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 112 EARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164
+ + A Y R HRDL N L+ +K++DFGLS
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS------ 221
Query: 165 RD-----------DGLLHTTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVIL 204
R+ + + P + PE + Y +T D+W+ GV+L
Sbjct: 222 RNIYSADYYKADGNDAI------P--IRWMPPESIFYNRY--TTESDVWAYGVVL 266
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 55/230 (23%)
Query: 14 EVGRTIGEGTFAKVKFAR-------NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
+G+ +GEG F +V A + VA+K+L K+ + +++ + E+ MK
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEMEMMK 141
Query: 67 -LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---------KIVNHGRMKEDEARRY 116
+ KH N++ L +++++E+ + G L + ++ + E +
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 117 FQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--- 166
F+ L++ Y S+ HRDL N+L+ +K++DFGL+ RD
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINN 255
Query: 167 --------DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF 205
+G L P V APE L DR Y +D+WS GV+++
Sbjct: 256 IDYYKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 296
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 56/225 (24%), Positives = 87/225 (38%), Gaps = 50/225 (22%)
Query: 16 GRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
G+ +G G F +V A + T VA+K+L KE + + E+ + +
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRA-LMSELKILIHIGH 89
Query: 70 HPNVVRLYEV-MGSKTKIFIVLEFVTGGELFD---------KIVNHGRMKEDEARRYFQQ 119
H NVV L + +++EF G L + +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 120 LIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 172
LI + + SR HRDL N+LL +K+ DFGL+ RD ++
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD---IYK 200
Query: 173 TCGTPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
P+YV APE + DR Y +D+WS GV+L+
Sbjct: 201 ---DPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 241
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 5e-16
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG G F KV + G VALK E + + + E+ T+ +HP++V L
Sbjct: 47 IGHGVFGKV-YKGVLRDGAKVALKRRTPESSQGIE---EFETEIETLSFCRHPHLVSLIG 102
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD------YCHSRGV 132
+ ++ ++ +++ G L + +G + + Q+L + Y H+R +
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT---CGTPNYVAPE-----V 184
HRD+K N+LLD K++DFG+S + H + GT Y+ PE
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGT---ELDQTHLSTVVKGTLGYIDPEYFIKGR 217
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217
L ++ +D++S GV+LF +L S
Sbjct: 218 LTEK------SDVYSFGVVLFEVLCARSAIVQS 244
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 57/233 (24%), Positives = 90/233 (38%), Gaps = 56/233 (24%)
Query: 14 EVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-L 67
E G+ +G G F KV A + VA+K+L KEK + + E+ M L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREA-LMSELKMMTQL 105
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL----------------FDKIVNHGRMKED 111
H N+V L I+++ E+ G+L + +ED
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 112 EARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164
F+ L+ A + + HRDL N+L+ +K+ DFGL+
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA------ 219
Query: 165 RDDGLLHTTCGTPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
RD + + NYV APE L + Y +D+WS G++L+
Sbjct: 220 RD---IMS---DSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLW 265
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 76.1 bits (186), Expect = 2e-15
Identities = 39/192 (20%), Positives = 59/192 (30%), Gaps = 48/192 (25%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKIL-----DKEKVLKHKMAEQIKREVATMK 66
K + IGEG F +V PVA+KI+ D K E+I E+ K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 67 LV---------KHPNVVRLYEV------------------------------MGSKTKIF 87
+ + + L V ++F
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDA 146
IVLEF GG +++ A+ QL ++ + HRDL N+LL
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 147 YGNLKVSDFGLS 158
K+
Sbjct: 198 TSLKKLHYTLNG 209
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 46/236 (19%), Positives = 88/236 (37%), Gaps = 46/236 (19%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
++ +G+ IG G F + A + E A + KV + + E+ + V
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHV---VKVEYQE-NGPLFSELKFYQRVAK 92
Query: 71 PNVVRLYEVMGSKTKI-------------------FIVLEFVTGGELFDKIVNHGRMKED 111
+ ++ + + F+V+E + G +L +G K+
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKS 151
Query: 112 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV--SDFGLSALSQQVRDDGL 169
+ ++++ ++Y H H D+K NLLL +V +D+G LS + +G
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYG---LSYRYCPNGN 208
Query: 170 L----------HTTCGTPNYVAPEVLND-RGYDGS-TADLWSCGVILFVLLAGYLP 213
H GT + + L+ +G S +D+ G + L G LP
Sbjct: 209 HKQYQENPRKGHN--GTIEFTS---LDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 41/237 (17%), Positives = 84/237 (35%), Gaps = 45/237 (18%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
++VG IG+G F + + + + E V KV + E+ +
Sbjct: 35 AAWKVGLPIGQGGFGCI-YLADMNSSESVGSDAPCVVKVEPSD-NGPLFTELKFYQRAAK 92
Query: 71 PNVVRLYEVMGSKTKI-------------------FIVLEFVTG---GELFDKIVNHGRM 108
P ++ + + F++++ G ++++ N R
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRF 149
Query: 109 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV--SDFGLSALSQQVRD 166
+ ++++ ++Y H H D+K NLLL+ +V D+G L+ +
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYG---LAYRYCP 206
Query: 167 DGLL--------HTTCGTPNYVAPEVLND-RGYDGS-TADLWSCGVILFVLLAGYLP 213
+G+ GT + + ++ G S DL G + L G+LP
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 36/244 (14%), Positives = 78/244 (31%), Gaps = 59/244 (24%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETG--------EPVALKI------LDKEKVLKHKMA- 55
++++ + A + T + +LK+ L E+ + A
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 56 -EQIKREVATMKLVKHPNVVRLYEVMGSKTKI--FIVLEFVTGGELFDKIVNHGRMKEDE 112
Q+ + + G F+VL + G L + +
Sbjct: 102 PLQVNKWKKLYST-PLLAIPTCMG-FGVHQDKYRFLVLPSL-GRSLQSALDVSPK----- 153
Query: 113 ARRYF---------QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV--SDFGLSALS 161
+L++A+++ H H ++ EN+ +D +V + +G +
Sbjct: 154 --HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYG---FA 208
Query: 162 QQVRDDG----------LLHTTCGTPNYVAPEVLND-RGYDGS-TADLWSCGVILFVLLA 209
+ G H G +++ ++ +G S +DL S G + L
Sbjct: 209 FRYCPSGKHVAYVEGSRSPHE--GDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLKWLY 263
Query: 210 GYLP 213
G+LP
Sbjct: 264 GFLP 267
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 2e-09
Identities = 67/405 (16%), Positives = 114/405 (28%), Gaps = 132/405 (32%)
Query: 42 KILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KTKIFIVL------EFVT 94
++ K V + + ++++ A ++L NV+ + V+GS KT + +
Sbjct: 124 QVFAKYNVSRLQPYLKLRQ--ALLELRPAKNVL-IDGVLGSGKT----WVALDVCLSYKV 176
Query: 95 GGELFDKI--VNHGRMKEDEAR-RYFQQLINAVD--YC----HSRGVYHR--DLK----- 138
++ KI +N E Q+L+ +D + HS + R ++
Sbjct: 177 QCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236
Query: 139 -------PENLL-LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
LL L N K +A + + +L TT R
Sbjct: 237 LLKSKPYENCLLVLLNVQNAKA----WNAFNLSCK---ILLTT--------------R-- 273
Query: 191 DGSTAD-LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249
D L + L + + +L K +L + L +L
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK----------YLDCRPQDLPREVL 323
Query: 250 DPNPMTRITIPEILEDE---WFKKDYKPPVFEEKKDT-------NLDDVE--------AV 291
NP I E + D W D V +K T L+ E +V
Sbjct: 324 TTNPRRLSIIAESIRDGLATW---DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV 380
Query: 292 FKDSEEHHVTEQ----------KEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETR- 340
F S H+ K + V +N SL E+ K T
Sbjct: 381 FPPSA--HIPTILLSLIWFDVIKSDVMVVVNKLHKYSL-----------VEKQPKESTIS 427
Query: 341 -----FTSRCPANEIINK----IEEAAKPLGFDVHKK------NY 370
+ ++ P FD Y
Sbjct: 428 IPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY 472
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 5e-04
Identities = 24/142 (16%), Positives = 48/142 (33%), Gaps = 22/142 (15%)
Query: 275 PVFEE--KKDTNLDDVE----AVFKDSEEHHVTEQKEEQPVAMNAFELISLSKGLNLGNL 328
VFE+ + + DV+ ++ E H+ K+ + F + LSK +
Sbjct: 23 SVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTL-LSKQEEMVQK 81
Query: 329 F--DA-EQDFK-RETRFTSRCPANEIINKI-EEAAKPLGFDVH--KKNYKMRLENMKAGR 381
F + ++K + + ++ ++ E L D K RL+ R
Sbjct: 82 FVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR 141
Query: 382 KG--NLNVATEVFQVAPSLH-M 400
+ L A V + +
Sbjct: 142 QALLELRPAKNVL-----IDGV 158
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 5e-07
Identities = 32/99 (32%), Positives = 46/99 (46%), Gaps = 25/99 (25%)
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
Q+ +++ SR HRDL N+LL +K+ DFGL+ RD P+
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD------IYKDPD 248
Query: 179 YV------------APEVLNDRGYDGSTADLWSCGVILF 205
YV APE + DR Y + D+WS GV+L+
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQS-DVWSFGVLLW 286
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 22/99 (22%), Positives = 40/99 (40%), Gaps = 9/99 (9%)
Query: 14 EVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-L 67
++G+ +G G F +V A + T VA+K+L + A E+ + +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM--SELKILIHI 82
Query: 68 VKHPNVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNH 105
H NVV L + +++EF G L + +
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} PDB: 1ul7_A Length = 120 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 3e-06
Identities = 14/77 (18%), Positives = 33/77 (42%), Gaps = 2/77 (2%)
Query: 342 TSRCPANEIINKIEEAAKPLGFDVHKKN-YKMRLENMKAGRKGNLNVATEVFQVA-PSLH 399
TS N+++ +I + D +K + + + A + + EV ++ SL+
Sbjct: 34 TSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLN 93
Query: 400 MVEVRKAKGDTLEFHKV 416
V ++ G ++ F +
Sbjct: 94 GVRFKRISGTSIAFKNI 110
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 6e-06
Identities = 25/159 (15%), Positives = 58/159 (36%), Gaps = 28/159 (17%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI-------------- 58
+G+ +GEG + V + + +K K+ E+
Sbjct: 92 DAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 59 -KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 117
+ E ++ ++ V ++Y G+ +++E + EL+ ++ +
Sbjct: 151 ARNEFRALQKLQGLAVPKVYAWEGNA----VLMELIDAKELYR-------VRVENPDEVL 199
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156
++ V + RG+ H DL N+L+ + + DF
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 40.0 bits (93), Expect = 8e-04
Identities = 32/168 (19%), Positives = 55/168 (32%), Gaps = 26/168 (15%)
Query: 13 YEVGRTIGEGTFAKVKFARN--SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+G I G A V +A +A+KI E KM E + +
Sbjct: 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRIS 108
Query: 71 P-------------NVVRLYEVMGSKTKIF------IVLEFVTGGELFDKIVNH--GRMK 109
P N+ R E S + + +++EF+ EL + +K
Sbjct: 109 PKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELK 168
Query: 110 EDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFG 156
E + F ++ V + + H DL N++ + D G
Sbjct: 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYI--DKVYFIDMG 214
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 416 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 99.93 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.24 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.21 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 99.02 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.92 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 98.78 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 98.74 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.74 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.73 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.66 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 98.65 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 98.57 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.55 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.44 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.39 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 98.32 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.23 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.17 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 97.98 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.94 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.87 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.8 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.71 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.5 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.5 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.48 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.37 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.36 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.25 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.21 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.97 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.89 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.64 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.93 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.13 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.45 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.98 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.6 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-70 Score=526.78 Aligned_cols=262 Identities=31% Similarity=0.578 Sum_probs=244.9
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
...++|++++.||+|+||+||+|+++.+|+.||||++++....+....+.+.+|+.+|+.++|||||++++++++++.+|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 45678999999999999999999999999999999999877666666788999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
+|||||+||+|+++|.+.+.++|..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+........
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999876544444
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~ 247 (416)
....+.|||+.|||||++.+.+|+ .++|||||||++|+|++|++||.+.+...++.+|....+.+|..+|+++++||++
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence 556778999999999999988885 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCHhH------HhcCccccc
Q 014909 248 ILDPNPMTRITIPE------ILEDEWFKK 270 (416)
Q Consensus 248 ~L~~dP~~R~t~~e------il~h~~~~~ 270 (416)
||++||++|||++| |++||||+.
T Consensus 268 lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp HSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 99999999999998 578999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-70 Score=517.58 Aligned_cols=261 Identities=49% Similarity=0.920 Sum_probs=224.9
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
+..+++|++.+.||+|+||+||+|++..+|+.||||++++.........+.+.+|+.+|+.++|||||++++++.+++.+
T Consensus 9 G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 9 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp -----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 56789999999999999999999999999999999999887666666678899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+||||| +|+|++++...+++++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 164 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--- 164 (275)
T ss_dssp EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC---
Confidence 9999999 679999999999999999999999999999999999999999999999999999999999999975432
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~ 246 (416)
.....+.+||+.|||||++.+..|++.++|||||||++|+|++|++||.+.+...+++.+..+.+.+|.++|+++++||+
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 244 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIK 244 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 33445789999999999999988888899999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCHhHHhcCcccccC
Q 014909 247 RILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
+||++||++|||++|+++||||+..
T Consensus 245 ~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 245 RMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHccCChhHCcCHHHHHcCcccccC
Confidence 9999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-67 Score=507.73 Aligned_cols=256 Identities=28% Similarity=0.455 Sum_probs=230.5
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
..|++.+.||+|+||+||+|+++.+|+.||||++++..... .+.+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999998655332 456889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
|||+||+|++++.. +++++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.... .....
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~ 227 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRR 227 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCB
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCcc
Confidence 99999999998876 6799999999999999999999999999999999999999999999999999986543 22345
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc---CCCCCCCHHHHHHHHH
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTARKLIAR 247 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~ll~~ 247 (416)
.+.|||+.|||||++.+.+|+ .++|||||||++|+|++|++||.+.+....+..+..... ..+..+|+++++||.+
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 678999999999999988885 899999999999999999999999988888888766532 2334589999999999
Q ss_pred hcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 248 ILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 248 ~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
||+.||++|||++|+|+||||++...
T Consensus 307 ~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 99999999999999999999987654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-67 Score=512.46 Aligned_cols=260 Identities=29% Similarity=0.573 Sum_probs=229.4
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
.+++|++++.||+|+||+||+|+++.+|+.||||++++..... ...+.+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 4679999999999999999999999999999999998766433 346789999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 89 VLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|||||+||+|+++|...+ .+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 178 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-- 178 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence 999999999999997643 5799999999999999999999999999999999999999999999999999865431
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc-CCCCCCCHHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLI 245 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~ll 245 (416)
.....+.|||+.|||||++.+..|+ .++|||||||++|+|++|+.||.+.+..+++.++..+.+ ..+..+|+++++||
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li 257 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLV 257 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred cccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence 1223567899999999999988885 899999999999999999999999999988888877765 45667999999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 246 ARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
.+||++||++|||++|+|+||||++..
T Consensus 258 ~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 258 SQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp HHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred HHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 999999999999999999999998643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-67 Score=503.03 Aligned_cols=257 Identities=33% Similarity=0.602 Sum_probs=228.0
Q ss_pred ccCEEEEeEEeecCceEEEEEEEC---CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
.++|++++.||+|+||+||+|++. .+++.||||++++...... ...++.+|+.+|++++|||||++++++.+++.+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 467999999999999999999984 4678999999987654332 234688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+|||||+||+|++++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... .
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 179 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--H 179 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--C
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999975432 2
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~ 246 (416)
.....+.|||+.|||||++.+.+|+ .++|||||||++|+|++|++||.+.+..+++.+|....+.+|..+|+++++||+
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 258 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 3345678999999999999988886 899999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCC-----HhHHhcCccccc
Q 014909 247 RILDPNPMTRIT-----IPEILEDEWFKK 270 (416)
Q Consensus 247 ~~L~~dP~~R~t-----~~eil~h~~~~~ 270 (416)
+||++||++||| ++|+++||||+.
T Consensus 259 ~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 259 MLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 999999999998 589999999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-65 Score=516.25 Aligned_cols=404 Identities=38% Similarity=0.675 Sum_probs=315.9
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
...+++|.+++.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46789999999999999999999999999999999999876654444567899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++.....
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~--- 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--- 168 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT---
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc---
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999976432
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~ 246 (416)
.....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+....+.++..+.+..|..+++++.+||+
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 248 (476)
T 2y94_A 169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLK 248 (476)
T ss_dssp TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHH
T ss_pred cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHH
Confidence 33456779999999999999888877899999999999999999999999998899999988888889999999999999
Q ss_pred HhcCCCCCCCCCHhHHhcCcccccCCCCCccccccc--CChhhHHH---hh---ccccc------------ccc------
Q 014909 247 RILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKD--TNLDDVEA---VF---KDSEE------------HHV------ 300 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~h~~~~~~~~~~~~~~~~~--~~~~~~~~---~~---~~~~~------------~~~------ 300 (416)
+||+.||.+|||++++++||||+.......++.... ....+.+. .. ...++ ...
T Consensus 249 ~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~y~l 328 (476)
T 2y94_A 249 HMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHL 328 (476)
T ss_dssp HHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC---------------------------
T ss_pred HHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHHHHHH
Confidence 999999999999999999999987543322211110 00000000 00 00000 000
Q ss_pred -ccccc-----------cCccc-cc--------hhhhhhcCCCCC------CCCCCc--c----cccccccceeEecCCH
Q 014909 301 -TEQKE-----------EQPVA-MN--------AFELISLSKGLN------LGNLFD--A----EQDFKRETRFTSRCPA 347 (416)
Q Consensus 301 -~~~~~-----------~~~~~-~~--------~~~~~~~~~~~~------~~~~~~--~----~~~~~~~~~f~~~~~~ 347 (416)
...+. ..|.. .. .......+.+.. ++.... . ....+...++.|+.+|
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~lgi~s~~~p 408 (476)
T 2y94_A 329 IIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRP 408 (476)
T ss_dssp ----CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTTSSSTTTCSCCCCCCEEESEEECSCH
T ss_pred HHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCcccccccccccccccccccccceeeecCccCCCH
Confidence 00000 00000 00 000000000000 010000 0 0134566788999999
Q ss_pred HHHHHHHHHhcccCCcEEEee-cceEEEEEeecCCCcceEEEEEEEEEcCCeEEEEEEEcCCCccce
Q 014909 348 NEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEF 413 (416)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~v~~~~~~gd~~e~ 413 (416)
.+||.+|.+|++.+||.|+.. .+.++++...+.....++|.+++|+++++.+||||++..|+.++|
T Consensus 409 ~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~~~~~~~llDf~~~~~~~~~~ 475 (476)
T 2y94_A 409 NDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475 (476)
T ss_dssp HHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred HHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEEEecCCcEEEEeeecCCCcccc
Confidence 999999999999999999986 799999765554456788999999999999999999999999987
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-65 Score=508.82 Aligned_cols=256 Identities=28% Similarity=0.463 Sum_probs=230.8
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
..|++.+.||+|+||.||+|+++.+|+.||||+++...... .+.+.+|+.+|+.++|||||++++++.+++.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999998654332 456889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
|||+||+|.+++.. +++++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.... .....
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~ 304 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRR 304 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCCCB
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCccc
Confidence 99999999998875 6799999999999999999999999999999999999999999999999999986533 23345
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc---cCCCCCCCHHHHHHHHH
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIAR 247 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~ll~~ 247 (416)
.+.|||+.|||||++.+..|+ .++|||||||++|+|++|++||.+.+....+..|.... ...+..+|+++++||.+
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 678999999999999988885 89999999999999999999999998888888776553 33445689999999999
Q ss_pred hcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 248 ILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 248 ~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
||+.||++|||++|+|+||||++...
T Consensus 384 ~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 384 LLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 99999999999999999999987543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-64 Score=482.49 Aligned_cols=254 Identities=26% Similarity=0.501 Sum_probs=222.2
Q ss_pred ccCE-EEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CC
Q 014909 10 VGKY-EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----KT 84 (416)
Q Consensus 10 ~~~y-~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~ 84 (416)
.++| ++.+.||+|+||+||+|.+..++..||+|++....... ...+.+.+|+.+|++++|||||++++++.+ +.
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence 3566 78889999999999999999999999999998765433 346789999999999999999999999865 45
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCcEEecc-CCCeEEeeccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDA-YGNLKVSDFGLSALS 161 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~g--ivHrDlkp~NILl~~-~~~vkl~DFGla~~~ 161 (416)
.+|+|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+||||+. +|.+||+|||+|+..
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 68999999999999999999899999999999999999999999999 999999999999985 799999999999753
Q ss_pred ccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc-hHHHHHHhhcCcc--CCCCCCC
Q 014909 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAAEF--TCPPWLS 238 (416)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~-~~~~~~~i~~~~~--~~~~~~s 238 (416)
. .....+.||||.|||||++.+ .| +.++|||||||++|+|+||+.||.+.+ ...++..+..+.. .++...+
T Consensus 183 ~----~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 256 (290)
T 3fpq_A 183 R----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp C----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred C----CCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCC
Confidence 2 334567899999999999875 56 489999999999999999999997654 4456666655432 3455689
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 239 FTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 239 ~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
+++++||.+||++||++|||++|+|+||||++
T Consensus 257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-64 Score=490.73 Aligned_cols=256 Identities=26% Similarity=0.375 Sum_probs=224.8
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
..++.|++.+.||+|+||+||+|+++.+|+.||||+++++.. ..+|+.+|+.++|||||++++++.+++.+|
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 356779999999999999999999999999999999986543 236999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC-CeEEeecccccccccccC
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~~ 166 (416)
+|||||+||+|.++|...+.+++..++.|+.||+.||+|||++||+||||||+||||+.+| ++||+|||+|+.......
T Consensus 127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999999999999989999999999999999999999999999999999999999988 699999999986543222
Q ss_pred CC---CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc---CCCCCCCHH
Q 014909 167 DG---LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFT 240 (416)
Q Consensus 167 ~~---~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~ 240 (416)
.. ...+.|||+.|||||++.+.+|+ .++|||||||++|+|++|++||.+.+...+..++..... ..|+.+|++
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 285 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPL 285 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHH
T ss_pred ccceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHH
Confidence 11 12346899999999999998885 899999999999999999999998877766777766543 467889999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHH-------------hcCcccccCC
Q 014909 241 ARKLIARILDPNPMTRITIPEI-------------LEDEWFKKDY 272 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~ei-------------l~h~~~~~~~ 272 (416)
+.+||.+||++||.+|||+.|+ ++|||+....
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 9999999999999999999997 5799997643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-62 Score=489.76 Aligned_cols=261 Identities=28% Similarity=0.402 Sum_probs=226.3
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe------CC
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------KT 84 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~ 84 (416)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 479999999999999999999999999999999976543 23345778899999999999999999999764 36
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
.+|+|||||. |+|++++...+++++..++.|++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 7999999996 589999999999999999999999999999999999999999999999999999999999999865332
Q ss_pred --cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCC---------
Q 014909 165 --RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC--------- 233 (416)
Q Consensus 165 --~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~--------- 233 (416)
.......+.|||+.|||||++.+..+++.++||||+|||+|+|++|++||.+.+....+..|.......
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 123345678999999999999987777799999999999999999999999998887777664322111
Q ss_pred ----------------------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 234 ----------------------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 234 ----------------------~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
.+.+|+++++||.+||..||++|||++|+|+||||++...
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 1246899999999999999999999999999999987543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-62 Score=504.98 Aligned_cols=261 Identities=29% Similarity=0.460 Sum_probs=231.6
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHH---HHHHHHHhcCCCCCcceEEEEEEe
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI---KREVATMKLVKHPNVVRLYEVMGS 82 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~---~~Ei~il~~l~hpnIv~l~~~~~~ 82 (416)
....+++|++++.||+|+||+||+|+++.+|+.||||++++...........+ ++++.+++.++|||||++++++.+
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 35678999999999999999999999999999999999987665433333333 445677788899999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
.+.+|+|||||+||+|+++|...+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|....
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999997643
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCC---chHHHHHHhhcCccCCCCCCCH
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAAEFTCPPWLSF 239 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~ 239 (416)
. ....+.||||.|||||++.+...++.++|||||||++|+|++|.+||.+. +...+...+....+.+|..+|+
T Consensus 344 ~----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~ 419 (689)
T 3v5w_A 344 K----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 419 (689)
T ss_dssp S----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred C----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCH
Confidence 2 23467899999999999975433358999999999999999999999764 3345667777888899999999
Q ss_pred HHHHHHHHhcCCCCCCCCC-----HhHHhcCccccc
Q 014909 240 TARKLIARILDPNPMTRIT-----IPEILEDEWFKK 270 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t-----~~eil~h~~~~~ 270 (416)
++++||.+||++||.+|++ ++||++||||+.
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 9999999999999999998 799999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-61 Score=464.97 Aligned_cols=255 Identities=27% Similarity=0.455 Sum_probs=204.6
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC---
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--- 84 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 84 (416)
+.+++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 2 R~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred CcchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence 45678999999999999999999999999999999997654 3344678999999999999999999999986543
Q ss_pred ---------EEEEEEeccCCCchHHHHHhCCCC---CHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEE
Q 014909 85 ---------KIFIVLEFVTGGELFDKIVNHGRM---KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152 (416)
Q Consensus 85 ---------~~~lV~E~~~gg~L~~~i~~~~~l---~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl 152 (416)
.+|+|||||+||+|.+++...+.+ ++..++.|+.||++||+|||++||+||||||+|||++.+|++||
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence 479999999999999999876654 45678999999999999999999999999999999999999999
Q ss_pred eecccccccccccCC----------CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH-H
Q 014909 153 SDFGLSALSQQVRDD----------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-N 221 (416)
Q Consensus 153 ~DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~-~ 221 (416)
+|||+|+........ ....+.|||+.|||||++.+..|+ .++|||||||++|+|++ ||...... .
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~ 235 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVR 235 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence 999999865432211 122456899999999999988885 89999999999999996 88654322 2
Q ss_pred HHHHhhcCccCCCC---CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 222 LYKKISAAEFTCPP---WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 222 ~~~~i~~~~~~~~~---~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
....+.... +|+ ..++.+.+||++||++||.+|||+.|+++||||+.
T Consensus 236 ~~~~~~~~~--~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 236 TLTDVRNLK--FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHHHTTC--CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHHHhcCC--CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 333333332 332 25677899999999999999999999999999975
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-60 Score=467.29 Aligned_cols=256 Identities=27% Similarity=0.453 Sum_probs=210.3
Q ss_pred cccccCEEEEeEEeecCceEEEEEEEC---CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS 82 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 82 (416)
+..-++|++.+.||+|+||+||+|+++ .+++.||||.+.+.. ...++.+|+.+|+.+ +|||||++++++.+
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 445578999999999999999999875 467899999986543 235678999999988 69999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC-CCeEEeeccccccc
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALS 161 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~-~~vkl~DFGla~~~ 161 (416)
.+.+|+||||++||+|.+++ +.+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 99999999999999999998 459999999999999999999999999999999999999876 89999999999754
Q ss_pred cccc--------------------------CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCC
Q 014909 162 QQVR--------------------------DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 215 (416)
Q Consensus 162 ~~~~--------------------------~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~ 215 (416)
.... ......+.|||+.|+|||++.+..+++.++||||+|||+|+|++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 3211 11123456899999999999887766799999999999999999999995
Q ss_pred CC-chHHHHHHhhc--------------------------------------Ccc----------------CCCCCCCHH
Q 014909 216 DS-NLMNLYKKISA--------------------------------------AEF----------------TCPPWLSFT 240 (416)
Q Consensus 216 ~~-~~~~~~~~i~~--------------------------------------~~~----------------~~~~~~s~~ 240 (416)
.. +.......|.. ... .....+|++
T Consensus 249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~ 328 (361)
T 4f9c_A 249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE 328 (361)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence 43 33333222211 000 011237899
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 241 ARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
+++||++||+.||++|||++|+|+||||+.
T Consensus 329 a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 329 AYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999999974
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-60 Score=455.41 Aligned_cols=256 Identities=22% Similarity=0.344 Sum_probs=222.5
Q ss_pred cccCEEEEeEEeecCceEEEEEEEC-----CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
.-++|.+.+.||+|+||+||+|++. .++..||||+++... ....+.+.+|+.+|++++|||||++++++.++
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 3467999999999999999999875 357889999997542 33467899999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCe
Q 014909 84 TKIFIVLEFVTGGELFDKIVNH-------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~-------------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~v 150 (416)
+.+|+|||||+||+|.+++... ..+++..+..++.||++||+|||+++|+||||||+|||++.++++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 9999999999999999999764 369999999999999999999999999999999999999999999
Q ss_pred EEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC
Q 014909 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA 229 (416)
Q Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~ 229 (416)
||+|||+|+..............+||+.|||||++.+..|+ .++|||||||++|||+| |+.||.+.+..+....+..+
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999865433222223345799999999999988885 89999999999999998 99999999888888888776
Q ss_pred c-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 230 E-FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 230 ~-~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
. ...|+.+|+++.+|+.+||+.||++|||+++| |+|+++
T Consensus 247 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 247 RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 5 56788899999999999999999999999999 567753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-59 Score=489.47 Aligned_cols=259 Identities=30% Similarity=0.584 Sum_probs=234.8
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
.+++|++++.||+|+||.||+|.++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||++++++.+...+|+
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 45799999999999999999999999999999999976542 235678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC--CCeEEeeccccccccccc
Q 014909 89 VLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY--GNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~--~~vkl~DFGla~~~~~~~ 165 (416)
|||||+||+|+++|.. .+.+++.+++.|++||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+....
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~-- 309 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-- 309 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT--
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC--
Confidence 9999999999999964 4679999999999999999999999999999999999999854 8999999999986532
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC----CCCCHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~ 241 (416)
.....+.|||+.|||||++.+.+|. .++|||||||++|+|++|.+||.+.+..+.+..|....+.++ +.+|+++
T Consensus 310 -~~~~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 310 -KQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp -TSEEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred -CCceeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 3445678999999999999998885 899999999999999999999999999999999888776654 4589999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
++||++||+.||.+|||+.|+|+||||+....+
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 999999999999999999999999999976654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-59 Score=453.31 Aligned_cols=253 Identities=21% Similarity=0.332 Sum_probs=214.7
Q ss_pred cccCEEEEeEEeecCceEEEEEEEC-----CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
.-.+|.+.+.||+|+||+||+|+.. .+++.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEG 115 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3457899999999999999999864 36789999999754 234467899999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC
Q 014909 84 TKIFIVLEFVTGGELFDKIVNH---------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~---------------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~ 148 (416)
..+|+|||||++|+|.+++... +++++.++..|+.||+.||+|||+++|+||||||+||||++++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 9999999999999999999764 3589999999999999999999999999999999999999999
Q ss_pred CeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhh
Q 014909 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS 227 (416)
Q Consensus 149 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~ 227 (416)
++||+|||+|+..............+||+.|||||++.+..|+ .++|||||||+||||+| |+.||.+.+..+....+.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999865443333334567899999999999988885 89999999999999998 999999988888888776
Q ss_pred cC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 228 AA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 228 ~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.+ .+..|+.+|+++.+|+.+||+.||++|||+.||+++
T Consensus 275 ~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 275 QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 65 467788899999999999999999999999999763
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-58 Score=445.84 Aligned_cols=264 Identities=43% Similarity=0.817 Sum_probs=243.9
Q ss_pred cccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
.....+++|++.+.||+|+||.||+|.+..+|+.||||++.+... .....+.+.+|+.+|+.++||||+++++++.+.+
T Consensus 9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK 87 (328)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 445688999999999999999999999999999999999987654 3345677899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
.+|+||||++||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++.....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~- 166 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV- 166 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS-
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC-
Confidence 9999999999999999999889999999999999999999999999999999999999999999999999999875432
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHH
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 244 (416)
.......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.......+..+.+..|..+|+++.+|
T Consensus 167 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 244 (328)
T 3fe3_A 167 --GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL 244 (328)
T ss_dssp --SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred --CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 334567799999999999998888778999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 245 IARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
|++||+.||.+|||++|+++||||+...
T Consensus 245 i~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-59 Score=448.11 Aligned_cols=255 Identities=22% Similarity=0.350 Sum_probs=223.7
Q ss_pred ccccCEEEEeEEeecCceEEEEEEEC-----CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (416)
...+.+++.+.||+|+||+||+|... .+++.||||+++... .....+.+.+|+.+|++++|||||++++++.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 35678999999999999999999853 467889999997543 22345789999999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA 146 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~ 146 (416)
++.+|+|||||++|+|.++|... ..+++..+..++.||+.||+|||+++|+||||||+||||++
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 99999999999999999999653 35899999999999999999999999999999999999999
Q ss_pred CCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHH
Q 014909 147 YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKK 225 (416)
Q Consensus 147 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~ 225 (416)
++++||+|||+|+..............+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+..+....
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999866544334445567899999999999988875 89999999999999998 9999999998888888
Q ss_pred hhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 226 ISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 226 i~~~~-~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
+..+. .+.|+.+++++.+|+.+||+.||++|||+.||+++
T Consensus 260 i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 260 IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 77654 46678899999999999999999999999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-59 Score=445.56 Aligned_cols=251 Identities=22% Similarity=0.375 Sum_probs=205.6
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
..+++++.+.||+|+||+||+|+.. ..||||+++.... .....+.+.+|+.+|++++|||||++++++.. +.+|+
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 3467889999999999999999864 3599999975443 33456789999999999999999999998754 56899
Q ss_pred EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
|||||+||+|.+++... +++++..+..++.||+.||+|||++||+||||||+||||++++++||+|||+|+........
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999999999764 57999999999999999999999999999999999999999999999999999876543334
Q ss_pred CCcccccCCcccccchhhccC---CCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHH-HhhcCc-----cCCCCCCC
Q 014909 168 GLLHTTCGTPNYVAPEVLNDR---GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK-KISAAE-----FTCPPWLS 238 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~---~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~-~i~~~~-----~~~~~~~s 238 (416)
....+.+||+.|||||++.+. .| +.++|||||||+||||+||+.||.+.+...... .+..+. ...++.+|
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y-~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 267 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPF-SFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCP 267 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSC
T ss_pred eeecccccCCCccCHHHhhccCCCCC-CcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccch
Confidence 445677999999999999743 34 589999999999999999999998866544333 333322 12345689
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 239 FTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 239 ~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
+++.+|+.+||+.||++|||+.||+++
T Consensus 268 ~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 268 KAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999988654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-56 Score=435.65 Aligned_cols=260 Identities=33% Similarity=0.613 Sum_probs=239.2
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
..+++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 35789999999999999999999999999999999998765544445678899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..... ..
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~ 159 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CC
Confidence 9999999999999999888999999999999999999999999999999999999999999999999999874322 22
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~ 247 (416)
....+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+..+......+|..+|+++.+||.+
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 344567999999999999887774 8999999999999999999999999988889888888888999999999999999
Q ss_pred hcCCCCCCCC-----CHhHHhcCccccc
Q 014909 248 ILDPNPMTRI-----TIPEILEDEWFKK 270 (416)
Q Consensus 248 ~L~~dP~~R~-----t~~eil~h~~~~~ 270 (416)
||+.||.+|| +++++++||||..
T Consensus 239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 9999999999 8999999999974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-57 Score=442.26 Aligned_cols=261 Identities=34% Similarity=0.630 Sum_probs=233.8
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 85 (416)
...+++|++.+.||+|+||+||+|++..+|+.||||++.+.........+.+.+|..+++.+ +||||+++++++.+...
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 45788999999999999999999999999999999999887655555677889999999988 69999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+|+||||++||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~-- 176 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC-- 176 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc--
Confidence 999999999999999999989999999999999999999999999999999999999999999999999999874322
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll 245 (416)
......+.|||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+...++..+......+|.++++++.+||
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 255 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGIL 255 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCccccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 22334567999999999999887774 89999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCH------hHHhcCccccc
Q 014909 246 ARILDPNPMTRITI------PEILEDEWFKK 270 (416)
Q Consensus 246 ~~~L~~dP~~R~t~------~eil~h~~~~~ 270 (416)
++||+.||.+||++ ++|++||||+.
T Consensus 256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 99999999999998 89999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-57 Score=442.96 Aligned_cols=262 Identities=48% Similarity=0.908 Sum_probs=239.3
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
+..+++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 56899999999999999999999999999999999999876554444456799999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~--- 160 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--- 160 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT---
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC---
Confidence 9999999 679999999889999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~ 246 (416)
.....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.........+....+..|..+|+++.+||+
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 240 (336)
T 3h4j_B 161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIR 240 (336)
T ss_dssp SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 33456778999999999999888777899999999999999999999998877777777777778889999999999999
Q ss_pred HhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 247 RILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
+||+.||.+|||++|+++||||+...
T Consensus 241 ~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 241 RMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp TTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred HHcCCChhHCcCHHHHHhChhhccCC
Confidence 99999999999999999999998754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-57 Score=444.41 Aligned_cols=253 Identities=23% Similarity=0.379 Sum_probs=216.0
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCC-----CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCC-CCcceEEEEEEe-
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNVVRLYEVMGS- 82 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~- 82 (416)
-++|++++.||+|+||+||+|.+..+ ++.||||.+..... ....+.+.+|+.+|++++| ||||++++++..
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 46899999999999999999987653 35799999976432 2345779999999999975 999999999865
Q ss_pred CCEEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA 146 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~ 146 (416)
+..+|+|||||++|+|.++|... ..+++..+..|+.||+.||+|||+++|+||||||+|||+++
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 46789999999999999999753 34899999999999999999999999999999999999999
Q ss_pred CCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchH-HHHH
Q 014909 147 YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM-NLYK 224 (416)
Q Consensus 147 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~-~~~~ 224 (416)
++.+||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+.. ....
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999865432222233456899999999999988885 89999999999999998 99999886543 4444
Q ss_pred HhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 225 KISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 225 ~i~~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.+..+ .+..|+.+++++.+|+.+||+.||++|||+.+|++|
T Consensus 300 ~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 45443 467788899999999999999999999999999987
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-56 Score=436.60 Aligned_cols=263 Identities=30% Similarity=0.591 Sum_probs=237.4
Q ss_pred cccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 014909 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (416)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 83 (416)
..+..+++|++.+.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|..+++.+ +||||+++++++.+.
T Consensus 11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90 (345)
T ss_dssp -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence 3467889999999999999999999999999999999999876554444567788999999876 899999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
..+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999874322
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHH
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ 243 (416)
......+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+..+......+|.++|+++.+
T Consensus 171 --~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 247 (345)
T 1xjd_A 171 --GDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 247 (345)
T ss_dssp --TTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred --CCCcccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHH
Confidence 22334567999999999999987774 899999999999999999999999999999999988888999999999999
Q ss_pred HHHHhcCCCCCCCCCHh-HHhcCccccc
Q 014909 244 LIARILDPNPMTRITIP-EILEDEWFKK 270 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~-eil~h~~~~~ 270 (416)
||.+||+.||.+||++. +|++||||+.
T Consensus 248 li~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 248 LLVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHHHhcCCHhHcCCChHHHHcCccccC
Confidence 99999999999999998 9999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=427.62 Aligned_cols=257 Identities=34% Similarity=0.718 Sum_probs=238.3
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
..+++|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 46789999999999999999999999999999999998765544445677889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence 9999999999999999988999999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~ 247 (416)
...+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+.++......+|+.+++++.+||++
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred -ccccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 23467899999999999887775 8999999999999999999999999988999999888889999999999999999
Q ss_pred hcCCCCCCCC-----CHhHHhcCccccc
Q 014909 248 ILDPNPMTRI-----TIPEILEDEWFKK 270 (416)
Q Consensus 248 ~L~~dP~~R~-----t~~eil~h~~~~~ 270 (416)
||..||.+|| +++++++||||+.
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 9999999999 9999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-55 Score=431.43 Aligned_cols=262 Identities=29% Similarity=0.533 Sum_probs=237.5
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 84 (416)
.+..+++|++.+.||+|+||+||+|++..+|+.||||++.+.........+.+.+|..+++.+ +||||+++++++.+.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 356789999999999999999999999999999999999887654444567788999999988 7999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
.+|+||||++||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 173 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 173 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc-
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999999874322
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHH
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 244 (416)
......+.+||+.|+|||++.+..|. .++|||||||++|+|++|+.||.+.+...++..+......+|..+|+++.+|
T Consensus 174 -~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 251 (353)
T 2i0e_A 174 -DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI 251 (353)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred -CCcccccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 22334567999999999999888774 8999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCC-----HhHHhcCccccc
Q 014909 245 IARILDPNPMTRIT-----IPEILEDEWFKK 270 (416)
Q Consensus 245 l~~~L~~dP~~R~t-----~~eil~h~~~~~ 270 (416)
|++||..||.+||+ +++|++||||+.
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 99999999999995 699999999974
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-55 Score=438.02 Aligned_cols=261 Identities=30% Similarity=0.575 Sum_probs=232.2
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 85 (416)
...+++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|..+++++ +||||+++++++.+...
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 45678999999999999999999999999999999999987665555567788999999877 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+|+||||++||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~-- 205 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-- 205 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc--
Confidence 999999999999999999989999999999999999999999999999999999999999999999999999874222
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCC---------chHHHHHHhhcCccCCCCC
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---------NLMNLYKKISAAEFTCPPW 236 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~---------~~~~~~~~i~~~~~~~~~~ 236 (416)
......+.|||+.|+|||++.+..|. .++|||||||++|+|++|+.||... ....++..+......+|..
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred CCCccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 23345678999999999999988774 8999999999999999999999642 2345677788888899999
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCH------hHHhcCccccc
Q 014909 237 LSFTARKLIARILDPNPMTRITI------PEILEDEWFKK 270 (416)
Q Consensus 237 ~s~~~~~ll~~~L~~dP~~R~t~------~eil~h~~~~~ 270 (416)
+|+++.+||++||+.||.+||++ +||++||||+.
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 99999999999999999999985 79999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-55 Score=429.42 Aligned_cols=258 Identities=33% Similarity=0.648 Sum_probs=239.7
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
...+++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+|+.++||||+++++++.+...+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45789999999999999999999999999999999999877655444567889999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--- 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC---
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~ 246 (416)
...+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..+...+|..+++++.+||+
T Consensus 194 --~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 270 (350)
T 1rdq_E 194 --RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred --CcccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 23467899999999999987775 899999999999999999999999999999999998989999999999999999
Q ss_pred HhcCCCCCCCCC-----HhHHhcCccccc
Q 014909 247 RILDPNPMTRIT-----IPEILEDEWFKK 270 (416)
Q Consensus 247 ~~L~~dP~~R~t-----~~eil~h~~~~~ 270 (416)
+||+.||.+||+ +++|++||||..
T Consensus 271 ~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 999999999998 999999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-55 Score=427.21 Aligned_cols=261 Identities=31% Similarity=0.586 Sum_probs=235.4
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 85 (416)
...+++|++.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+...
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 45678999999999999999999999999999999999987666666678899999999988 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~-- 162 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-- 162 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999874322
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCC---------CchHHHHHHhhcCccCCCCC
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD---------SNLMNLYKKISAAEFTCPPW 236 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~---------~~~~~~~~~i~~~~~~~~~~ 236 (416)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.. .....++..+......+|..
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 241 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred CCCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence 2233456799999999999998777 4899999999999999999999975 23345667777788889999
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCH------hHHhcCccccc
Q 014909 237 LSFTARKLIARILDPNPMTRITI------PEILEDEWFKK 270 (416)
Q Consensus 237 ~s~~~~~ll~~~L~~dP~~R~t~------~eil~h~~~~~ 270 (416)
+|.++.+||++||+.||.+||++ +++++||||+.
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 99999999999999999999995 89999999974
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-55 Score=428.30 Aligned_cols=260 Identities=33% Similarity=0.591 Sum_probs=233.9
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcH---HHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
....++|++++.||+|+||.||+|.+..+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 3456789999999999999999999999999999999987543221 1246789999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC----CeEEeeccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSA 159 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~----~vkl~DFGla~ 159 (416)
..+|+||||++||+|++++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999999999888999999999999999999999999999999999999998877 79999999997
Q ss_pred ccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC----C
Q 014909 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----P 235 (416)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~----~ 235 (416)
.... .......+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+..+....+.++ +
T Consensus 168 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 168 EIED---GVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp ECCT---TCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred EcCC---CCccccCCCCccEECchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence 5433 2334567899999999999887774 899999999999999999999999998888888888777665 4
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 236 ~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.+|+++++||.+||..||.+|||+.|+++||||+.
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 58999999999999999999999999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=421.69 Aligned_cols=263 Identities=40% Similarity=0.695 Sum_probs=227.5
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
.+++|++.+.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 678999999999999999999999999999999999765432 234678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999998655433344
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH-HHHHHhhcCccCCC--CCCCHHHHHHH
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCP--PWLSFTARKLI 245 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~s~~~~~ll 245 (416)
.....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+.. ..+..+.......+ ..+++.+.+||
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence 4556789999999999998877668899999999999999999999876543 33333333333333 34899999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 246 ARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
.+||+.||.+|||++|+++||||++...
T Consensus 243 ~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 243 HKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHccCChhhCcCHHHHhhChhhccccc
Confidence 9999999999999999999999987543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=428.54 Aligned_cols=261 Identities=34% Similarity=0.587 Sum_probs=228.9
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHH-HhcCCCCCcceEEEEEEeCCE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT-MKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~ 85 (416)
....++|++.+.||+|+||+||+|+++.+++.||||++.+...........+.+|..+ ++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 4577899999999999999999999999999999999988766555556677788877 577899999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~-- 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-- 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC--
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999875322
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll 245 (416)
......+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+..+......+|+.++.++++||
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 270 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 270 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence 22345677999999999999987775 89999999999999999999999999999999998888888999999999999
Q ss_pred HHhcCCCCCCCCCH----hHHhcCccccc
Q 014909 246 ARILDPNPMTRITI----PEILEDEWFKK 270 (416)
Q Consensus 246 ~~~L~~dP~~R~t~----~eil~h~~~~~ 270 (416)
++||+.||.+||++ .+|++||||+.
T Consensus 271 ~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 99999999999987 69999999974
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-54 Score=435.98 Aligned_cols=266 Identities=36% Similarity=0.661 Sum_probs=232.8
Q ss_pred CCcccccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 014909 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM 80 (416)
Q Consensus 1 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 80 (416)
|+........++|++.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++
T Consensus 1 M~~~~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~ 79 (444)
T 3soa_A 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSI 79 (444)
T ss_dssp ------CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred CCccccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence 344445566789999999999999999999999999999999998765433 3457789999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEec---cCCCeEEeeccc
Q 014909 81 GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD---AYGNLKVSDFGL 157 (416)
Q Consensus 81 ~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~---~~~~vkl~DFGl 157 (416)
.+.+..|+||||+.||+|++.+...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 80 SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp ECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 99999999999999999999999999999999999999999999999999999999999999998 457899999999
Q ss_pred ccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCC--
Q 014909 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-- 235 (416)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~-- 235 (416)
|..... ........+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+....+..+..+.+.+|.
T Consensus 160 a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 236 (444)
T 3soa_A 160 AIEVEG--EQQAWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE 236 (444)
T ss_dssp CBCCCT--TCCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred eEEecC--CCceeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc
Confidence 975443 22234567899999999999887774 8999999999999999999999999998888888887765543
Q ss_pred --CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 236 --WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 236 --~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.+|+++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 237 ~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 237 WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 47999999999999999999999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=426.73 Aligned_cols=260 Identities=27% Similarity=0.559 Sum_probs=235.1
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
...+++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+|+.++||||+++++++.+...+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 45788999999999999999999999999999999999877655555567899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+||||+.||+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--- 167 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--- 167 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT---
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC---
Confidence 99999999999999999988999999999999999999999999999999999999999999999999999975432
Q ss_pred CCCcccccCCcccccchhhccC---CCCCChhhHHHHHHHHHHHhhCCCCCCCC---chHHHHHHhhcCccCCCCCCCHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDR---GYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAAEFTCPPWLSFT 240 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~---~~~~~~~DIwSlGvil~~ml~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~~ 240 (416)
.....+.+||+.|+|||++... +| +.++|||||||++|+|++|..||... ........+......+|..+|++
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~ 246 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQE 246 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred CCceeccCCCccccCCeeeccCCCCCC-CccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHH
Confidence 3345678999999999999742 34 58999999999999999999999743 34566667777788889999999
Q ss_pred HHHHHHHhcCCCCCCCCC-HhHHhcCccccc
Q 014909 241 ARKLIARILDPNPMTRIT-IPEILEDEWFKK 270 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t-~~eil~h~~~~~ 270 (416)
+.+||.+||+.||.+||+ ++++++||||..
T Consensus 247 ~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 247 MVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 999999999999999998 999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=436.03 Aligned_cols=261 Identities=33% Similarity=0.611 Sum_probs=228.1
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
....++|++.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 34678999999999999999999999999999999999876554555567788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~-~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
|+||||++||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|.....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 301 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-- 301 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--
Confidence 9999999999999999988899999999999999999999998 9999999999999999999999999999875322
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll 245 (416)
........+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 380 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 380 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 22334567899999999999887774 89999999999999999999999999999999998888899999999999999
Q ss_pred HHhcCCCCCCCC-----CHhHHhcCccccc
Q 014909 246 ARILDPNPMTRI-----TIPEILEDEWFKK 270 (416)
Q Consensus 246 ~~~L~~dP~~R~-----t~~eil~h~~~~~ 270 (416)
.+||+.||.+|| |++|+++||||..
T Consensus 381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 999999999999 9999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=408.90 Aligned_cols=259 Identities=28% Similarity=0.484 Sum_probs=228.0
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
++...++|++.+.||+|+||.||+|.+..+++.||||++....... .+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 91 (297)
T 3fxz_A 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (297)
T ss_dssp SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCE
Confidence 4556789999999999999999999999999999999997654333 4668899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
.|+||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 169 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE- 169 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST-
T ss_pred EEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc-
Confidence 99999999999999999764 6999999999999999999999999999999999999999999999999998754332
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhc---CccCCCCCCCHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---AEFTCPPWLSFTAR 242 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~---~~~~~~~~~s~~~~ 242 (416)
.......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+.. .....|..++..+.
T Consensus 170 -~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T 3fxz_A 170 -QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (297)
T ss_dssp -TCCBCCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHH
T ss_pred -ccccCCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHH
Confidence 2234566899999999999988774 899999999999999999999998876655544432 23445667899999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 243 KLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
+||.+||+.||.+|||++|+++||||+..
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 99999999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=432.14 Aligned_cols=264 Identities=34% Similarity=0.578 Sum_probs=231.2
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
+....++|++.+.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 34567899999999999999999999999999999999987554433334568899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+|+||||++||+|.+++.. ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|.......
T Consensus 144 ~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 9999999999999999876 579999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCCcccccCCcccccchhhccCC---CCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc--cCCC--CCCC
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCP--PWLS 238 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~---~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~s 238 (416)
.....+.+||+.|+|||++.+.+ +.+.++|||||||++|+|++|+.||.+.+....+.++.... +.+| ..+|
T Consensus 223 -~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 301 (410)
T 3v8s_A 223 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301 (410)
T ss_dssp -EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred -cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence 11234678999999999998655 23589999999999999999999999999888888876542 3444 4699
Q ss_pred HHHHHHHHHhcCCCCCC--CCCHhHHhcCcccccC
Q 014909 239 FTARKLIARILDPNPMT--RITIPEILEDEWFKKD 271 (416)
Q Consensus 239 ~~~~~ll~~~L~~dP~~--R~t~~eil~h~~~~~~ 271 (416)
+++++||++||..+|.+ |++++||++||||+..
T Consensus 302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 99999999999999999 9999999999999863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-54 Score=404.45 Aligned_cols=266 Identities=48% Similarity=0.900 Sum_probs=232.5
Q ss_pred cccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
......++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 44567899999999999999999999999999999999998765444445678999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
..|+||||+++++|.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~- 163 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD- 163 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC-
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999999875432
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHH
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 244 (416)
.......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.......+.......|..++.++.+|
T Consensus 164 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 241 (276)
T 2h6d_A 164 --GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATL 241 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred --CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHH
Confidence 223345689999999999988777668999999999999999999999998888888888888888888999999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 245 IARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
|.+||+.||.+|||+.++++||||++...
T Consensus 242 i~~~l~~~p~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 242 LMHMLQVDPLKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHHHccCChhhCCCHHHHHhChhhccCch
Confidence 99999999999999999999999987653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=404.32 Aligned_cols=263 Identities=36% Similarity=0.685 Sum_probs=237.4
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
....+++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 35678999999999999999999999999999999999987665555556789999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
.|+||||+++|+|.+.+.....+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~-- 161 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 161 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999998864322
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll 245 (416)
......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......|..++.++.+||
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (279)
T 3fdn_A 162 --SRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred --ccccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHH
Confidence 22345689999999999987666 489999999999999999999999999888888888888889999999999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 246 ARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
.+||+.||.+|||++|+++||||+....
T Consensus 239 ~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 239 SRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp HHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred HHHhccChhhCCCHHHHhhCccccCCcc
Confidence 9999999999999999999999987554
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=404.85 Aligned_cols=258 Identities=33% Similarity=0.503 Sum_probs=218.4
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+++|++.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 4789999999999999999999999999999999986553 233457788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 90 LEFVTGGELFDKIV-NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 90 ~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
|||+.+ +|.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 156 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVR 156 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCS
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--ccc
Confidence 999987 5555554 467899999999999999999999999999999999999999999999999999976532 223
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCC-CCCCchHHHHHHhhcCc-----------------
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKISAAE----------------- 230 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~P-f~~~~~~~~~~~i~~~~----------------- 230 (416)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..| |.+.+.......+....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 345668999999999998776556999999999999999988777 55555555554442210
Q ss_pred ------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 231 ------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 231 ------------~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
....+.+++++++||++||+.||++|||++|+++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 01123478999999999999999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=419.72 Aligned_cols=257 Identities=37% Similarity=0.689 Sum_probs=231.1
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
..++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 346799999999999999999999999999999999876543 3345779999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC---CeEEeeccccccccccc
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALSQQVR 165 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~---~vkl~DFGla~~~~~~~ 165 (416)
||||++||+|++.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~-- 183 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-- 183 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT--
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC--
Confidence 999999999999999888999999999999999999999999999999999999998654 599999999875432
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCC----CCCHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLSFTA 241 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~ 241 (416)
.......+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+..+..+.+.+|. .+++++
T Consensus 184 -~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (362)
T 2bdw_A 184 -SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 261 (362)
T ss_dssp -CCSCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred -CcccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 2334567899999999999887775 8999999999999999999999999888888888877766553 379999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 242 RKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.+||.+||+.||.+|||+.++|+||||..
T Consensus 262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 262 KSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 99999999999999999999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=413.79 Aligned_cols=261 Identities=34% Similarity=0.609 Sum_probs=224.8
Q ss_pred cccccCEEEEeEEeecCceEEEEEEEC---CCCCeEEEEEeechhhhc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLK-HKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (416)
....++|++.+.||+|+||.||+|++. .+|+.||+|++.+..... ......+.+|+.+|+.++||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 456789999999999999999999985 689999999998754322 2234668899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
.+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999987532
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHH
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~ 242 (416)
. ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|+.+++++.
T Consensus 173 ~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 249 (327)
T 3a62_A 173 H--DGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR 249 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred c--CCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 2 1223456789999999999988777 489999999999999999999999999888888888888889999999999
Q ss_pred HHHHHhcCCCCCCCC-----CHhHHhcCccccc
Q 014909 243 KLIARILDPNPMTRI-----TIPEILEDEWFKK 270 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~-----t~~eil~h~~~~~ 270 (416)
+||.+||+.||.+|| +++++++||||+.
T Consensus 250 ~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 999999999999999 8899999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=413.35 Aligned_cols=255 Identities=25% Similarity=0.494 Sum_probs=229.8
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 4689999999999999999999999999999999997543 234668899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc--CCCeEEeeccccccccccc
Q 014909 89 VLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~--~~~vkl~DFGla~~~~~~~ 165 (416)
||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~-- 156 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence 999999999999997754 7999999999999999999999999999999999999987 78999999999976532
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC----CCCCHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~ 241 (416)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....+.++ +.+|.++
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 157 -GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp -TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred -CCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence 233456789999999999987655 5899999999999999999999999988888888887776665 3689999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
.+||.+||..||.+|||+.|+++||||+..
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 999999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-54 Score=432.12 Aligned_cols=263 Identities=27% Similarity=0.495 Sum_probs=229.5
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
....++|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 45668999999999999999999999999999999999875544433345588999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
|+||||++||+|.+++.. .+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|......
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~- 228 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED- 228 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC-
Confidence 999999999999999987 578999999999999999999999999999999999999999999999999999754321
Q ss_pred CCCCcccccCCcccccchhhcc----CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC--ccCCCC---C
Q 014909 166 DDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPP---W 236 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~----~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~--~~~~~~---~ 236 (416)
........+||+.|+|||++.. ....+.++|||||||++|+|++|+.||.+.+..+.+.++... .+.+|. .
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 308 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCC
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccccc
Confidence 1112334689999999999972 233358999999999999999999999999988888887543 344554 4
Q ss_pred CCHHHHHHHHHhcCCCCCC--CCCHhHHhcCccccc
Q 014909 237 LSFTARKLIARILDPNPMT--RITIPEILEDEWFKK 270 (416)
Q Consensus 237 ~s~~~~~ll~~~L~~dP~~--R~t~~eil~h~~~~~ 270 (416)
+|+++++||++||..+|++ |++++|+++||||+.
T Consensus 309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 309 VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 8999999999999999988 999999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=411.77 Aligned_cols=260 Identities=36% Similarity=0.605 Sum_probs=231.0
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcH---HHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
....++|++.+.||+|+||.||+|.+..+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.+.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3455789999999999999999999999999999999986543211 1256789999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC----CeEEeeccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSA 159 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~----~vkl~DFGla~ 159 (416)
...|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999999999998888999999999999999999999999999999999999999887 79999999997
Q ss_pred ccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC----C
Q 014909 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----P 235 (416)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~----~ 235 (416)
.... .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+......++ +
T Consensus 167 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 167 KIDF---GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp ECCT---TSCCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred ECCC---CCccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 6532 2234566899999999999877764 899999999999999999999999888887777776665554 4
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 236 ~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.++..+.+||++||+.||.+|||+.++++||||+.
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 58999999999999999999999999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=418.33 Aligned_cols=259 Identities=42% Similarity=0.758 Sum_probs=217.7
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
...++|++.+.||+|+||.||+|++..+++.||||++...... .+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 4568999999999999999999999999999999999765432 256789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCC--eEEeeccccccccccc
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVR 165 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~--vkl~DFGla~~~~~~~ 165 (416)
+||||++||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|.....
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-- 170 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 170 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence 99999999999999998889999999999999999999999999999999999999987765 99999999874322
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch----HHHHHHhhcCccCCCC--CCCH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFTCPP--WLSF 239 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~----~~~~~~i~~~~~~~~~--~~s~ 239 (416)
.......+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+... ......+......+|. .+++
T Consensus 171 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 171 -HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred -cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence 22334568999999999999888876669999999999999999999987543 3455556556665555 4799
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
++.+||.+||+.||.+|||+.|+++||||.+...
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 9999999999999999999999999999987543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=407.13 Aligned_cols=261 Identities=36% Similarity=0.675 Sum_probs=221.2
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhc-----------------------HHHHHHHHHHHH
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-----------------------HKMAEQIKREVA 63 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~-----------------------~~~~~~~~~Ei~ 63 (416)
...+++|++.+.||+|+||.||+|.+..+++.||||++.+..... ....+.+.+|+.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 457899999999999999999999999999999999997654321 112456889999
Q ss_pred HHhcCCCCCcceEEEEEEe--CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCc
Q 014909 64 TMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141 (416)
Q Consensus 64 il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~N 141 (416)
+++.++||||+++++++.+ ...+|+||||+++++|.+++. ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 9999999999999999986 678999999999999987543 4679999999999999999999999999999999999
Q ss_pred EEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCC--CCChhhHHHHHHHHHHHhhCCCCCCCCch
Q 014909 142 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY--DGSTADLWSCGVILFVLLAGYLPFDDSNL 219 (416)
Q Consensus 142 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~--~~~~~DIwSlGvil~~ml~G~~Pf~~~~~ 219 (416)
||++.++.+||+|||++..... ........+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+.+.
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 9999999999999999875432 1223345689999999999976542 45789999999999999999999999888
Q ss_pred HHHHHHhhcCccCCC--CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 220 MNLYKKISAAEFTCP--PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 220 ~~~~~~i~~~~~~~~--~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
......+.......| +.+++++.+||.+||+.||.+|||+.|+++||||++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 777777766655444 468999999999999999999999999999999963
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-53 Score=400.55 Aligned_cols=265 Identities=34% Similarity=0.712 Sum_probs=239.0
Q ss_pred ccccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
+.....+++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 86 (284)
T 2vgo_A 7 PKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR 86 (284)
T ss_dssp ---CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC
Confidence 44566789999999999999999999999999999999999876554444457899999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
...|+||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999865432
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHH
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ 243 (416)
......+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+......+|+.++.++.+
T Consensus 167 ----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T 2vgo_A 167 ----LRRRTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKD 241 (284)
T ss_dssp ----SCBCCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHH
T ss_pred ----cccccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHH
Confidence 223456899999999999887764 899999999999999999999999888888888888888889999999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 244 LIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
||.+||+.||.+|||++++++||||+...+
T Consensus 242 li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 242 LISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 999999999999999999999999986543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-53 Score=447.45 Aligned_cols=261 Identities=30% Similarity=0.542 Sum_probs=238.8
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 85 (416)
...+++|++++.||+|+||.||+|.+..+++.||||++.+.........+.+.+|..++..+ +||||+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 34678999999999999999999999999999999999876554445567788999999988 69999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+|+||||++||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|.....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~-- 494 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-- 494 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--
Confidence 999999999999999999988999999999999999999999999999999999999999999999999999874322
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll 245 (416)
......+.+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+...++..|......+|..+|+++.+||
T Consensus 495 ~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 573 (674)
T 3pfq_A 495 DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 573 (674)
T ss_dssp TTCCBCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 22345677999999999999888874 89999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCH-----hHHhcCccccc
Q 014909 246 ARILDPNPMTRITI-----PEILEDEWFKK 270 (416)
Q Consensus 246 ~~~L~~dP~~R~t~-----~eil~h~~~~~ 270 (416)
++||+.||.+||++ +||++||||+.
T Consensus 574 ~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 99999999999998 99999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=426.01 Aligned_cols=263 Identities=27% Similarity=0.494 Sum_probs=228.2
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
.....++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|..++..++||||+++++++.+...
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 34567899999999999999999999999999999999987654444445668899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
+|+||||++||+|.+++...+ .+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|......
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 999999999999999998754 7999999999999999999999999999999999999999999999999999754321
Q ss_pred cCCCCcccccCCcccccchhhcc------CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC--ccCCC--
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLND------RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCP-- 234 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~------~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~--~~~~~-- 234 (416)
. .......+||+.|+|||++.. ....+.++|||||||++|+|++|+.||.+.+....+.++... ...+|
T Consensus 216 ~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 294 (412)
T 2vd5_A 216 G-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294 (412)
T ss_dssp S-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred C-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence 1 111235689999999999973 223358999999999999999999999999888888777643 23334
Q ss_pred -CCCCHHHHHHHHHhcCCCCCCC---CCHhHHhcCccccc
Q 014909 235 -PWLSFTARKLIARILDPNPMTR---ITIPEILEDEWFKK 270 (416)
Q Consensus 235 -~~~s~~~~~ll~~~L~~dP~~R---~t~~eil~h~~~~~ 270 (416)
..+|+++++||++||. +|.+| ++++||++||||+.
T Consensus 295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 5799999999999999 99998 59999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=416.87 Aligned_cols=267 Identities=24% Similarity=0.382 Sum_probs=224.1
Q ss_pred ccccccccCEEEEeEEeec--CceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 014909 4 PKIKRRVGKYEVGRTIGEG--TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (416)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G--~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 81 (416)
++.....++|++++.||+| +||.||+|.+..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++.
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 96 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFI 96 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence 3456678999999999999 9999999999999999999999876543 345688999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 82 SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 82 ~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
+.+.+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 999999999999999999999876 679999999999999999999999999999999999999999999999999876
Q ss_pred cccccc-----CCCCcccccCCcccccchhhcc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc--
Q 014909 160 LSQQVR-----DDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-- 230 (416)
Q Consensus 160 ~~~~~~-----~~~~~~~~~gt~~y~aPEvl~~--~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~-- 230 (416)
...... ........+||+.|+|||++.+ ..| +.++|||||||++|+|++|+.||.+.+.......+..+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 432211 1122334589999999999987 345 589999999999999999999998765544333322111
Q ss_pred --------------------------------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCc
Q 014909 231 --------------------------------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDE 266 (416)
Q Consensus 231 --------------------------------------------~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~ 266 (416)
...+..+++++.+||++||+.||.+|||+.|+|+||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 113345789999999999999999999999999999
Q ss_pred ccccCC
Q 014909 267 WFKKDY 272 (416)
Q Consensus 267 ~~~~~~ 272 (416)
||+...
T Consensus 336 ~f~~~~ 341 (389)
T 3gni_B 336 FFKQIK 341 (389)
T ss_dssp GGGGC-
T ss_pred HHHHHh
Confidence 998643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-53 Score=414.25 Aligned_cols=258 Identities=35% Similarity=0.651 Sum_probs=223.3
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcH--HHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH--KMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
.-++|++.+.||+|+||.||+|.+..+|+.||||++........ ...+.+.+|+.+++.++||||+++++++.+...+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34689999999999999999999999999999999976543221 1256789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCC---eEEeeccccc
Q 014909 87 FIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSA 159 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~---vkl~DFGla~ 159 (416)
|+||||++||+|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999998887643 35899999999999999999999999999999999999987655 9999999997
Q ss_pred ccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC----C
Q 014909 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----P 235 (416)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~----~ 235 (416)
.... ........+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.. ...+..+..+.+..+ +
T Consensus 182 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~ 257 (351)
T 3c0i_A 182 QLGE--SGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWS 257 (351)
T ss_dssp ECCT--TSCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHT
T ss_pred EecC--CCeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccc
Confidence 6543 1222345689999999999988777 489999999999999999999998854 455566666655544 4
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 236 ~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 58999999999999999999999999999999975
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-53 Score=400.04 Aligned_cols=264 Identities=34% Similarity=0.643 Sum_probs=211.8
Q ss_pred cccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
.++..+++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (278)
T 3cok_A 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN 84 (278)
T ss_dssp HHCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred ccccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence 35678899999999999999999999999999999999998765544445678999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999999999875 5799999999999999999999999999999999999999999999999999876442
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHH
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ 243 (416)
.. ......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......|..++.++.+
T Consensus 165 ~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (278)
T 3cok_A 165 PH--EKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKD 241 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHH
T ss_pred CC--CcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHH
Confidence 21 22335679999999999987666 4889999999999999999999998777666666666667788889999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 244 LIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
||.+||+.||.+|||++++++||||...
T Consensus 242 li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 242 LIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 9999999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-53 Score=406.34 Aligned_cols=262 Identities=28% Similarity=0.429 Sum_probs=217.1
Q ss_pred cccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
......++|++.+.||+|+||.||+|.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSER 92 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence 34557789999999999999999999995 589999999976542 2334577889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
..|+||||+++ +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99999999986 888887765 4599999999999999999999999999999999999999999999999999976532
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc--c----------
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--F---------- 231 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~--~---------- 231 (416)
........+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+.... .
T Consensus 172 --~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 172 --PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp --CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred --CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 22234456899999999999875555689999999999999999999998776554444432210 0
Q ss_pred ------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 232 ------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 232 ------------------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
...+.+++++.+||.+||+.||.+|||++|+++||||+.-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 0123467899999999999999999999999999999853
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=408.60 Aligned_cols=247 Identities=21% Similarity=0.307 Sum_probs=193.5
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----EE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----KI 86 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~ 86 (416)
.+|.+.+.||+|+||+||+|++ +|+.||||+++.... .....+.|+..+.+++|||||++++++..++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4689999999999999999997 588999999975432 1223445777778899999999999987643 68
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeecCCCCcEEeccCCCeEEeecccc
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR--------GVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~--------givHrDlkp~NILl~~~~~vkl~DFGla 158 (416)
|+|||||+||+|.+++.. .+++++.+..++.|++.||+|||++ +|+||||||+||||+.++++||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999999976 5699999999999999999999987 9999999999999999999999999999
Q ss_pred cccccccC--CCCcccccCCcccccchhhccCCC-----CCChhhHHHHHHHHHHHhhCCCCCCCC--------------
Q 014909 159 ALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGY-----DGSTADLWSCGVILFVLLAGYLPFDDS-------------- 217 (416)
Q Consensus 159 ~~~~~~~~--~~~~~~~~gt~~y~aPEvl~~~~~-----~~~~~DIwSlGvil~~ml~G~~Pf~~~-------------- 217 (416)
+....... .......+||+.|||||++.+... .+.++|||||||+||||+||.+||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 86543221 112335689999999999976421 246899999999999999998766321
Q ss_pred -chHHHHHHhhcCc--cCCCCC-----CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 218 -NLMNLYKKISAAE--FTCPPW-----LSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 218 -~~~~~~~~i~~~~--~~~~~~-----~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
....+...+.... +.+|.. .+..+.+|+.+||+.||++|||+.||++
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1223333333222 233322 2246789999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=396.84 Aligned_cols=264 Identities=35% Similarity=0.579 Sum_probs=240.5
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
...++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45678999999999999999999999999999999998776555566788999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
+||||++|++|.+++...+.+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--G 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC--c
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998764322 2
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~ 247 (416)
......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||........+..+.......|..+++.+.+||.+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence 23345679999999999987766 48999999999999999999999998888888888888888889999999999999
Q ss_pred hcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 248 ILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 248 ~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
||+.||++|||++++++||||.....+
T Consensus 249 ~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 249 MLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred HcccChhhCcCHHHHhhChheecCCcC
Confidence 999999999999999999999876644
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-53 Score=435.26 Aligned_cols=260 Identities=28% Similarity=0.443 Sum_probs=233.5
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
....++|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+...+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 35678899999999999999999999999999999999876655444567788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
|+||||++||+|.+++...+ .+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~- 338 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE- 338 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc-
Confidence 99999999999999998754 499999999999999999999999999999999999999999999999999975432
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc----hHHHHHHhhcCccCCCCCCCHH
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPPWLSFT 240 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~ 240 (416)
.......+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+ ...+...+......+|..+|++
T Consensus 339 --~~~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~ 415 (576)
T 2acx_A 339 --GQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ 415 (576)
T ss_dssp --TCCEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred --CccccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHH
Confidence 2334567999999999999887775 89999999999999999999998753 3456667777777788899999
Q ss_pred HHHHHHHhcCCCCCCCC-----CHhHHhcCccccc
Q 014909 241 ARKLIARILDPNPMTRI-----TIPEILEDEWFKK 270 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~-----t~~eil~h~~~~~ 270 (416)
+++||++||+.||.+|| +++|+++||||+.
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 99999999999999999 7899999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=405.32 Aligned_cols=265 Identities=35% Similarity=0.577 Sum_probs=241.3
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
...++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34578999999999999999999999999999999998776555566788999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
+||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~ 195 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--G 195 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC--c
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998765322 2
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~ 247 (416)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........+..+.......|..+++.+.+||.+
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 23345689999999999988766 48999999999999999999999998888888888888888899999999999999
Q ss_pred hcCCCCCCCCCHhHHhcCcccccCCCCC
Q 014909 248 ILDPNPMTRITIPEILEDEWFKKDYKPP 275 (416)
Q Consensus 248 ~L~~dP~~R~t~~eil~h~~~~~~~~~~ 275 (416)
||+.||.+|||++++++||||...+.+.
T Consensus 275 ~l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 275 MLQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HccCChhHCcCHHHHhcCccccCCCccc
Confidence 9999999999999999999999876543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=431.41 Aligned_cols=261 Identities=27% Similarity=0.400 Sum_probs=233.8
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
+...++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+|+.++||||+++++++.+...+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999877655444567889999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
|+||||++||+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||++....
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999999764 369999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCC----chHHHHHHhhcCccCCCCCCC
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS----NLMNLYKKISAAEFTCPPWLS 238 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s 238 (416)
.. .......+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+. ....+...+......+|+.+|
T Consensus 341 ~~--~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s 417 (543)
T 3c4z_A 341 AG--QTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417 (543)
T ss_dssp TT--CCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred CC--CcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccC
Confidence 21 2223456999999999999987775 8999999999999999999999875 345677777778888899999
Q ss_pred HHHHHHHHHhcCCCCCCCCC-----HhHHhcCccccc
Q 014909 239 FTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 270 (416)
Q Consensus 239 ~~~~~ll~~~L~~dP~~R~t-----~~eil~h~~~~~ 270 (416)
+++.+||++||+.||.+||+ +++|++||||+.
T Consensus 418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 99999999999999999996 489999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=399.92 Aligned_cols=256 Identities=32% Similarity=0.490 Sum_probs=214.9
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+++|++.+.||+|+||.||+|.+ .+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 47899999999999999999999 67899999999765432 22346788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
|||+++ +|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VR 155 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--cc
Confidence 999986 899988764 67999999999999999999999999999999999999999999999999998754321 12
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC--cc---------------
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EF--------------- 231 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~--~~--------------- 231 (416)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+... ..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 2345678999999999987655568999999999999999999999988766555444221 00
Q ss_pred ------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 232 ------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 232 ------------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.....+++++.+||++||+.||++|||++|+++||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 112347899999999999999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=391.31 Aligned_cols=260 Identities=36% Similarity=0.680 Sum_probs=232.1
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
...++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+....|
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 3568999999999999999999999999999999999876543 334577899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCC---eEEeecccccccccc
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQV 164 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~---vkl~DFGla~~~~~~ 164 (416)
+||||++|++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~- 160 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND- 160 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc-
Confidence 99999999999999998889999999999999999999999999999999999999987665 99999999875432
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC----CCCCHH
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFT 240 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~ 240 (416)
........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+..+....| ..++++
T Consensus 161 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T 3kk8_A 161 --SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 237 (284)
T ss_dssp --SCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred --CccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHH
Confidence 233345689999999999988777 4899999999999999999999999888888888777665544 357999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
+.+||.+||+.||.+|||++++++||||+...
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 238 AKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 99999999999999999999999999998643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=394.72 Aligned_cols=263 Identities=40% Similarity=0.695 Sum_probs=228.6
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
.+++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 678999999999999999999999999999999999765432 245788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++..........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 99999999999999887889999999999999999999999999999999999999999999999999987654433333
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH-HHHHHhhcCccCCC--CCCCHHHHHHH
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCP--PWLSFTARKLI 245 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~s~~~~~ll 245 (416)
.....+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.. ..+..+.......+ ..+++.+.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 4456789999999999988777667899999999999999999999876543 33333333322222 35899999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 246 ARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
.+||+.||.+|||++++++||||++...
T Consensus 243 ~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 243 HKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHCCCCchhCCCHHHHhcCccccChhh
Confidence 9999999999999999999999987543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=413.03 Aligned_cols=260 Identities=27% Similarity=0.542 Sum_probs=229.3
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
+...++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+|+.++||||+++++++.+...+
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 4556899999999999999999999999999999999976532 2245788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc--CCCeEEeeccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~--~~~vkl~DFGla~~~~~ 163 (416)
|+||||+.||+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999999999997654 7999999999999999999999999999999999999974 47799999999975432
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC----CCCCH
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSF 239 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 239 (416)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++ ..+++
T Consensus 204 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 279 (387)
T 1kob_A 204 ---DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279 (387)
T ss_dssp ---TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ---CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCH
Confidence 233456689999999999988776 4899999999999999999999999888877777766654443 35799
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
++.+||.+||+.||.+|||+.++++||||+....
T Consensus 280 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 9999999999999999999999999999987543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=405.30 Aligned_cols=260 Identities=29% Similarity=0.460 Sum_probs=207.6
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++.+++..|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 35789999999999999999999999999999999976542 2224668899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 89 VLEFVTGGELFDKIVNH------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
||||++| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9999985 999988754 358999999999999999999999999999999999999999999999999987653
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc------------
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------ 230 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~------------ 230 (416)
.. .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 160 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 21 2234456899999999999875544689999999999999999999999888766655542210
Q ss_pred ----------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 231 ----------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 231 ----------------------~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
...+..++.++.+||.+||+.||.+|||++|+++||||...+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 0112247889999999999999999999999999999987554
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=415.42 Aligned_cols=262 Identities=29% Similarity=0.409 Sum_probs=211.1
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCC--
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKT-- 84 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~-- 84 (416)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.+. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 35689999999999999999999999999999999987543 23344677889999999997 999999999997544
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
.+|+||||+.+ +|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 85 DVYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp CEEEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 79999999984 89888876 57999999999999999999999999999999999999999999999999999754321
Q ss_pred -------------------cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHH
Q 014909 165 -------------------RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK 225 (416)
Q Consensus 165 -------------------~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~ 225 (416)
.........+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0112234568999999999998755556899999999999999999999999887766655
Q ss_pred hhcCcc-----------------------------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014909 226 ISAAEF-----------------------------------------------TCPPWLSFTARKLIARILDPNPMTRIT 258 (416)
Q Consensus 226 i~~~~~-----------------------------------------------~~~~~~s~~~~~ll~~~L~~dP~~R~t 258 (416)
+..... ..+..+++++.+||++||+.||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 532100 011257889999999999999999999
Q ss_pred HhHHhcCcccccCC
Q 014909 259 IPEILEDEWFKKDY 272 (416)
Q Consensus 259 ~~eil~h~~~~~~~ 272 (416)
++|+|+||||+...
T Consensus 323 ~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 323 ANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHTTSTTTTTTC
T ss_pred HHHHhCCHHHHHhc
Confidence 99999999997643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-52 Score=398.29 Aligned_cols=259 Identities=28% Similarity=0.458 Sum_probs=217.1
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 5799999999999999999999999999999999876542 333457788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
|||+++++|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..... ....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~ 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG--PSDY 158 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC--cccc
Confidence 99999999999988888899999999999999999999999999999999999999999999999999976442 2223
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC--------------------
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------------------- 229 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~-------------------- 229 (416)
....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 345689999999999987555568999999999999999999999988766544433211
Q ss_pred -ccCCC----------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 230 -EFTCP----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 230 -~~~~~----------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
..+.+ +.++.++.+||.+||+.||.+|||++++++||||+.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 00111 3478899999999999999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=407.01 Aligned_cols=262 Identities=27% Similarity=0.413 Sum_probs=213.6
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
....+++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.+...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 45678899999999999999999999999999999999976543 23345667899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEec-----cCCCeEEeecccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-----AYGNLKVSDFGLSAL 160 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~-----~~~~vkl~DFGla~~ 160 (416)
+|+||||+.| +|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999985 9999999988999999999999999999999999999999999999994 445599999999976
Q ss_pred cccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc--c-------
Q 014909 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--F------- 231 (416)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~--~------- 231 (416)
.... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.... .
T Consensus 187 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 187 FGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 5322 2234556789999999999876655699999999999999999999999887766655543211 0
Q ss_pred --CCCC-------------------CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 232 --TCPP-------------------WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 232 --~~~~-------------------~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
..+. .+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 0011 167899999999999999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=409.89 Aligned_cols=254 Identities=35% Similarity=0.646 Sum_probs=222.5
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 86 (416)
...++|++.+.||+|+||.||+|.+..+|+.||||++.+... ...+|+.++.++ +||||+++++++.+....
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 346789999999999999999999999999999999976542 234688888777 799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC-C---CeEEeecccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-G---NLKVSDFGLSALSQ 162 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~-~---~vkl~DFGla~~~~ 162 (416)
|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+... + .+||+|||++....
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999999999999998899999999999999999999999999999999999998543 3 49999999997643
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCC---CchHHHHHHhhcCccCCC----C
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD---SNLMNLYKKISAAEFTCP----P 235 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~---~~~~~~~~~i~~~~~~~~----~ 235 (416)
. ......+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+ .+...+...+..+.+.++ +
T Consensus 172 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 248 (342)
T 2qr7_A 172 A--ENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248 (342)
T ss_dssp C--TTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred C--CCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence 3 22345577999999999999877665 899999999999999999999986 345567777777766554 4
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 236 ~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
.+|+++.+||++||..||.+|||+.++++||||...
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 589999999999999999999999999999999754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-52 Score=391.71 Aligned_cols=258 Identities=40% Similarity=0.683 Sum_probs=231.4
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
.+...++|++.+.||+|+||.||+|.+..++..||+|++...... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD 80 (277)
T ss_dssp --CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence 345667899999999999999999999999999999999765432 25678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEe---ccCCCeEEeecccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl---~~~~~vkl~DFGla~~~~ 162 (416)
.|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999999999999988899999999999999999999999999999999999999 778999999999987543
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCC----CCC
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLS 238 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s 238 (416)
. .......+||+.|+|||++.+. + +.++||||||+++|+|++|..||...+.......+..+....|. .++
T Consensus 161 ~---~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (277)
T 3f3z_A 161 P---GKMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVS 235 (277)
T ss_dssp T---TSCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSC
T ss_pred C---ccchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCC
Confidence 2 2334567899999999998754 4 58999999999999999999999999888888888877776664 589
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 239 FTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 239 ~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
+.+.+||.+||+.||.+|||+.++++||||++.
T Consensus 236 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 236 PQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 999999999999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=429.29 Aligned_cols=260 Identities=36% Similarity=0.660 Sum_probs=233.3
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
...++|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34568999999999999999999999999999999998765544445678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEe---ccCCCeEEeecccccccccc
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl---~~~~~vkl~DFGla~~~~~~ 164 (416)
+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|.....
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~- 181 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA- 181 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc-
Confidence 999999999999999998999999999999999999999999999999999999999 4678999999999875432
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC--C--CCCHH
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--P--WLSFT 240 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~--~--~~s~~ 240 (416)
.......+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+.+.......+..+.+.++ . .+|++
T Consensus 182 --~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 257 (484)
T 3nyv_A 182 --SKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 257 (484)
T ss_dssp --CCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred --ccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence 234456789999999999976 45 5899999999999999999999999998888888877765443 2 38999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
+++||++||+.||.+|||+.++|+||||+...
T Consensus 258 ~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 258 AKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred HHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 99999999999999999999999999998654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-52 Score=425.03 Aligned_cols=262 Identities=34% Similarity=0.635 Sum_probs=230.1
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcH----------HHHHHHHHHHHHHhcCCCCCcceE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH----------KMAEQIKREVATMKLVKHPNVVRL 76 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~----------~~~~~~~~Ei~il~~l~hpnIv~l 76 (416)
+...++|++++.||+|+||.||+|.+..+++.||+|++.+...... ...+.+.+|+.+|+.++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 3456789999999999999999999999999999999987543321 235678999999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC---CeEEe
Q 014909 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVS 153 (416)
Q Consensus 77 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~---~vkl~ 153 (416)
++++.+...+|+||||++||+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999999999999888999999999999999999999999999999999999998876 69999
Q ss_pred ecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCC
Q 014909 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 233 (416)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~ 233 (416)
|||+|..... .......+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+.+.......+..+.+.+
T Consensus 192 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 192 DFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp CCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred ECCCCEEcCC---CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999976543 233456789999999999874 45 589999999999999999999999999999988888887665
Q ss_pred C----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 234 P----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 234 ~----~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
+ +.+|+++++||++||+.||.+|||++|+|+||||++...
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 5 458999999999999999999999999999999987543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=399.43 Aligned_cols=260 Identities=33% Similarity=0.589 Sum_probs=231.4
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcH---HHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
....++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4456789999999999999999999999999999999986543221 1256789999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC----CeEEeeccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSA 159 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~----~vkl~DFGla~ 159 (416)
...|+||||++|++|.+++...+.+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999999999888899999999999999999999999999999999999999888 79999999987
Q ss_pred ccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC----C
Q 014909 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----P 235 (416)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~----~ 235 (416)
.... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+ +
T Consensus 168 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 168 EIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp ECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred ecCc---cccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence 5433 223345679999999999987776 4899999999999999999999999888888887777666554 4
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 236 ~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.+++.+.+||.+||+.||.+|||++++++||||..
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 68999999999999999999999999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=404.32 Aligned_cols=255 Identities=36% Similarity=0.681 Sum_probs=205.4
Q ss_pred cccCEEEE---eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCC
Q 014909 9 RVGKYEVG---RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKT 84 (416)
Q Consensus 9 ~~~~y~~~---~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 84 (416)
...+|++. +.||+|+||.||+|.+..+++.||||++.+.. ...+.+|+.+++.+. ||||+++++++.+..
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 45678886 78999999999999999999999999997542 456779999999997 999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC---CeEEeeccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALS 161 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~---~vkl~DFGla~~~ 161 (416)
..|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999999999989999999999999999999999999999999999999998766 7999999999754
Q ss_pred ccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc-------hHHHHHHhhcCccCCC
Q 014909 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-------LMNLYKKISAAEFTCP 234 (416)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~-------~~~~~~~i~~~~~~~~ 234 (416)
.. ........+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+ .......+..+.+.++
T Consensus 160 ~~--~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 160 PP--DNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp CC------------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred CC--CCCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 33 22334567899999999999887775 89999999999999999999998643 3456677777766655
Q ss_pred C----CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 235 P----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 235 ~----~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
. .+|+++.+||.+||+.||.+|||++++++||||+...
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 3 4899999999999999999999999999999998654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=424.33 Aligned_cols=261 Identities=35% Similarity=0.635 Sum_probs=230.0
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
+...++|++.+.||+|+||.||+|.+..+++.||||++.+...... ....+.+|+.+|+.++||||+++++++.+...+
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence 4567889999999999999999999999999999999986543322 356789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEec---cCCCeEEeeccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD---AYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~---~~~~vkl~DFGla~~~~~ 163 (416)
|+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|.....
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999999999888999999999999999999999999999999999999995 456799999999976533
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC--C--CCCH
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--P--WLSF 239 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~--~--~~s~ 239 (416)
.......+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+.+.......+..+.+.++ . .+|+
T Consensus 177 ---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 251 (486)
T 3mwu_A 177 ---NTKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (486)
T ss_dssp ---C----CCTTGGGGCCGGGGGS-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCH
T ss_pred ---CCccCCCcCCCCCCCHHHhCC-CC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCH
Confidence 233456789999999999976 35 5899999999999999999999999998888888877765443 2 3899
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
++++||++||+.||.+|||+.++|+||||+....
T Consensus 252 ~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 9999999999999999999999999999987543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=423.77 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=213.5
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 83 (416)
..++|++++.||+|+||.||+|.+..+|+.||||++.+.. ......+++.+|+.+|+.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 4688999999999999999999999999999999998653 3344567889999999999999999999999654
Q ss_pred -CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 84 -~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
..+|+||||+.+ +|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 468999999986 5767664 359999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccC----------
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT---------- 232 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~---------- 232 (416)
. .......+||+.|+|||++.+..|. .++|||||||++|+|++|++||.+.+....+.++......
T Consensus 216 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 216 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred C---CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 2 3345667999999999999988775 8999999999999999999999998877666655321100
Q ss_pred -----------------C----CCC-----------CCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 233 -----------------C----PPW-----------LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 233 -----------------~----~~~-----------~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
+ |.. .++++++||++||+.||++|||++|+|+||||+....
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 0 000 1567999999999999999999999999999987553
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=390.21 Aligned_cols=258 Identities=32% Similarity=0.589 Sum_probs=220.6
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
.+...++|.+.+.||+|+||.||+|.+..++..||+|++...... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 94 (285)
T 3is5_A 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN 94 (285)
T ss_dssp SSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence 355678999999999999999999999999999999999875432 235778999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEe---ccCCCeEEeecccc
Q 014909 86 IFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLS 158 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl---~~~~~vkl~DFGla 158 (416)
.|+||||++||+|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 9999999999999998854 3679999999999999999999999999999999999999 45678999999999
Q ss_pred cccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC---C
Q 014909 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP---P 235 (416)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~---~ 235 (416)
..... .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+.......+.......+ .
T Consensus 175 ~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (285)
T 3is5_A 175 ELFKS---DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR 249 (285)
T ss_dssp CC-------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--C
T ss_pred eecCC---cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccC
Confidence 75443 223356689999999999864 44 5899999999999999999999999888777766655443333 2
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 236 ~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.+++++.+||.+||+.||.+|||+.|+++||||++
T Consensus 250 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 37899999999999999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=402.97 Aligned_cols=256 Identities=36% Similarity=0.662 Sum_probs=209.8
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
...++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.+++.++||||+++++++.+....|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 34567999999999999999999999999999999997543 2356889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc---CCCeEEeecccccccccc
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~---~~~vkl~DFGla~~~~~~ 164 (416)
+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~- 203 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH- 203 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc-
Confidence 99999999999999998888999999999999999999999999999999999999975 78999999999875432
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH-HHHHHhhcCccCCC----CCCCH
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCP----PWLSF 239 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~-~~~~~i~~~~~~~~----~~~s~ 239 (416)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ..+..+.......+ +.++.
T Consensus 204 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 204 --QVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp -----------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred --ccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 223456789999999999988776 48999999999999999999999876544 35666655544332 34789
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
++.+||++||+.||++|||+.++++||||....
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 999999999999999999999999999998654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=422.71 Aligned_cols=256 Identities=36% Similarity=0.647 Sum_probs=223.6
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
..++|++++.||+|+||.||+|.+..++..||+|++.+...... ....+.+|+.+++.++||||+++++++.+...+|+
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 44579999999999999999999999999999999987543222 24678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC---CCeEEeeccccccccccc
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~---~~vkl~DFGla~~~~~~~ 165 (416)
||||++||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||+|.....
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~-- 191 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN-- 191 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT--
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC--
Confidence 99999999999999988899999999999999999999999999999999999999764 4599999999976543
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC----CCCCHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~ 241 (416)
.......+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+.+.......+..+.+.++ +.+|+++
T Consensus 192 -~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 268 (494)
T 3lij_A 192 -QKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268 (494)
T ss_dssp -TBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred -CccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence 223456789999999999864 45 5899999999999999999999999999888888887766554 2489999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 242 RKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
++||++||+.||.+|||+.++|+||||+.
T Consensus 269 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 269 KDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 99999999999999999999999999985
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=407.27 Aligned_cols=255 Identities=31% Similarity=0.517 Sum_probs=224.8
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcH-----HHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH-----KMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (416)
...++|++.+.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 456789999999999999999999999999999999987643221 123457789999999999999999999999
Q ss_pred CCEEEEEEeccCCC-chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccc
Q 014909 83 KTKIFIVLEFVTGG-ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (416)
Q Consensus 83 ~~~~~lV~E~~~gg-~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~ 161 (416)
.+.+|+||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999999776 99999999889999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHH
Q 014909 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241 (416)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~ 241 (416)
.. .......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.... .........|..+++++
T Consensus 181 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~l 251 (335)
T 3dls_A 181 ER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKEL 251 (335)
T ss_dssp CT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHHH
T ss_pred CC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHHH
Confidence 32 3334567899999999999988887789999999999999999999997632 22334455667799999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
.+||.+||+.||.+|||++++++||||+..
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 999999999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=396.25 Aligned_cols=260 Identities=29% Similarity=0.420 Sum_probs=213.9
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhc--HHHHHHHHHHHHHHhcCC---CCCcceEEEEEEe
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLVK---HPNVVRLYEVMGS 82 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~ 82 (416)
...++|++.+.||+|+||.||+|.+..+++.||||++....... ......+.+|+.+++.++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 45689999999999999999999999999999999997543211 111245667787777665 9999999999987
Q ss_pred CC-----EEEEEEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeec
Q 014909 83 KT-----KIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (416)
Q Consensus 83 ~~-----~~~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DF 155 (416)
.. .+++||||+.+ +|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 65 58999999975 99999987654 999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccC---
Q 014909 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT--- 232 (416)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~--- 232 (416)
|+|..... .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+......
T Consensus 165 g~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 165 GLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp SCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred ccccccCC---CcccCCccccccccCchHHcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 99975432 3334567899999999999887774 8999999999999999999999998877666655321100
Q ss_pred ------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 233 ------------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 233 ------------------------~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
..+.+++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 1134788999999999999999999999999999998753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-52 Score=419.27 Aligned_cols=261 Identities=28% Similarity=0.354 Sum_probs=200.8
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-----CC
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-----KT 84 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~ 84 (416)
.++|++++.||+|+||.||+|.+..+++.||||++.... ......+++.+|+.+|+.++||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 478999999999999999999999999999999997643 233456789999999999999999999999843 36
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
.+|+||||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 7999999985 699999998889999999999999999999999999999999999999999999999999999865422
Q ss_pred cCC-------------------------CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh----------
Q 014909 165 RDD-------------------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA---------- 209 (416)
Q Consensus 165 ~~~-------------------------~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~---------- 209 (416)
... ......+||+.|+|||++......+.++|||||||++|+|++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 111 123456899999999987654544699999999999999998
Q ss_pred -CCCCCCCCch--------------------HHHHHHhhcC-------------------------------ccCCCCCC
Q 014909 210 -GYLPFDDSNL--------------------MNLYKKISAA-------------------------------EFTCPPWL 237 (416)
Q Consensus 210 -G~~Pf~~~~~--------------------~~~~~~i~~~-------------------------------~~~~~~~~ 237 (416)
|.+||.+.+. ......+... .....+..
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 7777866441 1111111000 00112346
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 238 s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
++++.+||++||..||.+|||++|+|+||||+...
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 89999999999999999999999999999998643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=393.89 Aligned_cols=265 Identities=32% Similarity=0.617 Sum_probs=229.3
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhc-HHHHHHHHHHHHHHhcCCCCCcceEEEEE--EeCC
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-HKMAEQIKREVATMKLVKHPNVVRLYEVM--GSKT 84 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~--~~~~ 84 (416)
..+++|++++.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++ .+..
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 35789999999999999999999999999999999998765332 23457899999999999999999999998 4556
Q ss_pred EEEEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
..|+||||+.++ |.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 899999999886 7777765 3579999999999999999999999999999999999999999999999999997654
Q ss_pred cccCCCCcccccCCcccccchhhccCC-CCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHH
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~-~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~ 241 (416)
............||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+.......+.......|..+++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 240 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHH
Confidence 333333445667999999999997643 3357899999999999999999999999888888888888888888999999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
.+||.+||+.||.+|||++++++||||++...
T Consensus 241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 99999999999999999999999999987554
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=403.30 Aligned_cols=266 Identities=30% Similarity=0.416 Sum_probs=222.4
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-----
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----- 82 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----- 82 (416)
..+++|++.+.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 46799999999999999999999999999999999987654322 234567799999999999999999999977
Q ss_pred ---CCEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccc
Q 014909 83 ---KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (416)
Q Consensus 83 ---~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla 158 (416)
.+.+|+||||+.+ +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 4568999999986 777777654 57999999999999999999999999999999999999999999999999999
Q ss_pred ccccccc--CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCC
Q 014909 159 ALSQQVR--DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 236 (416)
Q Consensus 159 ~~~~~~~--~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 236 (416)
....... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.......++.
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 7654221 12234556899999999999875555689999999999999999999999988776666554322222111
Q ss_pred --------------------------------CCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCCCC
Q 014909 237 --------------------------------LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275 (416)
Q Consensus 237 --------------------------------~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~~ 275 (416)
.++.+.+||.+||+.||.+|||++|+++||||+....+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 267899999999999999999999999999998765443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=400.99 Aligned_cols=258 Identities=26% Similarity=0.411 Sum_probs=212.2
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+++|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 47899999999999999999999999999999999754321 1123455799999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 90 LEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
|||+.| +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~~~ 155 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTK 155 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC--Ccc
Confidence 999985 8988887754 599999999999999999999999999999999999999999999999999875432 122
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc-----------------
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF----------------- 231 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~----------------- 231 (416)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 344568899999999998755556899999999999999999999999887766555432110
Q ss_pred -------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 232 -------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 232 -------------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
..++.+++++.+||.+||+.||.+|||++|+++||||....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 01124688999999999999999999999999999998654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=395.46 Aligned_cols=261 Identities=32% Similarity=0.571 Sum_probs=218.0
Q ss_pred cccccCEEEE-eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 014909 7 KRRVGKYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (416)
Q Consensus 7 ~~~~~~y~~~-~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 84 (416)
+...++|++. +.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++++ +||||+++++++.+.+
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEED 84 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 4566789995 789999999999999999999999999976532 2356788999999885 7999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCC---eEEeeccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALS 161 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~---vkl~DFGla~~~ 161 (416)
.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999999999998889999999999999999999999999999999999999998776 999999998754
Q ss_pred ccccC-----CCCcccccCCcccccchhhcc-----CCCCCChhhHHHHHHHHHHHhhCCCCCCCCc-------------
Q 014909 162 QQVRD-----DGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSN------------- 218 (416)
Q Consensus 162 ~~~~~-----~~~~~~~~gt~~y~aPEvl~~-----~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~------------- 218 (416)
..... .......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 32211 112335679999999999975 234 488999999999999999999998753
Q ss_pred --hHHHHHHhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 219 --LMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 219 --~~~~~~~i~~~~~~~~----~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
.......+..+.+.+| ..+++++.+||++||+.||.+|||+.|+++||||+..
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 2345566666666665 3589999999999999999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=410.93 Aligned_cols=262 Identities=27% Similarity=0.391 Sum_probs=211.9
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 83 (416)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+++.+|+.+|+.++||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 3578999999999999999999999999999999997643 3344567899999999999999999999999766
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
..+|+||||+.+ +|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 103 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 579999999974 9999999888899999999999999999999999999999999999999999999999999986543
Q ss_pred ccCC--------------------CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhC-----------CC
Q 014909 164 VRDD--------------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-----------YL 212 (416)
Q Consensus 164 ~~~~--------------------~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G-----------~~ 212 (416)
.... ......+||+.|+|||++......+.++|||||||++|+|++| .+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 2211 1246678999999999976555456999999999999999984 44
Q ss_pred CCCCCch-----------------HHHHHHh------------------------hcCccCC-------CCCCCHHHHHH
Q 014909 213 PFDDSNL-----------------MNLYKKI------------------------SAAEFTC-------PPWLSFTARKL 244 (416)
Q Consensus 213 Pf~~~~~-----------------~~~~~~i------------------------~~~~~~~-------~~~~s~~~~~l 244 (416)
+|.+.+. ......+ ....... .+.+++++.+|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 4444320 1111111 1111111 14579999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 245 IARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
|++||+.||.+|||++|+|+||||+...
T Consensus 342 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 9999999999999999999999998653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=410.02 Aligned_cols=255 Identities=35% Similarity=0.628 Sum_probs=210.9
Q ss_pred cccccCEEEE-eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHH-hcCCCCCcceEEEEEEe--
Q 014909 7 KRRVGKYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVRLYEVMGS-- 82 (416)
Q Consensus 7 ~~~~~~y~~~-~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~-- 82 (416)
+..+++|.+. +.||+|+||+||+|.+..+|+.||||++... ..+.+|+.++ +..+||||+++++++..
T Consensus 57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 3467889887 7899999999999999999999999998642 2466788887 45589999999999876
Q ss_pred --CCEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc---CCCeEEeec
Q 014909 83 --KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDF 155 (416)
Q Consensus 83 --~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~---~~~vkl~DF 155 (416)
...+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 667999999999999999998754 5999999999999999999999999999999999999998 788999999
Q ss_pred ccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH----HHHHHhhcCcc
Q 014909 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----NLYKKISAAEF 231 (416)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~----~~~~~i~~~~~ 231 (416)
|++..... .....+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+.. .....+..+.+
T Consensus 209 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~ 284 (400)
T 1nxk_A 209 GFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284 (400)
T ss_dssp TTCEECC--------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC
T ss_pred ccccccCC---CCccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc
Confidence 99875432 2334577899999999999887775 8999999999999999999999865432 24445555555
Q ss_pred CCC----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 232 TCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 232 ~~~----~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
.+| ..++.++.+||++||+.||.+|||+.++++||||.....
T Consensus 285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 330 (400)
T 1nxk_A 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330 (400)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence 444 348999999999999999999999999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=392.14 Aligned_cols=254 Identities=28% Similarity=0.483 Sum_probs=222.5
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
.|...+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 388889999999999999999999999999999765422 34678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcc
Q 014909 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (416)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 171 (416)
|++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~ 199 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRK 199 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCCBC
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC--ccccc
Confidence 9999999998865 57999999999999999999999999999999999999999999999999998754332 12234
Q ss_pred cccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc---CCCCCCCHHHHHHHHHh
Q 014909 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTARKLIARI 248 (416)
Q Consensus 172 ~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~ll~~~ 248 (416)
..+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+..... ..+..+++.+.+||.+|
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred cccCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence 56899999999999877664 899999999999999999999998887776666654432 22335789999999999
Q ss_pred cCCCCCCCCCHhHHhcCcccccCC
Q 014909 249 LDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 249 L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
|+.||.+|||+.++++||||....
T Consensus 279 l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 279 LVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp SCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred ccCChhhCcCHHHHhcChhhccCC
Confidence 999999999999999999998643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-51 Score=400.53 Aligned_cols=258 Identities=34% Similarity=0.602 Sum_probs=226.8
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhh-----hcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-----LKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~-----~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 83 (416)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+.+|+.+++.+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 4679999999999999999999999999999999976431 1123356788999999999 799999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
...|+||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCCcccccCCcccccchhhccC-----CCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC----
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDR-----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP---- 234 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~-----~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~---- 234 (416)
.......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||...+.......+..+....+
T Consensus 253 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 253 ---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp ---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred ---CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 2334567899999999998632 2235889999999999999999999998888777777766665443
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 235 ~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
..++..+.+||.+||+.||.+|||+.++++||||++
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 357899999999999999999999999999999973
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=400.45 Aligned_cols=265 Identities=34% Similarity=0.553 Sum_probs=222.0
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhh--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
....++|++.+.||+|+||.||+|.+..+++.||+|++.+.... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 34457899999999999999999999999999999999876432 2334678999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 014909 85 KIFIVLEFVTGGELFDKIVN----------------------------------------HGRMKEDEARRYFQQLINAV 124 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~----------------------------------------~~~l~e~~~~~~~~qll~al 124 (416)
..|+||||++||+|.+++.. ...+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 99999999999999998852 11246788899999999999
Q ss_pred HHHHhCCcEeecCCCCcEEeccCC--CeEEeecccccccccccCCC--CcccccCCcccccchhhccC-CCCCChhhHHH
Q 014909 125 DYCHSRGVYHRDLKPENLLLDAYG--NLKVSDFGLSALSQQVRDDG--LLHTTCGTPNYVAPEVLNDR-GYDGSTADLWS 199 (416)
Q Consensus 125 ~~LH~~givHrDlkp~NILl~~~~--~vkl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPEvl~~~-~~~~~~~DIwS 199 (416)
+|||++||+||||||+|||++.++ .+||+|||++.......... .....+||+.|+|||++.+. ...+.++||||
T Consensus 182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 999999999999999999998776 89999999998654322221 23466899999999999752 33358999999
Q ss_pred HHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCC----CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 200 CGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 200 lGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
|||++|+|++|..||.+.+.......+......++. .+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 999999999999999998888777776655543332 379999999999999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=403.61 Aligned_cols=255 Identities=28% Similarity=0.416 Sum_probs=214.0
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK------ 83 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 83 (416)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+|+.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 468999999999999999999999999999999996643 2344567889999999999999999999999765
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
..+|+||||+ |++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 3469999999 7899998876 6799999999999999999999999999999999999999999999999999975432
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-------------
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------- 230 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~------------- 230 (416)
.....+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+....
T Consensus 181 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 181 -----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp -----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred -----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 23456899999999999874444689999999999999999999999887766555443211
Q ss_pred ------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 231 ------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 231 ------------------~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
....+..++.+.+||.+||+.||.+|||++++|+||||....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 012245789999999999999999999999999999998644
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=397.97 Aligned_cols=260 Identities=28% Similarity=0.442 Sum_probs=219.7
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
..+++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+....|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 468899999999999999999999999999999999876542 3334567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 178 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--G 178 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--c
Confidence 99999999999888887888999999999999999999999999999999999999999999999999998754332 2
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC------------------
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------ 229 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~------------------ 229 (416)
......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 23455689999999999987655568999999999999999999999987765544433210
Q ss_pred -ccCC------------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 230 -EFTC------------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 230 -~~~~------------~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.... .+.+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 0011 1246899999999999999999999999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=385.66 Aligned_cols=263 Identities=32% Similarity=0.522 Sum_probs=228.5
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhh------hcHHHHHHHHHHHHHHhcCC-CCCcceEEE
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV------LKHKMAEQIKREVATMKLVK-HPNVVRLYE 78 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~------~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~ 78 (416)
.....++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+.+|+.+++++. ||||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 45678999999999999999999999999999999999975431 11234567889999999996 999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccc
Q 014909 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (416)
Q Consensus 79 ~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla 158 (416)
++.+....|+||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999999998889999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCcccccCCcccccchhhcc-----CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCC
Q 014909 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 233 (416)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~-----~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~ 233 (416)
..... .......+||+.|+|||++.+ ....+.++||||||+++|+|++|..||...+.......+.......
T Consensus 172 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 172 CQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp EECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred hhcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence 75432 233455689999999999852 2233589999999999999999999999888877777776665544
Q ss_pred C----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 234 P----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 234 ~----~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
+ +.++..+.+||.+||+.||.+|||+.++++||||++.
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 3 2478999999999999999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=398.26 Aligned_cols=251 Identities=25% Similarity=0.423 Sum_probs=216.0
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-----CCCcceEEEEEEe
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-----HPNVVRLYEVMGS 82 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~~~~~~ 82 (416)
..-++|++.+.||+|+||.||+|.+..+++.||||++.... .......+|+.+++.+. ||||+++++++..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 45679999999999999999999999999999999997432 23456778999999986 9999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc--------------
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-------------- 146 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~-------------- 146 (416)
.+..|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 99999999999 889999998754 5999999999999999999999999999999999999975
Q ss_pred -----------CCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCC
Q 014909 147 -----------YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 215 (416)
Q Consensus 147 -----------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~ 215 (416)
++.+||+|||+|..... .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCCCCCC
Confidence 78999999999975332 23456899999999999988775 89999999999999999999999
Q ss_pred CCchHHHHHHhhcCccCCCC----------------------------------------------CCCHHHHHHHHHhc
Q 014909 216 DSNLMNLYKKISAAEFTCPP----------------------------------------------WLSFTARKLIARIL 249 (416)
Q Consensus 216 ~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~s~~~~~ll~~~L 249 (416)
..+.......+.......|. ..++.+.+||.+||
T Consensus 261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 340 (360)
T 3llt_A 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL 340 (360)
T ss_dssp CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence 87776655544332222111 12367889999999
Q ss_pred CCCCCCCCCHhHHhcCcccc
Q 014909 250 DPNPMTRITIPEILEDEWFK 269 (416)
Q Consensus 250 ~~dP~~R~t~~eil~h~~~~ 269 (416)
+.||.+|||+.|+|+||||+
T Consensus 341 ~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 341 QIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CSSGGGSCCHHHHTTSGGGC
T ss_pred cCChhhCCCHHHHhcCcccC
Confidence 99999999999999999995
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-51 Score=384.81 Aligned_cols=257 Identities=36% Similarity=0.649 Sum_probs=225.2
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcH---HHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
.++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 4689999999999999999999999999999999976543221 1356789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC----CeEEeecccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSALSQ 162 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~----~vkl~DFGla~~~~ 162 (416)
|+||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999998888999999999999999999999999999999999999998877 79999999987543
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC----CCCC
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLS 238 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s 238 (416)
. ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.......+ +.++
T Consensus 164 ~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T 3bhy_A 164 A---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239 (283)
T ss_dssp -----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred C---CCcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCC
Confidence 2 222345679999999999987766 4899999999999999999999999888877777766655444 4688
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 239 FTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 239 ~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
..+.+||.+||+.||.+|||+.++++||||+.
T Consensus 240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 99999999999999999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=397.95 Aligned_cols=265 Identities=24% Similarity=0.421 Sum_probs=223.0
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT- 84 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 84 (416)
.....++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 86 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence 3557789999999999999999999999999999999998766556666788999999999999999999999987543
Q ss_pred ---EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccc
Q 014909 85 ---KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (416)
Q Consensus 85 ---~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~ 161 (416)
..|+||||++|++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 35999999999999999998889999999999999999999999999999999999999999999999999998755
Q ss_pred ccccCC-CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCC----CCC
Q 014909 162 QQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----PPW 236 (416)
Q Consensus 162 ~~~~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~----~~~ 236 (416)
...... ......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.......+....... ++.
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence 432211 223345799999999999887764 89999999999999999999999888776655554443322 245
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 237 ~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
++.++.+||.+||+.||.+||+..+++.|+|++..
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 89999999999999999999999999999999854
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=404.01 Aligned_cols=253 Identities=32% Similarity=0.554 Sum_probs=217.7
Q ss_pred cCEEE--EeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 11 GKYEV--GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 11 ~~y~~--~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
..|.+ .+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+|+.++||||+++++++.+.+..|+
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 34555 6789999999999999999999999999986542 235678999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEe--ccCCCeEEeeccccccccccc
Q 014909 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL--DAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl--~~~~~vkl~DFGla~~~~~~~ 165 (416)
||||++|++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~-- 241 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP-- 241 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT--
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC--
Confidence 99999999999988764 469999999999999999999999999999999999999 5667899999999986543
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC----CCCCHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~ 241 (416)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++ +.+++++
T Consensus 242 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 242 -REKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp -TCBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred -ccccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 223445689999999999987655 4899999999999999999999999888888777766655444 4589999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 242 RKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.+||.+||+.||.+|||+.|+++||||..
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 99999999999999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-51 Score=396.86 Aligned_cols=265 Identities=25% Similarity=0.421 Sum_probs=218.0
Q ss_pred cccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCC--CCcceEEEEEEe
Q 014909 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH--PNVVRLYEVMGS 82 (416)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~ 82 (416)
.+...-++|++.+.||+|+||.||+|.+. +++.||||++..... .....+.+.+|+.+|+.++| |||+++++++.+
T Consensus 3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 80 (343)
T 3dbq_A 3 CISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 80 (343)
T ss_dssp CEESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred eeeeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence 34556778999999999999999999984 688999999986543 33446789999999999986 999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
...+|+||| +.+++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|....
T Consensus 81 ~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 81 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred CCEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999999999 45779999999999999999999999999999999999999999999999997 5889999999998654
Q ss_pred cccCCCCcccccCCcccccchhhcc----------CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH-HHHHHhh--cC
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLND----------RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKIS--AA 229 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~----------~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~-~~~~~i~--~~ 229 (416)
...........+||+.|+|||++.+ ....+.++|||||||++|+|++|..||...... .....+. ..
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence 4333333456789999999999864 123358999999999999999999999874332 3333332 23
Q ss_pred ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 230 EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 230 ~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
...+|...+.++.+||.+||+.||.+|||+.++++||||+....
T Consensus 239 ~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 45667778899999999999999999999999999999986543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=399.92 Aligned_cols=265 Identities=28% Similarity=0.407 Sum_probs=215.1
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
++...++|++.+.||+|+||.||+|.+..+|+.||||++....... ......+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 4567899999999999999999999999999999999997543221 11234678999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
...|+||||+.+ +|.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 999999999986 8888887653 68999999999999999999999999999999999999999999999999997653
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc--cC--------
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FT-------- 232 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~--~~-------- 232 (416)
. ........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+....+..+.... ..
T Consensus 164 ~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 164 S--PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp S--CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred C--CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence 3 22334567899999999999765545689999999999999999999999988776665553210 00
Q ss_pred -C-----------------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 233 -C-----------------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 233 -~-----------------~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
. ...++.++.+||++||+.||.+|||+.|+++||||+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 0 1345789999999999999999999999999999987543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-51 Score=389.70 Aligned_cols=256 Identities=36% Similarity=0.684 Sum_probs=226.3
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
...++|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+....|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 4567899999999999999999999999999999999864322 2356889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEe---ccCCCeEEeecccccccccc
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl---~~~~~vkl~DFGla~~~~~~ 164 (416)
+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~- 161 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161 (304)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence 999999999999999888899999999999999999999999999999999999999 7789999999999875322
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC----CCCCHH
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFT 240 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~ 240 (416)
......+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+..+...++ +.++++
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (304)
T 2jam_A 162 ---GIMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES 237 (304)
T ss_dssp ---BTTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred ---CccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHH
Confidence 233456799999999999877664 899999999999999999999999888888887776654433 457999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 241 ARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
+.+||.+||..||.+|||+.++++||||...
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 238 AKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 9999999999999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=397.47 Aligned_cols=260 Identities=25% Similarity=0.433 Sum_probs=220.4
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----C
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-----T 84 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 84 (416)
.++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 358999999999999999999999999999999997533 333457889999999999999999999999765 4
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
..|+||||+.| +|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 78999999985 99998876 57999999999999999999999999999999999999999999999999999865433
Q ss_pred cC-CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc------------
Q 014909 165 RD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------------ 231 (416)
Q Consensus 165 ~~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~------------ 231 (416)
.. .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 22 22345568999999999987655456899999999999999999999998776655444321100
Q ss_pred -------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 232 -------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 232 -------------------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
..++.+++++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 012457899999999999999999999999999999987543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=402.96 Aligned_cols=260 Identities=25% Similarity=0.427 Sum_probs=217.6
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC--CCCcceEEEEEEeCCEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK--HPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~ 86 (416)
...+|++.+.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+|+.++ ||||+++++++...+.+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34569999999999999999999865 89999999987653 3345678999999999996 59999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|+||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 99999 56789999999988999999999999999999999999999999999999995 58999999999986544332
Q ss_pred CCCcccccCCcccccchhhccC----------CCCCChhhHHHHHHHHHHHhhCCCCCCCCch-HHHHHHhhcC--ccCC
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDR----------GYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAA--EFTC 233 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~----------~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~-~~~~~~i~~~--~~~~ 233 (416)
.......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||..... ......+... ...+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 289 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCC
Confidence 2334567899999999999752 2345899999999999999999999987533 2334444333 3456
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 234 PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 234 ~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
|.+.+.++.+||.+||+.||.+|||+.++++||||+...
T Consensus 290 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 788899999999999999999999999999999998654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=386.91 Aligned_cols=260 Identities=22% Similarity=0.385 Sum_probs=220.3
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
..-++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 34578999999999999999999999999999999997765555666788999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
+||||++|++|.+++...+++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 166 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-L 166 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc-c
Confidence 999999999999999998899999999999999999999999999999999999999999999999999987653321 1
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc-----CCCCCCCHHHH
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-----TCPPWLSFTAR 242 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~s~~~~ 242 (416)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+......+...... ..++.+++.+.
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245 (294)
T ss_dssp --------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred cccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence 22345679999999999988776 4889999999999999999999998877655544433322 23456899999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCcccc
Q 014909 243 KLIARILDPNPMTRITIPEILEDEWFK 269 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t~~eil~h~~~~ 269 (416)
++|.+||+.||.+||+..+.+.+.|..
T Consensus 246 ~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 246 NVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 999999999999999666666666654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=389.99 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=205.3
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHH-hcCCCCCcceEEEEEEeCCEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
++|++.+.||+|+||+||+|.+..+|+.||||++......... ......|+..+ +..+||||+++++++.+....|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 6799999999999999999999999999999998764433333 33344455544 445899999999999999999999
Q ss_pred EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
|||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~---~~ 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT---AG 211 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc---CC
Confidence 9999 56898888764 4699999999999999999999999999999999999999999999999999875432 22
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc--cCCCCCCCHHHHHHHH
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPWLSFTARKLIA 246 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~~~ll~ 246 (416)
.....+||+.|+|||++.+ .+ +.++|||||||++|+|++|..|+.+... +..+.... ...+..+++++.+||.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~ 286 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLV 286 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred CCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHH
Confidence 3445679999999999886 45 5899999999999999999766654332 22232222 1234568999999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccccc
Q 014909 247 RILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
+||+.||.+|||++++++||||++
T Consensus 287 ~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 287 MMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=380.96 Aligned_cols=255 Identities=21% Similarity=0.297 Sum_probs=216.8
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 85 (416)
....++|++.+.||+|+||.||+|.+..+++.||+|++........ ....+.+|+..+..+ +||||+++++++.+.+.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~ 85 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH 85 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence 3456899999999999999999999999999999999986543333 356788999999999 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC--------------
Q 014909 86 IFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-------------- 147 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~-------------- 147 (416)
.|+||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999999775 679999999999999999999999999999999999999854
Q ss_pred -----CCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHH
Q 014909 148 -----GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL 222 (416)
Q Consensus 148 -----~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~ 222 (416)
..+||+|||++..... ....+||+.|+|||++.+....+.++|||||||++|+|++|.+|+.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred ccCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence 4799999999875432 23356999999999998765555799999999999999999988765543
Q ss_pred HHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 223 YKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 223 ~~~i~~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
...+..+ ....|..+++++.+||.+||+.||.+|||+.++++||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 237 WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 2233333 345667899999999999999999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=409.64 Aligned_cols=257 Identities=37% Similarity=0.681 Sum_probs=210.8
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhc-----HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-----HKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
..++|.+.+.||+|+||.||+|.+..+++.||||++.+..... ......+.+|+.+|++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4578999999999999999999999999999999998765321 1223458899999999999999999999854
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC---CeEEeecccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSAL 160 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~---~vkl~DFGla~~ 160 (416)
...|+||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|..
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 56899999999999999998888999999999999999999999999999999999999997654 599999999986
Q ss_pred cccccCCCCcccccCCcccccchhhcc---CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH-HHHHHhhcCccCCC--
Q 014909 161 SQQVRDDGLLHTTCGTPNYVAPEVLND---RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCP-- 234 (416)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPEvl~~---~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~-~~~~~i~~~~~~~~-- 234 (416)
... .......+||+.|+|||++.+ ..| +.++|||||||++|+|++|..||...... .....+..+....+
T Consensus 292 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~ 367 (419)
T 3i6u_A 292 LGE---TSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367 (419)
T ss_dssp CC--------------CTTCCTTTTC----CTT-HHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHH
T ss_pred cCC---CccccccCCCCCccCceeeecCCCCCC-CchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCch
Confidence 532 233456789999999999864 334 47899999999999999999999865433 34445555554443
Q ss_pred --CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 235 --PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 235 --~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
..+++.+.+||.+||+.||.+|||++++++||||+.
T Consensus 368 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred hhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 358999999999999999999999999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=393.48 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=221.6
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
.+|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999998655444455678999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 91 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
||+. |+|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence 9998 478887754 56799999999999999999999999999999999999999999999999999875432
Q ss_pred cccccCCcccccchhhc---cCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccC--CCCCCCHHHHHH
Q 014909 170 LHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT--CPPWLSFTARKL 244 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~---~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~l 244 (416)
....+||+.|+|||++. ...+ +.++|||||||++|+|++|..||.+.+.......+...... .+..+++.+.+|
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 285 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 285 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred CCcccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 23568999999999985 3344 58999999999999999999999988776655555444322 234689999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 245 IARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
|.+||+.||.+|||++++++||||.....
T Consensus 286 i~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 286 VDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp HHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 99999999999999999999999987543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=400.25 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=211.2
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-----
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----- 82 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----- 82 (416)
...++|++++.||+|+||.||+|.+..+|+.||||++..... ...+|+.+|+.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 456799999999999999999999999999999999865432 23479999999999999999999843
Q ss_pred ---------------------------------CCEEEEEEeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHH
Q 014909 83 ---------------------------------KTKIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVD 125 (416)
Q Consensus 83 ---------------------------------~~~~~lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~al~ 125 (416)
...+++||||++| +|.+.+. ....+++..++.++.||+.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3458999999985 7666554 4578999999999999999999
Q ss_pred HHHhCCcEeecCCCCcEEec-cCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHH
Q 014909 126 YCHSRGVYHRDLKPENLLLD-AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 204 (416)
Q Consensus 126 ~LH~~givHrDlkp~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil 204 (416)
|||++||+||||||+|||++ .++.+||+|||+|..... .......+||+.|+|||++.+....+.++||||+||++
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 99999999999999999998 678999999999975432 23345668899999999998766556899999999999
Q ss_pred HHHhhCCCCCCCCchHHHHHHhhcC-----------------cc------------CCCCCCCHHHHHHHHHhcCCCCCC
Q 014909 205 FVLLAGYLPFDDSNLMNLYKKISAA-----------------EF------------TCPPWLSFTARKLIARILDPNPMT 255 (416)
Q Consensus 205 ~~ml~G~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~~~~~s~~~~~ll~~~L~~dP~~ 255 (416)
|+|++|+.||.+.+..+....+... .. .+|..+++++.+||.+||+.||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999988776665554321 00 134557899999999999999999
Q ss_pred CCCHhHHhcCccccc
Q 014909 256 RITIPEILEDEWFKK 270 (416)
Q Consensus 256 R~t~~eil~h~~~~~ 270 (416)
|||+.|+++||||+.
T Consensus 313 R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 313 RINPYEAMAHPFFDH 327 (383)
T ss_dssp SCCHHHHHTSGGGHH
T ss_pred CCCHHHHhcCHHHHH
Confidence 999999999999974
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-51 Score=393.65 Aligned_cols=258 Identities=25% Similarity=0.424 Sum_probs=210.5
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC---
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--- 84 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 84 (416)
..+++|++.+.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+.+|++++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 45789999999999999999999999999999999997654 2334678999999999999999999999985543
Q ss_pred ------------------------------------------------------EEEEEEeccCCCchHHHHHhCCC---
Q 014909 85 ------------------------------------------------------KIFIVLEFVTGGELFDKIVNHGR--- 107 (416)
Q Consensus 85 ------------------------------------------------------~~~lV~E~~~gg~L~~~i~~~~~--- 107 (416)
..|+||||++||+|.+++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 38999999999999999987653
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC----------CCcccccCCc
Q 014909 108 MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD----------GLLHTTCGTP 177 (416)
Q Consensus 108 l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~----------~~~~~~~gt~ 177 (416)
.++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... ......+||+
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 456678999999999999999999999999999999999999999999999865432211 1234467999
Q ss_pred ccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccC-CCCCCCHHHHHHHHHhcCCCCCCC
Q 014909 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARILDPNPMTR 256 (416)
Q Consensus 178 ~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~ll~~~L~~dP~~R 256 (416)
.|+|||++.+..+ +.++|||||||++|+|++|..|+... ......+.....+ .+...++++.+||.+||+.||.+|
T Consensus 241 ~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 241 LYMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp GGSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred CccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence 9999999998777 48999999999999999998775321 2222223222211 112357788999999999999999
Q ss_pred CCHhHHhcCccccc
Q 014909 257 ITIPEILEDEWFKK 270 (416)
Q Consensus 257 ~t~~eil~h~~~~~ 270 (416)
||+.++++||||+.
T Consensus 318 ps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 318 PEATDIIENAIFEN 331 (332)
T ss_dssp CCHHHHHHSTTCCC
T ss_pred CCHHHHhhchhhhc
Confidence 99999999999974
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=398.37 Aligned_cols=262 Identities=31% Similarity=0.550 Sum_probs=224.5
Q ss_pred ccccCEEEEeEEeecCceEEEEEEEC---CCCCeEEEEEeechhhh-cHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS 82 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 82 (416)
..+++|++.+.||+|+||.||+|++. .+++.||||++.+.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 45689999999999999999999984 58899999999764321 112235577899999999 69999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
...+|+||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCCcccccCCcccccchhhccC-CCCCChhhHHHHHHHHHHHhhCCCCCCCC----chHHHHHHhhcCccCCCCCC
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDS----NLMNLYKKISAAEFTCPPWL 237 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~-~~~~~~~DIwSlGvil~~ml~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~ 237 (416)
... .......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... ........+.......|..+
T Consensus 211 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T 1vzo_A 211 ADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289 (355)
T ss_dssp GGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCccc
Confidence 221 1223456899999999999853 23358999999999999999999999743 33455556666677788889
Q ss_pred CHHHHHHHHHhcCCCCCCCC-----CHhHHhcCccccc
Q 014909 238 SFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 270 (416)
Q Consensus 238 s~~~~~ll~~~L~~dP~~R~-----t~~eil~h~~~~~ 270 (416)
+..+.+||.+||..||.+|| |++++++||||..
T Consensus 290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 99999999999999999999 9999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=399.78 Aligned_cols=256 Identities=27% Similarity=0.431 Sum_probs=209.3
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT---- 84 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 84 (416)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 46899999999999999999999999999999999976432 3345677889999999999999999999997665
Q ss_pred --EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 85 --KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 85 --~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
..|+||||+.+ +|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 78999999985 7888885 469999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCC---------
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC--------- 233 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~--------- 233 (416)
. .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+.......
T Consensus 179 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 179 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred c---ccccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 2234456899999999999987775 89999999999999999999999988776666554321100
Q ss_pred ---------------------------CCC------CCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 234 ---------------------------PPW------LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 234 ---------------------------~~~------~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
|.. .+.++++||++||+.||.+|||++|+++||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 000 156789999999999999999999999999998654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=388.42 Aligned_cols=263 Identities=28% Similarity=0.438 Sum_probs=217.6
Q ss_pred cccccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014909 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (416)
Q Consensus 3 ~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (416)
.+......++|++.+.||+|+||.||+|.+ +|+.||||++..... .....+.+.+|+.++++++||||+++++++.+
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 344566788999999999999999999987 578899999976543 33346778999999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCcEEeccCCCeEEeeccc
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGL 157 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~~~---l~e~~~~~~~~qll~al~~LH~~g--ivHrDlkp~NILl~~~~~vkl~DFGl 157 (416)
....|+||||++||+|.+++...+. +++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 9999999999999999999987654 999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHh--hcCccCCCC
Q 014909 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTCPP 235 (416)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i--~~~~~~~~~ 235 (416)
+...... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+ .......|.
T Consensus 186 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (309)
T 3p86_A 186 SRLKAST--FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPR 262 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCT
T ss_pred Ccccccc--ccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCc
Confidence 8754321 122345689999999999988777 48999999999999999999999988877766655 344566778
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhc--CcccccC
Q 014909 236 WLSFTARKLIARILDPNPMTRITIPEILE--DEWFKKD 271 (416)
Q Consensus 236 ~~s~~~~~ll~~~L~~dP~~R~t~~eil~--h~~~~~~ 271 (416)
.+++++.+||.+||+.||.+|||+.++++ ++|++..
T Consensus 263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 89999999999999999999999999987 5666543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=378.76 Aligned_cols=254 Identities=25% Similarity=0.472 Sum_probs=219.0
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CCE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----KTK 85 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~ 85 (416)
-..|++.+.||+|+||.||+|.+..++..||+|++...... ....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 34589999999999999999999999999999999866543 3346789999999999999999999999865 466
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCcEEec-cCCCeEEeecccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLD-AYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~g--ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~ 162 (416)
+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 8999999999999999998889999999999999999999999999 99999999999998 78999999999986432
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch-HHHHHHhhcCc--cCCCCCCCH
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAE--FTCPPWLSF 239 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~-~~~~~~i~~~~--~~~~~~~s~ 239 (416)
.......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||..... ......+..+. ...+...++
T Consensus 184 ----~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (290)
T 1t4h_A 184 ----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp ----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred ----ccccccccCCcCcCCHHHHhc-cC-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence 223455689999999999874 34 5899999999999999999999987544 34444444332 233455789
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 240 TARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
++.+||.+||+.||.+|||++++++||||+.
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 9999999999999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=382.17 Aligned_cols=261 Identities=33% Similarity=0.548 Sum_probs=226.2
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE--eCC
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG--SKT 84 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~ 84 (416)
+...++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++. ...
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence 34688999999999999999999999999999999999865433 334678999999999999999999999874 467
Q ss_pred EEEEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----cEeecCCCCcEEeccCCCeEEeec
Q 014909 85 KIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRG-----VYHRDLKPENLLLDAYGNLKVSDF 155 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~al~~LH~~g-----ivHrDlkp~NILl~~~~~vkl~DF 155 (416)
..|+||||++|++|.+++... ..+++..+..++.||+.||+|||++| |+||||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 899999999999999998763 34999999999999999999999999 999999999999999999999999
Q ss_pred ccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc-CCC
Q 014909 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCP 234 (416)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~-~~~ 234 (416)
|++...... .......+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+..+.. ..|
T Consensus 161 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 237 (279)
T 2w5a_A 161 GLARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 237 (279)
T ss_dssp CHHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCC
T ss_pred chheeeccc--cccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCC
Confidence 998754321 1122345799999999999887664 899999999999999999999999888777777766654 566
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 235 ~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
..++.++.+||.+||+.||.+|||+.++++|+|+..+
T Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 7799999999999999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=389.29 Aligned_cols=260 Identities=31% Similarity=0.525 Sum_probs=222.9
Q ss_pred ccccCEEEE-eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCE
Q 014909 8 RRVGKYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTK 85 (416)
Q Consensus 8 ~~~~~y~~~-~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 85 (416)
..-++|.+. +.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+++.+. ||||+++++++.+...
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 345678887 89999999999999999999999999998654332 23567889999999995 6999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc---CCCeEEeecccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDFGLSAL 160 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~---~~~vkl~DFGla~~ 160 (416)
.|+||||+.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 99999999999999988653 67999999999999999999999999999999999999988 78999999999976
Q ss_pred cccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC----CC
Q 014909 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PW 236 (416)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~ 236 (416)
... .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+.......+ ..
T Consensus 184 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 259 (327)
T 3lm5_A 184 IGH---ACELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS 259 (327)
T ss_dssp C------------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred cCC---ccccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcc
Confidence 533 2233456899999999999887774 899999999999999999999999888877777665544333 35
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 237 ~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
+++.+.+||.+||+.||.+|||++++++||||+...
T Consensus 260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 889999999999999999999999999999998643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=394.37 Aligned_cols=257 Identities=25% Similarity=0.425 Sum_probs=220.3
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+....|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 35678999999999999999999999999999999997653 3345678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~-givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
+||||++|++|.+++...+.+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 9999999999999999888999999999999999999999996 9999999999999999999999999998754321
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHH---------------------
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK--------------------- 225 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~--------------------- 225 (416)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 23456899999999999887764 899999999999999999999987665433221
Q ss_pred ---------------------hhcCc-cCCC-CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 226 ---------------------ISAAE-FTCP-PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 226 ---------------------i~~~~-~~~~-~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
+.... ...+ ..++.++.+||++||+.||.+|||++++++||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 11111 1111 2378899999999999999999999999999999863
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=381.19 Aligned_cols=261 Identities=23% Similarity=0.370 Sum_probs=205.7
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
+....++|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.++...++.++||||+++++++.+.+.
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~ 80 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence 356778999999999999999999999999999999999765322 2234445566666888999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCcEEeccCCCeEEeecccccc
Q 014909 86 IFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~~-givHrDlkp~NILl~~~~~vkl~DFGla~~ 160 (416)
.|+||||++| +|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++..
T Consensus 81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999999985 87776643 56899999999999999999999998 999999999999999999999999999875
Q ss_pred cccccCCCCcccccCCcccccchhhc---cCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc-h-HHHHHHhhcCccCCC-
Q 014909 161 SQQVRDDGLLHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-L-MNLYKKISAAEFTCP- 234 (416)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPEvl~---~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~-~-~~~~~~i~~~~~~~~- 234 (416)
... .......+||+.|+|||++. .....+.++|||||||++|+|++|..||.... . ......+.......+
T Consensus 160 ~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (290)
T 3fme_A 160 LVD---DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT
T ss_pred ccc---cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccc
Confidence 433 22234457999999999973 22333589999999999999999999998632 2 233333443333333
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 235 ~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
..+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 4589999999999999999999999999999999853
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=399.00 Aligned_cols=256 Identities=27% Similarity=0.390 Sum_probs=201.7
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 83 (416)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 3478999999999999999999999999999999997643 2334467788999999999999999999998654
Q ss_pred -CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 84 -~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
..+|+||||+ +++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 5689999999 6799988865 679999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc------------
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------ 230 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~------------ 230 (416)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 184 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 184 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred c-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 23456899999999999874455689999999999999999999999888766555443210
Q ss_pred -----------cCC--------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 231 -----------FTC--------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 231 -----------~~~--------~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
... .+..++.+.+||++||+.||.+|||+.++|+||||....
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 000 124688999999999999999999999999999998654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=396.15 Aligned_cols=258 Identities=24% Similarity=0.499 Sum_probs=226.9
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHH--------------HHHHHHHHHHHHhcCCCCC
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK--------------MAEQIKREVATMKLVKHPN 72 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~--------------~~~~~~~Ei~il~~l~hpn 72 (416)
....++|++.+.||+|+||.||+|.+ +|+.||||++......... ..+.+.+|+.+++.++|||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999999999 8999999999865443221 1277899999999999999
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCchHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCcEE
Q 014909 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDK------IVN--HGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLL 143 (416)
Q Consensus 73 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~------i~~--~~~l~e~~~~~~~~qll~al~~LH~-~givHrDlkp~NIL 143 (416)
|+++++++.+.+..|+||||++||+|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+||+
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999999999999999999999999998 665 5679999999999999999999999 99999999999999
Q ss_pred eccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccC-CCCCChhhHHHHHHHHHHHhhCCCCCCCCch-HH
Q 014909 144 LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MN 221 (416)
Q Consensus 144 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~-~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~-~~ 221 (416)
++.++.+||+|||++...... ......||+.|+|||++.+. .+.+.++|||||||++|+|++|..||...+. ..
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999998764322 34556899999999999876 4543489999999999999999999998776 67
Q ss_pred HHHHhhcCccCCC-------------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 222 LYKKISAAEFTCP-------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 222 ~~~~i~~~~~~~~-------------------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
....+.......| ..+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 7777777766666 568999999999999999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-52 Score=409.03 Aligned_cols=250 Identities=16% Similarity=0.202 Sum_probs=207.0
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHH---HHhcCCCCCcceEE-------E
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA---TMKLVKHPNVVRLY-------E 78 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~---il~~l~hpnIv~l~-------~ 78 (416)
..++|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+. +++.++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3578999999999999999999999999999999998655444556688999995 55555799999998 7
Q ss_pred EEEeCCE-----------------EEEEEeccCCCchHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCcEe
Q 014909 79 VMGSKTK-----------------IFIVLEFVTGGELFDKIVNHGRMKE-------DEARRYFQQLINAVDYCHSRGVYH 134 (416)
Q Consensus 79 ~~~~~~~-----------------~~lV~E~~~gg~L~~~i~~~~~l~e-------~~~~~~~~qll~al~~LH~~givH 134 (416)
++.+.+. .|+||||+ +|+|.+++...+.+++ ..+..++.||+.||+|||++||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 7776543 89999999 5799999987665665 778889999999999999999999
Q ss_pred ecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccC-----------CCCCChhhHHHHHHH
Q 014909 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-----------GYDGSTADLWSCGVI 203 (416)
Q Consensus 135 rDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~-----------~~~~~~~DIwSlGvi 203 (416)
|||||+|||++.+|.+||+|||+|.... ......+| +.|+|||++.+. .+ +.++|||||||+
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~i 302 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLV 302 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHH
Confidence 9999999999999999999999987422 23456678 999999999876 55 589999999999
Q ss_pred HHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 204 LFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 204 l~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
+|+|++|+.||.+.+.......+. ..++.+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 999999999998765443333332 234678999999999999999999999999999999974
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=385.52 Aligned_cols=251 Identities=25% Similarity=0.450 Sum_probs=211.4
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEe--CCE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGS--KTK 85 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~ 85 (416)
..++|++.+.||+|+||.||+|.+..+++.||||++.... .+.+.+|+.+++.++ ||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 4578999999999999999999999999999999987432 356889999999997 9999999999987 678
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC-CeEEeecccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQV 164 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~ 164 (416)
.++||||+.+++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~- 183 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 183 (330)
T ss_dssp EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT-
T ss_pred eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC-
Confidence 999999999999988874 489999999999999999999999999999999999999777 899999999975433
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc-hHHHHHH-------------hhcCc
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKK-------------ISAAE 230 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~-~~~~~~~-------------i~~~~ 230 (416)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||.... ....... +....
T Consensus 184 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 184 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred --CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 2334566899999999999875555689999999999999999999995432 2111111 11111
Q ss_pred cCC------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 231 FTC------------------------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 231 ~~~------------------------~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
... +..+++++.+||.+||+.||.+|||++|+|+||||+.-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 111 12278999999999999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=387.78 Aligned_cols=259 Identities=36% Similarity=0.660 Sum_probs=214.5
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhh-----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (416)
...++|++.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 3457899999999999999999999999999999999765431 11223568899999999999999999999977
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCC---eEEeeccccc
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSA 159 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~---vkl~DFGla~ 159 (416)
.. .|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred Cc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 65 8999999999999999998889999999999999999999999999999999999999987665 9999999987
Q ss_pred ccccccCCCCcccccCCcccccchhhcc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH-HHHHHhhcCccCCC--
Q 014909 160 LSQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCP-- 234 (416)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~--~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~-~~~~~i~~~~~~~~-- 234 (416)
.... .......+||+.|+|||++.+ ....+.++|||||||++|+|++|..||...... .....+..+....+
T Consensus 166 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T 2ycf_A 166 ILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242 (322)
T ss_dssp ECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHH
T ss_pred eccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCch
Confidence 5432 222345679999999999842 233358999999999999999999999765432 33344444443332
Q ss_pred --CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 235 --PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 235 --~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
..++..+.+||.+||+.||.+|||+.++++||||+.
T Consensus 243 ~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 457999999999999999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=401.42 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=213.3
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC------CCCCcceEEEEEEe
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV------KHPNVVRLYEVMGS 82 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l------~hpnIv~l~~~~~~ 82 (416)
...+|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ +|+||+++++++..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 3467999999999999999999999999999999997543 2345677888888776 57899999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCC--eEEeecccc
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--LKVSDFGLS 158 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~--vkl~DFGla 158 (416)
...+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999999996 59999998754 4999999999999999999999999999999999999999887 999999998
Q ss_pred cccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc-------
Q 014909 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------- 231 (416)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~------- 231 (416)
.... ....+.+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+.......+.....
T Consensus 250 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 250 CYEH-----QRVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323 (429)
T ss_dssp EETT-----CCCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eecC-----CcccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 6432 23346789999999999998877 4899999999999999999999998877655544321100
Q ss_pred -------------C---------------------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCH
Q 014909 232 -------------T---------------------------------------CPPWLSFTARKLIARILDPNPMTRITI 259 (416)
Q Consensus 232 -------------~---------------------------------------~~~~~s~~~~~ll~~~L~~dP~~R~t~ 259 (416)
. ++...++.+.+||++||+.||++|||+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 0 011237889999999999999999999
Q ss_pred hHHhcCcccccCCC
Q 014909 260 PEILEDEWFKKDYK 273 (416)
Q Consensus 260 ~eil~h~~~~~~~~ 273 (416)
+|+|+||||++...
T Consensus 404 ~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 404 GQALRHPWLRRRLP 417 (429)
T ss_dssp HHHHTSTTTC----
T ss_pred HHHhCChhhccCCC
Confidence 99999999987543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=386.99 Aligned_cols=264 Identities=28% Similarity=0.421 Sum_probs=218.2
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-- 83 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 83 (416)
.....++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence 3445679999999999999999999999999999999996432 333456788999999999999999999988654
Q ss_pred ---CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccc
Q 014909 84 ---TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (416)
Q Consensus 84 ---~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~ 160 (416)
...|+||||+. ++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 84 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 84 ENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 67999999997 489988876 6799999999999999999999999999999999999999999999999999876
Q ss_pred cccccCCC--------CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC---
Q 014909 161 SQQVRDDG--------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--- 229 (416)
Q Consensus 161 ~~~~~~~~--------~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~--- 229 (416)
........ .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 54321111 1234579999999999876455568999999999999999999999988765444332110
Q ss_pred ---------------------cc--------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 230 ---------------------EF--------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 230 ---------------------~~--------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
.. ..++.+++++.+||.+||+.||.+|||+.++++||||+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 00 012457899999999999999999999999999999986543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=379.82 Aligned_cols=259 Identities=36% Similarity=0.649 Sum_probs=227.9
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
+...++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 456789999999999999999999999999999999997654322 2356788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC---CCeEEeeccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGLSALSQQ 163 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~---~~vkl~DFGla~~~~~ 163 (416)
|+||||+++++|.+.+.....+++..+..++.||+.||.|||++|++||||||+||+++.+ +.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 9999999999999999888899999999999999999999999999999999999999764 4699999999875533
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC----CCCCH
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSF 239 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 239 (416)
........||+.|+|||++.+. + +.++||||||+++|+|++|..||.+.+.......+..+....+ ..+++
T Consensus 177 ---~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 2wei_A 177 ---NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (287)
T ss_dssp ---CSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred ---CCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence 2223445689999999998764 4 5899999999999999999999999888887777776654433 35899
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 240 TARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
++.+||.+||+.||.+|||+.++++||||++.
T Consensus 252 ~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=378.82 Aligned_cols=259 Identities=28% Similarity=0.473 Sum_probs=227.3
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
.-+.|++.+.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 345799999999999999999999999999999999865432 235779999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
||||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 174 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I 174 (303)
T ss_dssp EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--C
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc--c
Confidence 9999999999998865 679999999999999999999999999999999999999999999999999987543321 2
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHHHHHHHH
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIAR 247 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ll~~ 247 (416)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...........+.... ...+..++..+.+||.+
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 253 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 253 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHH
T ss_pred ccCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHH
Confidence 23456799999999999887765 89999999999999999999999887776665554443 34556789999999999
Q ss_pred hcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 248 ILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 248 ~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
||+.||.+|||+.++++||||.....
T Consensus 254 ~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 254 CLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp HCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred HcCCChhhCcCHHHHhhChhhhcCCC
Confidence 99999999999999999999987543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=381.26 Aligned_cols=257 Identities=29% Similarity=0.477 Sum_probs=217.3
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 45789999999999999999999999999999999975432 235678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 89 VLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 171 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-- 171 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--
Confidence 9999999999998876 4679999999999999999999999999999999999999999999999999876432211
Q ss_pred CCcccccCCcccccchhhc-----cCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc---CCCCCCCH
Q 014909 168 GLLHTTCGTPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSF 239 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~-----~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~ 239 (416)
......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||...+.......+..... ..+..++.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV 250 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred cccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCH
Confidence 1123457999999999984 3344 5899999999999999999999998887766665554432 23456899
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 240 TARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
.+.+||.+||+.||.+|||+.++++||||...
T Consensus 251 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 99999999999999999999999999999863
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=385.54 Aligned_cols=267 Identities=23% Similarity=0.352 Sum_probs=203.2
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCC---eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (416)
.....++|++.+.||+|+||.||+|.+..++. .||||++....... ...+.+.+|+.+++.++||||+++++++..
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 34456789999999999999999999887665 79999997654333 346789999999999999999999999987
Q ss_pred CCEE------EEEEeccCCCchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCe
Q 014909 83 KTKI------FIVLEFVTGGELFDKIVNHG------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (416)
Q Consensus 83 ~~~~------~lV~E~~~gg~L~~~i~~~~------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~v 150 (416)
.... |+||||+.+|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 7665 99999999999999986543 59999999999999999999999999999999999999999999
Q ss_pred EEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC
Q 014909 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA 229 (416)
Q Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~ 229 (416)
||+|||+|................+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+...
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 255 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence 99999999765433222233345678899999999887764 89999999999999999 99999988877777666544
Q ss_pred -ccCCCCCCCHHHHHHHHHhcCCCCCCCCC-------HhHHhcCcccccCCCC
Q 014909 230 -EFTCPPWLSFTARKLIARILDPNPMTRIT-------IPEILEDEWFKKDYKP 274 (416)
Q Consensus 230 -~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-------~~eil~h~~~~~~~~~ 274 (416)
....++.+++++.+||.+||+.||.+||| +++++.|||+......
T Consensus 256 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 256 NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 45667789999999999999999999999 7888899999875443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=391.56 Aligned_cols=254 Identities=24% Similarity=0.412 Sum_probs=220.3
Q ss_pred ccccCEEEEeEEeecCceEEEEEEEC-------CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNS-------ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEV 79 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 79 (416)
...++|++++.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+|+.+ +||||++++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 35578999999999999999999874 345679999997653 334567899999999999 89999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEE
Q 014909 80 MGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 143 (416)
Q Consensus 80 ~~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NIL 143 (416)
+.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 999999999999999999999998753 4789999999999999999999999999999999999
Q ss_pred eccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHH
Q 014909 144 LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNL 222 (416)
Q Consensus 144 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~ 222 (416)
++.+|.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+....
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999999865433222233445678999999999887764 89999999999999999 9999999887777
Q ss_pred HHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 223 YKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 223 ~~~i~~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
...+..+ ....|..++.++.+||.+||+.||.+|||+.|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 315 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7766555 34567779999999999999999999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=385.64 Aligned_cols=255 Identities=23% Similarity=0.408 Sum_probs=210.9
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--E
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--K 85 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~ 85 (416)
..-++|++.+.||+|+||.||+|.+..+++.||||++....... ..+.+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 45678999999999999999999999999999999998654333 2566789999999999999999999998765 7
Q ss_pred EEEEEeccCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEe----ccCCCeEEeecccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLS 158 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~---l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl----~~~~~vkl~DFGla 158 (416)
.|+||||++|++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 8999999999999999987543 9999999999999999999999999999999999999 77788999999999
Q ss_pred cccccccCCCCcccccCCcccccchhhcc-------CCCCCChhhHHHHHHHHHHHhhCCCCCCCCc----hHHHHHHhh
Q 014909 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLND-------RGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKIS 227 (416)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~-------~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~----~~~~~~~i~ 227 (416)
..... .......+||+.|+|||++.. ....+.++|||||||++|+|++|..||.... ......++.
T Consensus 164 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCC---CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 75433 233445689999999999862 2333589999999999999999999996432 223333333
Q ss_pred cCcc---------------------CC----CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcc
Q 014909 228 AAEF---------------------TC----PPWLSFTARKLIARILDPNPMTRITIPEILEDEW 267 (416)
Q Consensus 228 ~~~~---------------------~~----~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~ 267 (416)
.+.+ +. +..++..+.+||++||+.||++|||++|+++||=
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 2221 11 1123567889999999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=396.99 Aligned_cols=251 Identities=31% Similarity=0.438 Sum_probs=207.4
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT---- 84 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 84 (416)
...+|++.+.||+|+||.||+|.+..+++ ||+|.+...... ..+|+.+|+.++||||+++++++....
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 45679999999999999999999987666 888887643321 237999999999999999999985433
Q ss_pred --EEEEEEeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEec-cCCCeEEeeccc
Q 014909 85 --KIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-AYGNLKVSDFGL 157 (416)
Q Consensus 85 --~~~lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~-~~~~vkl~DFGl 157 (416)
.+|+||||++++ +.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 110 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 110 EVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp CEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 388999999875 433332 356899999999999999999999999999999999999999 789999999999
Q ss_pred ccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC--------
Q 014909 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------- 229 (416)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~-------- 229 (416)
|..... .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 189 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 189 AKILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp CEECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 976432 223345688999999999987655568999999999999999999999988766555444221
Q ss_pred ---------cc------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 230 ---------EF------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 230 ---------~~------------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
.. .+++.+++++.+||.+||+.||.+|||+.|+++||||+.-
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 00 1234578999999999999999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=379.26 Aligned_cols=255 Identities=29% Similarity=0.482 Sum_probs=217.2
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+.+|+.+++.++||||+++++++......|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 4568999999999999999999999999999999997643 23568899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 89 VLEFVTGGELFDKIV-NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 89 V~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
||||+++++|.+++. ....+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~ 179 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT--M 179 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--B
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--c
Confidence 999999999999987 4568999999999999999999999999999999999999999999999999998754332 1
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC---ccCCCCCCCHHHHHH
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKL 244 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~l 244 (416)
.......||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+... ....+..++..+.+|
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 258 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDF 258 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred cccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHH
Confidence 223456799999999999887765 8899999999999999999999987766554444332 233355679999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 245 IARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
|.+||+.||.+|||+.++++||||+..
T Consensus 259 i~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 259 VKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 999999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=397.70 Aligned_cols=251 Identities=29% Similarity=0.406 Sum_probs=208.1
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe------C
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------K 83 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~ 83 (416)
..+|++.+.||+|+||.||+|.+..+|+.||||++..... ...+|+.+|+.++||||+++++++.. .
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 4479999999999999999999999999999999875432 23479999999999999999998843 2
Q ss_pred CEEEEEEeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC-CCeEEeecccc
Q 014909 84 TKIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLS 158 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~-~~vkl~DFGla 158 (416)
..+++||||+++ +|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 246799999986 6665554 35679999999999999999999999999999999999999965 56899999999
Q ss_pred cccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhc----------
Q 014909 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---------- 228 (416)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~---------- 228 (416)
+.... .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+.+.++..
T Consensus 205 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 205 KQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp EECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 75432 22334568999999999998764446899999999999999999999998876655444322
Q ss_pred -------CccC------------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 229 -------AEFT------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 229 -------~~~~------------~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
..+. +++.+++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 0111 234568999999999999999999999999999999754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=383.85 Aligned_cols=263 Identities=28% Similarity=0.477 Sum_probs=197.8
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
....++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 3456789999999999999999999998999999999876532 22356788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccc
Q 014909 87 FIVLEFVTGGELFDKIVN--------HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~--------~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla 158 (416)
|+||||++|++|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999999874 456999999999999999999999999999999999999999999999999998
Q ss_pred ccccccc---CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc----
Q 014909 159 ALSQQVR---DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---- 231 (416)
Q Consensus 159 ~~~~~~~---~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~---- 231 (416)
....... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.............
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence 7543321 112234567999999999997633335899999999999999999999988665544433322211
Q ss_pred ------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 232 ------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 232 ------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
..+..++.++.+||.+||+.||.+|||+.++++||||++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 1224578899999999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=380.13 Aligned_cols=260 Identities=27% Similarity=0.435 Sum_probs=216.4
Q ss_pred cccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe-
Q 014909 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS- 82 (416)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~- 82 (416)
.+....++|++.+.||+|+||.||+|.+..+|+.||||++..... ..+.+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 455677899999999999999999999999999999999975432 235688999999998 79999999999976
Q ss_pred -----CCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeec
Q 014909 83 -----KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (416)
Q Consensus 83 -----~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DF 155 (416)
....|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 56899999999999999999874 47999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCcccccCCcccccchhhc-----cCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc
Q 014909 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230 (416)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~-----~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~ 230 (416)
|++...... .......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+.......+....
T Consensus 174 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 174 GVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp TTTC---------------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred cCceecCcC--ccccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 998754321 12234567999999999997 3334 588999999999999999999998877665555544332
Q ss_pred c--CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 231 F--TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 231 ~--~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
. ..+..++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 251 APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 2 2235589999999999999999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=388.69 Aligned_cols=254 Identities=27% Similarity=0.417 Sum_probs=213.5
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE--
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI-- 86 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~-- 86 (416)
.-++|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 34689999999999999999999999999999999976542 344567889999999999999999999999877654
Q ss_pred ----EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 87 ----FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 87 ----~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
|+||||+. ++|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred ceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999998 48887773 459999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc------------
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------ 230 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~------------ 230 (416)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 196 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 196 A-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred c-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 2 23456889999999999874444689999999999999999999999887665554442210
Q ss_pred -------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 231 -------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 231 -------------------~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
...++.+++++.+||++||+.||.+|||+.|+++||||+..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 01123468999999999999999999999999999999854
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=393.72 Aligned_cols=259 Identities=20% Similarity=0.294 Sum_probs=223.6
Q ss_pred cccCEEEEeEEeecCceEEEEEE-----ECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
..++|++++.||+|+||.||+|. +..++..||||++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 45789999999999999999999 44577889999996432 233456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC---CeEEe
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHG-------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVS 153 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~-------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~---~vkl~ 153 (416)
...|+||||++||+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.+| .+||+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999999998653 589999999999999999999999999999999999999655 49999
Q ss_pred ecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc-c
Q 014909 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-F 231 (416)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~-~ 231 (416)
|||+|................||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+. .
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999765443333344556789999999999887775 89999999999999998 999999998888887776654 4
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 232 ~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
..+..++..+.+||.+||+.||.+|||+.+|++|.|+..
T Consensus 306 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 306 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 566779999999999999999999999999999988764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=388.77 Aligned_cols=262 Identities=24% Similarity=0.349 Sum_probs=205.6
Q ss_pred cccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
.....+++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+++..++.++||||+++++++....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 3456789999999999999999999999999999999998654322 234567788888899999999999986533
Q ss_pred -------EEEEEEeccCCCchHHH----HHhCCCCCHHHHHHHHHHHHHHHHHHH--hCCcEeecCCCCcEEecc-CCCe
Q 014909 85 -------KIFIVLEFVTGGELFDK----IVNHGRMKEDEARRYFQQLINAVDYCH--SRGVYHRDLKPENLLLDA-YGNL 150 (416)
Q Consensus 85 -------~~~lV~E~~~gg~L~~~----i~~~~~l~e~~~~~~~~qll~al~~LH--~~givHrDlkp~NILl~~-~~~v 150 (416)
.+|+||||+.++ |.+. +.....+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp SSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEE
T ss_pred cccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcE
Confidence 288999999874 4433 335667999999999999999999999 999999999999999997 8999
Q ss_pred EEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc
Q 014909 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230 (416)
Q Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~ 230 (416)
||+|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 172 kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 172 KLCDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EECCCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEeeCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 9999999975543 2233456899999999999776655699999999999999999999999887766655543210
Q ss_pred --------------------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 231 --------------------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 231 --------------------------------~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
...+...++++.+||.+||+.||.+|||+.|+++||||+....+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 01112256789999999999999999999999999999875443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=379.40 Aligned_cols=259 Identities=26% Similarity=0.414 Sum_probs=211.3
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE-------
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG------- 81 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~------- 81 (416)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 4579999999999999999999999999999999987543 344677899999999999999999999873
Q ss_pred -------eCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEec-cCCCeEEe
Q 014909 82 -------SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-AYGNLKVS 153 (416)
Q Consensus 82 -------~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~-~~~~vkl~ 153 (416)
.....|+||||+. |+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 4478999999998 599998864 6799999999999999999999999999999999999997 56789999
Q ss_pred eccccccccccc-CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc-
Q 014909 154 DFGLSALSQQVR-DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF- 231 (416)
Q Consensus 154 DFGla~~~~~~~-~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~- 231 (416)
|||++....... .........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999998654321 122334567899999999987644456899999999999999999999998876655544432110
Q ss_pred -----------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 232 -----------------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 232 -----------------------------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
..++.++.++.+||++||+.||.+|||++++++||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 11245899999999999999999999999999999998643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=389.43 Aligned_cols=263 Identities=25% Similarity=0.392 Sum_probs=211.5
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhh--------hcHHHHHHHHHHHHHHhcCCCCCcceEEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--------LKHKMAEQIKREVATMKLVKHPNVVRLYE 78 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~--------~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 78 (416)
....++|++.+.||+|+||.||+|.+.. |+.||||++..... ......+.+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 4566899999999999999999999865 89999999865322 22334578999999999999999999999
Q ss_pred EEEe-----CCEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEE
Q 014909 79 VMGS-----KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152 (416)
Q Consensus 79 ~~~~-----~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl 152 (416)
++.. ...+|+||||+. |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 9843 347899999998 4888887764 37999999999999999999999999999999999999999999999
Q ss_pred eecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc--
Q 014909 153 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-- 230 (416)
Q Consensus 153 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~-- 230 (416)
+|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 176 ~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 176 CDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp CCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99999874332 2233456899999999999874445689999999999999999999999887665555442210
Q ss_pred ----------------------c--------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 231 ----------------------F--------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 231 ----------------------~--------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
. ..++..++.+.+||.+||+.||.+|||+.++++||||+..+.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 0 1123468899999999999999999999999999999876543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=381.35 Aligned_cols=251 Identities=28% Similarity=0.452 Sum_probs=212.2
Q ss_pred cccCEEEEeEEeecCceEEEEEEE-CCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCC------CcceEEEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARN-SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP------NVVRLYEVMG 81 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~-~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp------nIv~l~~~~~ 81 (416)
..++|++.+.||+|+||.||+|.+ ..+++.||||++.... ...+.+.+|+.+++.++|+ +++++++++.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 457999999999999999999998 5678999999997532 2356788999999888765 4999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc-------------
Q 014909 82 SKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA------------- 146 (416)
Q Consensus 82 ~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~------------- 146 (416)
+.+..|+||||+ +++|.+++...+ ++++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999999 889999998765 6899999999999999999999999999999999999987
Q ss_pred ------CCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH
Q 014909 147 ------YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220 (416)
Q Consensus 147 ------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~ 220 (416)
++.+||+|||++..... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+..
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 66899999999875322 23456899999999999887774 8999999999999999999999987765
Q ss_pred HHHHHhhcCccCC--------------------------------------------CCCCCHHHHHHHHHhcCCCCCCC
Q 014909 221 NLYKKISAAEFTC--------------------------------------------PPWLSFTARKLIARILDPNPMTR 256 (416)
Q Consensus 221 ~~~~~i~~~~~~~--------------------------------------------~~~~s~~~~~ll~~~L~~dP~~R 256 (416)
.....+....... +...++++.+||.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 5443332211111 11124678899999999999999
Q ss_pred CCHhHHhcCccccc
Q 014909 257 ITIPEILEDEWFKK 270 (416)
Q Consensus 257 ~t~~eil~h~~~~~ 270 (416)
||+.|+++||||+.
T Consensus 321 pt~~ell~hp~f~~ 334 (339)
T 1z57_A 321 ITLREALKHPFFDL 334 (339)
T ss_dssp CCHHHHTTSGGGGG
T ss_pred cCHHHHhcCHHHHH
Confidence 99999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=395.00 Aligned_cols=255 Identities=17% Similarity=0.197 Sum_probs=195.9
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC--CCCCcceEE-------EE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV--KHPNVVRLY-------EV 79 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~-------~~ 79 (416)
...+|++.+.||+|+||.||+|.+..+|+.||||++...........+.+++|+.+++.+ +||||++++ ++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 344699999999999999999999999999999999986654455567788885544444 699988755 55
Q ss_pred EEeC-----------------CEEEEEEeccCCCchHHHHHhCC-CCCHHHH------HHHHHHHHHHHHHHHhCCcEee
Q 014909 80 MGSK-----------------TKIFIVLEFVTGGELFDKIVNHG-RMKEDEA------RRYFQQLINAVDYCHSRGVYHR 135 (416)
Q Consensus 80 ~~~~-----------------~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~------~~~~~qll~al~~LH~~givHr 135 (416)
+... ..+|+||||++ |+|.+++...+ .+++... ..++.||+.||+|||++||+||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr 218 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence 5433 34899999999 79999998743 3444444 4666999999999999999999
Q ss_pred cCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhcc--CCCCCChhhHHHHHHHHHHHhhCCCC
Q 014909 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLP 213 (416)
Q Consensus 136 Dlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~--~~~~~~~~DIwSlGvil~~ml~G~~P 213 (416)
||||+|||++.+|.+||+|||+|..... ......||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.|
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999875432 1224567799999999976 455 5899999999999999999999
Q ss_pred CCCCchH--HHHHH-----hhcCccCC--CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 214 FDDSNLM--NLYKK-----ISAAEFTC--PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 214 f~~~~~~--~~~~~-----i~~~~~~~--~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
|.+.... ..+.. .......+ ++.+++.+.+||.+||+.||++|||+.++++||||+.
T Consensus 293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 9876432 11111 11112222 3468999999999999999999999999999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=379.57 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=218.6
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCe---EEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEP---VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~---vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
...++|++.+.||+|+||.||+|.+..+++. ||||++.... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 4567899999999999999999999866654 9999997543 2334577999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
..|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999999999765 5799999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCC-CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHH
Q 014909 164 VRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (416)
Q Consensus 164 ~~~~~-~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 240 (416)
..... ......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ....|..+++.
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHA 282 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHH
Confidence 22211 12234567889999999877664 89999999999999999 99999998888877776655 45567779999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 241 ARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+.+||.+||+.||.+|||+.++++
T Consensus 283 l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 283 LHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=378.26 Aligned_cols=265 Identities=31% Similarity=0.439 Sum_probs=218.0
Q ss_pred CCcccccccccCEEEEeEEeecCceEEEEEEEC-CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC---CCCCcceE
Q 014909 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNS-ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRL 76 (416)
Q Consensus 1 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l 76 (416)
|..+.+....++|++.+.||+|+||.||+|.+. .+|+.||+|++....... .....+.+|+.+++.+ +||||+++
T Consensus 1 m~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~ 79 (326)
T 1blx_A 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRL 79 (326)
T ss_dssp ----CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCE
T ss_pred CCCccccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEee
Confidence 444555667789999999999999999999995 678899999997644221 1123456777777666 89999999
Q ss_pred EEEEE-----eCCEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCC
Q 014909 77 YEVMG-----SKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149 (416)
Q Consensus 77 ~~~~~-----~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~ 149 (416)
++++. .....++||||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 80 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~ 158 (326)
T 1blx_A 80 FDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ 158 (326)
T ss_dssp EEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC
Confidence 99987 5678999999998 59999998754 4999999999999999999999999999999999999999999
Q ss_pred eEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC
Q 014909 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 229 (416)
Q Consensus 150 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~ 229 (416)
+||+|||++...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+...
T Consensus 159 ~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 159 IKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp EEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EEEecCcccccccCC---CCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 999999998754322 22345689999999999988776 48999999999999999999999988776665554321
Q ss_pred c---------------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 230 E---------------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 230 ~---------------------------~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
. ..+++.++..+.+||.+||+.||.+|||+.++++||||+.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 0 01234578999999999999999999999999999999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=397.26 Aligned_cols=260 Identities=26% Similarity=0.398 Sum_probs=196.7
Q ss_pred cccCEEE-EeEEeecCceEEEEEEEC--CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE--eC
Q 014909 9 RVGKYEV-GRTIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG--SK 83 (416)
Q Consensus 9 ~~~~y~~-~~~LG~G~fg~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~ 83 (416)
.-+.|++ ++.||+|+||.||+|.+. .+++.||||++..... ...+.+|+.+|+.++||||+++++++. ..
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHAD 92 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence 4456887 568999999999999976 5688999999975432 245779999999999999999999995 47
Q ss_pred CEEEEEEeccCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEe----ccCCCe
Q 014909 84 TKIFIVLEFVTGGELFDKIVNH---------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNL 150 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl----~~~~~v 150 (416)
..+|+||||+.| +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 93 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 789999999975 888877632 249999999999999999999999999999999999999 677899
Q ss_pred EEeeccccccccccc-CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH---------
Q 014909 151 KVSDFGLSALSQQVR-DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM--------- 220 (416)
Q Consensus 151 kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~--------- 220 (416)
||+|||+|....... ........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+....
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 999999998654321 1123456789999999999988665568999999999999999999999765431
Q ss_pred HHHHHhhcC--ccCC------------------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHhHH
Q 014909 221 NLYKKISAA--EFTC------------------------------------PPWLSFTARKLIARILDPNPMTRITIPEI 262 (416)
Q Consensus 221 ~~~~~i~~~--~~~~------------------------------------~~~~s~~~~~ll~~~L~~dP~~R~t~~ei 262 (416)
.....+... .+.. ....++.+.+||++||+.||.+|||++|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 222222110 0000 01127789999999999999999999999
Q ss_pred hcCcccccCCCC
Q 014909 263 LEDEWFKKDYKP 274 (416)
Q Consensus 263 l~h~~~~~~~~~ 274 (416)
|+||||.....+
T Consensus 332 L~hp~f~~~~~~ 343 (405)
T 3rgf_A 332 MQDPYFLEDPLP 343 (405)
T ss_dssp HTSGGGTSSSCC
T ss_pred hcChhhccCCCC
Confidence 999999876543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=378.13 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=222.1
Q ss_pred cccccccCEEEEeEEeecCceEEEEEEEC-----CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEE
Q 014909 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEV 79 (416)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 79 (416)
+......+|++.+.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.++||||++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 34456689999999999999999999983 456889999997543 33446789999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCcEee
Q 014909 80 MGSKTKIFIVLEFVTGGELFDKIVNHGR------------------------MKEDEARRYFQQLINAVDYCHSRGVYHR 135 (416)
Q Consensus 80 ~~~~~~~~lV~E~~~gg~L~~~i~~~~~------------------------l~e~~~~~~~~qll~al~~LH~~givHr 135 (416)
+.+.+..|+||||++||+|.+++..... +++..+..++.||+.||.|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 9999999999999999999999987543 8999999999999999999999999999
Q ss_pred cCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCC
Q 014909 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPF 214 (416)
Q Consensus 136 Dlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf 214 (416)
||||+|||++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999998755432222223345678899999999876664 89999999999999999 99999
Q ss_pred CCCchHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 215 DDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 215 ~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.+.+.......+... ....+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 254 PGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 988877777666554 345667799999999999999999999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=377.30 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=215.5
Q ss_pred cccccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014909 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (416)
Q Consensus 3 ~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (416)
.+......++|++++.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 2 ~p~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 78 (310)
T 3s95_A 2 MPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK 78 (310)
T ss_dssp CCCEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CcceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEec
Confidence 344445678999999999999999999999999999999998543 33456789999999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccc
Q 014909 83 KTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~ 161 (416)
....|+||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 79 DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLM 158 (310)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceec
Confidence 9999999999999999999987 567999999999999999999999999999999999999999999999999999765
Q ss_pred ccccCCC------------CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHH---Hh
Q 014909 162 QQVRDDG------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK---KI 226 (416)
Q Consensus 162 ~~~~~~~------------~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~---~i 226 (416)
....... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.......... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~ 237 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR 237 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh
Confidence 3322110 11256899999999999887775 89999999999999999999997532211000 00
Q ss_pred hcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 227 SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 227 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.......|+.+++.+.+|+.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 238 GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00112346778899999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=373.04 Aligned_cols=256 Identities=31% Similarity=0.535 Sum_probs=209.3
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe------
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------ 82 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 82 (416)
..++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 457899999999999999999999999999999999653 2345778999999999999999999998754
Q ss_pred -------CCEEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEee
Q 014909 83 -------KTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSD 154 (416)
Q Consensus 83 -------~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~D 154 (416)
....|+||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 467899999999999999998644 688999999999999999999999999999999999999999999999
Q ss_pred ccccccccccc------------CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCC-chHH
Q 014909 155 FGLSALSQQVR------------DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMN 221 (416)
Q Consensus 155 FGla~~~~~~~------------~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~-~~~~ 221 (416)
||++....... ........+||+.|+|||++.+.+..+.++|||||||++|+|++ ||... +...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99987543211 01223456799999999999876545689999999999999998 66532 3334
Q ss_pred HHHHhhcCccCCCC----CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 222 LYKKISAAEFTCPP----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 222 ~~~~i~~~~~~~~~----~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
....+......+|+ ..+..+.+||++||+.||.+|||+.++++||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 55555555444443 356779999999999999999999999999999753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=391.03 Aligned_cols=250 Identities=26% Similarity=0.428 Sum_probs=206.4
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC--------CCCcceEEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK--------HPNVVRLYEVM 80 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--------hpnIv~l~~~~ 80 (416)
..++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.++ ||||+++++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 3478999999999999999999999999999999997542 34567889999999885 78899999998
Q ss_pred E----eCCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCcEEeccCC-----
Q 014909 81 G----SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYG----- 148 (416)
Q Consensus 81 ~----~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~-givHrDlkp~NILl~~~~----- 148 (416)
. +...+|+||||+ +++|.+.+... +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence 7 567899999999 55777777654 4699999999999999999999999 999999999999999775
Q ss_pred --------------------------------------------CeEEeecccccccccccCCCCcccccCCcccccchh
Q 014909 149 --------------------------------------------NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184 (416)
Q Consensus 149 --------------------------------------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEv 184 (416)
.+||+|||+|..... .....+||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCChh
Confidence 799999999875432 2345689999999999
Q ss_pred hccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch------HHHHHHhhcC------------c----------------
Q 014909 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL------MNLYKKISAA------------E---------------- 230 (416)
Q Consensus 185 l~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~------~~~~~~i~~~------------~---------------- 230 (416)
+.+..+. .++|||||||++|+|++|..||...+. ......+... .
T Consensus 265 ~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 265 LIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHTSCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hcCCCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 9988775 899999999999999999999976441 1111111110 0
Q ss_pred --------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 014909 231 --------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (416)
Q Consensus 231 --------------~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~ 269 (416)
...+...+..+.+||.+||+.||.+|||++|+|+||||+
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 011112346788999999999999999999999999996
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=374.42 Aligned_cols=259 Identities=25% Similarity=0.384 Sum_probs=212.4
Q ss_pred ccccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
+..+..+++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 2h34_A 27 SREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID 106 (309)
T ss_dssp -------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred cCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence 34577899999999999999999999999999999999999876655555678899999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
+..|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999875433
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc---cCCCCCCCHH
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFT 240 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~ 240 (416)
.. .......+||+.|+|||++.+..+. .++||||||+++|+|++|..||.+.+.......+.... ...++.++++
T Consensus 187 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T 2h34_A 187 EK-LTQLGNTVGTLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVA 264 (309)
T ss_dssp -----------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTH
T ss_pred cc-cccccccCCCcCccCHHHHcCCCCC-chHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHH
Confidence 21 1223456799999999999877664 88999999999999999999999887665554444332 2345678999
Q ss_pred HHHHHHHhcCCCCCCCC-CHhHHhc
Q 014909 241 ARKLIARILDPNPMTRI-TIPEILE 264 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~-t~~eil~ 264 (416)
+.+||.+||+.||.+|| |++++++
T Consensus 265 l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 265 FDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHhccCCHHHHHHhHHHHHH
Confidence 99999999999999999 7888775
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=388.05 Aligned_cols=255 Identities=23% Similarity=0.389 Sum_probs=215.7
Q ss_pred ccccCEEEEeEEeecCceEEEEEE-----ECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG 81 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 81 (416)
...++|++++.||+|+||.||+|. +..+++.||||++.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 456799999999999999999998 55677899999997643 233457799999999999 7999999999998
Q ss_pred eCC-EEEEEEeccCCCchHHHHHhCCC-----------------------------------------------------
Q 014909 82 SKT-KIFIVLEFVTGGELFDKIVNHGR----------------------------------------------------- 107 (416)
Q Consensus 82 ~~~-~~~lV~E~~~gg~L~~~i~~~~~----------------------------------------------------- 107 (416)
+.+ .+|+||||++||+|.+++.....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 755 48999999999999999987543
Q ss_pred -------------CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCccccc
Q 014909 108 -------------MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (416)
Q Consensus 108 -------------l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 174 (416)
+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++................
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 8999999999999999999999999999999999999999999999999997653322222334567
Q ss_pred CCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHH-HHHHhhc-CccCCCCCCCHHHHHHHHHhcCC
Q 014909 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN-LYKKISA-AEFTCPPWLSFTARKLIARILDP 251 (416)
Q Consensus 175 gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~-~~~~i~~-~~~~~~~~~s~~~~~ll~~~L~~ 251 (416)
||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+..... ....+.. .....|..+++++.+||.+||+.
T Consensus 257 ~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 335 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 335 (359)
T ss_dssp ECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 89999999999887775 89999999999999998 999998866443 3333333 34566778999999999999999
Q ss_pred CCCCCCCHhHHhcC
Q 014909 252 NPMTRITIPEILED 265 (416)
Q Consensus 252 dP~~R~t~~eil~h 265 (416)
||.+|||+.++++|
T Consensus 336 dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 336 EPSQRPTFSELVEH 349 (359)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCCCHHHHHHH
Confidence 99999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=381.27 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=221.6
Q ss_pred cccccCEEEEeEEeecCceEEEEEEEC-----CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 81 (416)
....++|++.+.||+|+||.||+|.+. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 345679999999999999999999987 345889999997643 3345678999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecC
Q 014909 82 SKTKIFIVLEFVTGGELFDKIVNH------------------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137 (416)
Q Consensus 82 ~~~~~~lV~E~~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~qll~al~~LH~~givHrDl 137 (416)
+.+..|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999999874 56899999999999999999999999999999
Q ss_pred CCCcEEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCC
Q 014909 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDD 216 (416)
Q Consensus 138 kp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~ 216 (416)
||+|||++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999998765433222333456789999999999877764 89999999999999999 9999999
Q ss_pred CchHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 217 SNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 217 ~~~~~~~~~i~~~~-~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.+.......+..+. ...|..+++++.+||.+||+.||.+|||+.++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 88887777776654 3567789999999999999999999999999976
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=367.67 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=220.0
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
.....+|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+....
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 345679999999999999999999987 4778999999865432 35688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
|+||||+++++|.+++... +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 9999999999999999764 468999999999999999999999999999999999999999999999999987543321
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (416)
. .......||+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+... ....|...++.+.+
T Consensus 161 ~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T 4hcu_A 161 Y-TSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 238 (269)
T ss_dssp H-HSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred c-ccccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHH
Confidence 1 122345678899999999877764 89999999999999999 99999998888887777665 44556678999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcC
Q 014909 244 LIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~h 265 (416)
|+.+||+.||.+|||+.++++|
T Consensus 239 li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 239 IMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCCcccCcCHHHHHHH
Confidence 9999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=382.67 Aligned_cols=254 Identities=27% Similarity=0.412 Sum_probs=213.0
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE---
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK--- 85 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--- 85 (416)
..++|.+.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 3478999999999999999999999999999999997643 234456788999999999999999999999987654
Q ss_pred ---EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 86 ---IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 86 ---~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
+|+||||+. ++|.+.+. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred ceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 599999998 48887764 459999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC-------------
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------- 229 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~------------- 229 (416)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 178 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 178 A-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred C-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 2 2345678999999999987444468999999999999999999999987765544433210
Q ss_pred ------------------ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 230 ------------------EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 230 ------------------~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
....++.+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 011234578999999999999999999999999999999754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=384.96 Aligned_cols=256 Identities=23% Similarity=0.412 Sum_probs=223.2
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECC-------CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYE 78 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 78 (416)
....++|.+++.||+|+||.||+|.+.. .+..||||++.... .......+.+|+.+++.+ +||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 4456899999999999999999999753 33579999997653 333467899999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcE
Q 014909 79 VMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENL 142 (416)
Q Consensus 79 ~~~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NI 142 (416)
++.+.+..|+||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 9999999999999999999999998754 499999999999999999999999999999999999
Q ss_pred EeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHH
Q 014909 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 221 (416)
Q Consensus 143 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~ 221 (416)
|++.++.+||+|||+|................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+...
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999865443332334455678999999999887664 89999999999999999 999999988888
Q ss_pred HHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 222 LYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 222 ~~~~i~~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
....+..+ ....|..+++++.+||.+||+.||.+|||+.+++++
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77777655 455677799999999999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=383.67 Aligned_cols=255 Identities=31% Similarity=0.534 Sum_probs=222.5
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcH---HHHHHHHHHHHHHhcCC--CCCcceEEEEEEe
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVK--HPNVVRLYEVMGS 82 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~ 82 (416)
...++|++.+.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+++.++ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 456789999999999999999999999999999999987643221 11245678999999996 5999999999999
Q ss_pred CCEEEEEEeccCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEec-cCCCeEEeecccccc
Q 014909 83 KTKIFIVLEFVTG-GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-AYGNLKVSDFGLSAL 160 (416)
Q Consensus 83 ~~~~~lV~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~-~~~~vkl~DFGla~~ 160 (416)
.+..++|||++.+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 9999999999986 89999999888999999999999999999999999999999999999999 678999999999876
Q ss_pred cccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHH
Q 014909 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240 (416)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 240 (416)
... .......||+.|+|||++.+..+.+.++|||||||++|+|++|..||.... .+.......+..++++
T Consensus 200 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~ 269 (320)
T 3a99_A 200 LKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSE 269 (320)
T ss_dssp CCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHH
T ss_pred ccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCHH
Confidence 532 233456799999999999887776688999999999999999999997642 2334455677789999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
+.+||.+||+.||.+|||++++++||||+...
T Consensus 270 ~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 270 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 99999999999999999999999999998643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=373.57 Aligned_cols=267 Identities=25% Similarity=0.429 Sum_probs=215.7
Q ss_pred ccccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC--CCCcceEEEEEE
Q 014909 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK--HPNVVRLYEVMG 81 (416)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~ 81 (416)
+.+....++|++.+.||+|+||.||+|.+. +++.||||++..... .....+.+.+|+.+++.++ ||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 344556678999999999999999999985 488999999976543 2345678999999999997 599999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccc
Q 014909 82 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (416)
Q Consensus 82 ~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~ 161 (416)
+....|+||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++...
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred cCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 9999999999 567899999999889999999999999999999999999999999999999964 89999999999865
Q ss_pred ccccCCCCcccccCCcccccchhhccC----------CCCCChhhHHHHHHHHHHHhhCCCCCCCCch-HHHHHHhhc--
Q 014909 162 QQVRDDGLLHTTCGTPNYVAPEVLNDR----------GYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISA-- 228 (416)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPEvl~~~----------~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~-~~~~~~i~~-- 228 (416)
............+||+.|+|||++.+. ...+.++|||||||++|+|++|..||..... ......+..
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 256 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence 443332233456899999999998752 2335789999999999999999999986533 233333322
Q ss_pred CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 229 AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 229 ~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
....+|...+.++.+||.+||+.||.+|||+.++++||||+....+
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~ 302 (313)
T 3cek_A 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302 (313)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence 2345667789999999999999999999999999999999875443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=387.76 Aligned_cols=254 Identities=25% Similarity=0.395 Sum_probs=218.3
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
...++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+|+.++||||+++++++.+....|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 34578999999999999999999999899999999987542 2334567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
+||||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|........
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 9999999999999998754 699999999999999999999999999999999999999999999999999875322111
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 244 (416)
........+++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++++.+|
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 347 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRL 347 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eecCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1111223356789999999877664 89999999999999998 99999988877766665544 456677899999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc
Q 014909 245 IARILDPNPMTRITIPEILE 264 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~ 264 (416)
|.+||+.||.+|||+.++++
T Consensus 348 i~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 348 MEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999975
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=364.31 Aligned_cols=252 Identities=24% Similarity=0.390 Sum_probs=218.7
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
....++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 456789999999999999999999886 5677999999765432 35688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
|+||||+++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999999998754 59999999999999999999999999999999999999999999999999987543321
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 243 (416)
. .......||+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+.... ...|...++.+.+
T Consensus 159 ~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 159 Y-VSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp E-EECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred h-hcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHH
Confidence 1 112334567789999999877765 88999999999999999 999999888877777666554 4456668999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcC
Q 014909 244 LIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~h 265 (416)
|+.+||+.||.+|||+.+++++
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 237 IMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=369.01 Aligned_cols=256 Identities=27% Similarity=0.437 Sum_probs=212.2
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
+|.....||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 3344459999999999999999999999999997643 2335778999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc-CCCeEEeecccccccccccCC
Q 014909 92 FVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 92 ~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~~~~ 167 (416)
|+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++...... .
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~ 177 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--N 177 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC--C
Confidence 999999999998752 4678999999999999999999999999999999999987 899999999998754331 1
Q ss_pred CCcccccCCcccccchhhccCC-CCCChhhHHHHHHHHHHHhhCCCCCCCCchH--HHHH-HhhcCccCCCCCCCHHHHH
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLM--NLYK-KISAAEFTCPPWLSFTARK 243 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~-~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~--~~~~-~i~~~~~~~~~~~s~~~~~ 243 (416)
.......||+.|+|||++.+.. ..+.++||||||+++|+|++|..||...... .... .........|..+++++.+
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA 257 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHH
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHH
Confidence 2234567999999999997643 2358999999999999999999999754322 2222 2233445667789999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 244 LIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
||.+||+.||.+|||+.++++||||+...
T Consensus 258 li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 258 FILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999998643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=384.03 Aligned_cols=253 Identities=30% Similarity=0.429 Sum_probs=211.9
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CC-----CcceEEEEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HP-----NVVRLYEVMG 81 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hp-----nIv~l~~~~~ 81 (416)
...++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++ |+ +|+++++++.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 45689999999999999999999999999999999997542 23566778888888875 55 4999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--hCCcEeecCCCCcEEec--cCCCeEEeec
Q 014909 82 SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCH--SRGVYHRDLKPENLLLD--AYGNLKVSDF 155 (416)
Q Consensus 82 ~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH--~~givHrDlkp~NILl~--~~~~vkl~DF 155 (416)
..+..|+||||+.+ +|.+++... ..+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+||
T Consensus 127 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 99999999999975 999999875 46999999999999999999999 57999999999999995 4788999999
Q ss_pred ccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCC--
Q 014909 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-- 233 (416)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~-- 233 (416)
|+|..... .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.......+.......
T Consensus 206 G~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 279 (382)
T 2vx3_A 206 GSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA 279 (382)
T ss_dssp TTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred cCceeccc-----ccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99975432 23457899999999999987775 89999999999999999999999887766655543211000
Q ss_pred -----------------------------------CCC---------------------------CCHHHHHHHHHhcCC
Q 014909 234 -----------------------------------PPW---------------------------LSFTARKLIARILDP 251 (416)
Q Consensus 234 -----------------------------------~~~---------------------------~s~~~~~ll~~~L~~ 251 (416)
|.. .++++.+||.+||+.
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 359 (382)
T 2vx3_A 280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY 359 (382)
T ss_dssp HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence 000 013789999999999
Q ss_pred CCCCCCCHhHHhcCcccccC
Q 014909 252 NPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 252 dP~~R~t~~eil~h~~~~~~ 271 (416)
||++|||++|+|+||||+..
T Consensus 360 dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 360 DPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp CTTTSCCHHHHTTSGGGCC-
T ss_pred ChhhCCCHHHHhcCcccccC
Confidence 99999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=378.06 Aligned_cols=251 Identities=27% Similarity=0.443 Sum_probs=210.3
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCC-CeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCC------cceEEEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETG-EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN------VVRLYEVMG 81 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~l~~~~~ 81 (416)
..++|++.+.||+|+||.||+|.+..++ +.||+|++.... ...+.+.+|+.+++.++|++ ++.+++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 4579999999999999999999998776 689999997532 23567888999999987665 999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEe---------------
Q 014909 82 SKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL--------------- 144 (416)
Q Consensus 82 ~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl--------------- 144 (416)
.....|+||||+ +++|.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence 999999999999 567778777654 69999999999999999999999999999999999999
Q ss_pred ----ccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH
Q 014909 145 ----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220 (416)
Q Consensus 145 ----~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~ 220 (416)
+.++.+||+|||++..... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+..
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 5678999999999875322 23456899999999999887775 8999999999999999999999987765
Q ss_pred HHHHHhhcCccCCC--------------------------------------------CCCCHHHHHHHHHhcCCCCCCC
Q 014909 221 NLYKKISAAEFTCP--------------------------------------------PWLSFTARKLIARILDPNPMTR 256 (416)
Q Consensus 221 ~~~~~i~~~~~~~~--------------------------------------------~~~s~~~~~ll~~~L~~dP~~R 256 (416)
.....+.......| ...+.++.+||++||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 54443322111111 1124578899999999999999
Q ss_pred CCHhHHhcCccccc
Q 014909 257 ITIPEILEDEWFKK 270 (416)
Q Consensus 257 ~t~~eil~h~~~~~ 270 (416)
||+.++++||||+.
T Consensus 326 pt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 326 ITLAEALLHPFFAG 339 (355)
T ss_dssp CCHHHHTTSGGGGG
T ss_pred cCHHHHhcChhhcC
Confidence 99999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=378.62 Aligned_cols=255 Identities=33% Similarity=0.572 Sum_probs=213.0
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcH---HHHHHHHHHHHHHhcC----CCCCcceEEEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLV----KHPNVVRLYEV 79 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l----~hpnIv~l~~~ 79 (416)
....++|++.+.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 3456789999999999999999999999999999999976543221 1234466799999888 89999999999
Q ss_pred EEeCCEEEEEEec-cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEec-cCCCeEEeeccc
Q 014909 80 MGSKTKIFIVLEF-VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-AYGNLKVSDFGL 157 (416)
Q Consensus 80 ~~~~~~~~lV~E~-~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~-~~~~vkl~DFGl 157 (416)
+.+.+..++|||| +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999999 78999999999888999999999999999999999999999999999999999 789999999999
Q ss_pred ccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCC
Q 014909 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL 237 (416)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 237 (416)
+..... .......||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.... .+......++..+
T Consensus 187 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~ 256 (312)
T 2iwi_A 187 GALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPAHV 256 (312)
T ss_dssp CEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCTTS
T ss_pred hhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcccC
Confidence 876543 223456799999999999887776668999999999999999999997532 2334556677889
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 238 s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
+..+.+||.+||+.||.+|||++++++||||+..
T Consensus 257 ~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 9999999999999999999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=367.48 Aligned_cols=255 Identities=26% Similarity=0.398 Sum_probs=208.5
Q ss_pred cccccccCEEEEeEEeecCceEEEEEEECCC---CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 014909 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (416)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 81 (416)
......++|++.+.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 4456778999999999999999999998754 4569999986532 3345678999999999999999999999984
Q ss_pred eCCEEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccc
Q 014909 82 SKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (416)
Q Consensus 82 ~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~ 160 (416)
.+..|+||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 567899999999999999998654 699999999999999999999999999999999999999999999999999876
Q ss_pred cccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCC
Q 014909 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLS 238 (416)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 238 (416)
..... ........+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ....++.++
T Consensus 166 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (281)
T 1mp8_A 166 MEDST-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 243 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred cCccc-ccccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCC
Confidence 54321 1122344678899999999877774 89999999999999996 99999988777776666554 355677899
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 239 FTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 239 ~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+++.+||.+||+.||.+|||+.++++
T Consensus 244 ~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 244 PTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=366.40 Aligned_cols=252 Identities=23% Similarity=0.375 Sum_probs=217.0
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
.....+|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 456679999999999999999999886 5778999999865432 35688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999999999977 4679999999999999999999999999999999999999999999999999987543321
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (416)
. .......||+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+... ....|...++.+.+
T Consensus 175 ~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 252 (283)
T 3gen_A 175 Y-TSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT 252 (283)
T ss_dssp H-HSTTSTTSCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred c-ccccCCccCcccCCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHH
Confidence 1 122344578899999999877764 89999999999999998 99999998888777777665 34556678999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcC
Q 014909 244 LIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~h 265 (416)
||.+||+.||.+|||+.++++|
T Consensus 253 li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 253 IMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHHH
Confidence 9999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=376.45 Aligned_cols=254 Identities=22% Similarity=0.358 Sum_probs=209.9
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeE----EEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPV----ALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~v----aiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
...++|++.+.||+|+||.||+|.+..+++.+ |+|.+.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 35678999999999999999999998877754 777765432 223457789999999999999999999999876
Q ss_pred CEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
. .++|+||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+|....
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 78899999999999999874 579999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHH
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 240 (416)
............||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ....|+.++.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CCcccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 43333333445678899999999887774 89999999999999999 99999988777666665544 35667789999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 241 ARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
+.+|+.+||+.||.+|||+.+++++
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=378.25 Aligned_cols=254 Identities=19% Similarity=0.349 Sum_probs=215.0
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCe----EEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEP----VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
...++|++.+.||+|+||.||+|.+..+++. ||+|.+..... ......+.+|+.+++.++||||+++++++. .
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 3457899999999999999999999888876 67777654321 112345778999999999999999999986 4
Q ss_pred CEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
...++||||+.+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|....
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 5689999999999999999875 579999999999999999999999999999999999999999999999999998765
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHH
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 240 (416)
............||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.........+... ....|..++.+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTID 245 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTT
T ss_pred cccccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHH
Confidence 44333344556788899999999877764 89999999999999999 99999988777776666555 45567778999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 241 ARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
+.+||.+||+.||.+|||+.++++|
T Consensus 246 ~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 246 VYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=369.64 Aligned_cols=248 Identities=23% Similarity=0.287 Sum_probs=212.1
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCC-------CeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETG-------EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM 80 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 80 (416)
...++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 45689999999999999999999998777 469999997543 23457789999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCC--------eE
Q 014909 81 GSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--------LK 151 (416)
Q Consensus 81 ~~~~~~~lV~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~--------vk 151 (416)
.+.+..|+||||++||+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999987654 999999999999999999999999999999999999999887 99
Q ss_pred EeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhC-CCCCCCCchHHHHHHhhcCc
Q 014909 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAAE 230 (416)
Q Consensus 152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G-~~Pf~~~~~~~~~~~i~~~~ 230 (416)
|+|||++..... .....||+.|+|||++.+....+.++|||||||++|+|++| .+||...+..... ......
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~~ 234 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDR 234 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTT
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhcc
Confidence 999999864321 23456899999999998744456899999999999999995 5555555444333 333455
Q ss_pred cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 231 FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 231 ~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
...|...++++.+||.+||+.||.+|||+.++++|
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 56677788999999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=378.16 Aligned_cols=257 Identities=20% Similarity=0.322 Sum_probs=215.2
Q ss_pred ccccCEEEEeEEeecCceEEEEEEEC-----CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG 81 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 81 (416)
...++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34578999999999999999999973 456789999997543 223357789999999999 8999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCC
Q 014909 82 SKTKIFIVLEFVTGGELFDKIVNHG-----------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138 (416)
Q Consensus 82 ~~~~~~lV~E~~~gg~L~~~i~~~~-----------------------~l~e~~~~~~~~qll~al~~LH~~givHrDlk 138 (416)
..+..|+||||++||+|.+++.... .+++..+..++.||+.||+|||++||+|||||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 9999999999999999999998753 27899999999999999999999999999999
Q ss_pred CCcEEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCC
Q 014909 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDS 217 (416)
Q Consensus 139 p~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~ 217 (416)
|+|||++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999765443222223445678899999999877764 89999999999999998 99999887
Q ss_pred chHHHHHH-hhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcc
Q 014909 218 NLMNLYKK-ISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 267 (416)
Q Consensus 218 ~~~~~~~~-i~~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~ 267 (416)
+....... +... ....|..+++++.+||.+||+.||.+|||+.++++|..
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 65443333 3322 34567779999999999999999999999999998654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=378.02 Aligned_cols=254 Identities=32% Similarity=0.587 Sum_probs=185.7
Q ss_pred cccccCEEEEe-EEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe---
Q 014909 7 KRRVGKYEVGR-TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--- 82 (416)
Q Consensus 7 ~~~~~~y~~~~-~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--- 82 (416)
....++|.+.+ .||+|+||.||+|.+..+|+.||||++..... ...+....++.++||||+++++++..
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 34678999965 69999999999999999999999999965321 12223334567799999999999876
Q ss_pred -CCEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC---CCeEEeecc
Q 014909 83 -KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFG 156 (416)
Q Consensus 83 -~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~---~~vkl~DFG 156 (416)
....|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 556899999999999999998764 69999999999999999999999999999999999999864 559999999
Q ss_pred cccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHH----HHHhhcCccC
Q 014909 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL----YKKISAAEFT 232 (416)
Q Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~----~~~i~~~~~~ 232 (416)
++..... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||........ ...+......
T Consensus 177 ~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (336)
T 3fhr_A 177 FAKETTQ----NALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG 251 (336)
T ss_dssp TCEEC--------------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred cceeccc----cccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence 9875432 234567899999999999776664 889999999999999999999977654332 2223233332
Q ss_pred CC----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 233 CP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 233 ~~----~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
.+ ..+++++.+||.+||+.||.+|||++++++||||+...
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 22 35899999999999999999999999999999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=361.62 Aligned_cols=251 Identities=27% Similarity=0.452 Sum_probs=205.4
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-HKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
....++|++.+.||+|+||.||+|.+. ++.||||++....... ....+.+.+|+.+++.++||||+++++++.+...
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 346789999999999999999999984 7889999987643322 2335778999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---cEeecCCCCcEEecc--------CCCeEEee
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG---VYHRDLKPENLLLDA--------YGNLKVSD 154 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~g---ivHrDlkp~NILl~~--------~~~vkl~D 154 (416)
.|+||||++|++|.+++. .+++++..+..++.|++.||.|||++| |+||||||+|||++. ++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999988885 468999999999999999999999999 999999999999986 67899999
Q ss_pred cccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC--ccC
Q 014909 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFT 232 (416)
Q Consensus 155 FGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~--~~~ 232 (416)
||++...... ......||+.|+|||++.+..+. .++||||||+++|+|++|..||.+.+.......+... ...
T Consensus 160 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 234 (271)
T 3dtc_A 160 FGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP 234 (271)
T ss_dssp CCC-----------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC
T ss_pred CCcccccccc----cccCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC
Confidence 9998754332 22356799999999999887764 8999999999999999999999988776665555443 345
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 233 CPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 233 ~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.|..+++.+.+|+.+||+.||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 235 IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 567789999999999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=372.23 Aligned_cols=257 Identities=19% Similarity=0.280 Sum_probs=221.4
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEEC-----CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM 80 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 80 (416)
.....++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 3455688999999999999999999876 357889999997543 223456788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCe
Q 014909 81 GSKTKIFIVLEFVTGGELFDKIVNH----------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (416)
Q Consensus 81 ~~~~~~~lV~E~~~gg~L~~~i~~~----------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~v 150 (416)
.+....|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 9999999999999999999998753 357999999999999999999999999999999999999999999
Q ss_pred EEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC
Q 014909 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA 229 (416)
Q Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~ 229 (416)
||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+...
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 256 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 256 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence 99999998755433222223345678999999999877764 89999999999999999 89999998887777766554
Q ss_pred c-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 230 E-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 230 ~-~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
. ...+..++..+.+||.+||+.||.+|||+.++++|
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 257 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 4 45667799999999999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=373.68 Aligned_cols=257 Identities=24% Similarity=0.413 Sum_probs=219.6
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEEC-------CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEE
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNS-------ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLY 77 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 77 (416)
.....++|++++.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.+ +||||++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 3445689999999999999999999975 356789999997543 233467799999999999 899999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCc
Q 014909 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141 (416)
Q Consensus 78 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~N 141 (416)
+++.+.+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 99999999999999999999999998754 38999999999999999999999999999999999
Q ss_pred EEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchH
Q 014909 142 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM 220 (416)
Q Consensus 142 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~ 220 (416)
||++.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 9999999999999999875543222122234467889999999987666 489999999999999999 99999998887
Q ss_pred HHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 221 NLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 221 ~~~~~i~~~~-~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.....+..+. ...+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7777665543 45667799999999999999999999999999873
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=371.64 Aligned_cols=256 Identities=22% Similarity=0.359 Sum_probs=216.8
Q ss_pred cccccCEEEEeEEeecCceEEEEEEE-----CCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVM 80 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 80 (416)
....++|++.+.||+|+||.||+|.+ ..+++.||+|++..... ....+.+.+|+.+++++ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 34557999999999999999999985 45778999999976532 23457899999999999 899999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcE
Q 014909 81 GSKTKIFIVLEFVTGGELFDKIVNHG------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENL 142 (416)
Q Consensus 81 ~~~~~~~lV~E~~~gg~L~~~i~~~~------------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NI 142 (416)
.+.+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 99999999999999999999998754 489999999999999999999999999999999999
Q ss_pred EeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHH
Q 014909 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 221 (416)
Q Consensus 143 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~ 221 (416)
+++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.....
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 9999999999999998765443222223345678899999999877664 89999999999999998 999998766543
Q ss_pred HHHH-hhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 222 LYKK-ISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 222 ~~~~-i~~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.... +... ....+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 3332 2222 334466789999999999999999999999999873
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=368.07 Aligned_cols=260 Identities=24% Similarity=0.380 Sum_probs=200.2
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
....+++|++.+.||+|+||.||+|.+..+|+.||||++...... ....+.+.++..+++.++||||+++++++.+.+.
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence 345788999999999999999999999999999999999865432 2233445556667888999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~-givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
.|+||||+ ++.+...... .+.+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99999999 4455554443 56799999999999999999999995 999999999999999999999999999875432
Q ss_pred ccCCCCcccccCCcccccchhhcc----CCCCCChhhHHHHHHHHHHHhhCCCCCCCC-chHHHHHHhhcCcc-CCC--C
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKISAAEF-TCP--P 235 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~----~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~-~~~~~~~~i~~~~~-~~~--~ 235 (416)
.......+||+.|+|||++.. ....+.++|||||||++|+|++|..||... ........+..... ..| .
T Consensus 178 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (318)
T 2dyl_A 178 ---DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM 254 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSS
T ss_pred ---CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccC
Confidence 222345679999999999952 223358999999999999999999999873 34444554444332 223 3
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 236 ~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.+++++.+||.+||+.||.+|||++++++||||+.
T Consensus 255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 47999999999999999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=360.49 Aligned_cols=249 Identities=18% Similarity=0.309 Sum_probs=217.1
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-- 83 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 83 (416)
.....++|++.+.||+|+||.||+|.+. ++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 3567889999999999999999999984 888999999875432 33457799999999999999999999999887
Q ss_pred CEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~g--ivHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
...++||||++||+|.+++.... .+++..+..++.||+.||+|||++| ++||||||+||+++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 78899999999999999998765 4899999999999999999999999 9999999999999999999999999865
Q ss_pred ccccccCCCCcccccCCcccccchhhccCCCCCC--hhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC--ccCCCC
Q 014909 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGS--TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPP 235 (416)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~--~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~--~~~~~~ 235 (416)
.. ......||+.|+|||++.+..+... ++|||||||++|+|++|..||.+.+.......+... ....|.
T Consensus 162 ~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (271)
T 3kmu_A 162 SF-------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234 (271)
T ss_dssp TT-------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCT
T ss_pred ee-------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCC
Confidence 32 1234578999999999987655433 799999999999999999999988877665555433 455677
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 236 WLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 236 ~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.+++++.+||.+||+.||.+|||++++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 235 GISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 89999999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=364.41 Aligned_cols=260 Identities=23% Similarity=0.326 Sum_probs=217.2
Q ss_pred CCcccccccccCEEEEeEEeecCceEEEEEEECC---CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEE
Q 014909 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLY 77 (416)
Q Consensus 1 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~ 77 (416)
|+.++.+...++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+.+|+.+++.++||||++++
T Consensus 2 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~ 79 (281)
T 3cc6_A 2 MGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLI 79 (281)
T ss_dssp --CCCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred CCCccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEE
Confidence 6777888899999999999999999999998654 33469999997653 233467899999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecc
Q 014909 78 EVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (416)
Q Consensus 78 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFG 156 (416)
+++.+. ..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 80 ~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 80 GIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp EEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred EEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccC
Confidence 998754 568999999999999999765 459999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCC
Q 014909 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCP 234 (416)
Q Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~ 234 (416)
++....... ........+|+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+... ....|
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (281)
T 3cc6_A 159 LSRYIEDED-YYKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP 236 (281)
T ss_dssp GGGCC----------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC
T ss_pred CCccccccc-ccccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC
Confidence 987654321 1122345678899999999877764 89999999999999998 99999877666655555443 45566
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 235 PWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 235 ~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 7799999999999999999999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=374.39 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=210.2
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 87 (416)
.-++|++.+.||+|+||.||+|.+..+|+.||||++..... .+.+.+|+.+++.+ +||||+++++++.+....|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 44789999999999999999999999999999999875432 23578999999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCC-----eEEeeccccccc
Q 014909 88 IVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-----LKVSDFGLSALS 161 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~-----vkl~DFGla~~~ 161 (416)
+||||+ |++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|...
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 89999999873 68999999999999999999999999999999999999998887 999999999865
Q ss_pred ccccCCC-----CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCC---chHHHHHHhhcCccCC
Q 014909 162 QQVRDDG-----LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAAEFTC 233 (416)
Q Consensus 162 ~~~~~~~-----~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~---~~~~~~~~i~~~~~~~ 233 (416)
....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. .....+..+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 4322211 1246789999999999998777 48999999999999999999999874 3344455554333322
Q ss_pred C-----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 234 P-----PWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 234 ~-----~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+ ..++ ++.+|+.+||+.||.+||++++|++
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2 2244 9999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=366.32 Aligned_cols=254 Identities=22% Similarity=0.376 Sum_probs=208.9
Q ss_pred cccccCEEEEeEEeecCceEEEEEE----ECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (416)
....++|++.+.||+|+||.||+|. +..+++.||||++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3466899999999999999999998 56789999999997542 3345779999999999999999999999854
Q ss_pred --CCEEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 83 --KTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 83 --~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
...+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 456899999999999999998754 59999999999999999999999999999999999999999999999999998
Q ss_pred ccccccCC-CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH----------------HH
Q 014909 160 LSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----------------NL 222 (416)
Q Consensus 160 ~~~~~~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~----------------~~ 222 (416)
........ .......||+.|+|||++.+..+. .++|||||||++|+|++|..||...... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 65432211 122344577889999999887774 8999999999999999999998754321 11
Q ss_pred HHHh-hcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 223 YKKI-SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 223 ~~~i-~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
...+ .......|..+++++.+||.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1222 22345667789999999999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=371.97 Aligned_cols=253 Identities=22% Similarity=0.355 Sum_probs=209.5
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeE----EEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPV----ALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~v----aiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
...++|++.+.||+|+||.||+|.+..+++.+ |+|.+.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 35678999999999999999999998888766 556554322 222457789999999999999999999999876
Q ss_pred CEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
. .++|+||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 78999999999999999874 579999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHH
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 240 (416)
............||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ....|+.++.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 43333333445678899999999987775 89999999999999999 99999988877766666554 35667789999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 241 ARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+.+||.+||+.||.+|||+.++++
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=380.13 Aligned_cols=254 Identities=24% Similarity=0.442 Sum_probs=207.8
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-----------CCCcceE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-----------HPNVVRL 76 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l 76 (416)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ..+.+.+|+.++++++ ||||+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc----chhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 356799999999999999999999999999999999975432 3466788999998886 8999999
Q ss_pred EEEEEeCC----EEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCcEEecc---
Q 014909 77 YEVMGSKT----KIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDA--- 146 (416)
Q Consensus 77 ~~~~~~~~----~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~-givHrDlkp~NILl~~--- 146 (416)
++++.... .+++||||+ +++|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99987654 789999999 88999999873 4599999999999999999999998 9999999999999954
Q ss_pred ---CCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch----
Q 014909 147 ---YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---- 219 (416)
Q Consensus 147 ---~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~---- 219 (416)
.+.+||+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 34799999999875432 2345689999999999998777 4899999999999999999999986541
Q ss_pred --HHHHHHhhc------------------------------------------CccCCCCCCCHHHHHHHHHhcCCCCCC
Q 014909 220 --MNLYKKISA------------------------------------------AEFTCPPWLSFTARKLIARILDPNPMT 255 (416)
Q Consensus 220 --~~~~~~i~~------------------------------------------~~~~~~~~~s~~~~~ll~~~L~~dP~~ 255 (416)
......+.. ....++...+.++.+||.+||+.||.+
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 111111110 111223335678899999999999999
Q ss_pred CCCHhHHhcCcccccCC
Q 014909 256 RITIPEILEDEWFKKDY 272 (416)
Q Consensus 256 R~t~~eil~h~~~~~~~ 272 (416)
|||++|+++||||+...
T Consensus 325 Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 325 RADAGGLVNHPWLKDTL 341 (373)
T ss_dssp CBCHHHHHTCGGGTTCT
T ss_pred cCCHHHHhhChhhhccc
Confidence 99999999999998643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=361.98 Aligned_cols=250 Identities=21% Similarity=0.265 Sum_probs=212.1
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 86 (416)
..-++|++.+.||+|+||.||+|.+..+++.||||++..... .+.+.+|+.+++.+ +|+|++++++++......
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 456689999999999999999999999999999999875432 24578899999999 799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCC-----eEEeecccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-----LKVSDFGLSAL 160 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~-----vkl~DFGla~~ 160 (416)
|+||||+ |++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999999 899999998754 5999999999999999999999999999999999999988776 99999999986
Q ss_pred cccccCC-----CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc---hHHHHHHhhcCcc-
Q 014909 161 SQQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEF- 231 (416)
Q Consensus 161 ~~~~~~~-----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~---~~~~~~~i~~~~~- 231 (416)
....... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+ ....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 5433221 12345689999999999988776 489999999999999999999998743 3333433332221
Q ss_pred ----CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 232 ----TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 232 ----~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
..++.+++++.+|+.+||+.||.+|||++++++
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 223468999999999999999999999999976
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=372.89 Aligned_cols=260 Identities=20% Similarity=0.282 Sum_probs=217.9
Q ss_pred ccccCEEEEeEEeecCceEEEEEE-----ECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (416)
...++|++.+.||+|+||.||+|. +..++..||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 456799999999999999999999 55678899999996432 23345678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC---CCeEE
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNHG-------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKV 152 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~~-------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~---~~vkl 152 (416)
....|+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999999998753 48999999999999999999999999999999999999854 46999
Q ss_pred eecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-c
Q 014909 153 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-E 230 (416)
Q Consensus 153 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~ 230 (416)
+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+ .
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 999998754433222333456789999999999877764 89999999999999998 99999988877777766554 3
Q ss_pred cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 231 FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 231 ~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
...+..++..+.+||.+||+.||.+|||+.++++|.|+..
T Consensus 264 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 4566779999999999999999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=371.39 Aligned_cols=253 Identities=22% Similarity=0.363 Sum_probs=216.6
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeE--EEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPV--ALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~v--aiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 83 (416)
....++|++.+.||+|+||.||+|.+..++..+ |+|.+.... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 98 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence 346789999999999999999999998888765 999887432 233456789999999999 899999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~ 147 (416)
+..|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence 99999999999999999998754 69999999999999999999999999999999999999999
Q ss_pred CCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHh
Q 014909 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (416)
Q Consensus 148 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i 226 (416)
+.+||+|||++...... .......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+
T Consensus 179 ~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 254 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254 (327)
T ss_dssp GCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred CeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence 99999999998743221 122345678899999999876664 89999999999999998 99999998888887777
Q ss_pred hcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 227 SAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 227 ~~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
..+ ....|..+++++.+||.+||+.||.+|||+++++++
T Consensus 255 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 255 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 655 345666789999999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=357.72 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=218.7
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
...++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 34578999999999999999999986 5778999999865432 356889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 88 IVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
+||||+++++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 158 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 158 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc-
Confidence 999999999999999875 468999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 244 (416)
........||+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+..+ ....|...+..+.+|
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 237 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 237 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred ccccccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHH
Confidence 1122345678899999999877764 89999999999999999 99999998888777777665 344566789999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcC
Q 014909 245 IARILDPNPMTRITIPEILED 265 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~h 265 (416)
+.+||+.||.+|||+.+++++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 238 MNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=363.16 Aligned_cols=254 Identities=30% Similarity=0.540 Sum_probs=206.5
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
..+++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+..|
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 46789999999999999999999999999999999998655455556788999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 88 IVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
+||||+.+++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999998864 45699999999999999999999999999999999999999999999999999875433
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc--hHHHHHHhhcCccCC--CCCCCH
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN--LMNLYKKISAAEFTC--PPWLSF 239 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~--~~~~~~~i~~~~~~~--~~~~s~ 239 (416)
. ........||+.|+|||++.+..+. .++||||||+++|+|++|..||.+.. .......+....... +..++.
T Consensus 189 ~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 189 K--TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred C--CccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence 2 2223456799999999999877664 89999999999999999999997643 334445554443322 245899
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 240 TARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
++.+||.+||+.||.+|||+.++++
T Consensus 266 ~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 266 ELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=364.03 Aligned_cols=254 Identities=25% Similarity=0.369 Sum_probs=222.0
Q ss_pred cccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
.......+|++.+.||+|+||.||+|.+..++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 345577899999999999999999999999999999999975432 3567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
..|+||||++|++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999999999874 359999999999999999999999999999999999999999999999999987654
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHH
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 240 (416)
... ........||+.|+|||++.+..+. .++||||||+++|+|++ |..||.+.+.......+... ....|..+++.
T Consensus 163 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T 3kfa_A 163 GDT-YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240 (288)
T ss_dssp SSS-SEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred CCc-cccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHH
Confidence 221 1122344578899999999877764 89999999999999999 99999988877666666544 45567779999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 241 ARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+.+||.+||+.||.+|||+.++++
T Consensus 241 l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 241 VYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhCCChhhCcCHHHHHH
Confidence 999999999999999999999976
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=362.04 Aligned_cols=255 Identities=21% Similarity=0.306 Sum_probs=215.7
Q ss_pred cccccCEEEEe-EEeecCceEEEEEE--ECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 7 KRRVGKYEVGR-TIGEGTFAKVKFAR--NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 7 ~~~~~~y~~~~-~LG~G~fg~V~~a~--~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
....++|++.+ .||+|+||.||+|. +..+++.||||++..... .....+.+.+|+.+++.++||||+++++++ ..
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 34557899998 99999999999995 456778999999976542 233467899999999999999999999999 56
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
...|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 77899999999999999999988899999999999999999999999999999999999999999999999999875433
Q ss_pred ccCC-CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHH
Q 014909 164 VRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (416)
Q Consensus 164 ~~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 240 (416)
.... .......||+.|+|||++.+..+. .++||||||+++|+|++ |..||.+.+.......+..+ ....|..+++.
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 248 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CCCcccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 2111 112234567899999999877664 89999999999999999 99999998887777766554 35567789999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 241 ARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+.++|.+||+.||.+|||+.++++
T Consensus 249 l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 249 MYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=370.09 Aligned_cols=255 Identities=23% Similarity=0.387 Sum_probs=215.3
Q ss_pred ccccCEEEEeEEeecCceEEEEEEE-----CCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG 81 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 81 (416)
...++|++.+.||+|+||.||+|.+ ..+++.||||++.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 4557999999999999999999985 4567899999997643 233456789999999999 6999999999987
Q ss_pred eCC-EEEEEEeccCCCchHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEe
Q 014909 82 SKT-KIFIVLEFVTGGELFDKIVNHGR----------------MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL 144 (416)
Q Consensus 82 ~~~-~~~lV~E~~~gg~L~~~i~~~~~----------------l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl 144 (416)
..+ .+|+||||++||+|.+++..... +++..+..++.||+.||.|||++||+||||||+||++
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 654 58999999999999999987654 8999999999999999999999999999999999999
Q ss_pred ccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchH-HH
Q 014909 145 DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM-NL 222 (416)
Q Consensus 145 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~-~~ 222 (416)
+.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.... ..
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 99999999999999765432222223345688999999999887774 89999999999999998 99999876543 33
Q ss_pred HHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 223 YKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 223 ~~~i~~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
...+..+ ....|..+++++.++|.+||+.||.+|||+.++++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 261 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3333333 456677899999999999999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=371.24 Aligned_cols=258 Identities=21% Similarity=0.345 Sum_probs=193.5
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~ 85 (416)
....++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+. +++.++||||+++++++.+.+.
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 4566899999999999999999999999999999999976432 223344555655 7788899999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 86 IFIVLEFVTGGELFDKIVN-----HGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~-----~~~l~e~~~~~~~~qll~al~~LH~~-givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
.|+||||+.| +|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999999986 78777763 56799999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccCCCCcccccCCcccccchhhc----cCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH-HHHHHhhcCcc-CC
Q 014909 160 LSQQVRDDGLLHTTCGTPNYVAPEVLN----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEF-TC 233 (416)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPEvl~----~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~-~~~~~i~~~~~-~~ 233 (416)
.... .......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||...+.. .....+..+.. ..
T Consensus 175 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3aln_A 175 QLVD---SIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250 (327)
T ss_dssp C---------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred eccc---ccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence 5432 12233457999999999983 3344 58999999999999999999999875432 22222222221 12
Q ss_pred ----CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 234 ----PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 234 ----~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
+..+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus 251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 23478999999999999999999999999999999753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=371.72 Aligned_cols=255 Identities=21% Similarity=0.353 Sum_probs=216.0
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCC-----eEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGE-----PVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVM 80 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 80 (416)
....++|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3456789999999999999999999977664 79999997643 233467799999999999 899999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc
Q 014909 81 GSKTKIFIVLEFVTGGELFDKIVNH--------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA 146 (416)
Q Consensus 81 ~~~~~~~lV~E~~~gg~L~~~i~~~--------------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~ 146 (416)
.+.+..|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 9999999999999999999998753 35899999999999999999999999999999999999999
Q ss_pred CCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHH
Q 014909 147 YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKK 225 (416)
Q Consensus 147 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~ 225 (416)
++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.........
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 999999999999765433222223345678899999999877764 89999999999999998 9999987665443333
Q ss_pred hh-c-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 226 IS-A-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 226 i~-~-~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+. . .....|...++.+.+||.+||+.||.+|||+.++++
T Consensus 279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 32 2 234456778999999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=361.40 Aligned_cols=258 Identities=23% Similarity=0.335 Sum_probs=218.9
Q ss_pred ccccccCEEEEe-EEeecCceEEEEEEEC--CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014909 6 IKRRVGKYEVGR-TIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (416)
Q Consensus 6 ~~~~~~~y~~~~-~LG~G~fg~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (416)
+...-++|.+.+ .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++ .
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 345567888887 9999999999999864 467889999997643 334567899999999999999999999999 4
Q ss_pred CCEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccc
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~ 161 (416)
.+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 56699999999999999999754 46999999999999999999999999999999999999999999999999998765
Q ss_pred ccccC-CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCC
Q 014909 162 QQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLS 238 (416)
Q Consensus 162 ~~~~~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 238 (416)
..... ........||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+ ....|+.++
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 239 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP 239 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCcceeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcC
Confidence 32211 1122344578999999999876664 89999999999999998 99999988877777766554 356677899
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhcCcc
Q 014909 239 FTARKLIARILDPNPMTRITIPEILEDEW 267 (416)
Q Consensus 239 ~~~~~ll~~~L~~dP~~R~t~~eil~h~~ 267 (416)
+++.+||.+||+.||.+|||+.++++|.+
T Consensus 240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 240 PELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 99999999999999999999999998654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=366.75 Aligned_cols=258 Identities=23% Similarity=0.333 Sum_probs=208.2
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECC---CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (416)
+....++|.+.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 34456789999999999999999998765 455899999976543 23345778999999999999999999999876
Q ss_pred CC-----EEEEEEeccCCCchHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeE
Q 014909 83 KT-----KIFIVLEFVTGGELFDKIVN------HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (416)
Q Consensus 83 ~~-----~~~lV~E~~~gg~L~~~i~~------~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vk 151 (416)
.. ..|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+|
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence 55 35999999999999999843 35699999999999999999999999999999999999999999999
Q ss_pred EeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-
Q 014909 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA- 229 (416)
Q Consensus 152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~- 229 (416)
|+|||++................+++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..+
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 266 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH 266 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence 9999998765432222223445678899999999887764 89999999999999999 99999988877776666554
Q ss_pred ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 230 EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 230 ~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
....|..+++++.+||.+||..||.+|||+.+++++
T Consensus 267 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 267 RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 455667799999999999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=369.40 Aligned_cols=254 Identities=21% Similarity=0.243 Sum_probs=205.0
Q ss_pred ccccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
+.+....++|++.+.||+|+||.||+|.+. ++.||||++..... ......+|+.+++.++||||+++++++...
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK----QSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch----HHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 344556789999999999999999999885 78999999975432 234566799999999999999999999774
Q ss_pred C----EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CcEeecCCCCcEEeccCCC
Q 014909 84 T----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR----------GVYHRDLKPENLLLDAYGN 149 (416)
Q Consensus 84 ~----~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~----------givHrDlkp~NILl~~~~~ 149 (416)
. .+|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred CCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence 3 47999999999999999976 5699999999999999999999999 9999999999999999999
Q ss_pred eEEeecccccccccccCCCCcccccCCcccccchhhccCCC----CCChhhHHHHHHHHHHHhhCCCCCCCCch------
Q 014909 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY----DGSTADLWSCGVILFVLLAGYLPFDDSNL------ 219 (416)
Q Consensus 150 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~----~~~~~DIwSlGvil~~ml~G~~Pf~~~~~------ 219 (416)
+||+|||+|...............+||+.|+|||++.+... .+.++|||||||++|+|++|+.||.+...
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 99999999976554333333455689999999999986322 23578999999999999999999975421
Q ss_pred ----------HHHHHHhhcCcc--CCCCC-----CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 220 ----------MNLYKKISAAEF--TCPPW-----LSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 220 ----------~~~~~~i~~~~~--~~~~~-----~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
......+..... ..+.. .+.++.+||.+||+.||++|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 122222222111 11111 2345999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=358.99 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=210.8
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHH----HHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM----AEQIKREVATMKLVKHPNVVRLYEVMGS 82 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~----~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (416)
....++|++.+.||+|+||.||+|.+..+++.||+|++.......... .+.+.+|+.+++.++||||+++++++.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 345679999999999999999999999999999999997644332211 1678999999999999999999999977
Q ss_pred CCEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCcEEeccCCC-----eEEee
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGN-----LKVSD 154 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~g--ivHrDlkp~NILl~~~~~-----vkl~D 154 (416)
.. ++||||+++|+|.+.+... ..+++..+..++.|++.||+|||++| |+||||||+|||++.++. +||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 66 6999999999999988664 47999999999999999999999999 999999999999988776 99999
Q ss_pred cccccccccccCCCCcccccCCcccccchhhccC-CCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHH--HHHhhc--C
Q 014909 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL--YKKISA--A 229 (416)
Q Consensus 155 FGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~-~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~--~~~i~~--~ 229 (416)
||++.... ......+||+.|+|||++... ...+.++|||||||++|+|++|..||...+.... ...+.. .
T Consensus 173 fg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 173 FGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp CTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred CCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 99987432 233456899999999998432 2335789999999999999999999987554322 333322 2
Q ss_pred ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 230 EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 230 ~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 34567779999999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=376.27 Aligned_cols=253 Identities=22% Similarity=0.359 Sum_probs=206.5
Q ss_pred cccCEEEEeEEeecCceEEEEEEEC---CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
..++|++.+.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+|++++||||+++++++.+...
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 4568999999999999999999886 457789999997543 33346789999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
.|+||||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 999999999999999998754 6999999999999999999999999999999999999999999999999999765432
Q ss_pred cCCC-CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHH
Q 014909 165 RDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (416)
Q Consensus 165 ~~~~-~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 241 (416)
.... ......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+ ....+..++..+
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 279 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279 (373)
T ss_dssp -------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHH
T ss_pred CccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 2111 11223457789999999887775 89999999999999997 99999988887777766554 344556789999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 014909 242 RKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.+|+.+||+.||.+||++.++++
T Consensus 280 ~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 280 YQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCcChhhCcCHHHHHH
Confidence 99999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=365.12 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=211.7
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCC----CeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETG----EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
..-.+|++.+.||+|+||.||+|.+..++ ..||||++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 34568999999999999999999986543 359999997543 233456789999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
...|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999999999765 579999999999999999999999999999999999999999999999999987654
Q ss_pred cccCCC-CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCH
Q 014909 163 QVRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSF 239 (416)
Q Consensus 163 ~~~~~~-~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 239 (416)
...... ......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..+ ....+..++.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 277 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred cccccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCH
Confidence 322111 12233567899999999877764 89999999999999998 99999988887777776655 4455667899
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 240 TARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.+.+||.+||+.||.+||++.+++++
T Consensus 278 ~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 278 AIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=361.99 Aligned_cols=252 Identities=25% Similarity=0.421 Sum_probs=208.3
Q ss_pred ccCEEEEeEEeecCceEEEEEE----ECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 014909 10 VGKYEVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-- 83 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 83 (416)
-.+|++.+.||+|+||.||+|. +..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 3569999999999999999999 567899999999976542 22357789999999999999999999999876
Q ss_pred CEEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
..+|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 678999999999999999954 4579999999999999999999999999999999999999999999999999987654
Q ss_pred cccCC-CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc---------------hHHHHHHh
Q 014909 163 QVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---------------LMNLYKKI 226 (416)
Q Consensus 163 ~~~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~---------------~~~~~~~i 226 (416)
..... .......||+.|+|||++.+..+. .++|||||||++|+|++|..||.... .......+
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 32111 123455788999999999887765 89999999999999999999864321 11222222
Q ss_pred hc-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 227 SA-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 227 ~~-~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.. .....|+.+++++.+||.+||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 22 345567789999999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=381.06 Aligned_cols=244 Identities=25% Similarity=0.450 Sum_probs=212.4
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-EE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-KI 86 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~ 86 (416)
...++|++.+.||+|+||.||+|.+. |+.||||++.... ..+.+.+|+.+|++++||||+++++++.... .+
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 45678999999999999999999985 7799999997643 2467889999999999999999999987654 79
Q ss_pred EEEEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
|+||||+++|+|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~- 341 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 341 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc-
Confidence 999999999999999987654 79999999999999999999999999999999999999999999999999874322
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHH
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 242 (416)
......+++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+ ....|..+++++.
T Consensus 342 ----~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 416 (450)
T 1k9a_A 342 ----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 416 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ----cccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 12234678899999999887775 89999999999999998 99999987777666666554 4567788999999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhc
Q 014909 243 KLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+||.+||+.||.+|||+.++++
T Consensus 417 ~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 417 DVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=375.01 Aligned_cols=258 Identities=22% Similarity=0.324 Sum_probs=212.1
Q ss_pred cccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 5 ~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
.+....++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34556789999999999999999999974 689999999875432 23577899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHG----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~ 160 (416)
..|+||||++||+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999999999886543 589999999999999999999999999999999999999999999999999876
Q ss_pred cccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHH---H----HHhhcCc---
Q 014909 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL---Y----KKISAAE--- 230 (416)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~---~----~~i~~~~--- 230 (416)
.............+||+.|+|||++.+..+. .++|||||||++|+|++|+.||........ . .......
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 4433333334456799999999999877664 899999999999999999999976432211 0 1111111
Q ss_pred ---cC----CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcc
Q 014909 231 ---FT----CPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 267 (416)
Q Consensus 231 ---~~----~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~ 267 (416)
.. .++..+..+.+++.+||+.||++|||+.++++|..
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11 11224567899999999999999999999997643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=358.30 Aligned_cols=248 Identities=26% Similarity=0.403 Sum_probs=213.2
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe------
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------ 82 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 82 (416)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 4478999999999999999999999999999999997543 246689999999999999999998854
Q ss_pred ----------CCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCe
Q 014909 83 ----------KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (416)
Q Consensus 83 ----------~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~v 150 (416)
...+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence 45689999999999999999754 579999999999999999999999999999999999999999999
Q ss_pred EEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc
Q 014909 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230 (416)
Q Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~ 230 (416)
||+|||++..... ........||+.|+|||++.+..+. .++|||||||++|+|++|..||... ......+...
T Consensus 162 kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~- 234 (284)
T 2a19_B 162 KIGDFGLVTSLKN---DGKRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG- 234 (284)
T ss_dssp EECCCTTCEESSC---CSCCCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT-
T ss_pred EECcchhheeccc---cccccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc-
Confidence 9999999875433 2233456799999999999887764 8999999999999999999987532 2333333332
Q ss_pred cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 231 FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 231 ~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
..+..++..+.+||.+||+.||.+|||+.++++|.|..+.
T Consensus 235 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 235 -IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred -cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 3456789999999999999999999999999999887653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=359.98 Aligned_cols=252 Identities=23% Similarity=0.436 Sum_probs=198.4
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
...-++|++.+.||+|+||.||+|.+. ..||+|++..... .....+.+.+|+.+++.++||||++++++. .....
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 456679999999999999999999864 3599999976543 334567899999999999999999999965 55678
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
++||||+.|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence 9999999999999999653 569999999999999999999999999999999999999999999999999987654433
Q ss_pred CCCCcccccCCcccccchhhc---cCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHH-HHHHhhcCccC-----CCCC
Q 014909 166 DDGLLHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYKKISAAEFT-----CPPW 236 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~---~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~-~~~~i~~~~~~-----~~~~ 236 (416)
........+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+..... ....+...... .+..
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred ccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence 333445668999999999996 3334 478999999999999999999998765443 33333333222 2345
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 237 ~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+++.+.+||.+||+.||.+|||+.++++
T Consensus 254 ~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 254 CPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 7899999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=371.33 Aligned_cols=253 Identities=15% Similarity=0.195 Sum_probs=201.6
Q ss_pred ccCEEEEeEEeecCceEEEEEEECC---CCCeEEEEEeechhhhcH--------HHHHHHHHHHHHHhcCCCCCcceEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLKH--------KMAEQIKREVATMKLVKHPNVVRLYE 78 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~---~~~~vaiK~i~~~~~~~~--------~~~~~~~~Ei~il~~l~hpnIv~l~~ 78 (416)
-++|++.+.||+|+||.||+|.+.. ++..||||++........ .....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3689999999999999999999987 788999999976432110 11234668899999999999999999
Q ss_pred EEEe----CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC--CeEE
Q 014909 79 VMGS----KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG--NLKV 152 (416)
Q Consensus 79 ~~~~----~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~--~vkl 152 (416)
++.. ....|+||||+ |++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9987 78899999999 999999998878999999999999999999999999999999999999999887 9999
Q ss_pred eecccccccccccCC-----CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCC--chHHHHHH
Q 014909 153 SDFGLSALSQQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS--NLMNLYKK 225 (416)
Q Consensus 153 ~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~--~~~~~~~~ 225 (416)
+|||+|......... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. +.......
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 999999765432211 12245689999999999988766 48999999999999999999999652 22222211
Q ss_pred hhcCccCCC---------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 226 ISAAEFTCP---------PWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 226 i~~~~~~~~---------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
........| ..++.++.+||.+||+.||++|||++++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 111111122 268899999999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=357.95 Aligned_cols=256 Identities=23% Similarity=0.312 Sum_probs=211.8
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCC---CeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEE-E
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM-G 81 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~ 81 (416)
++....+|++.+.||+|+||.||+|.+..++ ..+|+|.+.... .....+.+.+|+.++++++||||+++++++ .
T Consensus 20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence 4556678999999999999999999976433 358999987532 334567899999999999999999999985 5
Q ss_pred eCCEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccc
Q 014909 82 SKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (416)
Q Consensus 82 ~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~ 160 (416)
.+...|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccc
Confidence 567889999999999999999764 4689999999999999999999999999999999999999999999999999975
Q ss_pred cccccC--CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc-cCCCCC
Q 014909 161 SQQVRD--DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPW 236 (416)
Q Consensus 161 ~~~~~~--~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~ 236 (416)
...... ........||+.|+|||++.+..+. .++|||||||++|+|++ |.+||...+.......+.... ...|..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 256 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTT
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCcc
Confidence 533221 1223345678899999999887764 89999999999999999 778888777666655555443 344667
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 237 ~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
++..+.+++.+||+.||.+|||+.++++
T Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 257 CPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8999999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=355.55 Aligned_cols=249 Identities=20% Similarity=0.270 Sum_probs=207.1
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEE-EeCCEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM-GSKTKIF 87 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~ 87 (416)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.++|++++..+..+ ......|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 45789999999999999999999999999999999876442 23578999999999988866665554 6778899
Q ss_pred EEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEe---ccCCCeEEeeccccccccc
Q 014909 88 IVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl---~~~~~vkl~DFGla~~~~~ 163 (416)
+||||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999999 8899999974 4579999999999999999999999999999999999999 4789999999999976544
Q ss_pred ccCC-----CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc---hHHHHHHhhcCccCC--
Q 014909 164 VRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEFTC-- 233 (416)
Q Consensus 164 ~~~~-----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~---~~~~~~~i~~~~~~~-- 233 (416)
.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+ ....+..+.......
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred cccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 3221 12345689999999999988776 489999999999999999999998643 222333333222222
Q ss_pred ---CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 234 ---PPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 234 ---~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
++.+|+++.+|+.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 3678999999999999999999999999976
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=363.14 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=207.3
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE----eC
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG----SK 83 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~ 83 (416)
..-++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++. ..
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 34568999999999999999999999999999999986532 334677899999999999999999999986 34
Q ss_pred CEEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
...|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 578999999999999999876 4679999999999999999999999999999999999999999999999999887
Q ss_pred ccccccCCC-------CcccccCCcccccchhhccCCC--CCChhhHHHHHHHHHHHhhCCCCCCCCch--HHHHHHhh-
Q 014909 160 LSQQVRDDG-------LLHTTCGTPNYVAPEVLNDRGY--DGSTADLWSCGVILFVLLAGYLPFDDSNL--MNLYKKIS- 227 (416)
Q Consensus 160 ~~~~~~~~~-------~~~~~~gt~~y~aPEvl~~~~~--~~~~~DIwSlGvil~~ml~G~~Pf~~~~~--~~~~~~i~- 227 (416)
......... ......||+.|+|||++.+... .+.++|||||||++|+|++|..||..... ......+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 262 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence 543211110 1123468999999999876442 35899999999999999999999964211 01111111
Q ss_pred cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCc
Q 014909 228 AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDE 266 (416)
Q Consensus 228 ~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~ 266 (416)
....+.++.+++++.+||.+||+.||.+|||+.+++++-
T Consensus 263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 223344557899999999999999999999999999853
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=355.63 Aligned_cols=254 Identities=22% Similarity=0.347 Sum_probs=212.9
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCC---eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
..--.|.+.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence 344468888999999999999999765554 79999987532 3344678899999999999999999999998766
Q ss_pred EE-EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 85 KI-FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 85 ~~-~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
.. ++||||+.+|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 55 999999999999999987 4568999999999999999999999999999999999999999999999999987543
Q ss_pred ccc--CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCC
Q 014909 163 QVR--DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLS 238 (416)
Q Consensus 163 ~~~--~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 238 (416)
... .........||+.|+|||++.+..+. .++|||||||++|+|++ |.+||...+.......+... ....+..++
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCP 254 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCC
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccch
Confidence 221 12233455788999999999887764 89999999999999999 56666666666666555444 355667799
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 239 FTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 239 ~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+.+.+|+.+||+.||.+|||+.++++
T Consensus 255 ~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 255 DSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=370.76 Aligned_cols=252 Identities=16% Similarity=0.204 Sum_probs=201.2
Q ss_pred cCEEEEeEEeecCceEEEEEEECCC-----CCeEEEEEeechhhhcHH--------HHHHHHHHHHHHhcCCCCCcceEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHK--------MAEQIKREVATMKLVKHPNVVRLY 77 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~-----~~~vaiK~i~~~~~~~~~--------~~~~~~~Ei~il~~l~hpnIv~l~ 77 (416)
++|++++.||+|+||.||+|.+..+ ++.||||++......... ....+..|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 4899999999999999999998764 578999998764321110 112344677788889999999999
Q ss_pred EEEEeC----CEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEec--cCCCe
Q 014909 78 EVMGSK----TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD--AYGNL 150 (416)
Q Consensus 78 ~~~~~~----~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~--~~~~v 150 (416)
+++... ...|+||||+ |++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++ .++.+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 998764 5689999999 99999999876 6799999999999999999999999999999999999999 88999
Q ss_pred EEeecccccccccccCC-----CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHH
Q 014909 151 KVSDFGLSALSQQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK 225 (416)
Q Consensus 151 kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~ 225 (416)
||+|||+|......... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+......+..
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 99999999765433221 12234569999999999988776 4899999999999999999999985322211111
Q ss_pred -hh----cC------ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 226 -IS----AA------EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 226 -i~----~~------~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.. .. ....+..++.++.+|+.+||..||.+||++.+|++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 273 DSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 10 00 00112567899999999999999999999999976
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=379.84 Aligned_cols=249 Identities=22% Similarity=0.368 Sum_probs=214.8
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
...++|++.+.||+|+||.||+|.+. ++..||||++..... ..+.+.+|+.+|+.++||||+++++++. ....|
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 44578999999999999999999986 467899999976432 2567899999999999999999999986 56789
Q ss_pred EEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999999999999754 368999999999999999999999999999999999999999999999999997643211
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (416)
. .......+|+.|+|||++....+. .++|||||||++|+|++ |..||.+.+..+....+..+ ....|..+++++.+
T Consensus 339 ~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 416 (454)
T 1qcf_A 339 Y-TAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 416 (454)
T ss_dssp H-HTTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred e-eccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 112234567899999999877764 89999999999999999 99999998887777776554 45567789999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhc
Q 014909 244 LIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~ 264 (416)
||.+||+.||.+|||+++|++
T Consensus 417 li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 417 IMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHH
Confidence 999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=359.18 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=207.1
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECC-CCC--eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSE-TGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~-~~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
....++|++.+.||+|+||.||+|.+.. +++ .||+|++...........+.+.+|+.+++.++||||+++++++.+.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 3455789999999999999999998643 333 6899999876554555678899999999999999999999999876
Q ss_pred CEEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
. .++||||+++++|.+++... +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 88999999999999999764 569999999999999999999999999999999999999999999999999987653
Q ss_pred cccCC-CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc--cCCCCCCC
Q 014909 163 QVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE--FTCPPWLS 238 (416)
Q Consensus 163 ~~~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s 238 (416)
..... .......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||.+.+.......+.... ...+..++
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence 32111 122345678899999999877664 89999999999999999 999999988887777765543 34556789
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 239 FTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 239 ~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.++.++|.+||+.||.+|||+.++++
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=355.31 Aligned_cols=245 Identities=24% Similarity=0.443 Sum_probs=207.0
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-CE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-TK 85 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~ 85 (416)
....++|++.+.||+|+||.||+|.+. |+.||+|++.... ..+.+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred cCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 456789999999999999999999884 8899999997543 356788999999999999999999997544 57
Q ss_pred EEEEEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
.|+||||+++++|.+++...+. +++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 8999999999999999987543 89999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHH
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 241 (416)
. .....+++.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+..+ ....+..+++.+
T Consensus 170 ~-----~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (278)
T 1byg_A 170 T-----QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 243 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHH
T ss_pred c-----ccCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHH
Confidence 1 2344678999999999877664 89999999999999998 99999988777766666544 455677899999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 014909 242 RKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.++|.+||+.||.+|||+.++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=386.56 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=218.6
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
....+|++.+.||+|+||.||+|.+..++..||||++..... ..+.+.+|+.+|++++||||+++++++.....+|
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 345679999999999999999999998899999999976432 2467899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999999999864 458999999999999999999999999999999999999999999999999997643211
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (416)
........+++.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ....|..+++.+.+
T Consensus 373 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 450 (495)
T 1opk_A 373 -YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 450 (495)
T ss_dssp -EECCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -eeecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1112234567899999999877664 89999999999999999 99999988877766666544 45567789999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhc
Q 014909 244 LIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~ 264 (416)
||.+||+.||.+|||+.++++
T Consensus 451 li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 451 LMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCcChhHCcCHHHHHH
Confidence 999999999999999999976
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=378.05 Aligned_cols=251 Identities=24% Similarity=0.432 Sum_probs=206.6
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--E
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--K 85 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~ 85 (416)
..-++|++.+.||+|+||.||+|.+..+|+.||||++....... ..+.+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 35678999999999999999999999999999999998654332 2567789999999999999999999998755 7
Q ss_pred EEEEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEe----ccCCCeEEeecccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLS 158 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl----~~~~~vkl~DFGla 158 (416)
.|+||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 899999999999999997643 39999999999999999999999999999999999999 77788999999999
Q ss_pred cccccccCCCCcccccCCcccccchhhcc--------CCCCCChhhHHHHHHHHHHHhhCCCCCCCC----chHHHHHHh
Q 014909 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLND--------RGYDGSTADLWSCGVILFVLLAGYLPFDDS----NLMNLYKKI 226 (416)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~--------~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~----~~~~~~~~i 226 (416)
...... ......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||... .......++
T Consensus 164 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 164 RELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp EECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred eEccCC---CccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 765332 22345689999999999865 233 47899999999999999999999642 223334444
Q ss_pred hcCccC-------------------CC------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 227 SAAEFT-------------------CP------PWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 227 ~~~~~~-------------------~~------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
..+.+. .| ..++..+.+||++||+.||++|||++++++
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 332211 11 113457889999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=354.98 Aligned_cols=249 Identities=21% Similarity=0.285 Sum_probs=203.3
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEE-EeCCEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM-GSKTKIF 87 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~ 87 (416)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|++++..+..+ ......+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 45789999999999999999999999999999998765432 23578899999999988776666554 7788899
Q ss_pred EEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEe---ccCCCeEEeeccccccccc
Q 014909 88 IVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl---~~~~~vkl~DFGla~~~~~ 163 (416)
+||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999999 8899999985 4579999999999999999999999999999999999999 7889999999999986544
Q ss_pred ccCC-----CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch---HHHHHHhhcCccCCC-
Q 014909 164 VRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---MNLYKKISAAEFTCP- 234 (416)
Q Consensus 164 ~~~~-----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~---~~~~~~i~~~~~~~~- 234 (416)
.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+. ......+.......|
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 3221 12345689999999999998776 4899999999999999999999986432 122333322222222
Q ss_pred ----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 235 ----PWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 235 ----~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
..+++++.+||.+||+.||++|||++++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 567999999999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=363.18 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=212.2
Q ss_pred cccCEEEEeEEeecCceEEEEEE----ECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE--e
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG--S 82 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~ 82 (416)
.-.+|++.+.||+|+||.||+|. +..+++.||||++.... ....+.+.+|+.+++.++||||+++++++. +
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 34689999999999999999999 56788999999997643 334577899999999999999999999886 5
Q ss_pred CCEEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccc
Q 014909 83 KTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~ 161 (416)
....|+||||++|++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 6679999999999999999987 356999999999999999999999999999999999999999999999999999765
Q ss_pred ccccCC-CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH---------------HHHHH
Q 014909 162 QQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---------------NLYKK 225 (416)
Q Consensus 162 ~~~~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~---------------~~~~~ 225 (416)
...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 432111 12234568889999999987766 48999999999999999999999654332 22222
Q ss_pred hhc-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 226 ISA-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 226 i~~-~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
+.. .....++.+++++.+||.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222 2345677899999999999999999999999999753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=376.31 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=196.0
Q ss_pred cccccccccCE-EEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 014909 3 QPKIKRRVGKY-EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVM 80 (416)
Q Consensus 3 ~~~~~~~~~~y-~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 80 (416)
.|.....++++ .+.+.||+|+||+||.+. ..+|+.||||++..+. .+.+.+|+.+++.+ +||||+++++++
T Consensus 6 ~p~~~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~ 78 (434)
T 2rio_A 6 IPNFEQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSE 78 (434)
T ss_dssp --CCSCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred ccchhhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEE
Confidence 45555555555 557889999999998764 4579999999986542 34577899999876 899999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC------
Q 014909 81 GSKTKIFIVLEFVTGGELFDKIVNHGRMK-------EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY------ 147 (416)
Q Consensus 81 ~~~~~~~lV~E~~~gg~L~~~i~~~~~l~-------e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~------ 147 (416)
.+...+|+||||+. |+|.+++....... +..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 79 ~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~ 157 (434)
T 2rio_A 79 TTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTAD 157 (434)
T ss_dssp ECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSC
T ss_pred ecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccc
Confidence 99999999999996 59999998765332 33457799999999999999999999999999999754
Q ss_pred -------CCeEEeecccccccccccCC--CCcccccCCcccccchhhcc------CCCCCChhhHHHHHHHHHHHhh-CC
Q 014909 148 -------GNLKVSDFGLSALSQQVRDD--GLLHTTCGTPNYVAPEVLND------RGYDGSTADLWSCGVILFVLLA-GY 211 (416)
Q Consensus 148 -------~~vkl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPEvl~~------~~~~~~~~DIwSlGvil~~ml~-G~ 211 (416)
+.+||+|||+|......... ......+||+.|+|||++.+ ....+.++|||||||++|+|++ |.
T Consensus 158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~ 237 (434)
T 2rio_A 158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237 (434)
T ss_dssp CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence 47999999999865432211 12345689999999999975 1334689999999999999998 99
Q ss_pred CCCCCCchHHHHHHhhcCccCCCC-------CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 212 LPFDDSNLMNLYKKISAAEFTCPP-------WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 212 ~Pf~~~~~~~~~~~i~~~~~~~~~-------~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.||.+..... ..+..+....+. .+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 238 ~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 238 HPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp CTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 9998654433 122222222221 24578999999999999999999999999999974
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=351.85 Aligned_cols=250 Identities=21% Similarity=0.353 Sum_probs=213.9
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
....++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+ +..
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 82 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCc
Confidence 345679999999999999999999985 567899999975432 24678899999999999999999999864 558
Q ss_pred EEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
|+||||++|++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999999999987543 6999999999999999999999999999999999999999999999999998765332
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHH
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 242 (416)
.. .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+ ....+..++.++.
T Consensus 163 ~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 240 (279)
T 1qpc_A 163 EY-TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY 240 (279)
T ss_dssp CE-ECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cc-ccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHH
Confidence 11 11234457889999999987666 489999999999999999 99999988877777766554 3455667899999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhc
Q 014909 243 KLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+|+.+||+.||.+|||+.++++
T Consensus 241 ~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 241 QLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=368.70 Aligned_cols=246 Identities=16% Similarity=0.215 Sum_probs=201.9
Q ss_pred ccccCEEEEeEEeecCceEEEEE-----EECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC---CCCcceEEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFA-----RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK---HPNVVRLYEV 79 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a-----~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~ 79 (416)
..-++|++.+.||+|+||.||+| .+..+++.||||++.... ...+.+|+.+++.++ |+||++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 34567999999999999999999 466789999999997543 345778888888887 9999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc--------
Q 014909 80 MGSKTKIFIVLEFVTGGELFDKIVN-----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-------- 146 (416)
Q Consensus 80 ~~~~~~~~lV~E~~~gg~L~~~i~~-----~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~-------- 146 (416)
+...+..|+||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999999974 467999999999999999999999999999999999999998
Q ss_pred ---CCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHH
Q 014909 147 ---YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY 223 (416)
Q Consensus 147 ---~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~ 223 (416)
++.+||+|||+|...............+||+.|+|||++.+..|. .++|||||||++|+|++|+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~-- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGE-- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence 899999999999765443334445667899999999999988775 89999999999999999999996433210
Q ss_pred HHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 224 KKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 224 ~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
..........+.++.+.+++.+||+.+|.+|++..+.+.
T Consensus 293 --~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 293 --CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp --EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred --eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 000111112245778999999999999999976544444
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=354.09 Aligned_cols=236 Identities=33% Similarity=0.590 Sum_probs=196.4
Q ss_pred ccccccCEEEE-eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHH-hcCCCCCcceEEEEEEe-
Q 014909 6 IKRRVGKYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVRLYEVMGS- 82 (416)
Q Consensus 6 ~~~~~~~y~~~-~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~- 82 (416)
.+..+++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++..
T Consensus 12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 35678899998 7899999999999999999999999998642 3466788887 66789999999999987
Q ss_pred ---CCEEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc---CCCeEEee
Q 014909 83 ---KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSD 154 (416)
Q Consensus 83 ---~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~---~~~vkl~D 154 (416)
...+|+||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 778999999999999999998764 6999999999999999999999999999999999999998 78899999
Q ss_pred cccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHH----HhhcCc
Q 014909 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK----KISAAE 230 (416)
Q Consensus 155 FGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~----~i~~~~ 230 (416)
||++.... +..+ +.++|||||||++|+|++|..||.+.+...... .+....
T Consensus 164 fg~a~~~~------------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 218 (299)
T 3m2w_A 164 FGFAKETT------------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218 (299)
T ss_dssp CTTCEECT------------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTC
T ss_pred cccccccc------------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcc
Confidence 99886321 1223 478999999999999999999998765443322 122223
Q ss_pred cCCC----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 231 FTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 231 ~~~~----~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
...| ..+++++.+||.+||+.||.+|||+.|+++||||+.....
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~ 266 (299)
T 3m2w_A 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266 (299)
T ss_dssp CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGS
T ss_pred ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccC
Confidence 3333 4589999999999999999999999999999999876543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=376.07 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=196.8
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
+|.+.+.||+|+||+|+.. ...+|+.||||++...... .+.+|+.+|+.+ +|||||++++++.+....|+||
T Consensus 25 ~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 4999999999999997643 3457899999999764322 256899999999 7999999999999999999999
Q ss_pred eccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc---CC--CeEEeecccccccccc
Q 014909 91 EFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YG--NLKVSDFGLSALSQQV 164 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~---~~--~vkl~DFGla~~~~~~ 164 (416)
||+.| +|.+++.... ..++..+..++.||+.||+|||++||+||||||+|||++. ++ .+||+|||+|......
T Consensus 98 E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 99974 9999998754 4666677899999999999999999999999999999953 23 5789999999765432
Q ss_pred cC-CCCcccccCCcccccchhhccC--CCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCccCC---CCCC
Q 014909 165 RD-DGLLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTC---PPWL 237 (416)
Q Consensus 165 ~~-~~~~~~~~gt~~y~aPEvl~~~--~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~~~~---~~~~ 237 (416)
.. .......+||+.|+|||++.+. ...+.++|||||||++|+|++ |..||...........+....... +...
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHH
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccc
Confidence 11 1223456899999999999742 223478999999999999999 999997665544433332222211 1224
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 238 s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
+..+.+||.+||+.||.+|||+.++++||||..
T Consensus 257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 567899999999999999999999999999974
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=365.13 Aligned_cols=245 Identities=15% Similarity=0.175 Sum_probs=202.9
Q ss_pred ccCEEEEeEEeecCceEEEEEEECC--------CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcce------
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSE--------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR------ 75 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~--------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~------ 75 (416)
.++|++.+.||+|+||.||+|.+.. .++.||+|++... +.+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 3799999999999999999999987 4889999998754 35779999999999999987
Q ss_pred ---------EEEEEEe-CCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEE
Q 014909 76 ---------LYEVMGS-KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 143 (416)
Q Consensus 76 ---------l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NIL 143 (416)
+++++.. ....|+||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6677765 78899999999 99999999886 78999999999999999999999999999999999999
Q ss_pred eccCC--CeEEeecccccccccccCC-----CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCC
Q 014909 144 LDAYG--NLKVSDFGLSALSQQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216 (416)
Q Consensus 144 l~~~~--~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~ 216 (416)
++.++ .+||+|||++......... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCccc
Confidence 99988 8999999999765433221 12234589999999999988766 4899999999999999999999987
Q ss_pred Cc--hHHHHHHh---hcCccCCC------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 217 SN--LMNLYKKI---SAAEFTCP------PWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 217 ~~--~~~~~~~i---~~~~~~~~------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.. ........ ......++ ..+++++.+||.+||+.||.+|||++++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 53 22222221 22222111 246899999999999999999999999976
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=375.76 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=210.3
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
..-++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|++++||||+++++++.+ ...|
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 345689999999999999999999865 467999999764422 3568899999999999999999999876 6789
Q ss_pred EEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 999999999999999753 569999999999999999999999999999999999999999999999999997653211
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (416)
........+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+ ....|+.+++.+.+
T Consensus 335 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 412 (452)
T 1fmk_A 335 -YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 412 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred -eecccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1122334578899999999877764 89999999999999999 99999998887777776554 45667789999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhc
Q 014909 244 LIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~ 264 (416)
||.+||+.||++|||++++++
T Consensus 413 li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 413 LMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=359.57 Aligned_cols=254 Identities=28% Similarity=0.415 Sum_probs=190.0
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEE-----
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMG----- 81 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~----- 81 (416)
..-.+|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 33458999999999999999999999999999999986543 334567889999999996 999999999983
Q ss_pred ---eCCEEEEEEeccCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCcEEeccCCCeEEe
Q 014909 82 ---SKTKIFIVLEFVTGGELFDKIVN---HGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVS 153 (416)
Q Consensus 82 ---~~~~~~lV~E~~~gg~L~~~i~~---~~~l~e~~~~~~~~qll~al~~LH~~g--ivHrDlkp~NILl~~~~~vkl~ 153 (416)
....+++||||+. |+|.+++.. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence 4456899999996 589888765 567999999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccccCC----------CCcccccCCcccccchhhc---cCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH
Q 014909 154 DFGLSALSQQVRDD----------GLLHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220 (416)
Q Consensus 154 DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPEvl~---~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~ 220 (416)
|||++......... ......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 99999765432111 0112457999999999983 3344 58999999999999999999999876544
Q ss_pred HHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 221 NLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 221 ~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
...... .....+...+..+.+||.+||+.||.+|||+.++++|-+-
T Consensus 260 ~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 260 RIVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp --------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HhhcCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 333221 1233345578899999999999999999999999987543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=352.32 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=197.1
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhc--CCCCCcceEEEEEEe--
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL--VKHPNVVRLYEVMGS-- 82 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~-- 82 (416)
....++|++.+.||+|+||.||+|.+ +++.||||++.... .....+|..++.. ++||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34678999999999999999999988 68899999987542 2344556666655 799999999998643
Q ss_pred --CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEeecCCCCcEEeccCCCeEE
Q 014909 83 --KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH--------SRGVYHRDLKPENLLLDAYGNLKV 152 (416)
Q Consensus 83 --~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH--------~~givHrDlkp~NILl~~~~~vkl 152 (416)
....|+||||+++|+|.+++.. ..+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 3568999999999999999954 57999999999999999999999 999999999999999999999999
Q ss_pred eecccccccccccCC--CCcccccCCcccccchhhccCCCC-----CChhhHHHHHHHHHHHhhC----------CCCCC
Q 014909 153 SDFGLSALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYD-----GSTADLWSCGVILFVLLAG----------YLPFD 215 (416)
Q Consensus 153 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPEvl~~~~~~-----~~~~DIwSlGvil~~ml~G----------~~Pf~ 215 (416)
+|||+|......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999998754332111 112345899999999999875322 2589999999999999999 88986
Q ss_pred CCc----hHHHHHHhhcC---ccCCCCC-----CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 216 DSN----LMNLYKKISAA---EFTCPPW-----LSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 216 ~~~----~~~~~~~i~~~---~~~~~~~-----~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
... ........... ....|.. .++++.+||.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 532 11222222211 1222221 3467999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=363.86 Aligned_cols=261 Identities=23% Similarity=0.308 Sum_probs=209.6
Q ss_pred cccccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014909 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (416)
Q Consensus 3 ~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 82 (416)
...+....++|++.+.||+|+||.||+|.+. +|+.||||++....... ....+.+|+.+++.++||||+++++++.+
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEec
Confidence 3445567789999999999999999999864 68899999997654222 22368899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcEeecCCCCcEEeccCCCeEEeec
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNHG----RMKEDEARRYFQQLINAVDYCHSR---GVYHRDLKPENLLLDAYGNLKVSDF 155 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~al~~LH~~---givHrDlkp~NILl~~~~~vkl~DF 155 (416)
....++||||+.+|+|.+++.... .+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence 999999999999999999998653 499999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc--------hHHHHHHhh
Q 014909 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN--------LMNLYKKIS 227 (416)
Q Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~--------~~~~~~~i~ 227 (416)
|++...... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... .........
T Consensus 179 g~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 179 GLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp SSCEECCSS-SSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred ccccccCcc-cccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 999765432 2223345569999999999987766 489999999999999999999996211 111111110
Q ss_pred cC-c------c----CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 228 AA-E------F----TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 228 ~~-~------~----~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
.. . . ..++..+..+.+|+.+||+.||.+|||+.++++|-+-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 00 0 0 1111134678999999999999999999999987653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=357.69 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=207.6
Q ss_pred cccCE-EEEeEEeecCceEEEEEE----ECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-
Q 014909 9 RVGKY-EVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS- 82 (416)
Q Consensus 9 ~~~~y-~~~~~LG~G~fg~V~~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 82 (416)
.-++| ++++.||+|+||.||++. +..+++.||||++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 44455 999999999999998875 34578899999998653 23446779999999999999999999999987
Q ss_pred -CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccc
Q 014909 83 -KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (416)
Q Consensus 83 -~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~ 161 (416)
...+|+||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 46899999999999999998764 5999999999999999999999999999999999999999999999999999765
Q ss_pred ccccCC-CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH---------------HHHHH
Q 014909 162 QQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---------------NLYKK 225 (416)
Q Consensus 162 ~~~~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~---------------~~~~~ 225 (416)
...... .......||+.|+|||++.+..+. .++|||||||++|+|++|..||...... .....
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 432111 123345688899999999887765 8999999999999999999999764321 11122
Q ss_pred hhc-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 226 ISA-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 226 i~~-~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+.. .....+..+++++.+||++||+.||.+|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 222 234566779999999999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=386.83 Aligned_cols=249 Identities=21% Similarity=0.334 Sum_probs=210.4
Q ss_pred EEE-EeEEeecCceEEEEEEE--CCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 13 YEV-GRTIGEGTFAKVKFARN--SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 13 y~~-~~~LG~G~fg~V~~a~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+.+ .+.||+|+||.||+|.+ ..+++.||||++..... .....+.+.+|+.+|+.++|||||++++++.. ...++|
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv 447 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 447 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEE
Confidence 444 34899999999999954 45678999999976532 33446789999999999999999999999975 458899
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC-CC
Q 014909 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-DG 168 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-~~ 168 (416)
|||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|........ ..
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999999999999988999999999999999999999999999999999999999999999999999986543221 11
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHHH
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIA 246 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll~ 246 (416)
......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..+ ....|..++.++.+||.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 606 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 606 (635)
T ss_dssp -------CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 22334578899999999887775 89999999999999998 99999998888877777655 35667789999999999
Q ss_pred HhcCCCCCCCCCHhHHhc
Q 014909 247 RILDPNPMTRITIPEILE 264 (416)
Q Consensus 247 ~~L~~dP~~R~t~~eil~ 264 (416)
+||+.||++|||+.++++
T Consensus 607 ~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 607 LCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHTCSSTTTSCCHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHH
Confidence 999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=353.30 Aligned_cols=242 Identities=29% Similarity=0.469 Sum_probs=200.0
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
...++|++.+.||+|+||.||+|.+. ++.||||++.... ..+.+.+|+.++++++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 35689999999999999999999984 7889999986432 34678899999999999999999998764 478
Q ss_pred EEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCcEeecCCCCcEEeccCCC-eEEeecccccc
Q 014909 88 IVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHS---RGVYHRDLKPENLLLDAYGN-LKVSDFGLSAL 160 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~al~~LH~---~givHrDlkp~NILl~~~~~-vkl~DFGla~~ 160 (416)
+||||++||+|.+++.... .+++..+..++.||+.||+|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999998765 37899999999999999999999 89999999999999998887 79999999875
Q ss_pred cccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch--HHHHHHh-hcCccCCCCCC
Q 014909 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL--MNLYKKI-SAAEFTCPPWL 237 (416)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~--~~~~~~i-~~~~~~~~~~~ 237 (416)
... ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||..... ......+ .......+..+
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
T 2eva_A 156 IQT-----HMTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229 (307)
T ss_dssp --------------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTC
T ss_pred ccc-----ccccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCccccc
Confidence 432 12345799999999999887664 899999999999999999999985432 2222222 23344556678
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 238 SFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 238 s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+..+.+||.+||+.||.+|||++++++
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=356.21 Aligned_cols=249 Identities=23% Similarity=0.344 Sum_probs=203.5
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhh-hcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
|..++.||+|+||.||+|.+ +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 33458999999999999986 588999999875432 223456789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 92 FVTGGELFDKIVN---HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 92 ~~~gg~L~~~i~~---~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
|+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 9999999999874 3469999999999999999999999999999999999999999999999999987654332222
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH----HHHHHhhcCcc-----------CC
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----NLYKKISAAEF-----------TC 233 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~----~~~~~i~~~~~-----------~~ 233 (416)
.....+||+.|+|||++.+. + +.++|||||||++|+|++|..||...... .....+..... ..
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred cccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 23456799999999998753 4 58999999999999999999999865432 22222221111 11
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 234 PPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 234 ~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 22245678999999999999999999999863
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=367.94 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=202.5
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCC---CeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE-eCC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG-SKT 84 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~ 84 (416)
....|++.+.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+.++++++||||+++++++. ..+
T Consensus 87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 164 (373)
T 3c1x_A 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164 (373)
T ss_dssp TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence 3446899999999999999999875432 468999986532 3345678999999999999999999999864 456
Q ss_pred EEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
..|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence 8899999999999999998654 588999999999999999999999999999999999999999999999999975432
Q ss_pred ccCC--CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCH
Q 014909 164 VRDD--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSF 239 (416)
Q Consensus 164 ~~~~--~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 239 (416)
.... .......+|+.|+|||++.+..+. .++|||||||++|+|++ |.+||.+.+.......+..+ ....|..++.
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~ 323 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 323 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCH
T ss_pred cccccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 2111 112334678899999999887774 89999999999999999 78899877665555555444 3455677999
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 240 TARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.+.+++.+||+.||.+|||+.++++
T Consensus 324 ~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 324 PLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=354.61 Aligned_cols=249 Identities=22% Similarity=0.361 Sum_probs=196.7
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC--CCCCcceEEEEEEeC--
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV--KHPNVVRLYEVMGSK-- 83 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~~~~~~~-- 83 (416)
...++|++.+.||+|+||.||+|.+. ++.||||++.... .....+|..++..+ +||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 34578999999999999999999985 8899999986542 23344555555554 899999999999877
Q ss_pred --CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeecCCCCcEEeccCCCeEEe
Q 014909 84 --TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR--------GVYHRDLKPENLLLDAYGNLKVS 153 (416)
Q Consensus 84 --~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~--------givHrDlkp~NILl~~~~~vkl~ 153 (416)
...|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 789999999999999999976 4799999999999999999999999 99999999999999999999999
Q ss_pred ecccccccccccCCC--CcccccCCcccccchhhccCCCCCC-----hhhHHHHHHHHHHHhhC----------CCCCCC
Q 014909 154 DFGLSALSQQVRDDG--LLHTTCGTPNYVAPEVLNDRGYDGS-----TADLWSCGVILFVLLAG----------YLPFDD 216 (416)
Q Consensus 154 DFGla~~~~~~~~~~--~~~~~~gt~~y~aPEvl~~~~~~~~-----~~DIwSlGvil~~ml~G----------~~Pf~~ 216 (416)
|||++.......... .....+||+.|+|||++.+..+... ++|||||||++|+|++| ..||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999987543322111 1235689999999999987665533 48999999999999999 777764
Q ss_pred Cc-----hHHHHHHhh--cCccCCCC-----CCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 217 SN-----LMNLYKKIS--AAEFTCPP-----WLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 217 ~~-----~~~~~~~i~--~~~~~~~~-----~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.. .......+. ......|. .+++++.+||.+||+.||.+|||+.++++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 32 112222221 11222332 245679999999999999999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=358.29 Aligned_cols=263 Identities=20% Similarity=0.291 Sum_probs=194.9
Q ss_pred ccccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE--
Q 014909 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG-- 81 (416)
Q Consensus 4 ~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-- 81 (416)
+.....+++|++.+.||+|+||.||+|.+ +++.||||++...... ......|+..++.++||||+++++.+.
T Consensus 6 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ----NFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp ---CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh----hHHHHHHHHHHHhccCcchhhheeccccc
Confidence 34567889999999999999999999987 6889999999754321 112233444455689999999998653
Q ss_pred ---eCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEeecCCCCcEEeccCCC
Q 014909 82 ---SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR---------GVYHRDLKPENLLLDAYGN 149 (416)
Q Consensus 82 ---~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~---------givHrDlkp~NILl~~~~~ 149 (416)
....+|+||||+++|+|.+++... ..++..+..++.||+.||.|||++ ||+||||||+|||++.++.
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 234679999999999999999764 468999999999999999999999 9999999999999999999
Q ss_pred eEEeeccccccccccc------CCCCcccccCCcccccchhhccCC------CCCChhhHHHHHHHHHHHhhCCCCCCCC
Q 014909 150 LKVSDFGLSALSQQVR------DDGLLHTTCGTPNYVAPEVLNDRG------YDGSTADLWSCGVILFVLLAGYLPFDDS 217 (416)
Q Consensus 150 vkl~DFGla~~~~~~~------~~~~~~~~~gt~~y~aPEvl~~~~------~~~~~~DIwSlGvil~~ml~G~~Pf~~~ 217 (416)
+||+|||+|....... ........+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999999997643221 112233567999999999997631 2236799999999999999997766321
Q ss_pred -c-----------------hHHHHHHh--hcCccCCCCC------CCHHHHHHHHHhcCCCCCCCCCHhHHh------cC
Q 014909 218 -N-----------------LMNLYKKI--SAAEFTCPPW------LSFTARKLIARILDPNPMTRITIPEIL------ED 265 (416)
Q Consensus 218 -~-----------------~~~~~~~i--~~~~~~~~~~------~s~~~~~ll~~~L~~dP~~R~t~~eil------~h 265 (416)
. .......+ ......+|.. .++++.+||.+||+.||++|||+.|++ .+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 1 01111111 1112233332 344799999999999999999999995 46
Q ss_pred cccccCCC
Q 014909 266 EWFKKDYK 273 (416)
Q Consensus 266 ~~~~~~~~ 273 (416)
+|-++...
T Consensus 319 ~~~~~~~~ 326 (336)
T 3g2f_A 319 IWERNKSV 326 (336)
T ss_dssp CCCC----
T ss_pred HHHhcccC
Confidence 77765543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=382.57 Aligned_cols=251 Identities=23% Similarity=0.343 Sum_probs=209.0
Q ss_pred ccCEEEEe-EEeecCceEEEEEEECC--CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 10 VGKYEVGR-TIGEGTFAKVKFARNSE--TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 10 ~~~y~~~~-~LG~G~fg~V~~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
-+++.+.+ .||+|+||.||+|.+.. ++..||||++.... .....+.+.+|+.+|+.++|||||++++++.+ +.+
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence 34566666 89999999999998753 55679999997643 22245779999999999999999999999976 569
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
|+||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 9999999999999999754 469999999999999999999999999999999999999999999999999997653321
Q ss_pred CC-CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHH
Q 014909 166 DD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (416)
Q Consensus 166 ~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 242 (416)
.. .......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+ ....|+.+++++.
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 569 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 569 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 11 111233467899999999877775 89999999999999998 99999998888777777655 3567778999999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhc
Q 014909 243 KLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+||.+||+.||.+|||+.++++
T Consensus 570 ~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 570 ALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999854
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=353.39 Aligned_cols=253 Identities=22% Similarity=0.372 Sum_probs=209.3
Q ss_pred ccccCEEEEeEEeecCceEEEEEE----ECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
...++|++++.||+|+||.||+|. +..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 345679999999999999999998 45689999999997542 33467899999999999999999999998654
Q ss_pred C--EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccc
Q 014909 84 T--KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (416)
Q Consensus 84 ~--~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~ 160 (416)
+ .+++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 4 789999999999999999876 4699999999999999999999999999999999999999999999999999976
Q ss_pred cccccCC-CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH----------------HHH
Q 014909 161 SQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----------------NLY 223 (416)
Q Consensus 161 ~~~~~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~----------------~~~ 223 (416)
....... .......+++.|+|||++.+..+. .++|||||||++|+|++|..||...... .+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 5432111 112334678889999999877664 8999999999999999999998643211 111
Q ss_pred HHhhc-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 224 KKISA-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 224 ~~i~~-~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
..+.. .....|..+++++.+||.+||+.||.+|||+.++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22222 234567779999999999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=377.32 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=214.5
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
...++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|+.++||||+++++++.+ ..+|
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 445789999999999999999999865 467999999765422 3568899999999999999999999876 6789
Q ss_pred EEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 999999999999999753 569999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (416)
. .......++..|+|||++....+. .++|||||||++|+|++ |..||.+....+....+..+ ....|..++..+.+
T Consensus 418 ~-~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 495 (535)
T 2h8h_A 418 Y-TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 495 (535)
T ss_dssp H-HTTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred e-ecccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 0 112234567899999999877764 89999999999999999 99999998887777776555 34567789999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhc
Q 014909 244 LIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~ 264 (416)
||.+||+.||++|||+++|++
T Consensus 496 li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 496 LMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=390.10 Aligned_cols=259 Identities=28% Similarity=0.405 Sum_probs=208.0
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe---
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--- 82 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--- 82 (416)
.+..+++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 9 pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK 86 (676)
T ss_dssp --------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred CCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence 4567899999999999999999999999999999999987542 33446779999999999999999999999765
Q ss_pred ---CCEEEEEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCC---eEEe
Q 014909 83 ---KTKIFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVS 153 (416)
Q Consensus 83 ---~~~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~---vkl~ 153 (416)
....|+||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 677899999999999999998754 6999999999999999999999999999999999999997765 9999
Q ss_pred ecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHH--------
Q 014909 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK-------- 225 (416)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~-------- 225 (416)
|||++..... .......+||+.|+|||++.+..+. .++||||+||++|+|++|..||........+..
T Consensus 167 DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 167 DLGYAKELDQ---GELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp SCCCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred cccccccccc---ccccccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 9999876433 2334556899999999999887775 899999999999999999999976533221100
Q ss_pred ------hhcCcc------CCC----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 226 ------ISAAEF------TCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 226 ------i~~~~~------~~~----~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
...+.. +.| +.+++.+.+||.+||..||.+|||+.++++||||..
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 001111 111 125678999999999999999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=355.72 Aligned_cols=253 Identities=22% Similarity=0.361 Sum_probs=209.5
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
....++|++.+.||+|+||.||+|.+.. .+|+|++...... ....+.+.+|+.+++.++||||+++++++.+....
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 4567899999999999999999999853 4999999764322 22235577899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
|+||||++|++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+|||++ ++.+||+|||++.......
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 99999999999999998755 699999999999999999999999999999999999998 6899999999987543221
Q ss_pred ---CCCCcccccCCcccccchhhccC--------CCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCC-
Q 014909 166 ---DDGLLHTTCGTPNYVAPEVLNDR--------GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC- 233 (416)
Q Consensus 166 ---~~~~~~~~~gt~~y~aPEvl~~~--------~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~- 233 (416)
.........||+.|+|||++.+. ...+.++|||||||++|+|++|..||...+.......+..+....
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 263 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL 263 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC
Confidence 12233455799999999999752 223578999999999999999999999988877776665553322
Q ss_pred -CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 234 -PPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 234 -~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+..++.++.+||.+||+.||.+|||+.++++
T Consensus 264 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2347889999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=380.52 Aligned_cols=252 Identities=26% Similarity=0.402 Sum_probs=213.6
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCC---CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
...++|++.+.||+|+||.||+|.+..+ +..||||.+.... .....+.+.+|+.+|+.++||||+++++++. .+
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 4567899999999999999999998654 4569999986532 3344678999999999999999999999985 45
Q ss_pred EEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
..|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 6899999999999999998654 699999999999999999999999999999999999999999999999999976533
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHH
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 241 (416)
.. ........||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..+ ....|+.+++.+
T Consensus 544 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 621 (656)
T 2j0j_A 544 ST-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 621 (656)
T ss_dssp -----------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred Cc-ceeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 21 1122344678899999999877764 89999999999999997 99999998888777776554 356778899999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 014909 242 RKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.+||.+||+.||.+|||+.++++
T Consensus 622 ~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 622 YSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=369.00 Aligned_cols=250 Identities=18% Similarity=0.203 Sum_probs=196.5
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCC-CCc---------ce---
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNV---------VR--- 75 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnI---------v~--- 75 (416)
....|.+.+.||+|+||.||+|.+..+|+.||||++...........+.+++|+.+++.++| +|. +.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34468999999999999999999999999999999985443333345779999999999987 321 11
Q ss_pred ---------EEEEEEe-----CCEEEEEEeccCCCchHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEe
Q 014909 76 ---------LYEVMGS-----KTKIFIVLEFVTGGELFDKIVN-------HGRMKEDEARRYFQQLINAVDYCHSRGVYH 134 (416)
Q Consensus 76 ---------l~~~~~~-----~~~~~lV~E~~~gg~L~~~i~~-------~~~l~e~~~~~~~~qll~al~~LH~~givH 134 (416)
+..++.. ...++++|+++ +++|.+++.. ...+++..+..++.||+.||+|||++||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 1111111 23467888876 5699988842 234778888999999999999999999999
Q ss_pred ecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhc----------cCCCCCChhhHHHHHHHH
Q 014909 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN----------DRGYDGSTADLWSCGVIL 204 (416)
Q Consensus 135 rDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~----------~~~~~~~~~DIwSlGvil 204 (416)
|||||+|||++.++.+||+|||++...... ....+| +.|+|||++. +..+ +.++|||||||++
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil 307 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAI 307 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHH
Confidence 999999999999999999999998754332 456688 9999999993 3334 4799999999999
Q ss_pred HHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 205 FVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 205 ~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
|+|++|+.||...+.......+.. ....+|+++.+||.+||+.||.+|||+.++++||||+.
T Consensus 308 ~elltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHCCCCCCCcchhhhHHHHHh----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 999999999988765443333322 23457899999999999999999999999999999974
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=363.31 Aligned_cols=250 Identities=21% Similarity=0.287 Sum_probs=207.8
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCC-CCcceEEEEEEeCCEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNVVRLYEVMGSKTKI 86 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~ 86 (416)
...++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++| ++|..+..++......
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 3457899999999999999999999999999999998765432 347789999999986 5666666777888899
Q ss_pred EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEe---ccCCCeEEeecccccccc
Q 014909 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl---~~~~~vkl~DFGla~~~~ 162 (416)
|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||++....
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 8899999985 4679999999999999999999999999999999999999 688999999999998654
Q ss_pred cccCC-----CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch---HHHHHHhhcCcc---
Q 014909 163 QVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---MNLYKKISAAEF--- 231 (416)
Q Consensus 163 ~~~~~-----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~---~~~~~~i~~~~~--- 231 (416)
..... ......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+... ...+.++.....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 43221 122366899999999999987774 899999999999999999999987433 333333322211
Q ss_pred --CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 232 --TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 232 --~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
..+..++.++.+||.+||+.||.+||++.+|++
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 223567899999999999999999999998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=347.52 Aligned_cols=247 Identities=22% Similarity=0.344 Sum_probs=201.5
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhc--CCCCCcceEEEEEEeCC---
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL--VKHPNVVRLYEVMGSKT--- 84 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~--- 84 (416)
.++|++.+.||+|+||.||+|.+ +|+.||||++.... ...+.+|+.+++. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 46899999999999999999998 48899999996542 3456788888887 78999999999998776
Q ss_pred -EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEeecCCCCcEEeccCCCeEEeec
Q 014909 85 -KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH--------SRGVYHRDLKPENLLLDAYGNLKVSDF 155 (416)
Q Consensus 85 -~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH--------~~givHrDlkp~NILl~~~~~vkl~DF 155 (416)
..|+||||+++|+|.+++.. ..+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 89999999999999999976 56999999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccCC--CCcccccCCcccccchhhccCCCC-----CChhhHHHHHHHHHHHhhC----------CCCCCCCc
Q 014909 156 GLSALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYD-----GSTADLWSCGVILFVLLAG----------YLPFDDSN 218 (416)
Q Consensus 156 Gla~~~~~~~~~--~~~~~~~gt~~y~aPEvl~~~~~~-----~~~~DIwSlGvil~~ml~G----------~~Pf~~~~ 218 (416)
|++......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 998765432111 023455899999999999865322 1579999999999999999 88997642
Q ss_pred -----hHHHHHHhhcCc--cCCCCC-----CCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 219 -----LMNLYKKISAAE--FTCPPW-----LSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 219 -----~~~~~~~i~~~~--~~~~~~-----~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.......+.... ...|.. .+..+.+||.+||+.||++|||+.++++|
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 233333333222 222221 23578899999999999999999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=366.60 Aligned_cols=244 Identities=23% Similarity=0.290 Sum_probs=196.6
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhh-----cHHHHHHHHHHHHHHhcCC---------CCCcc
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMKLVK---------HPNVV 74 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~---------hpnIv 74 (416)
..++|++.+.||+|+||+||+|++ +|+.||||++...... .....+.+.+|+.+|+.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 357899999999999999999998 6899999999875421 2223467889999998885 88888
Q ss_pred eEEEEEE------------------------------eCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 014909 75 RLYEVMG------------------------------SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124 (416)
Q Consensus 75 ~l~~~~~------------------------------~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al 124 (416)
++.+++. +...+|+||||+++|++.+.+.. +.+++..++.++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 8877642 26889999999999988777754 6789999999999999999
Q ss_pred HHHH-hCCcEeecCCCCcEEeccCC--------------------CeEEeecccccccccccCCCCcccccCCcccccch
Q 014909 125 DYCH-SRGVYHRDLKPENLLLDAYG--------------------NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183 (416)
Q Consensus 125 ~~LH-~~givHrDlkp~NILl~~~~--------------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 183 (416)
+||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|||
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChh
Confidence 9999 99999999999999999987 899999999986542 2458999999999
Q ss_pred hhccCCCCCChhhHHHHHHH-HHHHhhCCCCCCCCch-HHHHHHhhc-CccC--C----CCCCCHHHHHHHHHhcCCCCC
Q 014909 184 VLNDRGYDGSTADLWSCGVI-LFVLLAGYLPFDDSNL-MNLYKKISA-AEFT--C----PPWLSFTARKLIARILDPNPM 254 (416)
Q Consensus 184 vl~~~~~~~~~~DIwSlGvi-l~~ml~G~~Pf~~~~~-~~~~~~i~~-~~~~--~----~~~~s~~~~~ll~~~L~~dP~ 254 (416)
++.+.. +.++||||+|++ .+++++|..||.+... ......+.. .... . ++.+|+++.+||++||+.|
T Consensus 248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-- 323 (336)
T 2vuw_A 248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-- 323 (336)
T ss_dssp GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence 998765 589999998777 6788899999964322 112222221 1111 1 1236889999999999977
Q ss_pred CCCCHhHHh-cCcccc
Q 014909 255 TRITIPEIL-EDEWFK 269 (416)
Q Consensus 255 ~R~t~~eil-~h~~~~ 269 (416)
|++|+| +||||+
T Consensus 324 ---sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 ---SATDLLCQHSLFK 336 (336)
T ss_dssp ---SHHHHHHHCGGGC
T ss_pred ---CHHHHHhcCCCcC
Confidence 999999 999995
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=337.24 Aligned_cols=223 Identities=19% Similarity=0.243 Sum_probs=190.1
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
..++|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 34789999999999999999999999999999999987665555567889999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
||||++|++|.+++.. + ....++..++.||+.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence 9999999999999854 3 4666788999999999999999999999999999999999999998554
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHH---HhhcCcc----CCCCCCCHHH
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK---KISAAEF----TCPPWLSFTA 241 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~---~i~~~~~----~~~~~~s~~~ 241 (416)
|++| + +.++|||||||++|+|++|+.||.+.+...... +...... ..++.+++++
T Consensus 175 ----------~~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 175 ----------TMPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp ----------CCTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred ----------ccCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence 2332 3 589999999999999999999998765432110 1111111 1235689999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 014909 242 RKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.+||.+||+.||.+| |+.++++
T Consensus 237 ~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp HHHHHHHHCTTSSCC-CHHHHHH
T ss_pred HHHHHHHcccCCccC-CHHHHHH
Confidence 999999999999999 9999987
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=377.20 Aligned_cols=241 Identities=26% Similarity=0.390 Sum_probs=200.1
Q ss_pred ccCEEEEeEEeecCceEEEEEEECC-CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE---
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK--- 85 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--- 85 (416)
.++|++.+.||+|+||.||+|.+.. +|+.||||++.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 4899999999999999999999976 78999999986532 23445678899999999999999999999987655
Q ss_pred --EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 86 --IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 86 --~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
.|+||||++|++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||++.....
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred ceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 7999999999999987754 79999999999999999999999999999999999999884 999999999875432
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHH
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ 243 (416)
....+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+...... .........++.+.+
T Consensus 234 ------~~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------~~~~~~~~~~~~l~~ 299 (681)
T 2pzi_A 234 ------FGYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------PEDDPVLKTYDSYGR 299 (681)
T ss_dssp ------CSCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------CTTCHHHHHCHHHHH
T ss_pred ------CCccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCcccccccc------cccccccccCHHHHH
Confidence 1456799999999999764 3 5899999999999999999999875321100 000000114678999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCcccc
Q 014909 244 LIARILDPNPMTRITIPEILEDEWFK 269 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~h~~~~ 269 (416)
||.+||+.||.+||+..+.+.|+|+.
T Consensus 300 li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 300 LLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHhhhccCChhhCCCHHHHHHHHHHH
Confidence 99999999999999999999999875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=321.78 Aligned_cols=232 Identities=15% Similarity=0.141 Sum_probs=163.8
Q ss_pred EEeecCceEEEEEEECCCCCeEEEEEeechhh-------hcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEE
Q 014909 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKV-------LKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 18 ~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~-------~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV 89 (416)
.++.|++|.+..++....|+.||+|++.+... ..+...+.+.+|+.+|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45678888888777777899999999976422 1233457799999999999 699999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
|||++|++|.++|...+++++. .|+.||++||+|||++||+||||||+|||++.+|++||+|||+|+.... ....
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~--~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ--DCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CC
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC--CCcc
Confidence 9999999999999998888875 4899999999999999999999999999999999999999999986543 2234
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhc
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L 249 (416)
..+.+||+.|||||++.+.. ..++|+||+|+++++|.+|..|+. ..+.. .|+. ......+...++
T Consensus 396 ~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~~----~~~~-~~~~~~l~~~l~ 460 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNWL--------YAVWQ----EPVE-RWNFVLLLALFE 460 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH--------HHHHT----SCGG-GCSHHHHHHHHH
T ss_pred ccCceechhhccHHHhCCCC--CCcccccccccchhhhccccchhH--------HHhhc----CCCC-CCcHHHHHHHHh
Confidence 56779999999999998643 367899999999988876654431 11111 1111 113456777788
Q ss_pred CCCCCCCCCHhHHhcCcccc
Q 014909 250 DPNPMTRITIPEILEDEWFK 269 (416)
Q Consensus 250 ~~dP~~R~t~~eil~h~~~~ 269 (416)
..+|..|+.......|+|..
T Consensus 461 ~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 461 KKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp TGGGSCCGGGSSCCHHHHHH
T ss_pred CCCCCCCCChhhhccchhHH
Confidence 88888888887777777764
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-31 Score=271.21 Aligned_cols=189 Identities=22% Similarity=0.228 Sum_probs=145.0
Q ss_pred EEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhc-----HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-----HKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 14 ~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
...+.||+|+||.||+|. ..+..+|+|......... ....+++.+|+.+|++++||||+++..+.......|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 346789999999999994 457889999875533222 2234668999999999999999955444446677799
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
||||++|++|.+++.. +..++.||++||+|||++||+||||||+|||++. ++||+|||+|+.........
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999999875 6689999999999999999999999999999998 99999999998654321111
Q ss_pred -----CcccccCCcccccchhhcc--CCCCCChhhHHHHHHHHHHHhhCCCCCC
Q 014909 169 -----LLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFD 215 (416)
Q Consensus 169 -----~~~~~~gt~~y~aPEvl~~--~~~~~~~~DIwSlGvil~~ml~G~~Pf~ 215 (416)
...+.+||+.|+|||++.. .+|. ..+|+||..+-..+.+.++.+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhccccC
Confidence 1246689999999999986 5564 67899999988888877776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=224.12 Aligned_cols=145 Identities=17% Similarity=0.231 Sum_probs=116.4
Q ss_pred EEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcH---------------HHHHHHHHHHHHHhcCCCCCcceEEE
Q 014909 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---------------KMAEQIKREVATMKLVKHPNVVRLYE 78 (416)
Q Consensus 14 ~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~---------------~~~~~~~~Ei~il~~l~hpnIv~l~~ 78 (416)
.+++.||+|+||.||+|.+ .+|+.||||++........ .....+.+|+.+|+.++| +++++
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~ 168 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPK 168 (282)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCC
T ss_pred EecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCe
Confidence 3449999999999999999 8899999999965332111 235678999999999994 45555
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccc
Q 014909 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (416)
Q Consensus 79 ~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla 158 (416)
++.. +..|+||||++|++|.+ +. ...+..++.|++.||.|||++||+||||||+|||++ +|.+||+|||+|
T Consensus 169 ~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a 239 (282)
T 1zar_A 169 VYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS 239 (282)
T ss_dssp EEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred EEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence 4443 45699999999999987 42 134567999999999999999999999999999999 999999999988
Q ss_pred cccccccCCCCcccccCCcccccchhhc
Q 014909 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLN 186 (416)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~ 186 (416)
.. +..|+|||.+.
T Consensus 240 ~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 240 VE---------------VGEEGWREILE 252 (282)
T ss_dssp EE---------------TTSTTHHHHHH
T ss_pred eE---------------CCCCCHHHHHH
Confidence 62 44678999875
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=194.98 Aligned_cols=110 Identities=55% Similarity=0.890 Sum_probs=103.2
Q ss_pred CccccchhhhhhcCCCCCCCCCCccccc-ccccceeEecCCHHHHHHHHHHhcccCCcEEEeecceEEEEEeecCCCcce
Q 014909 307 QPVAMNAFELISLSKGLNLGNLFDAEQD-FKRETRFTSRCPANEIINKIEEAAKPLGFDVHKKNYKMRLENMKAGRKGNL 385 (416)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (416)
.|..+|||++|++|+|+||++||+..+. .+++|||+|+.|+++|+++|+++++++||.|++++++++++++.++++|.|
T Consensus 3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grkG~l 82 (143)
T 2ehb_D 3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKAGQL 82 (143)
T ss_dssp CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGGGCC
T ss_pred CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCcceE
Confidence 4678999999999999999999976542 688999999999999999999999999999999888999999999999999
Q ss_pred EEEEEEEEEcCCeEEEEEEEcCCCccceecC
Q 014909 386 NVATEVFQVAPSLHMVEVRKAKGDTLEFHKV 416 (416)
Q Consensus 386 ~~~~~~~~~~~~~~~v~~~~~~gd~~e~~~~ 416 (416)
.+.++||+|+|+++||||||++||++||++|
T Consensus 83 ~v~~EVfevapsl~vVEvrks~GD~lEy~k~ 113 (143)
T 2ehb_D 83 AVVIEIYEVAPSLFMVDVRKAAGETLEYHKF 113 (143)
T ss_dssp EEEEEEEEEETTEEEEEEEEEESCHHHHHHH
T ss_pred EEEEEEEEecCCEEEEEEEecCCChHHHHHH
Confidence 9999999999999999999999999999874
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-26 Score=186.95 Aligned_cols=106 Identities=32% Similarity=0.473 Sum_probs=94.0
Q ss_pred ccccchhhhhhcCCCCCCCCCCcccccccccceeEecCCHHHHHHHHHHhcccCCcEEEeecceEEEEEeecCCCcceEE
Q 014909 308 PVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIINKIEEAAKPLGFDVHKKNYKMRLENMKAGRKGNLNV 387 (416)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (416)
|..+|||++|++|+|+||++||++.+..+++|||+|+.||++|+++|+++++++||.|++++++ +.+.++++|.|.+
T Consensus 3 ~~~lNAFdiIs~S~g~dLSgLFe~~~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~---~~~~~g~kG~l~v 79 (123)
T 2zfd_B 3 ARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW---GMKIEGQKGNFAM 79 (123)
T ss_dssp -CCCCHHHHHHTSTTSSSGGGGGGGCSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT---EEEEEEGGGTEEE
T ss_pred cccccHHHHHHHCcCCCchHhcCcccccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc---cccccCCCccEEE
Confidence 5578999999999999999999764445779999999999999999999999999999988765 5677899999999
Q ss_pred EEEEEEEcCCeEEEEEEEcCCCccceecC
Q 014909 388 ATEVFQVAPSLHMVEVRKAKGDTLEFHKV 416 (416)
Q Consensus 388 ~~~~~~~~~~~~~v~~~~~~gd~~e~~~~ 416 (416)
.++||+|+|+++||||+|++||++||++|
T Consensus 80 ~~EVfev~p~l~vVEvrks~GD~lEy~~~ 108 (123)
T 2zfd_B 80 VVEINQLTDELVMIEVRKRQRAAASGRDL 108 (123)
T ss_dssp EEEEEECSSSCEEEEEEEEESCC---CCH
T ss_pred EEEEEEecCCEEEEEEEecCCChHHHHHH
Confidence 99999999999999999999999999985
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.6e-23 Score=192.92 Aligned_cols=139 Identities=23% Similarity=0.309 Sum_probs=109.7
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCe--EEEEEeechhhh---------------------cHHHHHHHHHHHHHHhcCC
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEP--VALKILDKEKVL---------------------KHKMAEQIKREVATMKLVK 69 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~--vaiK~i~~~~~~---------------------~~~~~~~~~~Ei~il~~l~ 69 (416)
|.+.+.||+|+||.||+|.+..+|+. ||||++...... .......+.+|+.+|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999778888 999997643211 0112246889999999998
Q ss_pred CCCc--ceEEEEEEeCCEEEEEEeccCC-C----chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCcEeecCCCCc
Q 014909 70 HPNV--VRLYEVMGSKTKIFIVLEFVTG-G----ELFDKIVNHGRMKEDEARRYFQQLINAVDYCH-SRGVYHRDLKPEN 141 (416)
Q Consensus 70 hpnI--v~l~~~~~~~~~~~lV~E~~~g-g----~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH-~~givHrDlkp~N 141 (416)
|+|+ ..+++. ...++||||+.+ | .|.+.... .++..+..++.||+.||.||| +.||+||||||+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 8764 444443 346899999942 3 66665432 345578899999999999999 9999999999999
Q ss_pred EEeccCCCeEEeecccccc
Q 014909 142 LLLDAYGNLKVSDFGLSAL 160 (416)
Q Consensus 142 ILl~~~~~vkl~DFGla~~ 160 (416)
||++. .++|+|||+|..
T Consensus 202 ILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EEESS--SEEECCCTTCEE
T ss_pred EEEcC--cEEEEECccccc
Confidence 99998 999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.4e-19 Score=177.23 Aligned_cols=136 Identities=19% Similarity=0.230 Sum_probs=101.9
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhh---------------cHH----HHHHHHHHHHHHhcCCCCCc
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL---------------KHK----MAEQIKREVATMKLVKHPNV 73 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~---------------~~~----~~~~~~~Ei~il~~l~hpnI 73 (416)
|.+++.||.|+||.||+|.+. +|+.||||+++..... ... ......+|...|.++.++++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999985 6999999997642210 000 11223567888888865554
Q ss_pred c--eEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCC--
Q 014909 74 V--RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-- 149 (416)
Q Consensus 74 v--~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~-- 149 (416)
. ..++. . ..++||||++|++|.... ....+..++.||+.+|.+||++||+||||||.|||++++|.
T Consensus 176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEE--E--TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeec--c--CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 2 33332 2 237999999998886432 22345678999999999999999999999999999988773
Q ss_pred --------eEEeeccccc
Q 014909 150 --------LKVSDFGLSA 159 (416)
Q Consensus 150 --------vkl~DFGla~ 159 (416)
+.|+||+-+-
T Consensus 246 d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp CTTSEEEEEEECCCTTCE
T ss_pred cccccccceEEEEeCCcc
Confidence 8899999654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=7.1e-14 Score=130.13 Aligned_cols=144 Identities=17% Similarity=0.150 Sum_probs=116.2
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCC
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKT 84 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 84 (416)
++..++.|++...+|.|+.+.||++... +..+++|+........ ...+.+|+.+++.+. +..+.+++++..+.+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~ 83 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCC
Confidence 3456788999999999999999999753 6789999987532111 235889999999885 677889999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS----------------------------------- 129 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~----------------------------------- 129 (416)
..|+||||++|.+|.+.+. +......++.++..+|..||+
T Consensus 84 ~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 84 WSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred ceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 9999999999998876531 222345788999999999998
Q ss_pred ------------------------CCcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 130 ------------------------RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 130 ------------------------~givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
.+++|+|++|.||++++++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999875556799999765
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.37 E-value=1.6e-12 Score=120.26 Aligned_cols=139 Identities=14% Similarity=0.124 Sum_probs=104.9
Q ss_pred ccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCC--cceEEEEEEeC
Q 014909 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEVMGSK 83 (416)
Q Consensus 6 ~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~ 83 (416)
+...+..|.+....+.|+.+.||++.. .+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++++..+.
T Consensus 15 l~~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 15 WVERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp GTTTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred HHHhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 445667788766555677799999965 457789999976431 245778999999886545 55688888888
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG-------------------------------- 131 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~g-------------------------------- 131 (416)
+..|+||||++|.+|. . ...+ ...++.++...|..||+..
T Consensus 88 ~~~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp SCEEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred CCCEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 8899999999998873 2 1122 2356778888888888753
Q ss_pred --------------------------cEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 132 --------------------------VYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 132 --------------------------ivHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
++|+|++|.||++++++.+.|+|||.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876667799999865
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.24 E-value=2.1e-11 Score=118.80 Aligned_cols=141 Identities=23% Similarity=0.355 Sum_probs=107.1
Q ss_pred EEEeEEeecCceEEEEEEECCCCCeEEEEEee--chhhhcHHHHHHHHHHHHHHhcCC--CCCcceEEEEEEeC---CEE
Q 014909 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILD--KEKVLKHKMAEQIKREVATMKLVK--HPNVVRLYEVMGSK---TKI 86 (416)
Q Consensus 14 ~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~--~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~---~~~ 86 (416)
.-.+.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+++.+. +..+.+++.++.+. +..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 34678999999999998864 4678899876 32211 12356889999999997 45578899888776 458
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS------------------------------------- 129 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~------------------------------------- 129 (416)
|+||||++|..+.+.. ...++......++.++...|..||+
T Consensus 117 ~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999999997774421 2347788889999999999999997
Q ss_pred ---------------------CCcEeecCCCCcEEeccCCC--eEEeecccccc
Q 014909 130 ---------------------RGVYHRDLKPENLLLDAYGN--LKVSDFGLSAL 160 (416)
Q Consensus 130 ---------------------~givHrDlkp~NILl~~~~~--vkl~DFGla~~ 160 (416)
.+++|+|++|.||+++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36999999999999998764 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.21 E-value=7.4e-12 Score=119.22 Aligned_cols=185 Identities=17% Similarity=0.186 Sum_probs=123.8
Q ss_pred EeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCC--cceEEEEEEeCC---EEEEE
Q 014909 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPN--VVRLYEVMGSKT---KIFIV 89 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpn--Iv~l~~~~~~~~---~~~lV 89 (416)
++.++.|....||++. ..+++|+.... .....+.+|..+|+.+. +.. +.+.+....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4569999999999863 46899986533 23567889999998874 333 345555443333 35899
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 014909 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS---------------------------------------- 129 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~---------------------------------------- 129 (416)
|++++|..|.+... ..++..+...++.|+...+..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988875433 347888888899999999999996
Q ss_pred ------------------CCcEeecCCCCcEEecc--CCCeEEeecccccccccccCCCCcccccCCcccccchhhcc--
Q 014909 130 ------------------RGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND-- 187 (416)
Q Consensus 130 ------------------~givHrDlkp~NILl~~--~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~-- 187 (416)
..++|+|++|.||++++ .+.+.|+||+.+.......+-....... .-..|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~---~~~~~~~~~~~l 249 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD---EEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT---TSCCHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc---cccCHHHHHHHH
Confidence 13799999999999998 4567899999876532211100000000 0012222110
Q ss_pred CCCCC-----------ChhhHHHHHHHHHHHhhCCCCCC
Q 014909 188 RGYDG-----------STADLWSCGVILFVLLAGYLPFD 215 (416)
Q Consensus 188 ~~~~~-----------~~~DIwSlGvil~~ml~G~~Pf~ 215 (416)
..|.. .-.+.|++|.++|.+.+|..+|-
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 01110 12589999999999999988864
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=99.02 E-value=6.7e-10 Score=90.24 Aligned_cols=75 Identities=19% Similarity=0.299 Sum_probs=67.7
Q ss_pred EecCCHHHHHHHHHHhcccCCcEEEee-cceEEEEEeecCCCcceEEEEEEEEEc-CCeEEEEEEEcCCCccceecC
Q 014909 342 TSRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVA-PSLHMVEVRKAKGDTLEFHKV 416 (416)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~v~~~~~~gd~~e~~~~ 416 (416)
+|+.+|++|+.+|++++.++|+.|+++ .|.+++.......++.+.|.+||+++. +++++|+|+|.+||.+.|+++
T Consensus 34 TS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~l 110 (120)
T 3ose_A 34 TSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNI 110 (120)
T ss_dssp EECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHH
T ss_pred cccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHH
Confidence 789999999999999999999999987 589999765555567899999999996 899999999999999999874
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=98.78 E-value=3.6e-08 Score=81.80 Aligned_cols=74 Identities=16% Similarity=0.280 Sum_probs=62.4
Q ss_pred ceeEecCCHHHHHHHHHHhcccCCcEEEee-cceEEEEEeecCCCcceEEEEEEEEEcCCeEEEEEEEcCCCccc
Q 014909 339 TRFTSRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLE 412 (416)
Q Consensus 339 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~v~~~~~~gd~~e 412 (416)
-...|+.+|.+||.+|.+|++.||+.|++. .|.++++...+.....++|.+++|++.++.+||||++..||+.|
T Consensus 7 LGIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e 81 (157)
T 2v8q_A 7 LGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 81 (157)
T ss_dssp ESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred eecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence 345688899999999999999999999986 79999987655444469999999999999999999999999866
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=5.2e-08 Score=81.85 Aligned_cols=75 Identities=16% Similarity=0.278 Sum_probs=62.9
Q ss_pred cceeEecCCHHHHHHHHHHhcccCCcEEEee-cceEEEEEeecCCCcceEEEEEEEEEcCCeEEEEEEEcCCCccc
Q 014909 338 ETRFTSRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLE 412 (416)
Q Consensus 338 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~v~~~~~~gd~~e 412 (416)
.-...|+..|.+||.+|.+|++.||+.|++. .|.++++...+.....++|.+++|++.++.+||||++..||+.|
T Consensus 20 hLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~e 95 (173)
T 2y8l_A 20 HLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 95 (173)
T ss_dssp EESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred eeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEEecCCCccc
Confidence 3445788899999999999999999999986 79999986544434469999999999999999999999999866
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=1.4e-07 Score=87.64 Aligned_cols=140 Identities=14% Similarity=0.178 Sum_probs=102.7
Q ss_pred ccCEEEEeEEeecCce-EEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEE
Q 014909 10 VGKYEVGRTIGEGTFA-KVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg-~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 87 (416)
+..|+.. .+..|..+ .||+......+..+++|+-... ....+.+|...|+.+. +--+.+++.+..+.+..|
T Consensus 24 l~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~ 96 (272)
T 4gkh_A 24 LYGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAW 96 (272)
T ss_dssp HTTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred ccCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEE
Confidence 3445543 34445554 6998887777788999986533 2456888999998885 323667888888999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-------------------------------------- 129 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~-------------------------------------- 129 (416)
+|||+++|.++.+..... ......+..++...|.-||+
T Consensus 97 lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 97 LLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp EEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred EEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 999999998887765432 12334566777777777775
Q ss_pred --------------------CCcEeecCCCCcEEeccCCCeEEeecccccc
Q 014909 130 --------------------RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (416)
Q Consensus 130 --------------------~givHrDlkp~NILl~~~~~vkl~DFGla~~ 160 (416)
..++|+|+.|.||+++.++.+-|+||+.+..
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1279999999999999877677999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=2.5e-07 Score=87.95 Aligned_cols=134 Identities=20% Similarity=0.263 Sum_probs=97.5
Q ss_pred EeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCC---CcceEEEEEE-eCCEEEEEEe
Q 014909 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP---NVVRLYEVMG-SKTKIFIVLE 91 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~-~~~~~~lV~E 91 (416)
.+.++.|....||+. |..+++|+... ......+.+|..+|+.+.+. .+.+.+.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456889999999988 56789998532 22356789999999999752 2556666664 4556789999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 014909 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR----------------------------------------- 130 (416)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~----------------------------------------- 130 (416)
+++|..|.+... ..++......+..|+...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988866322 2345666666666666666666642
Q ss_pred -------------------CcEeecCCCCcEEecc---CCCe-EEeeccccccc
Q 014909 131 -------------------GVYHRDLKPENLLLDA---YGNL-KVSDFGLSALS 161 (416)
Q Consensus 131 -------------------givHrDlkp~NILl~~---~~~v-kl~DFGla~~~ 161 (416)
.++|+|++|.||+++. ++.+ .|+||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999987 4554 89999987653
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.66 E-value=1.1e-08 Score=83.08 Aligned_cols=74 Identities=14% Similarity=0.236 Sum_probs=65.4
Q ss_pred EecCCHHHHHHHHHHhcccCCcEEEee-cceEEEEEeecCCCcceEEEEEEEEEc-CCeEEEEEEEcCCCccceec
Q 014909 342 TSRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVA-PSLHMVEVRKAKGDTLEFHK 415 (416)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~v~~~~~~gd~~e~~~ 415 (416)
+|+.+|++|+.+|.++++++|+.|++. .|.+++....+..++.++|.+||+++. .+++.|+|+|.+||.+.|++
T Consensus 34 TSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~ 109 (126)
T 1v5s_A 34 GSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKN 109 (126)
T ss_dssp CCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHH
T ss_pred ecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHHH
Confidence 688899999999999999999999975 788998664444567899999999995 78999999999999999986
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=8.3e-08 Score=75.18 Aligned_cols=70 Identities=16% Similarity=0.281 Sum_probs=61.8
Q ss_pred eeEecCCHHHHHHHHHHhcccCCcEEEee-cceEEEEEeecCCCcceEEEEEEEEEcCCeEEEEEEEcCCC
Q 014909 340 RFTSRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGD 409 (416)
Q Consensus 340 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~v~~~~~~gd 409 (416)
...|+..|.+||.+|.+|++.+|+.|+.. .|.++++...+.....+.|.+++|++.++.+|+||++..||
T Consensus 11 GIrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g~ 81 (106)
T 4eai_A 11 GIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDG 81 (106)
T ss_dssp SEEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCSS
T ss_pred cceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccCC
Confidence 35688899999999999999999999976 79999976554445679999999999999999999999995
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=98.57 E-value=2.7e-07 Score=74.15 Aligned_cols=73 Identities=16% Similarity=0.297 Sum_probs=59.9
Q ss_pred eEecCCHHHHHHHHHHhcccCCcEEEee-cceEEEEEeecCCCcceEEEEEEEEEcCCeEEEEEEEcCCCccce
Q 014909 341 FTSRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLEF 413 (416)
Q Consensus 341 f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~v~~~~~~gd~~e~ 413 (416)
..|+..|.+||..|.+|++.+|+.|+.. .|.++++...+.....+.+.+++|++.++.+|+||++..||..|.
T Consensus 12 IrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~~ 85 (130)
T 4eag_A 12 IRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVEQ 85 (130)
T ss_dssp BCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC------
T ss_pred eecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcchhhc
Confidence 3577789999999999999999999987 799999876665556799999999999999999999999997554
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=4e-07 Score=89.63 Aligned_cols=80 Identities=15% Similarity=0.172 Sum_probs=50.8
Q ss_pred EeEEeecCceEEEEEEECCCCCeEEEEEeechhh-hcH---HHHHHHHHHHHHHhcCCC--CC-cceEEEEEEeCCEEEE
Q 014909 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-LKH---KMAEQIKREVATMKLVKH--PN-VVRLYEVMGSKTKIFI 88 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~h--pn-Iv~l~~~~~~~~~~~l 88 (416)
.+.||.|..+.||++....++..+++|....... ... ....++..|..+++.+.. |. +.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 5689999999999997665678899998653211 000 123456788888887742 33 4456654 3445689
Q ss_pred EEeccCCCc
Q 014909 89 VLEFVTGGE 97 (416)
Q Consensus 89 V~E~~~gg~ 97 (416)
|||+++|..
T Consensus 113 vmE~l~g~~ 121 (397)
T 2olc_A 113 VMEDLSHLK 121 (397)
T ss_dssp EECCCTTSE
T ss_pred EEEeCCCcc
Confidence 999998743
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=7.6e-07 Score=73.24 Aligned_cols=72 Identities=15% Similarity=0.173 Sum_probs=60.7
Q ss_pred cceeEecCCHHHHHHHHHHhcccCCcEEEee----------cceEEEEEeecCC-----CcceEEEEEEEEEcCCeEEEE
Q 014909 338 ETRFTSRCPANEIINKIEEAAKPLGFDVHKK----------NYKMRLENMKAGR-----KGNLNVATEVFQVAPSLHMVE 402 (416)
Q Consensus 338 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~-----~~~l~~~~~~~~~~~~~~~v~ 402 (416)
.-...|+..|.+||.+|.+|++.||+.|++. .|.|+++...+.. ...+.|.+++|++.++.+|||
T Consensus 14 hlGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YLlD 93 (137)
T 2qrd_A 14 HFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLD 93 (137)
T ss_dssp EESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEE
T ss_pred ccccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEEEE
Confidence 3445788899999999999999999999965 4888887654321 246899999999999999999
Q ss_pred EEEcCCC
Q 014909 403 VRKAKGD 409 (416)
Q Consensus 403 ~~~~~gd 409 (416)
|++..|+
T Consensus 94 Fk~~~~~ 100 (137)
T 2qrd_A 94 VKSNGYK 100 (137)
T ss_dssp EEEEEEE
T ss_pred EEecCCc
Confidence 9999998
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=5.9e-07 Score=86.96 Aligned_cols=85 Identities=11% Similarity=0.155 Sum_probs=55.8
Q ss_pred EEEeEE-eecCceEEEEEEEC---C---CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-C--CCcceEEEEEEeC
Q 014909 14 EVGRTI-GEGTFAKVKFARNS---E---TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-H--PNVVRLYEVMGSK 83 (416)
Q Consensus 14 ~~~~~L-G~G~fg~V~~a~~~---~---~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~ 83 (416)
...+.| +.|....+|+.... . ++..+++|+..............+.+|+.+|+.+. + -.+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345778 88999999988653 1 15678999875432000000134678888888875 3 3467788777655
Q ss_pred ---CEEEEEEeccCCCch
Q 014909 84 ---TKIFIVLEFVTGGEL 98 (416)
Q Consensus 84 ---~~~~lV~E~~~gg~L 98 (416)
...|+||||++|..+
T Consensus 103 ~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTTSSCEEEEECCCCBCC
T ss_pred CccCCceEEEEecCCCCh
Confidence 356899999998654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.17 E-value=1.9e-05 Score=75.28 Aligned_cols=135 Identities=14% Similarity=0.152 Sum_probs=77.6
Q ss_pred EeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-----CCCcceEE-E--EEEeCCEEE
Q 014909 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-----HPNVVRLY-E--VMGSKTKIF 87 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~~~ 87 (416)
.+.|+.|..+.||++... +..+++|+..... ..+..|..+++.|. .|.++... + +....+..|
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 355677788999998763 3358999987521 22334555555442 34444310 0 123467789
Q ss_pred EEEeccCCCchH--------------HHHHh-CCCC--C-----------HH--------H-------------------
Q 014909 88 IVLEFVTGGELF--------------DKIVN-HGRM--K-----------ED--------E------------------- 112 (416)
Q Consensus 88 lV~E~~~gg~L~--------------~~i~~-~~~l--~-----------e~--------~------------------- 112 (416)
++|+|++|..+. ..+.. ...+ + .. .
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986431 11111 0101 1 00 0
Q ss_pred ----HHHHHHHHHHHHHHHH-------------hCCcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 113 ----ARRYFQQLINAVDYCH-------------SRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 113 ----~~~~~~qll~al~~LH-------------~~givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
...+..++..++.+|+ ..+++|+|++|.||+++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1112223444566665 3589999999999999888899999999764
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=97.98 E-value=2e-05 Score=66.95 Aligned_cols=69 Identities=19% Similarity=0.247 Sum_probs=56.8
Q ss_pred ceeEecCCHHHHHHHHHHhcccCCcEEEee----cceEEEEEeec---------CCCcceEEEEEEEEEcCCeEEEEEEE
Q 014909 339 TRFTSRCPANEIINKIEEAAKPLGFDVHKK----NYKMRLENMKA---------GRKGNLNVATEVFQVAPSLHMVEVRK 405 (416)
Q Consensus 339 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~---------~~~~~l~~~~~~~~~~~~~~~v~~~~ 405 (416)
-...|+..|.+||.+|.+|++.+|+.|++. .|.++|+...+ +....+.|.+++|++.++.+||||+
T Consensus 53 LGIrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLDfk- 131 (179)
T 3t4n_A 53 FGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDFK- 131 (179)
T ss_dssp ESEEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEEEE-
T ss_pred eccccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEEEE-
Confidence 335788999999999999999999999974 68899975321 1123599999999999999999999
Q ss_pred cCC
Q 014909 406 AKG 408 (416)
Q Consensus 406 ~~g 408 (416)
..|
T Consensus 132 ~~G 134 (179)
T 3t4n_A 132 FDG 134 (179)
T ss_dssp EEE
T ss_pred ecc
Confidence 767
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.94 E-value=5e-05 Score=72.21 Aligned_cols=76 Identities=17% Similarity=0.264 Sum_probs=60.1
Q ss_pred EEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCEEEEEEe
Q 014909 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 15 ~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV~E 91 (416)
-.+.|+.|....+|+... ++..+++|+.... ....+..|...|+.|. ...+.+.+.+....+..|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 356789999999999875 4677889987643 2456788999888884 3567888888888889999999
Q ss_pred ccCCCch
Q 014909 92 FVTGGEL 98 (416)
Q Consensus 92 ~~~gg~L 98 (416)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.87 E-value=5.2e-05 Score=75.06 Aligned_cols=78 Identities=14% Similarity=0.101 Sum_probs=45.7
Q ss_pred HhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccC--CcccccchhhccCCC--CCChhhHHHHHHH
Q 014909 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG--TPNYVAPEVLNDRGY--DGSTADLWSCGVI 203 (416)
Q Consensus 128 H~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPEvl~~~~~--~~~~~DIwSlGvi 203 (416)
+...++|+|++|.||+++.++ +.++||+.+.......+-. ...+ ...|++|+....... .....++.++...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla---~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIG---AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQ 305 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHH---HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHH---HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHH
Confidence 356899999999999998876 9999999876432211100 0000 134566655432111 0112344567777
Q ss_pred HHHHhh
Q 014909 204 LFVLLA 209 (416)
Q Consensus 204 l~~ml~ 209 (416)
++..+.
T Consensus 306 ~~~~y~ 311 (420)
T 2pyw_A 306 TWNLFN 311 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 776654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00023 Score=63.32 Aligned_cols=121 Identities=18% Similarity=0.114 Sum_probs=80.1
Q ss_pred chHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCccccc
Q 014909 97 ELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (416)
Q Consensus 97 ~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~-~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 174 (416)
+|.+.+.. +.+++|++++.++.|.+.+|.-+-. ..-..+=+.|..|++..+|+|-+.+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------c
Confidence 67888765 5689999999999999999887622 2212334567899999999987763 2110 1
Q ss_pred CCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCC
Q 014909 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251 (416)
Q Consensus 175 gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L~~ 251 (416)
....+.|||... ...+.+.=|||||+++|..+-=.+| ..-++.+|+++.+||..|...
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~-----------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK-----------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC-----------------TTEEECCCHHHHHHHHHHTTC
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC-----------------cccchhhCHHHHHHHHHHHhc
Confidence 233577888864 2234778999999999987742222 122445899999999999866
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.71 E-value=6.7e-05 Score=70.65 Aligned_cols=132 Identities=15% Similarity=0.127 Sum_probs=75.3
Q ss_pred EeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEEEEEecc-
Q 014909 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFV- 93 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~- 93 (416)
.+.|+.|....+|++ ..+++|+...... ..-...+|+.+++.+...++ .+++.+ +.+.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence 788999999999998 4589998764311 01123468887877753333 355554 333457899999
Q ss_pred CCCchHHH------------------HHhCC-CCC-----HHHHHHHHHH--------------HHHHHHHHH----h--
Q 014909 94 TGGELFDK------------------IVNHG-RMK-----EDEARRYFQQ--------------LINAVDYCH----S-- 129 (416)
Q Consensus 94 ~gg~L~~~------------------i~~~~-~l~-----e~~~~~~~~q--------------ll~al~~LH----~-- 129 (416)
+|..|... +.... .++ ......+..+ +...+..+. .
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 66444211 11100 010 1111111111 111111111 1
Q ss_pred --CCcEeecCCCCcEEeccCCCeEEeecccccc
Q 014909 130 --RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (416)
Q Consensus 130 --~givHrDlkp~NILl~~~~~vkl~DFGla~~ 160 (416)
..++|+|+.|.||+ ..++.+.++||..+..
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 24899999999999 5667889999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.0006 Score=63.60 Aligned_cols=79 Identities=11% Similarity=0.077 Sum_probs=54.8
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCC---CcceEEEEEEeCCEEEE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP---NVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~~~~~~~l 88 (416)
+..-++.+|.|..+.||++... +|+.|.+|+........ ...+..|+..|+.|.-. -+.+.+.+. .-++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 4566788999999999999864 68899999865433211 23477899999888421 244555542 2378
Q ss_pred EEeccCCCch
Q 014909 89 VLEFVTGGEL 98 (416)
Q Consensus 89 V~E~~~gg~L 98 (416)
||||+.++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.0002 Score=68.37 Aligned_cols=135 Identities=16% Similarity=0.206 Sum_probs=71.2
Q ss_pred eEEeecCceE-EEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCC--CCcceEEEEEEeCCEEEEEEecc
Q 014909 17 RTIGEGTFAK-VKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH--PNVVRLYEVMGSKTKIFIVLEFV 93 (416)
Q Consensus 17 ~~LG~G~fg~-V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~~ 93 (416)
+.|+.|+... +|+... .+|..+++|....... ..+..|+.+++.+.. -.+.+++.+..... +++||++
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l 94 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL 94 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence 4566665554 556653 2356777876543210 234567777776642 23456666533333 7899999
Q ss_pred CCCchHHHHHhC--------------------------CCCCHHHHH-------H-HH------------HHHHHHHHHH
Q 014909 94 TGGELFDKIVNH--------------------------GRMKEDEAR-------R-YF------------QQLINAVDYC 127 (416)
Q Consensus 94 ~gg~L~~~i~~~--------------------------~~l~e~~~~-------~-~~------------~qll~al~~L 127 (416)
.|..+.+.+... ..+...... . +. ..+...+..+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 876665443221 011121110 0 00 0111222222
Q ss_pred ------HhCCcEeecCCCCcEEeccC----CCeEEeecccccc
Q 014909 128 ------HSRGVYHRDLKPENLLLDAY----GNLKVSDFGLSAL 160 (416)
Q Consensus 128 ------H~~givHrDlkp~NILl~~~----~~vkl~DFGla~~ 160 (416)
+...++|+|+.|.||+++.+ +.+.|+||+.+..
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 23479999999999999874 6789999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00018 Score=68.16 Aligned_cols=138 Identities=16% Similarity=0.163 Sum_probs=77.4
Q ss_pred EEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-----CCCcceEE-E--EEEeCCEE
Q 014909 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-----HPNVVRLY-E--VMGSKTKI 86 (416)
Q Consensus 15 ~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~~ 86 (416)
-.+.|+.|....+|++... +| .+++|+..... ....+..|..+++.+. -|.++... + +....+..
T Consensus 26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 3567788988999998763 23 68899987531 1234556777777664 23333210 0 11234667
Q ss_pred EEEEeccCCCchH--------------HHHHhC-CCC--------CHHHHHHH---------------HHHHHHHHHHHH
Q 014909 87 FIVLEFVTGGELF--------------DKIVNH-GRM--------KEDEARRY---------------FQQLINAVDYCH 128 (416)
Q Consensus 87 ~lV~E~~~gg~L~--------------~~i~~~-~~l--------~e~~~~~~---------------~~qll~al~~LH 128 (416)
+++|+|++|..+. -.+... ..+ ....-... -..+...++.++
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 9999999985431 011110 000 10000000 011334455555
Q ss_pred h-------CCcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 129 S-------RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 129 ~-------~givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
. .+++|+|+.|.||++++++.+.++||+.+.
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 2 479999999999999886656899999764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00039 Score=69.01 Aligned_cols=73 Identities=16% Similarity=0.224 Sum_probs=49.7
Q ss_pred EeEEeecCceEEEEEEECC-------CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEE
Q 014909 16 GRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIF 87 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~ 87 (416)
.+.|+.|....||++.... .+..+++|+..... . ...+.+|..+++.+...++ .++++.+.+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 4678889999999998653 25789999984321 1 1334578888888853333 567766542 2
Q ss_pred EEEeccCCCc
Q 014909 88 IVLEFVTGGE 97 (416)
Q Consensus 88 lV~E~~~gg~ 97 (416)
+|+||++|..
T Consensus 149 ~v~e~l~G~~ 158 (429)
T 1nw1_A 149 RLEEYIPSRP 158 (429)
T ss_dssp EEECCCCEEE
T ss_pred EEEEEeCCcc
Confidence 8999998743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00028 Score=68.92 Aligned_cols=136 Identities=16% Similarity=0.181 Sum_probs=81.7
Q ss_pred eEEeecCceEEEEEEECC-------CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEE
Q 014909 17 RTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 88 (416)
+.|..|-...+|++.... +++.+++|+.... . .....+.+|..+++.+. +.-..++++.+.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 567778888899988642 3578999986321 1 12345668999998885 3223566766543 28
Q ss_pred EEeccCCCchH----------HHH-------HhC----C-CC--CHHHHHHHHHHHHH-------------------HHH
Q 014909 89 VLEFVTGGELF----------DKI-------VNH----G-RM--KEDEARRYFQQLIN-------------------AVD 125 (416)
Q Consensus 89 V~E~~~gg~L~----------~~i-------~~~----~-~l--~e~~~~~~~~qll~-------------------al~ 125 (416)
||||++|..|. ..+ ... + .. -...+..|+.++-. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999985442 111 111 1 11 13455556655422 233
Q ss_pred HHH----h----CCcEeecCCCCcEEeccC----CCeEEeecccccc
Q 014909 126 YCH----S----RGVYHRDLKPENLLLDAY----GNLKVSDFGLSAL 160 (416)
Q Consensus 126 ~LH----~----~givHrDlkp~NILl~~~----~~vkl~DFGla~~ 160 (416)
.|. + ..++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 333 2 259999999999999876 7899999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0008 Score=63.78 Aligned_cols=135 Identities=18% Similarity=0.142 Sum_probs=77.2
Q ss_pred eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCC--cceEEEE-----EEeCCEEEEE
Q 014909 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEV-----MGSKTKIFIV 89 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~-----~~~~~~~~lV 89 (416)
..|+ |....||++.. .+|+.+++|+...... . ...+..|..+++.+...+ +.+++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88889998764 3466799999864321 1 245667888777764212 3333332 1235567899
Q ss_pred EeccCCCchH----H-------H---HHh---CC------CCCHHH----H------------------HHHHHHHHHHH
Q 014909 90 LEFVTGGELF----D-------K---IVN---HG------RMKEDE----A------------------RRYFQQLINAV 124 (416)
Q Consensus 90 ~E~~~gg~L~----~-------~---i~~---~~------~l~e~~----~------------------~~~~~qll~al 124 (416)
|++++|..+. + . +.. .. ..+... . ...+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999885431 0 0 111 00 011110 0 11112222222
Q ss_pred HHH----HhCCcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 125 DYC----HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 125 ~~L----H~~givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
.-+ ....++|+|++|.||+++ + .+.++||+.+.
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 222 234689999999999998 4 89999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00067 Score=65.66 Aligned_cols=74 Identities=15% Similarity=0.053 Sum_probs=44.9
Q ss_pred EeEEeecCceEEEEEEECC--------CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCEE
Q 014909 16 GRTIGEGTFAKVKFARNSE--------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMGSKTKI 86 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~--------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~ 86 (416)
.+.|+.|....+|++.... .+..+++|+...... .......|..+++.+...+ +.++++.. . -
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence 4678888889999998643 136789998754321 1112457888888775334 34666554 2 2
Q ss_pred EEEEeccCCCc
Q 014909 87 FIVLEFVTGGE 97 (416)
Q Consensus 87 ~lV~E~~~gg~ 97 (416)
++||||++|..
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999999854
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0028 Score=60.70 Aligned_cols=31 Identities=19% Similarity=0.319 Sum_probs=27.6
Q ss_pred CCcEeecCCCCcEEeccCCCeEEeecccccc
Q 014909 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (416)
Q Consensus 130 ~givHrDlkp~NILl~~~~~vkl~DFGla~~ 160 (416)
.+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999987764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0062 Score=60.83 Aligned_cols=75 Identities=13% Similarity=0.192 Sum_probs=49.0
Q ss_pred EeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEEEEEeccC
Q 014909 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFVT 94 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~ 94 (416)
.+.|+.|-...+|++.....+..+++|+..... .... ...+|..+++.|...++ .++++.+. + .+||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 467888999999999876545789999875421 1111 12588999998875555 46777663 2 25999998
Q ss_pred CCch
Q 014909 95 GGEL 98 (416)
Q Consensus 95 gg~L 98 (416)
|..|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 8443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.93 E-value=0.013 Score=57.86 Aligned_cols=75 Identities=15% Similarity=0.125 Sum_probs=48.3
Q ss_pred EeEEeecCceEEEEEEECCC-------CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCEEE
Q 014909 16 GRTIGEGTFAKVKFARNSET-------GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMGSKTKIF 87 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~-------~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~ 87 (416)
++.|..|....+|++..... +..+++|+..... . ..-...+|..+++.+...+ ..++++.+. + +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---G-KFYDSKVELDVFRYLSNINIAPNIIADFP--E--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---c-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--C
Confidence 45677788899999987521 5789999864321 1 1112457888888875323 345665432 2 6
Q ss_pred EEEeccCCCch
Q 014909 88 IVLEFVTGGEL 98 (416)
Q Consensus 88 lV~E~~~gg~L 98 (416)
.||||++|..|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998553
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.13 E-value=0.16 Score=49.53 Aligned_cols=29 Identities=31% Similarity=0.448 Sum_probs=24.9
Q ss_pred cEeecCCCCcEEe------ccCCCeEEeecccccc
Q 014909 132 VYHRDLKPENLLL------DAYGNLKVSDFGLSAL 160 (416)
Q Consensus 132 ivHrDlkp~NILl------~~~~~vkl~DFGla~~ 160 (416)
++|+|+.+.|||+ ++++.+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4457799999998764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.45 E-value=2.7 Score=37.08 Aligned_cols=82 Identities=16% Similarity=0.108 Sum_probs=63.2
Q ss_pred CCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHH-HHHhCCcEeecCCCCcEEeccC
Q 014909 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD-YCHSRGVYHRDLKPENLLLDAY 147 (416)
Q Consensus 69 ~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~-~LH~~givHrDlkp~NILl~~~ 147 (416)
.||++ -..+-.+++.+.+.++.-+++.-+..++ .++..+.++++.+|+.... ++ ..-+|-=|.|+||+++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence 58888 5555678888888777766665566664 4788888888888887666 43 455677799999999999
Q ss_pred CCeEEeeccc
Q 014909 148 GNLKVSDFGL 157 (416)
Q Consensus 148 ~~vkl~DFGl 157 (416)
+.+++.-.|+
T Consensus 121 ~~p~i~hRGi 130 (219)
T 4ano_A 121 LEPFFLHVGV 130 (219)
T ss_dssp CCEEESCCEE
T ss_pred CcEEEEEcCC
Confidence 9999997775
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.98 E-value=1.6 Score=38.53 Aligned_cols=138 Identities=18% Similarity=0.266 Sum_probs=88.0
Q ss_pred EEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHH
Q 014909 40 ALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 119 (416)
Q Consensus 40 aiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~q 119 (416)
-++.+.++++...+. .|+.+|. ..||+.+.. .+-.+.+.+.+.++.-+.+-=+..+ ..++....++++.+
T Consensus 20 ~~~~~~ks~ik~~~~-----~el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~n 89 (215)
T 4ann_A 20 DMREIPKSSIKPEHF-----HLMYLLE-QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLN 89 (215)
T ss_dssp CEEEEEGGGSCGGGG-----GGGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHH
T ss_pred HHHHhcHhhccccCH-----HHHHHHh-ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHH
Confidence 355666665543322 2333322 358999877 5667777777777665533334444 34788889999999
Q ss_pred HHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhH-H
Q 014909 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL-W 198 (416)
Q Consensus 120 ll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DI-w 198 (416)
|+....++ ..-+|-=|.|+||+++.++.+++.--|+-.. ++|. .....|. -
T Consensus 90 i~~l~~~~--~~r~tf~L~P~NL~f~~~~~p~i~~RGik~~-------------------l~P~-------~~~ee~fL~ 141 (215)
T 4ann_A 90 IKNLEEVN--RTRYTFVLAPDELFFTRDGLPIAKTRGLQNV-------------------VDPL-------PVSEAEFLT 141 (215)
T ss_dssp GGGGGGGG--GSSEECCCSGGGEEECTTSCEEESCCEETTT-------------------BSCC-------CCCHHHHHH
T ss_pred HHHHHHHh--cCceEEEEecceEEEcCCCCEEEEEccCccC-------------------CCCC-------CCCHHHHHH
Confidence 98877444 4456778999999999999999987775321 1111 1112232 3
Q ss_pred HHHHHHHHHhhCCCCCC
Q 014909 199 SCGVILFVLLAGYLPFD 215 (416)
Q Consensus 199 SlGvil~~ml~G~~Pf~ 215 (416)
..=|++..+++++..|.
T Consensus 142 qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 142 RYKALVICAFNEKQSFD 158 (215)
T ss_dssp HHHHHHHHHHCTTCCHH
T ss_pred HHHHHHHHHHcCCCCHH
Confidence 45577888888888774
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.60 E-value=0.063 Score=53.56 Aligned_cols=63 Identities=11% Similarity=0.130 Sum_probs=17.6
Q ss_pred EEeEEeecCceEEEEEEECCCCCeEEE------EEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 014909 15 VGRTIGEGTFAKVKFARNSETGEPVAL------KILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (416)
Q Consensus 15 ~~~~LG~G~fg~V~~a~~~~~~~~vai------K~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 81 (416)
+.+.|| ||.||++.......+||+ |........ .+....+.+|..+++.++|||+++.+.+..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~-~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVS-EKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCcccccccccc-ccccccccccccccccccccccCCCcceEE
Confidence 345566 999999988665567888 655432222 223456778999999999999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 416 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-91 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-89 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-86 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-82 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-82 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-81 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-81 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-80 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-78 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-77 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-77 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-77 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-76 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-76 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-74 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-74 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-74 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-73 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-73 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-72 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-72 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-71 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-71 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-70 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-68 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-67 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-66 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-65 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-63 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-63 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-63 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-63 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-62 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-60 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-60 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-60 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-59 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-57 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-56 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-53 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-52 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-49 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-42 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-23 | |
| d1ul7a_ | 102 | d.129.6.1 (A:) Map/microtubule affinity-regulating | 1e-18 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 274 bits (703), Expect = 1e-91
Identities = 96/260 (36%), Positives = 150/260 (57%), Gaps = 5/260 (1%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+E+GR +G+G F V AR ++ +ALK+L K ++ K + Q++REV ++HP
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N++RLY T+++++LE+ G ++ ++ + E Y +L NA+ YCHS+
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+KPENLLL + G LK++DFG S + T CGT +Y+ PE++ R +D
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
DLWS GV+ + L G PF+ + YK+IS EFT P +++ AR LI+R+L
Sbjct: 183 EK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241
Query: 252 NPMTRITIPEILEDEWFKKD 271
NP R + E+LE W +
Sbjct: 242 NPSQRPMLREVLEHPWITAN 261
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 268 bits (686), Expect = 7e-89
Identities = 107/267 (40%), Positives = 157/267 (58%), Gaps = 5/267 (1%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
V +++ +T+GEG + +V+ A N T E VA+KI+D ++ + E IK+E+ K++
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 61
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
H NVV+ Y ++ LE+ +GGELFD+I M E +A+R+F QL+ V Y H
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
G+ HRD+KPENLLLD NLK+SDFGL+ + + + LL+ CGT YVAPE+L R
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFD-DSNLMNLYKKISAAEFTCPPW--LSFTARKLIA 246
+ D+WSCG++L +LAG LP+D S+ Y + PW + L+
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 247 RILDPNPMTRITIPEILEDEWFKKDYK 273
+IL NP RITIP+I +D W+ K K
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKPLK 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 262 bits (670), Expect = 3e-86
Identities = 85/287 (29%), Positives = 146/287 (50%), Gaps = 8/287 (2%)
Query: 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
QP+ K+R ++ G+ +GEG+F+ V AR T A+KIL+K ++K + RE
Sbjct: 1 QPR-KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRER 59
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN 122
M + HP V+LY K++ L + GEL I G E R Y ++++
Sbjct: 60 DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 119
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
A++Y H +G+ HRDLKPEN+LL+ +++++DFG + + ++ GT YV+P
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242
E+L ++ ++DLW+ G I++ L+AG PF N +++KI E+ P AR
Sbjct: 180 ELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 238
Query: 243 KLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVE 289
L+ ++L + R+ E+ K P F + +++
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAH---PFF---ESVTWENLH 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 253 bits (648), Expect = 4e-82
Identities = 72/280 (25%), Positives = 132/280 (47%), Gaps = 14/280 (5%)
Query: 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
+ K Y++ +G G F V TG K ++ L +K E+
Sbjct: 21 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEI 77
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLI 121
+ M + HP ++ L++ K ++ ++LEF++GGELFD+I +M E E Y +Q
Sbjct: 78 SIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 137
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAY--GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
+ + H + H D+KPEN++ + ++K+ DFG L+ ++ D ++ T T +
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG---LATKLNPDEIVKVTTATAEF 194
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----P 235
APE+++ D+W+ GV+ +VLL+G PF + + + + ++
Sbjct: 195 AAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 253
Query: 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
+S A+ I +L P R+T+ + LE W K D+
Sbjct: 254 SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 293
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 252 bits (644), Expect = 6e-82
Identities = 70/282 (24%), Positives = 120/282 (42%), Gaps = 10/282 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ R IG G+F V FAR+ E VA+K + ++ + I +EV ++ ++HP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N ++ + ++V+E+ G V+ ++E E + + Y HS
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL--NDRG 189
+ HRD+K N+LL G +K+ DFG +++ ++ GTP ++APEV+ D G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEG 189
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW--LSFTARKLIAR 247
D+WS G+ L P + N M+ I+ E S R +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249
Query: 248 ILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVE 289
L P R T +L+ + ++ P V + D V
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVR 291
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (640), Expect = 1e-81
Identities = 80/285 (28%), Positives = 140/285 (49%), Gaps = 18/285 (6%)
Query: 6 IKRRVG---KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
+ R + +E+ +G+G F KV A+N ET A K++D + + E E+
Sbjct: 4 VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEI 60
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLI 121
+ HPN+V+L + + ++I++EF GG + ++ R + E + + +Q +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+A++Y H + HRDLK N+L G++K++DFG+SA + R + GTP ++A
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMA 178
Query: 182 PEVL-----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTC 233
PEV+ DR YD AD+WS G+ L + P + N M + KI+ +E
Sbjct: 179 PEVVMCETSKDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 237
Query: 234 PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFE 278
P S + + + L+ N R T ++L+ + D P+ E
Sbjct: 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRE 282
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (637), Expect = 4e-81
Identities = 76/279 (27%), Positives = 135/279 (48%), Gaps = 14/279 (5%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
KY IG+G V A + TG+ VA++ ++ ++ E I E+ M+ K+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKN 76
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
PN+V + ++++V+E++ GG L D +V M E + ++ + A+++ HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
V HRD+K +N+LL G++K++DFG A + T GTP ++APEV+ + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIAR 247
D+WS G++ ++ G P+ + N + I+ E P LS R + R
Sbjct: 194 G-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 248 ILDPNPMTRITIPEILEDEWFKK----DYKPPVFEEKKD 282
LD + R + E+L+ ++ K P+ K+
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKE 291
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 249 bits (638), Expect = 1e-80
Identities = 81/303 (26%), Positives = 140/303 (46%), Gaps = 14/303 (4%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ K + Y++ +G G F V TG A K + E +++E
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKE 73
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQL 120
+ TM +++HP +V L++ ++ ++ EF++GGELF+K+ + H +M EDEA Y +Q+
Sbjct: 74 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 133
Query: 121 INAVDYCHSRGVYHRDLKPENLLL--DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
+ + H H DLKPEN++ LK+ DFGL+A + + T GT
Sbjct: 134 CKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAE 190
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT----CP 234
+ APEV + G D+WS GV+ ++LL+G PF N + + + ++
Sbjct: 191 FAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 249
Query: 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKD 294
+S + I ++L +P TR+TI + LE W P + + + K
Sbjct: 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKT 309
Query: 295 SEE 297
+
Sbjct: 310 KYD 312
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 240 bits (613), Expect = 7e-78
Identities = 87/275 (31%), Positives = 138/275 (50%), Gaps = 19/275 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH------KMAEQIKREVATM 65
YE +G G + V+ + T + A+KI+D ++ E +EV +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 66 -KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
K+ HPN+++L + + T F+V + + GELFD + + E E R+ + L+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
H + HRDLKPEN+LLD N+K++DFG S Q+ L CGTP+Y+APE+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEI 180
Query: 185 L-----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW- 236
+ ++ G D+WS GVI++ LLAG PF M + + I + +F P W
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 237 -LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
S T + L++R L P R T E L +F++
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (612), Expect = 1e-77
Identities = 86/271 (31%), Positives = 135/271 (49%), Gaps = 16/271 (5%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
R YEV TIG G++ + + R G+ + K LD + + + + + EV ++ +
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLREL 60
Query: 69 KHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHGR----MKEDEARRYFQQLIN 122
KHPN+VR Y+ + +T ++IV+E+ GG+L I + + E+ R QL
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 123 AVDYCHSRG-----VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
A+ CH R V HRDLKP N+ LD N+K+ DFGL+ + D GTP
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTP 178
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPW 236
Y++PE +N Y+ +D+WS G +L+ L A PF + L KI +F P
Sbjct: 179 YYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237
Query: 237 LSFTARKLIARILDPNPMTRITIPEILEDEW 267
S ++I R+L+ R ++ EILE+
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 240 bits (614), Expect = 2e-77
Identities = 97/271 (35%), Positives = 149/271 (54%), Gaps = 13/271 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y+ +G G F++V A + T + VA+K + K+ + ++ E+A + +KHP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHP 67
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V L ++ S ++++++ V+GGELFD+IV G E +A R Q+++AV Y H G
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPENLL D + +SDFG LS+ +L T CGTP YVAPEVL +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFG---LSKMEDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKL 244
Y + D WS GVI ++LL GY PF D N L+++I AE+ +S +A+
Sbjct: 185 PYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
I +++ +P R T + L+ W D
Sbjct: 244 IRHLMEKDPEKRFTCEQALQHPWIAGDTALD 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 7e-77
Identities = 85/285 (29%), Positives = 145/285 (50%), Gaps = 15/285 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHP 71
+ + + +G+G+F KV A +T + A+K L K+ VL E E + L +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+ ++ +K +F V+E++ GG+L I + + A Y ++I + + HS+G
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ +RDLK +N+LLD G++K++DFG+ + D +T CGTP+Y+APE+L + Y+
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
S D WS GV+L+ +L G PF + L+ I P WL A+ L+ ++
Sbjct: 182 HS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240
Query: 252 NPMTRITIP-EILEDEWFK---------KDYKPPVFEEKKDTNLD 286
P R+ + +I + F+ K+ PP F K + D
Sbjct: 241 EPEKRLGVRGDIRQHPLFREINWEELERKEIDPP-FRPKVKSPFD 284
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (610), Expect = 1e-76
Identities = 66/271 (24%), Positives = 125/271 (46%), Gaps = 15/271 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY + +G G F V + + + K + K +K+E++ + + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHR 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSR 130
N++ L+E S ++ ++ EF++G ++F++I + E E Y Q+ A+ + HS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 131 GVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ H D++PEN++ +K+ +FG ++Q++ P Y APEV
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFG---QARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKL 244
+ D+WS G +++VLL+G PF + + I AE+T +S A
Sbjct: 179 VVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
+ R+L +R+T E L+ W K+ +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERV 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 237 bits (606), Expect = 3e-76
Identities = 101/317 (31%), Positives = 170/317 (53%), Gaps = 31/317 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+++ RT+G G+F +V R+ G A+K+L KE V++ K E E + +V HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
++R++ +IF++++++ GGELF + R A+ Y ++ A++Y HS+ +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPEN+LLD G++K++DFG + V +T CGTP+Y+APEV++ + Y+
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNK 180
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
S D WS G++++ +LAGY PF DSN M Y+KI AE PP+ + + L++R++ +
Sbjct: 181 S-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239
Query: 253 PMTRI-----TIPEILEDEWFKKD-------------YKPPVFEEKKDT-NLDDVEAVFK 293
R+ ++ WFK+ Y+PP+ + + DT D
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYP---- 295
Query: 294 DSEEHHVTEQKEEQPVA 310
EE + E P A
Sbjct: 296 --EEDINYGVQGEDPYA 310
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 234 bits (598), Expect = 2e-74
Identities = 91/368 (24%), Positives = 156/368 (42%), Gaps = 36/368 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK--- 69
+ V R IG G F +V R ++TG+ A+K LDK+++ + E + LV
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
P +V + + K+ +L+ + GG+L + HG E + R Y ++I +++ H+
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
R V +RDLKP N+LLD +G++++SD GL+ H + GT Y+APEVL
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEVLQKGV 181
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEFTCPPWLSFTARKLIA 246
S+AD +S G +LF LL G+ PF + + P S R L+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 247 RILDPNPMTRITIP-----EILEDEWFK---------KDYKPPVFEEKKDTNLDDVEAVF 292
+L + R+ E+ E +F+ + Y PP+ + + N D +
Sbjct: 242 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIG 301
Query: 293 KDSEEHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQDFKRETRFTSRCPANEIIN 352
EE T+ + + + +++E T N +
Sbjct: 302 SFDEE--DTKGIKLLDSDQELYRNFP----------LTISERWQQEVAETVFDTINAETD 349
Query: 353 KIEEAAKP 360
++E K
Sbjct: 350 RLEARKKT 357
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (594), Expect = 2e-74
Identities = 66/310 (21%), Positives = 117/310 (37%), Gaps = 52/310 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+E +G G V + +G +A K++ E +K + QI RE+ + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR- 130
+V Y S +I I +E + GG L + GR+ E + +I + Y +
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
+ HRD+KP N+L+++ G +K+ DFG+S D + ++ GT +Y++PE L Y
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTHY 180
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSN-------------------------------- 218
+D+WS G+ L + G P +
Sbjct: 181 S-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 219 ----------LMNLYKKISAAEFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDE 266
+ L I P S + + + L NP R + +++
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 267 WFKKDYKPPV 276
+ K+ V
Sbjct: 300 FIKRSDAEEV 309
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 4e-74
Identities = 97/287 (33%), Positives = 144/287 (50%), Gaps = 24/287 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK---MAEQIKREVATMKLV 68
Y+ G +G G FA VK R TG A K + K + + E I+REV+ +K +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
+HPNV+ L+EV +KT + ++LE V GGELFD + + E+EA + +Q++N V Y H
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 129 SRGVYHRDLKPENLLLDAYG----NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
S + H DLKPEN++L +K+ DFG L+ ++ GTP +VAPE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEI 187
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT----CPPWLSFT 240
+N AD+WS GVI ++LL+G PF +SA + S
Sbjct: 188 VNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFK---------KDYKPPVFE 278
A+ I R+L +P R+TI + L+ W K + P FE
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQFE 293
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 2e-73
Identities = 83/282 (29%), Positives = 131/282 (46%), Gaps = 20/282 (7%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM---AEQIKREVATMKL 67
+Y+VG +G G F V PVA+K ++K+++ ++ EV +K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 68 VK--HPNVVRLYEVMGSKTKIFIVLEFVTGG-ELFDKIVNHGRMKEDEARRYFQQLINAV 124
V V+RL + ++LE +LFD I G ++E+ AR +F Q++ AV
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 125 DYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+CH+ GV HRD+K EN+L+D G LK+ DFG AL D + GT Y PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPE 179
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243
+ Y G +A +WS G++L+ ++ G +PF+ +I + +S +
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQH 233
Query: 244 LIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNL 285
LI L P R T EI W + P +E + +L
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLP---QETAEIHL 272
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 2e-73
Identities = 68/270 (25%), Positives = 128/270 (47%), Gaps = 18/270 (6%)
Query: 11 GKY-EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
G++ + IG G+F V ++ET VA L K+ K + ++ K E +K ++
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQ 66
Query: 70 HPNVVRLYEVMGSKTK----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
HPN+VR Y+ S K I +V E +T G L + MK R + +Q++ +
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126
Query: 126 YCHSRG--VYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ H+R + HRDLK +N+ + G++K+ D GL+ L GTP ++AP
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAP 182
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKISAA--EFTCPPWLSF 239
E+ YD S D+++ G+ + + P+ + N +Y+++++ +
Sbjct: 183 EMYE-EKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 240 TARKLIARILDPNPMTRITIPEILEDEWFK 269
+++I + N R +I ++L +F+
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 1e-72
Identities = 94/299 (31%), Positives = 150/299 (50%), Gaps = 21/299 (7%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
K + ++ + +G+GTF KV R TG A+KIL KE ++ E ++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+HP + L + ++ V+E+ GGELF + E+ AR Y ++++A++Y
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
HSR V +RD+K ENL+LD G++K++DFGL + + D + T CGTP Y+APEVL
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246
D Y + D W GV+++ ++ G LPF + + L++ I E P LS A+ L+A
Sbjct: 179 DNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA 237
Query: 247 RILDPNPMTRI-----TIPEILEDEWFKK-------------DYKPPVFEEKKDTNLDD 287
+L +P R+ E++E +F +KP V E DD
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDD 296
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 4e-72
Identities = 94/321 (29%), Positives = 145/321 (45%), Gaps = 25/321 (7%)
Query: 3 QPKIKRRVGKYEV-GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
Q K + Y+V + +G G KV N T E ALK+L + +RE
Sbjct: 3 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARRE 54
Query: 62 VATM-KLVKHPNVVRLYEV----MGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEAR 114
V + + P++VR+ +V + + IV+E + GGELF +I + G E EA
Sbjct: 55 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 114
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174
+ + A+ Y HS + HRD+KPENLL + + +++ L T C
Sbjct: 115 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 174
Query: 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA----- 229
TP YVAPEVL YD S D+WS GVI+++LL GY PF ++ + + +
Sbjct: 175 YTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233
Query: 230 -EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLD 286
EF P W +S + LI +L P R+TI E + W + K P L
Sbjct: 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLK 293
Query: 287 DVEAVFKDSEEHHVTEQKEEQ 307
+ + ++D +E + +
Sbjct: 294 EDKERWEDVKEEMTSALATMR 314
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 224 bits (572), Expect = 1e-71
Identities = 65/268 (24%), Positives = 119/268 (44%), Gaps = 10/268 (3%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+YE+G +G G ++V AR+ VA+K+L + + +RE + H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 71 PNVVRLYEVMGSKTK----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
P +V +Y+ ++T +IV+E+V G L D + G M A A+++
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVL 185
H G+ HRD+KP N+++ A +KV DFG++ ++ GT Y++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241
D +D++S G +L+ +L G PF + +++ + + P LS
Sbjct: 187 RGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFK 269
++ + L NP R + + +
Sbjct: 246 DAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 8e-71
Identities = 58/263 (22%), Positives = 119/263 (45%), Gaps = 14/263 (5%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
G+ VG+ IG G+F V + VA+K+L+ ++ + K EV ++ +H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQL-QAFKNEVGVLRKTRH 63
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHS 129
N++ + ++ IV ++ G L+ + + + + + +Q +DY H+
Sbjct: 64 VNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ + HRDLK N+ L +K+ DFGL+ + + G+ ++APEV+ +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 190 YDGST--ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF------TA 241
+ + +D+++ G++L+ L+ G LP+ + N + + + P
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 242 RKLIARILDPNPMTRITIPEILE 264
++L+A L R P+IL
Sbjct: 243 KRLMAECLKKKRDERPLFPQILA 265
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 222 bits (566), Expect = 8e-70
Identities = 92/306 (30%), Positives = 156/306 (50%), Gaps = 24/306 (7%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ + ++ +++ +T+G G+F +V ++ E+G A+KILDK+KV+K K E E
Sbjct: 32 TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
++ V P +V+L + +++V+E+V GGE+F + GR E AR Y Q++
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+Y HS + +RDLKPENLL+D G ++V+DFG + R G T CGTP +A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA-----KRVKGRTWTLCGTPEALA 206
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PE++ +GY+ + D W+ GV+++ + AGY PF + +Y+KI + + P S
Sbjct: 207 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 242 RKLIARILDPNPMTRI-----TIPEILEDEWFKKD-------------YKPPVFEEKKDT 283
+ L+ +L + R + +I +WF + P +
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTS 325
Query: 284 NLDDVE 289
N DD E
Sbjct: 326 NFDDYE 331
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 7e-68
Identities = 79/309 (25%), Positives = 118/309 (38%), Gaps = 43/309 (13%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
V KYE IG+GTF +V AR+ +TG+ VALK + E K RE+ ++L
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQL 65
Query: 68 VKHPNVVRLYEV--------MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 119
+KH NVV L E+ K I++V +F + E +R Q
Sbjct: 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 125
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--GLLHTTCGTP 177
L+N + Y H + HRD+K N+L+ G LK++DFGL+ ++ T
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-- 235
Y PE+L G DLW G I+ + + + IS + P
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
Query: 236 ------------------------------WLSFTARKLIARILDPNPMTRITIPEILED 265
A LI ++L +P RI + L
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305
Query: 266 EWFKKDYKP 274
++F D P
Sbjct: 306 DFFWSDPMP 314
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 8e-67
Identities = 73/337 (21%), Positives = 136/337 (40%), Gaps = 42/337 (12%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+Y IGEG + V A ++ VA+K + + ++ RE+ + +H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 71 PNVVRLYEVMGSKT----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
N++ + +++ + T K ++ + G +L+ ++ + D + Q++ + Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK-LLKTQHLSNDHICYFLYQILRGLKY 124
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVL 185
HS V HRDLKP NLLL+ +LK+ DFGL+ ++ D T T Y APE++
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----------- 234
+ + D+WS G IL +L+ F + ++ I +
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 235 --------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274
P A L+ ++L NP RI + + L + ++ Y P
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304
Query: 275 ---PVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQP 308
P+ E +++ + + +E E QP
Sbjct: 305 SDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 341
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 4e-66
Identities = 73/291 (25%), Positives = 113/291 (38%), Gaps = 32/291 (10%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK--MAEQIKREVATMKLVKHP 71
E +GEG FA V AR+ T + VA+K + + K + RE+ ++ + HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N++ L + G K+ I +V +F+ N + + Y + ++Y H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ HRDLKP NLLLD G LK++DFGL+ + T Y APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLA--KSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----------------- 234
G D+W+ G IL LL + ++ +I T
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 235 -----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274
LI + NP RIT + L+ ++F P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 5e-65
Identities = 60/258 (23%), Positives = 116/258 (44%), Gaps = 18/258 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ ++ +TIG+G F V G VA+K + + A+ E + M ++H
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHS 60
Query: 72 NVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCH 128
N+V+L V + K ++IV E++ G L D + + GR + D ++ + A++Y
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
HRDL N+L+ KVSDFGL+ + +D T + APE L ++
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREK 175
Query: 189 GYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIA 246
+ +D+WS G++L+ + + G +P+ L ++ ++ P +++
Sbjct: 176 KFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234
Query: 247 RILDPNPMTRITIPEILE 264
+ R + ++ E
Sbjct: 235 NCWHLDAAMRPSFLQLRE 252
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 203 bits (518), Expect = 2e-63
Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 33/288 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY IGEGT+ V A+N+ GE ALK + EK + RE++ +K +KH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELKHS 60
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V+LY+V+ +K ++ +V E + V G ++ A+ + QL+N + YCH R
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRDLKP+NLL++ G LK++DFGL+ T Y AP+VL
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT------------------- 232
+T D+WS G I ++ G F + + +I T
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 233 ----------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
L + L++++L +P RIT + LE +FK+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (518), Expect = 2e-63
Identities = 88/294 (29%), Positives = 134/294 (45%), Gaps = 34/294 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KYE IGEGT+ V A+N ET E VALK + + + RE+ +K +KH
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHK 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+VRL++V+ S K+ +V EF +G + + + + QL+ + +CHSR
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRDLKP+NLL++ G LK+++FGL+ T Y P+VL
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 192 GSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKISAAEFT------------------ 232
++ D+WS G I L P F +++ + K+I T
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 233 -----------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
P L+ T R L+ +L NP+ RI+ E L+ +F D+ PP
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF-SDFCPP 292
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 3e-63
Identities = 65/260 (25%), Positives = 103/260 (39%), Gaps = 10/260 (3%)
Query: 13 YEVGRTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+ +G+G+F V+ S VA+K L + + + + + REV M +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCH 128
H N++RLY V + +V E G L D++ H G RY Q+ + Y
Sbjct: 70 HRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLND 187
S+ HRDL NLLL +K+ DFGL Q D ++ + APE L
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 188 RGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE--FTCPPWLSFTARKL 244
R + + +D W GV L+ + G P+ N + KI P +
Sbjct: 189 RTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 245 IARILDPNPMTRITIPEILE 264
+ + P R T + +
Sbjct: 248 MVQCWAHKPEDRPTFVALRD 267
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 3e-63
Identities = 79/293 (26%), Positives = 129/293 (44%), Gaps = 33/293 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++ IGEGT+ V ARN TGE VALK + + + RE++ +K + HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHP 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFV-TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
N+V+L +V+ ++ K+++V EF+ + F + + Y QL+ + +CHS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
V HRDLKP+NLL++ G +K++DFGL+ T Y APE+L Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP---------------- 234
+ D+WS G I ++ F + ++ +I T
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 235 -------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274
P L R L++++L +P RI+ L +F+ KP
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 5e-63
Identities = 55/261 (21%), Positives = 103/261 (39%), Gaps = 11/261 (4%)
Query: 17 RTIGEGTFAKVKFA--RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
+ +G G F VK + + + VA+KIL E + +++ E M+ + +P +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIV 71
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
R+ + ++ +V+E G L + + +K+ Q+ + Y H
Sbjct: 72 RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYDGS 193
RDL N+LL K+SDFGLS + + T + APE +N +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190
Query: 194 TADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDP 251
+D+WS GV+++ + G P+ + + E CP L+
Sbjct: 191 -SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 252 NPMTRITIPEI---LEDEWFK 269
+ R + L + ++
Sbjct: 250 DVENRPGFAAVELRLRNYYYD 270
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 3e-62
Identities = 83/336 (24%), Positives = 142/336 (42%), Gaps = 47/336 (13%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + +G G + V A + TG VA+K L + A++ RE+ +K ++H
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHE 77
Query: 72 NVVRLYEV------MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
NV+ L +V + T ++V+ F+ G K++ H ++ ED + Q++ +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
Y H+ G+ HRDLKP NL ++ LK+ DFGL+ + D + T Y APEV+
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RQADSEMTGYVVTRWYRAPEVI 190
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW--------- 236
+ T D+WS G I+ ++ G F S+ ++ K+I T P
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 237 ----------------------LSFTARKLIARILDPNPMTRITIPEILEDEWFKK--DY 272
S A L+ ++L + R+T E L +F+ D
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310
Query: 273 KPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQP 308
+ +K D + DDV+ + + E +P
Sbjct: 311 EDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 4e-62
Identities = 80/336 (23%), Positives = 131/336 (38%), Gaps = 53/336 (15%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
Y + IG G+F V A+ ++GE VA+K + ++K RE+ M+ + H N
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCN 74
Query: 73 VVRLYEVM------GSKTKIFIVLEFVTGG---ELFDKIVNHGRMKEDEARRYFQQLINA 123
+VRL + + +VL++V + + Y QL +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ Y HS G+ HRD+KP+NLLLD LK+ DFG ++Q+ + + Y AP
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG---SAKQLVRGEPNVSYICSRYYRAP 191
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP-------- 234
E++ S+ D+WS G +L LL G F + ++ +I T
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 235 ---------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273
P A L +R+L+ P R+T E +F +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311
Query: 274 PPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQPV 309
P V K N D A+F + + + +
Sbjct: 312 PNV----KLPNGRDTPALFNFTTQELSSNPPLATIL 343
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 3e-61
Identities = 61/260 (23%), Positives = 100/260 (38%), Gaps = 13/260 (5%)
Query: 19 IGEGTFAKVKFA--RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G F V+ R + VA+K+L + + E++ RE M + +P +VRL
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
V + +V+E GG L +V + Q+ + Y + HR
Sbjct: 75 IGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 136 DLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
DL N+LL K+SDFGLS AL + APE +N R +
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR- 192
Query: 195 ADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPN 252
+D+WS GV ++ L+ G P+ + I + CPP L++
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 252
Query: 253 PMTRITIPEI---LEDEWFK 269
R + + ++
Sbjct: 253 WEDRPDFLTVEQRMRACYYS 272
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-60
Identities = 56/256 (21%), Positives = 107/256 (41%), Gaps = 10/256 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G G F VK+ + VA+K++ + + + ++ E M + H
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIV-NHGRMKEDEARRYFQQLINAVDYCHSRG 131
+V+LY V + IFI+ E++ G L + + R + + + + A++Y S+
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
HRDL N L++ G +KVSDFGLS + + + PEVL +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 192 GSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFTCPPWLSFTARKLIARIL 249
+D+W+ GV+++ + + G +P++ + I P S ++
Sbjct: 180 SK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238
Query: 250 DPNPMTRITIPEILED 265
R T +L +
Sbjct: 239 HEKADERPTFKILLSN 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-60
Identities = 52/285 (18%), Positives = 110/285 (38%), Gaps = 35/285 (12%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGE-----PVALKILDKEKVLKHKMAEQIKREVATM- 65
E G+ +G G F KV A + VA+K+L ++ E + E+ M
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMT 95
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-------------------- 105
+L H N+V L I+++ E+ G+L + + +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 106 ---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162
+ ++ + Q+ +++ + HRDL N+L+ +K+ DFGL+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 221
+ + ++APE L + Y +D+WS G++L+ + + G P+ +
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 222 LYKKI--SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
+ K+ + + P + + ++ + R + P +
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 3e-60
Identities = 77/280 (27%), Positives = 136/280 (48%), Gaps = 16/280 (5%)
Query: 7 KRRVG--KYEVGRTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVL-KHKMAEQIKR 60
+VG +E+ + +G G + KV R +TG+ A+K+L K ++ K K E +
Sbjct: 18 AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 77
Query: 61 EVATMKLVKH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 119
E ++ ++ P +V L+ ++TK+ ++L+++ GGELF + R E E + Y +
Sbjct: 78 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 137
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
++ A+++ H G+ +RD+K EN+LLD+ G++ ++DFGLS +
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPP 235
V D WS GV+++ LL G PF + ++I +E P
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 236 WLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 270
+S A+ LI R+L +P R+ EI E +F+K
Sbjct: 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 195 bits (496), Expect = 5e-60
Identities = 59/261 (22%), Positives = 103/261 (39%), Gaps = 12/261 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
++ + IG G F +V G+ VA+K L K E + M
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD 85
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARRYFQQLINAVDYCH 128
HPNV+ L V+ T + I+ EF+ G L N G+ + + + + Y
Sbjct: 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT---CGTPNYVAPEVL 185
HRDL N+L+++ KVSDFGLS + D + + APE +
Sbjct: 146 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205
Query: 186 NDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243
R + + +D+WS G++++ +++ G P+ D ++ I P +
Sbjct: 206 QYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 264
Query: 244 LIARILDPNPMTRITIPEILE 264
L+ + R +I+
Sbjct: 265 LMLDCWQKDRNHRPKFGQIVN 285
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 6e-60
Identities = 56/264 (21%), Positives = 105/264 (39%), Gaps = 6/264 (2%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKE--KVLKHKMAEQIKREVATMKLVKH 70
++ + +G G F V GE V + + KE + K ++I E M V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
P+V RL + + T I G L + + + Q+ ++Y R
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
+ HRDL N+L+ ++K++DFGL+ L + ++A E + R Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 191 DGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARI 248
+D+WS GV ++ L+ G P+D + + E PP + ++ +
Sbjct: 191 THQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249
Query: 249 LDPNPMTRITIPEILED-EWFKKD 271
+ +R E++ + +D
Sbjct: 250 WMIDADSRPKFRELIIEFSKMARD 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 7e-60
Identities = 62/272 (22%), Positives = 113/272 (41%), Gaps = 17/272 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G+G F +V + T VA+K L + E +E MK ++H
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHS 129
+V+LY V+ S+ I+IV E+++ G L D + ++ + Q+ + + Y
Sbjct: 73 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
HRDL+ N+L+ KV+DFGL+ L + + + APE
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR 190
Query: 190 YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFTCPPWLSFTARKLIAR 247
+ +D+WS G++L L G +P+ + ++ CPP + L+ +
Sbjct: 191 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249
Query: 248 ILDPNPMTRITIPEILE--DEWFKK---DYKP 274
P R T + +++F Y+P
Sbjct: 250 CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 9e-60
Identities = 81/299 (27%), Positives = 124/299 (41%), Gaps = 42/299 (14%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSET-GEPVALKILDKEKVLKHKMAEQIKREVATMK 66
R +YE IGEG + KV AR+ + G VALK + + + M REVA ++
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLR 62
Query: 67 L---VKHPNVVRLYEVM-----GSKTKIFIVLEFVTGGEL-FDKIVNHGRMKEDEARRYF 117
+HPNVVRL++V +TK+ +V E V + V + + +
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
QL+ +D+ HS V HRDLKP+N+L+ + G +K++DFGL+ + + T
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTL 179
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT----- 232
Y APEVL Y DLWS G I + F S+ ++ KI
Sbjct: 180 WYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 233 ----------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269
+ + L+ + L NP RI+ L +F+
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 2e-59
Identities = 55/263 (20%), Positives = 108/263 (41%), Gaps = 14/263 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++ +G G F +V VA+K L + + + E MK ++H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEARRYFQQLINAVDYCHS 129
+VRLY V ++ I+I+ E++ G L D + +K ++ Q+ + +
Sbjct: 69 RLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
R HRDL+ N+L+ + K++DFGL+ L + + + APE +N
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGT 186
Query: 190 YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFTCPPWLSFTARKLIAR 247
+ +D+WS G++L ++ G +P+ + + + P +L+
Sbjct: 187 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245
Query: 248 ILDPNPMTRITIPEILE--DEWF 268
P R T + +++F
Sbjct: 246 CWKERPEDRPTFDYLRSVLEDFF 268
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 3e-59
Identities = 75/333 (22%), Positives = 130/333 (39%), Gaps = 51/333 (15%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y+ +G G + V A +++TG VA+K L + A++ RE+ +K +KH
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77
Query: 72 NVVRLYEVMGSKTKIF----IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
NV+ L +V + + L G + IV ++ +D + Q++ + Y
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND 187
HS + HRDLKP NL ++ LK+ DFGL+ D + T Y APE++ +
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRAPEIMLN 192
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL---------- 237
+ T D+WS G I+ LL G F ++ ++ K I T L
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 238 ---------------------SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP-- 274
+ A L+ ++L + RIT + L +F + + P
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312
Query: 275 --------PVFEEKKDTNLDDVEAVFKDSEEHH 299
FE + + + +
Sbjct: 313 EPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 345
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 5e-59
Identities = 59/255 (23%), Positives = 100/255 (39%), Gaps = 10/255 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ IG G F V + VA+K + + + + E E M + HP
Sbjct: 7 LTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPK 61
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+V+LY V + I +V EF+ G L D G + + + Y
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRDL N L+ +KVSDFG++ T + +PEV + Y
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 192 GSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARIL 249
S +D+WS GV+++ + + G +P+++ + + + IS P S +++
Sbjct: 181 -SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239
Query: 250 DPNPMTRITIPEILE 264
P R +L
Sbjct: 240 KERPEDRPAFSRLLR 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-58
Identities = 61/300 (20%), Positives = 111/300 (37%), Gaps = 28/300 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHP 71
+ IGEG F +V AR + G + I ++ E+ + KL HP
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARR 115
N++ L + +++ +E+ G L D + + +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
+ + +DY + HRDL N+L+ K++DFG LS+
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG---LSRGQEVYVKKTMGRL 188
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTC 233
++A E LN Y + +D+WS GV+L+ +++ G P+ LY+K+
Sbjct: 189 PVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247
Query: 234 PPWLSFTARKLIARILDPNPMTRITIPEILED-EWFKKDYKPPV----FEEKKDTNLDDV 288
P L+ + P R + +IL ++ K V +E+ +D
Sbjct: 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCS 307
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 190 bits (483), Expect = 2e-58
Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 12/278 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G G + +V + VA+K L ++ E+ +E A MK +KHP
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHP 73
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEARRYFQQLINAVDYCHS 129
N+V+L V + +I+ EF+T G L D + R + Q+ +A++Y
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ HRDL N L+ +KV+DFGLS L + APE L
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 190 YDGSTADLWSCGVILFVLL-AGYLPFDDSNLMNLYKKISA-AEFTCPPWLSFTARKLIAR 247
+ + W+ GV+L+ + G P+ +L +Y+ + P +L+
Sbjct: 193 FSIKSDV-WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251
Query: 248 ILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNL 285
NP R + EI + F+ ++ ++ + L
Sbjct: 252 CWQWNPSDRPSFAEIH--QAFETMFQESSISDEVEKEL 287
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 3e-58
Identities = 68/262 (25%), Positives = 115/262 (43%), Gaps = 15/262 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARN---SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+ E+GR IGEG F V VA+K + E+ +E TM+
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQF 65
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARRYFQQLINAVDYC 127
HP++V+L V+ ++ ++I++E T GEL V + Y QL A+ Y
Sbjct: 66 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC--GTPNYVAPEVL 185
S+ HRD+ N+L+ + +K+ DFG LS+ + D + ++APE +
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFG---LSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 186 NDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243
N R + + +D+W GV ++ +L+ G PF ++ +I E PP T
Sbjct: 182 NFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240
Query: 244 LIARILDPNPMTRITIPEILED 265
L+ + +P R E+
Sbjct: 241 LMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (475), Expect = 6e-57
Identities = 61/284 (21%), Positives = 101/284 (35%), Gaps = 34/284 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
E R IGEG F +V AR E VA+K+L +E M +RE A M
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR------------------- 107
+PN+V+L V + ++ E++ G+L + + +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 108 -----MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162
+ E +Q+ + Y R HRDL N L+ +K++DFGLS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL-PFDDSNLMN 221
++ PE + Y +D+W+ GV+L+ + + L P+
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 222 LYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
+ + CP L+ P R + I
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (467), Expect = 9e-56
Identities = 51/287 (17%), Positives = 94/287 (32%), Gaps = 27/287 (9%)
Query: 9 RVG-KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
RVG +Y +GR IG G+F + + GE VA+K+ + Q+ E K+
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKM 58
Query: 68 VKHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
++ + G+ +V+E + + Q+I+ ++Y
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 127 CHSRGVYHRDLKPENLL---LDAYGNLKVSDFGLS-----ALSQQVRDDGLLHTTCGTPN 178
HS+ HRD+KP+N L + + DFGL+ A + Q GT
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------- 231
Y + DL S G +L G LP+ +K
Sbjct: 179 YASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237
Query: 232 -TCPPWLSFTARKLIARILDPNPMTRIT---IPEILEDEWFKKDYKP 274
+ + + ++ + + ++ +
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 183 bits (466), Expect = 3e-55
Identities = 67/300 (22%), Positives = 122/300 (40%), Gaps = 54/300 (18%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKH 70
Y++ R +G G +++V A N E V +KIL K ++IKRE+ ++ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGG 89
Query: 71 PNVVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
PN++ L +++ +V E V + + + + R Y +++ A+DYCH
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146
Query: 129 SRGVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND 187
S G+ HRD+KP N+++D L++ D+GL+ + + + PE+L D
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVD 203
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSN--------------LMNLYKKISAAEFTC 233
+ D+WS G +L ++ PF + +LY I
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 234 PPW------------------------LSFTARKLIARILDPNPMTRITIPEILEDEWFK 269
P +S A + ++L + +R+T E +E +F
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 6e-55
Identities = 56/280 (20%), Positives = 109/280 (38%), Gaps = 30/280 (10%)
Query: 12 KYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATM- 65
+ G+T+G G F KV A S+ VA+K+L L + E + E+ +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLS 81
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI------------------VNHGR 107
L H N+V L ++ E+ G+L + + +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 108 MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167
+ ++ + Q+ + + S+ HRDL N+LL K+ DFGL+ + +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226
+ ++APE + + +D+WS G+ L+ L + G P+ + + + K+
Sbjct: 202 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 227 --SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
P ++ D +P+ R T +I++
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 1e-54
Identities = 59/280 (21%), Positives = 113/280 (40%), Gaps = 29/280 (10%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGE-------PVALKILDKEKVLKHKMAEQIKREVAT 64
+ +G+ +GEG F +V A + VA+K+L + K + E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEM 71
Query: 65 MK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------R 107
MK + KH N++ L +++++E+ + G L + + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 108 MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167
+ + Q+ ++Y S+ HRDL N+L+ +K++DFGL+ +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226
++APE L DR Y +D+WS GV+L+ + G P+ + L+K +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 227 SAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265
P + ++ P R T +++ED
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-53
Identities = 54/260 (20%), Positives = 102/260 (39%), Gaps = 11/260 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+ IG G F +V + PVA+K L K E M
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQF 66
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYC 127
H N++RL V+ + I+ E++ G L + G + + + + Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT-TCGTPNYVAPEVLN 186
+ HRDL N+L+++ KVSDFGLS + + + + + APE ++
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 187 DRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244
R + + +D+WS G++++ ++ G P+ + + + K I+ P +L
Sbjct: 187 YRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245
Query: 245 IARILDPNPMTRITIPEILE 264
+ + R +I+
Sbjct: 246 MMQCWQQERARRPKFADIVS 265
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 4e-53
Identities = 74/343 (21%), Positives = 132/343 (38%), Gaps = 60/343 (17%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+Y+ + IG G V A ++ VA+K L + A++ RE+ MK V H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNH 75
Query: 71 PNVVRLYEV------MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
N++ L V + +++V+E + + + Q++ +
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGI 132
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
+ HS G+ HRDLKP N+++ + LK+ DFGL+ + ++ T Y APEV
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEV 189
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW-------- 236
+ GY + D+WS G I+ ++ + F + ++ + K+ T P
Sbjct: 190 ILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 237 ----------------------------------LSFTARKLIARILDPNPMTRITIPEI 262
+ AR L++++L +P RI++ +
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 263 LEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKE 305
L+ + Y P E D D EH + E KE
Sbjct: 309 LQHPYINVWYDPAEVEAPPPQIYDKQ----LDEREHTIEEWKE 347
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 175 bits (444), Expect = 2e-52
Identities = 50/281 (17%), Positives = 95/281 (33%), Gaps = 27/281 (9%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
Y+VGR IGEG+F + N + VA+K + A Q++ E T KL+
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAG 59
Query: 71 -PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+ +Y +V++ + + + +Q++ V H
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 130 RGVYHRDLKPENLLLDAY-----GNLKVSDFGLSAL-----SQQVRDDGLLHTTCGTPNY 179
+ + +RD+KP+N L+ + V DFG+ ++Q GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL---YKKISAAEFTCPPW 236
++ R DL + G + L G LP+ Y++I + + P
Sbjct: 180 MSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 237 -----LSFTARKLIARILDPNPMTRITIPEILE--DEWFKK 270
K + + + + ++
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-52
Identities = 61/268 (22%), Positives = 106/268 (39%), Gaps = 12/268 (4%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
I IG G F V N A+K L++ Q E
Sbjct: 22 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEG 79
Query: 63 ATMKLVKHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQL 120
MK HPNV+ L + + S+ +VL ++ G+L + I N + + Q+
Sbjct: 80 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 139
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPN 178
+ + S+ HRDL N +LD +KV+DFGL+ D + + T
Sbjct: 140 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFTCPPW 236
++A E L + + +D+WS GV+L+ L+ G P+ D N ++ + P +
Sbjct: 200 WMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 258
Query: 237 LSFTARKLIARILDPNPMTRITIPEILE 264
+++ + P R + E++
Sbjct: 259 CPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 1e-50
Identities = 52/285 (18%), Positives = 109/285 (38%), Gaps = 22/285 (7%)
Query: 12 KYEVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
K + R +G+G+F V K E VA+K +++ ++ + + E + MK
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEASVMK 78
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----------MKEDEARRY 116
+VVRL V+ +++E +T G+L + + + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
++ + + Y ++ HRDL N ++ +K+ DFG++ +
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAAE-FTCP 234
+++PE L D + + WS GV+L+ + P+ + + + + P
Sbjct: 199 VRWMSPESLKDGVFTTYSDV-WSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 235 PWLSFTARKLIARILDPNPMTRITIPEILE--DEWFKKDYKPPVF 277
+L+ NP R + EI+ E + ++ F
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 302
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 7e-50
Identities = 58/279 (20%), Positives = 108/279 (38%), Gaps = 29/279 (10%)
Query: 12 KYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
+ ++G+ +G G F +V A + T VA+K+L + H + E+ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILI 71
Query: 67 LVKH-PNVVRLYEVMGSK-TKIFIVLEFVTGGELFDKIVNHGR----------------M 108
+ H NVV L + +++EF G L + + +
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 109 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168
+ Y Q+ +++ SR HRDL N+LL +K+ DFGL+ + D
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY-LPFDDSNLMNLYKKI- 226
++APE + DR Y +D+WS GV+L+ + + P+ + + +
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250
Query: 227 -SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
P + + + + P R T E++E
Sbjct: 251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 8e-49
Identities = 55/295 (18%), Positives = 111/295 (37%), Gaps = 48/295 (16%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+ +IG+G F +V + GE VA+KI + + + + E+ +++H
Sbjct: 3 RTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSS----REERSWFREAEIYQTVMLRH 56
Query: 71 PNVVRLYEVM----GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
N++ G+ T++++V ++ G LFD + N + + + + + +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAH 115
Query: 127 CHS--------RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGT 176
H + HRDLK +N+L+ G ++D GL+ D D + GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 177 PNYVAPEVLNDR-----GYDGSTADLWSCGVILFVLLAGYLPFD---------------D 216
Y+APEVL+D AD+++ G++ + + D
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 217 SNLMNLYKKISAAEF-------TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
++ + K + + K++ N R+T I +
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 150 bits (378), Expect = 4e-42
Identities = 54/327 (16%), Positives = 107/327 (32%), Gaps = 63/327 (19%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-------REVA 63
+Y + R +G G F+ V A++ VA+KI+ +KV ++IK +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT-----GGELFDKIVNHGRMKEDEARRYFQ 118
+ ++++L + K + + V K H + ++ +
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 119 QLINAVDYC-HSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRDDGLLHTTCGT 176
QL+ +DY G+ H D+KPEN+L++ + ++ L D + T
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK------------ 224
Y +PEVL + AD+WS ++F L+ G F+ + K
Sbjct: 193 REYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 225 ------------------------------------KISAAEFTCPPWLSFTARKLIARI 248
+ ++ + ++ +
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311
Query: 249 LDPNPMTRITIPEILEDEWFKKDYKPP 275
L +P R ++ W K
Sbjct: 312 LQLDPRKRADAGGLVNHPWLKDTLGME 338
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 93.3 bits (231), Expect = 5e-23
Identities = 33/213 (15%), Positives = 69/213 (32%), Gaps = 42/213 (19%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA---------------EQ 57
+G+ +GEG + V + E +K K+
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 58 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 117
+ E ++ ++ V ++Y G+ +++E + R++ +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAK-------ELYRVRVENPDEVL 109
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
++ V + RG+ H DL N+L+ G + + DF S + +L
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDV--- 165
Query: 178 NYVAPEVLND---RGYDGSTADLWSCGVILFVL 207
+ R Y + D+ S I +L
Sbjct: 166 -----RNIITYFSRTY-RTEKDINS--AIDRIL 190
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 78.6 bits (194), Expect = 1e-18
Identities = 11/77 (14%), Positives = 32/77 (41%), Gaps = 2/77 (2%)
Query: 342 TSRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVA-PSLH 399
TS ++++ +I + D ++ + + + + + EV ++ SL+
Sbjct: 16 TSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLN 75
Query: 400 MVEVRKAKGDTLEFHKV 416
V ++ G ++ F +
Sbjct: 76 GVRFKRISGTSIAFKNI 92
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 416 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.31 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 98.78 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.78 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.2 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.14 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 98.1 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 97.88 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.14 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.07 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.63 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-67 Score=490.17 Aligned_cols=258 Identities=37% Similarity=0.713 Sum_probs=240.8
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
.+++|++++.||+|+||+||+|+++.+++.||+|++.+....+....+.+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 36789999999999999999999999999999999988766555567889999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
|||||+||+|.+++...+.+++..++.++.||++||+|||++||+||||||+|||++.+|.+||+|||+|.... ..
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~----~~ 159 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SS 159 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC----CC
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC----CC
Confidence 99999999999999998999999999999999999999999999999999999999999999999999997543 23
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHh
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~ 248 (416)
.....+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+....+..+....+.+|+.+|+++++||.+|
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 238 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 238 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence 34567899999999999988875 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCHhHHhcCcccccC
Q 014909 249 LDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 249 L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
|++||++|||++|+|+||||+..
T Consensus 239 L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 239 LKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp TCSSGGGSCCHHHHHTCHHHHHH
T ss_pred ccCCHhHCcCHHHHHcCcCcCCc
Confidence 99999999999999999999753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-67 Score=492.16 Aligned_cols=263 Identities=40% Similarity=0.695 Sum_probs=228.9
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
.+++|++++.||+|+||+||+|+++.+|+.||||++++.... +..+.+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 468899999999999999999999999999999999865432 234678999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
|||||+||+|++++...+.+++..++.++.||++||+|||++||+||||||+|||++.+|++||+|||+|+.........
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998765444444
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH-HHHHHhhcCccCCC--CCCCHHHHHHH
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCP--PWLSFTARKLI 245 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~s~~~~~ll 245 (416)
...+.+||+.|+|||++.+.++++.++|||||||++|+|++|+.||...+.. ..+..+.......+ +.+|+++.+||
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 5567899999999999998888778899999999999999999999876543 33333333333333 34899999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 246 ARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
.+||+.||++|||++|+++||||++..+
T Consensus 241 ~~~L~~dP~~R~t~~eil~hpwf~~~l~ 268 (271)
T d1nvra_ 241 HKILVENPSARITIPDIKKDRWYNKPLK 268 (271)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence 9999999999999999999999987543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-66 Score=490.64 Aligned_cols=261 Identities=31% Similarity=0.584 Sum_probs=236.7
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 45789999999999999999999999999999999988766555567889999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++++|.+||+|||+|+.........
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998765544444
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHh
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~ 248 (416)
...+.+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+...++.++....+.+|..+|+++++||++|
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 244 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 244 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTT
T ss_pred ccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence 55677899999999999988875 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCHhH------HhcCccccc
Q 014909 249 LDPNPMTRITIPE------ILEDEWFKK 270 (416)
Q Consensus 249 L~~dP~~R~t~~e------il~h~~~~~ 270 (416)
|+.||++|||++| +++||||+.
T Consensus 245 L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 245 LVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp SCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred ccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 9999999999998 477888864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-65 Score=492.06 Aligned_cols=260 Identities=33% Similarity=0.611 Sum_probs=242.8
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
..+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++||||+++++++.+...+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 46789999999999999999999999999999999999876655556788999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
+|||||+||+|++++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ..
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~ 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999985432 23
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~ 247 (416)
....+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|++||.+.+...++..+....+.+|..+|+++++||++
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence 345678999999999999998885 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCC-----HhHHhcCccccc
Q 014909 248 ILDPNPMTRIT-----IPEILEDEWFKK 270 (416)
Q Consensus 248 ~L~~dP~~R~t-----~~eil~h~~~~~ 270 (416)
||++||.+|++ ++|+++||||+.
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred hccCCchhhcccccccHHHHHcCccccc
Confidence 99999999994 899999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-64 Score=476.93 Aligned_cols=253 Identities=29% Similarity=0.503 Sum_probs=225.8
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
++|++.+.||+|+||+||+|.+..+|+.||||++....... .+.+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 47999999999999999999999999999999998654332 467899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCc
Q 014909 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (416)
Q Consensus 91 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 170 (416)
|||+||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... .....
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~~~ 173 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKR 173 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCCB
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc--ccccc
Confidence 99999999998765 5799999999999999999999999999999999999999999999999999986533 22344
Q ss_pred ccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC---ccCCCCCCCHHHHHHHHH
Q 014909 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIAR 247 (416)
Q Consensus 171 ~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~ll~~ 247 (416)
...+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+.......+... .+..|+.+|+++++||.+
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred cccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 567899999999999988775 8999999999999999999999988776655544332 344566799999999999
Q ss_pred hcCCCCCCCCCHhHHhcCccccc
Q 014909 248 ILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 248 ~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
||++||++|||++|+|+||||+.
T Consensus 253 ~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HccCChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-63 Score=478.10 Aligned_cols=255 Identities=35% Similarity=0.726 Sum_probs=239.0
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+.+|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 56899999999999999999999999999999999877655555678899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
||||.||+|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..... .
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-----~ 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----V 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----C
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-----c
Confidence 99999999999999999999999999999999999999999999999999999999999999999999976432 2
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHhc
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~L 249 (416)
..+.+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+....+.++..+...+|+.+|++++++|++||
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 236 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 236 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 3567999999999999988886 899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCC-----CHhHHhcCccccc
Q 014909 250 DPNPMTRI-----TIPEILEDEWFKK 270 (416)
Q Consensus 250 ~~dP~~R~-----t~~eil~h~~~~~ 270 (416)
++||.+|+ |++++++||||+.
T Consensus 237 ~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 237 TRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred hhCHHhccccchhhHHHHHcCccccc
Confidence 99999996 9999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-63 Score=476.04 Aligned_cols=256 Identities=38% Similarity=0.695 Sum_probs=214.5
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
-++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 356999999999999999999999999999999998765432 246688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEec---cCCCeEEeecccccccccccC
Q 014909 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD---AYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~---~~~~vkl~DFGla~~~~~~~~ 166 (416)
||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++|.+||+|||+|.....
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~--- 162 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--- 162 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC---
Confidence 99999999999999989999999999999999999999999999999999999995 478999999999975432
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC----CCCCHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTAR 242 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~ 242 (416)
.....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+.......+......++ +.+|+++.
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp ----------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CCeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 3345667899999999999988875 899999999999999999999999988888888877765443 45899999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 243 KLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
+||.+||++||++|||++|+++||||+..
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-63 Score=466.19 Aligned_cols=256 Identities=34% Similarity=0.569 Sum_probs=217.9
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKI 86 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 86 (416)
+.++|++.+.||+|+||+||+|+++.+|+.||||++...... +...+.+.+|+.+|++++|||||++++++.+ ...+
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 457899999999999999999999999999999999876543 3346779999999999999999999999864 5668
Q ss_pred EEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cEeecCCCCcEEeccCCCeEEeeccc
Q 014909 87 FIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRG-----VYHRDLKPENLLLDAYGNLKVSDFGL 157 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~al~~LH~~g-----ivHrDlkp~NILl~~~~~vkl~DFGl 157 (416)
|+|||||+||+|.+++.. .+.+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999999999998864 457999999999999999999999976 99999999999999999999999999
Q ss_pred ccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc-CCCCC
Q 014909 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPW 236 (416)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~ 236 (416)
|+.... ......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+..++..++..+.. ..|..
T Consensus 161 a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 237 (269)
T d2java1 161 ARILNH--DTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237 (269)
T ss_dssp HHHC-------------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred eeeccc--CCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 986543 22334567899999999999887775 899999999999999999999999998888888877765 45667
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 014909 237 LSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (416)
Q Consensus 237 ~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~ 268 (416)
+|+++.+||++||+.||.+|||++|+++|||+
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999999999999999999999995
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-62 Score=479.30 Aligned_cols=257 Identities=33% Similarity=0.650 Sum_probs=240.1
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
..+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||++++++.+...+|
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 45789999999999999999999999999999999998776655556778999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
+||||+.||+|.+.+...+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---- 193 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc----
Confidence 9999999999999999989999999999999999999999999999999999999999999999999999986432
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~ 247 (416)
...+.+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+....+.++....+.+|+.+|+++.+||++
T Consensus 194 -~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 271 (350)
T d1rdqe_ 194 -RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred -ccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 23467899999999999988885 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCC-----CHhHHhcCccccc
Q 014909 248 ILDPNPMTRI-----TIPEILEDEWFKK 270 (416)
Q Consensus 248 ~L~~dP~~R~-----t~~eil~h~~~~~ 270 (416)
||++||.+|+ |++++++||||+.
T Consensus 272 ~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HhhhCHHhccccccccHHHHHcCccccC
Confidence 9999999995 9999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-63 Score=471.66 Aligned_cols=255 Identities=29% Similarity=0.482 Sum_probs=224.6
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
+.|++++.||+|+||+||+|++..+|+.||||++++... ...+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 469999999999999999999999999999999976532 23567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 91 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
|||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|...... ...
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~ 166 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR 166 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence 99999999998765 457999999999999999999999999999999999999999999999999998754322 112
Q ss_pred cccccCCcccccchhhc-----cCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc---CCCCCCCHHH
Q 014909 170 LHTTCGTPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTA 241 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~-----~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~ 241 (416)
..+.+||+.|+|||++. +.+| +.++|||||||++|+|++|+.||.+.+..+...++..... ..|+.+|+++
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 245 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred ccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence 34678999999999985 2334 5899999999999999999999999888777777766543 3355689999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
++||++||+.||++|||++|+++||||+..
T Consensus 246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-62 Score=470.86 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=228.3
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 91 (416)
.|++.+.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999987665555567889999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCcc
Q 014909 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (416)
Q Consensus 92 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 171 (416)
||.||+|..++...+++++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..... ..
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------AN 169 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------CC
Confidence 999999988888888999999999999999999999999999999999999999999999999999975432 34
Q ss_pred cccCCcccccchhhccC--CCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCC--CCCCCHHHHHHHHH
Q 014909 172 TTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC--PPWLSFTARKLIAR 247 (416)
Q Consensus 172 ~~~gt~~y~aPEvl~~~--~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~s~~~~~ll~~ 247 (416)
..+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+......++....... +..+|+++++||.+
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 56899999999999642 223589999999999999999999999888877777666554332 34589999999999
Q ss_pred hcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 248 ILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 248 ~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
||+.||.+|||++|+|+||||.+...
T Consensus 250 ~L~~dP~~Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 250 CLQKIPQDRPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HCcCChhHCcCHHHHHhCHHhcCCCC
Confidence 99999999999999999999986543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-62 Score=472.14 Aligned_cols=258 Identities=30% Similarity=0.581 Sum_probs=236.0
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHh-cCCCCCcceEEEEEEeCCEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~l 88 (416)
+++|++++.||+|+||+||+|.++.+|+.||||++.+.........+.+.+|+.++. .++|||||++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 478999999999999999999999999999999998766544444566777777665 6899999999999999999999
Q ss_pred EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCC
Q 014909 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 168 (416)
||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++++|++||+|||+|+.... ...
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~--~~~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDA 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTC
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc--ccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999975433 223
Q ss_pred CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHHHHHHHh
Q 014909 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248 (416)
Q Consensus 169 ~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ll~~~ 248 (416)
.....+||+.|+|||++.+.+|+ .++|||||||++|+|++|+.||.+.+...++.++....+.+|+.+|+++.+||++|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence 34567899999999999988886 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCHh-HHhcCccccc
Q 014909 249 LDPNPMTRITIP-EILEDEWFKK 270 (416)
Q Consensus 249 L~~dP~~R~t~~-eil~h~~~~~ 270 (416)
|+.||.+|||+. ++++||||+.
T Consensus 238 L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTT
T ss_pred cccCCCCCcCHHHHHHhCchhcc
Confidence 999999999996 8999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-62 Score=465.11 Aligned_cols=257 Identities=37% Similarity=0.621 Sum_probs=232.2
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcH---HHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
-++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|++++|||||++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3579999999999999999999999999999999986543321 2357799999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC----CeEEeecccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSALSQ 162 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~----~vkl~DFGla~~~~ 162 (416)
|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|....
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999999988999999999999999999999999999999999999998876 49999999987653
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC----CCCC
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLS 238 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s 238 (416)
. .....+.+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+..+.+..+......++ +.+|
T Consensus 169 ~---~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 169 F---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp T---SCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred C---CccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence 2 334456789999999999988767 5899999999999999999999999998888888888776554 5689
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 239 FTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 239 ~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
+++++||++||+.||++|||++|+++||||+.
T Consensus 245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.4e-62 Score=474.99 Aligned_cols=259 Identities=30% Similarity=0.584 Sum_probs=232.7
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
.+++|++++.||+|+||.||+|++..+|+.||||++.+... ...+.+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46799999999999999999999999999999999976542 235778999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc--CCCeEEeeccccccccccc
Q 014909 89 VLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~--~~~vkl~DFGla~~~~~~~ 165 (416)
|||||+||+|.+++.. .+++++..++.|+.||+.||+|||++||+||||||+|||++. +|.+||+|||+|+....
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~-- 178 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-- 178 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT--
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc--
Confidence 9999999999999954 467999999999999999999999999999999999999964 57899999999975432
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC----CCCCHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~ 241 (416)
.....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+..+.+..+.......+ +.+|+++
T Consensus 179 -~~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 256 (350)
T d1koaa2 179 -KQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256 (350)
T ss_dssp -TSCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHH
T ss_pred -ccccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 3345678999999999999988885 899999999999999999999999998888888887766554 3589999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
++||++||+.||++|||++|+|+||||+....+
T Consensus 257 ~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 999999999999999999999999999876543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.1e-62 Score=474.99 Aligned_cols=260 Identities=27% Similarity=0.540 Sum_probs=233.7
Q ss_pred cccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 7 ~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
+...++|++++.||+|+||.||+|++..+|+.||||++++.... ....+.+|+.+|++++|||||++++++.+++.+
T Consensus 25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 101 (352)
T d1koba_ 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 101 (352)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 34567899999999999999999999999999999999865432 246788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEec--cCCCeEEeeccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD--AYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~--~~~~vkl~DFGla~~~~~ 163 (416)
|+|||||+||+|++.+...+ ++++.+++.++.||+.||+|||++||+||||||+|||++ .+|.+||+|||+|.....
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999999999999887654 699999999999999999999999999999999999998 568999999999986543
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCC----CCCCH
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSF 239 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 239 (416)
.....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+..+....+.+| +.+|+
T Consensus 182 ---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 257 (352)
T d1koba_ 182 ---DEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257 (352)
T ss_dssp ---TSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ---CCceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 3455678999999999999988775 899999999999999999999999999888888887766554 45899
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCC
Q 014909 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (416)
++.+||.+||+.||.+|||++|+|+||||+....
T Consensus 258 ~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291 (352)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence 9999999999999999999999999999987543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-61 Score=456.35 Aligned_cols=253 Identities=25% Similarity=0.498 Sum_probs=220.2
Q ss_pred ccCE-EEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CC
Q 014909 10 VGKY-EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----KT 84 (416)
Q Consensus 10 ~~~y-~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~ 84 (416)
-++| ++.+.||+|+||+||+|.+..+++.||+|++...... ....+.+.+|+.+|++++|||||++++++.+ ..
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence 3456 7888999999999999999999999999999876543 3346789999999999999999999999865 45
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCcEEec-cCCCeEEeeccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLD-AYGNLKVSDFGLSALS 161 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~g--ivHrDlkp~NILl~-~~~~vkl~DFGla~~~ 161 (416)
.+|+||||++||+|.+++.+.+.+++..++.++.||++||+|||++| |+||||||+|||++ +++.+||+|||+|+..
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 68999999999999999999899999999999999999999999999 99999999999997 4789999999999753
Q ss_pred ccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCc-hHHHHHHhhcCcc--CCCCCCC
Q 014909 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAAEF--TCPPWLS 238 (416)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~-~~~~~~~i~~~~~--~~~~~~s 238 (416)
. .....+.+||+.|+|||++.+ .| +.++|||||||++|+|++|+.||.+.. ...++..+..+.. .++...+
T Consensus 166 ~----~~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (270)
T d1t4ha_ 166 R----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239 (270)
T ss_dssp C----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred c----CCccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCC
Confidence 2 233456799999999999875 46 589999999999999999999998654 4455666655432 3345589
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 014909 239 FTARKLIARILDPNPMTRITIPEILEDEWFK 269 (416)
Q Consensus 239 ~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~ 269 (416)
+++.+||.+||++||++|||++|+|+||||+
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999999999999999999999995
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.7e-61 Score=472.66 Aligned_cols=258 Identities=29% Similarity=0.461 Sum_probs=226.4
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHH---HHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI---KREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~---~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
.+++|++++.||+|+||.||+|++..+|+.||||++.+...........+ .+|+.+++.++|||||++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 46889999999999999999999999999999999987655433333333 345777888899999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+|+|||||+||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~-- 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-- 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS--
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999985533
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch---HHHHHHhhcCccCCCCCCCHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---MNLYKKISAAEFTCPPWLSFTAR 242 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~s~~~~ 242 (416)
......+||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+. ......+.......|..+|++++
T Consensus 160 --~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 --KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp --SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred --CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence 2345678999999999997655446899999999999999999999986543 34445555666777888999999
Q ss_pred HHHHHhcCCCCCCCCC-----HhHHhcCccccc
Q 014909 243 KLIARILDPNPMTRIT-----IPEILEDEWFKK 270 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t-----~~eil~h~~~~~ 270 (416)
+||.+||++||.+||| ++|+++||||+.
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 9999999999999999 799999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-62 Score=472.90 Aligned_cols=256 Identities=25% Similarity=0.423 Sum_probs=219.2
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
..-++|++++.||+|+||+||+|++..+|+.||+|+++++. .....+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 35678999999999999999999999999999999997653 2334578999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~-~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|......
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999999999999998999999999999999999999997 59999999999999999999999999999865432
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHH---------------------
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK--------------------- 225 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~--------------------- 225 (416)
...+.+||+.|+|||++.+..|+ .++||||+||++|+|++|+.||.+.+.......
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred --ccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 23467999999999999998875 899999999999999999999976543221100
Q ss_pred ---------------------hhcCc-cCCC-CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 226 ---------------------ISAAE-FTCP-PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 226 ---------------------i~~~~-~~~~-~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
+.... ...| ..+|.++++||.+||+.||.+|||++|+|+||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 00000 0111 125889999999999999999999999999999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.3e-61 Score=454.14 Aligned_cols=258 Identities=32% Similarity=0.543 Sum_probs=230.5
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhc------HHHHHHHHHHHHHHhcCC-CCCcceEEEEEEe
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK------HKMAEQIKREVATMKLVK-HPNVVRLYEVMGS 82 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~------~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 82 (416)
.++|++.+.||+|+||+||+|++..+|+.||||++.+..... ....+.+.+|+.+|++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999999999999999998754322 234467889999999997 9999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
++.+|+||||++||+|.++|...+++++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999998999999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCCcccccCCcccccchhhcc-----CCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCC--
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-- 235 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~-----~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~-- 235 (416)
. .......+||+.|+|||++.+ ....+.++||||+||++|+|++|+.||.+.+.......+..+....+.
T Consensus 162 ~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 162 P---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp T---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred C---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 3 233456789999999999863 223468999999999999999999999999988888888777654433
Q ss_pred --CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 236 --WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 236 --~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
.+|+++++||.+||++||.+|||++|+|+||||++
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 58999999999999999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-61 Score=463.56 Aligned_cols=255 Identities=25% Similarity=0.493 Sum_probs=231.2
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
..++|++++.||+|+||+||+|.++.+|+.||||++++.... ...+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 578999999999999999999999999999999999875432 3568899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC--CCeEEeeccccccccccc
Q 014909 89 VLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY--GNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~--~~vkl~DFGla~~~~~~~ 165 (416)
|||||+||+|+++|...+ .+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~--- 155 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--- 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc---
Confidence 999999999999998765 79999999999999999999999999999999999999854 479999999987543
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCC----CCCHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLSFTA 241 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~ 241 (416)
......+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+..|....+.++. .+|+++
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred cCCcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence 23345667899999999999887775 8999999999999999999999999999999999888776653 689999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 242 ~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
++||++||+.||.+|||++|+++||||++.
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 999999999999999999999999999764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-60 Score=450.08 Aligned_cols=252 Identities=31% Similarity=0.543 Sum_probs=223.2
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHH---HHHHHHHHHHHHhcCC--CCCcceEEEEEEeCC
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK---MAEQIKREVATMKLVK--HPNVVRLYEVMGSKT 84 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~---~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~ 84 (416)
-++|++++.||+|+||+||+|++..+|+.||||++.+....... ...++.+|+.+|++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46899999999999999999999999999999999876543211 1234678999999987 899999999999999
Q ss_pred EEEEEEeccCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccC-CCeEEeecccccccc
Q 014909 85 KIFIVLEFVTG-GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQ 162 (416)
Q Consensus 85 ~~~lV~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~-~~vkl~DFGla~~~~ 162 (416)
..|+||||+.+ +++.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|....
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999986 6888999888999999999999999999999999999999999999999854 789999999997543
Q ss_pred cccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCCCCCHHHH
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~ 242 (416)
. ....+.+||+.|+|||++.+..+++.++|||||||++|+|++|+.||.+.+ .+..+...+++.+|++++
T Consensus 163 ~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 163 D----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQ 232 (273)
T ss_dssp S----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHH
T ss_pred c----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHHH
Confidence 2 334567899999999999988887788999999999999999999998632 355667788889999999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 243 KLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
+||++||+.||++|||++|+++||||++-
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999999753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-60 Score=453.90 Aligned_cols=256 Identities=27% Similarity=0.361 Sum_probs=216.1
Q ss_pred EEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014909 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (416)
Q Consensus 15 ~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 92 (416)
.++.||+|+||+||+|+++.+|+.||||+++...... ....+.+.+|+.+|+.++|||||++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4688999999999999999999999999997654322 12235688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCCccc
Q 014909 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 172 (416)
Q Consensus 93 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 172 (416)
+.|+++.........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..... ......+
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~--~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--CCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC--Ccccccc
Confidence 99988877777677899999999999999999999999999999999999999999999999999975433 2233456
Q ss_pred ccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCcc--------------------C
Q 014909 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF--------------------T 232 (416)
Q Consensus 173 ~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~--------------------~ 232 (416)
.+||+.|+|||++....+++.++||||+||++|+|++|.+||.+.+..+...++..... .
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 78999999999998766657899999999999999999999999888777666532100 0
Q ss_pred --------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 233 --------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 233 --------~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
..+.+|+++.+||++||+.||++|||++|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 0124688999999999999999999999999999998644
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-59 Score=446.20 Aligned_cols=261 Identities=30% Similarity=0.473 Sum_probs=219.5
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+++|++++.||+|+||+||+|.+..+|+.||||++..... .+...+.+.+|+.+|++++|||||++++++.++..+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 4789999999999999999999999999999999976543 233457889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHH-h-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 90 LEFVTGGELFDKIV-N-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 90 ~E~~~gg~L~~~i~-~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
|||+.++ +.+.+. . ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|..... ..
T Consensus 80 ~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~ 156 (298)
T d1gz8a_ 80 FEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PV 156 (298)
T ss_dssp EECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CS
T ss_pred EeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--Cc
Confidence 9999865 444443 3 45799999999999999999999999999999999999999999999999999976433 22
Q ss_pred CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-----------------
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----------------- 230 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~----------------- 230 (416)
......+||+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+......++....
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 344567899999999999888888899999999999999999999999887766554432110
Q ss_pred -cCC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 231 -FTC-----------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 231 -~~~-----------~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
... .+.+|+++.+||++||+.||++|||++|+++||||+.-.+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 001 12467899999999999999999999999999999865443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-59 Score=454.36 Aligned_cols=255 Identities=35% Similarity=0.601 Sum_probs=217.1
Q ss_pred ccccCEEEEe-EEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhc-CCCCCcceEEEEEEe---
Q 014909 8 RRVGKYEVGR-TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL-VKHPNVVRLYEVMGS--- 82 (416)
Q Consensus 8 ~~~~~y~~~~-~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~--- 82 (416)
..+++|.+.+ .||+|+||+||+|++..+++.||||+++.. ..+.+|+.++.+ ++|||||++++++.+
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 4578999875 699999999999999999999999999643 346789998654 589999999999976
Q ss_pred -CCEEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc---CCCeEEeecc
Q 014909 83 -KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDFG 156 (416)
Q Consensus 83 -~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~---~~~vkl~DFG 156 (416)
...+|+|||||+||+|++++... .++++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 46799999999999999999874 36999999999999999999999999999999999999986 4679999999
Q ss_pred cccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHH----HHHHhhcCccC
Q 014909 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKISAAEFT 232 (416)
Q Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~----~~~~i~~~~~~ 232 (416)
+|+.... .......+||+.|+|||++.+..|+ .++|||||||++|+|++|++||.+.+... +...+....+.
T Consensus 160 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~ 235 (335)
T d2ozaa1 160 FAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235 (335)
T ss_dssp TCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred eeeeccC---CCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence 9975443 3345677999999999999988775 89999999999999999999998765433 33445555555
Q ss_pred CCC----CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 233 CPP----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 233 ~~~----~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
+|. .+|+++.+||++||+.||++|||+.|+++||||.+....
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 281 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 281 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSS
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCC
Confidence 553 389999999999999999999999999999999865543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.8e-58 Score=438.34 Aligned_cols=257 Identities=32% Similarity=0.472 Sum_probs=219.6
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+++|++.+.||+|+||+||+|+++ +|+.||||+++.... .....+++.+|+.+|++++|||||++++.+.+.+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 479999999999999999999996 789999999977653 233457899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
|||+.++.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... ...
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRK 156 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC--ccc
Confidence 999998888777777888999999999999999999999999999999999999999999999999998765432 222
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-------------------
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------------- 230 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~------------------- 230 (416)
.....|++.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+..+...++....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 3455799999999999887777899999999999999999999999887766655442110
Q ss_pred ----------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 231 ----------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 231 ----------~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
...++.+|+++.+||++||+.||++|||++|+|+||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0123346889999999999999999999999999999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.9e-58 Score=435.09 Aligned_cols=261 Identities=25% Similarity=0.424 Sum_probs=219.3
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC---
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--- 84 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 84 (416)
..-++|++.+.||+|+||+||+|++..+|+.||||++.++...+....+.+.+|+.+|+.++|||||++++++...+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 34578999999999999999999999999999999998877666667788999999999999999999999987643
Q ss_pred -EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 85 -KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 85 -~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
.+|+||||++||+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++..+++|||.+.....
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 4899999999999999999999999999999999999999999999999999999999999999999999998865433
Q ss_pred cc-CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCC----CCCCC
Q 014909 164 VR-DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----PPWLS 238 (416)
Q Consensus 164 ~~-~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~----~~~~s 238 (416)
.. ......+.+||+.|+|||++.+..|+ .++||||+||++|+|++|++||.+.+..+...++....... ++.+|
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242 (277)
T ss_dssp ---------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred ccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence 22 22234567899999999999887775 89999999999999999999999988887776665554433 35689
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 014909 239 FTARKLIARILDPNPMTRITIPEILEDEWFK 269 (416)
Q Consensus 239 ~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~ 269 (416)
+++.+||.+||++||.+||+..+.+.|+|.+
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 9999999999999999999544455577764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-57 Score=438.67 Aligned_cols=263 Identities=29% Similarity=0.377 Sum_probs=217.4
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe------
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------ 82 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 82 (416)
.+++|++++.||+|+||+||+|++..+|+.||||++.++... ......+.+|+.+|++++||||+++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 479999999999999999999999999999999999766433 2345678899999999999999999999854
Q ss_pred --CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccc
Q 014909 83 --KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (416)
Q Consensus 83 --~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~ 160 (416)
...+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 456899999999877766666667899999999999999999999999999999999999999999999999999975
Q ss_pred ccccc--CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCCCC---
Q 014909 161 SQQVR--DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP--- 235 (416)
Q Consensus 161 ~~~~~--~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~--- 235 (416)
..... ......+.+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+.......+......+++
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 54322 2234456789999999999987655568999999999999999999999988776665554332211111
Q ss_pred -----------------------------CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 236 -----------------------------WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 236 -----------------------------~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
..++++++||.+||+.||++|||++|+|+||||+..+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p 312 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 312 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence 0267889999999999999999999999999998653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-57 Score=433.49 Aligned_cols=257 Identities=31% Similarity=0.424 Sum_probs=213.7
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCC-CCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC---CCCCcceEEEEEEe--
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSET-GEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMGS-- 82 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~-- 82 (416)
..++|++++.||+|+||+||+|++..+ ++.||||++....... .....+.+|+.+|+.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 457999999999999999999999765 6679999997654322 2233466788877766 79999999999853
Q ss_pred ---CCEEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccc
Q 014909 83 ---KTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (416)
Q Consensus 83 ---~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla 158 (416)
...+|++|||+.++.+...... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 3578999999998876544433 457999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC---------
Q 014909 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------- 229 (416)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~--------- 229 (416)
..... .......+||+.|+|||++.+.+|+ .++||||+||++|+|++|++||.+.+..+....+...
T Consensus 164 ~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 164 RIYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCCCG---GGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhcc---cccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 75433 2334577899999999999988885 8999999999999999999999998877666554221
Q ss_pred ------------------ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 230 ------------------EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 230 ------------------~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
...+++.+|+.+++||++||+.||++|||++|+|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 01123457899999999999999999999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-56 Score=423.88 Aligned_cols=258 Identities=32% Similarity=0.477 Sum_probs=223.8
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 89 (416)
+++|++++.||+|+||+||+|++..+|+.||||+++.... ......++.+|+.+|+.++||||+++++++.+....++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 4689999999999999999999999999999999976653 344578899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 90 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
||++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|...... ...
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~--~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC--CSC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC--Ccc
Confidence 999999999999998899999999999999999999999999999999999999999999999999999765432 223
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCC-CCCchHHHHHHhhcCc------------------
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAAE------------------ 230 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf-~~~~~~~~~~~i~~~~------------------ 230 (416)
.....+++.|+|||++....+.+.++||||+||++|+|++|..|| .+.+..+...++....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 345567899999999988777779999999999999999999986 4455555544432110
Q ss_pred -----------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 231 -----------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 231 -----------~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
...++.+|+.+.+||++||+.||.+|||++|+|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 1122346889999999999999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-57 Score=438.31 Aligned_cols=252 Identities=20% Similarity=0.340 Sum_probs=214.6
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCC-----eEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGE-----PVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 84 (416)
++|++++.||+|+||+||+|++..+++ .||+|.+..... ......+.+|+.+|+++ +|||||++++++.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 689999999999999999999876544 699999875432 22346788999999988 8999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHG-----------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~-----------------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~N 141 (416)
.+|+|||||+||+|.++|.... .+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 9999999999999999997642 48999999999999999999999999999999999
Q ss_pred EEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchH
Q 014909 142 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM 220 (416)
Q Consensus 142 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~ 220 (416)
||++.++++||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||++|||++ |.+||.+.+..
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999865543333334456789999999999887775 89999999999999997 99999987665
Q ss_pred HHHHHhhcC--ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 221 NLYKKISAA--EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 221 ~~~~~i~~~--~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
....++... .+..|..+|+++.+||.+||+.||++|||++||++|
T Consensus 274 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 544444333 456677899999999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-57 Score=427.09 Aligned_cols=249 Identities=21% Similarity=0.349 Sum_probs=211.8
Q ss_pred eEEeecCceEEEEEEEC--CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014909 17 RTIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (416)
Q Consensus 17 ~~LG~G~fg~V~~a~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 94 (416)
+.||+|+||+||+|.+. .+++.||||++..... +....+.+.+|+.+|++++|||||++++++.++ ..|+||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 57999999999999864 4567899999976543 344567899999999999999999999999654 5789999999
Q ss_pred CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC-CCcccc
Q 014909 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTT 173 (416)
Q Consensus 95 gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~ 173 (416)
+|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........ ......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999765432111 122345
Q ss_pred cCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCC
Q 014909 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDP 251 (416)
Q Consensus 174 ~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll~~~L~~ 251 (416)
.||+.|+|||++.+..|+ .++|||||||++|||++ |++||.+.+..+....+..+ .+..|..+|+++.+||.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 789999999999887775 89999999999999997 99999998888888777665 4567788999999999999999
Q ss_pred CCCCCCCHhHHh---cCccc
Q 014909 252 NPMTRITIPEIL---EDEWF 268 (416)
Q Consensus 252 dP~~R~t~~eil---~h~~~ 268 (416)
||++|||+++|+ +|+|+
T Consensus 250 dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHh
Confidence 999999999984 56665
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-57 Score=428.20 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=206.8
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
.-++|++++.||+|+||+||+|+.. ..||||+++...... ...+.+++|+.+|++++|||||++++++. ...+|+
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l 80 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI 80 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence 4578999999999999999999863 359999997654333 34678999999999999999999999875 456899
Q ss_pred EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
|||||+||+|.+++... +++++..+..++.||++||+|||++||+||||||+|||++.++++||+|||+|+........
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999999999764 56999999999999999999999999999999999999999999999999999876544344
Q ss_pred CCcccccCCcccccchhhccCC--CCCChhhHHHHHHHHHHHhhCCCCCCCCchHHH-HHHhhcCcc-----CCCCCCCH
Q 014909 168 GLLHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL-YKKISAAEF-----TCPPWLSF 239 (416)
Q Consensus 168 ~~~~~~~gt~~y~aPEvl~~~~--~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~-~~~i~~~~~-----~~~~~~s~ 239 (416)
....+.+||+.|||||++.+.. ..+.++|||||||++|||+||+.||.+.+.... ...+..+.. ..+..+|+
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 240 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCH
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchH
Confidence 4456678999999999997432 235899999999999999999999988665433 333333321 24556899
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 240 TARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
++.+||.+||+.||++|||+++|+++
T Consensus 241 ~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 241 AMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=436.64 Aligned_cols=254 Identities=28% Similarity=0.424 Sum_probs=212.7
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-----
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----- 84 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----- 84 (416)
-++|++++.||+|+||+||+|.+..+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4789999999999999999999999999999999986543 4445678999999999999999999999997654
Q ss_pred -EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 85 -KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 85 -~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
.+|+||||+ |++|...+. .+++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|....
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~- 172 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD- 172 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC-
Confidence 579999999 556666554 5789999999999999999999999999999999999999999999999999997543
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCc-------------
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------- 230 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~------------- 230 (416)
......+||+.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+.......+....
T Consensus 173 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 173 ----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp ----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 234567899999999999887777799999999999999999999999877655443322110
Q ss_pred ------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 231 ------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 231 ------------------~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
....+.+|+++.+||++||..||++|||++|+|+||||+.-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 11234578999999999999999999999999999999863
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-56 Score=426.39 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=209.3
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCC---eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
..++|++.+.||+|+||+||+|.++.+++ .||||.+.... .....+.+.+|+.+|++++|||||++++++.+++.
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 45789999999999999999999987665 58899886543 23345779999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
+|+|||||+||+|.+++... +.+++..+..++.||++||+|||++||+||||||+|||++.++++||+|||+|+.....
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999999988774 46999999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCC---cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCH
Q 014909 165 RDDGL---LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSF 239 (416)
Q Consensus 165 ~~~~~---~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 239 (416)
..... .....||+.|+|||++.+..|+ .++|||||||++|||+| |+.||.+.+..+....+..+ ..+.|..+++
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 260 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS 260 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchH
Confidence 22111 1224579999999999887775 89999999999999998 89999998888888777655 3566777999
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 240 TARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 240 ~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
++.+|+.+||+.||++|||+.||+++
T Consensus 261 ~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 261 ALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=424.53 Aligned_cols=256 Identities=23% Similarity=0.354 Sum_probs=219.7
Q ss_pred ccCEEEEeE-EeecCceEEEEEEECC--CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 10 VGKYEVGRT-IGEGTFAKVKFARNSE--TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 10 ~~~y~~~~~-LG~G~fg~V~~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
-++|.+.+. ||+|+||+||+|.++. ++..||||+++... .....+.+.+|+.+|++++|||||++++++.++ .+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~ 83 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-AL 83 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eE
Confidence 357888885 9999999999998764 34579999997543 334467899999999999999999999998754 58
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
|+|||||+||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 9999999999999988654 579999999999999999999999999999999999999999999999999998654322
Q ss_pred C-CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHH
Q 014909 166 D-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (416)
Q Consensus 166 ~-~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 242 (416)
. .......+||+.|+|||++.+..++ .++|||||||++|||+| |+.||.+.+..+....+..+ .+..|+.+|+++.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 242 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 242 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 1 1223355789999999999887775 89999999999999998 99999998888887777665 4577888999999
Q ss_pred HHHHHhcCCCCCCCCCHhHH---hcCcccc
Q 014909 243 KLIARILDPNPMTRITIPEI---LEDEWFK 269 (416)
Q Consensus 243 ~ll~~~L~~dP~~R~t~~ei---l~h~~~~ 269 (416)
+||.+||+.||++|||+.+| |+|+|+.
T Consensus 243 ~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 243 ALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999888 5678875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-56 Score=432.35 Aligned_cols=261 Identities=26% Similarity=0.445 Sum_probs=215.0
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----EE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----KI 86 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~ 86 (416)
.+|++++.||+|+||+||+|.+..+|+.||||++++.. .....+.+.+|+.+|+.++||||+++++++.... ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 57999999999999999999999999999999997644 3445678899999999999999999999997653 23
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
+++|+|+.||+|++++.. .++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|........
T Consensus 86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 444455668999999976 5799999999999999999999999999999999999999999999999999976544322
Q ss_pred -CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC----------------
Q 014909 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---------------- 229 (416)
Q Consensus 167 -~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~---------------- 229 (416)
.......+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+...........
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 223456789999999999977666678999999999999999999999887755443332110
Q ss_pred ---------cc------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCCCC
Q 014909 230 ---------EF------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (416)
Q Consensus 230 ---------~~------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (416)
.. ...+.+|+++++||.+||+.||.+|||++|+|+||||+....+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 00 1123578899999999999999999999999999999866543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.7e-57 Score=426.55 Aligned_cols=250 Identities=25% Similarity=0.361 Sum_probs=217.2
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
..++|++.+.||+|+||+||+|.+..+|+.||||+++.+.. ..+++.+|+.+|++++|||||++++++.+++.+|+
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 45689999999999999999999999999999999976542 24678999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 89 VLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+......
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~- 169 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT- 169 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC-
Confidence 99999999999999764 578999999999999999999999999999999999999999999999999998653311
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCC-CCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL-PFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~-Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 244 (416)
........||+.|+|||++.+..|+ .++||||+||++|+|++|.. ||.+.+....+..+..+ .+..|+.+|+++.+|
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 248 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 248 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHH
Confidence 1122334688999999999988875 89999999999999999655 55566666666666544 456777899999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc
Q 014909 245 IARILDPNPMTRITIPEILE 264 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~ 264 (416)
|.+||+.||++|||++++++
T Consensus 249 i~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 249 MRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999965
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-56 Score=419.39 Aligned_cols=248 Identities=24% Similarity=0.394 Sum_probs=208.8
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
.+|++++.||+|+||.||+|.+. +++.||||+++..... .+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 57999999999999999999986 5678999999764432 356889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 91 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++++||+|||+|+....... ..
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 158 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc-ee
Confidence 999999999998765 5689999999999999999999999999999999999999999999999999976543221 22
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHHHH
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIAR 247 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll~~ 247 (416)
.....||+.|+|||++.+..|+ .++||||+||++|||+| |.+||...+..+....+..+ ....|..+++++.+|+.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 3446799999999999988875 89999999999999998 68888888887888777665 345667789999999999
Q ss_pred hcCCCCCCCCCHhHHhcC
Q 014909 248 ILDPNPMTRITIPEILED 265 (416)
Q Consensus 248 ~L~~dP~~R~t~~eil~h 265 (416)
||+.||++|||+++|++|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-56 Score=431.63 Aligned_cols=262 Identities=30% Similarity=0.547 Sum_probs=226.0
Q ss_pred ccccCEEEEeEEeecCceEEEEEEEC---CCCCeEEEEEeechhhhc-HHHHHHHHHHHHHHhcCCC-CCcceEEEEEEe
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLK-HKMAEQIKREVATMKLVKH-PNVVRLYEVMGS 82 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~---~~~~~vaiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~ 82 (416)
..+++|++++.||+|+||+||+|.+. .+|+.||||++++..... ....+.+.+|+.+|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 45688999999999999999999974 468999999997654322 2234668899999999976 899999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccc
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~ 162 (416)
...+|++|||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999997654
Q ss_pred cccCCCCcccccCCcccccchhhccCC-CCCChhhHHHHHHHHHHHhhCCCCCCCCchH----HHHHHhhcCccCCCCCC
Q 014909 163 QVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLM----NLYKKISAAEFTCPPWL 237 (416)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPEvl~~~~-~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~ 237 (416)
... .....+.+||+.|+|||.+.+.. +.+.++|||||||+||+|++|+.||.+.+.. .............|..+
T Consensus 181 ~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (322)
T d1vzoa_ 181 ADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259 (322)
T ss_dssp GGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred ccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence 322 23345678999999999997654 4468999999999999999999999875433 33444455667778889
Q ss_pred CHHHHHHHHHhcCCCCCCCC-----CHhHHhcCccccc
Q 014909 238 SFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 270 (416)
Q Consensus 238 s~~~~~ll~~~L~~dP~~R~-----t~~eil~h~~~~~ 270 (416)
|+++.+||++||++||++|| |++|+++||||+.
T Consensus 260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 99999999999999999999 5899999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-56 Score=432.61 Aligned_cols=250 Identities=30% Similarity=0.389 Sum_probs=209.9
Q ss_pred CEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe------CCE
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------KTK 85 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~~ 85 (416)
+|+..+.||+|+||+||+|++..+|+.||||++.+... ...+|+.+|++++||||+++++++.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 69999999999999999999999999999999976542 23479999999999999999999843 345
Q ss_pred EEEEEeccCCCchHH---HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC-CeEEeeccccccc
Q 014909 86 IFIVLEFVTGGELFD---KIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALS 161 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~---~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~-~vkl~DFGla~~~ 161 (416)
+|+||||++++.+.. .......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|...
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 899999998764322 234456799999999999999999999999999999999999999875 8999999998754
Q ss_pred ccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC------------
Q 014909 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------ 229 (416)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~------------ 229 (416)
.. .....+.+||+.|+|||++.+..+++.++||||+||++|+|++|+.||...+....+..+...
T Consensus 174 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 32 334556789999999999887665579999999999999999999999988766655444210
Q ss_pred -----ccC------------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccC
Q 014909 230 -----EFT------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (416)
Q Consensus 230 -----~~~------------~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (416)
... ..+.+++++.+||++||+.||++|||+.|+|+||||+.-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 011 123478999999999999999999999999999999764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-56 Score=421.21 Aligned_cols=254 Identities=21% Similarity=0.363 Sum_probs=218.1
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 88 (416)
.-++|++++.||+|+||+||+|.++ ++..||||+++..... .+.+.+|+.+|++++|||||++++++.+ +..|+
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 4478999999999999999999985 5778999999764422 3568999999999999999999998754 56799
Q ss_pred EEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccC
Q 014909 89 VLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 166 (416)
||||+++|+|.+++... .++++..+..++.||+.||+|||++||+||||||+||||++++.+||+|||+|+......
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~- 163 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE- 163 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc-
Confidence 99999999999977543 369999999999999999999999999999999999999999999999999998654321
Q ss_pred CCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 014909 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (416)
Q Consensus 167 ~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 244 (416)
........||+.|+|||++.+..|+ .++|||||||++|||+| |.+||...+.......+..+ ....|..+++++.+|
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 242 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHH
Confidence 1223456789999999999877774 89999999999999999 56677777777777777665 456678899999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc--Cccccc
Q 014909 245 IARILDPNPMTRITIPEILE--DEWFKK 270 (416)
Q Consensus 245 l~~~L~~dP~~R~t~~eil~--h~~~~~ 270 (416)
+.+||+.||++|||++++++ |+||..
T Consensus 243 i~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 243 MRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 99999999999999999998 788853
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=412.95 Aligned_cols=248 Identities=23% Similarity=0.389 Sum_probs=220.7
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 90 (416)
.+|++++.||+|+||+||+|+++ +++.||||++++.... .+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 57899999999999999999985 6788999999875432 356889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCCCC
Q 014909 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (416)
Q Consensus 91 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 169 (416)
||+++|+|.+++.. ...+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+|...... ....
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC-Ccee
Confidence 99999999998665 457999999999999999999999999999999999999999999999999999765432 2223
Q ss_pred cccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHHHHHH
Q 014909 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIAR 247 (416)
Q Consensus 170 ~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ll~~ 247 (416)
....+||+.|+|||++.+..|+ .++|||||||++|||+| |+.||.+.+..+...++..+ ....|...++++.+||++
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence 3456799999999999988875 89999999999999998 89999999988888888765 445677789999999999
Q ss_pred hcCCCCCCCCCHhHHhcC
Q 014909 248 ILDPNPMTRITIPEILED 265 (416)
Q Consensus 248 ~L~~dP~~R~t~~eil~h 265 (416)
||+.||++|||+++|++|
T Consensus 237 cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=429.24 Aligned_cols=256 Identities=27% Similarity=0.366 Sum_probs=215.7
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----C
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-----T 84 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 84 (416)
-++|++++.||+|+||+||+|++..+|+.||||++.+... .....+++.+|+.+|+.++|||||++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3689999999999999999999999999999999987543 333456789999999999999999999998643 3
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
..+++|+|+.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|.....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence 34666777889999998854 6799999999999999999999999999999999999999999999999999875432
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcCccCC-----------
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----------- 233 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~~~~~----------- 233 (416)
...+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 174 ----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 174 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp ----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred ----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 34567899999999999887777899999999999999999999999887766555543221111
Q ss_pred --------------------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 234 --------------------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 234 --------------------~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
...+|+++++||++||+.||.+|||++|+|+||||++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 124789999999999999999999999999999998654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.7e-55 Score=421.23 Aligned_cols=250 Identities=25% Similarity=0.452 Sum_probs=209.6
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEe--CCE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGS--KTK 85 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~ 85 (416)
..++|++++.||+|+||+||+|++..+|+.||||++++.. .+++.+|+.+|+.++ ||||+++++++.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 4578999999999999999999999999999999997543 356889999999996 9999999999974 456
Q ss_pred EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC-CeEEeecccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQV 164 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~ 164 (416)
+|+||||+.+++|.... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~- 182 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 182 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT-
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC-
Confidence 99999999999987653 5699999999999999999999999999999999999998765 599999999986543
Q ss_pred cCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH-HHHHHhh-------------cCc
Q 014909 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKIS-------------AAE 230 (416)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~-~~~~~i~-------------~~~ 230 (416)
.......+||+.|+|||++.+....+.++||||+||++|+|++|..||...... .....+. ...
T Consensus 183 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred --CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 233456789999999999987765569999999999999999999999765422 1111110 000
Q ss_pred c------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccc
Q 014909 231 F------------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (416)
Q Consensus 231 ~------------------------~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~ 270 (416)
. .....+|+++.+||++||+.||.+|||++|+|+||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0 011226889999999999999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-55 Score=410.84 Aligned_cols=251 Identities=27% Similarity=0.404 Sum_probs=207.2
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCC---CeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
-++|++++.||+|+||+||+|.+..++ ..||||.+.... .....+.+.+|+.+|++++|||||++++++. .+.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 368999999999999999999987543 458888875432 3445678999999999999999999999985 4678
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
|+||||+++|+|.+++... ..+++..++.++.||++||.|||++||+||||||+||+++.++.+||+|||+|+.....
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~- 161 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS- 161 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC-
Confidence 9999999999999987654 57999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 243 (416)
........+||+.|+|||++.+..|. .++|||||||++|||++ |.+||.+.+..+.+.++..+. .+.|+.+|+++.+
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 12233456789999999999987775 89999999999999997 999999988888888776664 5678889999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcC
Q 014909 244 LIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~h 265 (416)
||.+||+.||++|||+.||++|
T Consensus 241 li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 241 LMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-55 Score=419.31 Aligned_cols=252 Identities=23% Similarity=0.370 Sum_probs=211.8
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCC----eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 86 (416)
.+|++++.||+|+||+||+|.+..+|+ .||+|.+.... .....+.+.+|+.+|++++|||||++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 679999999999999999999988876 57888876432 223467799999999999999999999999865 56
Q ss_pred EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+++|||+.+|+|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 7888999999999888764 579999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc-cCCCCCCCHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 243 (416)
.........||+.|+|||++.+..|+ .++|||||||++|||+| |.+||.+.+..++...+..+. +..|+.+++++.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 33333445789999999999988775 89999999999999998 899999888777777776654 5677889999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCc
Q 014909 244 LIARILDPNPMTRITIPEILEDE 266 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~h~ 266 (416)
|+.+||+.||.+|||+.||++|.
T Consensus 245 li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHHH
Confidence 99999999999999999999874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-54 Score=407.30 Aligned_cols=253 Identities=21% Similarity=0.313 Sum_probs=208.7
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCC----CeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETG----EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
....|++.+.||+|+||+||+|.+..++ ..||||++..... ......+.+|+.+|++++|||||++++++.+..
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 4467999999999999999999987654 3699999975432 334567899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
..++||||+.+|++.+.+... +.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999999988765 5799999999999999999999999999999999999999999999999999986543
Q ss_pred ccCC-CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhC-CCCCCCCchHHHHHHhhcC-ccCCCCCCCHH
Q 014909 164 VRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (416)
Q Consensus 164 ~~~~-~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G-~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 240 (416)
.... .......||+.|+|||++.+..|+ .++|||||||++|||++| .+||.+.+.......+..+ ..+.|..++.+
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 241 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 241 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred CCccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHH
Confidence 2221 122345789999999999887775 899999999999999985 5666666777777776654 45667779999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 241 ARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+.+||.+||+.||++|||+.||++
T Consensus 242 l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 242 IYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHCcCCHhHCcCHHHHHH
Confidence 999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=424.79 Aligned_cols=255 Identities=26% Similarity=0.446 Sum_probs=205.0
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE------eC
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG------SK 83 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~------~~ 83 (416)
..+|++++.||+|+||+||+|+++.+|+.||||++.+... ......++.+|+.+|++++|||||++++++. +.
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 4789999999999999999999999999999999987654 3445678999999999999999999999995 34
Q ss_pred CEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccc
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 163 (416)
..+|+||||+.|+ +.+.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++.....
T Consensus 95 ~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 95 QDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 7899999999765 55555 35799999999999999999999999999999999999999999999999999875443
Q ss_pred ccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHHhhcC--------------
Q 014909 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------------- 229 (416)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~i~~~-------------- 229 (416)
.......+||+.|+|||++.+..+. +++||||+||++|+|++|++||.+.+......++...
T Consensus 172 ---~~~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 172 ---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ---ccccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 2334566899999999999987775 8999999999999999999999987766554443210
Q ss_pred --------ccCC--------------C------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccccCC
Q 014909 230 --------EFTC--------------P------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (416)
Q Consensus 230 --------~~~~--------------~------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (416)
.... + ...|+++.+||++||..||++|||++|+|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 0000 0 01366889999999999999999999999999998754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-54 Score=408.56 Aligned_cols=256 Identities=23% Similarity=0.382 Sum_probs=214.0
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 87 (416)
...++|++++.||+|+||+||+|++..+ +.||||++...... .+.+.+|+.+|++++|||||++++++.+ +.+|
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~ 87 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 87 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence 3457899999999999999999999754 57999999765432 3568999999999999999999999854 5679
Q ss_pred EEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 88 IVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+||||+++|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+......
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 99999999999988764 3579999999999999999999999999999999999999999999999999997653321
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (416)
.......+||+.|+|||++.+..+. .++||||+||++|||++ |.+||.+....+....+..+ ..+.|+.+|+++.+
T Consensus 168 -~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 245 (285)
T d1fmka3 168 -YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred -ceeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHH
Confidence 1223446799999999999887775 89999999999999999 46666777777777776554 45678889999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhc--CcccccC
Q 014909 244 LIARILDPNPMTRITIPEILE--DEWFKKD 271 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~--h~~~~~~ 271 (416)
||.+||+.||++|||+++|++ ++||...
T Consensus 246 li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 246 LMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 999999999999999999988 8888754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-54 Score=410.10 Aligned_cols=252 Identities=24% Similarity=0.339 Sum_probs=219.5
Q ss_pred ccCEEEEeEEeecCceEEEEEEEC-----CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 84 (416)
-++|++++.||+|+||+||+|+.+ .+++.||||+++... .....+.+.+|+.+|++++||||+++++++.+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 457999999999999999999875 356789999997543 2334678999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCC
Q 014909 85 KIFIVLEFVTGGELFDKIVNHG------------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPE 140 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~------------------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~ 140 (416)
..+++|||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 9999999999999999996532 3788999999999999999999999999999999
Q ss_pred cEEeccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCC-CCCCCCch
Q 014909 141 NLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY-LPFDDSNL 219 (416)
Q Consensus 141 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~-~Pf~~~~~ 219 (416)
|||++.++++||+|||+|+............+.+||+.|+|||++.+..|+ .++|||||||++|||++|. +||.+.+.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 999999999999999999866554444445567899999999999988875 8999999999999999984 78998888
Q ss_pred HHHHHHhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 220 MNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 220 ~~~~~~i~~~~~-~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.+....+..+.. ..|..+++++.+||.+||+.||++|||+.||++
T Consensus 249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888888776654 456779999999999999999999999999964
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-54 Score=411.69 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=203.4
Q ss_pred ccCEEEEeEEeecCceEEEEEEECC-----CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe-
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS- 82 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~- 82 (416)
-++|++++.||+|+||+||+|.+.. +++.||||++..... ....+.+.+|..++.++ +||||+.+++++..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 4789999999999999999999754 456899999875432 22346677787777766 68999999998765
Q ss_pred CCEEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc
Q 014909 83 KTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA 146 (416)
Q Consensus 83 ~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~ 146 (416)
...+|+|||||++|+|.+++... ..+++..+..++.||++||+|||++||+||||||+|||++.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 45689999999999999999753 24889999999999999999999999999999999999999
Q ss_pred CCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhC-CCCCCCCchHHH-HH
Q 014909 147 YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNL-YK 224 (416)
Q Consensus 147 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G-~~Pf~~~~~~~~-~~ 224 (416)
++++||+|||+|+..............+||+.|+|||++.+..|+ .++|||||||++|||++| .+||.+.+.... ..
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999865544333344566899999999999987774 899999999999999986 678887654433 33
Q ss_pred Hhhc-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 225 KISA-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 225 ~i~~-~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.+.. ..+..|..+++++.+||.+||+.||++|||++||++|
T Consensus 249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3433 3456777899999999999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=407.80 Aligned_cols=253 Identities=23% Similarity=0.415 Sum_probs=218.3
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCC-------CeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETG-------EPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVM 80 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 80 (416)
..++|++++.||+|+||.||+|++..++ ..||||++++... ......+.+|...+.++ +|||||++++++
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 4579999999999999999999876544 3699999976542 23356788888888888 799999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEe
Q 014909 81 GSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL 144 (416)
Q Consensus 81 ~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl 144 (416)
.++..+|+||||+++|+|.++|.... .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 99999999999999999999997543 48999999999999999999999999999999999999
Q ss_pred ccCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHH
Q 014909 145 DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLY 223 (416)
Q Consensus 145 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~ 223 (416)
+.++.+||+|||++...............+||+.|+|||++.+..|+ .++|||||||++|+|++ |.+||.+.+....+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 99999999999999877665555555667899999999999988875 89999999999999998 79999998888888
Q ss_pred HHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 224 KKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 224 ~~i~~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
..+..+ .+..|.++|+++.+||.+||+.||++|||+.||++
T Consensus 248 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 877654 46778889999999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=406.44 Aligned_cols=254 Identities=26% Similarity=0.399 Sum_probs=206.6
Q ss_pred cccCEEEEeEEeecCceEEEEEEECC-CCC--eEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSE-TGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~-~~~--~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 85 (416)
.-++|++.+.||+|+||+||+|+... +++ .||||++.+.........+.+.+|+.+|++++|||||++++++.+ ..
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 34679999999999999999998643 333 689999987766566667889999999999999999999999976 46
Q ss_pred EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccc
Q 014909 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (416)
Q Consensus 86 ~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 164 (416)
.++||||+++|+|.+.+... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 78999999999999877654 57999999999999999999999999999999999999999999999999999865433
Q ss_pred cCCC-CcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcCc--cCCCCCCCHH
Q 014909 165 RDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE--FTCPPWLSFT 240 (416)
Q Consensus 165 ~~~~-~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~ 240 (416)
.... .....+||+.|+|||++.+..++ .++|||||||++|||+| |..||.+.+..+...++.... ++.|+.+|++
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred CCcceecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHH
Confidence 2222 22345678899999999987664 88999999999999998 899999999988888876554 3556678999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 241 ARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 241 ~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
+.+||.+||+.||++|||+.+|++
T Consensus 244 l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 244 IYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999963
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-54 Score=410.18 Aligned_cols=252 Identities=22% Similarity=0.352 Sum_probs=216.0
Q ss_pred ccccCEEEEeEEeecCceEEEEEEECCCCCe--EEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 014909 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEP--VALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~--vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 84 (416)
...++|++.+.||+|+||+||+|.++.+|.. ||||.+.... .....+.+.+|+.+|+++ +|||||++++++.+.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 4667999999999999999999999888775 6677765332 233456799999999998 7999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCC
Q 014909 85 KIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~ 148 (416)
..|+||||++||+|.++|... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999754 5699999999999999999999999999999999999999999
Q ss_pred CeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhC-CCCCCCCchHHHHHHhh
Q 014909 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKIS 227 (416)
Q Consensus 149 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G-~~Pf~~~~~~~~~~~i~ 227 (416)
.+||+|||+|...... ......+||+.|+|||.+.+..|+ .++|||||||++|+|++| .+||.+.+...+...+.
T Consensus 165 ~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred ceEEcccccccccccc---ccccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999754432 222456799999999999888775 899999999999999996 56899888888888876
Q ss_pred cC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 014909 228 AA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 228 ~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h 265 (416)
.+ .+..|..+++++.+||.+||+.||++|||+.+|++|
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 65 566677899999999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=399.86 Aligned_cols=244 Identities=24% Similarity=0.441 Sum_probs=207.9
Q ss_pred cccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE-eCCEEE
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG-SKTKIF 87 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~ 87 (416)
..++|++++.||+|+||.||+|.++ |..||||+++++. ..+.+.+|+.+|++++||||+++++++. +.+.+|
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 4678999999999999999999984 7789999997543 2467899999999999999999999885 456689
Q ss_pred EEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccccccccccc
Q 014909 88 IVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (416)
Q Consensus 88 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 165 (416)
+||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++|+||||||+|||++.+|++||+|||+++....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-- 155 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 155 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC--
Confidence 9999999999999997643 589999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHHHhhcC-ccCCCCCCCHHHHH
Q 014909 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (416)
Q Consensus 166 ~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (416)
.....++|+.|+|||++.+..+ +.++|||||||++|||+| |++||...+..+....+..+ .+.+|+.+++++.+
T Consensus 156 ---~~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (262)
T d1byga_ 156 ---TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHH
T ss_pred ---CCccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 2345678999999999988777 489999999999999998 89999998888888777654 56778889999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcC
Q 014909 244 LIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~h 265 (416)
||++||+.||.+|||+.+++++
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHHH
Confidence 9999999999999999999873
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-53 Score=404.42 Aligned_cols=253 Identities=19% Similarity=0.274 Sum_probs=221.0
Q ss_pred cccCEEEEeEEeecCceEEEEEEECC-----CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014909 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (416)
Q Consensus 9 ~~~~y~~~~~LG~G~fg~V~~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 83 (416)
..++|++++.||+|+||+||+|.+.. ++..||||+++... .......+.+|+.++++++|||||++++++...
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 44899999999999999999998752 35789999997543 233456789999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEe
Q 014909 84 TKIFIVLEFVTGGELFDKIVNH----------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~----------~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~ 153 (416)
...++||||+++|+|.+++... ..++...+..++.|+++||.|||+++|+||||||+|||+++++++||+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence 9999999999999999988653 247889999999999999999999999999999999999999999999
Q ss_pred ecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhC-CCCCCCCchHHHHHHhhcCc-c
Q 014909 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAAE-F 231 (416)
Q Consensus 154 DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G-~~Pf~~~~~~~~~~~i~~~~-~ 231 (416)
|||+|+..............+||+.|+|||.+.+..+. .++|||||||++|||++| .+||.+.+..+.+..+..+. .
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~ 254 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence 99999866544333334455789999999999987775 899999999999999998 68999988888888776654 4
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 232 ~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
..|+.+++.+.+||.+||+.||++|||+++|++
T Consensus 255 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 567789999999999999999999999999997
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=401.95 Aligned_cols=252 Identities=21% Similarity=0.365 Sum_probs=215.6
Q ss_pred ccCEEEEeEEeecCceEEEEEEEC-----CCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 83 (416)
-++|++++.||+|+||.||+|+.. .+++.||||++++... ......+.+|+.+++.+ +|||||++++++.++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 478999999999999999999853 4667899999976542 33456789999999999 699999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEec
Q 014909 84 TKIFIVLEFVTGGELFDKIVNHG------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD 145 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L~~~i~~~~------------------~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~ 145 (416)
...|+|||||++|+|.+++.... .+++..+..++.||+.||+|||++|++||||||+|||++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 99999999999999999997643 589999999999999999999999999999999999999
Q ss_pred cCCCeEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCCchHHHHH
Q 014909 146 AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYK 224 (416)
Q Consensus 146 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~-G~~Pf~~~~~~~~~~ 224 (416)
.++.+|++|||+++..............+||+.|+|||++.+..+ +.++|||||||++|+|+| |.+||...+....+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999987654333333455689999999999987766 489999999999999998 777777766655444
Q ss_pred Hh-hcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 225 KI-SAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 225 ~i-~~~-~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
++ ..+ ....|..+|+++.+||.+||+.||++|||+++|++
T Consensus 259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 33 332 34556678999999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=387.28 Aligned_cols=250 Identities=22% Similarity=0.287 Sum_probs=205.4
Q ss_pred EEEEeEEeecCceEEEEEEECCCC---CeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CCEEEE
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KTKIFI 88 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~l 88 (416)
+.+.+.||+|+||+||+|.+..++ ..||||.+++. ......+++.+|+.+|++++|||||++++++.. +...++
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence 345789999999999999987643 25899998743 244456889999999999999999999999765 568999
Q ss_pred EEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeecccccccccccCC
Q 014909 89 VLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 167 (416)
|||||++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||+++++.+||+|||+++........
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999999999887543 5778899999999999999999999999999999999999999999999999865432211
Q ss_pred --CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCC-CchHHHHHHhhcC-ccCCCCCCCHHHHH
Q 014909 168 --GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAA-EFTCPPWLSFTARK 243 (416)
Q Consensus 168 --~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~-~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 243 (416)
.......||+.|+|||++....+ +.++|||||||++|||++|..||.. .+.......+..+ .+..|+.+++++.+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~ 265 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 265 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHH
Confidence 12234578999999999988777 4899999999999999997777654 3333444444443 45677889999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcC
Q 014909 244 LIARILDPNPMTRITIPEILED 265 (416)
Q Consensus 244 ll~~~L~~dP~~R~t~~eil~h 265 (416)
||.+||+.||++|||+.||++|
T Consensus 266 li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 266 VMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-50 Score=385.02 Aligned_cols=257 Identities=20% Similarity=0.265 Sum_probs=204.4
Q ss_pred cc-cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCEE
Q 014909 9 RV-GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMGSKTKI 86 (416)
Q Consensus 9 ~~-~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~ 86 (416)
++ ++|++++.||+|+||.||+|++..+|+.||||++..+.. ...+.+|+.+++.++|+| |+.+..++.+.+..
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence 45 479999999999999999999999999999999876532 234778999999998766 55556667888999
Q ss_pred EEEEeccCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc---CCCeEEeecccccccc
Q 014909 87 FIVLEFVTGGELFDKIV-NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDFGLSALSQ 162 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~---~~~vkl~DFGla~~~~ 162 (416)
++||||+.+ +|.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+...
T Consensus 79 ~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 79 VMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 999999955 5655554 4568999999999999999999999999999999999999854 4579999999998764
Q ss_pred cccCC-----CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchHHHHHH---hhcC-----
Q 014909 163 QVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK---ISAA----- 229 (416)
Q Consensus 163 ~~~~~-----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~~~~~~---i~~~----- 229 (416)
..... ....+.+||+.|+|||++.+.+++ .++|||||||++|+|++|..||........... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 43221 123456899999999999988875 899999999999999999999987554332221 1111
Q ss_pred ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhH---HhcCcccccCC
Q 014909 230 EFTCPPWLSFTARKLIARILDPNPMTRITIPE---ILEDEWFKKDY 272 (416)
Q Consensus 230 ~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e---il~h~~~~~~~ 272 (416)
....++.+|+++.+||.+||+.||++||++.+ +|+|+|.+...
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~ 282 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence 11234568999999999999999999999874 56788776554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.9e-49 Score=374.53 Aligned_cols=248 Identities=21% Similarity=0.272 Sum_probs=206.7
Q ss_pred ccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCC-CCcceEEEEEEeCCEEEE
Q 014909 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 10 ~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~l 88 (416)
-++|++++.||+|+||+||+|++..+|+.||||++..... ...+++|+.+++.++| +|++.+++++......|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 4689999999999999999999999999999999865432 2347789999999975 899999999999999999
Q ss_pred EEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEecc-----CCCeEEeecccccccc
Q 014909 89 VLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-----YGNLKVSDFGLSALSQ 162 (416)
Q Consensus 89 V~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~-----~~~vkl~DFGla~~~~ 162 (416)
||||+ |++|.+.+...+ .+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 679999887654 6999999999999999999999999999999999999974 5789999999998754
Q ss_pred cccCC-----CCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCch---HHHHHHhhcCc----
Q 014909 163 QVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---MNLYKKISAAE---- 230 (416)
Q Consensus 163 ~~~~~-----~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~---~~~~~~i~~~~---- 230 (416)
..... ....+.+||+.|||||++.+..++ .++|||||||++|+|++|..||.+... ...+.++....
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 32211 223456899999999999988775 899999999999999999999976432 23333332211
Q ss_pred -cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 231 -FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 231 -~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
...++.+|+++.+++..|+..+|++||+++.+.+
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1223568899999999999999999999877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-49 Score=374.78 Aligned_cols=247 Identities=21% Similarity=0.315 Sum_probs=192.5
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----EE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----KI 86 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~ 86 (416)
.+|.+.+.||+|+||.||+|+. +|+.||||+++.+.. .....+.|+..++.++|||||++++++.+.. .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 5789999999999999999987 588999999975432 1222345666667889999999999987543 68
Q ss_pred EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcEeecCCCCcEEeccCCCeEEeecccc
Q 014909 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS--------RGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (416)
Q Consensus 87 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~--------~givHrDlkp~NILl~~~~~vkl~DFGla 158 (416)
|+||||+++|+|.+++.+. ++++.....++.|++.||+|||+ +||+||||||+||||+.++++||+|||++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999999874 69999999999999999999996 59999999999999999999999999999
Q ss_pred cccccccC--CCCcccccCCcccccchhhccCCC-----CCChhhHHHHHHHHHHHhhCCCCCCCC--------------
Q 014909 159 ALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGY-----DGSTADLWSCGVILFVLLAGYLPFDDS-------------- 217 (416)
Q Consensus 159 ~~~~~~~~--~~~~~~~~gt~~y~aPEvl~~~~~-----~~~~~DIwSlGvil~~ml~G~~Pf~~~-------------- 217 (416)
........ .......+||+.|+|||++.+... .+.++|||||||+||||+||..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 86543221 123345689999999999876431 246899999999999999998887431
Q ss_pred -chHHHHHHhhcCcc--CCCCC-----CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 014909 218 -NLMNLYKKISAAEF--TCPPW-----LSFTARKLIARILDPNPMTRITIPEILE 264 (416)
Q Consensus 218 -~~~~~~~~i~~~~~--~~~~~-----~s~~~~~ll~~~L~~dP~~R~t~~eil~ 264 (416)
.............. .+|.. ....+.+|+.+||+.||++|||+.||++
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 11222222222222 22221 1235889999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-47 Score=374.90 Aligned_cols=250 Identities=23% Similarity=0.435 Sum_probs=195.8
Q ss_pred cCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-----------CCCcceEEEE
Q 014909 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-----------HPNVVRLYEV 79 (416)
Q Consensus 11 ~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l~~~ 79 (416)
+||++++.||+|+||+||+|++..+|+.||||+++++.. ..+.+.+|+.+++.++ ||||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 579999999999999999999999999999999986542 2456778888888775 5789999988
Q ss_pred EE--eCCEEEEEEeccCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCcEEeccCCC----
Q 014909 80 MG--SKTKIFIVLEFVTGGELFDKI---VNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGN---- 149 (416)
Q Consensus 80 ~~--~~~~~~lV~E~~~gg~L~~~i---~~~~~l~e~~~~~~~~qll~al~~LH~-~givHrDlkp~NILl~~~~~---- 149 (416)
+. .....+++|+++..+...... .....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 75 446677777777665433322 234579999999999999999999998 89999999999999987654
Q ss_pred --eEEeecccccccccccCCCCcccccCCcccccchhhccCCCCCChhhHHHHHHHHHHHhhCCCCCCCCchH------H
Q 014909 150 --LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM------N 221 (416)
Q Consensus 150 --vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPEvl~~~~~~~~~~DIwSlGvil~~ml~G~~Pf~~~~~~------~ 221 (416)
++++|||.|..... .....+||+.|+|||++.+..|+ .++||||+||++++|++|+.||...+.. .
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 99999999875432 23567899999999999988885 8999999999999999999999754321 1
Q ss_pred HHHHh-h--c---------------------------------------CccCCCCCCCHHHHHHHHHhcCCCCCCCCCH
Q 014909 222 LYKKI-S--A---------------------------------------AEFTCPPWLSFTARKLIARILDPNPMTRITI 259 (416)
Q Consensus 222 ~~~~i-~--~---------------------------------------~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~ 259 (416)
....+ . . .....+...++++.+||.+||+.||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 11000 0 0 0001111236789999999999999999999
Q ss_pred hHHhcCccccc
Q 014909 260 PEILEDEWFKK 270 (416)
Q Consensus 260 ~eil~h~~~~~ 270 (416)
+|+|+||||+.
T Consensus 323 ~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 323 GGLVNHPWLKD 333 (362)
T ss_dssp HHHHTCGGGTT
T ss_pred HHHhcCcccCC
Confidence 99999999984
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=1.7e-27 Score=210.90 Aligned_cols=136 Identities=18% Similarity=0.283 Sum_probs=109.5
Q ss_pred EEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhh---------------cHHHHHHHHHHHHHHhcCCCCCcceEE
Q 014909 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL---------------KHKMAEQIKREVATMKLVKHPNVVRLY 77 (416)
Q Consensus 13 y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~---------------~~~~~~~~~~Ei~il~~l~hpnIv~l~ 77 (416)
|.+++.||+|+||+||+|.+. +|+.||||+++..... .........+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 468999999999999999985 6899999987642211 111234566789999999999999988
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCcEEeccCCCeEEeeccc
Q 014909 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (416)
Q Consensus 78 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~~givHrDlkp~NILl~~~~~vkl~DFGl 157 (416)
++.. .+++|||++++.+. .+++..+..++.||+.+|+|||++||+||||||+|||++++ .++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 7642 27999999986543 25566778899999999999999999999999999999875 489999999
Q ss_pred cccc
Q 014909 158 SALS 161 (416)
Q Consensus 158 a~~~ 161 (416)
|...
T Consensus 149 a~~~ 152 (191)
T d1zara2 149 SVEV 152 (191)
T ss_dssp CEET
T ss_pred cccC
Confidence 8654
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.31 E-value=1.1e-12 Score=101.28 Aligned_cols=76 Identities=14% Similarity=0.248 Sum_probs=70.7
Q ss_pred eEecCCHHHHHHHHHHhcccCCcEEEee-cceEEEEEeecCCCcceEEEEEEEEEc-CCeEEEEEEEcCCCccceecC
Q 014909 341 FTSRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVA-PSLHMVEVRKAKGDTLEFHKV 416 (416)
Q Consensus 341 f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~v~~~~~~gd~~e~~~~ 416 (416)
.||+.+|++|+.+|+++++.+|+.|+++ +|.++++...+++++.+.|.++|+++. +++++|+|+|..||.++|++|
T Consensus 15 tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~l 92 (102)
T d1ul7a_ 15 TTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNI 92 (102)
T ss_dssp CCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHHH
T ss_pred cCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHHH
Confidence 3799999999999999999999999877 699999888888899999999999996 799999999999999999874
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.78 E-value=1.6e-08 Score=81.16 Aligned_cols=72 Identities=17% Similarity=0.298 Sum_probs=63.5
Q ss_pred eEecCCHHHHHHHHHHhcccCCcEEEee-cceEEEEEeecCCCcceEEEEEEEEEcCCeEEEEEEEcCCCccc
Q 014909 341 FTSRCPANEIINKIEEAAKPLGFDVHKK-NYKMRLENMKAGRKGNLNVATEVFQVAPSLHMVEVRKAKGDTLE 412 (416)
Q Consensus 341 f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~v~~~~~~gd~~e 412 (416)
+.|+..|.+||.+|.+|+++||+.|++. .|.++++.........++|.+++|+++++.|||||++..|+..|
T Consensus 5 IrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e 77 (153)
T d2v8qa1 5 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 77 (153)
T ss_dssp EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence 5688899999999999999999999976 79999988777667789999999999999999999999998655
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.78 E-value=9.5e-09 Score=92.85 Aligned_cols=148 Identities=17% Similarity=0.155 Sum_probs=105.0
Q ss_pred cccccccccCEEEEeEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEE
Q 014909 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMG 81 (416)
Q Consensus 3 ~~~~~~~~~~y~~~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~ 81 (416)
.|.+...++.|+..+..+.++.+.||+.. .+++.+++|......... ...+.+|...++.+. +--+.+++.+..
T Consensus 6 ~~~l~~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~ 80 (263)
T d1j7la_ 6 SPELKKLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFER 80 (263)
T ss_dssp CHHHHHHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred CHHHHHhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEe
Confidence 35567788999998887767778999876 356678899876543222 334678888887764 323567788888
Q ss_pred eCCEEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------
Q 014909 82 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-------------------------------- 129 (416)
Q Consensus 82 ~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~-------------------------------- 129 (416)
+++..|+||++++|..+.+..... .....+..++...+..||+
T Consensus 81 ~~~~~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 81 HDGWSNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp ETTEEEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred cCCceEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 889999999999998776543221 1223345556666666664
Q ss_pred ---------------------------CCcEeecCCCCcEEeccCCCeEEeecccccc
Q 014909 130 ---------------------------RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (416)
Q Consensus 130 ---------------------------~givHrDlkp~NILl~~~~~vkl~DFGla~~ 160 (416)
..++|+|+.|.||++++++.+-|.||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1379999999999999866667999997653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.20 E-value=1.9e-06 Score=76.74 Aligned_cols=136 Identities=15% Similarity=0.144 Sum_probs=87.6
Q ss_pred ccccCEEEEeEEeecC-ceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCC--CcceEEEEEEeCC
Q 014909 8 RRVGKYEVGRTIGEGT-FAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP--NVVRLYEVMGSKT 84 (416)
Q Consensus 8 ~~~~~y~~~~~LG~G~-fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~~ 84 (416)
..+..+.... +..|. -+.||+... .++..+++|...... ...+..|...++.+... .+.+++.+..+++
T Consensus 8 ~~l~g~~~~~-~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~ 79 (255)
T d1nd4a_ 8 ERLFGYDWAQ-QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAG 79 (255)
T ss_dssp TTTTTCEEEE-CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS
T ss_pred HhccCCceEE-cCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeeccccc
Confidence 3445555543 44454 468998875 456678899865432 23467788888777532 3567788888888
Q ss_pred EEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 014909 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS----------------------------------- 129 (416)
Q Consensus 85 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~al~~LH~----------------------------------- 129 (416)
..++||++++|..+.+. ..+.. ....++...|.-||+
T Consensus 80 ~~~~v~~~i~G~~~~~~-----~~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (255)
T d1nd4a_ 80 RDWLLLGEVPGQDLLSS-----HLAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 151 (255)
T ss_dssp CEEEEEECCSSEETTTS-----CCCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred ceEEEEEeeeccccccc-----cccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccc
Confidence 99999999998665320 11111 111233333333332
Q ss_pred -----------------------CCcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 130 -----------------------RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 130 -----------------------~givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
..++|+|+.|.||++++++.+-|+||+.+.
T Consensus 152 ~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 152 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 137999999999999987667899999764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.14 E-value=2.7e-06 Score=81.37 Aligned_cols=81 Identities=15% Similarity=0.146 Sum_probs=51.0
Q ss_pred EeEEeecCceEEEEEEECCCCCeEEEEEeechhhh-c---HHHHHHHHHHHHHHhcCC-C--CCcceEEEEEEeCCEEEE
Q 014909 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-K---HKMAEQIKREVATMKLVK-H--PNVVRLYEVMGSKTKIFI 88 (416)
Q Consensus 16 ~~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~-~---~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~~~~~l 88 (416)
.+.||.|....||++.+..+++.+++|.-...-.. . +....+...|...|+.+. + ..+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45789999999999998777888999965431100 0 112345667888887663 2 345566654 4455678
Q ss_pred EEeccCCCch
Q 014909 89 VLEFVTGGEL 98 (416)
Q Consensus 89 V~E~~~gg~L 98 (416)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987554
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=98.10 E-value=2.6e-06 Score=66.75 Aligned_cols=65 Identities=18% Similarity=0.298 Sum_probs=54.5
Q ss_pred eeEecCCHHHHHHHHHHhcccCCcEEEee-c---------ceEEEEEeec-----CCCcceEEEEEEEEEcCCeEEEEEE
Q 014909 340 RFTSRCPANEIINKIEEAAKPLGFDVHKK-N---------YKMRLENMKA-----GRKGNLNVATEVFQVAPSLHMVEVR 404 (416)
Q Consensus 340 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---------~~~~~~~~~~-----~~~~~l~~~~~~~~~~~~~~~v~~~ 404 (416)
...|+..|.+||..|.+|+++||+.|++. + +.|+++...+ .....+.|.+++|+++++.+||||+
T Consensus 6 GIRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YLlDFK 85 (127)
T d2qrda1 6 GVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLDVK 85 (127)
T ss_dssp SEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEEEE
T ss_pred ccccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEEEEEc
Confidence 45789999999999999999999999864 3 7898875432 2334689999999999999999997
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=97.88 E-value=1e-05 Score=66.62 Aligned_cols=69 Identities=17% Similarity=0.203 Sum_probs=51.6
Q ss_pred ccceeEecCCHHHHHHHHHHhcccCCcEEEee----cceEEEEEee---------cCCCcceEEEEEEEEEcCCeEEEEE
Q 014909 337 RETRFTSRCPANEIINKIEEAAKPLGFDVHKK----NYKMRLENMK---------AGRKGNLNVATEVFQVAPSLHMVEV 403 (416)
Q Consensus 337 ~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~---------~~~~~~l~~~~~~~~~~~~~~~v~~ 403 (416)
..-...|+.+|.+||..|.+|+++||+.|++. .|.++++... ......+.|.+++|+++++.+||||
T Consensus 46 WhfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlDF 125 (171)
T d2qlva1 46 WHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDF 125 (171)
T ss_dssp CEESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEEE
T ss_pred eeeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEEE
Confidence 33446799999999999999999999999875 3888887432 1222358999999999999999999
Q ss_pred EE
Q 014909 404 RK 405 (416)
Q Consensus 404 ~~ 405 (416)
+-
T Consensus 126 K~ 127 (171)
T d2qlva1 126 KF 127 (171)
T ss_dssp EE
T ss_pred ec
Confidence 73
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.14 E-value=0.00058 Score=62.77 Aligned_cols=69 Identities=19% Similarity=0.170 Sum_probs=44.5
Q ss_pred ceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCc--ceEE-----EEEEeCCEEEEEEeccCCC
Q 014909 24 FAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV--VRLY-----EVMGSKTKIFIVLEFVTGG 96 (416)
Q Consensus 24 fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI--v~l~-----~~~~~~~~~~lV~E~~~gg 96 (416)
--.||++.. .+|+.|++|+.+.... . .+++..|...|..|...++ +... ..+......+.+++++.|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~-s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCC-C---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 357999887 4688899999875432 1 3557788888877742222 1111 1234567788999999874
Q ss_pred c
Q 014909 97 E 97 (416)
Q Consensus 97 ~ 97 (416)
.
T Consensus 110 ~ 110 (325)
T d1zyla1 110 Q 110 (325)
T ss_dssp E
T ss_pred C
Confidence 3
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.07 E-value=0.0012 Score=62.37 Aligned_cols=77 Identities=17% Similarity=0.267 Sum_probs=51.9
Q ss_pred CEEEEeEEeecCceEEEEEEECC-------CCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeC
Q 014909 12 KYEVGRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSK 83 (416)
Q Consensus 12 ~y~~~~~LG~G~fg~V~~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~ 83 (416)
..++ +.|+.|-.-.+|++.... ..+.|.+++.-... . .-...+|..+++.+.-.++ .++++++.+
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--h---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 3444 678889999999998653 24568888865221 1 2345689999998863344 477777643
Q ss_pred CEEEEEEeccCCCch
Q 014909 84 TKIFIVLEFVTGGEL 98 (416)
Q Consensus 84 ~~~~lV~E~~~gg~L 98 (416)
.+||||++|..|
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---ceEEEEeccccC
Confidence 589999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.63 E-value=0.0044 Score=56.05 Aligned_cols=149 Identities=16% Similarity=0.180 Sum_probs=77.2
Q ss_pred ccccccccCEEEE-----eEEeecCceEEEEEEECCCCCeEEEEEeechhhhcHHHHHHHHHHHHHHhcCCC-----CCc
Q 014909 4 PKIKRRVGKYEVG-----RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-----PNV 73 (416)
Q Consensus 4 ~~~~~~~~~y~~~-----~~LG~G~fg~V~~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-----pnI 73 (416)
+++...+.+|.++ +.|..|---+.|+.... +| .+++|++..... .+.+..|+.+|..|.. |..
T Consensus 6 ~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~~-----~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 6 DELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp HHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred HHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCCC-----HHHHHHHHHHHHhhhhcccccccc
Confidence 3344445556543 44556666788988764 34 589999865321 2345667777776642 222
Q ss_pred ceEE---EEEEeCCEEEEEEeccCCCchH--------------HHHHh---CC------CCCH-----------------
Q 014909 74 VRLY---EVMGSKTKIFIVLEFVTGGELF--------------DKIVN---HG------RMKE----------------- 110 (416)
Q Consensus 74 v~l~---~~~~~~~~~~lV~E~~~gg~L~--------------~~i~~---~~------~l~e----------------- 110 (416)
+... .+..-......++.+..|.... ..+.. .. ....
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 2211 0122345566667766653321 00000 00 0000
Q ss_pred -HHHHHHHHHHHHHHHHHH----hCCcEeecCCCCcEEeccCCCeEEeeccccc
Q 014909 111 -DEARRYFQQLINAVDYCH----SRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (416)
Q Consensus 111 -~~~~~~~~qll~al~~LH----~~givHrDlkp~NILl~~~~~vkl~DFGla~ 159 (416)
......+..+...+.-.+ ..|++|+|+.++||+++++...-+.||+.|.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111122222333333322 2579999999999999988777899999764
|